
<html lang="en"     class="pb-page"  data-request-id="3d1ddd4b-e516-4aaa-bfea-b52132923dde"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-11;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.5b01281;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure–Function Perspective" /></meta><meta name="dc.Creator" content="Debashis  Ghosh" /></meta><meta name="dc.Creator" content="Jessica  Lo" /></meta><meta name="dc.Creator" content="Chinaza  Egbuta" /></meta><meta name="dc.Description" content="Human aromatase catalyzes the synthesis of estrogen from androgen with high substrate specificity. For the past 40 years, aromatase has been a target of intense inhibitor discovery research for the..." /></meta><meta name="Description" content="Human aromatase catalyzes the synthesis of estrogen from androgen with high substrate specificity. For the past 40 years, aromatase has been a target of intense inhibitor discovery research for the..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 19, 2016" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01281" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01281" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01281" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01281" /></link>
        
    
    

<title>Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure–Function Perspective | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01281" /></meta><meta property="og:title" content="Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure–Function Perspective" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0005.jpeg" /></meta><meta property="og:description" content="Human aromatase catalyzes the synthesis of estrogen from androgen with high substrate specificity. For the past 40 years, aromatase has been a target of intense inhibitor discovery research for the prevention and treatment of estrogen-dependent breast cancer. The so-called third generation aromatase inhibitors (AIs) letrozole, anastrozole, and the steroidal exemestane were approved in the U.S. in the late 1990s for estrogen-dependent postmenopausal breast cancer. Efforts to develop better AIs with higher selectivity and lower side effects were handicapped by the lack of an experimental structure of this unique P450. The year 2009 marked the publication of the crystal structure of aromatase purified from human placenta, revealing an androgen-specific active site. The structure has reinvigorated research activities on this fascinating enzyme and served as the catalyst for next generation AI discovery research. Here, we present an account of recent developments in the AI field from the perspective of the enzyme’s structure–function relationships." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01281"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01281">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01281&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01281&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01281&amp;href=/doi/10.1021/acs.jmedchem.5b01281" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 5131-5148</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00735" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.5b00671" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure–Function Perspective</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Debashis++Ghosh">Debashis Ghosh</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jessica++Lo">Jessica Lo</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chinaza++Egbuta">Chinaza Egbuta</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Pharmacology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, New York 13210, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#ddbab5b2aeb5b99da8adaea9bca9b8f3b8b9a8"><span class="__cf_email__" data-cfemail="93f4fbfce0fbf7d3e6e3e0e7f2e7f6bdf6f7e6">[email protected]</span></a>. Phone: 315-464-9677.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01281&amp;href=/doi/10.1021%2Facs.jmedchem.5b01281" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 5131–5148</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 21, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 August 2015</li><li><span class="item_label"><b>Published</b> online</span>19 January 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 June 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01281" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01281</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5131%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDebashis%2BGhosh%252C%2BJessica%2BLo%252C%2BChinaza%2BEgbuta%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D11%26contentID%3Dacs.jmedchem.5b01281%26title%3DRecent%2BProgress%2Bin%2Bthe%2BDiscovery%2Bof%2BNext%2BGeneration%2BInhibitors%2Bof%2BAromatase%2Bfrom%2Bthe%2BStructure%25E2%2580%2593Function%2BPerspective%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5148%26publicationDate%3DJune%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01281"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2221</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">45</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01281" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure–Function Perspective&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Debashis&quot;,&quot;last_name&quot;:&quot;Ghosh&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;Lo&quot;},{&quot;first_name&quot;:&quot;Chinaza&quot;,&quot;last_name&quot;:&quot;Egbuta&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;5131-5148&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01281&quot;},&quot;abstract&quot;:&quot;Human aromatase catalyzes the synthesis of estrogen from androgen with high substrate specificity. For the past 40 years, aromatase has been a target of intense inhibitor discovery research for the prevention and treatment of estrogen-dependent breast cancer. The so-called third generation aromatase inhibitors (AIs) letrozole, anastrozole, and the steroidal exemestane were approved in the U.S. in the late 1990s for estrogen-dependent postmenopausal breast cancer. Efforts to develop better AIs with higher selectivity and lower side effects were handicapped by the lack of an experimental structure of this unique P450. The year 2009 marked the publication of the crystal structure of aromatase purified from human placenta, revealing an androgen-specific active site. The structure has reinvigorated research activities on this fascinating enzyme and served as the catalyst for next generation AI discovery research. Here, we present an account of recent developments in the AI field from the perspective of the enzyme’&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01281&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01281" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01281&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01281" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01281&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01281" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01281&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01281&amp;href=/doi/10.1021/acs.jmedchem.5b01281" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01281" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01281" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01281%26sid%3Dliteratum%253Aachs%26pmid%3D26689671%26genre%3Darticle%26aulast%3DGhosh%26date%3D2016%26atitle%3DRecent%2BProgress%2Bin%2Bthe%2BDiscovery%2Bof%2BNext%2BGeneration%2BInhibitors%2Bof%2BAromatase%2Bfrom%2Bthe%2BStructure%25E2%2580%2593Function%2BPerspective%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D11%26spage%3D5131%26epage%3D5148%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/jmcmar.2016.59.issue-11/20160609/jmcmar.2016.59.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Human aromatase catalyzes the synthesis of estrogen from androgen with high substrate specificity. For the past 40 years, aromatase has been a target of intense inhibitor discovery research for the prevention and treatment of estrogen-dependent breast cancer. The so-called third generation aromatase inhibitors (AIs) letrozole, anastrozole, and the steroidal exemestane were approved in the U.S. in the late 1990s for estrogen-dependent postmenopausal breast cancer. Efforts to develop better AIs with higher selectivity and lower side effects were handicapped by the lack of an experimental structure of this unique P450. The year 2009 marked the publication of the crystal structure of aromatase purified from human placenta, revealing an androgen-specific active site. The structure has reinvigorated research activities on this fascinating enzyme and served as the catalyst for next generation AI discovery research. Here, we present an account of recent developments in the AI field from the perspective of the enzyme’s structure–function relationships.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cytochrome P450 aromatase (AROM) catalyzes with high substrate specificity the conversion of androstenedione (ASD), testosterone (TST), and 16α-hydroxytestosterone (all with the same androgen backbone) to estrone (E1), 17β-estradiol (E2), and 17β,16α-estriol (all with the same estrogen backbone), respectively. It is the only known enzyme in vertebrates capable of catalyzing the aromatization of a six-membered ring. The reaction requires coupling with its redox partner cytochrome P450 reductase (CPR), which uses NADPH as the source of electrons. AROM has been the subject of intense biochemical, biophysical, and clinical investigations for the past 50 years.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Inhibition of estrogen biosynthesis by AROM inhibitors (AI) constitutes one of the foremost therapies for postmenopausal estrogen-dependent breast cancer today.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a></div><div class="NLM_p">Nevertheless, many aspects of the aromatization reaction remained poorly understood. Until 2009,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> the absence of a crystal structure for human AROM had led to a number of homology models for the enzyme based on other experimental P450 structures and site-directed mutagenesis data.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11">(7-11)</a> Several androgen-binding scenarios at the active site, possible involvements of side chains in the catalytic process, and models for enzyme’s mechanism of action were proposed based on homology structures and functional analyses. However, none of these models could adequately explain the unique characteristics of AROM that set this P450 apart from all others. Details of the substrate and inhibitor binding interactions at the active site were crucial for the development of next generation AIs.</div><div class="NLM_p">Despite concerted efforts in many laboratories, no experimental molecular structure of AROM emerged for a very long time. The major impediments to AROM crystallization were its strong hydrophobic character and susceptibility to rapid denaturation in the absence of the protective lipid bilayer. Using term human placenta as a rich source of AROM and a purification technique that employs a highly specific monoclonal antibody-based affinity chromatography,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> we were able to purify large quantities of the enzyme in a pristine, active form that permitted the growth of diffraction-quality single crystals. This was the first and only microsomal P450 purified from a native source to date and the first full length P450 to be crystallized.<a onclick="showRef(event, 'ref6 ref13'); return false;" href="javascript:void(0);" class="ref ref6 ref13">(6, 13)</a> Employing the same crystallization protocols, a recombinant form of human AROM has more recently been crystallized.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Needless to say, the real atomic model has reinvigorated the field of AROM research, from perspectives of re-examining the reaction mechanism<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and novel AI discovery.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> One of many fundamental questions that remained unresolved for decades was the following: What are the two proton donors to the 3C═O and 17C═O groups involved in binding of the natural substrate ASD and its conversion to E1? Evidently, a direct structural observation of the binding interactions of ASD in the active site was necessary for the unequivocal answer in this case. Indeed, it would have been impossible to envision that one of the most unlikely candidates the Asp309 carboxylate, protonated at the physiological pH, is the proton donor to 3C═O and the equally imperceptible Met374 backbone amide to 17C═O <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). The predicted protonation of Asp309 side chain and its involvement in the aromatization reaction have since been validated by other works.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> These data, along with the nature of hydrophobic interactions that define the highly androgen-specific, tight active site cleft (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), are crucial to the discovery of future AIs.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The AROM active site is shaped like an androgen backbone. A van der Waals interaction surface cast by the protein and heme atoms at the active site is shown. The semitransparent surface closely resembles the shape, size, and puckering of the steroid backbone. The surfaces are color-coded green for hydrophobic and magenta for polar. The protein atoms defining the van der Waals surface are also shown: C gray, N blue, and O red. The only opening to the pocket is the one to the active site access channel indicated by an arrow. Water oxygen atoms in the channel and bound to the protonated Asp309 carboxylate are shown as red spheres. Adapted from ref <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">6</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Here we describe the recent advancements made toward design and discovery of novel AIs from the perspective of current understanding of the enzyme’s structure–function relationships, giving a brief context to the known AIs developed prior to the AROM structure. We summarize most, if not all, inhibitors that were developed since 2009 utilizing rational means, such as structure-based design, molecular docking, and virtual screening. We present a brief account of our own structure-guided efforts not only for design but also for validation of design. We compare and contrast the reported potencies of the inhibitors and the measurement protocols in an attempt to stress that the numbers are not always comparable. We conclude by describing the limitations in the current knowledge base and future directions.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Brief History of Current AROM Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00316" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00316" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">2.i First and Second Generation Inhibitors</h3><div class="NLM_p">The chronology of discovery of early generation AIs, inhibitory properties, clinical trial history, side effects, etc. is summarized in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. Shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, aminoglutethimide (AGT) was the first known potent AI.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> It was reported to reversibly suppress AROM activity in placental microsomes.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In fact, AGT also was a potent inhibitor of other P450s, such as P450scc<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and enzymes involved in the biosynthesis of cortisol, aldosterone, and thyroid hormones.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Although AGT treatment lacked AROM specificity,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> doses of 250–1000 mg of AGT effectively inhibited peripheral AROM activity and suppressed plasma E1 levels in postmenopausal women.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> Formestane (4-hydroxy-4-androstene-3,17-dione, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), first isolated as a byproduct of 2-hydroxy-steroid 4-en-3-ones synthesis,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> was one of the most promising second generation AIs that underwent multiple clinical trials.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31">(27-31)</a> It was also the first effective steroidal inhibitor of AROM<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> with limited side effects<a onclick="showRef(event, 'ref27 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref29 ref30">(27, 29, 30)</a> but was never approved for clinical use in the U.S. Formestane was reported as a competitive, irreversible, mechanism-based AROM inhibitor due to its time-dependent suppression of E1 biosynthesis in placental microsomes preincubated with ASD, NADPH, and inhibitor.<a onclick="showRef(event, 'ref20 ref33'); return false;" href="javascript:void(0);" class="ref ref20 ref33">(20, 33)</a> Fadrozole (FDZ, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), the prominent second generation AI, was more potent and specific than the other nonsteroidal AI AGT.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> It was reported to be a competitive and reversible AI,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> which had weak inhibitory effects on P450scc.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> It also underwent multiple clinical trials in the U.S. and other countries.<a onclick="showRef(event, 'ref31 ref35 ref37 ref38 ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref31 ref35 ref37 ref38 ref39 ref40 ref41 ref42">(31, 35, 37-42)</a> Although approved in Japan for treatment in estrogen-dependent postmenopausal breast cancer, FDZ never became a drug in the U.S.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Previous and current generation AIs. The chemical structures of known AIs are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Chronology of Discovery of Earlier Generation AIs</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">first generation AI</th><th class="rowsep1 colsep0" colspan="2" align="center">second generation AIs</th><th class="rowsep1 colsep0" colspan="3" align="center">third generation AIs</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">occurrence</th><th class="colsep0 rowsep0" align="center">aminoglutethimide</th><th class="colsep0 rowsep0" align="center">formestane</th><th class="colsep0 rowsep0" align="center">fadrozole</th><th class="colsep0 rowsep0" align="center">exemestane</th><th class="colsep0 rowsep0" align="center">letrozole</th><th class="colsep0 rowsep0" align="center">anastrozole</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Discovery/earliest reported use</td><td class="colsep0 rowsep0" align="left">1961 (treatment of epilepsy)<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a></td><td class="colsep0 rowsep0" align="left">1973 (synthesis)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">1987 (preclinical testing)<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a></td><td class="colsep0 rowsep0" align="left">1988 (preclinical testing)<a onclick="showRef(event, 'ref166 ref167'); return false;" href="javascript:void(0);" class="ref ref166 ref167">(166, 167)</a></td><td class="colsep0 rowsep0" align="left">1990 (preclinical testing)<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a></td><td class="colsep0 rowsep0" align="left">1994 (summary of preclinical testing and clinical studies)<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1966 (antithyroidal and antiadrenocortical activity)<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a></td><td class="colsep0 rowsep0" align="left">1977 (preclinical testing)<a onclick="showRef(event, 'ref32 ref163 ref164'); return false;" href="javascript:void(0);" class="ref ref32 ref163 ref164">(32, 163, 164)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">First reported use of AIs</td><td class="colsep0 rowsep0" align="left">1974 (in the U.S.)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></td><td class="colsep0 rowsep0" align="left">1984 (clinical trials in the UK first)<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref169'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref169">(27-31, 169)</a></td><td class="colsep0 rowsep0" align="left">1989 (clinical trials in the U.S. and later in Europe, South Africa, Japan)<a onclick="showRef(event, 'ref35 ref37 ref38 ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref35 ref37 ref38 ref39 ref40 ref41 ref42">(35, 37-42)</a></td><td class="colsep0 rowsep0" align="left">1995 (clinical trials in Italy first and later in Europe and U.S.)<a onclick="showRef(event, 'ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59">(50-59)</a></td><td class="colsep0 rowsep0" align="left">1993 (clinical trials in the U.S. and UK)<a onclick="showRef(event, 'ref67 ref68 ref74 ref170 ref171'); return false;" href="javascript:void(0);" class="ref ref67 ref68 ref74 ref170 ref171">(67, 68, 74, 170, 171)</a></td><td class="colsep0 rowsep0" align="left">1994 (clinical trials in the U.S.)<a onclick="showRef(event, 'ref60 ref61 ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62 ref63 ref64">(60-64)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> against pure enzyme</td><td class="colsep0 rowsep0" align="left">Not determined (5–7 μM against human placental microsomes<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a>)</td><td class="colsep0 rowsep0" align="left">49 nM <a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="left">Not determined (5 nM against human placental microsomes<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a>)</td><td class="colsep0 rowsep0" align="left">50 nM <a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="left">10 nM <a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="left">Not determined (23 nM against human placental microsomes<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub>/EC<sub>50</sub> in breast cancer cell line</td><td class="colsep0 rowsep0" align="left">10 μM against MCF-7 cells transfected with AROM;<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> 20 μM in particulate fractions of breast cancer;<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> 10 μM in culture of mammary adipose tissue fibroblasts<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">30 nM (particulate fractions of human breast cancer tissues)<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></td><td class="colsep0 rowsep0" align="left">50 pM in MCF-7 cells<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></td><td class="colsep0 rowsep0" align="left">5.6 nM in MCF-7 cells overexpressing AROM<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> (antiproliferation assay)</td><td class="colsep0 rowsep0" align="left">4 pM in MCF-7 cells overexpressing AROM<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> (antiproliferation assay)</td><td class="colsep0 rowsep0" align="left">3.6 nM in MCF-7 cells<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Dose in treatment</td><td class="colsep0 rowsep0" align="left">250 mg/4× daily orally<a onclick="showRef(event, 'ref24 ref45 ref175'); return false;" href="javascript:void(0);" class="ref ref24 ref45 ref175">(24, 45, 175)</a></td><td class="colsep0 rowsep0" align="left">250 mg daily orally or 500 mg via intramuscular injection every 2 weeks<a onclick="showRef(event, 'ref29 ref45 ref175'); return false;" href="javascript:void(0);" class="ref ref29 ref45 ref175">(29, 45, 175)</a></td><td class="colsep0 rowsep0" align="left">1.8–2 mg daily orally<a onclick="showRef(event, 'ref41 ref45 ref175'); return false;" href="javascript:void(0);" class="ref ref41 ref45 ref175">(41, 45, 175)</a></td><td class="colsep0 rowsep0" align="left">25 mg daily orally<a onclick="showRef(event, 'ref45 ref175'); return false;" href="javascript:void(0);" class="ref ref45 ref175">(45, 175)</a></td><td class="colsep0 rowsep0" align="left">2.5 mg daily orally<a onclick="showRef(event, 'ref45 ref175'); return false;" href="javascript:void(0);" class="ref ref45 ref175">(45, 175)</a></td><td class="colsep0 rowsep0" align="left">1 mg daily orally<a onclick="showRef(event, 'ref45 ref175'); return false;" href="javascript:void(0);" class="ref ref45 ref175">(45, 175)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Side effects/issues<a onclick="showRef(event, 'ref45 ref175'); return false;" href="javascript:void(0);" class="ref ref45 ref175">(45, 175)</a></td><td class="colsep0 rowsep0" align="left">Low selectivity for AROM</td><td class="colsep0 rowsep0" align="left">Poor oral bioavailability<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></td><td class="colsep0 rowsep0" align="left">Suppression of aldosterone release<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a></td><td class="colsep0 rowsep0" align="left">Hot flashes, fatigue, arthralgia (joint pain), headache, insomnia (difficulty sleeping), increased sweating, hypertension (high blood pressure), dizziness, cardiac ischemic events, reduced bone mineral density/osteoporosis<a onclick="showRef(event, 'ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59 ref181'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59 ref181">(50-59, 181)</a></td><td class="colsep0 rowsep0" align="left">Low-grade hot flashes, arthritis, arthralgia, and myalgia, and new diagnoses of osteoporosis<a onclick="showRef(event, 'ref67 ref68 ref74 ref170 ref171'); return false;" href="javascript:void(0);" class="ref ref67 ref68 ref74 ref170 ref171">(67, 68, 74, 170, 171)</a></td><td class="colsep0 rowsep0" align="left">Hepatic toxicity, blurred vision, angina pain, irregular heartbeat, edema in legs, headaches, dizziness, nervousness, shortness of breath<a onclick="showRef(event, 'ref60 ref61 ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62 ref63 ref64">(60-64)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Inhibition of cortisol, aldosterone, thyroid hormone synthesis. Induction of hepatic enzymes.</td><td class="colsep0 rowsep0" align="left">Local side effects due to intramuscular injection<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></td><td class="colsep0 rowsep0" align="left">Mild hot flashes, nausea and vomiting, fatigue, and mild loss of appetite<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Minor side effects: nystagmus, ataxia, lethargy, skin rash<a onclick="showRef(event, 'ref24 ref176 ref177 ref178'); return false;" href="javascript:void(0);" class="ref ref24 ref176 ref177 ref178">(24, 176-178)</a></td><td class="colsep0 rowsep0" align="left">Severe neutropenia (transient and reversible upon discontinuation of treatment)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Year of FDA approval as an AI</td><td class="colsep0 rowsep0" align="left">Not FDA-approved in the U.S.</td><td class="colsep0 rowsep0" align="left">Not FDA approved in the U.S.</td><td class="colsep0 rowsep0" align="left">Not FDA approved in the U.S.</td><td class="colsep0 rowsep0" align="left">1999<a onclick="showRef(event, 'ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref57 ref58 ref59">(57-59)</a></td><td class="colsep0 rowsep0" align="left">1998<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65, 66)</a></td><td class="colsep0 rowsep0" align="left">1995<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Current FDA-approval status</td><td class="colsep0 rowsep0" align="left">FDA-approved for Cushing syndrome</td><td class="colsep0 rowsep0" align="left">Initially approved as an AI in Europe</td><td class="colsep0 rowsep0" align="left">Approved as an AI in Japan<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a></td><td class="colsep0 rowsep0" align="left">Approved as an AI in the U.S.</td><td class="colsep0 rowsep0" align="left">Approved as an AI in the U.S.</td><td class="colsep0 rowsep0" align="left">Approved as an AI in the U.S.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Withdrawn due to poor oral bioavailability and discovery of third-generation orally active AIs</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.ii Third Generation AIs</h3><div class="NLM_p last">Anastrozole (ANZ; Arimidex), letrozole (LTZ; Femara), and exemestane (EXM; Aromasin) are the three AIs that received the FDA approval for use in estrogen-dependent breast cancer in the late 1990s (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Unlike their predecessors, these so-called third generation inhibitors all have high selectivity for AROM and low cross-reactivity to other targets.<a onclick="showRef(event, 'ref4 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref4 ref43 ref44 ref45">(4, 43-45)</a> EXM was reported to elicit time-dependent inactivation of AROM and classified as a sucicide inhibitor.<a onclick="showRef(event, 'ref20 ref33'); return false;" href="javascript:void(0);" class="ref ref20 ref33">(20, 33)</a> However, the crystal structure of the AROM–EXM complex at 3.2 Å resolution did not reveal a covalent bond between AROM and EXM.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> EXM binds in competition with the substrate but does not covalently link to protein in the absence of the reductase and electron source.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> There is no structural evidence suggesting that any of the AIs are either reversible or irreversible. We have reported the inhibition kinetics of LTZ and utilized statistical analyses to show that its mode of action could be either noncompetitive or mixed.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Furthermore, clinical data do not show superior efficacy of reversible AIs over irreversible AIs or of steroidal AIs over nonsteroidal AIs and vice versa. In the head-to-head trials evaluating the clinical efficacy of EXM and ANZ,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and LTZ and ANZ<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> in postmenopausal breast cancer, all were found to be equally effective. All three third generation AIs are more potent than the previous inhibitors and performed much better in clinical trials.<a onclick="showRef(event, 'ref4 ref5 ref43 ref44 ref45 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63 ref64 ref65 ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref43 ref44 ref45 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63 ref64 ref65 ref66 ref67 ref68">(4, 5, 43-45, 50-68)</a> Also noteworthy is the fact that all three AIs have shown better efficacies in major clinical trials in head-to-head comparison with the estrogen-receptor antagonist tamoxifen in the treatment of postmenopausal estrogen-dependent breast cancer.<a onclick="showRef(event, 'ref4 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref4 ref43 ref44 ref45">(4, 43-45)</a> They are proven to be more effective than tamoxifen in estrogen receptor (ER) positive tumors that upregulate progesterone receptor (PR) and epidermal growth factor receptors (EGFRs or HER-2/neu) as escape survival mechanisms from prolonged tamoxifen therapy.<a onclick="showRef(event, 'ref69 ref70 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref71 ref72">(69-72)</a> Regardless of growth factor receptor status, the third-generation AIs could circumvent endocrine resistance that might occur due to to estrogen genotoxicity,<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> activation of additional estrogen-dependent signaling pathways by tamoxifen metabolites,<a onclick="showRef(event, 'ref69 ref70 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref71 ref72">(69-72)</a> activation of growth factor receptor signaling pathways by partial agonistic activity of tamoxifen,<a onclick="showRef(event, 'ref69 ref70 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref71 ref72">(69-72)</a> and greater disease free survival compared to tamoxifen.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> The negative effects of third-generation AIs include total body loss of estrogen, joint pain, osteoporosis, and low bone mineral density.<a onclick="showRef(event, 'ref4 ref43 ref44 ref45 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref58 ref60 ref61 ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref4 ref43 ref44 ref45 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref58 ref60 ref61 ref62 ref63 ref64">(4, 43-45, 50-56, 58, 60-64)</a> Vorozole (Rivizor), another third-generation AI, underwent clinical trials for use in treating estrogen-dependent postmenopausal breast cancer in Europe and Canada.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> However, it never gained FDA approval in the U.S.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">3 Crystal Structure of Human AROM: How the Active Site Architecture Presented New Ideas</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77861" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77861" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.i Active Site</h3><div class="NLM_p">The crystal structure of the highly active human placental AROM in complex with the substrate ASD was originally determined at 2.90 Å resolution.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> More recently, the resolution has been extended to 2.75 Å.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The tertiary structure of AROM follows the characteristic cytochrome P450 fold. The active site of AROM is located at the heme-distal cavity, buried deep within the roughly spherical molecule near its geometrical center. ASD binds with its β-face oriented toward the heme group and C19 of the methyl group positioned 4.0 Å from the Fe atom.</div><div class="NLM_p">The steroid binding cleft is defined by residues Ile305, Ala306, Asp309, and Thr310 from I-helix, Phe221 and Trp224 from F-helix, Ile133 and Phe134 from the B–C loop, Val370, Leu372, and Val373 from the K-β3 loop, Met374 from β3, and Leu477 and Ser478 from the β8−β9 loop. These hydrophobic side chains and the heme porphyrin rings surround the steroid backbone to form a cavity complementary in shape to ASD (<a class="ref internalNav" href="#fig1" aria-label="Figures 1">Figures 1</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The side chains of residues Arg115, Ile133, Phe134, Phe221, Trp224, Ala306, Thr310, Val370, Val373, Met374, and Leu477 make direct van der Waals contacts with the bound ASD. Ile133, Phe134, Phe221, Trp224, and Leu477 approach the substrate from the α-face and follow contour and puckering of the steroid backbone, while Arg115, Ala306, and Met374 make contacts at its edge, and Thr310, Val370, and Val373 on the β-face of ASD. The combined surface creates a pocket of roughly 400 Å<sup>3</sup> that tightly encloses the bound ASD. This is considerably smaller than the volumes of the active site space in cytochrome P450s 3A4,<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> 2D6,<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77, 78)</a> 11A1,<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> 11B2,<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> 17A1,<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> 21A1,<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> 24A1,<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> and 51A1.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Androgen-binding environment: schematic diagram of the X-ray structure depicting the residues lining the ASD binding pocket, and ASD making hydrophobic and hydrogen-bonding contacts (hydrophobic, green; acidic, red; basic, blue; polar, purple; S-containing, yellow). Exposure at the C4 and C6 positions of the steroid to the access channel opening is indicated. Also shown schematically is a water molecule trapped between Asp309 and Arg192 side chains, postulated to have a role in the proton relay network and enolization of 3-keto. Arg192 and its salt bridge partner Glu483 are the “gatekeepers” of the access channel. Adapted from ref <a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">46</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 17-keto oxygen of ASD makes a hydrogen bond with the backbone amide of Met374. It is also at a distance of 3.4 Å from the NH1 of Arg115 side chain. The 3-keto oxygen at the other end is hydrogen bonded to a protonated Asp309 side chain at the crystallization pH of 7.4. The proposed roles of Asp309 side chain protonation in substrate binding, enolization of the 3-keto group, and proton relay network<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> have been supported by recent findings.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> The Asp309 side chain is linked by solvent molecules to the salt bridging Arg192-Glu478 side chain pair at the end of the solvent access channel at the lipid interface.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The “gatekeeper” residue Arg192, predicted to play an important catalytic role in proton relay,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> has since been shown to be critical for maintaining the enzyme activity.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Interestingly, recent clinical case reports establish that mutations of Arg192 result in AROM deficiency and virilization in human.<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84, 85)</a></div><div class="NLM_p last">Although the binding pocket is sealed tight, it has a doorway where water molecules are located (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), leading to an access channel that opens to the exterior of the protein surface. The Arg192-Glu478 side chain pair, polar residues Asp309, Thr310, and Ser478, and several hydrophobic side chains Phe221, Val313, and His480 line the channel (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). This channel hosts the proton relay network and is also the major transport route to and from the active site for water, oxygen, and steroid molecules. It was shown that flexibility and fluctuations in the channel-bordering regions permit the channel to “breathe” and swell, perhaps allowing the passage of steroids.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> This entire region adjacent to atoms C4 and C6 of the substrate leading to the access channel presents an intriguing mix of functional groups for AROM-specific inhibitor design ideas.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.ii New Perspective on Reaction Mechanism: A Tool for Inhibitor Design</h3><div class="NLM_p">The unique active site architecture, the novelty of steroid-binding interactions, and the proposed 3-keto enolization as well proton relay mechanisms<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> are all unprecedented in the previous homology models.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11">(7-11)</a> The structure, thus, has not only validated some of the previously held ideas but also provided a platform for further mechanistic studies on the aromatization reaction.<a onclick="showRef(event, 'ref18 ref87 ref88 ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref18 ref87 ref88 ref89 ref90">(18, 87-90)</a> In the experimentally observed substrate-bound state, the hydrogen atoms of C19 methyl group are at the viable H-abstraction distances<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> from the modeled oxygen of the reactive oxyferryl moiety (Fe(III) modeled as Fe(IV)═O, compound <b>I</b>), shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a. The residues that are directly involved in catalysis are Ala306, Asp309, and Thr310. In addition, Arg192, Glu483, Ser478, and His480 have critical roles in proton relay and/or aromatization. The location of Thr310 with respect to the heme iron is similar to other P450s and performs a similar role in the first two steps of hydroxylation yielding C19-aldehyde derivative of ASD and retaining the <i>pro-S</i> hydrogen.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The structure revealed a specific interaction involving Thr310 suggesting its crucial role in all three steps of catalysis. The C═O oxygen of 306Ala and OγH of Thr310 are at 3.7 and 3.8 Å, respectively, from H2β (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b) suggesting 306AlaC═O alone or in conjunction with a deprotonated Thr310Oγ<sup>–</sup> acts as a nucleophile for the abstraction of H2β. This action at C2 in conjunction with a protonated Asp309 side chain acting as an electrophile and interacting strongly with the C3-keto oxygen could promote H2β abstraction and enolization of the 3-keto. The presence of a water molecule could facilitate the deprotonation of the Thr310 side chain by weakening the Ala306CO···HOγThr310 hydrogen bond. This would free carbonyl for the nucleophilic attack for H2β abstraction by -H<sub>2</sub>C2-C3-keto to -HC2═C3-enol tautomarization (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>c). H1β is too far from this carbonyl (6.2 Å) to be abstracted by the same mechanism. It points at the heme Fe (4.2 Å) and is more likely abstracted during the peroxo-ferric nucleophilic attack on 19-aldehyde (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>c) as previously postulated.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The deprotonated Asp309 side chain is quickly reprotonated by the proton relay network. The direct involvement of Asp309 in protonation and aromatization appears to be unique to AROM.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reaction center and perspective on catalysis. (a) Modeling of Fe (III) as an oxyferryl Fe(IV)═O (compound <b>I</b>) moiety. The C19-methyl hydrogen atoms are shown at the calculated ideal positions. Important side chains, heme, and water molecules are depicted in element colors: C, gray; N, blue; O, red; S, yellow; Fe, firebrick; H, orange. The C atoms of ASD are colored in cornflower blue. (b) Close-up view of the 306AlaCO···HOThr310 pair that may have a role in aromatization of the A-ring of ASD. Calculated hydrogen atom positions of C2 of the bound ASD are shown. The distances shown are in Å. (c) Possible mechanism for H2β abstraction and 2,3-enolization. The direction of proton flow from the proton relay network through Asp309 carboxylate is indicated. Adapted from ref <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">6</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Many groups have attempted to determine the critical intermediate by theoretical calculations, electron paramagnetic resonance,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> resonance Raman spectroscopy,<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93, 94)</a> kinetic solvent isotope effect,<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> and molecular oxygen labeling experiments.<a onclick="showRef(event, 'ref36 ref96'); return false;" href="javascript:void(0);" class="ref ref36 ref96">(36, 96)</a> These results have shown the possibility that either the oxy-ferryl or peroxo-ferric can be involved in the aromatization reaction. These findings have also been previously summarized.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> None of the transition states have been directly observed by X-ray diffraction. Atomistic details of the functional groups in and around the active site, as well as understanding of the organometallics of aromatization chemistry, are critical to the design of superior inhibitors that are mechanism-based and/or transition state analogs and, therefore, exclusive to AROM.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">4 Recent Advances in the Discovery of Steroidal AROM Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38546" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38546" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The third generation AIs are remarkably effective against breast cancer. AIs have also been used for the treatments of endometriosis<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98, 99)</a> and ovarian<a onclick="showRef(event, 'ref98 ref100'); return false;" href="javascript:void(0);" class="ref ref98 ref100">(98, 100)</a> and lung<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> cancers. These AIs have high affinities for AROM but also show some cross-reactivity to other P450s. CYP1A2, CYP2C9, and CYP3A4 are inhibited by ANZ, and CYP2A6 and CYP2C19 are inhibited by LTZ.<a onclick="showRef(event, 'ref102 ref103 ref104 ref105'); return false;" href="javascript:void(0);" class="ref ref102 ref103 ref104 ref105">(102-105)</a> CYP2A6 and CYP3A4 metabolize LTZ.<a onclick="showRef(event, 'ref106 ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref106 ref107 ref108">(106-108)</a> Furthermore, EXM is androgenic<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> and also has weak ERα agonistic activity.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Despite high efficacy, some patients may fail to respond to AIs, which is known as AI resistance.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Rational approaches such as structure-guided design of next generation AIs could minimize the nonspecific and adverse effects.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">4.i Structure-Based Design</h3><div class="NLM_p">Crystallographic and computational results have shown that AROM structure has a rigid core; ligands are thus accommodated by modest adjustments of the catalytic cavity.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> By exploiting the active site architecture described in <a class="ref internalNav" href="#sec3_1" aria-label="section 3.i">section 3.i</a> above, derivatives of androsta-1,4-diene-3,17-dione have been synthesized. These compounds have undergone in vitro characterization in a MCF-7 breast cancer cell-based antiproliferation system and cell-free purified enzyme inhibition assays.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Three C6β-alkoxy/alkynyloxy derivatives, in particular, have exhibited the most potent AROM inhibition to date.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a><a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> summarizes the inhibitory and antiproliferative potencies of the three most potent compounds <b>4</b>, <b>5</b>, and <b>9</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, upper panel), in comparison to EXM. Compound <b>5</b>, the best in the series, has IC<sub>50</sub> and EC<sub>50</sub> roughly 4- and 187-fold, respectively, better than EXM (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The X-ray structures of the complexes of <b>4</b> and <b>5</b> with AROM reveal that the 2-alkynyloxy side chains fit tightly within the hydrophobic environment of the channel.<a onclick="showRef(event, 'ref6 ref46'); return false;" href="javascript:void(0);" class="ref ref6 ref46">(6, 46)</a> Both the structural and functional data are consistent in that <b>5</b> and <b>9</b> possess the right dimensions to traverse the access channel. The C24 methyl end of the <b>5</b> alkyne chain packs against the Val313 side chain, Asp309 main chain carbonyl, arene ring of Phe221 and His480 imidazole. The side group of <b>5</b> nearly extends to the polar residues Arg192 and Glu483 at the channel entrance at the membrane–protein interface. A C25 methyl and longer derivatives of <b>5</b> have progressively reduced inhibitory and antiproliferative potencies.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structural basis for the design of potent inhibitors. The chemical structures of the three most potent steroidal inhibitors <b>4</b>, <b>5</b>, and <b>9</b> of the 6β-2-alkynyloxy series are shown in the upper panel. Lower panel: Schematic diagram depicting the X-ray structure of the tight hydrophobic binding pocket for the designed steroidal inhibitor <b>5</b>, the proton donors at the 3- and 17-keto positions, and the 6β-2-alkynyloxy side group that nearly fills the access channel. Compound <b>4</b> also binds the same way. The residues lining the binding pocket making hydrophobic and hydrogen-bonding contacts are shown. Adapted from ref <a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">46</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Summary of IC<sub>50</sub> and EC<sub>50</sub> of the Most Potent C6β-Alkoxy/2-Alkynyloxy Series of Steroidal Aromatase Inhibitors and Controls</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">95% confidence interval (nM)</th><th class="colsep0 rowsep0" align="center" char=".">potency relative to EXM</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">95% confidence interval (nM)</th><th class="colsep0 rowsep0" align="center" char=".">potency relative to EXM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">exemestane (EXM)</td><td class="colsep0 rowsep0" align="char" char=".">50.1</td><td class="colsep0 rowsep0" align="left">40.9–61.4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="left">2.7–6.5</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b> (HDDG029)</td><td class="colsep0 rowsep0" align="char" char=".">112.3</td><td class="colsep0 rowsep0" align="left">78.2–161.3</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="left">1.2–2.2</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b> (HDDG046)</td><td class="colsep0 rowsep0" align="char" char=".">11.8</td><td class="colsep0 rowsep0" align="left">9.3–14.9</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="left">0.02–0.06</td><td class="colsep0 rowsep0" align="char" char=".">187.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b> (HDDG065)</td><td class="colsep0 rowsep0" align="char" char=".">20.0</td><td class="colsep0 rowsep0" align="left">18.1–22.0</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="left">0.2–0.4</td><td class="colsep0 rowsep0" align="char" char=".">18.7</td></tr></tbody></table></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">4.ii Other Rational Approaches</h3><div class="NLM_p">Several other groups have utilized the AROM structure to design new inhibitors. A summary of these newly designed inhibitors and their properties (all inhibition assays of the novel steroidal AIs are performed in vitro) is provided in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, and the chemical structures are shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a> (compound numbers are the same as in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). However, most of the binding modes and/or mechanisms are hypothetical. The inhibitors synthesized as derivatives of ASD<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> and TST<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> (compounds <b>10</b>–<b>16</b>) are reported to have submicromolar potencies in placental microsomes. The modifications are at the positions C3, C4, C5, C6, and C17, as well as C7α of allylandrostanes (<b>17</b>–<b>20)</b>.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Other designs include 16-imidazolyl substituted steroidal derivatives (<b>23</b>, <b>24)</b>,<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> pyrazole and isoxazole substitutions at C2 and C3 positions (<b>25</b>, <b>26)</b>,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> and synthesis of 16β-cyano-17β-hydroxy-4-phenylthia-4-androsten-3-one as a novel inhibitor (<b>27</b>).<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Recently developed steroidal and nonsteroidal AIs. The compounds are numbered and grouped in the same way as referenced in the text and in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. (b) Compounds that exhibit antiproliferative effects on breast cancer cells. Compounds <b>65</b> and <b>66</b> exhibit antiproliferative effects on breast cancer cells. No direct aromatase inhibition was measured; therefore, they are not classified as AIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Summary of New AROM Inhibitors Since 2009</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">type</th><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">assayed against, assay type</th><th class="colsep0 rowsep0" align="center">exptl binding mode verification</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>–<b>9</b></td><td class="colsep0 rowsep0" align="left">C6-substituted 2-alkynyloxy compounds<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="left">C6-substituted androsta-1,4-diene-3,17-dione</td><td class="colsep0 rowsep0" align="left">20–18100 nM</td><td class="colsep0 rowsep0" align="left">Purified AROM and MCF-7a,<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>3</sup>H<sub>2</sub>O, antiproliferation</td><td class="colsep0 rowsep0" align="left">Yes: X-ray</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">A- and D-ring ASD derivative<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></td><td class="colsep0 rowsep0" align="left">3β-Hydroxyandrost-4-en-17-one</td><td class="colsep0 rowsep0" align="left">0.18 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">A- and D-ring ASD derivative<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></td><td class="colsep0 rowsep0" align="left">Androst-4-en-17-one</td><td class="colsep0 rowsep0" align="left">0.14 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">A- and D-ring ASD derivative<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></td><td class="colsep0 rowsep0" align="left">4α,5α-Epoxyandrostan-17-one</td><td class="colsep0 rowsep0" align="left">0.97 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">A- and D-ring ASD derivative<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></td><td class="colsep0 rowsep0" align="left">5α-Androst-3-en-17-one</td><td class="colsep0 rowsep0" align="left">0.23 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">A- and D-ring ASD derivative<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></td><td class="colsep0 rowsep0" align="left">3α,4α-Epoxy-5α-androstan-17-one</td><td class="colsep0 rowsep0" align="left">0.15 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">A- and D-ring ASD derivative<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></td><td class="colsep0 rowsep0" align="left">5α-Androst-2-en-17-one</td><td class="colsep0 rowsep0" align="left">1.7 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">A- and D-ring ASD derivative<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></td><td class="colsep0 rowsep0" align="left">2α,3α-Epoxy-5α-androstan-17-one</td><td class="colsep0 rowsep0" align="left">1.2 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">7α-allylandrostanes<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></td><td class="colsep0 rowsep0" align="left">7α-Allylandrost-4-ene-3,17-dione</td><td class="colsep0 rowsep0" align="left">0.59 μM</td><td class="colsep0 rowsep0" align="left">Placental microsomes, <sup>3</sup>H<sub>2</sub>O (PMTW)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">7α-allylandrostane<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></td><td class="colsep0 rowsep0" align="left">7α-Allylandrost-4-en-17-one</td><td class="colsep0 rowsep0" align="left">0.75 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">7α-allylandrostane<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></td><td class="colsep0 rowsep0" align="left">7α-Allyl-3-oxoandrosta-1,4-dien-17β-ol</td><td class="colsep0 rowsep0" align="left">0.45 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">7α-allylandrostane<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></td><td class="colsep0 rowsep0" align="left">7α-Allylandrosta-1,4-diene-3,17-dione</td><td class="colsep0 rowsep0" align="left">0.47 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">NCI<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a> compound (B-nor-androstenedione scaffold)<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></td><td class="colsep0 rowsep0" align="left">3a,5b,10-Trimethyl-1,2,4,5,5a,6,7,10,10a,10b-decahydrocyclopenta[<i>a</i>]fluorene-3,8-dione</td><td class="colsep0 rowsep0" align="left">0.27 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">Imidazolyl substituted steroidal derivative<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a></td><td class="colsep0 rowsep0" align="left">16β-(Imidazol-1-yl)-4-androstene-3,17-dione</td><td class="colsep0 rowsep0" align="left">0.18 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">Imidazolyl substituted steroidal derivative<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a></td><td class="colsep0 rowsep0" align="left">16β-(Imidazol-1-yl)androsta-1,4-diene-3,17-dione</td><td class="colsep0 rowsep0" align="left">0.168 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">Androstane<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></td><td class="colsep0 rowsep0" align="left">17β-Hydroxy-4-oxo-5α-androstano[2,3-<i>d</i>]pyrazole</td><td class="colsep0 rowsep0" align="left">512.0 nM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No: MD<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">Androstane<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></td><td class="colsep0 rowsep0" align="left">2-Cyano-3,17β-dihydroxy-5α-androst-2-en-4-one</td><td class="colsep0 rowsep0" align="left">1019.8 nM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">Carbonitrile<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></td><td class="colsep0 rowsep0" align="left">16 β-Cyano-17 β-hydroxy-4-phenylthia-4-androsten-3-one</td><td class="colsep0 rowsep0" align="left">169.3 nM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Nonsteroidal AROM Inhibitors</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">NCI<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a> compound NSC613604<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></td><td class="colsep0 rowsep0" align="left">5-(4-Chloroanilino)-2-methyl-9-nitro-5<i>H</i>-chromeno[4,3-<i>b</i>]pyridine-3-carbonitrile</td><td class="colsep0 rowsep0" align="left">0.67 μM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">Quinoline derivative-dual CYP11B2/CYP19 inhibitor<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></td><td class="colsep0 rowsep0" align="left">8-[(3-Methylphenyl)(pyridin-4-yl)methyl]-1,2,5,6-tetrahydro-4<i>H</i>-pyrrolo[3,2,1-<i>ij</i>]quinolin-4-one</td><td class="colsep0 rowsep0" align="left">32 nM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">Azolylmethylpyrroloquinoline<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></td><td class="colsep0 rowsep0" align="left">4-((1<i>H</i>-Imidazol-1-yl)methyl)-7-ethyl-2-phenyl-7<i>H</i>-pyrrolo[2,3-<i>h</i>]quinoline</td><td class="colsep0 rowsep0" align="left">5.3 nM</td><td class="colsep0 rowsep0" align="left">Supersomes<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a>/H295R cells, FCA<a class="ref internalNav" href="#t3fn8" aria-label="h">h</a>/antiproliferation</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">Azolylmethylpyrroloquinoline<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></td><td class="colsep0 rowsep0" align="left">4-((1<i>H</i>-1,2,4-Triazol-1-yl)methyl)-2-(4-methoxyphenyl)-7<i>H</i>-pyrrolo [2,3-<i>h</i>]quinoline</td><td class="colsep0 rowsep0" align="left">>10000 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/H295R cells, FCA/antiproliferation</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">Azolylmethylpyrroloquinoline<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></td><td class="colsep0 rowsep0" align="left">9-((1<i>H</i>-Imidazol-1-yl)methyl)-3-ethyl-7-phenyl-3<i>H</i>-pyrrolo-[3,2-<i>f</i> ]quinoline</td><td class="colsep0 rowsep0" align="left">3.1 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/H295R cells, FCA/antiproliferation</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">Azolylmethylpyrroloquinoline<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></td><td class="colsep0 rowsep0" align="left">9-((1<i>H</i>-1,2,4-Triazol-1-yl)methyl)-3-ethyl-7-phenyl-3<i>H</i>-pyrrolo[3,2-<i>f</i> ]quinoline</td><td class="colsep0 rowsep0" align="left">13.3 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/H295R cells, FCA/antiproliferation</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">NNC<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a> compound (imidazolyl quinoline)<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></td><td class="colsep0 rowsep0" align="left">2-(4-Fluorophenyl)-4-(imidazol-1-yl)quinoline</td><td class="colsep0 rowsep0" align="left">0.8 μM</td><td class="colsep0 rowsep0" align="left">Supersomes/T47cells, E2 ELISA/antiproliferation</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">Isoflavanone derivative<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></td><td class="colsep0 rowsep0" align="left">3-(4-Phenoxyphenyl)chroman-4-one</td><td class="colsep0 rowsep0" align="left">2.4 μM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">Isoflavanone derivative<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></td><td class="colsep0 rowsep0" align="left">6-Methoxy-3-phenylchroman-4-one</td><td class="colsep0 rowsep0" align="left">0.3 μM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">Isoflavanone derivative<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></td><td class="colsep0 rowsep0" align="left">3-(Pyridin-3-yl)chroman-4-one</td><td class="colsep0 rowsep0" align="left">5.8 μM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">Flavans<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></td><td class="colsep0 rowsep0" align="left">5-Methoxy-8-formyl-4,7-dihydroxyflavan</td><td class="colsep0 rowsep0" align="left">40 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">4,7-disubstituted coumarin<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></td><td class="colsep0 rowsep0" align="left">7-(3,4-Difluorophenoxy)-4-(1<i>H</i>-imidazol-1-ylmethyl)-2<i>H</i>-chromen-2-one</td><td class="colsep0 rowsep0" align="left">47 nM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">4,7- disubstituted coumarin<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></td><td class="colsep0 rowsep0" align="left">4-(1<i>H</i>-Imidazol-1-ylmethyl)-7-phenoxy-2<i>H</i>-chromen-2-one</td><td class="colsep0 rowsep0" align="left">150 nM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">Dual AROM/STS inhibitor<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a></td><td class="colsep0 rowsep0" align="left">4-{[(4-Cyanophenyl)(1<i>H</i>-imidazol-1-yl)amino]methyl}-3-fluorophenyl sulfamate</td><td class="colsep0 rowsep0" align="left">0.2 nM</td><td class="colsep0 rowsep0" align="left">JEG3 cells, <sup>3</sup>H<sub>2</sub>O<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">Dual AROM/STS inhibitor<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></td><td class="colsep0 rowsep0" align="left">2-Bromo-4-(2-(4-cyanophenyl)-2-(1<i>H</i>-1,2,4-triazol-1-yl)ethyl)phenyl sulfamate</td><td class="colsep0 rowsep0" align="left">0.9 nM</td><td class="colsep0 rowsep0" align="left">JEG3 cells, <sup>3</sup>H<sub>2</sub>O<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">Dual AROM/STS inhibitor<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></td><td class="colsep0 rowsep0" align="left">5′-((1<i>H</i>-1,2,4-Triazol-1-yl)methyl)-2′-cyanobiphenyl-4-yl sulfamate</td><td class="colsep0 rowsep0" align="left">2 nM</td><td class="colsep0 rowsep0" align="left">JEG3 cells, <sup>3</sup>H<sub>2</sub>O<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">Dual AROM/STS inhibitor<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></td><td class="colsep0 rowsep0" align="left">5′-((1<i>H</i>-1,2,4-Triazol-1-yl)methyl)-3-chloro-2′-cyanobiphenyl-4-yl sulfamate</td><td class="colsep0 rowsep0" align="left">0.5 nM</td><td class="colsep0 rowsep0" align="left">JEG3 cells, <sup>3</sup>H<sub>2</sub>O<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">Dual AROM/STS inhibitor<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></td><td class="colsep0 rowsep0" align="left">2-Chloro-4-(((6-cyanobiphenyl-3-yl)(4<i>H</i>-1,2,4-triazol-4-yl)amino)methyl)phenyl sulfamate</td><td class="colsep0 rowsep0" align="left">15 pM</td><td class="colsep0 rowsep0" align="left">JEG3 cells, <sup>3</sup>H<sub>2</sub>O<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">Dual AROM/STS inhibitor<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></td><td class="colsep0 rowsep0" align="left">2-Bromo-4-(((6-cyanobiphenyl-3-yl)(4<i>H</i>-1,2,4-triazol-4-yl)amino)methyl)phenyl sulfamate</td><td class="colsep0 rowsep0" align="left">18 pM</td><td class="colsep0 rowsep0" align="left">JEG3 cells, <sup>3</sup>H<sub>2</sub>O<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">Tamoxifen metabolite<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></td><td class="colsep0 rowsep0" align="left">Z-4-Hydroxytamoxifen</td><td class="colsep0 rowsep0" align="left">530 μM</td><td class="colsep0 rowsep0" align="left">Supersomes/T to E2<a class="ref internalNav" href="#t3fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">Tamoxifen metabolite<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></td><td class="colsep0 rowsep0" align="left">Z-Norendoxifen</td><td class="colsep0 rowsep0" align="left">30 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/T to E2</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">Tamoxifen metabolite<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></td><td class="colsep0 rowsep0" align="left">Z-Endoxifen</td><td class="colsep0 rowsep0" align="left">6 μM</td><td class="colsep0 rowsep0" align="left">Supersomes/T to E2</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">Tamoxifen metabolite<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></td><td class="colsep0 rowsep0" align="left">(<i>Z</i>)-Norendoxifen</td><td class="colsep0 rowsep0" align="left">1029 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">Tamoxifen metabolite<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></td><td class="colsep0 rowsep0" align="left">(<i>E</i>)-Norendoxifen</td><td class="colsep0 rowsep0" align="left">77 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">Tamoxifen metabolite<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></td><td class="colsep0 rowsep0" align="left">(<i>E</i>,<i>Z</i>)-Norendoxifen</td><td class="colsep0 rowsep0" align="left">102 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">Sulfonamide derivative<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></td><td class="colsep0 rowsep0" align="left">7-((1-(3-((6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)sulfonyl)phenyl)-1<i>H</i>-1,2,3-triazol-4-yl)methoxy)-2<i>H</i>-chromen-2-one</td><td class="colsep0 rowsep0" align="left">0.2 μM</td><td class="colsep0 rowsep0" align="left">Supersomes/T to E2</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">ASINEX compounds (sulfonamide derivative)<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></td><td class="colsep0 rowsep0" align="left">1-(3-<i>tert</i>-Butyl-4-methoxybenzenesulfonyl)-3-(imidazol-1ylmethyl)piperdine</td><td class="colsep0 rowsep0" align="left">9.4 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">ASINEX compounds (sulfonamide derivative)<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></td><td class="colsep0 rowsep0" align="left"><i>N</i>-[3-(Imidazol-1-yl)propyl]-2,3-dihydro-1,4-benzodioxine-6-sulfonamide</td><td class="colsep0 rowsep0" align="left">119 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">Aryl halide<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></td><td class="colsep0 rowsep0" align="left">2-[7-Bromo-1-(3-ethoxypropyl)imidazo[4,5-c] pyridin-5-ium-5-yl]-1-phenylethanone</td><td class="colsep0 rowsep0" align="left">20 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">Indole–imidazole derivative<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></td><td class="colsep0 rowsep0" align="left">2-(Imidazol-1-ylmethyl)-1-[4-(trifluoromethyl)phenyl]indole</td><td class="colsep0 rowsep0" align="left">4.9 nM</td><td class="colsep0 rowsep0" align="left">Placental microsomes, ELISA</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">Casimiroin analogue<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></td><td class="colsep0 rowsep0" align="left">N-Methylated casimiroin analogues: 5,6,8-trimethoxy-1,4-dimethylquinolin-2(1<i>H</i>)-one</td><td class="colsep0 rowsep0" align="left">0.1 μM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">Casimiroin analogue<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></td><td class="colsep0 rowsep0" align="left">Non-N-methylated casimiroin analogues: 6-methyl[1,3]dioxolo[4,5-<i>h</i>]quinolin-8(9<i>H</i>)-one</td><td class="colsep0 rowsep0" align="left">>98.5 μM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">Casimiroin analogue<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></td><td class="colsep0 rowsep0" align="left">Casimiroin</td><td class="colsep0 rowsep0" align="left">3.9 μM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">Xanthone scaffold<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></td><td class="colsep0 rowsep0" align="left">4-Imidazol-1-ylmethylthioxanthen-9-one</td><td class="colsep0 rowsep0" align="left">4 nM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">Xanthone scaffold<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></td><td class="colsep0 rowsep0" align="left">1-(4-Nitro-2-phenylsulfanylbenzyl)-1<i>H</i>-imidazole</td><td class="colsep0 rowsep0" align="left">5.6 nM</td><td class="colsep0 rowsep0" align="left">PMTW</td><td class="colsep0 rowsep0" align="left">No</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">ASINEX compounds (morpholinoethanone derivative)<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></td><td class="colsep0 rowsep0" align="left">1-[2-(Imidazol-1-ylmethyl)morpholin-4-yl]-2-(3,4,5-trimethoxyphenyl)ethanone</td><td class="colsep0 rowsep0" align="left">59.2 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">ASINEX compounds (imdazolylacetamide)<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></td><td class="colsep0 rowsep0" align="left"><i>N</i>-[2-(4-Fluorophenoxy)phenyl]-2-(imidazol-1-yl)acetamide</td><td class="colsep0 rowsep0" align="left">248 nM</td><td class="colsep0 rowsep0" align="left">Supersomes/FCA</td><td class="colsep0 rowsep0" align="left">No: MD</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">MCF-7a: a MCF-7 cell line stably expressing AROM as described.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">PMTW: placental microsomes, tritiated water assay.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last"><sup>3</sup>H<sub>2</sub>O: tritiated water.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">MD: molecular docking.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">NCI: National Cancer Institute.</p></div><div class="footnote" id="t3fn6"><sup>f</sup><p class="last">NNC: National Nanjing Center for Drug Screening.</p></div><div class="footnote" id="t3fn7"><sup>g</sup><p class="last">Supersomes: commerical mixture of baculovirus AROM microsomes and reductase.</p></div><div class="footnote" id="t3fn8"><sup>h</sup><p class="last">FCA: fluorescent CYP19 inhibition assay, which measures the conversion of a fluorescence substrate to its metabolite, a hydroxylation reaction.</p></div><div class="footnote" id="t3fn9"><sup>i</sup><p class="last">T to E2 assay, which measures T to E2 conversion by HPLC.</p></div></div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">5 Recent Advances in the Discovery of Nonsteroidal AROM Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85865" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85865" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">5.i Binding Site Ambiguity in the Absence of Structural Data</h3><div class="NLM_p last">No structural data are available yet for unequivocal elucidation of the binding modes of nonsteroidal AIs, such as LTZ and ANZ. In the absence of experimentally determined binding modes of the nonsteroidal inhibitors, virtual docking results to the AROM active site widely reported in the literature are tentative at best. Our modeling data indicate that LTZ and ANZ do not easily fit into the AROM active site pocket<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> that resembles an androgen backbone (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Furthermore, recent inhibition kinetics data on LTZ and other azole compounds are indicative of mixed modes of inhibition, structural changes, and allostery.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Possibility of allosteric sites for nonsteroidal compounds has also been proposed from computational studies.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">5.ii Recent Reports</h3><div class="NLM_p"><a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> summarizes the reported nonsteroidal inhibitors. All inhibition/kinetic assays of the novel nonsteroidal AIs were performed in vitro. The chemical structures are shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>a. A brief description of each subclass of AI is provided below.</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">a Azole Derivatives</h4><div class="NLM_p last">Several imidazole, indole, and imidazolylbenzyl derivatives of LTZ were reported to have potencies similar to LTZ.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Vorozole is another older azole compound that causes a reversible inhibition of AROM with IC<sub>50</sub> value of 1.4 nM.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> The major AROM inhibitory activity of vorozole is attributable to the dextro isomer. Replacement of the 1<i>H</i>-benzo[<i>d</i>][1,2,3]triazole functional group in the vorozole molecule by benzofuran presented a potent racemic triazole derivative with IC<sub>50</sub> value of 10 nM.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">b Quinoline Derivatives</h4><div class="NLM_p last">AI treatment of postmenopausal breast cancer could increase the risk of cardiovascular diseases, which could be brought about by high aldosterone levels as a consequence of the estrogen deficiency.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Dual inhibitors of AROM (CYP19A1) and aldosterone synthase (CYP11B2) could be useful as adjuvant therapy to reduce the risk of cardiovascular disease for patients undergoing AI treatment. The design utilized the common feature of heme iron coordination by pyridinylmethyl moiety and the hydrophobic core of 1,2,5,6-tetrahydropyrrolo[3,2,1-<i>ij</i>]quinolin-4-one, important for potent CYP11B2 inhibition.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> The compound 8-[(3-methylphenyl)(pyridin-4-yl)methyl]-1,2,5,6-tetrahydro-4<i>H</i>-pyrrolo[3,2,1-<i>ij</i>]quinolin-4-one (<b>28</b>) exhibited strong dual inhibition.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> The design of other potent dual inhibitors included combining the pyrroloquinoline core of antimitotic phenylpyrroloquinolinone derivatives with elements of potent nonsteroidal AIs’ imidazole and triazole rings (<b>29</b>–<b>32</b>).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> A high-throughput approach identified several compounds with imidazolyl quinolone skeleton (<b>33</b>) as potent AIs.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">c Flavone Analogs</h4><div class="NLM_p last">Imidazole derivatives of flavonoids were shown to have AROM inhibitory properties.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> More recently, various modifications of this basic design have been made to synthesize potent AIs, including isoflavanone derivatives with functional groups such as methoxy, phenoxy, chloride, pyridyl, etc. (<b>34</b>–<b>36</b>).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> In addition, flavans from the roots of <i>Desmos cochinchinensis</i> exhibited potent AROM inhibitory activity at nanomolar levels, the most potent of them being 5-methoxy-8-formyl-4,7-dihydroxyflavan (<b>37</b>).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">d Coumarins</h4><div class="NLM_p last">Position 4-substituted coumarin derivatives were found to potently inhibit AROM.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> One of the most potent compounds in this series was 4-benzyl-3-(4′-chlorophenyl)-7- methoxycoumarin, a competitive inhibitor of AROM with a <i>K</i><sub>i</sub> of 84 nM.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Some of the imidazolyl derivatives of 4,7-substituted coumarins (<b>38</b>, <b>39</b>) were shown to be potent inhibitors of AROM with IC<sub>50</sub> values in the nanomolar range, higher selectivity over CYP17A1, and favorable interactions at the active site.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">e STS/AROM Dual Inhibitors</h4><div class="NLM_p last">Dual AROM/STS could prove more effective than the AIs, since both enzymes were reported to be simultaneously present in E2-dependent breast tumors.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Sulfamate moieties containing EMATE and 667-COUMATE are known potent inhibitors of STS.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> The first of these compounds generated by introducing the AI pharmacophore into a known biphenyl STS inhibitor template (i.e., sulfamate derivatives of LTZ and ANZ templates) was shown to have nanomolar level half-maximum effect.<a onclick="showRef(event, 'ref126 ref127 ref128 ref129'); return false;" href="javascript:void(0);" class="ref ref126 ref127 ref128 ref129">(126-129)</a> Sulfamate derivatives of other AI templates, such as vorozole, their halide substitutions, and enantiomorphic compounds were synthesized (<b>40</b>–<b>45</b>).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> However, the reported inhibition and antiproliferation potencies of these compounds measured in JEG3 cells with low AROM expression levels are not comparable to the others in the absence of standardized controls.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">f Tamoxifen Metabolites</h4><div class="NLM_p last">Metabolites of tamoxifen, a well-known selective estrogen receptor modulator (SERM), were shown to inhibit AROM.<a onclick="showRef(event, 'ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref131 ref132">(131, 132)</a> Such compounds (<b>46</b>, <b>47</b>) could serve dual purposes as a SERM agent and an AI. Among the metabolites tested, norendoxifen was found to be the most potent and more AROM selective over other liver CYPs and claimed to have favorable interactions at the active site.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Various isomers of norendoxifen were also prepared and tested (<b>48</b>–<b>51</b>).<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">g Others (Sulfonamide, Indole–Imidazole, Aryl Halide, Casimiroin, Xanthone Devrivatives)</h4><div class="NLM_p">A series of 1,4-disubstituted-1,2,3-triazoles containing sulfonamide moiety (<b>52</b>) were synthesized and shown to have anti-AROM inhibitory properties.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> A meta analog of triazole-benzene-sulfonamide bearing 6,7-dimethoxy substituents on the isoquinoline ring was most potent and fit in the AROM active site.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Aryl halide derivatives of a centrally flexible, five-component 1,2,3-triazole containing moiety (<b>55</b>) were prepared and evaluated as potential AIs.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Among novel indole–imidazole derivatives, 2-(imidazol-1-ylmethyl)-1-[4-(trifluoromethyl)phenyl]indole (<b>56</b>) was shown to be a highly potent AI.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Casimiroin derivatives (<b>57</b>–<b>59</b>) were shown to inhibit both AROM and quinone reductase 2. <i>N</i>-Methyl casimiroin analogue (<b>57</b>) exhibited potentency in the micromolar range.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Some imidazolyl derivatives of xanthone scaffold (<b>60</b>, <b>61</b>) were shown to be highly potent AIs.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Additionally, high-throughput in silico docking approach was used to identify existing compounds as potent AIs.<a onclick="showRef(event, 'ref138 ref139'); return false;" href="javascript:void(0);" class="ref ref138 ref139">(138, 139)</a> These include compounds with sulfonamide groups (<b>53</b>, <b>54</b>), and morpholino ethanone derivatives (<b>62</b>) and imidazole groups (<b>63</b>).<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></div><div class="NLM_p last">Several other compounds identified by in silico docking were reported to have antiproliferative properties in cancer cells.<a onclick="showRef(event, 'ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref140 ref141">(140, 141)</a> Among them, compounds 3-oxo-16,17-secoandrosta-1,4-diene-16,17a-dinitrile (<b>64</b>)<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> and 4-[2-(3-chlorophenyl)-1-(1<i>H</i>-1,2,4-triazol-1-yl)ethenyl]benzonitrile (<b>65</b>)<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>b) containing AI scaffolds exhibited antiproliferative potency in the micromolar range against MCF7 cells. However, these compounds were not shown to inhibit AROM and hence cannot be classified as new AIs.</div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">6 New Insights from Molecular Docking of Known AIs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Several groups utilized the 3D structure of AROM to predict the binding modes and/or deduce quantitative structure–activity relationships of known inhibitors/ligands by computational approaches. However, no inhibitory and/or antiproliferative properties for these compounds were experimentarily measured. Therefore, these compounds were excluded from <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> and <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>. The compounds attempted include flavonoids,<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> isoflavanone derivatives,<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> imidazolylmethyl-substituted flavone,<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> flavanone and isoflavones,<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> benzofuran scaffold,<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> steroidal backbones,<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> ASD derivatives,<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> nonsteroidal AIs based on an AROM structure-guided pharmacophore model,<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> and tetracyclic triterpenoids,<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> to name a few. There were also efforts to develop better strategy or algorithm for in silico screening and discovering novel AIs.<a onclick="showRef(event, 'ref16 ref144 ref150'); return false;" href="javascript:void(0);" class="ref ref16 ref144 ref150">(16, 144, 150)</a></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">7 Effects of Membrane Integration and Dynamics on Rational Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67556" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67556" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">7.i Membrane Integration</h3><div class="NLM_p">The 3D topology allows the enzyme to integrate into the endoplasmic reticulum and/or golgi membrane such that the substrates could utilize the lipid bilayer to gain access to the active site.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Lipophilicity of the AI scaffold is critical to integration and translocation through the lipid bilayer, as the inhibitors have to translocate through the endoplasmic reticulum membrane to gain access to the substrate-binding site from the access channel that opens toward the lumen of the endoplasmic reticulum. Membrane integration topology, the architecture of the access channel, and its flexibility are, therefore, useful information for the design of new AIs. The amino-terminal helix A<sub>NT</sub> of AROM spans the membrane and positions a putative glycosylation site at Asn12 in the luminal space,<a onclick="showRef(event, 'ref6 ref47 ref86'); return false;" href="javascript:void(0);" class="ref ref6 ref47 ref86">(6, 47, 86)</a> as shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>. The hydrophobic helix A′ (residues 57–68) and parts of helix A (residues 69–80) are embedded into the membrane, thereby positioning several arginine (Arg64, Arg79, and Arg86) and tryptophan (Trp67 and Trp88, as well as Trp239 from the F–G loop) residues at the lipid–protein interface, similar to other lipid integrating proteins.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> In this model, the entrance to the active site access channel and the amphipathic F–G loop including the G′ helix sits on the membrane surface (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), while the hydrophobic loop of residues 462–471 between β7 and β8 touches the interior of the membrane.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The side group of compound <b>5</b> nearly extends to the “gatekeeper” residues Arg192 and Glu483 at the channel entrance at the membrane–protein interface. The juxtaposition of these catalytically important residues<a onclick="showRef(event, 'ref6 ref14'); return false;" href="javascript:void(0);" class="ref ref6 ref14">(6, 14)</a> at the end of a hydrophobic channel and lipid interface suggests that membrane integration has an important role not only in steroid passage and proton relay critical to aromatization<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> but in substrate and inhibitor selectivity as well. The terminal C24 methyl of the 2-pentynyloxy derivative <b>5</b> has a favorable surrounding of large hydrophobic groups Phe221 and His480.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> However, a hydroxyl group at this position in <b>9</b> promotes polar interactions with the polar moieties at the end of the channel. Membrane integration of AROM determines the shape and size of the access channel and should be considered in inhibitor design.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Influence of lipid bilayer. In this membrane integration model, the opening to the active-site access channel rests on the lipid bilayer surface, allowing the steroids to enter the AROM active site directly from within the bilayer. The backbone ribbon is drawn in rainbow color: the N terminus is blue, and the C terminus is red. The model suggests lipid integration/association of the N-terminal helices A<sub>NT</sub>, A′, and A, the F–G loop that includes helix G′, and loop 7–8 between β7 and β8 near the C terminus. Asn12 is shown as facing the lumen of the endoplasmic reticulum. Atom color scheme is the following: oxygen in red; nitrogen blue; phosphorus orange; ASD in cornflower blue; heme and protein side chains in gray; lipid in light blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">7.ii Dynamics</h3><div class="NLM_p last">Normal mode analysis (NMA) of the X-ray structure revealed the intrinsic fluctuations of AROM, the internal modes in membrane-free and membrane-integrated monomers.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> The results confirmed the rigid-core structure of AROM centered at the active site is maintained in spite of the changes in steroid binding interactions. The NMA results showed that the N-terminal helix is the most mobile and flexible structural element identified, in agreement with the X-ray observation. The F–G loop is the next most flexible region of the AROM structure that is not significantly influenced by membrane integration. The F–G loop flexibility is one of the common features of P450s.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Evidence of the flexible loop undergoing an open/close motion, perhaps to allow steroids to enter into or leave from the active site through the access channel,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> was observed.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Furthermore, the NMA of a monomer revealed that the access channel could serve as a hinge for intramolecular bending and an interface for twisting motions. These motions, together with the intrinsic flexibility of the access channel, are likely to contribute to channel “breathing”, opening and closing of the channel mouth and the cavity, perceived necessary for entry and exit of steroids to and from the active site.<a onclick="showRef(event, 'ref6 ref86'); return false;" href="javascript:void(0);" class="ref ref6 ref86">(6, 86)</a> The hinge bending and twisting motions at the access channel are also present in the lipid-embedded AROM but at a higher frequency. Results from other dynamical simulations also have demonstrated similar flexibility of the AROM structure, especially in the access channel region, even on membrane insertion.<a onclick="showRef(event, 'ref153 ref154'); return false;" href="javascript:void(0);" class="ref ref153 ref154">(153, 154)</a> Despite the observed rigidity of the active site core, the likelihood of some ligand-induced flexibility cannot be ruled out. In addition, inhibition kinetics data<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> as well as computational analysis<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> suggest possible secondary binding sites for nonsteroidal ligands. Membrane integration, motion, and flexibility of AROM thus pose additional challenges to designing of AIs by rational means.</div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">8 Missing Information and New Concepts in Future Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14431" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14431" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">8.i Structural Data on Nonsteroidal Inhibitor–AROM Complexes</h3><div class="NLM_p last">As discussed earlier, no experimental structure data on a nonsteroidal inhibitor complex of AROM are available yet. This is a major handicap to the development of novel nonsteroidal AIs with superior clinical properties. Computational methodologies such as docking of LTZ and ANZ into the AROM active site cavity, molecular dynamics simulations, and energy minimization are inadequate for an unequivocal elucidation of the true binding mode. Our data suggest that a major conformational rearrangement of the androgen-binding cleft is necessary to accommodate these triazole ligands at the heme distal site.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Recent experimental data suggest<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> that the binding mode of ANZ is different from EXM in that the triazole does not use Asp309, the critically important active site residue, which is protonated at physiological pH and makes a hydrogen bond to the 3-keto oxygen of ASD and EXM in their binding modes.<a onclick="showRef(event, 'ref6 ref46'); return false;" href="javascript:void(0);" class="ref ref6 ref46">(6, 46)</a> Although the conventional wisdom suggests that the triazole ring nitrogen would coordinate with heme iron as the sixth ligand from the distal site, additional experimental structural data are necessary to settle this question once and for all.</div></div><div id="sec8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30">8.ii AROM Phosphorylation</h3><div class="NLM_p">Phosphorylation of the proximal cavity residue Tyr361 shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a> has recently been reported to increase AROM activity in breast cancer cells.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Short exposure of estrogen-dependent MCF-7 and ZR75 breast cancer epithelial cells to E2 induces an increase of AROM enzymatic activity. E2-induced enhancement of AROM activity does not correlate with increase in AROM mRNA and protein content. Site-directed mutagenesis experiments reveal that phosphorylation of Tyr361 is crucial in the up-regulation of enzymatic activity. E2 treatment enhances Tyr361 phosphorylation and activity of AROM by activating c-Src kinase or blocking the tyrosine phosphatase PTP1B. In the absence of E2, PTP1B reduces AROM activity by dephosphorylation of Tyr361.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Rapid E2 synthesis by a phosphorylated AROM and nongenomic autocrine E2 loop signaling via the plasma membrane-associated ER has long been proposed to be a mechanism by which estrogen performs neuroprotective, neurogenerative, and neurotransmitter roles in the brain and CNS.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> This positive feedback loop involving phosphorylation of AROM, elevated enzyme activity, and rapid E2 synthesis was first reported in the brains of songbirds and other mammals.<a onclick="showRef(event, 'ref158 ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref158 ref159 ref160">(158-160)</a></div><div class="NLM_p">The heme proximal cavity plays key roles in enzyme function during the transfer of electrons to heme.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> We have shown that Tyr361 lies in the path of transfer of electrons from CPR to heme (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) and Y361F mutation drastically reduces enzyme activity.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> X-ray data show unexplained residual electron density inside the proximal cavity,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> which could serve as a binding scaffold for small molecules. If AROM phosphorylation plays any role in AI resistance, the future AI design criteria would have to take the phosphorylation site(s) into consideration. The mechanism of modulation of the enzyme activity by phosphorylation–dephosphrylation could influence the inhibitory properties of AIs depending on their binding sites. Furthermore, targeting the proximal cavity at the AROM–CPR coupling interface is a concept that could lead to the discovery of a novel class of inhibitors of estrogen biosynthesis. Additionally, the putative secondary sites<a onclick="showRef(event, 'ref47 ref117'); return false;" href="javascript:void(0);" class="ref ref47 ref117">(47, 117)</a> could also be targeted for inhibition of enzyme activity.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Strategic location of Y361 in the proximal cavity. The redox partner cytochrome P450 reductase is presumed to bind at this interface, and electrons are transferred from FMN to heme as illustrated by the dashed line. Y361 side chain sits in the path of electron transfer. Atom color code is the same as in other figures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">9 Concluding Remarks</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45112" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45112" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Recent progress on structure–function relationships of AROM has revitalized the next generation AI discovery research. Since 2009 when the AROM structure came to light, roughly several hundred new compounds designed from structure-based modifications to existing inhibitors and belonging to 30 classes have been reported in 46 major publications. Overall, during this period roughly 1000 pieces of documents on design and discovery of novel AIs have appeared in the public domain. The evidence is clear that through rational design, three of the C6-substituted 2-alkynyloxy compounds are more potent than EXM in vitro.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> However, there are no in vivo data yet to suggest superiority to EXM. Structural data show that these novel AROM inhibitors bind in competition with the substrate at the small, tight, androgen-specific active site of AROM and also fill the access channel as they were designed to.<a onclick="showRef(event, 'ref6 ref13 ref46'); return false;" href="javascript:void(0);" class="ref ref6 ref13 ref46">(6, 13, 46)</a> They could, therefore, be more specific to AROM over other receptors. While the structure has resolved many outstanding issues, it has also raised new questions. The mechanism of conversion of androgens to estrogens by AROM is very complex and much remains to be achieved in this regard. Additionally, more comprehensive understanding of the aromatization process requires analysis of the structure of electron-transfer complex between AROM and CPR. This has proven to be difficult for any P450. Although steroidal inhibitor complexes of AROM have been crystallized, no experimental structural data on LTZ and ANZ complexes are available yet. This creates a void in our understanding of the molecular basis of inhibition and a hindrance to the discovery of rationally designed nonsteroidal compounds with superior efficacy. Paradoxically, crystallization of these complexes with AROM has been unsuccessful under the conditions that yielded the steroidal complex crystals. Conformational reorganization of the active site cavity induced by the nonsteroidal agents and/or mixed modes of binding resulting structural changes are distinct possibilities. The missing structural information is crucial for designing superior nonsteroidal AIs. Modulation of the enzyme activity by phosphorylation is another emerging area that could reshape the future of AI discovery research.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01281" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86110" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86110" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debashis Ghosh</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, New York 13210, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4c2b24233f24280c393c3f382d382962292839"><span class="__cf_email__" data-cfemail="62050a0d110a0622171211160316074c070617">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica Lo</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, New York 13210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chinaza Egbuta</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, New York 13210, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Debashis Ghosh</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=BIO-d1334e3480-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Debashis Ghosh</b> is a Professor of Pharmacology at the State University of New York (SUNY) Upstate Medical University, College of Medicine, in Syracuse, NY. He previously held the positions of Principal Scientist at the Hauptman-Woodward Institute and Associate Professor of Oncology at the Roswell Park Cancer Institute, in Buffalo, NY. He began working on steroidogenic enzymes nearly 25 years ago. The major objectives of his research have been elucidation of the molecular mechanism of estrogen biosynthesis in human by the three-enzyme system, cytochrome P450 aromatase, 17β-hydroxysteroid dehydrogenases, and steroid sulfatase, as well as rational design, synthesis, and evaluation of inhibitors of these enzymes for the treatment and prevention of estrogen-dependent breast cancer and other endocrine-related diseases.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Jessica Lo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=BIO-d1334e3485-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jessica Lo</b> studied biophysics at the State University of New York (SUNY) at Buffalo. She recently obtained a Ph.D. from SUNY Upstate Medical University in in the laboratory of Dr. Debashis Ghosh (Department of Pharmacology, SUNY Upstate Medical University in Syracuse, NY). Her doctoral work deals with the investigation of the functional properties of aromatase and determination of the potencies of novel steroidal aromatase inhibitors. She is currently a postdoctoral researcher in the laboratory of Dr. Ghosh.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Chinaza Egbuta</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=BIO-d1334e3490-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Chinaza Egbuta</b> studied pharmacology at the State University of New York (SUNY) at Buffalo and obtained a combined B.S. and M.S. in 2009. She is a Ph.D. candidate in the laboratory of Dr. Debashis Ghosh (Department of Pharmacology, SUNY Upstate Medical University in Syracuse, NY) where she is studying the interactions that modulate estrogen biosynthesis in human cytochrome P450 aromatase.</p></figure></div><div class="ack" id="ACK-d1334e3495-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70763" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70763" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work is supported in part by Grant GM086893 from the National Institutes of Health and Carol M. Baldwin Breast Cancer Research Fund of Central New York.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i36" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i36"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i37" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i37"> Abbreviations Used</h2><tr><td class="NLM_term"><sup>3</sup>H<sub>2</sub>O</td><td class="NLM_def"><p class="first last">tritiated water</p></td></tr><tr><td class="NLM_term">AI</td><td class="NLM_def"><p class="first last">AROM inhibitor</p></td></tr><tr><td class="NLM_term">ANZ</td><td class="NLM_def"><p class="first last">anastrozole</p></td></tr><tr><td class="NLM_term">AROM</td><td class="NLM_def"><p class="first last">cytochrome P450 aromatase</p></td></tr><tr><td class="NLM_term">ASD</td><td class="NLM_def"><p class="first last">androstenedione</p></td></tr><tr><td class="NLM_term">CPR</td><td class="NLM_def"><p class="first last">cytochrome P450 reductase</p></td></tr><tr><td class="NLM_term">E1</td><td class="NLM_def"><p class="first last">estrone</p></td></tr><tr><td class="NLM_term">E2</td><td class="NLM_def"><p class="first last">17β-estradiol</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epithelial growth factor receptor</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">EXM</td><td class="NLM_def"><p class="first last">exemestane</p></td></tr><tr><td class="NLM_term">FCA</td><td class="NLM_def"><p class="first last">fluorescent CYP19 inhibition assay</p></td></tr><tr><td class="NLM_term">HER2/neu</td><td class="NLM_def"><p class="first last">human EGFR2</p></td></tr><tr><td class="NLM_term">LTZ</td><td class="NLM_def"><p class="first last">letrozole</p></td></tr><tr><td class="NLM_term">MCF-7a</td><td class="NLM_def"><p class="first last">MCF-7 cell line stably expressing AROM</p></td></tr><tr><td class="NLM_term">MD</td><td class="NLM_def"><p class="first last">molecular docking</p></td></tr><tr><td class="NLM_term">mER</td><td class="NLM_def"><p class="first last">plasma membrane associated estrogen receptor</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate (reduced)</p></td></tr><tr><td class="NLM_term">NCI</td><td class="NLM_def"><p class="first last">National Cancer Institute</p></td></tr><tr><td class="NLM_term">NNC</td><td class="NLM_def"><p class="first last">National Nanjing Center for Drug Screening</p></td></tr><tr><td class="NLM_term">NMA</td><td class="NLM_def"><p class="first last">normal-mode analysis</p></td></tr><tr><td class="NLM_term">PR</td><td class="NLM_def"><p class="first last">progesterone receptor</p></td></tr><tr><td class="NLM_term">PMTW</td><td class="NLM_def"><p class="first last">pacental microsomes, tritiated water assay</p></td></tr><tr><td class="NLM_term">TST</td><td class="NLM_def"><p class="first last">testosterone</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10703" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10703" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 182 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Santen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siiteri, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, A.</span><span> </span><span class="NLM_article-title">History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span><span class="refDoi"> DOI: 10.1210/er.2008-0016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fer.2008-0016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19389994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVejt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=343-375&author=R.+J.+Santenauthor=H.+Brodieauthor=E.+R.+Simpsonauthor=P.+K.+Siiteriauthor=A.+Brodie&title=History+of+Aromatase%3A+Saga+of+an+Important+Biological+Mediator+and+Therapeutic+Target&doi=10.1210%2Fer.2008-0016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">History of aromatase: saga of an important biological mediator and therapeutic target</span></div><div class="casAuthors">Santen, R. J.; Brodie, H.; Simpson, E. R.; Siiteri, P. K.; Brodie, A.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-375</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Aromatase is the enzyme that catalyzes the conversion of androgens to estrogens.  Initial studies of its enzymic activity and function took place in an environment focused on estrogen as a component of the birth control pill.  At an early stage, investigators recognized that inhibition of this enzyme could have major practical applications for treatment of hormone-dependent breast cancer, alterations of ovarian and endometrial function, and treatment of benign disorders such as gynecomastia.  Two general approaches ultimately led to the development of potent and selective aromatase inhibitors.  One targeted the enzyme using analogs of natural steroidal substrates to work out the relationships between structure and function.  The other approach initially sought to block adrenal function as a treatment for breast cancer but led to the serendipitous finding that a nonsteroidal P 450 steroidogenesis inhibitor, aminoglutethimide, served as a potent but nonselective aromatase inhibitor.  Proof of the therapeutic concept of aromatase inhibition involved a variety of studies with aminoglutethimide and the selective steroidal inhibitor, formestane.  The requirement for even more potent and selective inhibitors led to intensive mol. studies to identify the structure of aromatase, to development of high-sensitivity estrogen assays, and to "mega" clin. trials of the third-generation aromatase inhibitors, letrozole, anastrozole, and exemestane, which are now in clin. use in breast cancer.  During these studies, unexpected findings led investigators to appreciate the important role of estrogens in males as well as in females and in multiple organs, particularly the bone and brain.  These studies identified the important regulatory properties of aromatase acting in an autocrine, paracrine, intracrine, neurocrine, and juxtacrine fashion and the organ-specific enhancers and promoters controlling its transcription.  The saga of these studies of aromatase and the ultimate utilization of inhibitors as highly effective treatments of breast cancer and for use in reproductive disorders serves as the basis for this first Endocrine Reviews history manuscript.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolTcJN4d5tIbVg90H21EOLACvtfcHk0ljxsyX4yvyrRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVejt7w%253D&md5=634ab7996e915361c7e0045dbda75e99</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1210%2Fer.2008-0016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2008-0016%26sid%3Dliteratum%253Aachs%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26aulast%3DBrodie%26aufirst%3DH.%26aulast%3DSimpson%26aufirst%3DE.%2BR.%26aulast%3DSiiteri%26aufirst%3DP.%2BK.%26aulast%3DBrodie%26aufirst%3DA.%26atitle%3DHistory%2520of%2520Aromatase%253A%2520Saga%2520of%2520an%2520Important%2520Biological%2520Mediator%2520and%2520Therapeutic%2520Target%26jtitle%3DEndocr.%2520Rev.%26date%3D2009%26volume%3D30%26spage%3D343%26epage%3D375%26doi%3D10.1210%2Fer.2008-0016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Simpson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boon, W. C.</span><span> </span><span class="NLM_article-title">Estrogen, a Fundamental Player in Energy Homeostasis</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2005.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jsbmb.2005.04.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=16054355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntVOhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=3-8&author=E.+Simpsonauthor=M.+Jonesauthor=M.+Missoauthor=K.+Hewittauthor=R.+Hillauthor=L.+Maffeiauthor=C.+Caraniauthor=W.+C.+Boon&title=Estrogen%2C+a+Fundamental+Player+in+Energy+Homeostasis&doi=10.1016%2Fj.jsbmb.2005.04.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen, a fundamental player in energy homeostasis</span></div><div class="casAuthors">Simpson, Evan; Jones, Margaret; Misso, Marie; Hewitt, Kylie; Hill, Rachel; Maffei, Laura; Carani, Cesare; Boon, Wah Chin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1-5</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The aromatase knockout mouse was generated to investigate the phenotypes resulting from lack of estrogen.  The main features of the phenotype of this mouse can be summarized as follows: infertility and lack of sexual behavior in both males and females; progressive defects in folliculogenesis and spermatogenesis; elevated gonadotropins and T levels; loss of bone mass; and a metabolic syndrome with insulin resistance, truncal obesity and hepatic steatosis.  Results from this mouse suggest that estrogen has an important role to play in energy homeostasis.  Lack of estrogen leads to the development of a metabolic syndrome.  This results in a sexually dimorphic partitioning of lipids such that in males there is profound hepatic steatosis which is not seen in females.  Estrogen administration results in a prompt reversal of these symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_6G87qfR5y7Vg90H21EOLACvtfcHk0ljxsyX4yvyrRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntVOhtbY%253D&md5=422cc945508783ef3da93c1d2b0b1288</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2005.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2005.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DSimpson%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DMisso%26aufirst%3DM.%26aulast%3DHewitt%26aufirst%3DK.%26aulast%3DHill%26aufirst%3DR.%26aulast%3DMaffei%26aufirst%3DL.%26aulast%3DCarani%26aufirst%3DC.%26aulast%3DBoon%26aufirst%3DW.%2BC.%26atitle%3DEstrogen%252C%2520a%2520Fundamental%2520Player%2520in%2520Energy%2520Homeostasis%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D95%26spage%3D3%26epage%3D8%26doi%3D10.1016%2Fj.jsbmb.2005.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ryan, K. J.</span><span> </span><span class="NLM_article-title">Biological Aromatization of Steroids</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=13630892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaG1MXksFGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1959&pages=268-272&author=K.+J.+Ryan&title=Biological+Aromatization+of+Steroids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Biological aromatization of steroids</span></div><div class="casAuthors">Ryan, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1959</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">268-72</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">cf. C.A. 52, 11147h.  A steroid aromatization reaction is described which reproducibly converts C19 steroids to estrogens in high yield.  The enzymic activity resides in the microsomal fraction of the human placenta and requires reduced triphosphopyridine nucleotide and O.  The relation of this reaction to other biol. aromatization systems is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKvbzogo4XxbVg90H21EOLACvtfcHk0ljxsyX4yvyrRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXksFGruw%253D%253D&md5=5dd35004decf78adab3f80abb0190152</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DK.%2BJ.%26atitle%3DBiological%2520Aromatization%2520of%2520Steroids%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1959%26volume%3D234%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Smith, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors in Breast Cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">2431</span><span class="NLM_x">–</span> <span class="NLM_lpage">2442</span><span class="refDoi"> DOI: 10.1056/NEJMra023246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1056%2FNEJMra023246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=12802030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksFKguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=2431-2442&author=I.+E.+Smithauthor=M.+Dowsett&title=Aromatase+Inhibitors+in+Breast+Cancer&doi=10.1056%2FNEJMra023246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase inhibitors in breast cancer</span></div><div class="casAuthors">Smith, Ian E.; Dowsett, Mitch</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2431-2442</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  This review discusses the role of aromatase inhibitors and assess their potential for clin. use in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYF49NFDFgm7Vg90H21EOLACvtfcHk0lhDnYbHW_okGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksFKguro%253D&md5=da7b56d4a1f0e7b2e27c8819a0ae0951</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMra023246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra023246%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DI.%2BE.%26aulast%3DDowsett%26aufirst%3DM.%26atitle%3DAromatase%2520Inhibitors%2520in%2520Breast%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D2431%26epage%3D2442%26doi%3D10.1056%2FNEJMra023246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Buzdar, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabholtz, J. M.</span><span> </span><span class="NLM_article-title">An Overview of the Pharmacology and Pharmacokinetics of the Newer Generation Aromatase Inhibitors Anastrozole, Letrozole, and Exemestane</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2006</span><span class="NLM_x">–</span> <span class="NLM_lpage">2016</span><span class="refDoi"> DOI: 10.1002/cncr.10908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fcncr.10908" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2002&pages=2006-2016&author=A.+U.+Buzdarauthor=J.+F.+Robertsonauthor=W.+Eiermannauthor=J.+M.+Nabholtz&title=An+Overview+of+the+Pharmacology+and+Pharmacokinetics+of+the+Newer+Generation+Aromatase+Inhibitors+Anastrozole%2C+Letrozole%2C+and+Exemestane&doi=10.1002%2Fcncr.10908"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fcncr.10908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcncr.10908%26sid%3Dliteratum%253Aachs%26aulast%3DBuzdar%26aufirst%3DA.%2BU.%26aulast%3DRobertson%26aufirst%3DJ.%2BF.%26aulast%3DEiermann%26aufirst%3DW.%26aulast%3DNabholtz%26aufirst%3DJ.%2BM.%26atitle%3DAn%2520Overview%2520of%2520the%2520Pharmacology%2520and%2520Pharmacokinetics%2520of%2520the%2520Newer%2520Generation%2520Aromatase%2520Inhibitors%2520Anastrozole%252C%2520Letrozole%252C%2520and%2520Exemestane%26jtitle%3DCancer%26date%3D2002%26volume%3D95%26spage%3D2006%26epage%3D2016%26doi%3D10.1002%2Fcncr.10908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangborn, W.</span><span> </span><span class="NLM_article-title">Structural Basis for Androgen Specificity and Oestrogen Synthesis in Human Aromatase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">457</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1038/nature07614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Fnature07614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19129847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlSitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2009&pages=219-223&author=D.+Ghoshauthor=J.+Griswoldauthor=M.+Ermanauthor=W.+Pangborn&title=Structural+Basis+for+Androgen+Specificity+and+Oestrogen+Synthesis+in+Human+Aromatase&doi=10.1038%2Fnature07614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for androgen specificity and estrogen synthesis in human aromatase</span></div><div class="casAuthors">Ghosh, Debashis; Griswold, Jennifer; Erman, Mary; Pangborn, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">7226</span>),
    <span class="NLM_cas:pages">219-223</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aromatase cytochrome P 450 is the only enzyme in vertebrates known to catalyze the biosynthesis of all estrogens from androgens.  Aromatase inhibitors therefore constitute a frontline therapy for estrogen-dependent breast cancer.  In a three-step process, each step requiring 1 mol of O2, 1 mol of NADPH, and coupling with its redox partner cytochrome P 450 reductase, aromatase converts androstenedione, testosterone and 16α-hydroxytestosterone to estrone, 17β-estradiol and 17β,16α-estriol, resp.  The first two steps are C19-Me hydroxylation steps, and the third involves the aromatization of the steroid A-ring, unique to aromatase.  Whereas most P450s are not highly substrate selective, it is the hallmark androgenic specificity that sets aromatase apart.  The structure of this enzyme of the endoplasmic reticulum membrane has remained unknown for decades, hindering elucidation of the biochem. mechanism.  Here we present the crystal structure of human placental aromatase, the only natural mammalian, full-length P 450 and P 450 in hormone biosynthetic pathways to be crystd. so far.  Unlike the active sites of many microsomal P450s that metabolize drugs and xenobiotics, aromatase has an androgen-specific cleft that binds the androstenedione mol. snugly.  Hydrophobic and polar residues exquisitely complement the steroid backbone.  The locations of catalytically important residues shed light on the reaction mechanism.  The relative juxtaposition of the hydrophobic amino-terminal region and the opening to the catalytic cleft shows why membrane anchoring is necessary for the lipophilic substrates to gain access to the active site.  The mol. basis for the enzyme's androgenic specificity and unique catalytic mechanism can be used for developing next-generation aromatase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyHy-xf0PxkbVg90H21EOLACvtfcHk0lhDnYbHW_okGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlSitA%253D%253D&md5=7f224e20c34cf5be770bb1c8b33c6e8c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature07614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07614%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DGriswold%26aufirst%3DJ.%26aulast%3DErman%26aufirst%3DM.%26aulast%3DPangborn%26aufirst%3DW.%26atitle%3DStructural%2520Basis%2520for%2520Androgen%2520Specificity%2520and%2520Oestrogen%2520Synthesis%2520in%2520Human%2520Aromatase%26jtitle%3DNature%26date%3D2009%26volume%3D457%26spage%3D219%26epage%3D223%26doi%3D10.1038%2Fnature07614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Szklarz, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halpert, J. R.</span><span> </span><span class="NLM_article-title">Use of Homology Modeling in Conjunction with Site-Directed Mutagenesis for Analysis of Structure-Function Relationships of Mammalian Cytochromes P450</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">2507</span><span class="NLM_x">–</span> <span class="NLM_lpage">2520</span><span class="refDoi"> DOI: 10.1016/S0024-3205(97)00717-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2FS0024-3205%2897%2900717-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1997&pages=2507-2520&author=G.+D.+Szklarzauthor=J.+R.+Halpert&title=Use+of+Homology+Modeling+in+Conjunction+with+Site-Directed+Mutagenesis+for+Analysis+of+Structure-Function+Relationships+of+Mammalian+Cytochromes+P450&doi=10.1016%2FS0024-3205%2897%2900717-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2897%2900717-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252897%252900717-0%26sid%3Dliteratum%253Aachs%26aulast%3DSzklarz%26aufirst%3DG.%2BD.%26aulast%3DHalpert%26aufirst%3DJ.%2BR.%26atitle%3DUse%2520of%2520Homology%2520Modeling%2520in%2520Conjunction%2520with%2520Site-Directed%2520Mutagenesis%2520for%2520Analysis%2520of%2520Structure-Function%2520Relationships%2520of%2520Mammalian%2520Cytochromes%2520P450%26jtitle%3DLife%2520Sci.%26date%3D1997%26volume%3D61%26spage%3D2507%26epage%3D2520%26doi%3D10.1016%2FS0024-3205%2897%2900717-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Laughton, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelbil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidle, S.</span><span> </span><span class="NLM_article-title">A Detailed Molecular Model for Human Aromatase</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.1016/0960-0760(93)90243-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2893%2990243-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=8476753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1eltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=399-407&author=C.+A.+Laughtonauthor=M.+J.+Zvelbilauthor=S.+Neidle&title=A+Detailed+Molecular+Model+for+Human+Aromatase&doi=10.1016%2F0960-0760%2893%2990243-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A detailed molecular model for human aromatase</span></div><div class="casAuthors">Laughton, C. A.; Zvelebil, M. J. J. M.; Neidle, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">Using a variety of techniques, including sequence alignment, secondary structure prediction, mol. mechanics and mol. dynamics, a model was constructed for the three-dimensional structure of P-450arom (human aromatase) based on that of P-450cam, the only cytochrome P 450 enzyme for which the crystal structure is known.  The predicted structure is found to be in good agreement with current exptl. data; both direct, from site-directed mutagenesis studies, and indirect, from the consideration of the structures and activities of known substrates and inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9ZRmHSnN_b7Vg90H21EOLACvtfcHk0lhn0_8ypHif8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1eltrc%253D&md5=3684a8d54578aa7b5e3a8d780b02b026</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2893%2990243-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252893%252990243-P%26sid%3Dliteratum%253Aachs%26aulast%3DLaughton%26aufirst%3DC.%2BA.%26aulast%3DZvelbil%26aufirst%3DM.%2BJ.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DA%2520Detailed%2520Molecular%2520Model%2520for%2520Human%2520Aromatase%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D44%26spage%3D399%26epage%3D407%26doi%3D10.1016%2F0960-0760%2893%2990243-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Three-Dimensional Model of the Human Aromatase Enzyme and Density Functional Parameterization of the Iron-Containing Protoporphyrin IX for a Molecular Dynamics Study of Heme-Cysteinato Cytochromes</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1074</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span><span class="refDoi"> DOI: 10.1002/prot.20829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fprot.20829" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=1074-1087&author=A.+D.+Faviaauthor=A.+Cavalliauthor=M.+Masettiauthor=A.+Carottiauthor=M.+Recanatini&title=Three-Dimensional+Model+of+the+Human+Aromatase+Enzyme+and+Density+Functional+Parameterization+of+the+Iron-Containing+Protoporphyrin+IX+for+a+Molecular+Dynamics+Study+of+Heme-Cysteinato+Cytochromes&doi=10.1002%2Fprot.20829"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fprot.20829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.20829%26sid%3Dliteratum%253Aachs%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DMasetti%26aufirst%3DM.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DThree-Dimensional%2520Model%2520of%2520the%2520Human%2520Aromatase%2520Enzyme%2520and%2520Density%2520Functional%2520Parameterization%2520of%2520the%2520Iron-Containing%2520Protoporphyrin%2520IX%2520for%2520a%2520Molecular%2520Dynamics%2520Study%2520of%2520Heme-Cysteinato%2520Cytochromes%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2006%26volume%3D62%26spage%3D1074%26epage%3D1087%26doi%3D10.1002%2Fprot.20829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Karkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtje, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahala, K.</span><span> </span><span class="NLM_article-title">A Three-Dimensional Model of CYP19 Aromatase for Structure-Based Drug Design</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2006.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jsbmb.2006.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=17583493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFyiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2007&pages=63-70&author=S.+Karkolaauthor=H.+D.+Holtjeauthor=K.+Wahala&title=A+Three-Dimensional+Model+of+CYP19+Aromatase+for+Structure-Based+Drug+Design&doi=10.1016%2Fj.jsbmb.2006.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A three-dimensional model of CYP19 aromatase for structure-based drug design</span></div><div class="casAuthors">Karkola, Sampo; Hoeltje, Hans-Dieter; Waehaelae, Kristiina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1-5</span>),
    <span class="NLM_cas:pages">63-70</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Aromatase (CYP 450arom, CYP19) is an enzyme responsible for converting the aliph. androgens androstenedione and testosterone to the arom. estrogens estrone and estradiol, resp.  These endogenous hormones are a key factor in cancer tumor formation and proliferation through a cascade starting from estrogen binding to estrogen receptor.  To interfere with the overprodn. of estrogens esp. in tumor tissue, it is possible to inhibit aromatase activity.  This can be achieved using aromatase inhibitors.  To design novel aromatase inhibitors, it is necessary to have an understanding of the active site of aromatase.  As no crystal structure of the enzyme has yet been published, we built a homol. model of aromatase using the first crystd. mammalian cytochrome enzyme, rabbit 21-progesterone hydroxylase 2C5, as a template structure.  The initial model was validated with exhaustive mol. dynamics simulation with and without the natural substrate androstenedione.  The resulting enzyme-substrate complex shows very good stability and only two of the residues are in disallowed regions in a Ramachandran plot.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprIT5CCNN_dbVg90H21EOLACvtfcHk0lh0yQNJmm8uhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFyiurw%253D&md5=284f56b899908a447896a402c075e726</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2006.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2006.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DKarkola%26aufirst%3DS.%26aulast%3DHoltje%26aufirst%3DH.%2BD.%26aulast%3DWahala%26aufirst%3DK.%26atitle%3DA%2520Three-Dimensional%2520Model%2520of%2520CYP19%2520Aromatase%2520for%2520Structure-Based%2520Drug%2520Design%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D105%26spage%3D63%26epage%3D70%26doi%3D10.1016%2Fj.jsbmb.2006.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Graham-Lorence, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarneh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, E. R.</span><span> </span><span class="NLM_article-title">A Three-Dimensional Model of Aromatase Cytochrome P450</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1080</span><span class="refDoi"> DOI: 10.1002/pro.5560040605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fpro.5560040605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=7549871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK2MXmsFyrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1995&pages=1065-1080&author=S.+Graham-Lorenceauthor=B.+Amarnehauthor=R.+E.+Whiteauthor=J.+A.+Petersonauthor=E.+R.+Simpson&title=A+Three-Dimensional+Model+of+Aromatase+Cytochrome+P450&doi=10.1002%2Fpro.5560040605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A three-dimensional model of aromatase cytochrome P450</span></div><div class="casAuthors">Graham-Lorence, Sandra; Amarneh, Bilal; White, Ronald E.; Peterson, Julian A.; Simpson, Evan R.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1065-80</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">P 450 heme proteins comprise a large gene superfamily that catalyzes monooxygenase reactions in the presence of a redox partner.  Because the mammalian members are, without exception, membrane-bound proteins, they have resisted structure-function anal. by means of x-ray crystallog. methods.  Among P 450-catalyzed reactions, the aromatase reaction that catalyzes the conversion of C19 steroids to estrogens is one of the most complex and least understood.  Thus, to better understand the reaction mechanism, we have constructed a three-dimensional model of P450arom not only to examine the active site and those residues potentially involved in catalysis, but to study other important structural features such as substrate recognition and redox-partner binding, which require examn. of the entire mol. (excepting the putative membrane-spanning region).  This model of P450arom was built based on a core structure identified from the structures of the sol., bacterial P450s (P450cam, P450terp, and P450BM-P) rather than by mol. replacement, after which the less conserved elements and loops were added in a rational fashion.  Minimization and dynamic simulations were used to optimize the model and the reasonableness of the structure was evaluated.  From this model we have postulated a membrane-assocd. hydrophobic region of aliph. and arom. residues involved in substrate recognition, a redox-partner binding region that may be unique compared to other P450s, as well as residues involved in active site orientation of substrates and an inhibitor of P450arom, namely vorozole.  We also have proposed a scheme for the reaction mechanism in which a threonine switch dets. whether oxygen insertion into the substrate mol. involves an oxygen radical or a peroxide intermediate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl2opoEDIt7LVg90H21EOLACvtfcHk0lh0yQNJmm8uhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsFyrs70%253D&md5=e5ae05ab3e8105eecc146d610f60174f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560040605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560040605%26sid%3Dliteratum%253Aachs%26aulast%3DGraham-Lorence%26aufirst%3DS.%26aulast%3DAmarneh%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DR.%2BE.%26aulast%3DPeterson%26aufirst%3DJ.%2BA.%26aulast%3DSimpson%26aufirst%3DE.%2BR.%26atitle%3DA%2520Three-Dimensional%2520Model%2520of%2520Aromatase%2520Cytochrome%2520P450%26jtitle%3DProtein%2520Sci.%26date%3D1995%26volume%3D4%26spage%3D1065%26epage%3D1080%26doi%3D10.1002%2Fpro.5560040605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Suppression of Human Cytochrome P450 Aromatase Activity by Monoclonal and Recombinant Antibody Fragments and Identification of a Stable Antigenic Complex</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2003.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jsbmb.2003.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=15120417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1eru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2004&pages=235-245&author=P.+Lalaauthor=T.+Higashiyamaauthor=M.+Ermanauthor=J.+Griswoldauthor=T.+Wagnerauthor=Y.+Osawaauthor=D.+Ghosh&title=Suppression+of+Human+Cytochrome+P450+Aromatase+Activity+by+Monoclonal+and+Recombinant+Antibody+Fragments+and+Identification+of+a+Stable+Antigenic+Complex&doi=10.1016%2Fj.jsbmb.2003.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of human cytochrome P450 aromatase activity by monoclonal and recombinant antibody fragments and identification of a stable antigenic complex</span></div><div class="casAuthors">Lala, Puloma; Higashiyama, Tadayoshi; Erman, Mary; Griswold, Jennifer; Wagner, Traci; Osawa, Yoshio; Ghosh, Debashis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-245</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">: Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Human cytochrome P 450 aromatase (P450arom) is responsible for biosynthesis of estrogens from androgens.  Monoclonal antibody MAb3-2C2 to P450arom specifically binds to a conformational epitope and suppresses the enzyme activity in a dose-dependent manner.  The crystal structure of the Fab fragment of MAb3-2C2 has been used to engineer a recombinant single chain antibody fragment (scFv) and a homodimeric variable domain of the light chain (VL2).  These recombinant antibody fragments have been expressed in Escherichia coli and purified.  Here, we show that the recombinant scFv suppresses P450arom activity with an IC50 value similar to that of natural MAb3-2C2 F(ab')2.  The recombinant VL2 also exhibits dose-dependent suppression of the P450arom activity, but at a reduced level, demonstrating that the homodimer is unable to fully mimic the complementarity detg. region (CDR) of a variable heavy chain (VH)-VL heterodimer.  We prep. and purify a stable complex of P450arom with MAb3-2C2 F(ab')2 and show that the complex migrates and ppts. as a single mol. assembly.  Efforts to crystallize P450arom for structure-function studies have yielded small single crystals.  Our results suggest that formation of stable complexes with fragments of the monoclonal antibody could provide an alternative method for crystn. of P450arom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSWKOHRdLUXbVg90H21EOLACvtfcHk0lh0yQNJmm8uhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1eru70%253D&md5=32e8d0389b8961fdc20e7ebfd1f684d0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2003.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2003.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DLala%26aufirst%3DP.%26aulast%3DHigashiyama%26aufirst%3DT.%26aulast%3DErman%26aufirst%3DM.%26aulast%3DGriswold%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DOsawa%26aufirst%3DY.%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DSuppression%2520of%2520Human%2520Cytochrome%2520P450%2520Aromatase%2520Activity%2520by%2520Monoclonal%2520and%2520Recombinant%2520Antibody%2520Fragments%2520and%2520Identification%2520of%2520a%2520Stable%2520Antigenic%2520Complex%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D88%26spage%3D235%26epage%3D245%26doi%3D10.1016%2Fj.jsbmb.2003.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangborn, W.</span><span> </span><span class="NLM_article-title">X-Ray Structure of Human Aromatase Reveals an Androgen-Specific Active Site</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2009.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jsbmb.2009.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19808095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlSltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=197-202&author=D.+Ghoshauthor=J.+Griswoldauthor=M.+Ermanauthor=W.+Pangborn&title=X-Ray+Structure+of+Human+Aromatase+Reveals+an+Androgen-Specific+Active+Site&doi=10.1016%2Fj.jsbmb.2009.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray structure of human aromatase reveals an androgen-specific active site</span></div><div class="casAuthors">Ghosh, Debashis; Griswold, Jennifer; Erman, Mary; Pangborn, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">197-202</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Aromatase (I) is a unique cytochrome P 450-dependent enzyme that catalyzes the removal of the 19-Me group and aromatization of the A-ring of androgens for the synthesis of estrogens.  All human estrogens are synthesized via this enzymic aromatization pathway.  I inhibitors thus constitute a frontline therapy for estrogen-dependent breast cancer.  Despite decades of intense investigation, this enzyme of the endoplasmic reticulum membrane has eluded all structure detn. efforts.  Here, the authors report the crystal structure of highly active I purified from human placenta, in complex with its natural substrate, androstenedione.  The structure showed the binding mode of androstenedione in the catalytically active oxidized high-spin ferric state of the enzyme.  H-bond-forming interactions and tight packing hydrophobic side-chains that complement the puckering of the steroid backbone provided the mol. basis for the exclusive androgenic specificity of I.  The locations of catalytic residues and water mols. shed new light on the mechanism of the aromatization step.  The structure also suggested a membrane integration model indicative of the passage of steroids through the lipid bilayer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowU4rLC5S_fbVg90H21EOLACvtfcHk0lhccPvH_Fmu4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlSltL4%253D&md5=19a6d40418c6f8f35c4b582ff6ae6439</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2009.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2009.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DGriswold%26aufirst%3DJ.%26aulast%3DErman%26aufirst%3DM.%26aulast%3DPangborn%26aufirst%3DW.%26atitle%3DX-Ray%2520Structure%2520of%2520Human%2520Aromatase%2520Reveals%2520an%2520Androgen-Specific%2520Active%2520Site%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D118%26spage%3D197%26epage%3D202%26doi%3D10.1016%2Fj.jsbmb.2009.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Lo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Nardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbuta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilardi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Structural Basis for the Functional Roles of Critical Residues in Human Cytochrome P450 Aromatase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5821</span><span class="NLM_x">–</span> <span class="NLM_lpage">5829</span><span class="refDoi"> DOI: 10.1021/bi400669h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi400669h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOqu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=5821-5829&author=J.+Loauthor=G.+Di+Nardoauthor=J.+Griswoldauthor=C.+Egbutaauthor=W.+Jiangauthor=G.+Gilardiauthor=D.+Ghosh&title=Structural+Basis+for+the+Functional+Roles+of+Critical+Residues+in+Human+Cytochrome+P450+Aromatase&doi=10.1021%2Fbi400669h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Functional Roles of Critical Residues in Human Cytochrome P450 Aromatase</span></div><div class="casAuthors">Lo, Jessica; Di Nardo, Giovanna; Griswold, Jennifer; Egbuta, Chinaza; Jiang, Wenhua; Gilardi, Gianfranco; Ghosh, Debashis</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5821-5829</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytochrome P 450 aromatase (CYP19A1) is the only enzyme known to catalyze the biosynthesis of estrogens from androgens.  The crystal structure of human placental aromatase (pArom) has paved the way toward understanding the structure-function relationships of this remarkable enzyme.  Using an amino terminus-truncated recombinant human aromatase (rArom) construct, we investigate the roles of key amino acids in the active site, at the intermol. interface, inside the access channel, and at the lipid-protein boundary for their roles in enzyme function and higher-order organization.  Replacing the active site residue D309 with an N yields an inactive enzyme, consistent with its proposed involvement in aromatization.  Mutation of R192 at the lipid interface, pivotal to the proton relay network in the access channel, results in the loss of enzyme activity.  In addn. to the distal catalytic residues, we show that mutation of K440 and Y361 of the heme-proximal region critically interferes with substrate binding, enzyme activity, and heme stability.  The D-E loop deletion mutant Del7 that disrupts the intermol. interaction significantly reduces enzyme activity.  However, the less drastic Del4 and point mutants E181A and E181K do not.  Furthermore, native gel electrophoresis, size-exclusion chromatog., and anal. ultracentrifugation are used to show that mutations in the intermol. interface alter the quaternary organization of the enzyme in soln.  As a validation for interpretation of the mutational results in the context of the innate mol., we det. the crystal structure of rArom to show that the active site, tertiary, and quaternary structures are identical to those of pArom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGBahgDCrIOLVg90H21EOLACvtfcHk0lhccPvH_Fmu4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOqu7vO&md5=eb67eab5c2902f2b57c04171452fa17d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fbi400669h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400669h%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DDi%2BNardo%26aufirst%3DG.%26aulast%3DGriswold%26aufirst%3DJ.%26aulast%3DEgbuta%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DGilardi%26aufirst%3DG.%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Functional%2520Roles%2520of%2520Critical%2520Residues%2520in%2520Human%2520Cytochrome%2520P450%2520Aromatase%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D5821%26epage%3D5829%26doi%3D10.1021%2Fbi400669h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Waterman, M. R.</span><span> </span><span class="NLM_article-title">Anticancer Drug Target Pictured</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">457</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span><span class="refDoi"> DOI: 10.1038/457159a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2F457159a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2009&pages=159-160&author=M.+R.+Waterman&title=Anticancer+Drug+Target+Pictured&doi=10.1038%2F457159a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2F457159a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F457159a%26sid%3Dliteratum%253Aachs%26aulast%3DWaterman%26aufirst%3DM.%2BR.%26atitle%3DAnticancer%2520Drug%2520Target%2520Pictured%26jtitle%3DNature%26date%3D2009%26volume%3D457%26spage%3D159%26epage%3D160%26doi%3D10.1038%2F457159a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Computational Methods for the Design of Potent Aromatase Inhibitors</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.1517/17460441.2013.768983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1517%2F17460441.2013.768983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=23373669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksVKksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=395-409&author=A.+D.+Faviaauthor=O.+Nicolottiauthor=A.+Stefanachiauthor=F.+Leonettiauthor=A.+Carotti&title=Computational+Methods+for+the+Design+of+Potent+Aromatase+Inhibitors&doi=10.1517%2F17460441.2013.768983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Computational methods for the design of potent aromatase inhibitors</span></div><div class="casAuthors">Favia, Angelo Danilo; Nicolotti, Orazio; Stefanachi, Angela; Leonetti, Francesco; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-409</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: It has long been considered that the most significant risks for breast cancer are gender and age but, as many other tumors, this cancer has also been undeniably linked to gene mutations.  The vast majority of breast cancers in postmenopausal women are estrogen-responsive, a hormone which is biosynthesized from blood-circulating androgens through an aromatization reaction, catalyzed by aromatase (AR).  One strategy, therefore, to combat breast cancer, has been to find compds. that can inhibit the activity of aromatase to reduce estrogen levels.  Areas covered: The authors provide a broad and updated overview of the general structure-activity relationships and on the latest ligand- and structure-based approaches applied to the discovery of potent, selective and safer breast cancer drugs.  Specifically the authors review the most consolidated techniques, based on structure-activity relationships, pharmacophore mapping, rigid and flexible mol. docking, as well as sophisticated and reliable protocols simulating crit. biol. events.  Expert opinion: The recently solved X-ray structures of aromatase represent solid milestones to breathe new life into the search of newer chemotypes with reduced risks of cross-reactivity toward other CYPs and safer pharmacol. profiles.  We anticipate that great benefits will arrive from the wealth of information obtained by integrating genomics, site-directed mutagenesis expts. with protein modeling.  Furthermore, we welcome the advent of GPU technol. that, in conjunction with dedicated algorithms, grants scientists an unprecedented point of view on physiol. relevant phenomena, occurring on the μs time scale, such as ligand binding/unbinding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1eHel0TrwSrVg90H21EOLACvtfcHk0ljGqJXzFwW-FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksVKksb8%253D&md5=5767757f7a3f8a19c1c64e3abe28eda1</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.768983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.768983%26sid%3Dliteratum%253Aachs%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DComputational%2520Methods%2520for%2520the%2520Design%2520of%2520Potent%2520Aromatase%2520Inhibitors%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D395%26epage%3D409%26doi%3D10.1517%2F17460441.2013.768983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Di Nardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilardi, G.</span><span> </span><span class="NLM_article-title">Evidence for an Elevated Aspartate pKa in the Active Site of Human Aromatase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">1186</span><span class="NLM_x">–</span> <span class="NLM_lpage">1196</span><span class="refDoi"> DOI: 10.1074/jbc.M114.595108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1074%2Fjbc.M114.595108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=25425647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFSjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=1186-1196&author=G.+Di+Nardoauthor=M.+Breitnerauthor=A.+Bandinoauthor=D.+Ghoshauthor=G.+K.+Jenningsauthor=J.+C.+Hackettauthor=G.+Gilardi&title=Evidence+for+an+Elevated+Aspartate+pKa+in+the+Active+Site+of+Human+Aromatase&doi=10.1074%2Fjbc.M114.595108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for an Elevated Aspartate pKa in the Active Site of Human Aromatase</span></div><div class="casAuthors">Di Nardo, Giovanna; Breitner, Maximilian; Bandino, Andrea; Ghosh, Debashis; Jennings, Gareth K.; Hackett, John C.; Gilardi, Gianfranco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1186-1196</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aromatase (CYP19A1), the enzyme that converts androgens to estrogens, is of significant mechanistic and therapeutic interest.  Crystal structures and computational studies of this enzyme shed light on the crit. role of Asp309 in substrate binding and catalysis.  These studies predicted an elevated pKa for Asp309 and proposed that protonation of this residue was required for function.  In this study, UV-visible absorption, CD, resonance Raman spectroscopy, and enzyme kinetics were used to study the impact of pH on aromatase structure and androstenedione binding.  Spectroscopic studies demonstrate that androstenedione binding is pH-dependent, whereas in contrast, the D309N mutant retains its ability to bind to androstenedione across the entire pH range studied.  Neither pH nor mutation perturbed the secondary structure or heme environment.  The origin of the obsd. pH dependence was further narrowed to the protonation equil. of Asp309 with a parallel set of spectroscopic studies using exemestane and anastrozole.  Because exemestane interacts with Asp309 based on its co-crystal structure with the enzyme, its binding is pH-dependent.  Aromatase binding to anastrozole is pH-independent, consistent with the hypothesis that this ligand exploits a distinct set of interactions in the active site.  In summary, we assign the apparent pKa of 8.2 obsd. for androstenedione binding to the side chain of Asp309.  To our knowledge, this work represents the first exptl. assignment of a pKa value to a residue in a cytochrome P 450.  This value is in agreement with theor. calcns. (7.7-8.1) despite the reliance of the computational methods on the conformational snapshots provided by crystal structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAKZ7aLlJ_RLVg90H21EOLACvtfcHk0ljGqJXzFwW-FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFSjsQ%253D%253D&md5=b26767f83835699a92e113915ae5e05d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.595108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.595108%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BNardo%26aufirst%3DG.%26aulast%3DBreitner%26aufirst%3DM.%26aulast%3DBandino%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DJennings%26aufirst%3DG.%2BK.%26aulast%3DHackett%26aufirst%3DJ.%2BC.%26aulast%3DGilardi%26aufirst%3DG.%26atitle%3DEvidence%2520for%2520an%2520Elevated%2520Aspartate%2520pKa%2520in%2520the%2520Active%2520Site%2520of%2520Human%2520Aromatase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D1186%26epage%3D1196%26doi%3D10.1074%2Fjbc.M114.595108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Sen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackett, J. C.</span><span> </span><span class="NLM_article-title">Coupled Electron Transfer and Proton Hopping in the Final Step of CYP19-Catalyzed Androgen Aromatization</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3039</span><span class="NLM_x">–</span> <span class="NLM_lpage">3049</span><span class="refDoi"> DOI: 10.1021/bi300017p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi300017p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlGnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=3039-3049&author=K.+Senauthor=J.+C.+Hackett&title=Coupled+Electron+Transfer+and+Proton+Hopping+in+the+Final+Step+of+CYP19-Catalyzed+Androgen+Aromatization&doi=10.1021%2Fbi300017p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Coupled electron transfer and proton hopping in the final step of CYP19-catalyzed androgen aromatization</span></div><div class="casAuthors">Sen, Kakali; Hackett, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3039-3049</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aromatase/cytochrome P 450 19 (CYP19) catalyzes the terminal step in estrogen biosynthesis, which requires 3 sep. oxidn. reactions, culminating in an enigmatic aromatization that converts an androgen to an estrogen.  A stable ferric peroxo (Fe3+O22-) intermediate has been seen by ESR, but its role in this complex reaction remains controversial.  Here, combining mol. dynamics (MD) simulation and hybrid quantum mechanics/mol. mechanics (QM/MM), the authors show that ferric peroxo addn. to the 19-aldehyde initiates the reaction.  Stepwise cleavage of the C10-C19 and O-O bonds of the peroxohemiacetal extrudes formate and yields compd. II, which in turn desaturates the steroid through successive abstraction of the 1β-H atom and deprotonation of the 2β-position.  Throughout the transformation, a proton is cyclically relayed between Arg-309 and the substrate to stabilize reaction intermediates.  This mechanism invokes novel O intermediates and provides a unifying interpretation of past exptl. mechanistic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOtW7FCj2vcrVg90H21EOLACvtfcHk0lhraTCtRfqWGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlGnu74%253D&md5=1fc5b54d48957c722b36ebc333b95ab6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi300017p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi300017p%26sid%3Dliteratum%253Aachs%26aulast%3DSen%26aufirst%3DK.%26aulast%3DHackett%26aufirst%3DJ.%2BC.%26atitle%3DCoupled%2520Electron%2520Transfer%2520and%2520Proton%2520Hopping%2520in%2520the%2520Final%2520Step%2520of%2520CYP19-Catalyzed%2520Androgen%2520Aromatization%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D3039%26epage%3D3049%26doi%3D10.1021%2Fbi300017p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Lipton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span> </span><span class="NLM_article-title">Proceedings: Medical Adrenalectomy Using Aminoglutethimide and Dexamethasone in Advanced Breast Cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span><span class="refDoi"> DOI: 10.1002/1097-0142(197402)33:2<503::AID-CNCR2820330227>3.0.CO;2-L</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2F1097-0142%28197402%2933%3A2%3C503%3A%3AAID-CNCR2820330227%3E3.0.CO%3B2-L" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1974&pages=503-512&author=A.+Liptonauthor=R.+J.+Santen&title=Proceedings%3A+Medical+Adrenalectomy+Using+Aminoglutethimide+and+Dexamethasone+in+Advanced+Breast+Cancer&doi=10.1002%2F1097-0142%28197402%2933%3A2%3C503%3A%3AAID-CNCR2820330227%3E3.0.CO%3B2-L"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2F1097-0142%28197402%2933%3A2%3C503%3A%3AAID-CNCR2820330227%3E3.0.CO%3B2-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0142%2528197402%252933%253A2%253C503%253A%253AAID-CNCR2820330227%253E3.0.CO%253B2-L%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DA.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26atitle%3DProceedings%253A%2520Medical%2520Adrenalectomy%2520Using%2520Aminoglutethimide%2520and%2520Dexamethasone%2520in%2520Advanced%2520Breast%2520Cancer%26jtitle%3DCancer%26date%3D1974%26volume%3D33%26spage%3D503%26epage%3D512%26doi%3D10.1002%2F1097-0142%28197402%2933%3A2%3C503%3A%3AAID-CNCR2820330227%3E3.0.CO%3B2-L" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giudici, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Exemestane (FCE 24304), a New Steroidal Aromatase Inhibitor</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1016/0960-0760(92)90198-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2892%2990198-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1525055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK38Xmt1KgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1992&pages=137-143&author=E.+di+Salleauthor=G.+Ornatiauthor=D.+Giudiciauthor=M.+Lassusauthor=T.+R.+Evansauthor=R.+C.+Coombes&title=Exemestane+%28FCE+24304%29%2C+a+New+Steroidal+Aromatase+Inhibitor&doi=10.1016%2F0960-0760%2892%2990198-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Exemestane (FCE 24304), a new steroidal aromatase inhibitor</span></div><div class="casAuthors">Di Salle, E.; Ornati, G.; Giudici, D.; Lassus, M.; Evans, T. R. J.; Coombes, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">137-43</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">A review with 42 refs.  Exemestane (FCE 24304; I) is a novel orally active irreversible aromatase inhibitor.  Its in vivo pharmacol. properties have been compared to 4-hydroxyandrostenedione (4-OHA).  In preincubation studies with human placental aromatase, I, like 4-OHA, showed enzyme-inactivating properties with a similar affinity (Ki 26 vs. 29 nM) and a lower rate of inactivation (t1/2 13.9 vs. 2.1 min).  Conversely, when tested in pregnant mares' serum gonodotropin-treated rats, I was more potent in reducing microsomal ovarian aromatase activity than 4-OHA, after both s.c. (ED50 1.8 vs. 3.1 mg/kg) and oral dosing (ED50 3.7 vs. >100 mg/kg).  No interference of I on desmolase or 5α-reductase activity was found.  I did not show any relevant binding affinity to steroidal receptors, but slight binding to the androgen receptor (≈0.2% of dihydrotestosterone), like 4-OHA.  In the 1st phase I trial, healthy postmenopausal volunteers were given single oral doses of I, ranging from 0.5 to 800 mg, and plasma [estrone (E1), estradiol (E2) and estrone sulfate (E1S)] and urinary estrogens (E1 and E2) were measured up to 5-8 days.  The minimal ED in decreasing estrogens was 5 mg.  At 25 mg the maximal suppression was obsd. at day 3: plasma estrogens fell to 35 (E1), 39 (E2) and 28% (E1S), and urinary estrogens fell to 20 (E1) and 25% (E2) of basal values, these effects still persisting on day 5.  No effects on plasma levels of cortisol, aldosterone, 17-hydroxyprogesterone, DHEAS, LH and FSH, and no significant adverse events were obsd. up to the highest tested dose of 800 mg I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovP_bOfA8wbbVg90H21EOLACvtfcHk0lhraTCtRfqWGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xmt1KgtL0%253D&md5=2ba0300b931351d69f4c95a2ad103a27</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2892%2990198-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252892%252990198-R%26sid%3Dliteratum%253Aachs%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26aulast%3DOrnati%26aufirst%3DG.%26aulast%3DGiudici%26aufirst%3DD.%26aulast%3DLassus%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DT.%2BR.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DExemestane%2520%2528FCE%252024304%2529%252C%2520a%2520New%2520Steroidal%2520Aromatase%2520Inhibitor%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1992%26volume%3D43%26spage%3D137%26epage%3D143%26doi%3D10.1016%2F0960-0760%2892%2990198-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Dexter, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ney, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddle, G. W.</span><span> </span><span class="NLM_article-title">Inhibition of Adrenal Corticosteroid Synthesis by Aminoglutethimide: Studies of the Mechanism of Action</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span><span class="refDoi"> DOI: 10.1210/jcem-27-4-473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem-27-4-473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=4290076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaF2sXhtFChtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1967&pages=473-480&author=R.+N.+Dexterauthor=L.+M.+Fishmanauthor=R.+L.+Neyauthor=G.+W.+Liddle&title=Inhibition+of+Adrenal+Corticosteroid+Synthesis+by+Aminoglutethimide%3A+Studies+of+the+Mechanism+of+Action&doi=10.1210%2Fjcem-27-4-473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of adrenal corticosteroid synthesis by aminoglutethimide:  the mechanism of action</span></div><div class="casAuthors">Dexter, Richard N.; Fishman, Lawrence M.; Ney, Robert L.; Liddle, Grant W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">473-80</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">cf. following abstr.  Aminoglutethimide phosphate (I) inhibited the synthesis of corticosterone by the rat adrenal cortex both in vivo and in vitro.  In intact rats the decrease in corticosterone production was accompanied by an increase in plasma ACTH.  In the presence of endogenous or exogenous ACTH, I caused a marked accumulation of adrenal cholesterol.  I did not impair the conversion of pregnenolone to corticosterone, indicating that the drug inhibited the conversion of cholesterol to pregnenolone.  I administration resulted in adrenal enlargement, an effect probably partly due to cholesterol accumulation and partly due to the adrenal growth-promoting effect of increased endogenous ACTH.  18 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNv8AAnJl98LVg90H21EOLACvtfcHk0ljMWXVhNf11yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXhtFChtb4%253D&md5=f02f236260689320215fcaabe837d057</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1210%2Fjcem-27-4-473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-27-4-473%26sid%3Dliteratum%253Aachs%26aulast%3DDexter%26aufirst%3DR.%2BN.%26aulast%3DFishman%26aufirst%3DL.%2BM.%26aulast%3DNey%26aufirst%3DR.%2BL.%26aulast%3DLiddle%26aufirst%3DG.%2BW.%26atitle%3DInhibition%2520of%2520Adrenal%2520Corticosteroid%2520Synthesis%2520by%2520Aminoglutethimide%253A%2520Studies%2520of%2520the%2520Mechanism%2520of%2520Action%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1967%26volume%3D27%26spage%3D473%26epage%3D480%26doi%3D10.1210%2Fjcem-27-4-473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Pittman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. W.</span><span> </span><span class="NLM_article-title">Antithyroid and Antiadrenocortical Activity of Aminoglutethimide</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1014</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span><span class="refDoi"> DOI: 10.1210/jcem-26-9-1014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem-26-9-1014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=4162763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaF28XkvVCqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1966&pages=1014-1016&author=J.+A.+Pittmanauthor=R.+W.+Brown&title=Antithyroid+and+Antiadrenocortical+Activity+of+Aminoglutethimide&doi=10.1210%2Fjcem-26-9-1014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Antithyroid and antiadrenocortical activity of aminoglutethimide</span></div><div class="casAuthors">Pittman, J. A.; Brown, R. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1014-16</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">Aminoglutethimide (I) (0.3% in the diet or at 10, 25, or 50 mg./100 g. body wt.) increased thyroid wt., depressed 131I uptake, and caused adrenal enlargement in rats to a degree comparable to that in rats given amphenone B, and in addn. caused ovarian enlargement; these changes were not observed in hypophysectomized rats.  I had a goitrogenic action in rats maintained on an I-rich diet.  I may prove useful in the investigation of adrenal physiology and may block steroid synthesis in the ovaries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiAKkuwJmHqLVg90H21EOLACvtfcHk0ljMWXVhNf11yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28XkvVCqsbk%253D&md5=585d75ea1a84b17b61c854270f10185e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1210%2Fjcem-26-9-1014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-26-9-1014%26sid%3Dliteratum%253Aachs%26aulast%3DPittman%26aufirst%3DJ.%2BA.%26aulast%3DBrown%26aufirst%3DR.%2BW.%26atitle%3DAntithyroid%2520and%2520Antiadrenocortical%2520Activity%2520of%2520Aminoglutethimide%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1966%26volume%3D26%26spage%3D1014%26epage%3D1016%26doi%3D10.1210%2Fjcem-26-9-1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Häusler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krähenbühl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span> </span><span class="NLM_article-title">An in Vitro Method to Determine the Selective Inhibition of Estrogen Biosynthesis by Aromatase Inhibitors</span> <span class="citation_source-journal">J. Steroid Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><span class="refDoi"> DOI: 10.1016/0022-4731(89)90367-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0022-4731%2889%2990367-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2527324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaL1MzktlajsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1989&pages=125-131&author=A.+H%C3%A4uslerauthor=L.+Schenkelauthor=C.+Kr%C3%A4henb%C3%BChlauthor=G.+Monnetauthor=A.+Bhatnagar&title=An+in+Vitro+Method+to+Determine+the+Selective+Inhibition+of+Estrogen+Biosynthesis+by+Aromatase+Inhibitors&doi=10.1016%2F0022-4731%2889%2990367-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">An in vitro method to determine the selective inhibition of estrogen biosynthesis by aromatase inhibitors</span></div><div class="casAuthors">Hausler A; Schenkel L; Krahenbuhl C; Monnet G; Bhatnagar A S</div><div class="citationInfo"><span class="NLM_cas:title">Journal of steroid biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-31</span>
        ISSN:<span class="NLM_cas:issn">0022-4731</span>.
    </div><div class="casAbstract">Potency and selectivity of aromatase inhibition are parameters which ultimately influence the therapeutic efficacy of aromatase inhibitors.  This report describes an in vitro model which allows an assessment of the selectivity with which aromatase inhibitors inhibit estrogen biosynthesis.  Estrogen production was stimulated by incubating adult female hamster ovarian tissue with ovine LH.  The production rates of estrogens (E), testosterone (T) and progesterone (P) were determined using radioimmunoassays to measure the amount of these steroids released into the incubation medium over a 4-hour incubation period.  The selectivity of aromatase inhibition was assessed by determining the IC50S with which each inhibitor inhibited the production of E (end product), T (immediate precursor of E) and P (early precursor of E).  Selectivity was studied for each of the 4 aromatase inhibitors, CGS 16949A (a new non-steroidal compound), 4-OH-androstenedione, aminoglutethimide and testolactone.  CGS 16949A was the most potent of the four, followed by 4-OH-androstenedione, aminoglutethimide and testolactone.  As far as selectivity was concerned, both CGS 16949A and 4-OH-androstenedione selectively inhibited aromatase judging from the IC50s for E and P production (CGS 16949A: IC50 for E & P = 0.03 & 160 microM, resp.; 4-OH-androstenedione: IC50 for E & P = 0.88 & greater than or equal to 330 microM, resp.).  Aminoglutethimide was the least selective inhibitor of aromatase (IC50 for E & P = 13 & 60 microM, resp.).  For testolactone, the least potent of the four (IC50 for E = 130 microM), no conclusive data were obtained concerning the selectivity of aromatase inhibition.  Thus a simple, effective and reproducible method is described for assessing the selectivity with which aromatase inhibitors inhibit aromatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFhjeLd4Ym9ynGiHuhFGv8fW6udTcc2eYfG1P9ucwt6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1MzktlajsA%253D%253D&md5=a58499083cdab46f25568abd546f1425</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0022-4731%2889%2990367-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-4731%252889%252990367-1%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A4usler%26aufirst%3DA.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DKr%25C3%25A4henb%25C3%25BChl%26aufirst%3DC.%26aulast%3DMonnet%26aufirst%3DG.%26aulast%3DBhatnagar%26aufirst%3DA.%26atitle%3DAn%2520in%2520Vitro%2520Method%2520to%2520Determine%2520the%2520Selective%2520Inhibition%2520of%2520Estrogen%2520Biosynthesis%2520by%2520Aromatase%2520Inhibitors%26jtitle%3DJ.%2520Steroid%2520Biochem.%26date%3D1989%26volume%3D33%26spage%3D125%26epage%3D131%26doi%3D10.1016%2F0022-4731%2889%2990367-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santner, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffcoate, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I. E.</span><span> </span><span class="NLM_article-title">Effective Inhibition by Low Dose Aminoglutethimide of Peripheral Aromatization in Postmenopausal Breast Cancer Patients</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1038/bjc.1985.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Fbjc.1985.144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=4015950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaL2M3lt1ClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1985&pages=31-35&author=M.+Dowsettauthor=S.+J.+Santnerauthor=R.+J.+Santenauthor=S.+L.+Jeffcoateauthor=I.+E.+Smith&title=Effective+Inhibition+by+Low+Dose+Aminoglutethimide+of+Peripheral+Aromatization+in+Postmenopausal+Breast+Cancer+Patients&doi=10.1038%2Fbjc.1985.144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients</span></div><div class="casAuthors">Dowsett M; Santner S J; Santen R J; Jeffcoate S L; Smith I E</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-5</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">Aminoglutethimide without glucocorticoid has been shown to be a clinically effective treatment for postmenopausal breast cancer in low dosage (250 mg day-1).  The mechanism of action of this approach is thought to be the inhibition of peripheral aromatase, the enzyme which converts androstenedione to oestrone.  The activity of this enzyme was measured in vivo by injection with 3H-androstenedione and 14C-oestrone and found to be 0.20% +/- 0.05 in 5 patients on low dose AG therapy.  In comparison with previously published data this demonstrates a 92% inhibition of peripheral aromatase activity confirming aromatase inhibition as a viable aim in the endocrine treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvz16H1bhpT4qdXsLcGTEUfW6udTcc2eZdcsFOByUEdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M3lt1ClsA%253D%253D&md5=443f9971349fee3d38aa4b62db348d78</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1985.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1985.144%26sid%3Dliteratum%253Aachs%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DSantner%26aufirst%3DS.%2BJ.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26aulast%3DJeffcoate%26aufirst%3DS.%2BL.%26aulast%3DSmith%26aufirst%3DI.%2BE.%26atitle%3DEffective%2520Inhibition%2520by%2520Low%2520Dose%2520Aminoglutethimide%2520of%2520Peripheral%2520Aromatization%2520in%2520Postmenopausal%2520Breast%2520Cancer%2520Patients%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1985%26volume%3D52%26spage%3D31%26epage%3D35%26doi%3D10.1038%2Fbjc.1985.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Santen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veldhuis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samojlik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruby, E.</span><span> </span><span class="NLM_article-title">Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1257</span><span class="NLM_x">–</span> <span class="NLM_lpage">1265</span><span class="refDoi"> DOI: 10.1210/jcem-47-6-1257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem-47-6-1257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=263348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaL3s7os1Kguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1978&pages=1257-1265&author=R.+Santenauthor=S.+Santnerauthor=B.+Davisauthor=J.+Veldhuisauthor=E.+Samojlikauthor=E.+Ruby&title=Aminoglutethimide+Inhibits+Extraglandular+Estrogen+Production+in+Postmenopausal+Women+with+Breast+Carcinoma*&doi=10.1210%2Fjcem-47-6-1257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma</span></div><div class="casAuthors">Santen R J; Santner S; Davis B; Veldhuis J; Samojlik E; Ruby E</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical endocrinology and metabolism</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1257-65</span>
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSU8gT-p8vnf36oPH0mYWL1fW6udTcc2eZdcsFOByUEdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s7os1Kguw%253D%253D&md5=749daeb3ca4ed3c89cb5494197483191</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1210%2Fjcem-47-6-1257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-47-6-1257%26sid%3Dliteratum%253Aachs%26aulast%3DSanten%26aufirst%3DR.%26aulast%3DSantner%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DVeldhuis%26aufirst%3DJ.%26aulast%3DSamojlik%26aufirst%3DE.%26aulast%3DRuby%26aufirst%3DE.%26atitle%3DAminoglutethimide%2520Inhibits%2520Extraglandular%2520Estrogen%2520Production%2520in%2520Postmenopausal%2520Women%2520with%2520Breast%2520Carcinoma%252A%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1978%26volume%3D47%26spage%3D1257%26epage%3D1265%26doi%3D10.1210%2Fjcem-47-6-1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Burnett, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, D. N.</span><span> </span><span class="NLM_article-title">Some Observations on the Preparation of 2-Hydroxy-Steroid 4-En-3 Ones</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1830</span><span class="NLM_x">–</span> <span class="NLM_lpage">1836</span><span class="refDoi"> DOI: 10.1039/p19730001830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1039%2Fp19730001830" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1973&pages=1830-1836&author=R.+D.+Burnettauthor=D.+N.+Kirk&title=Some+Observations+on+the+Preparation+of+2-Hydroxy-Steroid+4-En-3+Ones&doi=10.1039%2Fp19730001830"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2Fp19730001830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp19730001830%26sid%3Dliteratum%253Aachs%26aulast%3DBurnett%26aufirst%3DR.%2BD.%26aulast%3DKirk%26aufirst%3DD.%2BN.%26atitle%3DSome%2520Observations%2520on%2520the%2520Preparation%2520of%25202-Hydroxy-Steroid%25204-En-3%2520Ones%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1973%26volume%3D17%26spage%3D1830%26epage%3D1836%26doi%3D10.1039%2Fp19730001830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, A.</span><span> </span><span class="NLM_article-title">4-Hydroxyandrostenedione in Treatment of Postmenopausal Patients with Advanced Breast Cancer</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1237</span><span class="NLM_x">–</span> <span class="NLM_lpage">1239</span><span class="refDoi"> DOI: 10.1016/S0140-6736(84)92795-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2FS0140-6736%2884%2992795-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=1984&pages=1237-1239&author=R.+C.+Coombesauthor=P.+Gossauthor=M.+Dowsettauthor=J.+C.+Gazetauthor=A.+Brodie&title=4-Hydroxyandrostenedione+in+Treatment+of+Postmenopausal+Patients+with+Advanced+Breast+Cancer&doi=10.1016%2FS0140-6736%2884%2992795-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2884%2992795-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252884%252992795-8%26sid%3Dliteratum%253Aachs%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DGoss%26aufirst%3DP.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DGazet%26aufirst%3DJ.%2BC.%26aulast%3DBrodie%26aufirst%3DA.%26atitle%3D4-Hydroxyandrostenedione%2520in%2520Treatment%2520of%2520Postmenopausal%2520Patients%2520with%2520Advanced%2520Breast%2520Cancer%26jtitle%3DLancet%26date%3D1984%26volume%3D324%26spage%3D1237%26epage%3D1239%26doi%3D10.1016%2FS0140-6736%2884%2992795-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goss, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, A. M.</span><span> </span><span class="NLM_article-title">4-Hydroxyandrostenedione Treatment for Postmenopausal Patients with Advanced Breast Cancer</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span><span class="refDoi"> DOI: 10.1016/0039-128X(83)90075-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0039-128X%2883%2990075-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1987&pages=245-252&author=R.+C.+Coombesauthor=P.+E.+Gossauthor=M.+Dowsettauthor=G.+Hutchinsonauthor=D.+Cunninghamauthor=M.+Jarmanauthor=A.+M.+Brodie&title=4-Hydroxyandrostenedione+Treatment+for+Postmenopausal+Patients+with+Advanced+Breast+Cancer&doi=10.1016%2F0039-128X%2883%2990075-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0039-128X%2883%2990075-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0039-128X%252883%252990075-2%26sid%3Dliteratum%253Aachs%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DGoss%26aufirst%3DP.%2BE.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DHutchinson%26aufirst%3DG.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DJarman%26aufirst%3DM.%26aulast%3DBrodie%26aufirst%3DA.%2BM.%26atitle%3D4-Hydroxyandrostenedione%2520Treatment%2520for%2520Postmenopausal%2520Patients%2520with%2520Advanced%2520Breast%2520Cancer%26jtitle%3DSteroids%26date%3D1987%26volume%3D50%26spage%3D245%26epage%3D252%26doi%3D10.1016%2F0039-128X%2883%2990075-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehennin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Dose-Related Endocrine Effects and Pharmacokinetics of Oral and Intramuscular 4-Hydroxyandrostenedione in Postmenopausal Breast Cancer Patients</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span><span class="refDoi"> DOI: 10.1016/0378-5122(89)90231-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0378-5122%2889%2990231-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1989&pages=1306-1312&author=M.+Dowsettauthor=D.+C.+Cunninghamauthor=R.+C.+Steinauthor=S.+Evansauthor=L.+Dehenninauthor=A.+Hedleyauthor=R.+C.+Coombes&title=Dose-Related+Endocrine+Effects+and+Pharmacokinetics+of+Oral+and+Intramuscular+4-Hydroxyandrostenedione+in+Postmenopausal+Breast+Cancer+Patients&doi=10.1016%2F0378-5122%2889%2990231-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2F0378-5122%2889%2990231-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-5122%252889%252990231-4%26sid%3Dliteratum%253Aachs%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DCunningham%26aufirst%3DD.%2BC.%26aulast%3DStein%26aufirst%3DR.%2BC.%26aulast%3DEvans%26aufirst%3DS.%26aulast%3DDehennin%26aufirst%3DL.%26aulast%3DHedley%26aufirst%3DA.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DDose-Related%2520Endocrine%2520Effects%2520and%2520Pharmacokinetics%2520of%2520Oral%2520and%2520Intramuscular%25204-Hydroxyandrostenedione%2520in%2520Postmenopausal%2520Breast%2520Cancer%2520Patients%26jtitle%3DCancer%2520Res.%26date%3D1989%26volume%3D49%26spage%3D1306%26epage%3D1312%26doi%3D10.1016%2F0378-5122%2889%2990231-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Stein, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Treatment of Advanced Breast Cancer in Postmenopausal Women with 4-Hydroxyandrostenedione</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1007/BF02940300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2FBF02940300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2322991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK3c3htlOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1990&pages=75-78&author=R.+C.+Steinauthor=M.+Dowsettauthor=A.+Hedleyauthor=J.+Davenportauthor=J.+C.+Gazetauthor=H.+T.+Fordauthor=R.+C.+Coombes&title=Treatment+of+Advanced+Breast+Cancer+in+Postmenopausal+Women+with+4-Hydroxyandrostenedione&doi=10.1007%2FBF02940300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione</span></div><div class="casAuthors">Stein R C; Dowsett M; Hedley A; Davenport J; Gazet J C; Ford H T; Coombes R C</div><div class="citationInfo"><span class="NLM_cas:title">Cancer chemotherapy and pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-8</span>
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">4-Hydroxyandrostenedione (4-OHA), a new specific aromatase inhibitor, was used to treat 57 postmenopausal women with advanced breast cancer at a dose of 250 mg by i.m. injection every 2 weeks; 55 women were assessable for response.  In all, 18 patients (33%) had objective evidence of a response to treatment, with a median duration of 12 months; the disease stabilised in 8 (14%) patients.  Serum oestradiol levels, which were measured weekly in nine of the patients, were found to be suppressed to a mean of between 36% and 51% of pretreatment levels during the first 6 weeks of treatment.  Three patients were withdrawn from treatment because of toxicity (pain at injection site, sterile abscess and rash).  One patient had an isolated episode of anaphylaxis after 6 months of treatment.  In comparison with our previous reports of 4-OHA treatment, a dose of 250 mg given i.m. fortnightly appears to be the optimal dose regimen.  The efficacy of the drug seems to be similar to that of tamoxifen and aminoglutethimide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtCGYCvXCB4WhHGZei4OW9fW6udTcc2eZR-b0TWCy2f7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c3htlOltA%253D%253D&md5=aa22dceadf08dfdb28ad2ef47c866d2f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FBF02940300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02940300%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DR.%2BC.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DHedley%26aufirst%3DA.%26aulast%3DDavenport%26aufirst%3DJ.%26aulast%3DGazet%26aufirst%3DJ.%2BC.%26aulast%3DFord%26aufirst%3DH.%2BT.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DTreatment%2520of%2520Advanced%2520Breast%2520Cancer%2520in%2520Postmenopausal%2520Women%2520with%25204-Hydroxyandrostenedione%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1990%26volume%3D26%26spage%3D75%26epage%3D78%26doi%3D10.1007%2FBF02940300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Stein, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">The Clinical and Endocrine Effects of 4-Hydroxyandrostenedione Alone and in Combination with Goserelin in Premenopausal Women with Advanced Breast Cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span><span class="refDoi"> DOI: 10.1038/bjc.1990.356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Fbjc.1990.356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2145964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK3M%252FislCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1990&pages=679-683&author=R.+C.+Steinauthor=M.+Dowsettauthor=A.+Hedleyauthor=J.+C.+Gazetauthor=H.+T.+Fordauthor=R.+C.+Coombes&title=The+Clinical+and+Endocrine+Effects+of+4-Hydroxyandrostenedione+Alone+and+in+Combination+with+Goserelin+in+Premenopausal+Women+with+Advanced+Breast+Cancer&doi=10.1038%2Fbjc.1990.356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer</span></div><div class="casAuthors">Stein R C; Dowsett M; Hedley A; Gazet J C; Ford H T; Coombes R C</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">679-83</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">The aromatase inhibitor, 4-hydroxyandrostenedione (4OHA) is an effective treatment for advanced post-menopausal breast cancer.  The clinical and endocrine effects of 4OHA treatment were studied in five pre- and perimenopausal women with metastatic breast cancer.  Serum oestradiol levels were not significantly reduced as a result of treatment with 500 mg of 4OHA by weekly i.m. injections and no patient had a tumour response.  Four patients were subsequently treated with the luteinising hormone releasing hormone (LHRH) analogue, gosereline, and three had objective responses.  The endocrine effects of combined treatment with goserelin (Zoladex), and 4OHA were studied in a further five premenopausal women.  Serum oestradiol levels after treatment with goserelin alone were typical of post-menopausal women.  Addition of 4OHA led to a further suppression of oestradiol to within the range observed in post-menopausal patients treated with further suppression of oestradiol to within the range observed in post-menopausal patients treated with 4OHA.  Six patients whose tumours had regressed as a result of goserelin treatment and who subsequently relapsed were then given combined treatment.  Four of the six experienced a second remission.  We conclude that while 4OHA alone is unlikely to be a satisfactory treatment for premenopausal patients with advanced breast cancer, 4OHA in conjunction with goserelin leads to profound suppression of oestradiol.  The combination of LHRH analogue and aromatase inhibitor may prove to be a superior treatment to LHRH analogue alone in these patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSy1pRqlJLHcf3jf77P2BG3fW6udTcc2eZR-b0TWCy2f7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M%252FislCrsg%253D%253D&md5=dcbf6639d988d44a17231329ec1bc9c9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1990.356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1990.356%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DR.%2BC.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DHedley%26aufirst%3DA.%26aulast%3DGazet%26aufirst%3DJ.%2BC.%26aulast%3DFord%26aufirst%3DH.%2BT.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DThe%2520Clinical%2520and%2520Endocrine%2520Effects%2520of%25204-Hydroxyandrostenedione%2520Alone%2520and%2520in%2520Combination%2520with%2520Goserelin%2520in%2520Premenopausal%2520Women%2520with%2520Advanced%2520Breast%2520Cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1990%26volume%3D62%26spage%3D679%26epage%3D683%26doi%3D10.1038%2Fbjc.1990.356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Brodie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, H. J.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors and Their Use in Controlling Oestrogen-Dependent Processes</span> <span class="citation_source-journal">J. Steroid Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1016/0022-4731(79)90283-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0022-4731%2879%2990283-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=114710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaE1MXls1yqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1979&pages=107-112&author=A.+M.+Brodieauthor=D.+A.+Marshauthor=J.+T.+Wuauthor=H.+J.+Brodie&title=Aromatase+Inhibitors+and+Their+Use+in+Controlling+Oestrogen-Dependent+Processes&doi=10.1016%2F0022-4731%2879%2990283-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase inhibitors and their use in controlling estrogen-dependent processes</span></div><div class="casAuthors">Brodie, Angela M. H.; Marsh, David A.; Wu, J. T.; Brodie, Harry J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1A</span>),
    <span class="NLM_cas:pages">107-12</span>CODEN:
                <span class="NLM_cas:coden">JSTBBK</span>;
        ISSN:<span class="NLM_cas:issn">0022-4731</span>.
    </div><div class="casAbstract">In antifertility studies, rats were treated from diestrus 1 of the cycle with aromatase  [9039-48-9] inhibitors, 4-acetoxy-4-androstene-3,17-dione (I)  [61630-32-8], 4-hydroxy-4-androstene-3,17-dione  [566-48-3], and 1,4,6-androstatriene-3,17-dione  [633-35-2].  The estrogen surge and subsequent LH  [9002-67-9] surge normally occurring during proestrus were inhibited and mating and ovulation prevented.  These effects were counteracted when estradiol benzoate  [50-50-0] was administered concomitantly with aromatase inhibitors.  The compds. also retared implantation, an estrogen-dependent process in the rat, and ovarian estradiol  [50-28-2] secretion was reduced on day 4 of pregnancy.  In contrast, hamsters did not require estrogen for implantation and aromatase inhibitors were without effect.  The compds. were also highly effective in causing regression of dimethylbenzanthracene-induced, hormone-dependent, mammary tumors of the rat.  Ovarian estrogen secretion measured at the end of treatment with I was reduced compared with controls, and when supplemental estradiol was given, together with aromatase inhibitors, tumor regression was prevented.  Aromatase inhibitors apparently act in vivo to reduce estrogen prodn. by aromatase inhibition.  They thus have potential for treating estrogen-related disorders, for fertility control, and as tools for investigating the role of estrogen in physiol. and pathol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR2Wu7-6dA3bVg90H21EOLACvtfcHk0liLDpFViuZOSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXls1yqsb0%253D&md5=62cbfa21dc603adf0f39440990f27b89</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0022-4731%2879%2990283-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-4731%252879%252990283-8%26sid%3Dliteratum%253Aachs%26aulast%3DBrodie%26aufirst%3DA.%2BM.%26aulast%3DMarsh%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BT.%26aulast%3DBrodie%26aufirst%3DH.%2BJ.%26atitle%3DAromatase%2520Inhibitors%2520and%2520Their%2520Use%2520in%2520Controlling%2520Oestrogen-Dependent%2520Processes%26jtitle%3DJ.%2520Steroid%2520Biochem.%26date%3D1979%26volume%3D11%26spage%3D107%26epage%3D112%26doi%3D10.1016%2F0022-4731%2879%2990283-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briatico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giudici, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaccheo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzzetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzeri, A.</span><span> </span><span class="NLM_article-title">Novel Aromatase and 5 Alpha-Reductase Inhibitors</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1016/0960-0760(94)90270-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2894%2990270-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=8043491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFKhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1994&pages=289-294&author=E.+Di+Salleauthor=G.+Briaticoauthor=D.+Giudiciauthor=G.+Ornatiauthor=T.+Zaccheoauthor=F.+Buzzettiauthor=M.+Nesiauthor=A.+Panzeri&title=Novel+Aromatase+and+5+Alpha-Reductase+Inhibitors&doi=10.1016%2F0960-0760%2894%2990270-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel aromatase and 5α-reductase inhibitors</span></div><div class="casAuthors">Di Salle, E.; Briatico, G.; Giudici, D.; Ornati, G.; Zaccheo, T.; Buzzetti, F.; Nesi, M.; Panzeri, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">289-94</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">Inhibitors of aromatase and 5α-reductase may be of use for the therapy of postmenopausal breast cancer and benign prostatic hyperplasia, resp.  FCE 27993 is a novel steroidal irreversible aromatase inhibitor structurally related to exemestane (FCE 24304).  The compd. was found to be a very potent competitive inhibitor of human placental aromatase, with a Ki of 7.2 nM (4.3 nM for exemestane).  In preincubation studies with placental aromatase FCE 27993, like exemestane, was found to cause time-dependent inhibition with a higher rate of inactivation (t1/2 4.5 vs 15.1 min) and a similar Ki(inact) (56 vs 66 nM).  The compd. was found to have a very low binding affinity to the androgen receptor (RBA 0.09% of dihydrotestosterone) and, in contrast to exemestane, no androgenic activity up to 100 mg/kg/day s.c. in immature castrated rats.  Among a series of novel 4-azasteroids with fluoro-substituted-17β-amidic side chains, three compds., namely FCE 28260, FCE 28175 and FCE 27837, were identified as potent in vitro and in vivo inhibitors of prostatic 5α-reductase.  Their IC50 values were found to be 16, 38 and 51 nM for the inhibition of the human enzyme, and 15, 20 and 60 nM for the inhibition of the rat enzyme, resp.  When given orally for 7 days in castrated and testosterone (Silastic implants) supplemented rats, the new compds. were very effective in reducing prostate growth.  At a dose of 0.3 mg/kg/day inhibitions of 42, 36 and 41% were caused by FCE 28260, FCE 28175 and FCE 27837, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe1POpwjBSaLVg90H21EOLACvtfcHk0ljBJunNgZ0heQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFKhs7w%253D&md5=9575b614af25a96aaddeeedfdc695ce1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2894%2990270-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252894%252990270-4%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BSalle%26aufirst%3DE.%26aulast%3DBriatico%26aufirst%3DG.%26aulast%3DGiudici%26aufirst%3DD.%26aulast%3DOrnati%26aufirst%3DG.%26aulast%3DZaccheo%26aufirst%3DT.%26aulast%3DBuzzetti%26aufirst%3DF.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DPanzeri%26aufirst%3DA.%26atitle%3DNovel%2520Aromatase%2520and%25205%2520Alpha-Reductase%2520Inhibitors%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1994%26volume%3D49%26spage%3D289%26epage%3D294%26doi%3D10.1016%2F0960-0760%2894%2990270-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Santen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langecker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swerdloff, R.</span><span> </span><span class="NLM_article-title">Potency and Specificity of CGS-16949A as an Aromatase Inhibitor</span> <span class="citation_source-journal">Endocr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span><span class="refDoi"> DOI: 10.1080/07435809009035921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1080%2F07435809009035921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2139412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK3cXitFSlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1990&pages=77-91&author=R.+Santenauthor=P.+Langeckerauthor=S.+Santnerauthor=S.+Sikkaauthor=J.+Rajferauthor=R.+Swerdloff&title=Potency+and+Specificity+of+CGS-16949A+as+an+Aromatase+Inhibitor&doi=10.1080%2F07435809009035921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Potency and specificity of CGS-16949A as an aromatase inhibitor</span></div><div class="casAuthors">Santen, R. J.; Langecker, P.; Santner, S. J.; Sikka, S.; Rajfer, J.; Swerdloff, R.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-91</span>CODEN:
                <span class="NLM_cas:coden">ENRSE8</span>;
        ISSN:<span class="NLM_cas:issn">0743-5800</span>.
    </div><div class="casAbstract">The potency and specificity of a new aromatase inhibitor, CGS-16949A, were compared with that of aminoglutethimide in a variety of in vitro enzyme prepns.  CGS-16949A blocked aromatase by 50% in human breast cancer homogenates, live breast cancer cells, human placental microsomes and porcine ovarian microsomes at concns. of 0.008 to 0.02 μM.  In contrast, concns. of 10-25 μM of aminoglutethimide were required to inhibit aromatase similarly in these tissues.  For human placental microsomes, the Ki for CGS 16949A was 0.17 nM and for aminoglutethimide, 0.54 μM.  Preincubation studies indicated that CGS-16949A acts by a competitive inhibitory mechanism and not by "suicide inhibitory" properties.  With respect to specificity, CGS-16949A had no effect on cholesterol side-chain cleavage activity in rat testicular mitochondria.  A 54% redn. in enzyme activity was obsd. in adrenal mitochondria but only at concns. 5 orders of magnitude higher (i.e. 100 μM) than required to inhibit aromatase.  In contrast, 10 μM concns. of aminoglutethimide blocked cholesterol side-chain cleavage activity in rat testicular and adrenal mitochondria by 67 and 91%, resp.  These data suggest that CGS-16949A has favorable properties as a specific and potent aromatase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWRfSJqz10mLVg90H21EOLACvtfcHk0ljBJunNgZ0heQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFSlsLg%253D&md5=b5db121c5ba4f8102aefb99bf43a418f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1080%2F07435809009035921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07435809009035921%26sid%3Dliteratum%253Aachs%26aulast%3DSanten%26aufirst%3DR.%26aulast%3DLangecker%26aufirst%3DP.%26aulast%3DSantner%26aufirst%3DS.%26aulast%3DSikka%26aufirst%3DS.%26aulast%3DRajfer%26aufirst%3DJ.%26aulast%3DSwerdloff%26aufirst%3DR.%26atitle%3DPotency%2520and%2520Specificity%2520of%2520CGS-16949A%2520as%2520an%2520Aromatase%2520Inhibitor%26jtitle%3DEndocr.%2520Res.%26date%3D1990%26volume%3D16%26spage%3D77%26epage%3D91%26doi%3D10.1080%2F07435809009035921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Browne, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnager, A.</span><span> </span><span class="NLM_article-title">Fadrozole Hydrochloride: A Potent, Selective, Nonsteroidal Inhibitor of Aromatase for the Treatment of Estrogen-Dependent Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span><span class="refDoi"> DOI: 10.1021/jm00106a038</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00106a038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=725-736&author=L.+J.+Browneauthor=C.+Gudeauthor=H.+Rodriguezauthor=R.+E.+Steeleauthor=A.+Bhatnager&title=Fadrozole+Hydrochloride%3A+A+Potent%2C+Selective%2C+Nonsteroidal+Inhibitor+of+Aromatase+for+the+Treatment+of+Estrogen-Dependent+Disease&doi=10.1021%2Fjm00106a038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm00106a038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00106a038%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DL.%2BJ.%26aulast%3DGude%26aufirst%3DC.%26aulast%3DRodriguez%26aufirst%3DH.%26aulast%3DSteele%26aufirst%3DR.%2BE.%26aulast%3DBhatnager%26aufirst%3DA.%26atitle%3DFadrozole%2520Hydrochloride%253A%2520A%2520Potent%252C%2520Selective%252C%2520Nonsteroidal%2520Inhibitor%2520of%2520Aromatase%2520for%2520the%2520Treatment%2520of%2520Estrogen-Dependent%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D725%26epage%3D736%26doi%3D10.1021%2Fjm00106a038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Bossche, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moereels, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koymans, L. M.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors—Mechanisms for Non-Steroidal Inhibitors</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1007/BF00682740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2FBF00682740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=7949204" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1994&pages=43-55&author=H.+V.+Bosscheauthor=H.+Moereelsauthor=L.+M.+Koymans&title=Aromatase+Inhibitors%E2%80%94Mechanisms+for+Non-Steroidal+Inhibitors&doi=10.1007%2FBF00682740"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2FBF00682740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00682740%26sid%3Dliteratum%253Aachs%26aulast%3DBossche%26aufirst%3DH.%2BV.%26aulast%3DMoereels%26aufirst%3DH.%26aulast%3DKoymans%26aufirst%3DL.%2BM.%26atitle%3DAromatase%2520Inhibitors%25E2%2580%2594Mechanisms%2520for%2520Non-Steroidal%2520Inhibitors%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1994%26volume%3D30%26spage%3D43%26epage%3D55%26doi%3D10.1007%2FBF00682740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Santen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demers, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adlercreutz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, A.</span><span> </span><span class="NLM_article-title">Inhibition of Aromatase with CGS 16949A in Postmenopausal Women</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1210/jcem-68-1-99</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem-68-1-99" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2521224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaL1MXhtVOksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1989&pages=99-106&author=R.+J.+Santenauthor=L.+M.+Demersauthor=H.+Adlercreutzauthor=H.+Harveyauthor=S.+Santnerauthor=S.+Sandersauthor=A.+Lipton&title=Inhibition+of+Aromatase+with+CGS+16949A+in+Postmenopausal+Women&doi=10.1210%2Fjcem-68-1-99"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of aromatase with CGS 16949A in postmenopausal women</span></div><div class="casAuthors">Santen, R. J.; Demers, L. M.; Adlercreutz, H.; Harvey, H.; Santner, S.; Sanders, S.; Lipton, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-106</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">The effects of CGS 16949 (I), a nonsteroidal inhibitor of aromatase activity were evaluated, in postmenopausal women with breast cancer by measuring plasma and/or urinary androgens and estrogens after oral administration at 0.6-16 mg daily, given for 2 wk.  The 0.6-mg daily dose partially lowered estrogen levels, and max. redn. occurred at 2-16 mg daily.  The fall in plasma and urinary estrogens without a concomitant fall in plasma androgens confirmed the blockade of aromatase activity.  The degree of estrogen redn. was greatest for urinary estrone, followed in order by plasma estrone sulfate, plasma estrone, urine estradiol, and plasma estradiol.  Use of gas liq. chromatog.-mass spectrometry techniques revealed similar patterns of redn. in catechol estrogens, estriol, and total urinary estrogens, suggesting that CGS 16949A does not alter the pathways of estrogen metab.  The degree of estrogen redn. was remarkably similar to that caused with aminoglutethimide.  At 4-16 mg daily, CGS 16949A inhibited the C21-hydroxylase enzyme as well, based on concomitant rises in plasma androstenedione, testosterone, and 17α-hydroxyprogesterone.  This effect was insufficient to lower urinary cortisol excretion during the study.  However, a blunting of plasma cortisol responses to ACTH occurred with the 16-mg daily dose.  No changes in plasma dehydroepiandrosterone sulfate levels or in thyroid, hematol., liver, or renal parameters were found.  No side-effects of the medication were encountered.  CGS 16949A appears to be a specific inhibitor of aromatase at <4 mg daily and to lack apparent side-effects or toxic actions at ≤16 mg daily.  This agent shows promise as a potent aromatase inhibitor for physiol. and clin. studies, and to be useful for the treatment of breast cancer and other disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxq61cvYJMgbVg90H21EOLACvtfcHk0lj7zq6HDxRGbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtVOksbo%253D&md5=aab246213f8d762a4b0777e94da3129e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1210%2Fjcem-68-1-99&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-68-1-99%26sid%3Dliteratum%253Aachs%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26aulast%3DDemers%26aufirst%3DL.%2BM.%26aulast%3DAdlercreutz%26aufirst%3DH.%26aulast%3DHarvey%26aufirst%3DH.%26aulast%3DSantner%26aufirst%3DS.%26aulast%3DSanders%26aufirst%3DS.%26aulast%3DLipton%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520Aromatase%2520with%2520CGS%252016949A%2520in%2520Postmenopausal%2520Women%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1989%26volume%3D68%26spage%3D99%26epage%3D106%26doi%3D10.1210%2Fjcem-68-1-99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Lipton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demers, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanagan, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulagha, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochak, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzsimmons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span> </span><span class="NLM_article-title">A Phase I Trial of CGS 16949A. A New Aromatase Inhibitor</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1285</span><span class="refDoi"> DOI: 10.1002/1097-0142(19900315)65:6<1279::AID-CNCR2820650604>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2F1097-0142%2819900315%2965%3A6%3C1279%3A%3AAID-CNCR2820650604%3E3.0.CO%3B2-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1990&pages=1279-1285&author=A.+Liptonauthor=H.+A.+Harveyauthor=L.+M.+Demersauthor=J.+R.+Hanaganauthor=M.+T.+Mulaghaauthor=G.+M.+Kochakauthor=S.+Fitzsimmonsauthor=S.+I.+Sandersauthor=R.+J.+Santen&title=A+Phase+I+Trial+of+CGS+16949A.+A+New+Aromatase+Inhibitor&doi=10.1002%2F1097-0142%2819900315%2965%3A6%3C1279%3A%3AAID-CNCR2820650604%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2F1097-0142%2819900315%2965%3A6%3C1279%3A%3AAID-CNCR2820650604%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0142%252819900315%252965%253A6%253C1279%253A%253AAID-CNCR2820650604%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DA.%26aulast%3DHarvey%26aufirst%3DH.%2BA.%26aulast%3DDemers%26aufirst%3DL.%2BM.%26aulast%3DHanagan%26aufirst%3DJ.%2BR.%26aulast%3DMulagha%26aufirst%3DM.%2BT.%26aulast%3DKochak%26aufirst%3DG.%2BM.%26aulast%3DFitzsimmons%26aufirst%3DS.%26aulast%3DSanders%26aufirst%3DS.%2BI.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26atitle%3DA%2520Phase%2520I%2520Trial%2520of%2520CGS%252016949A.%2520A%2520New%2520Aromatase%2520Inhibitor%26jtitle%3DCancer%26date%3D1990%26volume%3D65%26spage%3D1279%26epage%3D1285%26doi%3D10.1002%2F1097-0142%2819900315%2965%3A6%3C1279%3A%3AAID-CNCR2820650604%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Potency and Selectivity of the Non-Steroidal Aromatase Inhibitor CGS 16949A in Postmenopausal Breast Cancer Patients</span> <span class="citation_source-journal">Clin. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span><span class="refDoi"> DOI: 10.1111/j.1365-2265.1990.tb00906.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1111%2Fj.1365-2265.1990.tb00906.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2142026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK3czgsFWqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1990&pages=623-634&author=M.+Dowsettauthor=R.+C.+Steinauthor=A.+Mehtaauthor=R.+C.+Coombes&title=Potency+and+Selectivity+of+the+Non-Steroidal+Aromatase+Inhibitor+CGS+16949A+in+Postmenopausal+Breast+Cancer+Patients&doi=10.1111%2Fj.1365-2265.1990.tb00906.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients</span></div><div class="casAuthors">Dowsett M; Stein R C; Mehta A; Coombes R C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical endocrinology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">623-34</span>
        ISSN:<span class="NLM_cas:issn">0300-0664</span>.
    </div><div class="casAbstract">A selective inhibitor of aromatase is widely sought for the treatment of postmenopausal women with breast cancer.  CGS 16949A has been shown to be a highly selective, potent inhibitor of aromatase in vitro.  Its potency as an oestrogen suppressant and its selectivity were examined by treating 24 postmenopausal patients with advanced breast cancer for 4 weeks with doses of 0.3, 1.0 and 2.0 mg twice daily.  The study was conducted in two parts which compared the two lower doses and the two higher doses separately in a cross-over design protocol.  All doses significantly suppressed serum oestradiol and oestrone levels below pretreatment levels.  Cross-over analysis indicated that the 2.0 mg twice daily dose achieved significantly greater suppression of oestradiol levels than 0.1 mg twice daily but there was no significant differences between any of the doses in the suppression of oestrone.  No significant effects were noted on serum levels of LH, FSH, SHBG, prolactin, testosterone, androstenedione, 17-hydroxyprogesterone or cortisol.  For the four steroids this was true both for basal samples and those collected after Synacthen stimulation.  However, serum aldosterone levels were significantly suppressed by 1.0 mg twice daily CGS 16949A and further suppressed by 2.0 mg twice daily.  It is concluded that CGS 16949A is a potent oestrogen suppressant in postmenopausal patients but that its effect is not totally selective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhFUz3M74neYUSrryheKE6fW6udTcc2eZm7Z3kUaFTQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3czgsFWqsg%253D%253D&md5=1296c601596b6c535f2f0e217d2f42b8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2265.1990.tb00906.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2265.1990.tb00906.x%26sid%3Dliteratum%253Aachs%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DStein%26aufirst%3DR.%2BC.%26aulast%3DMehta%26aufirst%3DA.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DPotency%2520and%2520Selectivity%2520of%2520the%2520Non-Steroidal%2520Aromatase%2520Inhibitor%2520CGS%252016949A%2520in%2520Postmenopausal%2520Breast%2520Cancer%2520Patients%26jtitle%3DClin.%2520Endocrinol.%26date%3D1990%26volume%3D32%26spage%3D623%26epage%3D634%26doi%3D10.1111%2Fj.1365-2265.1990.tb00906.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Stein, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Preliminary Study of the Treatment of Advanced Breast Cancer in Postmenopausal Women with the Aromatase Inhibitor CGS 16949A</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=1381-1384&author=R.+C.+Steinauthor=M.+Dowsettauthor=J.+Davenportauthor=A.+Hedleyauthor=H.+T.+Fordauthor=J.+C.+Gazetauthor=R.+C.+Coombes&title=Preliminary+Study+of+the+Treatment+of+Advanced+Breast+Cancer+in+Postmenopausal+Women+with+the+Aromatase+Inhibitor+CGS+16949A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DR.%2BC.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DDavenport%26aufirst%3DJ.%26aulast%3DHedley%26aufirst%3DA.%26aulast%3DFord%26aufirst%3DH.%2BT.%26aulast%3DGazet%26aufirst%3DJ.%2BC.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DPreliminary%2520Study%2520of%2520the%2520Treatment%2520of%2520Advanced%2520Breast%2520Cancer%2520in%2520Postmenopausal%2520Women%2520with%2520the%2520Aromatase%2520Inhibitor%2520CGS%252016949A%26jtitle%3DCancer%2520Res.%26date%3D1990%26volume%3D50%26spage%3D1381%26epage%3D1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Santen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demers, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulagha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanagan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garber, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navari, R. M.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Specificity of Low Dose Fadrozole Hydrochloride (CGS 16949A) as an Aromatase Inhibitor</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1210/jcem-73-1-99</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem-73-1-99" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1646219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK3M3lvVGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1991&pages=99-106&author=R.+J.+Santenauthor=L.+M.+Demersauthor=J.+Lynchauthor=H.+Harveyauthor=A.+Liptonauthor=M.+Mulaghaauthor=J.+Hanaganauthor=J.+E.+Garberauthor=I.+C.+Hendersonauthor=R.+M.+Navari&title=Specificity+of+Low+Dose+Fadrozole+Hydrochloride+%28CGS+16949A%29+as+an+Aromatase+Inhibitor&doi=10.1210%2Fjcem-73-1-99"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor</span></div><div class="casAuthors">Santen R J; Demers L M; Lynch J; Harvey H; Lipton A; Mulagha M; Hanagan J; Garber J E; Henderson I C; Navari R M; et al</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical endocrinology and metabolism</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-106</span>
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">CGS 16949A (fadrozole hydrochloride), a potent cytochrome P450-mediated steroidogenesis inhibitor, blocks aromatase at low doses, but other biosynthetic steps at higher concentrations.  Recent studies demonstrated inhibition of C11-hydroxylase, corticosterone methyloxidase-II, and deoxycorticosterone to corticosterone conversion with this agent at some-what higher concentrations than those required for blockade of aromatase.  Based upon phase I studies, we postulated that relatively selective inhibition of aromatase might be possible if sufficiently low doses of CGS 16949A were used.  A phase II study in 54 postmenopausal women with metastatic breast cancer examined the effects of low dose CGS 16949A on estrogen, mineralocorticoid, and glucocorticoid secretion.  Two dose schedules and two dose levels were chosen based upon our prior dose escalation protocol study.  Plasma estrone, estradiol, and estrone sulfate as well as urinary estrone and estradiol fell equally with 1.8-4 mg CGS 16949A given either on a twice daily or three times daily dose schedule.  Isotopic kinetic studies demonstrated an 84% decrease in the rate of conversion of androstenedione to estrone to 0.40 +/- 0.07% (patients receiving 1.8-4 mg CGS 16949A daily).  With these three regimens, basal levels of aldosterone and cortisol did not change significantly over a 12-week period of observation.  Clinical examination, plasma electrolytes, and urinary sodium/potassium ratios suggested no biological evidence of mineralo-corticoid deficiency.  ACTH-stimulated cortisol concentrations, however, were blunted at each dose level compared to pretreatment values.  Nonetheless, peak responses exceeded 550 nmol/L, or a basal to peak difference of 190 nmol/L or greater, in 97% of instances.  This probably reflected inhibition of C11-hydroxylase, since basal and ACTH-stimulated levels of 11-deoxycortisol were increased in response to CGS 16949A.  Androstenedione and 17 alpha-hydroxyprogesterone also exhibited an upward trend in response to drug treatment.  ACTH-stimulated aldosterone levels were blunted to a greater extent than those of cortisol, probably as a reflection of corticosterone methyloxidase type II blockade.  Overall, the results suggest that CGS 16949A, at doses of 1.8-2 mg daily, blocks aromatase effectively and does not produce clinically important inhibition of cortisol or aldosterone biosynthesis.  Thus, this agent can probably be used safely without glucocorticoid or mineralocorticoid supplementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSG3H0oyaye84FEOhA_Im3cfW6udTcc2ea1Xf9qSJqVMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3lvVGitw%253D%253D&md5=49734a62d6a4be5f05ffb6e5e0853cc6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1210%2Fjcem-73-1-99&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-73-1-99%26sid%3Dliteratum%253Aachs%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26aulast%3DDemers%26aufirst%3DL.%2BM.%26aulast%3DLynch%26aufirst%3DJ.%26aulast%3DHarvey%26aufirst%3DH.%26aulast%3DLipton%26aufirst%3DA.%26aulast%3DMulagha%26aufirst%3DM.%26aulast%3DHanagan%26aufirst%3DJ.%26aulast%3DGarber%26aufirst%3DJ.%2BE.%26aulast%3DHenderson%26aufirst%3DI.%2BC.%26aulast%3DNavari%26aufirst%3DR.%2BM.%26atitle%3DSpecificity%2520of%2520Low%2520Dose%2520Fadrozole%2520Hydrochloride%2520%2528CGS%252016949A%2529%2520as%2520an%2520Aromatase%2520Inhibitor%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1991%26volume%3D73%26spage%3D99%26epage%3D106%26doi%3D10.1210%2Fjcem-73-1-99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Raats, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falkson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falkson, H. C.</span><span> </span><span class="NLM_article-title">A Study of Fadrozole, a New Aromatase Inhibitor, in Postmenopausal Women with Advanced Metastatic Breast Cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1530798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK38%252Fpt1Smsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1992&pages=111-116&author=J.+I.+Raatsauthor=G.+Falksonauthor=H.+C.+Falkson&title=A+Study+of+Fadrozole%2C+a+New+Aromatase+Inhibitor%2C+in+Postmenopausal+Women+with+Advanced+Metastatic+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer</span></div><div class="casAuthors">Raats J I; Falkson G; Falkson H C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-6</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">PURPOSE:  The study investigated the therapeutic effects of fadrozole (CGS 16949A), a new aromatase inhibitor, in women who had received prior treatment for metastatic breast cancer.  MATERIALS AND METHODS:  Eighty postmenopausal women who had received prior treatment for metastatic breast cancer were randomized to receive fadrozole 1 mg/d or 4 mg/d per day orally.  Seventy-eight patients were assessable for toxicity and response.  RESULTS:  Toxicity was limited to mild (grade 1) to moderate (grade 2) hot flashes in 28%, nausea and vomiting in 13%, fatigue in 8%, and mild loss of appetite in 5% of patients.  No electrolyte or unanticipated hormonal changes occurred.  The overall response was 23% (complete response, 10%; partial response, 13%).  In addition, 45% of the patients had a no change status.  There was no difference in response rate between the patients randomized to the two different doses of fadrozole.  Only dominant site of metastases significantly affected response.  The median time to treatment failure (TTF) was 4.4 months (4.7 months on 1 mg/d and 3.7 months on 4 mg/d).  The median survival was 22.6 months (17.5 months on 1 mg/d; median survival has not been reached in patients on 4 mg/d).  The response and survival in patients with estrogen receptor (ER)-positive and ER-unknown disease were not significantly different.  CONCLUSIONS:  Fadrozole has good therapeutic effect as a second-line treatment in postmenopausal women with metastatic breast cancer.  In this study there was no significant difference in toxicity or response between 1 mg/d and 4 mg/d.  Further trials comparing fadrozole to other hormone treatment are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDFxhnqm7MlIFEOhA_Im3cfW6udTcc2ea1Xf9qSJqVMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38%252Fpt1Smsw%253D%253D&md5=6a702f198ab97dff12812e224eccf309</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaats%26aufirst%3DJ.%2BI.%26aulast%3DFalkson%26aufirst%3DG.%26aulast%3DFalkson%26aufirst%3DH.%2BC.%26atitle%3DA%2520Study%2520of%2520Fadrozole%252C%2520a%2520New%2520Aromatase%2520Inhibitor%252C%2520in%2520Postmenopausal%2520Women%2520with%2520Advanced%2520Metastatic%2520Breast%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D1992%26volume%3D10%26spage%3D111%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Miller, W. R.</span><span> </span><span class="NLM_article-title">Biology of Aromatase Inhibitors: Pharmacology/Endocrinology within the Breast</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1677/erc.0.0060187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1677%2Ferc.0.0060187" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=187-195&author=W.+R.+Miller&title=Biology+of+Aromatase+Inhibitors%3A+Pharmacology%2FEndocrinology+within+the+Breast&doi=10.1677%2Ferc.0.0060187"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1677%2Ferc.0.0060187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Ferc.0.0060187%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DW.%2BR.%26atitle%3DBiology%2520of%2520Aromatase%2520Inhibitors%253A%2520Pharmacology%252FEndocrinology%2520within%2520the%2520Breast%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D1999%26volume%3D6%26spage%3D187%26epage%3D195%26doi%3D10.1677%2Ferc.0.0060187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Brodie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njar, V. C.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors in Advanced Breast Cancer: Mechanism of Action and Clinical Implications</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1016/S0960-0760(98)00022-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2FS0960-0760%2898%2900022-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=9712406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK1cXkvV2gs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1998&pages=1-10&author=A.+M.+Brodieauthor=V.+C.+Njar&title=Aromatase+Inhibitors+in+Advanced+Breast+Cancer%3A+Mechanism+of+Action+and+Clinical+Implications&doi=10.1016%2FS0960-0760%2898%2900022-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications</span></div><div class="casAuthors">Brodie, Angela M. H.; Njar, Vincent C. O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 84 refs.  A no. of potent and selective inhibitors of aromatase have been developed that possess impressive pharmacol. and clin. properties in breast tumors.  Three compds., formestane, anastrozole, and letrozole, are now available for use in treatment of advanced breast cancer in postmenopausal women.  Other promising aromatase inhibitors are presently in clin. trials.  As drug resistance remains a major problem in cancer treatment, the variety of well-tolerated aromatase inhibitors with differing chem. structures offers the possibility that several useful drugs will be available for extending the treatment of breast cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovYubbfg1MrLVg90H21EOLACvtfcHk0lhlSWnq4g0QVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvV2gs74%253D&md5=53296b1a231cdc13af8aa3d979ae0961</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2898%2900022-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252898%252900022-3%26sid%3Dliteratum%253Aachs%26aulast%3DBrodie%26aufirst%3DA.%2BM.%26aulast%3DNjar%26aufirst%3DV.%2BC.%26atitle%3DAromatase%2520Inhibitors%2520in%2520Advanced%2520Breast%2520Cancer%253A%2520Mechanism%2520of%2520Action%2520and%2520Clinical%2520Implications%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D66%26spage%3D1%26epage%3D10%26doi%3D10.1016%2FS0960-0760%2898%2900022-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Gibson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliss, J. M.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors for Treatment of Advanced Breast Cancer in Postmenopausal Women</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD003370</span><span class="refDoi"> DOI: 10.1002/14651858.CD003370.pub2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2F14651858.CD003370.pub2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=CD003370&author=L.+J.+Gibsonauthor=C.+Dawsonauthor=D.+H.+Lawrenceauthor=J.+M.+Bliss&title=Aromatase+Inhibitors+for+Treatment+of+Advanced+Breast+Cancer+in+Postmenopausal+Women&doi=10.1002%2F14651858.CD003370.pub2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD003370.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD003370.pub2%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DL.%2BJ.%26aulast%3DDawson%26aufirst%3DC.%26aulast%3DLawrence%26aufirst%3DD.%2BH.%26aulast%3DBliss%26aufirst%3DJ.%2BM.%26atitle%3DAromatase%2520Inhibitors%2520for%2520Treatment%2520of%2520Advanced%2520Breast%2520Cancer%2520in%2520Postmenopausal%2520Women%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2007%26spage%3DCD003370%26doi%3D10.1002%2F14651858.CD003370.pub2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbuta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, H. M.</span><span> </span><span class="NLM_article-title">Novel Aromatase Inhibitors by Structure-Guided Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8464</span><span class="NLM_x">–</span> <span class="NLM_lpage">8476</span><span class="refDoi"> DOI: 10.1021/jm300930n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300930n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12ru7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8464-8476&author=D.+Ghoshauthor=J.+Loauthor=D.+Mortonauthor=D.+Valetteauthor=J.+Xiauthor=J.+Griswoldauthor=S.+Hubbellauthor=C.+Egbutaauthor=W.+Jiangauthor=J.+Anauthor=H.+M.+Davies&title=Novel+Aromatase+Inhibitors+by+Structure-Guided+Design&doi=10.1021%2Fjm300930n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Aromatase Inhibitors by Structure-Guided Design</span></div><div class="casAuthors">Ghosh, Debashis; Lo, Jessica; Morton, Daniel; Valette, Damien; Xi, Jingle; Griswold, Jennifer; Hubbell, Susan; Egbuta, Chinaza; Jiang, Wenhua; An, Jing; Davies, Huw M. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8464-8476</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human cytochrome P 450 aromatase catalyzes with high specificity the synthesis of estrogens from androgens.  Aromatase inhibitors (AIs) such as exemestane, 6-methylideneandrosta-1,4-diene-3,17-dione, are preeminent drugs for the treatment of estrogen-dependent breast cancer.  The crystal structure of human placental aromatase has shown an androgen-specific active site.  By utilization of the structural data, novel C6-substituted androsta-1,4-diene-3,17-dione inhibitors have been designed.  Several of the C6-substituted 2-alkynyloxy compds. inhibit purified placental aromatase with IC50 values in the nanomolar range.  Antiproliferation studies in a MCF-7 breast cancer cell line demonstrate that some of these compds. have EC50 values better than 1 nM, exceeding that for exemestane.  X-ray structures of aromatase complexes of two potent compds. reveal that, per their design, the novel side groups protrude into the opening to the access channel unoccupied in the enzyme-substrate/exemestane complexes.  The obsd. structure-activity relationship is borne out by the x-ray data.  Structure-guided design permits utilization of the aromatase-specific interactions for the development of next generation AIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6lNS6WadtgLVg90H21EOLACvtfcHk0lhlSWnq4g0QVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12ru7bN&md5=4417d055eedf62bf196f5f0172067585</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm300930n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300930n%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DMorton%26aufirst%3DD.%26aulast%3DValette%26aufirst%3DD.%26aulast%3DXi%26aufirst%3DJ.%26aulast%3DGriswold%26aufirst%3DJ.%26aulast%3DHubbell%26aufirst%3DS.%26aulast%3DEgbuta%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DAn%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DH.%2BM.%26atitle%3DNovel%2520Aromatase%2520Inhibitors%2520by%2520Structure-Guided%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8464%26epage%3D8476%26doi%3D10.1021%2Fjm300930n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Egbuta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Mechanism of Inhibition of Estrogen Biosynthesis by Azole Fungicides</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">4622</span><span class="NLM_x">–</span> <span class="NLM_lpage">4628</span><span class="refDoi"> DOI: 10.1210/en.2014-1561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fen.2014-1561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=25243857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsVOntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=4622-4628&author=C.+Egbutaauthor=J.+Loauthor=D.+Ghosh&title=Mechanism+of+Inhibition+of+Estrogen+Biosynthesis+by+Azole+Fungicides&doi=10.1210%2Fen.2014-1561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of inhibition of estrogen biosynthesis by azole fungicides</span></div><div class="casAuthors">Egbuta, Chinaza; Lo, Jessica; Ghosh, Debashis</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4622-4628, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">1945-7170</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Biosynthesis of estrogens from androgens is catalyzed by cytochrome P 450 aromatase.  Aromatase inhibition by the triazole compds. letrozole (LTZ) and anastrozole is a prevalent therapy for estrogen-dependent postmenopausal breast cancer.  Azoles are widely used as agricultural fungicides and antimycotic drugs that target 14α-demethylase.  Some were previously shown to inhibit aromatase, thereby raising the possibility of endocrine disruptive effects.  However, mechanistic anal. of their inhibition has never been undertaken.  We have evaluated the inhibitory effects of 3 common fungicides, bifonazole, imazalil, and flusilazole, in human aromatase purified from placenta and compared them with LTZ, the most potent inhibitor of aromatase.  Bifonazole exhibits strong inhibitory effects with an IC50 of 270nM and Ki (Michaeles-Menten inhibition const.) of 68nM, compared with 10nM and 13nM, resp., for LTZ.  The IC50 and Ki are 1100nM and 278nM for imazilil and 3200nM and 547nM for flusilazole, resp.  Analyses of inhibition kinetics suggest that the modes of inhibition by azole fungicides are mixed or competitive, whereas LTZ inhibition could be noncompetitive or mixed.  We interpret the inhibition mechanism in the context of the x-ray structure of aromatase-androstenedione complex.  Structural data show that aromatase has 3 binding pockets in relation to the heme.  The substrate-binding cavity at the heme-distal site closely compliments the structures of the natural substrate, androstenedione, and steroidal aromatase inhibitors.  Because the structures of LTZ and the azole fungicides are entirely dissimilar to the androstenedione backbone, the azoles possibly inhibit by binding to a structurally rearranged active site, the 2 other catalytically important sites, or both, in agreement with the kinetics data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoirx-jImpAnbVg90H21EOLACvtfcHk0ljVGqweNbs8uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsVOntA%253D%253D&md5=b0e5b6a2a92f87dd112b9abefbb42bc3</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1210%2Fen.2014-1561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2014-1561%26sid%3Dliteratum%253Aachs%26aulast%3DEgbuta%26aufirst%3DC.%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DMechanism%2520of%2520Inhibition%2520of%2520Estrogen%2520Biosynthesis%2520by%2520Azole%2520Fungicides%26jtitle%3DEndocrinology%26date%3D2014%26volume%3D155%26spage%3D4622%26epage%3D4628%26doi%3D10.1210%2Fen.2014-1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Goss, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingle, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sledge, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabaglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Souza, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalchal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spadafora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liedke, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelmon, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, L. E.</span><span> </span><span class="NLM_article-title">Exemestane Versus Anastrozole in Postmenopausal Women with Early Breast Cancer: NCIC CTG MA.27--a Randomized Controlled Phase Iii Trial</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1398</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span><span class="refDoi"> DOI: 10.1200/JCO.2012.44.7805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1200%2FJCO.2012.44.7805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=23358971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt12rtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=1398-1404&author=P.+E.+Gossauthor=J.+N.+Ingleauthor=K.+I.+Pritchardauthor=M.+J.+Ellisauthor=G.+W.+Sledgeauthor=G.+T.+Buddauthor=M.+Rabaglioauthor=R.+H.+Ansariauthor=D.+B.+Johnsonauthor=R.+Tozerauthor=D.+P.+D%E2%80%99Souzaauthor=H.+Chalchalauthor=S.+Spadaforaauthor=V.+Stearnsauthor=E.+A.+Perezauthor=P.+E.+Liedkeauthor=I.+Langauthor=C.+Elliottauthor=K.+A.+Gelmonauthor=J.+A.+Chapmanauthor=L.+E.+Shepherd&title=Exemestane+Versus+Anastrozole+in+Postmenopausal+Women+with+Early+Breast+Cancer%3A+NCIC+CTG+MA.27%2D%2Da+Randomized+Controlled+Phase+Iii+Trial&doi=10.1200%2FJCO.2012.44.7805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27-a randomized controlled phase III trial</span></div><div class="casAuthors">Goss, Paul E.; Ingle, James N.; Pritchard, Kathleen I.; Ellis, Matthew J.; Sledge, George W.; Budd, G. Thomas; Rabaglio, Manuela; Ansari, Rafat H.; Johnson, David B.; Tozer, Richard; D'Souza, David P.; Chalchal, Haji; Spadafora, Silvana; Stearns, Vered; Perez, Edith A.; Liedke, Pedro E. R.; Lang, Istvan; Elliott, Catherine; Gelmon, Karen A.; Chapman, Judy-Anne W.; Shepherd, Lois E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1398-1404</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: In patients with hormone-dependent postmenopausal breast cancer, std. adjuvant therapy involves 5 years of the nonsteroidal aromatase inhibitors anastrozole and letrozole.  The steroidal inhibitor exemestane is partially non-cross-resistant with nonsteroidal aromatase inhibitors and is a mild androgen and could prove superior to anastrozole regarding efficacy and toxicity, specifically with less bone loss.  Patients and Methods: We designed an open-label, randomized, phase III trial of 5 years of exemestane vs. anastrozole with a two-sided test of superiority to detect a 2.4% improvement with exemestane in 5-yr event-free survival (EFS).  Secondary objectives included assessment of overall survival, distant disease-free survival, incidence of contralateral new primary breast cancer, and safety.  Results: In the study, 7,576 women (median age, 64.1 years) were enrolled.  At median follow-up of 4.1 years, 4-yr EFS was 91% for exemestane and 91.2% for anastrozole (stratified hazard ratio, 1.02; 95% CI, 0.87 to 1.18; P = .85).  Overall, distant disease-free survival and disease-specific survival were also similar.  In all, 31.6% of patients discontinued treatment as a result of adverse effects, concomitant disease, or study refusal.  Osteoporosis/osteopenia, hypertriglyceridemia, vaginal bleeding, and hypercholesterolemia were less frequent on exemestane, whereas mild liver function abnormalities and rare episodes of atrial fibrillation were less frequent on anastrozole.  Vasomotor and musculoskeletal symptoms were similar between arms.  Conclusion: This first comparison of steroidal and nonsteroidal classes of aromatase inhibitors showed neither to be superior in terms of breast cancer outcomes as 5-yr initial adjuvant therapy for postmenopausal breast cancer by two-way test.  Less toxicity on bone is compatible with one hypothesis behind MA.27 but requires confirmation.  Exemestane should be considered another option as up-front adjuvant therapy for postmenopausal hormone receptor-pos. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHX4Gl5b5J6rVg90H21EOLACvtfcHk0ljVGqweNbs8uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt12rtbc%253D&md5=9198d6feed728d6d7426b70973cb9e48</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1200%2FJCO.2012.44.7805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2012.44.7805%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DP.%2BE.%26aulast%3DIngle%26aufirst%3DJ.%2BN.%26aulast%3DPritchard%26aufirst%3DK.%2BI.%26aulast%3DEllis%26aufirst%3DM.%2BJ.%26aulast%3DSledge%26aufirst%3DG.%2BW.%26aulast%3DBudd%26aufirst%3DG.%2BT.%26aulast%3DRabaglio%26aufirst%3DM.%26aulast%3DAnsari%26aufirst%3DR.%2BH.%26aulast%3DJohnson%26aufirst%3DD.%2BB.%26aulast%3DTozer%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DD.%2BP.%26aulast%3DChalchal%26aufirst%3DH.%26aulast%3DSpadafora%26aufirst%3DS.%26aulast%3DStearns%26aufirst%3DV.%26aulast%3DPerez%26aufirst%3DE.%2BA.%26aulast%3DLiedke%26aufirst%3DP.%2BE.%26aulast%3DLang%26aufirst%3DI.%26aulast%3DElliott%26aufirst%3DC.%26aulast%3DGelmon%26aufirst%3DK.%2BA.%26aulast%3DChapman%26aufirst%3DJ.%2BA.%26aulast%3DShepherd%26aufirst%3DL.%2BE.%26atitle%3DExemestane%2520Versus%2520Anastrozole%2520in%2520Postmenopausal%2520Women%2520with%2520Early%2520Breast%2520Cancer%253A%2520NCIC%2520CTG%2520MA.27--a%2520Randomized%2520Controlled%2520Phase%2520Iii%2520Trial%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D31%26spage%3D1398%26epage%3D1404%26doi%3D10.1200%2FJCO.2012.44.7805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renshaw, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. M.</span><span> </span><span class="NLM_article-title">A Randomised Study of the Effects of Letrozole and Anastrozole on Oestrogen Receptor Positive Breast Cancers in Postmenopausal Women</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1007/s10549-008-0027-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2Fs10549-008-0027-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=18438705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFSqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=495-501&author=J.+Murrayauthor=O.+E.+Youngauthor=L.+Renshawauthor=S.+Whiteauthor=L.+Williamsauthor=D.+B.+Evansauthor=J.+S.+Thomasauthor=M.+Dowsettauthor=J.+M.+Dixon&title=A+Randomised+Study+of+the+Effects+of+Letrozole+and+Anastrozole+on+Oestrogen+Receptor+Positive+Breast+Cancers+in+Postmenopausal+Women&doi=10.1007%2Fs10549-008-0027-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women</span></div><div class="casAuthors">Murray, J.; Young, O. E.; Renshaw, L.; White, S.; Williams, L.; Evans, D. B.; Thomas, J. St. J.; Dowsett, M.; Dixon, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-501</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Changes in proliferation as measured by Ki67 occur within 14 days of starting treatment with an aromatase inhibitor and these changes have been shown to be predictors of long term outcome.  This study aimed to compare changes in proliferation following 14 days of treatment with anastrozole and letrozole.  Two hundred and six women with 209 estrogen receptor (ER) pos. operable breast cancers (three bilateral) were randomly allocated to receive either 14 days treatment with 2.5 mg of letrozole or 1 mg of anastrozole prior to surgery.  Changes in expression of estrogen (ER) and progesterone receptors (PgR) as assessed by ALLRED scores and proliferation as assessed by Ki67 were analyzed.  The HER2 status of each tumor was also assessed using a combination of the Hercept test and FISH.  Both letrozole and anastrozole reduced ER expression (ALLRED score) by a mean of 0.32 (0.20-0.44), P < 0.001 and PgR fell by a mean of 2.54 (2.20-2.89) P < 0.0001.  Letrozole reduced proliferation from a geometric mean of 6.37% to 0.81%, P < 0.0001 and anastrozole reduced proliferation from 5.81% to 0.77%, P < 0.0001.  There was no differences between drugs in the fall in ER, PgR or proliferation.  Both letrozole and anastrozole produced significant falls in proliferation in both HER2 pos. and HER2 neg. cancers, all P < 0.001.  Fourteen days of both letrozole and anastrozole reduces proliferation, ER and PgR expression.  No significant difference between these two drugs was identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqINvh0jx6zBrVg90H21EOLACvtfcHk0lhT_gf_yJ9TXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFSqt7s%253D&md5=0e4221284288466ecd88c48739aff862</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2Fs10549-008-0027-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-008-0027-0%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DO.%2BE.%26aulast%3DRenshaw%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26aulast%3DThomas%26aufirst%3DJ.%2BS.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DDixon%26aufirst%3DJ.%2BM.%26atitle%3DA%2520Randomised%2520Study%2520of%2520the%2520Effects%2520of%2520Letrozole%2520and%2520Anastrozole%2520on%2520Oestrogen%2520Receptor%2520Positive%2520Breast%2520Cancers%2520in%2520Postmenopausal%2520Women%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2009%26volume%3D114%26spage%3D495%26epage%3D501%26doi%3D10.1007%2Fs10549-008-0027-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Zilembo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noberasco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajetta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orefice, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzzoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bartolomeo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Leo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laffranchi, A.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Endocrinological and Clinical Evaluation of Exemestane, a New Steroidal Aromatase Inhibitor</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span><span class="refDoi"> DOI: 10.1038/bjc.1995.451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Fbjc.1995.451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=7547212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK2MXptlKjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1995&pages=1007-1012&author=N.+Zilemboauthor=C.+Noberascoauthor=E.+Bajettaauthor=A.+Martinettiauthor=L.+Marianiauthor=S.+Oreficeauthor=R.+Buzzoniauthor=M.+Di+Bartolomeoauthor=A.+Di+Leoauthor=A.+Laffranchi&title=Endocrinological+and+Clinical+Evaluation+of+Exemestane%2C+a+New+Steroidal+Aromatase+Inhibitor&doi=10.1038%2Fbjc.1995.451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor</span></div><div class="casAuthors">Zilembo, N.; Noberasco, C.; Bajetta, E.; Martinetti, A.; Mariani, L.; Orefice, S.; Buzzoni, R.; Di Bartolomeo, M.; Di Leo, A.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1007-12</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Scientific & Medical Division</span>)
        </div><div class="casAbstract">The androstenedione deriv., exemestane (FCE 24304), is a new orally active irreversible aromatase inhibitor.  Fifty-six post-menopausal advanced breast cancer patients entered this study to evaluate the activity of four low exemestane doses in reducing estrogen levels.  The drug's tolerability and clin. efficacy were also assessed.  Exemestane was orally administered to four consecutive groups at daily doses of 25, 12.5, 5 and 2.5 mg, and the changes in estrogen, gonadotrophins, sex-hormone binding globulin and dehydroepiandrosterone sulfate levels were evaluated.  Drug selectivity was studied by measuring 17-hydroxycorticosteroid urinary levels.  After 7 days of treatment, mean estrone and estradiol levels had decreased by resp. 64% and 65% (a decrease which was maintained over time); in the 2.5 mg group, oestrone sulfate levels also decreased by 74%.  Gonadotropin-levels were significantly higher, whereas no changes in the other serum hormone levels or any interference with adrenal synthesis were detected.  Treatment tolerability was satisfactory: nausea and dyspepsia were reported in 16% of patients.  The overall objective response rate was 18%.  In conclusion, exemestane is effective in reducing estrogen levels at all of the tested doses and shows interesting clin. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr7k3C7fR6jbVg90H21EOLACvtfcHk0lhT_gf_yJ9TXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlKjurk%253D&md5=8ff051c0df55fb4de7ad26c617d97b3f</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1995.451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1995.451%26sid%3Dliteratum%253Aachs%26aulast%3DZilembo%26aufirst%3DN.%26aulast%3DNoberasco%26aufirst%3DC.%26aulast%3DBajetta%26aufirst%3DE.%26aulast%3DMartinetti%26aufirst%3DA.%26aulast%3DMariani%26aufirst%3DL.%26aulast%3DOrefice%26aufirst%3DS.%26aulast%3DBuzzoni%26aufirst%3DR.%26aulast%3DDi%2BBartolomeo%26aufirst%3DM.%26aulast%3DDi%2BLeo%26aufirst%3DA.%26aulast%3DLaffranchi%26aufirst%3DA.%26atitle%3DEndocrinological%2520and%2520Clinical%2520Evaluation%2520of%2520Exemestane%252C%2520a%2520New%2520Steroidal%2520Aromatase%2520Inhibitor%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1995%26volume%3D72%26spage%3D1007%26epage%3D1012%26doi%3D10.1038%2Fbjc.1995.451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Johannessen, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurlo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paolini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvinnsland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonning, P. E.</span><span> </span><span class="NLM_article-title">Endocrine and Clinical Effects of Exemestane (PNU155971), a Novel Steroidal Aromatase Inhibitor, in Postmenopausal Breast Cancer Patients: A Phase I Study</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1101</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=9815789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFCgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=1101-1108&author=D.+C.+Johannessenauthor=T.+Enganauthor=E.+Di+Salleauthor=M.+G.+Zurloauthor=J.+Paoliniauthor=G.+Ornatiauthor=G.+Piscitelliauthor=S.+Kvinnslandauthor=P.+E.+Lonning&title=Endocrine+and+Clinical+Effects+of+Exemestane+%28PNU155971%29%2C+a+Novel+Steroidal+Aromatase+Inhibitor%2C+in+Postmenopausal+Breast+Cancer+Patients%3A+A+Phase+I+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study</span></div><div class="casAuthors">Johannessen, Dag Clement; Engan, Terje; Salle, Enrico Di; Zurlo, Maria Grazia; Paolini, Jolanda; Ornati, Giorgio; Piscitelli, Gabriella; Kvinnsland, Stener; Loenning, Per Eystein</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1101-1108</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Clin. and endocrinol. effects of exemestane (6-methylenandrosta-1,4-diene-3,17-dione; PNU 155971) were evaluated in an open Phase I study.  Thirteen postmenopausal women suffering from advanced breast cancer received exemestane in escalating doses over a 12-wk period.  Starting on 5 mg once daily (o.d.), exemestane was subsequently escalated at 2-wk intervals to 10, 25, 50, 100, and 200 mg o.d.  Each patient subsequently continued treatment on the highest tolerated dose until time of progression.  One patient terminated treatment after 6 days due to diarrhea that was probably not related to drug therapy, although a relationship could not be excluded.  Apart from this, no serious side effects were seen during the dose escalation period.  Exemestane (10 mg o.d.) caused maximal suppression of plasma estradiol (E2) and estrone (E1) to a mean of 14.6 and 5.8% of pretreatment levels, resp., whereas 25 mg of exemestane o.d. suppressed estrone sulfate (E1S) to 8.9% of pretreatment levels.  No fall in adrenal steroid levels was recorded.  Exemestane (5 mg o.d.) suppressed urinary E2 and E1 to a mean of 11.9 and 12.2% of pretreatment levels, resp.  Administering exemestane at doses of 50-200 mg o.d. caused no further suppression of urinary E1, whereas urinary E2 fell to 6-7% of pretreatment levels.  Median time to progression was 63 wk.  We conclude that exemestane is a well-tolerated aromatase inhibitor that effectively suppresses plasma and urinary estrogens in postmenopausal patients with breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDaBiEQ3tJP7Vg90H21EOLACvtfcHk0lhTZKChCP2S-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFCgsLw%253D&md5=841bd78e5623a850ccda005b9dd64903</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohannessen%26aufirst%3DD.%2BC.%26aulast%3DEngan%26aufirst%3DT.%26aulast%3DDi%2BSalle%26aufirst%3DE.%26aulast%3DZurlo%26aufirst%3DM.%2BG.%26aulast%3DPaolini%26aufirst%3DJ.%26aulast%3DOrnati%26aufirst%3DG.%26aulast%3DPiscitelli%26aufirst%3DG.%26aulast%3DKvinnsland%26aufirst%3DS.%26aulast%3DLonning%26aufirst%3DP.%2BE.%26atitle%3DEndocrine%2520and%2520Clinical%2520Effects%2520of%2520Exemestane%2520%2528PNU155971%2529%252C%2520a%2520Novel%2520Steroidal%2520Aromatase%2520Inhibitor%252C%2520in%2520Postmenopausal%2520Breast%2520Cancer%2520Patients%253A%2520A%2520Phase%2520I%2520Study%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1997%26volume%3D3%26spage%3D1101%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Lonning, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paridaens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurlimann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span> </span><span class="NLM_article-title">Exemestane Experience in Breast Cancer Treatment</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span><span class="refDoi"> DOI: 10.1016/S0960-0760(97)80007-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2FS0960-0760%2897%2980007-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=9365185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1antL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1997&pages=151-155&author=P.+E.+Lonningauthor=R.+Paridaensauthor=B.+Thurlimannauthor=G.+Piscitelliauthor=E.+di+Salle&title=Exemestane+Experience+in+Breast+Cancer+Treatment&doi=10.1016%2FS0960-0760%2897%2980007-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Exemestane experience in breast cancer treatment</span></div><div class="casAuthors">Lonning, P. E.; Paridaens, R.; Thurlimann, B.; Piscitelli, G.; di Salle, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3-6</span>),
    <span class="NLM_cas:pages">151-155</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 32 refs.  Exemestane is a very potent, orally active, selective and long-lasting steroidal irreversible inhibitor of aromatase.  It is 150 times more potent than aminoglutethimide (AG) in inhibiting human placental aromatase (Ki of 4.3 and 671 nM, resp.).  The compd. is presently under phase III evaluation in Europe and the U.S.A. for the treatment of postmenopausal advanced breast cancer (ABC).  Clin. pharmacol. studies have been carried out with single doses ranging from 0.5 to 800 mg and repeated doses of up to 600 mg a day, in 132 postmenopausal healthy volunteers and in 185 postmenopausal women with ABC.  Results obtained using a very specific and sensitive anal. method (high performance liq. chromatog.-RIA; HPLC-RIA) indicted that exemestane is extremely effective in inhibiting plasma estrogens levels.  Estrogen inhibition is clearly evident at 5 mg a day and maximal suppression for E2, E1 aned E1S (>85%, >90% and >90%, resp.) is obtained at 10-25 mg a day.  Data from non-controlled phase II studies involving more than 400 patients indicated a clear anti-tumor activity in postmenopausal ABC patients failing multiple hormonal treatments.  In 62 patients progressing on AG (≥500 mg a day) exemestane treatment resulted in an objective response rate of approx. 24%; disease stabilization ≥24 wk was obsd. in an addnl. 24% of cases.  With regard to safety, although daily doses up to 600 mg were administered, the maximal tolerated dose was not achieved; reported symptoms were mainly related to the pharmacol. action of the compd. and were usually mild to moderate in severity, resulting in the discontinuation of therapy in less than 3% of cases.  In conclusion, the available results suggest that exemestane treatment is assocd. with minimal toxicity, and may be of significant benefit for ABC women who have exhausted conventional therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt23tph81cyrVg90H21EOLACvtfcHk0lhTZKChCP2S-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1antL4%253D&md5=3e2b4a70aba3192c9f9e954ac1db698b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2897%2980007-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252897%252980007-6%26sid%3Dliteratum%253Aachs%26aulast%3DLonning%26aufirst%3DP.%2BE.%26aulast%3DParidaens%26aufirst%3DR.%26aulast%3DThurlimann%26aufirst%3DB.%26aulast%3DPiscitelli%26aufirst%3DG.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26atitle%3DExemestane%2520Experience%2520in%2520Breast%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D61%26spage%3D151%26epage%3D155%26doi%3D10.1016%2FS0960-0760%2897%2980007-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Thurlimann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paridaens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneterre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzalone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurlo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, G.</span><span> </span><span class="NLM_article-title">Third-Line Hormonal Treatment with Exemestane in Postmenopausal Patients with Advanced Breast Cancer Progressing on Aminoglutethimide: A Phase II Multicentre Multinational Study. Exemestane Study Group</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1773</span><span class="refDoi"> DOI: 10.1016/S0959-8049(97)00283-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2FS0959-8049%2897%2900283-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1997&pages=1767-1773&author=B.+Thurlimannauthor=R.+Paridaensauthor=D.+Serinauthor=J.+Bonneterreauthor=H.+Rocheauthor=R.+Murrayauthor=E.+di+Salleauthor=S.+Lanzaloneauthor=M.+G.+Zurloauthor=G.+Piscitelli&title=Third-Line+Hormonal+Treatment+with+Exemestane+in+Postmenopausal+Patients+with+Advanced+Breast+Cancer+Progressing+on+Aminoglutethimide%3A+A+Phase+II+Multicentre+Multinational+Study.+Exemestane+Study+Group&doi=10.1016%2FS0959-8049%2897%2900283-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2897%2900283-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252897%252900283-9%26sid%3Dliteratum%253Aachs%26aulast%3DThurlimann%26aufirst%3DB.%26aulast%3DParidaens%26aufirst%3DR.%26aulast%3DSerin%26aufirst%3DD.%26aulast%3DBonneterre%26aufirst%3DJ.%26aulast%3DRoche%26aufirst%3DH.%26aulast%3DMurray%26aufirst%3DR.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26aulast%3DLanzalone%26aufirst%3DS.%26aulast%3DZurlo%26aufirst%3DM.%2BG.%26aulast%3DPiscitelli%26aufirst%3DG.%26atitle%3DThird-Line%2520Hormonal%2520Treatment%2520with%2520Exemestane%2520in%2520Postmenopausal%2520Patients%2520with%2520Advanced%2520Breast%2520Cancer%2520Progressing%2520on%2520Aminoglutethimide%253A%2520A%2520Phase%2520II%2520Multicentre%2520Multinational%2520Study.%2520Exemestane%2520Study%2520Group%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1997%26volume%3D33%26spage%3D1767%26epage%3D1773%26doi%3D10.1016%2FS0959-8049%2897%2900283-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Geisler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonning, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span> </span><span class="NLM_article-title">In Vivo Inhibition of Aromatization by Exemestane, a Novel Irreversible Aromatase Inhibitor, in Postmenopausal Breast Cancer Patients</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2089</span><span class="NLM_x">–</span> <span class="NLM_lpage">2093</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=9748124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK1cXmslCjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=2089-2093&author=J.+Geislerauthor=N.+Kingauthor=G.+Ankerauthor=G.+Ornatiauthor=E.+Di+Salleauthor=P.+E.+Lonningauthor=M.+Dowsett&title=In+Vivo+Inhibition+of+Aromatization+by+Exemestane%2C+a+Novel+Irreversible+Aromatase+Inhibitor%2C+in+Postmenopausal+Breast+Cancer+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients</span></div><div class="casAuthors">Geisler, Jurgen; King, Nick; Anker, Gun; Ornati, Giorgio; Di Salle, Enrico; Lonning, Per Eystein; Dowsett, Mitch</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2089-2093</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The effect of exemestane (6-methylenandrosta-1,4-diene-3,17-dione) 25 mg p.o. once daily on in vivo aromatization was studied in 10 postmenopausal women with advanced breast cancer.  Aromatization was detd. before treatment and after 6-8 wk on therapy by administering a bolus injection of [3H]androstenedione (500 μCi) and [14C]estrone (5 μCi) followed by measurement of the isotope ratio of urinary estrogens after high-performance liq. chromatog. purifn.  In addn., plasma endogenous estrogens were measured with highly sensitive RIAs after sepn. with high-performance liq. chromatog.  Treatment with exemestane suppressed whole body aromatization from a mean pretreatment value of 2.059% to 0.042% (mean suppression of 97.9%).  Plasma levels of estrone, estradiol, and estrone sulfate were found to be suppressed by 94.5%, 92.2%, and 93.2%, resp.  This is the first study revealing near total aromatase inhibition in vivo with the use of a steroidal aromatase inhibitor.  The observation that exemestane is a highly potent aromatase inhibitor, together with the fact that the drug is administered p.o. and causes limited side effects, suggests that exemestane is a promising new drug for the treatment of hormone sensitive breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv3SeR-LYYP7Vg90H21EOLACvtfcHk0ljzn6H2mEcpeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmslCjs70%253D&md5=df5ccff7835d08261cd63c0a5a06199e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeisler%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DN.%26aulast%3DAnker%26aufirst%3DG.%26aulast%3DOrnati%26aufirst%3DG.%26aulast%3DDi%2BSalle%26aufirst%3DE.%26aulast%3DLonning%26aufirst%3DP.%2BE.%26aulast%3DDowsett%26aufirst%3DM.%26atitle%3DIn%2520Vivo%2520Inhibition%2520of%2520Aromatization%2520by%2520Exemestane%252C%2520a%2520Novel%2520Irreversible%2520Aromatase%2520Inhibitor%252C%2520in%2520Postmenopausal%2520Breast%2520Cancer%2520Patients%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1998%26volume%3D4%26spage%3D2089%26epage%3D2093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Lonning, P. E.</span><span> </span><span class="NLM_article-title">Pharmacological Profiles of Exemestane and Formestane, Steroidal Aromatase Inhibitors Used for Treatment of Postmenopausal Breast Cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S45</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><div class="note"><p class="first last">(discussion S73–47)</p></div><span class="refDoi"> DOI: 10.1023/A:1006048722559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1023%2FA%3A1006048722559" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1998&pages=S45-52&issue=Suppl.+1&author=P.+E.+Lonning&title=Pharmacological+Profiles+of+Exemestane+and+Formestane%2C+Steroidal+Aromatase+Inhibitors+Used+for+Treatment+of+Postmenopausal+Breast+Cancer&doi=10.1023%2FA%3A1006048722559"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006048722559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006048722559%26sid%3Dliteratum%253Aachs%26aulast%3DLonning%26aufirst%3DP.%2BE.%26atitle%3DPharmacological%2520Profiles%2520of%2520Exemestane%2520and%2520Formestane%252C%2520Steroidal%2520Aromatase%2520Inhibitors%2520Used%2520for%2520Treatment%2520of%2520Postmenopausal%2520Breast%2520Cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1998%26volume%3D49%26issue%3DSuppl.%25201%26spage%3DS45%26epage%3D52%26doi%3D10.1023%2FA%3A1006048722559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arkhipov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehrenbacher, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiffany, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Consonni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L.</span><span> </span><span class="NLM_article-title">Multicenter, Phase II Trial of Exemestane as Third-Line Hormonal Therapy of Postmenopausal Women with Metastatic Breast Cancer. Aromasin Study Group</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3418</span><span class="NLM_x">–</span> <span class="NLM_lpage">3425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10550136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK1MXnvVGlt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=3418-3425&author=S.+Jonesauthor=C.+Vogelauthor=A.+Arkhipovauthor=L.+Fehrenbacherauthor=P.+Eisenbergauthor=B.+Cooperauthor=S.+Honigauthor=A.+Polliauthor=F.+Whaleyauthor=E.+di+Salleauthor=J.+Tiffanyauthor=A.+Consonniauthor=L.+Miller&title=Multicenter%2C+Phase+II+Trial+of+Exemestane+as+Third-Line+Hormonal+Therapy+of+Postmenopausal+Women+with+Metastatic+Breast+Cancer.+Aromasin+Study+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer</span></div><div class="casAuthors">Jones, S.; Vogel, C.; Arkhipov, A.; Fehrenbacher, L.; Eisenberg, P.; Cooper, B.; Honig, S.; Polli, A.; Whaley, F.; Di Salle, E.; Tiffany, J.; Consonni, A.; Miller, L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3418-3425</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose: To assess the antitumor activity, safety, and hormone-suppressive effects of the irreversible aromatase inactivator, exemestane (Aromasin, Pharmacia & Upjohn, Kalamazoo, MI), administered as third-line hormone therapy to postmenopausal women with metastatic breast cancer that is refractory to tamoxifen and megestrol acetate.  Patients and Methods: Exemestane was administered at a dose of 25 mg/d orally until patients experienced disease progression.  The efficacy and safety of exemestane were clin. and radiog. evaluated.  The impact of exemestane treatment on tumor-related signs and symptoms was assessed.  The effect of exemestane on serum levels of estrogens and other steroidal hormones was detd.  Results: Ninety-one patients were treated.  There were four complete responses (CR) and eight partial responses (PR), for an objective response rate of 13% in the entire treated population.  The overall success rate (CR, PR, or stable disease [SD] ≥ 24 wk) was 30%.  The median duration of response and overall success was 9 mo and 8 mo, resp.  Most patients with CR/PR (83%; 10 of 12 patients) and SD ≥ 24 wk (80%; 12 of 15 patients) had improved or stable tumor-related signs and symptoms.  Mean levels of circulating estrone (E1), estradiol (E2), and estrone sulfate decreased to 11%, 22%, and 13% of baseline levels, resp. (at week 8 or 16 of treatment).  One half of the patients had undetectable E1 and E2 levels during treatment, including at the time of disease progression.  Mild nausea (20% of patients) and hot flashes (20%) were the most common drug-related adverse events and were generally grade 1.  Conclusion: Exemestane is an active and well-tolerated third-line hormonal therapy that represents a new treatment option for postmenopausal patients with advanced breast cancer that has become refractory to std. first- and second-line hormonal therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPcIYUNTviuLVg90H21EOLACvtfcHk0ljzn6H2mEcpeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvVGlt70%253D&md5=02a686e394759597612e998815b1f43f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%26aulast%3DVogel%26aufirst%3DC.%26aulast%3DArkhipov%26aufirst%3DA.%26aulast%3DFehrenbacher%26aufirst%3DL.%26aulast%3DEisenberg%26aufirst%3DP.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DHonig%26aufirst%3DS.%26aulast%3DPolli%26aufirst%3DA.%26aulast%3DWhaley%26aufirst%3DF.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26aulast%3DTiffany%26aufirst%3DJ.%26aulast%3DConsonni%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DL.%26atitle%3DMulticenter%252C%2520Phase%2520II%2520Trial%2520of%2520Exemestane%2520as%2520Third-Line%2520Hormonal%2520Therapy%2520of%2520Postmenopausal%2520Women%2520with%2520Metastatic%2520Breast%2520Cancer.%2520Aromasin%2520Study%2520Group%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D1999%26volume%3D17%26spage%3D3418%26epage%3D3425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Kaufmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajetta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirix, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massimini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, G.</span><span> </span><span class="NLM_article-title">Exemestane Improves Survival Compared with Megoestrol Acetate in Postmenopausal Patients with Advanced Breast Cancer Who Have Failed on Tamoxifen. Results of a Double-Blind Randomised Phase III Trial</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">S86</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1016/S0959-8049(00)00240-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2FS0959-8049%2800%2900240-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2000&pages=S86-87&issue=Suppl.+4&author=M.+Kaufmannauthor=E.+Bajettaauthor=L.+Y.+Dirixauthor=L.+E.+Feinauthor=S.+E.+Jonesauthor=J.+Cervekauthor=C.+Fowstauthor=A.+Polliauthor=E.+Di+Salleauthor=G.+Massiminiauthor=G.+Piscitelli&title=Exemestane+Improves+Survival+Compared+with+Megoestrol+Acetate+in+Postmenopausal+Patients+with+Advanced+Breast+Cancer+Who+Have+Failed+on+Tamoxifen.+Results+of+a+Double-Blind+Randomised+Phase+III+Trial&doi=10.1016%2FS0959-8049%2800%2900240-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2800%2900240-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252800%252900240-9%26sid%3Dliteratum%253Aachs%26aulast%3DKaufmann%26aufirst%3DM.%26aulast%3DBajetta%26aufirst%3DE.%26aulast%3DDirix%26aufirst%3DL.%2BY.%26aulast%3DFein%26aufirst%3DL.%2BE.%26aulast%3DJones%26aufirst%3DS.%2BE.%26aulast%3DCervek%26aufirst%3DJ.%26aulast%3DFowst%26aufirst%3DC.%26aulast%3DPolli%26aufirst%3DA.%26aulast%3DDi%2BSalle%26aufirst%3DE.%26aulast%3DMassimini%26aufirst%3DG.%26aulast%3DPiscitelli%26aufirst%3DG.%26atitle%3DExemestane%2520Improves%2520Survival%2520Compared%2520with%2520Megoestrol%2520Acetate%2520in%2520Postmenopausal%2520Patients%2520with%2520Advanced%2520Breast%2520Cancer%2520Who%2520Have%2520Failed%2520on%2520Tamoxifen.%2520Results%2520of%2520a%2520Double-Blind%2520Randomised%2520Phase%2520III%2520Trial%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2000%26volume%3D36%26issue%3DSuppl.%25204%26spage%3DS86%26epage%3D87%26doi%3D10.1016%2FS0959-8049%2800%2900240-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Kaufmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajetta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirix, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zilembo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugardyn, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasurdi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennel, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arkhipov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massimini, G.</span><span> </span><span class="NLM_article-title">Exemestane Improves Survival in Metastatic Breast Cancer: Results of a Phase III Randomized Study</span> <span class="citation_source-journal">Clin. Breast Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S15</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.3816/CBC.2000.s.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.3816%2FCBC.2000.s.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=S15-18&issue=Suppl.+1&author=M.+Kaufmannauthor=E.+Bajettaauthor=L.+Y.+Dirixauthor=L.+E.+Feinauthor=S.+E.+Jonesauthor=N.+Zilemboauthor=J.+L.+Dugardynauthor=C.+Nasurdiauthor=R.+G.+Mennelauthor=J.+Cervekauthor=C.+Fowstauthor=A.+Polliauthor=E.+di+Salleauthor=A.+Arkhipovauthor=G.+Piscitelliauthor=L.+L.+Millerauthor=G.+Massimini&title=Exemestane+Improves+Survival+in+Metastatic+Breast+Cancer%3A+Results+of+a+Phase+III+Randomized+Study&doi=10.3816%2FCBC.2000.s.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.3816%2FCBC.2000.s.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCBC.2000.s.003%26sid%3Dliteratum%253Aachs%26aulast%3DKaufmann%26aufirst%3DM.%26aulast%3DBajetta%26aufirst%3DE.%26aulast%3DDirix%26aufirst%3DL.%2BY.%26aulast%3DFein%26aufirst%3DL.%2BE.%26aulast%3DJones%26aufirst%3DS.%2BE.%26aulast%3DZilembo%26aufirst%3DN.%26aulast%3DDugardyn%26aufirst%3DJ.%2BL.%26aulast%3DNasurdi%26aufirst%3DC.%26aulast%3DMennel%26aufirst%3DR.%2BG.%26aulast%3DCervek%26aufirst%3DJ.%26aulast%3DFowst%26aufirst%3DC.%26aulast%3DPolli%26aufirst%3DA.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26aulast%3DArkhipov%26aufirst%3DA.%26aulast%3DPiscitelli%26aufirst%3DG.%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DMassimini%26aufirst%3DG.%26atitle%3DExemestane%2520Improves%2520Survival%2520in%2520Metastatic%2520Breast%2520Cancer%253A%2520Results%2520of%2520a%2520Phase%2520III%2520Randomized%2520Study%26jtitle%3DClin.%2520Breast%2520Cancer%26date%3D2000%26volume%3D1%26issue%3DSuppl.%25201%26spage%3DS15%26epage%3D18%26doi%3D10.3816%2FCBC.2000.s.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Kaufmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajetta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirix, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zilembo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugardyn, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasurdi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennel, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arkhipov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massimini, G.</span><span> </span><span class="NLM_article-title">Exemestane Is Superior to Megestrol Acetate after Tamoxifen Failure in Postmenopausal Women with Advanced Breast Cancer: Results of a Phase Iii Randomized Double-Blind Trial. The Exemestane Study Group</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10735887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivVeisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=1399-1411&author=M.+Kaufmannauthor=E.+Bajettaauthor=L.+Y.+Dirixauthor=L.+E.+Feinauthor=S.+E.+Jonesauthor=N.+Zilemboauthor=J.+L.+Dugardynauthor=C.+Nasurdiauthor=R.+G.+Mennelauthor=J.+Cervekauthor=C.+Fowstauthor=A.+Polliauthor=E.+di+Salleauthor=A.+Arkhipovauthor=G.+Piscitelliauthor=L.+L.+Millerauthor=G.+Massimini&title=Exemestane+Is+Superior+to+Megestrol+Acetate+after+Tamoxifen+Failure+in+Postmenopausal+Women+with+Advanced+Breast+Cancer%3A+Results+of+a+Phase+Iii+Randomized+Double-Blind+Trial.+The+Exemestane+Study+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial</span></div><div class="casAuthors">Kaufmann, Manfred; Bajetta, Emilio; Dirix, Luc Yves; Fein, Luis Enrique; Jones, Stephen E.; Zilembo, Nicoletta; Dugardyn, Jean-Louis; Nasurdi, Cristina; Mennel, Robert G.; Cervek, Jozica; Fowst, Camilla; Polli, Anna; Di Salle, Enrico; Arkhipov, Alexei; Piscitelli, Gabriella; Miller, Langdon L.; Massimini, Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1399-1411</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose: This phase III, double-blind, randomized, multicenter study evaluated the efficacy, pharmacodynamics, and safety of the oral aromatase inactivator exemestane (EXE) vs. megestrol acetate (MA) in postmenopausal women with progressive advanced breast cancer who experienced failure of tamoxifen.  Patients and Methods: A total of 769 patients were randomized to EXE 25 mg/d (n = 366) or MA (n = 403) 40 mg four times daily.  Tumor response, duration of tumor control, tumor-related signs and symptoms (TRSS), quality of life (QOL), survival, and tolerability were evaluated.  Results: Overall objective response (OR) rates were higher in patients treated with EXE than in those treated with MA (15.0% v 12.4%); a similar trend was noted in patients with visceral metastases (13.5% v 10.5%).  Median survival time was significantly longer with EXE (median not reached) than with MA (123.4 wk; P =.039), as were the median duration of overall success (OR or stable disease ≥ 24 wk; 60.1 v 49.1 wk; P =.025), time to tumor progression (20.3 v 16.6 wk; P =.037), and time to treatment failure (16.3 v 15.7 wk; P =.042).  Compared with MA, there were similar or greater improvements in pain, TRSS, and QOL with EXE.  Both drugs were well tolerated.  Grade 3 or 4 wt. changes were more common with MA (17.1% v 7.6%; P =.001).  Conclusion: EXE prolongs survival time, time to tumor progression, and time to treatment failure compared with MA and offers a well-tolerated treatment option for postmenopausal women with progressive advanced breast cancer who experienced failure of tamoxifen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrffZzAcqsFVbVg90H21EOLACvtfcHk0liFlJ9vq-vldw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivVeisrw%253D&md5=64645ae933bb362b518597871e910c6e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaufmann%26aufirst%3DM.%26aulast%3DBajetta%26aufirst%3DE.%26aulast%3DDirix%26aufirst%3DL.%2BY.%26aulast%3DFein%26aufirst%3DL.%2BE.%26aulast%3DJones%26aufirst%3DS.%2BE.%26aulast%3DZilembo%26aufirst%3DN.%26aulast%3DDugardyn%26aufirst%3DJ.%2BL.%26aulast%3DNasurdi%26aufirst%3DC.%26aulast%3DMennel%26aufirst%3DR.%2BG.%26aulast%3DCervek%26aufirst%3DJ.%26aulast%3DFowst%26aufirst%3DC.%26aulast%3DPolli%26aufirst%3DA.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26aulast%3DArkhipov%26aufirst%3DA.%26aulast%3DPiscitelli%26aufirst%3DG.%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DMassimini%26aufirst%3DG.%26atitle%3DExemestane%2520Is%2520Superior%2520to%2520Megestrol%2520Acetate%2520after%2520Tamoxifen%2520Failure%2520in%2520Postmenopausal%2520Women%2520with%2520Advanced%2520Breast%2520Cancer%253A%2520Results%2520of%2520a%2520Phase%2520Iii%2520Randomized%2520Double-Blind%2520Trial.%2520The%2520Exemestane%2520Study%2520Group%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2000%26volume%3D18%26spage%3D1399%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Plourde, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyroff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukes, M.</span><span> </span><span class="NLM_article-title">Arimidex: A Potent and Selective Fourth-Generation Aromatase Inhibitor</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1007/BF00682745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2FBF00682745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=7949201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fjs1ektw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1994&pages=103-111&author=P.+V.+Plourdeauthor=M.+Dyroffauthor=M.+Dukes&title=Arimidex%3A+A+Potent+and+Selective+Fourth-Generation+Aromatase+Inhibitor&doi=10.1007%2FBF00682745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Arimidex: a potent and selective fourth-generation aromatase inhibitor</span></div><div class="casAuthors">Plourde P V; Dyroff M; Dukes M</div><div class="citationInfo"><span class="NLM_cas:title">Breast cancer research and treatment</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-11</span>
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    </div><div class="casAbstract">Arimidex is a potent and selective aromatase inhibitor undergoing evaluation as a treatment for postmenopausal women with advanced breast cancer.  Studies to determine the pharmacology of Arimidex were conducted in both animals and humans.  In animals, Arimidex was selective for the aromatase enzyme, elicited maximal activity at about 0.1 mg/kg, did not interfere with steroid hormones produced by the adrenal glands, and, at a dose of 1 mg/kg, had no detectable pharmacologic activity other than aromatase inhibition.  Absorption of ZD1033, the active component of Arimidex, was rapid and virtually complete after oral administration to animals.  ZD1033 was extensively metabolized in animals after oral administration; the metabolites were excreted predominantly in urine.  The pharmacodynamic, pharmacokinetic, and safety profiles of single and multiple daily doses of Arimidex were determined in humans.  Doses of 1 to 10 mg of Arimidex suppressed estradiol to the maximum degree measurable.  Arimidex had no clinically significant effects on key enzymes that regulate cortisol and aldosterone biosynthesis.  Absorption of ZD1033 was rapid, with maximum plasma concentrations occurring within 2 hours after oral administration.  Plasma concentrations of ZD1033 rose with increasing doses of Arimidex.  The elimination half-life of ZD1033 in humans ranged from 30 to 60 hours.  Urinary excretion accounted for a small percentage of each dose.  A 3- to 4-fold accumulation of ZD1033 in plasma occurred after daily administration of 3-, 5-, or 10-mg doses.  Arimidex was well tolerated.  Phase III studies are under way to determine the efficacy and safety of Arimidex in postmenopausal women with advanced breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTC7v8Jka1FsgyMywPm6HgQfW6udTcc2eYd7HpKGHkcBbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fjs1ektw%253D%253D&md5=ef2d16210e3f984ab59c9a3904a5c0dd</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1007%2FBF00682745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00682745%26sid%3Dliteratum%253Aachs%26aulast%3DPlourde%26aufirst%3DP.%2BV.%26aulast%3DDyroff%26aufirst%3DM.%26aulast%3DDukes%26aufirst%3DM.%26atitle%3DArimidex%253A%2520A%2520Potent%2520and%2520Selective%2520Fourth-Generation%2520Aromatase%2520Inhibitor%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1994%26volume%3D30%26spage%3D103%26epage%3D111%26doi%3D10.1007%2FBF00682745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Dukes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Large, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, T.</span><span> </span><span class="NLM_article-title">The Preclinical Pharmacology of “Arimidex” (Anastrozole; ZD1033)--a Potent, Selective Aromatase Inhibitor</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span><span class="refDoi"> DOI: 10.1016/0960-0760(96)00064-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2896%2900064-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=8903429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK28Xmslaht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1996&pages=439-445&author=M.+Dukesauthor=P.+N.+Edwardsauthor=M.+Largeauthor=I.+K.+Smithauthor=T.+Boyle&title=The+Preclinical+Pharmacology+of+%E2%80%9CArimidex%E2%80%9D+%28Anastrozole%3B+ZD1033%29%2D%2Da+Potent%2C+Selective+Aromatase+Inhibitor&doi=10.1016%2F0960-0760%2896%2900064-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The preclinical pharmacology of "Arimidex" (anastrozole; ZD1033) - a potent, selective aromatase inhibitor</span></div><div class="casAuthors">Dukes, Michael; Edwards, Philip N.; Large, Michael; Smith, Ian K.; Boyle, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">439-445</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Anastrozole is a comparatively simple, achiral benzyltriazole deriv., 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropiononitrile), that inhibits human placental aromatase with an IC50 of 15 nM and elicits maximal activity in vivo in rats (inhibition of ovulation and androstenedione-induced uterine hypertrophy) and monkeys (lowering of plasma estradiol) at 0.1 mg/kg p.o.  At 30 times this dose, anastrozole does not elevate plasma 11-deoxycorticosterone in monkeys, and at 100 times this dose, does not affect plasma aldosterone levels or Na+/K+ excretion in rats, plasma K+ concns. in dogs, or cause adrenal hypertrophy in rats or dogs.  It therefore has no discernible effect on adrenocorticoid hormone synthesis in vivo at very large multiples of its maximally effective aromatase-inhibiting dose.  At similar large multiples in rats it displays no estrogenic, anti-estrogenic, androgenic, anti-androgenic, progestogenic, glucocorticoid, antiglucocorticoid or mineralocorticoid activity.  Anastrozole is thus a potent and highly selective aromatase inhibitor, with no intrinsic hormonal activities - a pharmacol. profile particularly suitable for the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhHcAJCkrdrVg90H21EOLACvtfcHk0liYg2yCGv3oWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmslaht7o%253D&md5=e30e5876b89cbe19d8555bdf7878b34b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2896%2900064-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252896%252900064-7%26sid%3Dliteratum%253Aachs%26aulast%3DDukes%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DP.%2BN.%26aulast%3DLarge%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DI.%2BK.%26aulast%3DBoyle%26aufirst%3DT.%26atitle%3DThe%2520Preclinical%2520Pharmacology%2520of%2520%25E2%2580%259CArimidex%25E2%2580%259D%2520%2528Anastrozole%253B%2520ZD1033%2529--a%2520Potent%252C%2520Selective%2520Aromatase%2520Inhibitor%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D58%26spage%3D439%26epage%3D445%26doi%3D10.1016%2F0960-0760%2896%2900064-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Buzdar, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonat, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomqvist, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolter, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span> </span><span class="NLM_article-title">Anastrozole Versus Megestrol Acetate in the Treatment of Postmenopausal Women with Advanced Breast Carcinoma: Results of a Survival Update Based on a Combined Analysis of Data from Two Mature Phase III Trials. Arimidex Study Group</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span><span class="refDoi"> DOI: 10.1002/(SICI)1097-0142(19980915)83:6<1142::AID-CNCR13>3.0.CO;2-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1142%3A%3AAID-CNCR13%3E3.0.CO%3B2-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1998&pages=1142-1152&author=A.+U.+Buzdarauthor=W.+Jonatauthor=A.+Howellauthor=S.+E.+Jonesauthor=C.+P.+Blomqvistauthor=C.+L.+Vogelauthor=W.+Eiermannauthor=J.+M.+Wolterauthor=M.+Steinbergauthor=A.+Websterauthor=D.+Lee&title=Anastrozole+Versus+Megestrol+Acetate+in+the+Treatment+of+Postmenopausal+Women+with+Advanced+Breast+Carcinoma%3A+Results+of+a+Survival+Update+Based+on+a+Combined+Analysis+of+Data+from+Two+Mature+Phase+III+Trials.+Arimidex+Study+Group&doi=10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1142%3A%3AAID-CNCR13%3E3.0.CO%3B2-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1142%3A%3AAID-CNCR13%3E3.0.CO%3B2-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0142%252819980915%252983%253A6%253C1142%253A%253AAID-CNCR13%253E3.0.CO%253B2-5%26sid%3Dliteratum%253Aachs%26aulast%3DBuzdar%26aufirst%3DA.%2BU.%26aulast%3DJonat%26aufirst%3DW.%26aulast%3DHowell%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DS.%2BE.%26aulast%3DBlomqvist%26aufirst%3DC.%2BP.%26aulast%3DVogel%26aufirst%3DC.%2BL.%26aulast%3DEiermann%26aufirst%3DW.%26aulast%3DWolter%26aufirst%3DJ.%2BM.%26aulast%3DSteinberg%26aufirst%3DM.%26aulast%3DWebster%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DD.%26atitle%3DAnastrozole%2520Versus%2520Megestrol%2520Acetate%2520in%2520the%2520Treatment%2520of%2520Postmenopausal%2520Women%2520with%2520Advanced%2520Breast%2520Carcinoma%253A%2520Results%2520of%2520a%2520Survival%2520Update%2520Based%2520on%2520a%2520Combined%2520Analysis%2520of%2520Data%2520from%2520Two%2520Mature%2520Phase%2520III%2520Trials.%2520Arimidex%2520Study%2520Group%26jtitle%3DCancer%26date%3D1998%26volume%3D83%26spage%3D1142%26epage%3D1152%26doi%3D10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1142%3A%3AAID-CNCR13%3E3.0.CO%3B2-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Yates, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyld, P. J.</span><span> </span><span class="NLM_article-title">Arimidex (ZD1033): A Selective, Potent Inhibitor of Aromatase in Postmenopausal Female Volunteers</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1038/bjc.1996.94</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Fbjc.1996.94" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=8595172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK28Xhs1Kjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1996&pages=543-548&author=R.+A.+Yatesauthor=M.+Dowsettauthor=G.+V.+Fisherauthor=A.+Selenauthor=P.+J.+Wyld&title=Arimidex+%28ZD1033%29%3A+A+Selective%2C+Potent+Inhibitor+of+Aromatase+in+Postmenopausal+Female+Volunteers&doi=10.1038%2Fbjc.1996.94"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Arimidex (ZD1033): A selective, potent inhibitor of aromatase in postmenopausal female volunteers</span></div><div class="casAuthors">Yates, R. A.; Dowsett, M.; Fisher, G. V.; Selen, A.; Wyld, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">543-8</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">Two multiple-dose studies were conducted in healthy post-menopausal female volunteers to investigate the pharmacokinetics and effects on endocrinol. of Arimidex (ZD1033).  Volunteers in the first trial were dosed with 3 mg of ZD1033 daily over 10 days to assess the effects on endocrinol. of ZD1033 and establish the pharmacokinetic profile.  In the second trial volunteers received 14 daily doses of either 0.5 or 1.0 mg of ZD1033 to assess the pharmacokinetics of ZD1033 and the effects of low doses of ZD1033 on serum estradiol concns.  Following multiple dosing a significant redn. in the concn. of serum estradiol of approx. 80% of baseline was obtained with all three doses; no recovery in estradiol was apparent for up to 144 h after the last dose.  There was no overall difference in the level of estradiol suppression between the 0.5 or 1.0 mg doses of ZD1033.  However, comparison of the no. of volunteers with estradiol concns. below the limits of detection of the assay, 24 h after the last dose of ZD1033, suggested that 1.0 mg was the minimal dose required for maximal suppression of estradiol.  No significant effect was recorded on serum concns. of gonadotropins over the dosing period.  Serum concns. of a range of adrenal steroids were not affected by administration of ZD1033; furthermore, steroid response to std. adrenocorticotrophic hormone (ACTH) challenge was unimpaired by ZD1033.  Together these data demonstrate the potency, tolerability and selectivity of ZD1033.  The pharmacokinetic profile of ZD1033 supports its use as a once-daily treatment given orally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVnIc317voOrVg90H21EOLACvtfcHk0lhjF79YIV2Wtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhs1Kjt7o%253D&md5=1584550bccbcdd7dec7eb8f000b11e08</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1996.94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1996.94%26sid%3Dliteratum%253Aachs%26aulast%3DYates%26aufirst%3DR.%2BA.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DFisher%26aufirst%3DG.%2BV.%26aulast%3DSelen%26aufirst%3DA.%26aulast%3DWyld%26aufirst%3DP.%2BJ.%26atitle%3DArimidex%2520%2528ZD1033%2529%253A%2520A%2520Selective%252C%2520Potent%2520Inhibitor%2520of%2520Aromatase%2520in%2520Postmenopausal%2520Female%2520Volunteers%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1996%26volume%3D73%26spage%3D543%26epage%3D548%26doi%3D10.1038%2Fbjc.1996.94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Buzdar, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plourde, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, A.</span><span> </span><span class="NLM_article-title">A Phase III Trial Comparing Anastrozole (1 and 10 Milligrams), a Potent and Selective Aromatase Inhibitor, with Megestrol Acetate in Postmenopausal Women with Advanced Breast Carcinoma. Arimidex Study Group</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span><span class="refDoi"> DOI: 10.1002/(SICI)1097-0142(19970215)79:4<730::AID-CNCR10>3.0.CO;2-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2F%28SICI%291097-0142%2819970215%2979%3A4%3C730%3A%3AAID-CNCR10%3E3.0.CO%3B2-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1997&pages=730-739&author=A.+U.+Buzdarauthor=S.+E.+Jonesauthor=C.+L.+Vogelauthor=J.+Wolterauthor=P.+Plourdeauthor=A.+Webster&title=A+Phase+III+Trial+Comparing+Anastrozole+%281+and+10+Milligrams%29%2C+a+Potent+and+Selective+Aromatase+Inhibitor%2C+with+Megestrol+Acetate+in+Postmenopausal+Women+with+Advanced+Breast+Carcinoma.+Arimidex+Study+Group&doi=10.1002%2F%28SICI%291097-0142%2819970215%2979%3A4%3C730%3A%3AAID-CNCR10%3E3.0.CO%3B2-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0142%2819970215%2979%3A4%3C730%3A%3AAID-CNCR10%3E3.0.CO%3B2-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0142%252819970215%252979%253A4%253C730%253A%253AAID-CNCR10%253E3.0.CO%253B2-0%26sid%3Dliteratum%253Aachs%26aulast%3DBuzdar%26aufirst%3DA.%2BU.%26aulast%3DJones%26aufirst%3DS.%2BE.%26aulast%3DVogel%26aufirst%3DC.%2BL.%26aulast%3DWolter%26aufirst%3DJ.%26aulast%3DPlourde%26aufirst%3DP.%26aulast%3DWebster%26aufirst%3DA.%26atitle%3DA%2520Phase%2520III%2520Trial%2520Comparing%2520Anastrozole%2520%25281%2520and%252010%2520Milligrams%2529%252C%2520a%2520Potent%2520and%2520Selective%2520Aromatase%2520Inhibitor%252C%2520with%2520Megestrol%2520Acetate%2520in%2520Postmenopausal%2520Women%2520with%2520Advanced%2520Breast%2520Carcinoma.%2520Arimidex%2520Study%2520Group%26jtitle%3DCancer%26date%3D1997%26volume%3D79%26spage%3D730%26epage%3D739%26doi%3D10.1002%2F%28SICI%291097-0142%2819970215%2979%3A4%3C730%3A%3AAID-CNCR10%3E3.0.CO%3B2-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Buzdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabholtz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, C.</span><span> </span><span class="NLM_article-title">Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol Acetate</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3357</span><span class="NLM_x">–</span> <span class="NLM_lpage">3366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=11454883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvVamsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=3357-3366&author=A.+Buzdarauthor=J.+Doumaauthor=N.+Davidsonauthor=R.+Elledgeauthor=M.+Morganauthor=R.+Smithauthor=L.+Porterauthor=J.+Nabholtzauthor=X.+Xiangauthor=C.+Brady&title=Phase+III%2C+Multicenter%2C+Double-Blind%2C+Randomized+Study+of+Letrozole%2C+an+Aromatase+Inhibitor%2C+for+Advanced+Breast+Cancer+Versus+Megestrol+Acetate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate</span></div><div class="casAuthors">Buzdar, A.; Douma, J.; Davidson, N.; Elledge, R.; Morgan, M.; Smith, R.; Porter, L.; Nabholtz, J.; Xiang, X.; Brady, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3357-3366</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Aim of this study was to compare two doses of letrozole (0.5 mg and 2.5 mg every day) and megestrol acetate (40 mg qid) as endocrine therapy in postmenopausal women with advanced breast cancer previously treated with antiestrogens.  This double-blind, randomized, multicenter, multinational study enrolled 602 patients, all of whom were included in the primary anal. in the protocol.  Patients had advanced or metastatic breast cancer with evidence of disease progression while receiving continuous adjuvant antiestrogen therapy, had experienced relapse within 12 mo of stopping adjuvant antiestrogen therapy given for at least 6 mo, or had experienced disease progression while receiving antiestrogen therapy for advanced disease.  Tumors were required to be estrogen receptor- and/or progesterone receptor-pos. or of unknown status.  Confirmed objective response rate was the primary efficacy variable.  Karnofsky Performance Status and European Organization for Research and Treatment of Cancer quality-of-life assessments were collected for 1 yr.  There were no statistically significant differences among the three treatment groups for overall objective tumor response.  Patients treated with letrozole 0.5 mg had improvements in disease progression (P = .044) and a decreased risk of treatment failure (P = .018), compared with patients treated with megestrol acetate.  Letrozole 0.5 mg showed a trend (P = .053) for survival benefit when compared with megestrol acetate.  Megestrol acetate was more likely to produce wt. gain, dyspnea, and vaginal bleeding, and the letrozole groups were more likely to experience headache, hair thinning, and diarrhea.  Given a favorable tolerability profile, once-daily dosing, and evidence of clin. relevant benefit, letrozole is equiv. to megestrol acetate and should be considered for use as an alternative treatment of advanced breast cancer in postmenopausal women after treatment failure with antiestrogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3SFhM4_v_irVg90H21EOLACvtfcHk0lhjF79YIV2Wtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvVamsro%253D&md5=a46e148001b32c3dc78275f7477d77b1</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuzdar%26aufirst%3DA.%26aulast%3DDouma%26aufirst%3DJ.%26aulast%3DDavidson%26aufirst%3DN.%26aulast%3DElledge%26aufirst%3DR.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DPorter%26aufirst%3DL.%26aulast%3DNabholtz%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DX.%26aulast%3DBrady%26aufirst%3DC.%26atitle%3DPhase%2520III%252C%2520Multicenter%252C%2520Double-Blind%252C%2520Randomized%2520Study%2520of%2520Letrozole%252C%2520an%2520Aromatase%2520Inhibitor%252C%2520for%2520Advanced%2520Breast%2520Cancer%2520Versus%2520Megestrol%2520Acetate%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2001%26volume%3D19%26spage%3D3357%26epage%3D3366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Cohen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazdur, R.</span><span> </span><span class="NLM_article-title">Approval Summary: Letrozole in the Treatment of Postmenopausal Women with Advanced Breast Cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=11895893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD38XislOqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=665-669&author=M.+H.+Cohenauthor=J.+R.+Johnsonauthor=N.+Liauthor=G.+Chenauthor=R.+Pazdur&title=Approval+Summary%3A+Letrozole+in+the+Treatment+of+Postmenopausal+Women+with+Advanced+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer</span></div><div class="casAuthors">Cohen, Martin H.; Johnson, John R.; Li, Ning; Chen, Gang; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">665-669</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Letrozole (Femara; Novartis Pharmaceuticals Corp., East Hanover, NJ) is a nonsteroidal inhibitor of aromatase enzyme complex.  It inhibits the peripheral conversion of circulating androgens to estrogens.  In postmenopausal women, letrozole decreases plasma concns. of estradiol, estrone, and estrone sulfate by 75-95% from baseline with maximal suppression achieved within 2-3 days of treatment initiation.  Suppression is dose related, with doses of ≥0.5 mg giving estrone and estrone sulfate values that were often below assay detection limits.  At clin. used dosage, letrozole does not impair adrenal synthesis of glucocorticoids or aldosterone.  In 1998, letrozole was approved by the United States Food and Drug Administration (FDA) for the treatment of advanced breast cancer in postmenopausal women, with hormone receptor pos. or unknown breast cancer, who had failed one prior antiestrogen treatment (i.e., for "second-line" treatment).  Approval was based on two randomized trials comparing tumor RRs of patients receiving 0.5 mg of letrozole, 2.5 mg of letrozole, and either megestrol acetate (MA) or aminoglutethimide.  In the megestrol trial, 2.5 mg/day letrozole was superior to 0.5 mg of letrozole and MA (RRs 24, 13, and 16%, resp.), whereas in the aminoglutethimide trial, there was no significant difference in 2.5 mg of letrozole and 0.5 mg of letrozole RRs (20 and 17%).  There was a trend toward RR superiority of 2.5 mg of letrozole over aminoglutethimide (P = 0.06).  Letrozole (2.5 mg) was the dose chosen for comparison with tamoxifen in the first-line setting.  In July 2000, a marketing application for first-line letrozole treatment of postmenopausal women with hormone receptor pos. or hormone receptor unknown locally advanced or metastatic breast cancer was submitted to the FDA.  A single double-blind, double dummy, randomized, and multicenter trial compared 2.5 mg of letrozole to 20 mg of tamoxifen (456 patients/arm).  Letrozole was superior to tamoxifen with regard to time to progression (TTP) and objective response rate (RR).  The median TTP for letrozole treatment was 9.9 mo [95% confidence interval (CI) 9.1-12.2] vs. 6.2 mo (95% CI 5.8-8.5) for tamoxifen, P = 0.0001, hazard ratio 0.713, (95% CI 0.61-0.84).  RR was 32% for letrozole vs. 21% for tamoxifen (odds ratio 1.74, 95% CI 1.29-2.34, P = 0.0003).  Preliminary survival data (survival data are still blinded) indicate that letrozole is unlikely to be worse than tamoxifen.  Both treatments were similarly tolerated.  On the basis of these results, the United States FDA approved letrozole tablets, 2.5 mg/day, for first-line treatment of postmenopausal women with hormone receptor-pos. or hormone receptor-unknown locally advanced or metastatic breast cancer.  The manufacturer made a commitment to provide updated information on survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9jwOPyOIOh7Vg90H21EOLACvtfcHk0ljaadN32D5Jtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislOqt7o%253D&md5=697123a2d97086fae20a5d8bedc47648</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DM.%2BH.%26aulast%3DJohnson%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DApproval%2520Summary%253A%2520Letrozole%2520in%2520the%2520Treatment%2520of%2520Postmenopausal%2520Women%2520with%2520Advanced%2520Breast%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D665%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Goss, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingle, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muss, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castiglione, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pater, J. L.</span><span> </span><span class="NLM_article-title">Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1262</span><span class="NLM_x">–</span> <span class="NLM_lpage">1271</span><span class="refDoi"> DOI: 10.1093/jnci/dji250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1093%2Fjnci%2Fdji250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=16145047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFKjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2005&pages=1262-1271&author=P.+E.+Gossauthor=J.+N.+Ingleauthor=S.+Martinoauthor=N.+J.+Robertauthor=H.+B.+Mussauthor=M.+J.+Piccartauthor=M.+Castiglioneauthor=D.+Tuauthor=L.+E.+Shepherdauthor=K.+I.+Pritchardauthor=R.+B.+Livingstonauthor=N.+E.+Davidsonauthor=L.+Nortonauthor=E.+A.+Perezauthor=J.+S.+Abramsauthor=D.+A.+Cameronauthor=M.+J.+Palmerauthor=J.+L.+Pater&title=Randomized+Trial+of+Letrozole+Following+Tamoxifen+as+Extended+Adjuvant+Therapy+in+Receptor-Positive+Breast+Cancer%3A+Updated+Findings+from+NCIC+CTG+MA.17&doi=10.1093%2Fjnci%2Fdji250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17</span></div><div class="casAuthors">Goss, Paul E.; Ingle, James N.; Martino, Silvana; Robert, Nicholas J.; Muss, Hyman B.; Piccart, Martine J.; Castiglione, Monica; Tu, Dongsheng; Shepherd, Lois E.; Pritchard, Kathleen I.; Livingston, Robert B.; Davidson, Nancy E.; Norton, Larry; Perez, Edith A.; Abrams, Jeffrey S.; Cameron, David A.; Palmer, Michael J.; Pater, Joseph L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1262-1271</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Most recurrences in women with breast cancer receiving 5 years of adjuvant tamoxifen occur after 5 years.  The MA.17 trial, which was designed to det. whether extended adjuvant therapy with the aromatase inhibitor letrozole after tamoxifen reduces the risk of such late recurrences, was stopped early after an interim anal. showed that letrozole improved disease-free survival.  This report presents updated findings from the trial.  Methods: Postmenopausal women completing 5 years of tamoxifen treatment were randomly assigned to a planned 5 years of letrozole (n = 2593) or placebo (n = 2594).  The primary endpoint was disease-free survival (DFS); secondary endpoints included distant disease-free survival, overall survival, incidence of contralateral tumors, and toxic effects.  Survival was examd. using Kaplan-Meier anal. and log-rank tests.  Planned subgroup analyses included those by axillary lymph node status.  All statistical tests were two-sided.  Results: After a median follow-up of 30 mo (range = 1.5-61.4 mo), women in the letrozole arm had statistically significantly better DFS and distant DFS than women in the placebo arm (DFS: hazard ratio [HR] for recurrence or contralateral breast cancer = 0.58, 95% confidence interval [CI] = 0.45 to 0.76; P < .001; distant DFS: HR = 0.60, 95% CI = 0.43 to 0.84; P = .002).  Overall survival was the same in both arms (HR for death from any cause = 0.82, 95% CI = 0.57 to 1.19; P = .3).  However, among lymph node-pos. patients, overall survival was statistically significantly improved with letrozole (HR = 0.61, 95% CI = 0.38 to 0.98; P = .04).  The incidence of contralateral breast cancer was lower in women receiving letrozole, but the difference was not statistically significant.  Women receiving letrozole experienced more hormonally related side effects than those receiving placebo, but the incidences of bone fractures and cardiovascular events were the same.  Conclusion: Letrozole after tamoxifen is well-tolerated and improves both disease-free and distant disease-free survival but not overall survival, except in node-pos. patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW5fLONV5SxbVg90H21EOLACvtfcHk0ljaadN32D5Jtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFKjsrY%253D&md5=465c4494254315b309a70b8f7edd41dc</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdji250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdji250%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DP.%2BE.%26aulast%3DIngle%26aufirst%3DJ.%2BN.%26aulast%3DMartino%26aufirst%3DS.%26aulast%3DRobert%26aufirst%3DN.%2BJ.%26aulast%3DMuss%26aufirst%3DH.%2BB.%26aulast%3DPiccart%26aufirst%3DM.%2BJ.%26aulast%3DCastiglione%26aufirst%3DM.%26aulast%3DTu%26aufirst%3DD.%26aulast%3DShepherd%26aufirst%3DL.%2BE.%26aulast%3DPritchard%26aufirst%3DK.%2BI.%26aulast%3DLivingston%26aufirst%3DR.%2BB.%26aulast%3DDavidson%26aufirst%3DN.%2BE.%26aulast%3DNorton%26aufirst%3DL.%26aulast%3DPerez%26aufirst%3DE.%2BA.%26aulast%3DAbrams%26aufirst%3DJ.%2BS.%26aulast%3DCameron%26aufirst%3DD.%2BA.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DPater%26aufirst%3DJ.%2BL.%26atitle%3DRandomized%2520Trial%2520of%2520Letrozole%2520Following%2520Tamoxifen%2520as%2520Extended%2520Adjuvant%2520Therapy%2520in%2520Receptor-Positive%2520Breast%2520Cancer%253A%2520Updated%2520Findings%2520from%2520NCIC%2520CTG%2520MA.17%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2005%26volume%3D97%26spage%3D1262%26epage%3D1271%26doi%3D10.1093%2Fjnci%2Fdji250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Goss, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingle, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muss, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castiglione, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therasse, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pater, J. L.</span><span> </span><span class="NLM_article-title">A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1802</span><span class="refDoi"> DOI: 10.1056/NEJMoa032312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1056%2FNEJMoa032312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=14551341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosl2gtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2003&pages=1793-1802&author=P.+E.+Gossauthor=J.+N.+Ingleauthor=S.+Martinoauthor=N.+J.+Robertauthor=H.+B.+Mussauthor=M.+J.+Piccartauthor=M.+Castiglioneauthor=D.+Tuauthor=L.+E.+Shepherdauthor=K.+I.+Pritchardauthor=R.+B.+Livingstonauthor=N.+E.+Davidsonauthor=L.+Nortonauthor=E.+A.+Perezauthor=J.+S.+Abramsauthor=P.+Therasseauthor=M.+J.+Palmerauthor=J.+L.+Pater&title=A+Randomized+Trial+of+Letrozole+in+Postmenopausal+Women+after+Five+Years+of+Tamoxifen+Therapy+for+Early-Stage+Breast+Cancer&doi=10.1056%2FNEJMoa032312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer</span></div><div class="casAuthors">Goss, Paul E.; Ingle, James N.; Martino, Silvana; Robert, Nicholas J.; Muss, Hyman B.; Piccart, Martine J.; Castiglione, Monica; Tu, Dongsheng; Shepherd, Lois E.; Pritchard, Kathleen I.; Livingston, Robert B.; Davidson, Nancy E.; Norton, Larry; Perez, Edith A.; Abrams, Jeffrey S.; Therasse, Patrick; Palmer, Michael J.; Pater, Joseph L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1793-1802</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: In hormone-dependent breast cancer, five years of postoperative tamoxifen therapy - but not tamoxifen therapy of longer duration - prolongs disease-free and overall survival.  The aromatase inhibitor letrozole, by suppressing estrogen prodn., might improve the outcome after the discontinuation of tamoxifen therapy.  Methods: We conducted a double-blind, placebo-controlled trial to test the effectiveness of five years of letrozole therapy in postmenopausal women with breast cancer who have completed five years of tamoxifen therapy.  The primary end point was disease-free survival.  Results: A total of 5187 women were enrolled (median follow-up, 2.4 yr).  At the first interim anal., there were 207 local or metastatic recurrences of breast cancer or new primary cancers in the contralateral breast - 75 in the letrozole group and 132 in the placebo group - with estd. four-year disease-free survival rates of 93% and 87%, resp., in the two groups (p ≤ 0.001 for the comparison of disease-free survival).  A total of 42 women in the placebo group and 31 women in the letrozole group died (P = 0.25 for the comparison of overall survival).  Low-grade hot flashes, arthritis, arthralgia, and myalgia were more frequent in the letrozole group, but vaginal bleeding was less frequent.  There were new diagnoses of osteoporosis in 5.8% of the women in the letrozole group and 4.5% of the women in the placebo group (P = 0.07); the rates of fracture were similar.  After the first interim anal., the independent data and safety monitoring committee recommended termination of the trial and prompt communication of the results to the participants.  Conclusions: As compared with placebo, letrozole therapy after the completion of std. tamoxifen treatment significantly improves disease-free survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn8Yeh_0VFRbVg90H21EOLACvtfcHk0lhI_Pvq6oGhFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosl2gtbc%253D&md5=b7ccc0fb80f769bc70d2768567a4c31f</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa032312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa032312%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DP.%2BE.%26aulast%3DIngle%26aufirst%3DJ.%2BN.%26aulast%3DMartino%26aufirst%3DS.%26aulast%3DRobert%26aufirst%3DN.%2BJ.%26aulast%3DMuss%26aufirst%3DH.%2BB.%26aulast%3DPiccart%26aufirst%3DM.%2BJ.%26aulast%3DCastiglione%26aufirst%3DM.%26aulast%3DTu%26aufirst%3DD.%26aulast%3DShepherd%26aufirst%3DL.%2BE.%26aulast%3DPritchard%26aufirst%3DK.%2BI.%26aulast%3DLivingston%26aufirst%3DR.%2BB.%26aulast%3DDavidson%26aufirst%3DN.%2BE.%26aulast%3DNorton%26aufirst%3DL.%26aulast%3DPerez%26aufirst%3DE.%2BA.%26aulast%3DAbrams%26aufirst%3DJ.%2BS.%26aulast%3DTherasse%26aufirst%3DP.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DPater%26aufirst%3DJ.%2BL.%26atitle%3DA%2520Randomized%2520Trial%2520of%2520Letrozole%2520in%2520Postmenopausal%2520Women%2520after%2520Five%2520Years%2520of%2520Tamoxifen%2520Therapy%2520for%2520Early-Stage%2520Breast%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D349%26spage%3D1793%26epage%3D1802%26doi%3D10.1056%2FNEJMoa032312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Lipton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudri-Ross, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, W.</span><span> </span><span class="NLM_article-title">Serum HER-2/Neu Conversion to Positive at the Time of Disease Progression in Patients with Breast Carcinoma on Hormone Therapy</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span><span class="refDoi"> DOI: 10.1002/cncr.21202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fcncr.21202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2005&pages=257-263&author=A.+Liptonauthor=K.+Leitzelauthor=S.+M.+Aliauthor=L.+Demersauthor=H.+A.+Harveyauthor=H.+A.+Chaudri-Rossauthor=D.+Evansauthor=R.+Langauthor=W.+Hacklauthor=P.+Hamerauthor=W.+Carney&title=Serum+HER-2%2FNeu+Conversion+to+Positive+at+the+Time+of+Disease+Progression+in+Patients+with+Breast+Carcinoma+on+Hormone+Therapy&doi=10.1002%2Fcncr.21202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fcncr.21202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcncr.21202%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DA.%26aulast%3DLeitzel%26aufirst%3DK.%26aulast%3DAli%26aufirst%3DS.%2BM.%26aulast%3DDemers%26aufirst%3DL.%26aulast%3DHarvey%26aufirst%3DH.%2BA.%26aulast%3DChaudri-Ross%26aufirst%3DH.%2BA.%26aulast%3DEvans%26aufirst%3DD.%26aulast%3DLang%26aufirst%3DR.%26aulast%3DHackl%26aufirst%3DW.%26aulast%3DHamer%26aufirst%3DP.%26aulast%3DCarney%26aufirst%3DW.%26atitle%3DSerum%2520HER-2%252FNeu%2520Conversion%2520to%2520Positive%2520at%2520the%2520Time%2520of%2520Disease%2520Progression%2520in%2520Patients%2520with%2520Breast%2520Carcinoma%2520on%2520Hormone%2520Therapy%26jtitle%3DCancer%26date%3D2005%26volume%3D104%26spage%3D257%26epage%3D263%26doi%3D10.1002%2Fcncr.21202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Meng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shete, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashfaq, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beitsch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Euhus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenkel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifford, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitetta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlyn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terstappen, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehm, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhr, J.</span><span> </span><span class="NLM_article-title">HER-2 Gene Amplification Can Be Acquired as Breast Cancer Progresses</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">9393</span><span class="NLM_x">–</span> <span class="NLM_lpage">9398</span><span class="refDoi"> DOI: 10.1073/pnas.0402993101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1073%2Fpnas.0402993101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=9393-9398&author=S.+Mengauthor=D.+Tripathyauthor=S.+Sheteauthor=R.+Ashfaqauthor=B.+Haleyauthor=S.+Perkinsauthor=P.+Beitschauthor=A.+Khanauthor=D.+Euhusauthor=C.+Osborneauthor=E.+Frenkelauthor=S.+Hooverauthor=M.+Leitchauthor=E.+Cliffordauthor=E.+Vitettaauthor=L.+Morrisonauthor=D.+Herlynauthor=L.+W.+Terstappenauthor=T.+Flemingauthor=T.+Fehmauthor=T.+Tuckerauthor=N.+Laneauthor=J.+Wangauthor=J.+Uhr&title=HER-2+Gene+Amplification+Can+Be+Acquired+as+Breast+Cancer+Progresses&doi=10.1073%2Fpnas.0402993101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0402993101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0402993101%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DS.%26aulast%3DTripathy%26aufirst%3DD.%26aulast%3DShete%26aufirst%3DS.%26aulast%3DAshfaq%26aufirst%3DR.%26aulast%3DHaley%26aufirst%3DB.%26aulast%3DPerkins%26aufirst%3DS.%26aulast%3DBeitsch%26aufirst%3DP.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DEuhus%26aufirst%3DD.%26aulast%3DOsborne%26aufirst%3DC.%26aulast%3DFrenkel%26aufirst%3DE.%26aulast%3DHoover%26aufirst%3DS.%26aulast%3DLeitch%26aufirst%3DM.%26aulast%3DClifford%26aufirst%3DE.%26aulast%3DVitetta%26aufirst%3DE.%26aulast%3DMorrison%26aufirst%3DL.%26aulast%3DHerlyn%26aufirst%3DD.%26aulast%3DTerstappen%26aufirst%3DL.%2BW.%26aulast%3DFleming%26aufirst%3DT.%26aulast%3DFehm%26aufirst%3DT.%26aulast%3DTucker%26aufirst%3DT.%26aulast%3DLane%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DUhr%26aufirst%3DJ.%26atitle%3DHER-2%2520Gene%2520Amplification%2520Can%2520Be%2520Acquired%2520as%2520Breast%2520Cancer%2520Progresses%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D9393%26epage%3D9398%26doi%3D10.1073%2Fpnas.0402993101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Hu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokbel, K.</span><span> </span><span class="NLM_article-title">Does C-Erbb2/HER2 Overexpression Predict Adjuvant Tamoxifen Failure in Patients with Early Breast Cancer?</span> <span class="citation_source-journal">European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span><span class="refDoi"> DOI: 10.1053/ejso.2000.1078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1053%2Fejso.2000.1078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=11417974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFeisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2001&pages=335-337&author=J.+C.+Huauthor=K.+Mokbel&title=Does+C-Erbb2%2FHER2+Overexpression+Predict+Adjuvant+Tamoxifen+Failure+in+Patients+with+Early+Breast+Cancer%3F&doi=10.1053%2Fejso.2000.1078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of silicon on physiological target and yield of hybrid rice</span></div><div class="casAuthors">Hu, Ruizhi; Fang, Shuijiao; Chen, Guiqiu</div><div class="citationInfo"><span class="NLM_cas:title">Hunan Nongye Daxue Xuebao</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">335-338</span>CODEN:
                <span class="NLM_cas:coden">HNDXFL</span>;
        ISSN:<span class="NLM_cas:issn">1007-1032</span>.
    
            (<span class="NLM_cas:orgname">Hunan Nongye Daxue Xuebao Bianjibu</span>)
        </div><div class="casAbstract">The soil-less culture was used to study of the effects of silicon on the contents of MDA, the REC (relative elec. cond.), SOD in hybrid rice and the component of yield.  The results show that suitable silicon contents can decrease the contents of MDA and REC in hybrid rice plant, while increase the activities of SOD, strengthen the resistance of adverse circumstances and increase its yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy0z4pD5OhGrVg90H21EOLACvtfcHk0lhwJM0RnNbN4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFeisb4%253D&md5=e1847ef225425c42c3fe9581f815c3e2</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1053%2Fejso.2000.1078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fejso.2000.1078%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%2BC.%26aulast%3DMokbel%26aufirst%3DK.%26atitle%3DDoes%2520C-Erbb2%252FHER2%2520Overexpression%2520Predict%2520Adjuvant%2520Tamoxifen%2520Failure%2520in%2520Patients%2520with%2520Early%2520Breast%2520Cancer%253F%26jtitle%3DEuropean%2520journal%2520of%2520surgical%2520oncology%253A%2520the%2520journal%2520of%2520the%2520European%2520Society%2520of%2520Surgical%2520Oncology%2520and%2520the%2520British%2520Association%2520of%2520Surgical%2520Oncology%26date%3D2001%26volume%3D27%26spage%3D335%26epage%3D337%26doi%3D10.1053%2Fejso.2000.1078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Osborne, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopp, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamness, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilsenbeck, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuqua, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allred, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, R.</span><span> </span><span class="NLM_article-title">Role of the Estrogen Receptor Coactivator AIB1 (Src-3) and HER-2/Neu in Tamoxifen Resistance in Breast Cancer</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span><span class="refDoi"> DOI: 10.1093/jnci/95.5.353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1093%2Fjnci%2F95.5.353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=12618500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVeqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2003&pages=353-361&author=C.+K.+Osborneauthor=V.+Bardouauthor=T.+A.+Hoppauthor=G.+C.+Chamnessauthor=S.+G.+Hilsenbeckauthor=S.+A.+Fuquaauthor=J.+Wongauthor=D.+C.+Allredauthor=G.+M.+Clarkauthor=R.+Schiff&title=Role+of+the+Estrogen+Receptor+Coactivator+AIB1+%28Src-3%29+and+HER-2%2FNeu+in+Tamoxifen+Resistance+in+Breast+Cancer&doi=10.1093%2Fjnci%2F95.5.353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer</span></div><div class="casAuthors">Osborne, C. Kent; Bardou, Valerie; Hopp, Torsten A.; Chamness, Gary C.; Hilsenbeck, Susan G.; Fuqua, Suzanne A. W.; Wong, Jiemin; Allred, D. Craig; Clark, Gary M.; Schiff, Rachel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">353-361</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">AIB1 (SRC-3) is an estrogen receptor (ER) coactivator that, when overexpressed in cultured cells, can reduce the antagonist activity of tamoxifen-bound ERs.  Signaling through the HER-2 receptor pathway activates AIB1 by phosphorylation.  To det. whether high AIB1 expression alone or together with HER-2 reduces the effectiveness of tamoxifen in breast cancer patients, we quantified expression of AIB1 and HER-2 in tumors from breast cancer patients with long-term clin. follow-up who received either no adjuvant therapy or adjuvant tamoxifen therapy after breast cancer surgery.  AIB1 and HER-2 protein levels in tumors from 316 breast cancer patients were detd. using western blot anal.  Mol. variables (e.g., expression of AIB1, ER, progesterone receptor, p53, Bcl-2), tumor characteristics, and patient outcome were assessed using Spearman rank correlation.  Disease-free survival (DFS) curves were derived from Kaplan-Meier ests., and the curves were compared by log-rank tests.  The effect of AIB1 on DFS adjusted for other prognostic factors was assessed by multivariable anal. using the Cox proportional hazards model.  All statistical tests were two-sided.  High AIB1 expression in patients not receiving adjuvant tamoxifen therapy was assocd. with better prognosis and longer DFS (P = .018, log-rank test).  In contrast, for patients who did receive tamoxifen therapy, high AIB1 expression was assocd. with worse DFS (P = .049, log-rank test), which is indicative of tamoxifen resistance.  The test for interaction between AIB1 expression and tamoxifen therapy was statistically significant (P = .004).  When expression of AIB1 and HER-2 were considered together, patients whose tumors expressed high levels of both AIB1 and HER-2 had worse outcomes with tamoxifen therapy than all other patients combined (P = .002, log-rank test).  The antitumor activity of tamoxifen in patients with breast cancer may be detd., in part, by tumor levels of AIB1 and HER-2.  Thus, AIB1 may be an important diagnostic and therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC6PAwU7VOrrVg90H21EOLACvtfcHk0lhwJM0RnNbN4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVeqsrg%253D&md5=5469b2ee206ada6b884eab780a5884e4</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F95.5.353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F95.5.353%26sid%3Dliteratum%253Aachs%26aulast%3DOsborne%26aufirst%3DC.%2BK.%26aulast%3DBardou%26aufirst%3DV.%26aulast%3DHopp%26aufirst%3DT.%2BA.%26aulast%3DChamness%26aufirst%3DG.%2BC.%26aulast%3DHilsenbeck%26aufirst%3DS.%2BG.%26aulast%3DFuqua%26aufirst%3DS.%2BA.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DAllred%26aufirst%3DD.%2BC.%26aulast%3DClark%26aufirst%3DG.%2BM.%26aulast%3DSchiff%26aufirst%3DR.%26atitle%3DRole%2520of%2520the%2520Estrogen%2520Receptor%2520Coactivator%2520AIB1%2520%2528Src-3%2529%2520and%2520HER-2%252FNeu%2520in%2520Tamoxifen%2520Resistance%2520in%2520Breast%2520Cancer%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2003%26volume%3D95%26spage%3D353%26epage%3D361%26doi%3D10.1093%2Fjnci%2F95.5.353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Liehr, J. G.</span><span> </span><span class="NLM_article-title">Is Estradiol a Genotoxic Mutagenic Carcinogen?</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1210/edrv.21.1.0386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fedrv.21.1.0386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10696569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhs12hu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=40-54&author=J.+G.+Liehr&title=Is+Estradiol+a+Genotoxic+Mutagenic+Carcinogen%3F&doi=10.1210%2Fedrv.21.1.0386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Is estradiol a genotoxic mutagenic carcinogen?</span></div><div class="casAuthors">Liehr, Joachim G.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-54</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review, with 203 refs.  The natural hormone 17β-estradiol (E2) induces tumors in various organs of rats, mice, and hamsters.  In humans, slightly elevated circulating estrogen levels caused either by increased endogenous hormone prodn. or by therapeutic doses of estrogen medications increase breast or uterine cancer risk.  Several epigenetic mechanisms of tumor induction by this hormone have been proposed based on its lack of mutagenic activity in bacterial and mammalian cell test systems.  More recent evidence supports a dual role of estrogen in carcinogenesis as a hormone stimulating cell proliferation and as a procarcinogen inducing genetic damage.  Tumors may be initiated by metabolic conversion of E2 to 4-hydroxyestradiol catalyzed by a specific 4-hydroxylase (CYP1B1) and by further activation of this catechol to reactive semiquinone/quinone intermediates.  Several types of direct and indirect free radical-mediated DNA damage are induced by E2, 4-hydroxyestradiol, or its corresponding quinone in cell-free systems, in cells in culture, and/or in vivo.  E2 also induces various chromosomal and genetic lesions including aneuploidy, chromosomal aberrations, gene amplification, and microsatellite instability in cells in culture and/or in vivo and gene mutations in several cell test systems.  These data suggest that E2 is a weak carcinogen and weak mutagen capable of inducing genetic lesions with low frequency.  Tumors may develop by hormone receptor-mediated proliferation of such damaged cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomqHoWEpbMYLVg90H21EOLACvtfcHk0lhsc3_xKI6MEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhs12hu74%253D&md5=b6d420c699606d51e070a59aae34b803</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1210%2Fedrv.21.1.0386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fedrv.21.1.0386%26sid%3Dliteratum%253Aachs%26aulast%3DLiehr%26aufirst%3DJ.%2BG.%26atitle%3DIs%2520Estradiol%2520a%2520Genotoxic%2520Mutagenic%2520Carcinogen%253F%26jtitle%3DEndocr.%2520Rev.%26date%3D2000%26volume%3D21%26spage%3D40%26epage%3D54%26doi%3D10.1210%2Fedrv.21.1.0386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Breast International Group 1-98 Collaborative Group</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurlimann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshaviah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouridsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauriac, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paridaens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castiglione-Gertsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelber, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabaglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldhirsch, A.</span><span> </span><span class="NLM_article-title">Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">2747</span><span class="NLM_x">–</span> <span class="NLM_lpage">2757</span><span class="refDoi"> DOI: 10.1056/NEJMoa052258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1056%2FNEJMoa052258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=16382061" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=2747-2757&author=Breast+International+Group+1-98+Collaborative+Groupauthor=B.+Thurlimannauthor=A.+Keshaviahauthor=A.+S.+Coatesauthor=H.+Mouridsenauthor=L.+Mauriacauthor=J.+F.+Forbesauthor=R.+Paridaensauthor=M.+Castiglione-Gertschauthor=R.+D.+Gelberauthor=M.+Rabaglioauthor=I.+Smithauthor=A.+Wardleyauthor=K.+N.+Priceauthor=A.+Goldhirsch&title=Comparison+of+Letrozole+and+Tamoxifen+in+Postmenopausal+Women+with+Early+Breast+Cancer&doi=10.1056%2FNEJMoa052258"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa052258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa052258%26sid%3Dliteratum%253Aachs%26aulast%3D%26aulast%3DThurlimann%26aufirst%3DB.%26aulast%3DKeshaviah%26aufirst%3DA.%26aulast%3DCoates%26aufirst%3DA.%2BS.%26aulast%3DMouridsen%26aufirst%3DH.%26aulast%3DMauriac%26aufirst%3DL.%26aulast%3DForbes%26aufirst%3DJ.%2BF.%26aulast%3DParidaens%26aufirst%3DR.%26aulast%3DCastiglione-Gertsch%26aufirst%3DM.%26aulast%3DGelber%26aufirst%3DR.%2BD.%26aulast%3DRabaglio%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DI.%26aulast%3DWardley%26aufirst%3DA.%26aulast%3DPrice%26aufirst%3DK.%2BN.%26aulast%3DGoldhirsch%26aufirst%3DA.%26atitle%3DComparison%2520of%2520Letrozole%2520and%2520Tamoxifen%2520in%2520Postmenopausal%2520Women%2520with%2520Early%2520Breast%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D2747%26epage%3D2757%26doi%3D10.1056%2FNEJMoa052258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Goss, P. E.</span><span> </span><span class="NLM_article-title">Pre-Clinical and Clinical Review of Vorozole, a New Third Generation Aromatase Inhibitor</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S59</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><div class="note"><p class="first last">(discussion S73–57)</p></div><span class="refDoi"> DOI: 10.1023/A:1006052923468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1023%2FA%3A1006052923468" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1998&pages=S59-65&issue=Suppl.+1&author=P.+E.+Goss&title=Pre-Clinical+and+Clinical+Review+of+Vorozole%2C+a+New+Third+Generation+Aromatase+Inhibitor&doi=10.1023%2FA%3A1006052923468"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006052923468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006052923468%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DP.%2BE.%26atitle%3DPre-Clinical%2520and%2520Clinical%2520Review%2520of%2520Vorozole%252C%2520a%2520New%2520Third%2520Generation%2520Aromatase%2520Inhibitor%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1998%26volume%3D49%26issue%3DSuppl.%25201%26spage%3DS59%26epage%3D65%26doi%3D10.1023%2FA%3A1006052923468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Goss, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winer, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannock, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, L. H.</span><span> </span><span class="NLM_article-title">Randomized Phase III Trial Comparing the New Potent and Selective Third-Generation Aromatase Inhibitor Vorozole with Megestrol Acetate in Postmenopausal Advanced Breast Cancer Patients. North American Vorozole Study Group</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10458218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK1MXltVyktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=52-63&author=P.+E.+Gossauthor=E.+P.+Winerauthor=I.+F.+Tannockauthor=L.+H.+Schwartz&title=Randomized+Phase+III+Trial+Comparing+the+New+Potent+and+Selective+Third-Generation+Aromatase+Inhibitor+Vorozole+with+Megestrol+Acetate+in+Postmenopausal+Advanced+Breast+Cancer+Patients.+North+American+Vorozole+Study+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients</span></div><div class="casAuthors">Goss, P. E.; Winer, E. P.; Tannock, I. F.; Schwartz, L. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-63</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">To compare the efficacy and safety of vorozole (VOR) 2.5 mg once daily with that of megestrol acetate (MA) 40 mg four times per day as second-line therapy in postmenopausal women with advanced breast cancer whose disease progressed after tamoxifen treatment.  A total of 452 patients were enrolled onto an open, multicenter, randomized phase III trial comparing VOR to MA for tumor response, safety, and quality of life (as indicated by the Functional Living Index-Cancer score).  Vorozole produced a response rate of 9.7%, compared with 6.8% for MA (P = .24).  Clin. benefit (complete response + partial response + no change in > 6 mo) was demonstrated in 23.5% and 27.2% of patients treated with VOR and MA, resp. (P = .42).  Median duration of response was 18.2 mo for VOR vs. 12.5 mo for MA (P = .074).  There was no significant difference in time to progression or survival between the treatment groups.  Discontinuation of treatment because of adverse events occurred less frequently in the VOR-treated group (3.1% v 6.2%; P = .18).  Patients on the VOR arm reported significantly more nausea, hot flushes, arthralgia, upper respiratory tract infection, anorexia, and paresthesia, whereas those treated with MA had significantly more dyspnea, increased appetite, and wt. increase.  There was no difference between the two treatment groups in Functional Living Index-Cancer scores (total or subscales).  However, when analyzed by objective response, patients with complete or partial responses (P = .032) or no change (P = .033) who were receiving VOR had significant improvement in the psychol. well-being subscale, compared with patients given MA.  Vorozole is well tolerated and as effective as MA in the treatment of postmenopausal advanced breast cancer patients with disease progression after tamoxifen treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLOMxt055ACLVg90H21EOLACvtfcHk0ljiKZoIjo28IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVyktw%253D%253D&md5=31c654185ca7aaa4d792ced51d59202c</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DP.%2BE.%26aulast%3DWiner%26aufirst%3DE.%2BP.%26aulast%3DTannock%26aufirst%3DI.%2BF.%26aulast%3DSchwartz%26aufirst%3DL.%2BH.%26atitle%3DRandomized%2520Phase%2520III%2520Trial%2520Comparing%2520the%2520New%2520Potent%2520and%2520Selective%2520Third-Generation%2520Aromatase%2520Inhibitor%2520Vorozole%2520with%2520Megestrol%2520Acetate%2520in%2520Postmenopausal%2520Advanced%2520Breast%2520Cancer%2520Patients.%2520North%2520American%2520Vorozole%2520Study%2520Group%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D1999%26volume%3D17%26spage%3D52%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Williams, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinkovic, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angove, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tickle, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span><span class="refDoi"> DOI: 10.1126/science.1099736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1126%2Fscience.1099736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=15256616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFWqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=683-686&author=P.+A.+Williamsauthor=J.+Cosmeauthor=D.+M.+Vinkovicauthor=A.+Wardauthor=H.+C.+Angoveauthor=P.+J.+Dayauthor=C.+Vonrheinauthor=I.+J.+Tickleauthor=H.+Jhoti&title=Crystal+Structures+of+Human+Cytochrome+P450+3A4+Bound+to+Metyrapone+and+Progesterone&doi=10.1126%2Fscience.1099736"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone</span></div><div class="casAuthors">Williams, Pamela A.; Cosme, Jose; Vinkovic, Dijana Matak; Ward, Alison; Angove, Hayley C.; Day, Philip J.; Vonrhein, Clemens; Tickle, Ian J.; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">5684</span>),
    <span class="NLM_cas:pages">683-686</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cytochromes P 450 (P 450s) metabolize a wide range of endogenous compds. and xenobiotics, such as pollutants, environmental compds., and drug mols.  The microsomal, membrane-assocd., P 450 isoforms CYP3A4, CYP2D6, CYP2C9, CYP2C19, CYP2E1, and CYP1A2 are responsible for the oxidative metab. of >90% of marketed drugs.  Cytochrome P 450 3A4 (CYP3A4) metabolizes more drug mols. than all other isoforms combined.  Here, the authors report 3 crystal structures of CYP3A4: (1) unliganded, (2) bound to the inhibitor, metyrapone, and (3) bound to the substrate, progesterone.  The structures revealed a surprisingly small active site, with little conformational change assocd. with the binding of either compd.  An unexpected peripheral binding site was identified, located above a Phe cluster, which may be involved in the initial recognition of substrates or allosteric effectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMG5YfnJT6DrVg90H21EOLACvtfcHk0liZtbnB0Wksag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFWqsrY%253D&md5=a2275c2d7ee2dc65e3e99be3bfa56331</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1126%2Fscience.1099736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1099736%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DCosme%26aufirst%3DJ.%26aulast%3DVinkovic%26aufirst%3DD.%2BM.%26aulast%3DWard%26aufirst%3DA.%26aulast%3DAngove%26aufirst%3DH.%2BC.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DCrystal%2520Structures%2520of%2520Human%2520Cytochrome%2520P450%25203A4%2520Bound%2520to%2520Metyrapone%2520and%2520Progesterone%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D683%26epage%3D686%26doi%3D10.1126%2Fscience.1099736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leydon, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxbrow, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggleston, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenery, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. M.</span><span> </span><span class="NLM_article-title">Crystal Structure of Human Cytochrome P450 2D6</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">7614</span><span class="NLM_x">–</span> <span class="NLM_lpage">7622</span><span class="refDoi"> DOI: 10.1074/jbc.M511232200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1074%2Fjbc.M511232200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=16352597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ygtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7614-7622&author=P.+Rowlandauthor=F.+E.+Blaneyauthor=M.+G.+Smythauthor=J.+J.+Jonesauthor=V.+R.+Leydonauthor=A.+K.+Oxbrowauthor=C.+J.+Lewisauthor=M.+G.+Tennantauthor=S.+Modiauthor=D.+S.+Egglestonauthor=R.+J.+Cheneryauthor=A.+M.+Bridges&title=Crystal+Structure+of+Human+Cytochrome+P450+2D6&doi=10.1074%2Fjbc.M511232200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human cytochrome P 450 2D6</span></div><div class="casAuthors">Rowland, Paul; Blaney, Frank E.; Smyth, Martin G.; Jones, Jo J.; Leydon, Vaughan R.; Oxbrow, Amanda K.; Lewis, Ceri J.; Tennant, Mike G.; Modi, Sandeep; Eggleston, Drake S.; Chenery, Richard J.; Bridges, Angela M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7614-7622</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 2D6 is a heme-contg. enzyme that is responsible for the metab. of at least 20% of known drugs.  Substrates of 2D6 typically contain a basic N atom and a planar arom. ring.  Here, the crystal structure of human 2D6 was solved and refined to 3.0Å resoln.  The structure showed the characteristic P 450 fold as seen in other members of the family, with the lengths and orientations of the individual secondary structural elements being very similar to those seen in 2C9.  There were, however, several important differences, the most notable involving the F helix, the F-G loop, the B' helix, β-sheet 4, and part of β-sheet 1, all of which were situated on the distal face of the protein.  The 2D6 structure had a well-defined active site cavity above the heme group, contg. many important residues that have been implicated in substrate recognition and binding, including Asp-301, Glu-216, Phe-483, and Phe-120.  The crystal structure helped to explain how Asp-301, Glu-216, and Phe-483 could act as substrate-binding residues and suggested that the role of Phe-120 is to control the orientation of the arom. ring found in most substrates with respect to the heme.  The structure was compared with published homol. models and has been used to explain much of the reported site-directed mutagenesis data and to help understand the metab. of several compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon7FdjHI2WD7Vg90H21EOLACvtfcHk0liZtbnB0Wksag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ygtbg%253D&md5=f31403bf56fadab86a694b1add06859c</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M511232200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M511232200%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DSmyth%26aufirst%3DM.%2BG.%26aulast%3DJones%26aufirst%3DJ.%2BJ.%26aulast%3DLeydon%26aufirst%3DV.%2BR.%26aulast%3DOxbrow%26aufirst%3DA.%2BK.%26aulast%3DLewis%26aufirst%3DC.%2BJ.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DChenery%26aufirst%3DR.%2BJ.%26aulast%3DBridges%26aufirst%3DA.%2BM.%26atitle%3DCrystal%2520Structure%2520of%2520Human%2520Cytochrome%2520P450%25202D6%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7614%26epage%3D7622%26doi%3D10.1074%2Fjbc.M511232200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Strushkevich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilep, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usanov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. W.</span><span> </span><span class="NLM_article-title">Structural Insights into Aldosterone Synthase Substrate Specificity and Targeted Inhibition</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><span class="refDoi"> DOI: 10.1210/me.2012-1287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fme.2012-1287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=23322723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=315-324&author=N.+Strushkevichauthor=A.+A.+Gilepauthor=L.+Shenauthor=C.+H.+Arrowsmithauthor=A.+M.+Edwardsauthor=S.+A.+Usanovauthor=H.+W.+Park&title=Structural+Insights+into+Aldosterone+Synthase+Substrate+Specificity+and+Targeted+Inhibition&doi=10.1210%2Fme.2012-1287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into aldosterone synthase substrate specificity and targeted inhibition</span></div><div class="casAuthors">Strushkevich, Natallia; Gilep, Andrei A.; Shen, Limin; Arrowsmith, Cheryl H.; Edwards, Aled M.; Usanov, Sergey A.; Park, Hee-Won</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">315-324</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Aldosterone is a major mineralocorticoid hormone that plays a key role in the regulation of electrolyte balance and blood pressure.  Excess aldosterone levels can arise from dysregulation of the renin-angiotensin-aldosterone system and are implicated in the pathogenesis of hypertension and heart failure.  Aldosterone synthase (cytochrome P 450 11B2, CYP11B2) is the sole enzyme responsible for the prodn. of aldosterone in humans.  Blocking of aldosterone synthesis by mediating aldosterone synthase activity is thus a recently emerging pharmacol. therapy for hypertension, yet a lack of structural information has limited this approach.  Here, we present the crystal structures of human aldosterone synthase in complex with a substrate deoxycorticosterone and an inhibitor fadrozole.  The structures reveal a hydrophobic cavity with specific features assocd. with corticosteroid recognition.  The substrate binding mode, along with biochem. data, explains the high 11β-hydroxylase activity of aldosterone synthase toward both gluco- and mineralocorticoid formation.  The low processivity of aldosterone synthase with a high extent of intermediates release might be one of the mechanisms of controlled aldosterone prodn. from deoxycorticosterone.  Although the active site pocket is lined by identical residues between CYP11B isoforms, most of the divergent residues that confer addnl. 18-oxidase activity of aldosterone synthase are located in the I-helix (vicinity of the O2 activation path) and loops around the H-helix (affecting an egress channel closure required for retaining intermediates in the active site).  This intrinsic flexibility is also reflected in isoform-selective inhibitor binding.  Fadrozole binds to aldosterone synthase in the R-configuration, using part of the active site cavity pointing toward the egress channel.  The structural organization of aldosterone synthase provides crit. insights into the mol. mechanism of catalysis and enables rational design of more specific antihypertensive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy06hMTGcZQ7Vg90H21EOLACvtfcHk0liXHyvv28yayA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOgur8%253D&md5=808e61fa02a12b63809bf3787ba83318</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1210%2Fme.2012-1287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2012-1287%26sid%3Dliteratum%253Aachs%26aulast%3DStrushkevich%26aufirst%3DN.%26aulast%3DGilep%26aufirst%3DA.%2BA.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DUsanov%26aufirst%3DS.%2BA.%26aulast%3DPark%26aufirst%3DH.%2BW.%26atitle%3DStructural%2520Insights%2520into%2520Aldosterone%2520Synthase%2520Substrate%2520Specificity%2520and%2520Targeted%2520Inhibition%26jtitle%3DMol.%2520Endocrinol.%26date%3D2013%26volume%3D27%26spage%3D315%26epage%3D324%26doi%3D10.1210%2Fme.2012-1287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">DeVore, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, E. E.</span><span> </span><span class="NLM_article-title">Structures of Cytochrome P450 17A1 with Prostate Cancer Drugs Abiraterone and Tok-001</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">482</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span><span class="refDoi"> DOI: 10.1038/nature10743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Fnature10743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22266943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=116-119&author=N.+M.+DeVoreauthor=E.+E.+Scott&title=Structures+of+Cytochrome+P450+17A1+with+Prostate+Cancer+Drugs+Abiraterone+and+Tok-001&doi=10.1038%2Fnature10743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001</span></div><div class="casAuthors">DeVore, Natasha M.; Scott, Emily E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">7383</span>),
    <span class="NLM_cas:pages">116-119</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The structures of CYP17A1 with steroid inhibitors abiraterone or TOK-001 provide a better understanding of the enzyme's catalytic capabilities and inhibition, and hence assist in understanding steroidogenic diseases and designing drugs to improve the treatment of prostate and other steroid-responsive cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRAzwETu-JGbVg90H21EOLACvtfcHk0liXHyvv28yayA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGqsb0%253D&md5=6cb6058ac0e52c951cd09d86d0eee613</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fnature10743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10743%26sid%3Dliteratum%253Aachs%26aulast%3DDeVore%26aufirst%3DN.%2BM.%26aulast%3DScott%26aufirst%3DE.%2BE.%26atitle%3DStructures%2520of%2520Cytochrome%2520P450%252017A1%2520with%2520Prostate%2520Cancer%2520Drugs%2520Abiraterone%2520and%2520Tok-001%26jtitle%3DNature%26date%3D2012%26volume%3D482%26spage%3D116%26epage%3D119%26doi%3D10.1038%2Fnature10743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guengerich, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterman, M. R.</span><span> </span><span class="NLM_article-title">Three-Dimensional Structure of Steroid 21-Hydroxylase (Cytochrome P450 21A2) with Two Substrates Reveals Locations of Disease-Associated Variants</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">10613</span><span class="NLM_x">–</span> <span class="NLM_lpage">10622</span><span class="refDoi"> DOI: 10.1074/jbc.M111.323501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1074%2Fjbc.M111.323501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22262854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlKrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=10613-10622&author=B.+Zhaoauthor=L.+Leiauthor=N.+Kagawaauthor=M.+Sundaramoorthyauthor=S.+Banerjeeauthor=L.+D.+Nagyauthor=F.+P.+Guengerichauthor=M.+R.+Waterman&title=Three-Dimensional+Structure+of+Steroid+21-Hydroxylase+%28Cytochrome+P450+21A2%29+with+Two+Substrates+Reveals+Locations+of+Disease-Associated+Variants&doi=10.1074%2Fjbc.M111.323501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Three-dimensional structure of steroid 21-hydroxylase (cytochrome P 450 21A2) with two substrates reveals locations of disease-associated variants</span></div><div class="casAuthors">Zhao, Bin; Lei, Li; Kagawa, Norio; Sundaramoorthy, Munirathinam; Banerjee, Surajit; Nagy, Leslie D.; Guengerich, F. Peter; Waterman, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">10613-10622</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Steroid 21-hydroxylase (cytochrome P 450 21A2; CYP21A2) deficiency accounts for ∼95% of individuals with congenital adrenal hyperplasia, a common autosomal recessive metabolic disorder of adrenal steroidogenesis.  The effects of amino acid mutations on CYP21A2 activity lead to impairment of the synthesis of cortisol and aldosterone and the excessive prodn. of androgens.  In order to understand the structural and mol. basis of this group of diseases, the bovine CYP21A2 crystal structure complexed with the substrate, 17-hydroxyprogesterone (17OHP), was detd. to 3.0 Å resoln.  An intriguing result from this structure was that there were 2 mols. of 17OHP bound to the enzyme, the distal one being located at the entrance of the substrate access channel and the proximal one bound in the active site.  The substrate-binding features located the key substrate recognition residues not only around the heme but also along the substrate access channel.  In addn., orientation of the skeleton of the proximal mol. was toward the interior of the enzyme away from the substrate access channel.  The 17OHP complex of CYP21A2 provided a good relation between the crystal structure, clin. data, and genetic mutants documented in the literature, thereby enhancing the understanding of congenital adrenal hyperplasia.  In addn., the location of certain CYP21A2 mutations provided general understanding of structure-function relations in P 450s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotrfBvem3dXbVg90H21EOLACvtfcHk0liXHyvv28yayA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlKrtr4%253D&md5=ce4b02f036d51904af1d1d4250587104</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.323501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.323501%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DLei%26aufirst%3DL.%26aulast%3DKagawa%26aufirst%3DN.%26aulast%3DSundaramoorthy%26aufirst%3DM.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DNagy%26aufirst%3DL.%2BD.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DWaterman%26aufirst%3DM.%2BR.%26atitle%3DThree-Dimensional%2520Structure%2520of%2520Steroid%252021-Hydroxylase%2520%2528Cytochrome%2520P450%252021A2%2529%2520with%2520Two%2520Substrates%2520Reveals%2520Locations%2520of%2520Disease-Associated%2520Variants%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D10613%26epage%3D10622%26doi%3D10.1074%2Fjbc.M111.323501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Annalora, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodin, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span> </span><span class="NLM_article-title">Crystal Structure of CYP24A1, a Mitochondrial Cytochrome P450 Involved in Vitamin D Metabolism</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">396</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span><span class="refDoi"> DOI: 10.1016/j.jmb.2009.11.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jmb.2009.11.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19961857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12murk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2010&pages=441-451&author=A.+J.+Annaloraauthor=D.+B.+Goodinauthor=W.+X.+Hongauthor=Q.+Zhangauthor=E.+F.+Johnsonauthor=C.+D.+Stout&title=Crystal+Structure+of+CYP24A1%2C+a+Mitochondrial+Cytochrome+P450+Involved+in+Vitamin+D+Metabolism&doi=10.1016%2Fj.jmb.2009.11.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of CYP24A1, a Mitochondrial Cytochrome P450 Involved in Vitamin D Metabolism</span></div><div class="casAuthors">Annalora, Andrew J.; Goodin, David B.; Hong, Wen-Xu; Zhang, Qinghai; Johnson, Eric F.; Stout, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-451</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cytochrome P 450 (CYP) 24A1 catalyzes the side-chain oxidn. of the hormonal form of vitamin D.  Expression of CYP24A1 is up-regulated to attenuate vitamin D signaling assocd. with calcium homeostasis and cellular growth processes.  The development of therapeutics for disorders linked to vitamin D insufficiency would be greatly facilitated by structural knowledge of CYP24A1.  Here, we report the crystal structure of rat CYP24A1 at 2.5 Å resoln.  The structure exhibits an open cleft leading to the active-site heme prosthetic group on the distal surface that is likely to define the path of substrate access into the active site.  The entrance to the cleft is flanked by conserved hydrophobic residues on helixes A' and G', suggesting a mode of insertion into the inner mitochondrial membrane.  A docking model for 1α,25-dihydroxyvitamin D3 binding in the open form of CYP24A1 that clarifies the structural determinants of secosteroid recognition and validates the predictive power of existing homol. models of CYP24A1 is proposed.  Anal. of CYP24A1's proximal surface identifies the determinants of adrenodoxin recognition as a constellation of conserved residues from helixes K, K'', and L that converge with an adjacent lysine-rich loop for binding the redox protein.  Overall, the CYP24A1 structure provides the first template for understanding membrane insertion, substrate binding, and redox partner interaction in mitochondrial P450s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeevmsDxW8SrVg90H21EOLACvtfcHk0lhUTNyeAbv4gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12murk%253D&md5=76c9ed44d954363c5a11e614b2efa388</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.11.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.11.057%26sid%3Dliteratum%253Aachs%26aulast%3DAnnalora%26aufirst%3DA.%2BJ.%26aulast%3DGoodin%26aufirst%3DD.%2BB.%26aulast%3DHong%26aufirst%3DW.%2BX.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStout%26aufirst%3DC.%2BD.%26atitle%3DCrystal%2520Structure%2520of%2520CYP24A1%252C%2520a%2520Mitochondrial%2520Cytochrome%2520P450%2520Involved%2520in%2520Vitamin%2520D%2520Metabolism%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D396%26spage%3D441%26epage%3D451%26doi%3D10.1016%2Fj.jmb.2009.11.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Strushkevich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usanov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. W.</span><span> </span><span class="NLM_article-title">Structural Basis of Human CYP51 Inhibition by Antifungal Azoles</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">397</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1078</span><span class="refDoi"> DOI: 10.1016/j.jmb.2010.01.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jmb.2010.01.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=20149798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2010&pages=1067-1078&author=N.+Strushkevichauthor=S.+A.+Usanovauthor=H.+W.+Park&title=Structural+Basis+of+Human+CYP51+Inhibition+by+Antifungal+Azoles&doi=10.1016%2Fj.jmb.2010.01.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Human CYP51 Inhibition by Antifungal Azoles</span></div><div class="casAuthors">Strushkevich, Natallia; Usanov, Sergey A.; Park, Hee-Won</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">397</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1067-1078</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The obligatory step in sterol biosynthesis in eukaryotes is demethylation of sterol precursors at the C14-position, which is catalyzed by CYP51 (sterol 14α demethylase) in three sequential reactions.  In mammals, the final product of the pathway is cholesterol, while important intermediates, meiosis-activating sterols, are produced by CYP51.  Three crystal structures of human CYP51, ligand-free and complexed with antifungal drugs ketoconazole and econazole, were detd., allowing anal. of the mol. basis for functional conservation within the CYP51 family.  Azole binding occurs mostly through hydrophobic interactions with conservative residues of the active site.  The substantial conformational changes in the B' helix and F-G loop regions are induced upon ligand binding, consistent with the membrane nature of the protein and its substrate.  The access channel is typical for mammalian sterol-metabolizing P 450 enzymes, but is different from that obsd. in Mycobacterium tuberculosis CYP51.  Comparison of the azole-bound structures provides insight into the relative binding affinities of human and bacterial P 450 enzymes to ketoconazole and fluconazole, which can be useful for the rational design of antifungal compds. and specific modulators of human CYP51.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpno6jtTo75W7Vg90H21EOLACvtfcHk0lhUTNyeAbv4gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKmurY%253D&md5=4d48592355aedba6ea92da98faef2ebd</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.01.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.01.075%26sid%3Dliteratum%253Aachs%26aulast%3DStrushkevich%26aufirst%3DN.%26aulast%3DUsanov%26aufirst%3DS.%2BA.%26aulast%3DPark%26aufirst%3DH.%2BW.%26atitle%3DStructural%2520Basis%2520of%2520Human%2520CYP51%2520Inhibition%2520by%2520Antifungal%2520Azoles%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D397%26spage%3D1067%26epage%3D1078%26doi%3D10.1016%2Fj.jmb.2010.01.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Bouchoucha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samara-Boustani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bony-Trifunovic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigrain, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluck, C. E.</span><span> </span><span class="NLM_article-title">Characterization of a Novel CYP19A1 (Aromatase) R192H Mutation Causing Virilization of a 46,XX Newborn, Undervirilization of the 46,XY Brother, but No Virilization of the Mother During Pregnancies</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">390</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1016/j.mce.2014.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.mce.2014.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=24705274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotlOrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2014&pages=8-17&author=N.+Bouchouchaauthor=D.+Samara-Boustaniauthor=A.+V.+Pandeyauthor=H.+Bony-Trifunovicauthor=G.+Hoferauthor=Y.+Aigrainauthor=M.+Polakauthor=C.+E.+Fluck&title=Characterization+of+a+Novel+CYP19A1+%28Aromatase%29+R192H+Mutation+Causing+Virilization+of+a+46%2CXX+Newborn%2C+Undervirilization+of+the+46%2CXY+Brother%2C+but+No+Virilization+of+the+Mother+During+Pregnancies&doi=10.1016%2Fj.mce.2014.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies</span></div><div class="casAuthors">Bouchoucha, Nadia; Samara-Boustani, Dinane; Pandey, Amit V.; Bony-Trifunovic, Helene; Hofer, Gaby; Aigrain, Yves; Polak, Michel; Fluck, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">8-17</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">P 450 aromatase (CYP19A1) is essential for the biosynthesis of estrogens from androgen precursors.  Mutations in the coding region of CYP19A1 lead to autosomal recessive aromatase deficiency.  To date over 20 subjects have been reported with aromatase deficiency which may manifest during fetal life with maternal virilization and virilization of the external genitalia of a female fetus due to low aromatase activity in the steroid metabolizing fetal-placental unit and thus high androgen levels.  During infancy, girls often have ovarian cysts and thereafter fail to enter puberty showing signs of variable degree of androgen excess.  Moreover, impact on growth, skeletal maturation and other metabolic parameters is seen in both sexes.  We found a novel homozygous CYP19A1 mutation in a 46,XX girl who was born at term to consanguineous parents.  Although the mother did not virilize during pregnancy, the baby was found to have a complex genital anomaly at birth (enlarged genital tubercle, fusion of labioscrotal folds) with elevated androgens at birth, normalizing thereafter.  Presence of 46,XX karyotype and female internal genital organs (uterus, vagina) together with biochem. findings and follow-up showing regression of clitoral hypertrophy, as well as elevated FSH suggested aromatase deficiency.  Interestingly, her older brother presented with mild hypospadias and bilateral cryptorchidism and was found to carry the same homozygous CYP19A1 mutation.  To confirm the clin. diagnosis, genetic, functional and computational studies were performed.  Genetic anal. revealed a homozygous R192H mutation in the CYP19A1 gene.  This novel mutation was characterized for its enzymic activity (Km, Vmax) in a cell model and found to have markedly reduced catalytic activity when compared to wild-type aromatase; thus explaining the phenotype.  Computational studies suggest that R192H disrupts the substrate access channel in CYP19A1 that may affect binding of substrates and exit of catalytic products.  R192H is a novel CYP19A1 mutation which causes a severe phenotype of aromatase deficiency in a 46,XX newborn and maybe hypospadias and cryptorchidism in a 46,XY, but no maternal androgen excess during pregnancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVLq-hMwHdUbVg90H21EOLACvtfcHk0ljbIhU1DfNY6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotlOrtrs%253D&md5=92559defb684341aa3f6215264beb9a0</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2014.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2014.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DBouchoucha%26aufirst%3DN.%26aulast%3DSamara-Boustani%26aufirst%3DD.%26aulast%3DPandey%26aufirst%3DA.%2BV.%26aulast%3DBony-Trifunovic%26aufirst%3DH.%26aulast%3DHofer%26aufirst%3DG.%26aulast%3DAigrain%26aufirst%3DY.%26aulast%3DPolak%26aufirst%3DM.%26aulast%3DFluck%26aufirst%3DC.%2BE.%26atitle%3DCharacterization%2520of%2520a%2520Novel%2520CYP19A1%2520%2528Aromatase%2529%2520R192H%2520Mutation%2520Causing%2520Virilization%2520of%2520a%252046%252CXX%2520Newborn%252C%2520Undervirilization%2520of%2520the%252046%252CXY%2520Brother%252C%2520but%2520No%2520Virilization%2520of%2520the%2520Mother%2520During%2520Pregnancies%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2014%26volume%3D390%26spage%3D8%26epage%3D17%26doi%3D10.1016%2Fj.mce.2014.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Marino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez Garrido, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guercio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juanes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaccio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, G.</span><span> </span><span class="NLM_article-title">Five New Cases of 46, XX Aromatase Deficiency: Clinical Follow-up from Birth to Puberty, a Novel Mutation, and a Founder Effect</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">E301</span><span class="NLM_x">–</span> <span class="NLM_lpage">E307</span><span class="refDoi"> DOI: 10.1210/jc.2014-2967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjc.2014-2967" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=E301-E307&author=R.+Marinoauthor=N.+Perez+Garridoauthor=M.+Costanzoauthor=G.+Guercioauthor=M.+Juanesauthor=C.+Roccoauthor=P.+Ramirezauthor=D.+M.+Warmanauthor=M.+Ciaccioauthor=G.+Pena&title=Five+New+Cases+of+46%2C+XX+Aromatase+Deficiency%3A+Clinical+Follow-up+from+Birth+to+Puberty%2C+a+Novel+Mutation%2C+and+a+Founder+Effect&doi=10.1210%2Fjc.2014-2967"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1210%2Fjc.2014-2967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2014-2967%26sid%3Dliteratum%253Aachs%26aulast%3DMarino%26aufirst%3DR.%26aulast%3DPerez%2BGarrido%26aufirst%3DN.%26aulast%3DCostanzo%26aufirst%3DM.%26aulast%3DGuercio%26aufirst%3DG.%26aulast%3DJuanes%26aufirst%3DM.%26aulast%3DRocco%26aufirst%3DC.%26aulast%3DRamirez%26aufirst%3DP.%26aulast%3DWarman%26aufirst%3DD.%2BM.%26aulast%3DCiaccio%26aufirst%3DM.%26aulast%3DPena%26aufirst%3DG.%26atitle%3DFive%2520New%2520Cases%2520of%252046%252C%2520XX%2520Aromatase%2520Deficiency%253A%2520Clinical%2520Follow-up%2520from%2520Birth%2520to%2520Puberty%252C%2520a%2520Novel%2520Mutation%252C%2520and%2520a%2520Founder%2520Effect%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2015%26volume%3D100%26spage%3DE301%26epage%3DE307%26doi%3D10.1210%2Fjc.2014-2967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Motion and Flexibility in Human Cytochrome P450 Aromatase</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e32565</span><span class="refDoi"> DOI: 10.1371/journal.pone.0032565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1371%2Fjournal.pone.0032565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22384274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFyktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e32565&author=W.+Jiangauthor=D.+Ghosh&title=Motion+and+Flexibility+in+Human+Cytochrome+P450+Aromatase&doi=10.1371%2Fjournal.pone.0032565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Motion and flexibility in human cytochrome P450 aromatase</span></div><div class="casAuthors">Jiang, Wenhua; Ghosh, Debashis</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e32565</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The crystal structures of human placental aromatase in complex with the substrate androstenedione and exemestane have revealed an androgen-specific active site and the structural basis for higher order organization.  However, X-ray structures do not provide accounts of movements due to short-range fluctuations, ligand binding and protein-protein assocn.  In this work, we conduct normal mode anal. (NMA) revealing the intrinsic fluctuations of aromatase, deduce the internal modes in membrane-free and membrane-integrated monomers as well as the intermol. modes in oligomers, and propose a quaternary organization for the endoplasmic reticulum (ER) membrane integration.  Dynamics of the crystallog. oligomers from NMA is found to be in agreement with the isotropic thermal factors from the X-ray anal.  Calcns. of the root mean square fluctuations of the C-alpha atoms from their equil. positions confirm that the rigid-core structure of aromatase is intrinsic regardless of the changes in steroid binding interactions, and that aromatase self-assocn. does not deteriorate the rigidity of the catalytic cleft.  Furthermore, NMA on membrane-integrated aromatase shows that the internal modes in all likelihood contribute to breathing of the active site access channel.  The collective intermol. hinge bending and twisting modes provide the flexibility in the quaternary assocn. necessary for membrane integration of the aromatase oligomers.  Taken together, fluctuations of the active site, the access channel, and the heme-proximal cavity, and a dynamic quaternary organization could all be essential components of the functional aromatase in its role as an ER membrane-embedded steroidogenic enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryfsCESF8WQbVg90H21EOLACvtfcHk0ljbIhU1DfNY6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFyktr8%253D&md5=5270cea39643ecccbf45c2e2b2f4e30a</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0032565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0032565%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DMotion%2520and%2520Flexibility%2520in%2520Human%2520Cytochrome%2520P450%2520Aromatase%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De32565%26doi%3D10.1371%2Fjournal.pone.0032565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Akhtar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calder, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corina, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. N.</span><span> </span><span class="NLM_article-title">Mechanistic Studies on C-19 Demethylation in Oestrogen Biosynthesis</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1042/bj2010569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1042%2Fbj2010569" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=1982&pages=569-580&author=M.+Akhtarauthor=M.+R.+Calderauthor=D.+L.+Corinaauthor=J.+N.+Wright&title=Mechanistic+Studies+on+C-19+Demethylation+in+Oestrogen+Biosynthesis&doi=10.1042%2Fbj2010569"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1042%2Fbj2010569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2010569%26sid%3Dliteratum%253Aachs%26aulast%3DAkhtar%26aufirst%3DM.%26aulast%3DCalder%26aufirst%3DM.%2BR.%26aulast%3DCorina%26aufirst%3DD.%2BL.%26aulast%3DWright%26aufirst%3DJ.%2BN.%26atitle%3DMechanistic%2520Studies%2520on%2520C-19%2520Demethylation%2520in%2520Oestrogen%2520Biosynthesis%26jtitle%3DBiochem.%2520J.%26date%3D1982%26volume%3D201%26spage%3D569%26epage%3D580%26doi%3D10.1042%2Fbj2010569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Akhtar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njar, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. N.</span><span> </span><span class="NLM_article-title">Mechanistic Studies on Aromatase and Related C-C Bond Cleaving P-450 Enzymes</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1016/0960-0760(93)90241-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2893%2990241-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=8476751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1enurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=375-387&author=M.+Akhtarauthor=V.+C.+Njarauthor=J.+N.+Wright&title=Mechanistic+Studies+on+Aromatase+and+Related+C-C+Bond+Cleaving+P-450+Enzymes&doi=10.1016%2F0960-0760%2893%2990241-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic studies on aromatase and related carbon-carbon bond cleaving P-450 enzymes</span></div><div class="casAuthors">Akhtar, Muhammad; Njar, Vincent C. O.; Wright, J. Neville</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">375-87</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">Some cytochrome P 450 systems, notably aromatase and 14α-dimethylase, catalyze not only the hydroxylate reaction but also the oxidn. of an alc. into a carbonyl compd. as well as a C-C bond cleavage process.  All these reactions occur at the same active site.  A somewhat analogous situation is noted with 17α-hydroxylase-17,20-lyase that participates in hydroxylation as well as C-C bond cleavage reactions.  It is argued that all three types of reaction catalyzed by these enzymes may be viewed as variations on a common theme.  In P 450-dependent hydroxylation, the initially formed FeIII-O-O. species is converted into FeIII-O-OH and the heterolysis of the oxygen-oxygen bond of the latter then gives the oxo deriv., for which a no. of canonical structures are possible.  One of these, FeIV-O. behaves like an alkoxyl radical and participates in hydrogen abstraction from C-H bond to produce FeIV-OH and carbon radical.  The latter is then quenched by the delivery of a hydroxyl radical from FeIV-OH.  The latter species may thus be regarded as a carrier of a hydroxyl radical.  It has been proposed that the C-C bond cleavage reaction occurs through the participation of a FeIII-O-OH species that is trapped by the electrophilic property of the carbonyl compd. giving a peroxide adduct that fragments to produce an acyl-carbon cleavage.  Scientific developments leading up to this conclusion are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBUI3llod9srVg90H21EOLACvtfcHk0lgRaj9EeCvDPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1enurc%253D&md5=d16d7726c82037b6699f0dd3107382a0</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2893%2990241-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252893%252990241-N%26sid%3Dliteratum%253Aachs%26aulast%3DAkhtar%26aufirst%3DM.%26aulast%3DNjar%26aufirst%3DV.%2BC.%26aulast%3DWright%26aufirst%3DJ.%2BN.%26atitle%3DMechanistic%2520Studies%2520on%2520Aromatase%2520and%2520Related%2520C-C%2520Bond%2520Cleaving%2520P-450%2520Enzymes%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D44%26spage%3D375%26epage%3D387%26doi%3D10.1016%2F0960-0760%2893%2990241-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Hackett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggemeier, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadad, C. M.</span><span> </span><span class="NLM_article-title">The Final Catalytic Step of Cytochrome P450 Aromatase: A Density Functional Theory Study</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">5224</span><span class="NLM_x">–</span> <span class="NLM_lpage">5237</span><span class="refDoi"> DOI: 10.1021/ja044716w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja044716w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVyqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=5224-5237&author=J.+C.+Hackettauthor=R.+W.+Brueggemeierauthor=C.+M.+Hadad&title=The+Final+Catalytic+Step+of+Cytochrome+P450+Aromatase%3A+A+Density+Functional+Theory+Study&doi=10.1021%2Fja044716w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">The Final Catalytic Step of Cytochrome P450 Aromatase: A Density Functional Theory Study</span></div><div class="casAuthors">Hackett, John C.; Brueggemeier, Robert W.; Hadad, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5224-5237</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">B3LYP d. functional theory calcns. are used to unravel the mysterious third step of aromatase catalysis.  The feasibility of mechanisms in which the reduced ferrous dioxygen intermediate mediates androgen aromatization is explored and detd. to be unlikely.  However, proton-assisted homolysis of the peroxo hemiacetal intermediate to produce P 450 compd. I and the C19 gem-diol likely proceeds with a low energetic barrier.  Mechanisms for the aromatization and deformylation sequence which are initiated by 1β-hydrogen atom abstraction by P 450 compd. I are considered. 1β-Hydrogen atom abstraction from substrates in the presence of the 2,3-enol encounters strikingly low barriers (5.3-7.8 kcal/mol), whereas barriers for this same process rise to 17.0-27.1 kcal/mol in the keto tautomer.  Transition states for 1β-hydrogen atom abstraction from enolized substrates in the presence of the 19-gem-diol decayed directly to the exptl. obsd. products.  If the C19 aldehyde remains unhydrated, aromatization occurs with concomitant decarbonylation and therefore does not support dehydration of the C19 aldehyde prior to the final catalytic step.  On the doublet surface, the transition state connects to a potentially labile 1(10) dehydrogenated product, which may undergo rapid aromatization, as well as formic acid.  Ab initio mol. dynamics confirmed that the 1β-hydrogen atom abstraction and deformylation or decarbonylation occur in a nonsynchronous, coordinated manner.  These calcns. support a dehydrogenase behavior of aromatase in the final catalytic step, which can be summarized by 1β-hydrogen atom abstraction followed by gem-diol deprotonation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmOr8sj-omyrVg90H21EOLACvtfcHk0lgRaj9EeCvDPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVyqu7k%253D&md5=adb795b16645e13ccc0071806e6ea337</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fja044716w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja044716w%26sid%3Dliteratum%253Aachs%26aulast%3DHackett%26aufirst%3DJ.%2BC.%26aulast%3DBrueggemeier%26aufirst%3DR.%2BW.%26aulast%3DHadad%26aufirst%3DC.%2BM.%26atitle%3DThe%2520Final%2520Catalytic%2520Step%2520of%2520Cytochrome%2520P450%2520Aromatase%253A%2520A%2520Density%2520Functional%2520Theory%2520Study%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D5224%26epage%3D5237%26doi%3D10.1021%2Fja044716w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Akhtar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee-Robichaud, P.</span><span> </span><span class="NLM_article-title">A Review of Mechanistic Studies on Aromatase (CYP19) and 17alpha-Hydroxylase-17,20-Lyase (CYP17)</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2010.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jsbmb.2010.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=21094255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvVeitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2011&pages=2-12&author=M.+Akhtarauthor=J.+N.+Wrightauthor=P.+Lee-Robichaud&title=A+Review+of+Mechanistic+Studies+on+Aromatase+%28CYP19%29+and+17alpha-Hydroxylase-17%2C20-Lyase+%28CYP17%29&doi=10.1016%2Fj.jsbmb.2010.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">A review of mechanistic studies on aromatase (CYP19) and 17α-hydroxylase-17,20-lyase (CYP17)</span></div><div class="casAuthors">Akhtar, Muhammad; Wright, J. Neville; Lee-Robichaud, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In the conventional cytochrome P 450 (CYP)-dependent hydroxylation reaction, the FeIII resting state of the enzyme, by a single electron transfer, is reduced to FeII, which reacts with O2 to produce a FeIII-O-O· intermediate.  The latter following the transfer of another electron furnishes a ferric-peroxyanion, FeIII-O-O-, which after protonation leads to the fission of the O-O bond resulting in the formation of FeV:O, the key player in the hydroxylation process.  Certain members of the P 450 family, including CYP17 and CYP19, catalyze, at the same active site, not only the hydroxylation process but also an acyl-C bond cleavage reaction which has been interpreted to involve the nucleophilic attack of the ferric-peroxyanion, FeIII-O-O-, on the acyl C atom to furnish a tetrahedral intermediate which fragments, leading to acyl-C cleavage.  Evidence is presented to show that in the case of CYP17 the attack of FeIII-O-O- on the target C atom is promoted by cytochrome b5, which acts as a conformational regulator of CYP17.  It is this regulation of CYP17 that provides a safety mechanism which ensures that during corticoid biosynthesis, which involves 17α-hydroxylation by CYP17, androgen formation is avoided.  Finally, a brief account is presented of the inhibitors of the 2 enzymes, which have been designed on the basis of their mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK8H66p74u_7Vg90H21EOLACvtfcHk0lgRaj9EeCvDPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvVeitr0%253D&md5=3c096fa0a1b08c92f5b6a253423c2e13</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2010.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2010.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DAkhtar%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DJ.%2BN.%26aulast%3DLee-Robichaud%26aufirst%3DP.%26atitle%3DA%2520Review%2520of%2520Mechanistic%2520Studies%2520on%2520Aromatase%2520%2528CYP19%2529%2520and%252017alpha-Hydroxylase-17%252C20-Lyase%2520%2528CYP17%2529%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D125%26spage%3D2%26epage%3D12%26doi%3D10.1016%2Fj.jsbmb.2010.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Guallar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baik, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">Peripheral Heme Substituents Control the Hydrogen-Atom Abstraction Chemistry in Cytochromes P450</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">6998</span><span class="NLM_x">–</span> <span class="NLM_lpage">7002</span><span class="refDoi"> DOI: 10.1073/pnas.0732000100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1073%2Fpnas.0732000100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=12771375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkslOntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=6998-7002&author=V.+Guallarauthor=M.-H.+Baikauthor=S.+J.+Lippardauthor=R.+A.+Friesner&title=Peripheral+Heme+Substituents+Control+the+Hydrogen-Atom+Abstraction+Chemistry+in+Cytochromes+P450&doi=10.1073%2Fpnas.0732000100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral heme substituents control the hydrogen-atom abstraction chemistry in cytochromes P450</span></div><div class="casAuthors">Guallar, Victor; Baik, Mu-Hyun; Lippard, Stephen J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6998-7002</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We elucidate the hydroxylation of camphor by cytochrome P 450 with the use of d. functional and mixed quantum mechanics/mol. mechanics methods.  Our results reveal that the enzyme catalyzes the hydrogen-atom abstraction step with a remarkably low free-energy barrier.  This result provides a satisfactory explanation for the exptl. failure to trap the proposed catalytically competent high-valent heme Fe(IV) oxo (oxyferryl) species responsible for this hydroxylation chem.  The primary and previously unappreciated contribution to stabilization of the transition state is the interaction of pos. charged residues in the active-site cavity with carboxylate groups on the heme periphery.  A similar stabilization found in dioxygen binding to hemerythrin, albeit with reversed polarity, suggests that this mechanism for controlling the relative energetics of redox-active intermediates and transition states in metalloproteins may be widespread in nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz2gQwufu_37Vg90H21EOLACvtfcHk0lhaMPLyFD0NQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkslOntLY%253D&md5=42fb299da6a4d5987b6d7931da1a549d</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0732000100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0732000100%26sid%3Dliteratum%253Aachs%26aulast%3DGuallar%26aufirst%3DV.%26aulast%3DBaik%26aufirst%3DM.-H.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DPeripheral%2520Heme%2520Substituents%2520Control%2520the%2520Hydrogen-Atom%2520Abstraction%2520Chemistry%2520in%2520Cytochromes%2520P450%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D6998%26epage%3D7002%26doi%3D10.1073%2Fpnas.0732000100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Gantt, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denisov, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinkova, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sligar, S. G.</span><span> </span><span class="NLM_article-title">The Critical Iron-Oxygen Intermediate in Human Aromatase</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2009.06.154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bbrc.2009.06.154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19591804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptValtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=169-173&author=S.+L.+Ganttauthor=I.+G.+Denisovauthor=Y.+V.+Grinkovaauthor=S.+G.+Sligar&title=The+Critical+Iron-Oxygen+Intermediate+in+Human+Aromatase&doi=10.1016%2Fj.bbrc.2009.06.154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">The critical iron-oxygen intermediate in human aromatase</span></div><div class="casAuthors">Gantt, Stephanie L.; Denisov, Ilia G.; Grinkova, Yelena V.; Sligar, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-173</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aromatase (CYP19) is the target of several therapeutics used for breast cancer treatment and catalyzes the three-step conversion of androgens to estrogens, with an unusual C-C cleavage reaction in the third step.  To better understand the CYP19 reaction, the oxy-ferrous complex of CYP19 with androstenedione substrate was cryotrapped, characterized by UV-vis spectroscopy, and cryoreduced to generate the next reaction cycle intermediate.  EPR anal. revealed that the initial intermediate obsd. following cryoredn. is the unprotonated g1 = 2.254 peroxo-ferric intermediate, which is stable up to 180 K.  Upon gradual cryoannealing, the low-spin (g1 = 2.39) product complex is formed, with no evidence for accumulation of the g1 = 2.30 hydroperoxo-ferric intermediate.  The relative stabilization of the peroxo-ferric heme and the lack of obsd. hydroperoxo-ferric heme distinguish CYP19 from other P450s, suggesting that the proton delivery pathway is more hindered in CYP19 than in most other P450s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosKzr6ReLA4LVg90H21EOLACvtfcHk0lhaMPLyFD0NQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptValtrw%253D&md5=8c41e32ef0e498ea742a7fc70220959b</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.06.154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.06.154%26sid%3Dliteratum%253Aachs%26aulast%3DGantt%26aufirst%3DS.%2BL.%26aulast%3DDenisov%26aufirst%3DI.%2BG.%26aulast%3DGrinkova%26aufirst%3DY.%2BV.%26aulast%3DSligar%26aufirst%3DS.%2BG.%26atitle%3DThe%2520Critical%2520Iron-Oxygen%2520Intermediate%2520in%2520Human%2520Aromatase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D387%26spage%3D169%26epage%3D173%26doi%3D10.1016%2Fj.bbrc.2009.06.154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Tosha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterman, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, T.</span><span> </span><span class="NLM_article-title">Raman Evidence for Specific Substrate-Induced Structural Changes in the Heme Pocket of Human Cytochrome P450 Aromatase During the Three Consecutive Oxygen Activation Steps</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5631</span><span class="NLM_x">–</span> <span class="NLM_lpage">5640</span><span class="refDoi"> DOI: 10.1021/bi060094a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi060094a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=5631-5640&author=T.+Toshaauthor=N.+Kagawaauthor=T.+Ohtaauthor=S.+Yoshiokaauthor=M.+R.+Watermanauthor=T.+Kitagawa&title=Raman+Evidence+for+Specific+Substrate-Induced+Structural+Changes+in+the+Heme+Pocket+of+Human+Cytochrome+P450+Aromatase+During+the+Three+Consecutive+Oxygen+Activation+Steps&doi=10.1021%2Fbi060094a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fbi060094a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi060094a%26sid%3Dliteratum%253Aachs%26aulast%3DTosha%26aufirst%3DT.%26aulast%3DKagawa%26aufirst%3DN.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DYoshioka%26aufirst%3DS.%26aulast%3DWaterman%26aufirst%3DM.%2BR.%26aulast%3DKitagawa%26aufirst%3DT.%26atitle%3DRaman%2520Evidence%2520for%2520Specific%2520Substrate-Induced%2520Structural%2520Changes%2520in%2520the%2520Heme%2520Pocket%2520of%2520Human%2520Cytochrome%2520P450%2520Aromatase%2520During%2520the%2520Three%2520Consecutive%2520Oxygen%2520Activation%2520Steps%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D5631%26epage%3D5640%26doi%3D10.1021%2Fbi060094a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Mak, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sligar, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kincaid, J. R.</span><span> </span><span class="NLM_article-title">Resonance Raman Spectroscopy of the Oxygenated Intermediates of Human CYP19A1 Implicates a Compound I Intermediate in the Final Lyase Step</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">4825</span><span class="NLM_x">–</span> <span class="NLM_lpage">4828</span><span class="refDoi"> DOI: 10.1021/ja500054c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja500054c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=4825-4828&author=P.+J.+Makauthor=A.+Luthraauthor=S.+G.+Sligarauthor=J.+R.+Kincaid&title=Resonance+Raman+Spectroscopy+of+the+Oxygenated+Intermediates+of+Human+CYP19A1+Implicates+a+Compound+I+Intermediate+in+the+Final+Lyase+Step&doi=10.1021%2Fja500054c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fja500054c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja500054c%26sid%3Dliteratum%253Aachs%26aulast%3DMak%26aufirst%3DP.%2BJ.%26aulast%3DLuthra%26aufirst%3DA.%26aulast%3DSligar%26aufirst%3DS.%2BG.%26aulast%3DKincaid%26aufirst%3DJ.%2BR.%26atitle%3DResonance%2520Raman%2520Spectroscopy%2520of%2520the%2520Oxygenated%2520Intermediates%2520of%2520Human%2520CYP19A1%2520Implicates%2520a%2520Compound%2520I%2520Intermediate%2520in%2520the%2520Final%2520Lyase%2520Step%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D4825%26epage%3D4828%26doi%3D10.1021%2Fja500054c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Khatri, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sligar, S. G.</span><span> </span><span class="NLM_article-title">Kinetic Solvent Isotope Effect in Steady-State Turnover by CYP19A1 Suggests Involvement of Compound 1 for Both Hydroxylation and Aromatization Steps</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">588</span><span class="NLM_x">, </span> <span class="NLM_fpage">3117</span><span class="NLM_x">–</span> <span class="NLM_lpage">3122</span><span class="refDoi"> DOI: 10.1016/j.febslet.2014.06.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.febslet.2014.06.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=588&publication_year=2014&pages=3117-3122&author=Y.+Khatriauthor=A.+Luthraauthor=R.+Duggalauthor=S.+G.+Sligar&title=Kinetic+Solvent+Isotope+Effect+in+Steady-State+Turnover+by+CYP19A1+Suggests+Involvement+of+Compound+1+for+Both+Hydroxylation+and+Aromatization+Steps&doi=10.1016%2Fj.febslet.2014.06.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2014.06.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2014.06.050%26sid%3Dliteratum%253Aachs%26aulast%3DKhatri%26aufirst%3DY.%26aulast%3DLuthra%26aufirst%3DA.%26aulast%3DDuggal%26aufirst%3DR.%26aulast%3DSligar%26aufirst%3DS.%2BG.%26atitle%3DKinetic%2520Solvent%2520Isotope%2520Effect%2520in%2520Steady-State%2520Turnover%2520by%2520CYP19A1%2520Suggests%2520Involvement%2520of%2520Compound%25201%2520for%2520Both%2520Hydroxylation%2520and%2520Aromatization%2520Steps%26jtitle%3DFEBS%2520Lett.%26date%3D2014%26volume%3D588%26spage%3D3117%26epage%3D3122%26doi%3D10.1016%2Fj.febslet.2014.06.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Yoshimoto, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guengerich, F. P.</span><span> </span><span class="NLM_article-title">Mechanism of the Third Oxidative Step in the Conversion of Androgens to Estrogens by Cytochrome P450 19A1 Steroid Aromatase</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">15016</span><span class="NLM_x">–</span> <span class="NLM_lpage">15025</span><span class="refDoi"> DOI: 10.1021/ja508185d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja508185d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WlurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=15016-15025&author=F.+K.+Yoshimotoauthor=F.+P.+Guengerich&title=Mechanism+of+the+Third+Oxidative+Step+in+the+Conversion+of+Androgens+to+Estrogens+by+Cytochrome+P450+19A1+Steroid+Aromatase&doi=10.1021%2Fja508185d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of the Third Oxidative Step in the Conversion of Androgens to Estrogens by Cytochrome P450 19A1 Steroid Aromatase</span></div><div class="casAuthors">Yoshimoto, Francis K.; Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">15016-15025</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aromatase is the cytochrome P 450 enzyme that cleaves the C10-C19 carbon-carbon bond of androgens to form estrogens, in a three-step process.  Compd. I (FeO3+) and ferric peroxide (FeO2-) have both been proposed in the literature as the active iron species in the third step, yielding an estrogen and formic acid.  Incubation of purified aromatase with its 19-deutero-19-oxo androgen substrate was performed in the presence of 18O2, and the products were derivatized using a novel diazo reagent.  Anal. of the products by high-resoln. mass spectrometry showed a lack of 18O incorporation in the product formic acid, supporting only the Compd. I pathway.  Furthermore, a new androgen 19-carboxylic acid product was identified.  The rates of nonenzymic hydration of the 19-oxo androgen and dehydration of the 19,19-gem-diol were shown to be catalytically competent.  Thus, the evidence supports Compd. I and not ferric peroxide as the active iron species in the third step of the steroid aromatase reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooAoM6JkXTY7Vg90H21EOLACvtfcHk0lh3OC9pN-9aGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WlurzE&md5=39701c467c900a04e733842c711d7565</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fja508185d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja508185d%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimoto%26aufirst%3DF.%2BK.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DMechanism%2520of%2520the%2520Third%2520Oxidative%2520Step%2520in%2520the%2520Conversion%2520of%2520Androgens%2520to%2520Estrogens%2520by%2520Cytochrome%2520P450%252019A1%2520Steroid%2520Aromatase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D15016%26epage%3D15025%26doi%3D10.1021%2Fja508185d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Ghosh, D.; Lo, J.; Egbuta, C.</span><span> </span><span class="NLM_article-title">Structure, Function and Inhibition of Aromatase</span>. In  <span class="citation_source-book">Resistance to Aromatase Inhibitors in Breast Cancer</span>; <span class="NLM_publisher-name">Springer</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2F978-3-319-17972-8_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=33-61&author=D.+Ghosh&author=J.+Lo&author=C.+Egbuta&title=Resistance+to+Aromatase+Inhibitors+in+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-17972-8_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-17972-8_3%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DStructure%252C%2520Function%2520and%2520Inhibition%2520of%2520Aromatase%26btitle%3DResistance%2520to%2520Aromatase%2520Inhibitors%2520in%2520Breast%2520Cancer%26pub%3DSpringer%26date%3D2015%26spage%3D33%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Sasano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yajima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshihama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. R.</span><span> </span><span class="NLM_article-title">Effects of Aromatase Inhibitors on the Pathobiology of the Human Breast, Endometrial and Ovarian Carcinoma</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1677/erc.0.0060197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1677%2Ferc.0.0060197" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=197-204&author=H.+Sasanoauthor=S.+Satoauthor=K.+Itoauthor=A.+Yajimaauthor=J.+Nakamuraauthor=M.+Yoshihamaauthor=K.+Arigaauthor=T.+J.+Andersonauthor=W.+R.+Miller&title=Effects+of+Aromatase+Inhibitors+on+the+Pathobiology+of+the+Human+Breast%2C+Endometrial+and+Ovarian+Carcinoma&doi=10.1677%2Ferc.0.0060197"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1677%2Ferc.0.0060197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Ferc.0.0060197%26sid%3Dliteratum%253Aachs%26aulast%3DSasano%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DYajima%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DYoshihama%26aufirst%3DM.%26aulast%3DAriga%26aufirst%3DK.%26aulast%3DAnderson%26aufirst%3DT.%2BJ.%26aulast%3DMiller%26aufirst%3DW.%2BR.%26atitle%3DEffects%2520of%2520Aromatase%2520Inhibitors%2520on%2520the%2520Pathobiology%2520of%2520the%2520Human%2520Breast%252C%2520Endometrial%2520and%2520Ovarian%2520Carcinoma%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D1999%26volume%3D6%26spage%3D197%26epage%3D204%26doi%3D10.1677%2Ferc.0.0060197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Pavone, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulun, S. E.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors for the Treatment of Endometriosis</span> <span class="citation_source-journal">Fertil. Steril.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1370</span><span class="NLM_x">–</span> <span class="NLM_lpage">1379</span><span class="refDoi"> DOI: 10.1016/j.fertnstert.2012.08.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.fertnstert.2012.08.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22999792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2gtrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2012&pages=1370-1379&author=M.+E.+Pavoneauthor=S.+E.+Bulun&title=Aromatase+Inhibitors+for+the+Treatment+of+Endometriosis&doi=10.1016%2Fj.fertnstert.2012.08.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase inhibitors for the treatment of endometriosis</span></div><div class="casAuthors">Pavone, Mary Ellen; Bulun, Serdar E.</div><div class="citationInfo"><span class="NLM_cas:title">Fertility and Sterility</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1370-1379</span>CODEN:
                <span class="NLM_cas:coden">FESTAS</span>;
        ISSN:<span class="NLM_cas:issn">0015-0282</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">To review the use of aromatase inhibitors (AIs) for the treatment of endometriosis. Literature review. Most studies show that in reproductive-age women, the combination of AI with conventional therapy alleviates endometriosis-related pain.  In postmenopausal women, using an AI alone has been shown to be an effective treatment, although more studies are needed in this subgroup.  Side effects of using AIs appear to be tolerable in most women, although special consideration should be given to monitoring bone mineral d.  More studies need to be done examg. pregnancy rates and outcomes after AI treatment for endometriosis.  In addn., larger randomized clin. trials using AIs need to be done.  In summary, AIs may be effective in treating endometriosis-related chronic pelvic pain in both reproductive-age and postmenopausal women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovzBV_63oqkbVg90H21EOLACvtfcHk0lhz6K5r9P0fvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2gtrjI&md5=b4aef281162169d4a939e53de5b5d886</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.fertnstert.2012.08.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fertnstert.2012.08.053%26sid%3Dliteratum%253Aachs%26aulast%3DPavone%26aufirst%3DM.%2BE.%26aulast%3DBulun%26aufirst%3DS.%2BE.%26atitle%3DAromatase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Endometriosis%26jtitle%3DFertil.%2520Steril.%26date%3D2012%26volume%3D98%26spage%3D1370%26epage%3D1379%26doi%3D10.1016%2Fj.fertnstert.2012.08.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Li, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, S. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanagh, J. J.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors in Ovarian Cancer: Is There a Role?</span> <span class="citation_source-journal">International Gynecological Cancer Society</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span><span class="refDoi"> DOI: 10.1111/j.1525-1438.2007.01075.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1111%2Fj.1525-1438.2007.01075.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=17894799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADC%252BD1crisl2itg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=600-614&author=Y.+F.+Liauthor=W.+Huauthor=S.+Q.+Fuauthor=J.+D.+Liauthor=J.+H.+Liuauthor=J.+J.+Kavanagh&title=Aromatase+Inhibitors+in+Ovarian+Cancer%3A+Is+There+a+Role%3F&doi=10.1111%2Fj.1525-1438.2007.01075.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase inhibitors in ovarian cancer: is there a role?</span></div><div class="casAuthors">Li Y F; Hu W; Fu S Q; Li J D; Liu J H; Kavanagh J J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">600-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Estrogen plays a role in ovarian tumorigenesis.  Aromatase is the enzyme required for the synthesis of estrogen via conversion of androgen to estrogen, which is the major source of estrogen in postmenopausal women.  Aromatase is present in normal ovaries and other tissues (e.g., fat and muscle) as well as in 33-81% tumor tissues of ovarian cancer.  Aromatase inhibitors (AIs) block estrogen synthesis by inhibiting aromatase activity.  In patients with recurrent ovarian cancer, single-agent AI therapy has been shown to elicit clinical response rates of up to 35.7% and stable disease rates of 20-42%.  Given the limited treatment options for recurrent ovarian cancer and the favorable safety profile and convenient use, AI is a rational option for prolonging platinum-free interval in recurrent ovarian cancer.  Further studies are required to determine the efficacy of combination treatment with AIs and biological agents, determine the benefit of AIs for treating special types of ovarian cancer (e.g., endometrioid type), and identify biomarkers for targeted patient selection.  This review summarizes the current epidemiologic, preclinical, and clinical data regarding estrogen's role in ovarian cancer, the expression and regulation of aromatase in this disease, the development and characteristics of the three generations of AIs, and the preclinical and clinical studies of AIs in the treatment of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2sq3DigA5w5QHPYJuLg8TfW6udTcc2ebfiDc6PCR6i7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crisl2itg%253D%253D&md5=7d5655f8ea8fb13c0f9fd28f1964ea9c</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1111%2Fj.1525-1438.2007.01075.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1525-1438.2007.01075.x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BF.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DFu%26aufirst%3DS.%2BQ.%26aulast%3DLi%26aufirst%3DJ.%2BD.%26aulast%3DLiu%26aufirst%3DJ.%2BH.%26aulast%3DKavanagh%26aufirst%3DJ.%2BJ.%26atitle%3DAromatase%2520Inhibitors%2520in%2520Ovarian%2520Cancer%253A%2520Is%2520There%2520a%2520Role%253F%26jtitle%3DInternational%2520Gynecological%2520Cancer%2520Society%26date%3D2008%26volume%3D18%26spage%3D600%26epage%3D614%26doi%3D10.1111%2Fj.1525-1438.2007.01075.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Weinberg, O. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Garban, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishbein, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodglick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garban, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubinett, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietras, R. J.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors in Human Lung Cancer Therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">11287</span><span class="NLM_x">–</span> <span class="NLM_lpage">11291</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1158%2F0008-5472.CAN-05-2737" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=11287-11291&author=O.+K.+Weinbergauthor=D.+C.+Marquez-Garbanauthor=M.+C.+Fishbeinauthor=L.+Goodglickauthor=H.+J.+Garbanauthor=S.+M.+Dubinettauthor=R.+J.+Pietras&title=Aromatase+Inhibitors+in+Human+Lung+Cancer+Therapy&doi=10.1158%2F0008-5472.CAN-05-2737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2737%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberg%26aufirst%3DO.%2BK.%26aulast%3DMarquez-Garban%26aufirst%3DD.%2BC.%26aulast%3DFishbein%26aufirst%3DM.%2BC.%26aulast%3DGoodglick%26aufirst%3DL.%26aulast%3DGarban%26aufirst%3DH.%2BJ.%26aulast%3DDubinett%26aufirst%3DS.%2BM.%26aulast%3DPietras%26aufirst%3DR.%2BJ.%26atitle%3DAromatase%2520Inhibitors%2520in%2520Human%2520Lung%2520Cancer%2520Therapy%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D11287%26epage%3D11291%26doi%3D10.1158%2F0008-5472.CAN-05-2737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Brueggemeier, R. W.</span><span> </span><span class="NLM_article-title">Aromatase, Aromatase Inhibitors, and Breast Cancer</span> <span class="citation_source-journal">American Journal of Therapeutics.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1097/00045391-200109000-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1097%2F00045391-200109000-00007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=333-344&author=R.+W.+Brueggemeier&title=Aromatase%2C+Aromatase+Inhibitors%2C+and+Breast+Cancer&doi=10.1097%2F00045391-200109000-00007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1097%2F00045391-200109000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00045391-200109000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DBrueggemeier%26aufirst%3DR.%2BW.%26atitle%3DAromatase%252C%2520Aromatase%2520Inhibitors%252C%2520and%2520Breast%2520Cancer%26jtitle%3DAmerican%2520Journal%2520of%2520Therapeutics.%26date%3D2001%26volume%3D8%26spage%3D333%26epage%3D344%26doi%3D10.1097%2F00045391-200109000-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Brueggemeier, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Cruz, E. S.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors in the Treatment of Breast Cancer</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span><span class="refDoi"> DOI: 10.1210/er.2004-0015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fer.2004-0015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=15814851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVWru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=331-345&author=R.+W.+Brueggemeierauthor=J.+C.+Hackettauthor=E.+S.+Diaz-Cruz&title=Aromatase+Inhibitors+in+the+Treatment+of+Breast+Cancer&doi=10.1210%2Fer.2004-0015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase inhibitors in the treatment of breast cancer</span></div><div class="casAuthors">Brueggemeier, Robert W.; Hackett, John C.; Diaz-Cruz, Edgar S.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-345</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Estradiol, the most potent endogenous estrogen, is biosynthesized from androgens by the cytochrome P 450 enzyme complex called aromatase.  Aromatase is present in breast tissue, and intratumoral aromatase is the source of local estrogen prodn. in breast cancer tissues.  Inhibition of aromatase is an important approach for reducing growth-stimulatory effects of estrogens in estrogen-dependent breast cancer.  Steroidal inhibitors that have been developed to date build upon the basic androstenedione nucleus and incorporate chem. substituents at varying positions on the steroid.  Nonsteroidal aromatase inhibitors can be divided into three classes: aminoglutethimide-like mols., imidazole/triazole derivs., and flavonoid analogs.  Mechanism-based aromatase inhibitors are steroidal inhibitors that mimic the substrate, are converted by the enzyme to a reactive intermediate, and result in the inactivation of aromatase.  Both steroidal and non-steroidal aromatase inhibitors have shown clin. efficacy in the treatment of breast cancer.  The potent and selective third-generation aromatase inhibitors, anastrozole, letrozole, and exemestane, were introduced into the market as endocrine therapy in postmenopausal patients failing antiestrogen therapy alone or multiple hormonal therapies.  These agents are currently approved as first-line therapy for the treatment of postmenopausal women with metastatic estrogen-dependent breast cancer.  Several clin. studies of aromatase inhibitors are currently focusing on the use of these agents in the adjuvant setting for the treatment of early breast cancer.  Use of an aromatase inhibitor as initial therapy or after treatment with tamoxifen is now recommended as adjuvant hormonal therapy for a postmenopausal woman with hormone-dependent breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5rFlkckpA4bVg90H21EOLACvtfcHk0lgUSflukQ_J3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVWru7w%253D&md5=d65778c7f1aea9ad16a3d24f37dccb07</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1210%2Fer.2004-0015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2004-0015%26sid%3Dliteratum%253Aachs%26aulast%3DBrueggemeier%26aufirst%3DR.%2BW.%26aulast%3DHackett%26aufirst%3DJ.%2BC.%26aulast%3DDiaz-Cruz%26aufirst%3DE.%2BS.%26atitle%3DAromatase%2520Inhibitors%2520in%2520the%2520Treatment%2520of%2520Breast%2520Cancer%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26spage%3D331%26epage%3D345%26doi%3D10.1210%2Fer.2004-0015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Brueggemeier, R. W.</span><span> </span><span class="NLM_article-title">Update on the Use of Aromatase Inhibitors in Breast Cancer</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1919</span><span class="NLM_x">–</span> <span class="NLM_lpage">1930</span><span class="refDoi"> DOI: 10.1517/14656566.7.14.1919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1517%2F14656566.7.14.1919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=17020418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVartbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1919-1930&author=R.+W.+Brueggemeier&title=Update+on+the+Use+of+Aromatase+Inhibitors+in+Breast+Cancer&doi=10.1517%2F14656566.7.14.1919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the use of aromatase inhibitors in breast cancer</span></div><div class="casAuthors">Brueggemeier, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1919-1930</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Estrogens are biosynthesised from androgens by the CYP450 enzyme complex called aromatase.  Aromatase is expressed in the ovary, placenta, brain, bone, adipose tissue and breast tissue.  In breast cancer, intratumoral aromatase is the source for local estrogen prodn. in the tissue.  Inhibition of aromatase is an important approach for reducing growth stimulatory effects of estrogens in estrogen-dependent breast cancer.  The potent and selective third-generation aromatase inhibitors anastrozole, letrozole and exemestane were introduced to the market as endocrine therapy in postmenopausal patients failing anti-estrogen therapy alone, or multiple hormonal therapies.  Anastrozole and letrozole are both non-steroidal aromatase inhibitors that compete with the substrate for binding to the enzyme active site.  Exemestane is a mechanism-based steroidal inhibitor that mimics the substrate, is converted by the enzyme to a reactive intermediate, and results in inactivation of aromatase.  These third-generation aromatase inhibitors are currently approved as first-line therapy for the treatment of postmenopausal women with metastatic estrogen-dependent breast cancer.  The use of an aromatase inhibitor as initial therapy, or after treatment with tamoxifen, is now recommended as adjuvant hormonal therapy for postmenopausal women with hormone-dependent breast cancer.  Several clin. studies of aromatase inhibitors focus on the use of these agents in the adjuvant setting, for the treatment of early breast cancer.  Recently published results show improved responses with these agents compared with tamoxifen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDIjz5Yvq9k7Vg90H21EOLACvtfcHk0lgUSflukQ_J3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVartbfO&md5=2dabce35b873215f82f94bc15e7b3509</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1517%2F14656566.7.14.1919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.7.14.1919%26sid%3Dliteratum%253Aachs%26aulast%3DBrueggemeier%26aufirst%3DR.%2BW.%26atitle%3DUpdate%2520on%2520the%2520Use%2520of%2520Aromatase%2520Inhibitors%2520in%2520Breast%2520Cancer%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2006%26volume%3D7%26spage%3D1919%26epage%3D1930%26doi%3D10.1517%2F14656566.7.14.1919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Grimm, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyroff, M. C.</span><span> </span><span class="NLM_article-title">Inhibition of Human Drug Metabolizing Cytochromes P450 by Anastrozole, a Potent and Selective Inhibitor of Aromatase</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1997&pages=598-602&author=S.+W.+Grimmauthor=M.+C.+Dyroff&title=Inhibition+of+Human+Drug+Metabolizing+Cytochromes+P450+by+Anastrozole%2C+a+Potent+and+Selective+Inhibitor+of+Aromatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrimm%26aufirst%3DS.%2BW.%26aulast%3DDyroff%26aufirst%3DM.%2BC.%26atitle%3DInhibition%2520of%2520Human%2520Drug%2520Metabolizing%2520Cytochromes%2520P450%2520by%2520Anastrozole%252C%2520a%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Aromatase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1997%26volume%3D25%26spage%3D598%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Miller, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larionov, A. A.</span><span> </span><span class="NLM_article-title">Understanding the Mechanisms of Aromatase Inhibitor Resistance</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="refDoi"> DOI: 10.1186/bcr2931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1186%2Fbcr2931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22277572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis12nsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=201&author=W.+R.+Millerauthor=A.+A.+Larionov&title=Understanding+the+Mechanisms+of+Aromatase+Inhibitor+Resistance&doi=10.1186%2Fbcr2931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the mechanisms of aromatase inhibitor resistance</span></div><div class="casAuthors">Miller, William R.; Larionov, Alexey A.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201</span>CODEN:
                <span class="NLM_cas:coden">BRCRFS</span>;
        ISSN:<span class="NLM_cas:issn">1465-542X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Aromatase inhibitors (AIs) have a central role in the treatment of breast cancer; however, resistance is a major obstacle to optimal management.  Evidence from endocrine, mol. and pathol. measurements in clin. material taken before and after therapy with AIs and data from clin. trials in which AIs have been given as treatment either alone or in combination with other targeted agents suggest diverse causes for resistance.  These include inherent tumor insensitivity to estrogen, ineffective inhibition of aromatase, sources of estrogenic hormones independent of aromatase, activation of signalling by non-endocrine pathways, enhanced cell survival and selection of hormone-insensitive cellular clones during treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqclb5RObdyD7Vg90H21EOLACvtfcHk0lgUSflukQ_J3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis12nsbo%253D&md5=d50d0feed79bba2912273d1f946efff2</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1186%2Fbcr2931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fbcr2931%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DW.%2BR.%26aulast%3DLarionov%26aufirst%3DA.%2BA.%26atitle%3DUnderstanding%2520the%2520Mechanisms%2520of%2520Aromatase%2520Inhibitor%2520Resistance%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2012%26volume%3D14%26spage%3D201%26doi%3D10.1186%2Fbcr2931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Kamdem, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flockhart, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desta, Z.</span><span> </span><span class="NLM_article-title">In Vitro Cytochrome P450-Mediated Metabolism of Exemestane</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1124/dmd.110.032276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1124%2Fdmd.110.032276" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=98-105&author=L.+K.+Kamdemauthor=D.+A.+Flockhartauthor=Z.+Desta&title=In+Vitro+Cytochrome+P450-Mediated+Metabolism+of+Exemestane&doi=10.1124%2Fdmd.110.032276"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.032276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.032276%26sid%3Dliteratum%253Aachs%26aulast%3DKamdem%26aufirst%3DL.%2BK.%26aulast%3DFlockhart%26aufirst%3DD.%2BA.%26aulast%3DDesta%26aufirst%3DZ.%26atitle%3DIn%2520Vitro%2520Cytochrome%2520P450-Mediated%2520Metabolism%2520of%2520Exemestane%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D98%26epage%3D105%26doi%3D10.1124%2Fdmd.110.032276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span>Femara (Letrozole) Prescribing Information. Novartis, East Hanover, NJ,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Femara+%28Letrozole%29+Prescribing+Information.+Novartis%2C+East+Hanover%2C+NJ%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Ariazi, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oprea, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shupp, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyle, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madrack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donato, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, V. C.</span><span> </span><span class="NLM_article-title">Exemestane’s 17-Hydroxylated Metabolite Exerts Biological Effects as an Androgen</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2817</span><span class="NLM_x">–</span> <span class="NLM_lpage">2827</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-07-0312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1158%2F1535-7163.MCT-07-0312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=17989318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWkt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=2817-2827&author=E.+A.+Ariaziauthor=A.+Leitaoauthor=T.+I.+Opreaauthor=B.+Chenauthor=T.+Louisauthor=A.+M.+Bertucciauthor=C.+G.+Sharmaauthor=S.+D.+Gillauthor=H.+R.+Kimauthor=H.+A.+Shuppauthor=J.+R.+Pyleauthor=A.+Madrackauthor=A.+L.+Donatoauthor=D.+Chengauthor=J.+R.+Paigeauthor=V.+C.+Jordan&title=Exemestane%E2%80%99s+17-Hydroxylated+Metabolite+Exerts+Biological+Effects+as+an+Androgen&doi=10.1158%2F1535-7163.MCT-07-0312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen</span></div><div class="casAuthors">Ariazi, Eric A.; Leitao, Andrei; Oprea, Tudor I.; Chen, Bin; Louis, Teresa; Bertucci, Anne Marie; Sharma, Catherine G. N.; Gill, Shaun D.; Kim, Helen R.; Shupp, Heather A.; Pyle, Jennifer R.; Madrack, Alexis; Donato, Anne L.; Cheng, Dong; Paige, James R.; Jordan, V. Craig</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2817-2827</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aromatase inhibitors (AI) are being evaluated as long-term adjuvant therapies and chemopreventives in breast cancer.  However, there are concerns about bone mineral d. loss in an estrogen-free environment.  Unlike nonsteroidal AIs, the steroidal AI exemestane may exert beneficial effects on bone through its primary metabolite 17-hydroexemestane.  We investigated 17-hydroexemestane and obsd. it bound estrogen receptor α (ERα) very weakly and androgen receptor (AR) strongly.  Next, we evaluated 17-hydroexemestane in MCF-7 and T47D breast cancer cells and attributed dependency of its effects on ER or AR using the antiestrogen fulvestrant or the antiandrogen bicalutamide.  17-Hydroexemestane induced proliferation, stimulated cell cycle progression and regulated transcription at high sub-micromolar and micromolar concns. through ER in both cell lines, but through AR at low nanomolar concns. selectively in T47D cells.  Responses of each cell type to high and low concns. of the non-aromatizable synthetic androgen R1881 paralleled those of 17-hydroexemestane. 17-Hydroexemestane down-regulated ERα protein levels at high concns. in a cell type-specific manner similarly as 17β-estradiol, and increased AR protein accumulation at low concns. in both cell types similarly as R1881.  Computer docking indicated that the 17β-OH group of 17-hydroexemestane relative to the 17-keto group of exemestane contributed significantly more intermol. interaction energy toward binding AR than ERα.  Mol. modeling also indicated that 17-hydroexemestane interacted with ERα and AR through selective recognition motifs employed by 17β-estradiol and R1881, resp.  We conclude that 17-hydroexemestane exerts biol. effects as an androgen.  These results may have important implications for long-term maintenance of patients with AIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSPj7C1jpERLVg90H21EOLACvtfcHk0ljplxDisisYmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWkt7nN&md5=e342daad6dedd8bada898fe777182d0f</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0312%26sid%3Dliteratum%253Aachs%26aulast%3DAriazi%26aufirst%3DE.%2BA.%26aulast%3DLeitao%26aufirst%3DA.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DLouis%26aufirst%3DT.%26aulast%3DBertucci%26aufirst%3DA.%2BM.%26aulast%3DSharma%26aufirst%3DC.%2BG.%26aulast%3DGill%26aufirst%3DS.%2BD.%26aulast%3DKim%26aufirst%3DH.%2BR.%26aulast%3DShupp%26aufirst%3DH.%2BA.%26aulast%3DPyle%26aufirst%3DJ.%2BR.%26aulast%3DMadrack%26aufirst%3DA.%26aulast%3DDonato%26aufirst%3DA.%2BL.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DPaige%26aufirst%3DJ.%2BR.%26aulast%3DJordan%26aufirst%3DV.%2BC.%26atitle%3DExemestane%25E2%2580%2599s%252017-Hydroxylated%2520Metabolite%2520Exerts%2520Biological%2520Effects%2520as%2520an%2520Androgen%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D2817%26epage%3D2827%26doi%3D10.1158%2F1535-7163.MCT-07-0312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Masri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span> </span><span class="NLM_article-title">Characterization of the Weak Estrogen Receptor Alpha Agonistic Activity of Exemestane</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span><span class="refDoi"> DOI: 10.1007/s10549-008-0151-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2Fs10549-008-0151-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=18677558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGmtrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2009&pages=461-470&author=S.+Masriauthor=K.+Luiauthor=S.+Phungauthor=J.+Yeauthor=D.+Zhouauthor=X.+Wangauthor=S.+Chen&title=Characterization+of+the+Weak+Estrogen+Receptor+Alpha+Agonistic+Activity+of+Exemestane&doi=10.1007%2Fs10549-008-0151-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the weak estrogen receptor α agonistic activity of exemestane</span></div><div class="casAuthors">Masri, Selma; Lui, Ki; Phung, Sheryl; Ye, Jingjing; Zhou, Dujin; Wang, Xin; Chen, Shiuan</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-470</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Third generation aromatase inhibitors (AI) have shown good clin. efficacy in comparison to the anti-estrogen tamoxifen.  The steroidal AI, exemestane (EXE) has previously been shown to act as an androgen, but this report demonstrates the estrogen-like activity of EXE.  Based on genome-wide microarray anal., high correlation was seen between EXE-Only (EXE O, hormone-free) and hormone-contg. AI-resistant lines.  In addn., the top regulated genes in the EXE O lines were mostly estrogen-responsive genes.  This estrogen-like activity of EXE was further validated using estrogen receptor (ER) activity assays, where in comparison to 17β-estradiol (E2), EXE was able to induce ER activity, though at a higher concn.  Also, this EXE-mediated ER activity was blocked by the ER antagonist ICI as well as the ERα-specific antagonist methyl-piperidino-pyrazole (MPP).  Similarly, EXE was able to induce proliferation of breast cancer cell lines, MCF-7 and MCF-7aro, as well as activate transcription of known estrogen-responsive genes, i.e., PGR, pS2 and AREG.  These results suggest that EXE does have weak estrogen-like activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGougUhxJ93PqLVg90H21EOLACvtfcHk0ljplxDisisYmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGmtrzL&md5=0c9336f42035f88147b610c8939dd8ed</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1007%2Fs10549-008-0151-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-008-0151-x%26sid%3Dliteratum%253Aachs%26aulast%3DMasri%26aufirst%3DS.%26aulast%3DLui%26aufirst%3DK.%26aulast%3DPhung%26aufirst%3DS.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DCharacterization%2520of%2520the%2520Weak%2520Estrogen%2520Receptor%2520Alpha%2520Agonistic%2520Activity%2520of%2520Exemestane%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2009%26volume%3D116%26spage%3D461%26epage%3D470%26doi%3D10.1007%2Fs10549-008-0151-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Varela, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares da Silva, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaral, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia da Silva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalho, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roleira, F. M.</span><span> </span><span class="NLM_article-title">New Structure-Activity Relationships of A- and D-Ring Modified Steroidal Aromatase Inhibitors: Design, Synthesis, and Biochemical Evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3992</span><span class="NLM_x">–</span> <span class="NLM_lpage">4002</span><span class="refDoi"> DOI: 10.1021/jm300262w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300262w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3992-4002&author=C.+Varelaauthor=E.+J.+Tavares+da+Silvaauthor=C.+Amaralauthor=G.+Correia+da+Silvaauthor=T.+Baptistaauthor=S.+Alcaroauthor=G.+Costaauthor=R.+A.+Carvalhoauthor=N.+A.+Teixeiraauthor=F.+M.+Roleira&title=New+Structure-Activity+Relationships+of+A-+and+D-Ring+Modified+Steroidal+Aromatase+Inhibitors%3A+Design%2C+Synthesis%2C+and+Biochemical+Evaluation&doi=10.1021%2Fjm300262w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fjm300262w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300262w%26sid%3Dliteratum%253Aachs%26aulast%3DVarela%26aufirst%3DC.%26aulast%3DTavares%2Bda%2BSilva%26aufirst%3DE.%2BJ.%26aulast%3DAmaral%26aufirst%3DC.%26aulast%3DCorreia%2Bda%2BSilva%26aufirst%3DG.%26aulast%3DBaptista%26aufirst%3DT.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DG.%26aulast%3DCarvalho%26aufirst%3DR.%2BA.%26aulast%3DTeixeira%26aufirst%3DN.%2BA.%26aulast%3DRoleira%26aufirst%3DF.%2BM.%26atitle%3DNew%2520Structure-Activity%2520Relationships%2520of%2520A-%2520and%2520D-Ring%2520Modified%2520Steroidal%2520Aromatase%2520Inhibitors%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Biochemical%2520Evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3992%26epage%3D4002%26doi%3D10.1021%2Fjm300262w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Varela, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaral, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia-da-Silva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalho, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roleira, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares-da-Silva, E. J.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biochemical Studies of New 7alpha-Allylandrostanes as Aromatase Inhibitors</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span><span class="refDoi"> DOI: 10.1016/j.steroids.2013.02.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.steroids.2013.02.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=662-669&author=C.+L.+Varelaauthor=C.+Amaralauthor=G.+Correia-da-Silvaauthor=R.+A.+Carvalhoauthor=N.+A.+Teixeiraauthor=S.+C.+Costaauthor=F.+M.+Roleiraauthor=E.+J.+Tavares-da-Silva&title=Design%2C+Synthesis+and+Biochemical+Studies+of+New+7alpha-Allylandrostanes+as+Aromatase+Inhibitors&doi=10.1016%2Fj.steroids.2013.02.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2013.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2013.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DVarela%26aufirst%3DC.%2BL.%26aulast%3DAmaral%26aufirst%3DC.%26aulast%3DCorreia-da-Silva%26aufirst%3DG.%26aulast%3DCarvalho%26aufirst%3DR.%2BA.%26aulast%3DTeixeira%26aufirst%3DN.%2BA.%26aulast%3DCosta%26aufirst%3DS.%2BC.%26aulast%3DRoleira%26aufirst%3DF.%2BM.%26aulast%3DTavares-da-Silva%26aufirst%3DE.%2BJ.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biochemical%2520Studies%2520of%2520New%25207alpha-Allylandrostanes%2520as%2520Aromatase%2520Inhibitors%26jtitle%3DSteroids%26date%3D2013%26volume%3D78%26spage%3D662%26epage%3D669%26doi%3D10.1016%2Fj.steroids.2013.02.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Bansal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guleria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodhankar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patwardhan, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, A. L.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of Novel 16-Imidazolyl Substituted Steroidal Derivatives Possessing Potent Diversified Pharmacological Properties</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span><span class="refDoi"> DOI: 10.1016/j.steroids.2012.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.steroids.2012.02.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=621-629&author=R.+Bansalauthor=S.+Guleriaauthor=S.+Thotaauthor=S.+L.+Bodhankarauthor=M.+R.+Patwardhanauthor=C.+Zimmerauthor=R.+W.+Hartmannauthor=A.+L.+Harvey&title=Design%2C+Synthesis+and+Evaluation+of+Novel+16-Imidazolyl+Substituted+Steroidal+Derivatives+Possessing+Potent+Diversified+Pharmacological+Properties&doi=10.1016%2Fj.steroids.2012.02.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2012.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2012.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DBansal%26aufirst%3DR.%26aulast%3DGuleria%26aufirst%3DS.%26aulast%3DThota%26aufirst%3DS.%26aulast%3DBodhankar%26aufirst%3DS.%2BL.%26aulast%3DPatwardhan%26aufirst%3DM.%2BR.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DHarvey%26aufirst%3DA.%2BL.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%2520Novel%252016-Imidazolyl%2520Substituted%2520Steroidal%2520Derivatives%2520Possessing%2520Potent%2520Diversified%2520Pharmacological%2520Properties%26jtitle%3DSteroids%26date%3D2012%26volume%3D77%26spage%3D621%26epage%3D629%26doi%3D10.1016%2Fj.steroids.2012.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Yadav, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabale, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giridhar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haupenthal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Synthesis of Some Novel Androstanes as Potential Aromatase Inhibitors</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span><span class="refDoi"> DOI: 10.1016/j.steroids.2010.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.steroids.2010.12.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=464-470&author=M.+R.+Yadavauthor=P.+M.+Sabaleauthor=R.+Giridharauthor=C.+Zimmerauthor=J.+Haupenthalauthor=R.+W.+Hartmann&title=Synthesis+of+Some+Novel+Androstanes+as+Potential+Aromatase+Inhibitors&doi=10.1016%2Fj.steroids.2010.12.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2010.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2010.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DM.%2BR.%26aulast%3DSabale%26aufirst%3DP.%2BM.%26aulast%3DGiridhar%26aufirst%3DR.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DHaupenthal%26aufirst%3DJ.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DSynthesis%2520of%2520Some%2520Novel%2520Androstanes%2520as%2520Potential%2520Aromatase%2520Inhibitors%26jtitle%3DSteroids%26date%3D2011%26volume%3D76%26spage%3D464%26epage%3D470%26doi%3D10.1016%2Fj.steroids.2010.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Yadav, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabale, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giridhar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Steroidal Carbonitriles as Potential Aromatase Inhibitors</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">857</span><span class="refDoi"> DOI: 10.1016/j.steroids.2012.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.steroids.2012.04.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=850-857&author=M.+R.+Yadavauthor=P.+M.+Sabaleauthor=R.+Giridharauthor=C.+Zimmerauthor=R.+W.+Hartmann&title=Steroidal+Carbonitriles+as+Potential+Aromatase+Inhibitors&doi=10.1016%2Fj.steroids.2012.04.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2012.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2012.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DM.%2BR.%26aulast%3DSabale%26aufirst%3DP.%2BM.%26aulast%3DGiridhar%26aufirst%3DR.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DSteroidal%2520Carbonitriles%2520as%2520Potential%2520Aromatase%2520Inhibitors%26jtitle%3DSteroids%26date%3D2012%26volume%3D77%26spage%3D850%26epage%3D857%26doi%3D10.1016%2Fj.steroids.2012.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Ghosh, D.; Di Nardo, G.; Lo, J.; Jiang, W.; Griswold, J.; Gilardi, G.</span><span> </span><span class="NLM_article-title">Ligand-Binding Interactions and Quaternary Association in Human Aromatase</span>.  <span class="citation_source-book">36th FEBS Congress</span>, Torino, Italy; <span class="NLM_contrib-group">Perham, R.</span>, Ed.; <span class="NLM_publisher-name">Wiley-Blackwell</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">30</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=30&author=D.+Ghosh&author=G.+Di+Nardo&author=J.+Lo&author=W.+Jiang&author=J.+Griswold&author=G.+Gilardiauthor=R.+Perham&title=36th+FEBS+Congress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DLigand-Binding%2520Interactions%2520and%2520Quaternary%2520Association%2520in%2520Human%2520Aromatase%26btitle%3D36th%2520FEBS%2520Congress%26aulast%3DPerham%26aufirst%3DR.%26pub%3DWiley-Blackwell%26date%3D2011%26spage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Sgrignani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magistrato, A.</span><span> </span><span class="NLM_article-title">Computational Approaches Elucidate the Allosteric Mechanism of Human Aromatase Inhibition: A Novel Possible Route to Small-Molecule Regulation of Cyp450s Activities?</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2856</span><span class="NLM_x">–</span> <span class="NLM_lpage">2868</span><span class="refDoi"> DOI: 10.1021/ci500425y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500425y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVCmsrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=2856-2868&author=J.+Sgrignaniauthor=M.+Bonauthor=G.+Colomboauthor=A.+Magistrato&title=Computational+Approaches+Elucidate+the+Allosteric+Mechanism+of+Human+Aromatase+Inhibition%3A+A+Novel+Possible+Route+to+Small-Molecule+Regulation+of+Cyp450s+Activities%3F&doi=10.1021%2Fci500425y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Approaches Elucidate the Allosteric Mechanism of Human Aromatase Inhibition: A Novel Possible Route to Small-Molecule Regulation of CYP450s Activities?</span></div><div class="casAuthors">Sgrignani, Jacopo; Bon, Marta; Colombo, Giorgio; Magistrato, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2856-2868</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human aromatase (HA) is a P 450 cytochrome (CYP) with an essential role in estrogen biosynthesis.  Since more than 70% of breast cancers are pos. for estrogenic receptor (ER), the redn. of estrogen physiol. concns. through HA inhibition is one of most important therapeutic strategies against this cancer type.  Recently, exptl. evidence showed that selected taxmoxifen metabolites, which are typically used as estrogen receptor modulators (SERMs), inhibit HA through an allosteric mechanism.  In this work, we present a computational protocol to (i) characterize the structural framework and (ii) define the atomistic details of the determinants for the noncompetitive inhibition mechanism.  Our calcns. identify two putative binding sites able to efficiently bind all tamoxifen metabolites.  Anal. of long-scale mol. dynamics simulations reveal that endoxifen, the most effective noncompetitive inhibitor, induces significant enzyme rigidity by binding in one of the possible peripheral sites.  The consequence of this binding event is the suppression of one of the functional enzymic collective motions assocd. with breathing of the substrate access channel.  Moreover, an internal dynamics-based alignment of HA with six other human cytochromes shows that this collective motion is common to other members of the CYP450 protein family.  On this basis, our findings may thus be of help for the development of new (pan)inhibitors for the therapeutic treatment of cancer, targeting and modulating the activity of HA and of estrogen receptor, and may also stimulate the development of new drug design strategies for chemoprevention and chemoprotection via allosteric inhibition of CYP450 proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4wfeRHIieRrVg90H21EOLACvtfcHk0ljM6dDpH7ClCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVCmsrfN&md5=3199db4b7f97e188bfa5d9158092e30b</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fci500425y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500425y%26sid%3Dliteratum%253Aachs%26aulast%3DSgrignani%26aufirst%3DJ.%26aulast%3DBon%26aufirst%3DM.%26aulast%3DColombo%26aufirst%3DG.%26aulast%3DMagistrato%26aufirst%3DA.%26atitle%3DComputational%2520Approaches%2520Elucidate%2520the%2520Allosteric%2520Mechanism%2520of%2520Human%2520Aromatase%2520Inhibition%253A%2520A%2520Novel%2520Possible%2520Route%2520to%2520Small-Molecule%2520Regulation%2520of%2520Cyp450s%2520Activities%253F%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D2856%26epage%3D2868%26doi%3D10.1021%2Fci500425y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Jiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Q.</span><span> </span><span class="NLM_article-title">Recent Advancement in Nonsteroidal Aromatase Inhibitors for Treatment of Estrogen-Dependent Breast Cancer</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3476</span><span class="NLM_x">–</span> <span class="NLM_lpage">3487</span><span class="refDoi"> DOI: 10.2174/092986710792927877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.2174%2F092986710792927877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=20738251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWrt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=3476-3487&author=J.+Jiaoauthor=H.+Xiangauthor=Q.+Liao&title=Recent+Advancement+in+Nonsteroidal+Aromatase+Inhibitors+for+Treatment+of+Estrogen-Dependent+Breast+Cancer&doi=10.2174%2F092986710792927877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer</span></div><div class="casAuthors">Jiao, J.; Xiang, H.; Liao, Q.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">3476-3487</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Estrogen-dependent breast cancer (EDBC) is a kind of common malignant tumor in postmenopausal women with growing tendency in recent years.  Aromatase (AR) is the key enzyme responsible for estrogen biosynthesis and has been considered as an important target for designing inhibitors as potent therapeutic agents for EDBC.  AR inhibitors (AIs) are divided into steroidal and nonsteroidal compds., and the latter shows high inhibitory potency against AR.  This review summarizes recent advancement in nonsteroidal AIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuVwxKHLHeMbVg90H21EOLACvtfcHk0ljM6dDpH7ClCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWrt7fL&md5=d3dbcf26d22b72f07e8a3a32c3bd855c</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.2174%2F092986710792927877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710792927877%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DQ.%26atitle%3DRecent%2520Advancement%2520in%2520Nonsteroidal%2520Aromatase%2520Inhibitors%2520for%2520Treatment%2520of%2520Estrogen-Dependent%2520Breast%2520Cancer%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D3476%26epage%3D3487%26doi%3D10.2174%2F092986710792927877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Tetrahydropyrroloquinolinone Type Dual Inhibitors of Aromatase/Aldosterone Synthase as a Novel Strategy for Breast Cancer Patients with Elevated Cardiovascular Risks</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span><span class="refDoi"> DOI: 10.1021/jm301408t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301408t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVanug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=460-470&author=L.+Yinauthor=Q.+Huauthor=R.+W.+Hartmann&title=Tetrahydropyrroloquinolinone+Type+Dual+Inhibitors+of+Aromatase%2FAldosterone+Synthase+as+a+Novel+Strategy+for+Breast+Cancer+Patients+with+Elevated+Cardiovascular+Risks&doi=10.1021%2Fjm301408t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydropyrroloquinolinone Type Dual Inhibitors of Aromatase/Aldosterone Synthase as a Novel Strategy for Breast Cancer Patients with Elevated Cardiovascular Risks</span></div><div class="casAuthors">Yin, Lina; Hu, Qingzhong; Hartmann, Rolf W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">460-470</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The application of aromatase inhibitors to postmenopausal breast cancer patients increases the risk of cardiovascular diseases (CVD), which is believed to be caused by the abnormally high concns. of aldosterone as a consequence of the estrogen deficiency.  Dual inhibitors of aromatase (CYP19) and aldosterone synthase (CYP11B2) are therefore proposed as a novel strategy for the adjuvant therapy to reduce the CVD risk for these patients.  By combining decisive structural features of CYP11B2 and CYP19 inhibitors into a common template, a series of pyridinylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones were designed and synthesized.  Interestingly, the substituents on the methylene bridge showed strong influences on the inhibitory activities leading to opposite effects, i.e., a given substituent showed an increase in inhibition of one enzyme, while it led to a decrease for the other enzyme.  The compromise of this conflict led to compds. 3j, 3k, 3n, and 3p as potent and selective dual inhibitors of CYP19 and CYP11B2, esp. compd. 3p (I), which exhibited IC50 values of 32 and 41 nM for CYP19 and CYP11B2, resp., and a high selectivity toward CYP17 and CYP11B1.  This compd. is considered as a candidate for further evaluation in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwYyrAmpIzorVg90H21EOLACvtfcHk0lhNFA9iZmedWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVanug%253D%253D&md5=71a8d28d9b81108446073c259a48b498</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fjm301408t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301408t%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DTetrahydropyrroloquinolinone%2520Type%2520Dual%2520Inhibitors%2520of%2520Aromatase%252FAldosterone%2520Synthase%2520as%2520a%2520Novel%2520Strategy%2520for%2520Breast%2520Cancer%2520Patients%2520with%2520Elevated%2520Cardiovascular%2520Risks%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D460%26epage%3D470%26doi%3D10.1021%2Fjm301408t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Ferlin, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolozzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghodsi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimento, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pezzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanke, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola, G.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Structure-Activity Relationships of Azolylmethylpyrroloquinolines as Nonsteroidal Aromatase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7536</span><span class="NLM_x">–</span> <span class="NLM_lpage">7551</span><span class="refDoi"> DOI: 10.1021/jm400377z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400377z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7536-7551&author=M.+G.+Ferlinauthor=D.+Cartaauthor=R.+Bortolozziauthor=R.+Ghodsiauthor=A.+Chimentoauthor=V.+Pezziauthor=S.+Moroauthor=N.+Hankeauthor=R.+W.+Hartmannauthor=G.+Bassoauthor=G.+Viola&title=Design%2C+Synthesis%2C+and+Structure-Activity+Relationships+of+Azolylmethylpyrroloquinolines+as+Nonsteroidal+Aromatase+Inhibitors&doi=10.1021%2Fjm400377z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fjm400377z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400377z%26sid%3Dliteratum%253Aachs%26aulast%3DFerlin%26aufirst%3DM.%2BG.%26aulast%3DCarta%26aufirst%3DD.%26aulast%3DBortolozzi%26aufirst%3DR.%26aulast%3DGhodsi%26aufirst%3DR.%26aulast%3DChimento%26aufirst%3DA.%26aulast%3DPezzi%26aufirst%3DV.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DHanke%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DViola%26aufirst%3DG.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Structure-Activity%2520Relationships%2520of%2520Azolylmethylpyrroloquinolines%2520as%2520Nonsteroidal%2520Aromatase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7536%26epage%3D7551%26doi%3D10.1021%2Fjm400377z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Ji, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lao, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. Y.</span><span> </span><span class="NLM_article-title">Discovery of Novel Aromatase Inhibitors Using a Homogeneous Time-Resolved Fluorescence Assay</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1082</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span><span class="refDoi"> DOI: 10.1038/aps.2014.53</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Faps.2014.53" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=25047514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislOqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=1082-1092&author=J.+Z.+Jiauthor=K.+J.+Laoauthor=J.+Huauthor=T.+Pangauthor=Z.+Z.+Jiangauthor=H.+L.+Yuanauthor=J.+S.+Miaoauthor=X.+Chenauthor=S.+S.+Ningauthor=H.+Xiangauthor=Y.+M.+Guoauthor=M.+Yanauthor=L.+Y.+Zhang&title=Discovery+of+Novel+Aromatase+Inhibitors+Using+a+Homogeneous+Time-Resolved+Fluorescence+Assay&doi=10.1038%2Faps.2014.53"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel aromatase inhibitors using a homogeneous time-resolved fluorescence assay</span></div><div class="casAuthors">Ji, Jin-zi; Lao, Ke-jing; Hu, Jie; Pang, Tao; Jiang, Zhen-zhou; Yuan, Hao-liang; Miao, Jing-shan; Chen, Xin; Ning, Shan-shan; Xiang, Hua; Guo, Yu-meng; Yan, Ming; Zhang, Lu-yong</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1082-1092</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aim: Aromatase is an important target for drugs to treat hormone-dependent diseases, including breast cancer.  The aim of this study was to develop a homogeneous time-resolved fluorescence (HTRF) aromatase assay suitable for high-throughput screening (HTS).  Methods: A 384-well aromatase HTRF assay was established, and used to screen about 7000 compds. from a compd. library.  Anti-proliferation activity of the hit was evaluated using alamarBlue(R) assay in a hormone-dependent breast cancer cell line T47D.  Mol. docking was conducted to elucidate the binding mode of the hit using the Discovery Studio program.  Results: The Z' value and signal to background (S/B) ratio were 0.74 and 5.4, resp.  Among the 7000 compds., 4 hits (XHN22, XHN26, XHN27 and triptoquinone A) were found to inhibit aromatase with IC50 values of 1.60±0.07, 2.76±0.24, 0.81±0.08 and 45.8±11.3 μmol /L, resp.  The hits XHN22, XHN26 and XHN27 shared the same chem. scaffold of 4-imidazolyl quinoline.  Moreover, the most potent hit XHN27 at 10 and 50 μmol/L inhibited the proliferation of T47D cells by 45.3% and 35.2%, resp.  The docking study revealed that XHN27 docked within the active site of aromatase and might form a hydrogen bond and had a π-cation interaction with amino acid residues of the protein.  Conclusion: XHN27, an imidazolyl quinoline deriv. of flavonoid, is a potent aromatase inhibitor with anti-proliferation activity against breast cancer in vitro.  The established assay can be used in HTS for discovering novel aromatase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQmyHM4vOx77Vg90H21EOLACvtfcHk0lhNFA9iZmedWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislOqtQ%253D%253D&md5=b751337ce795ff615e33e4942daf24e0</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1038%2Faps.2014.53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2014.53%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DJ.%2BZ.%26aulast%3DLao%26aufirst%3DK.%2BJ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DZ.%2BZ.%26aulast%3DYuan%26aufirst%3DH.%2BL.%26aulast%3DMiao%26aufirst%3DJ.%2BS.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DNing%26aufirst%3DS.%2BS.%26aulast%3DXiang%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DY.%2BM.%26aulast%3DYan%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%2BY.%26atitle%3DDiscovery%2520of%2520Novel%2520Aromatase%2520Inhibitors%2520Using%2520a%2520Homogeneous%2520Time-Resolved%2520Fluorescence%2520Assay%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2014%26volume%3D35%26spage%3D1082%26epage%3D1092%26doi%3D10.1038%2Faps.2014.53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Bonfield, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankemper, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeler, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCallum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span> </span><span class="NLM_article-title">Development of a New Class of Aromatase Inhibitors: Design, Synthesis and Inhibitory Activity of 3-Phenylchroman-4-One (Isoflavanone) Derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2603</span><span class="NLM_x">–</span> <span class="NLM_lpage">2613</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.02.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bmc.2012.02.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2603-2613&author=K.+Bonfieldauthor=E.+Amatoauthor=T.+Bankemperauthor=H.+Agardauthor=J.+Stellerauthor=J.+M.+Keelerauthor=D.+Royauthor=A.+McCallumauthor=S.+Paulaauthor=L.+Ma&title=Development+of+a+New+Class+of+Aromatase+Inhibitors%3A+Design%2C+Synthesis+and+Inhibitory+Activity+of+3-Phenylchroman-4-One+%28Isoflavanone%29+Derivatives&doi=10.1016%2Fj.bmc.2012.02.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.02.042%26sid%3Dliteratum%253Aachs%26aulast%3DBonfield%26aufirst%3DK.%26aulast%3DAmato%26aufirst%3DE.%26aulast%3DBankemper%26aufirst%3DT.%26aulast%3DAgard%26aufirst%3DH.%26aulast%3DSteller%26aufirst%3DJ.%26aulast%3DKeeler%26aufirst%3DJ.%2BM.%26aulast%3DRoy%26aufirst%3DD.%26aulast%3DMcCallum%26aufirst%3DA.%26aulast%3DPaula%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DL.%26atitle%3DDevelopment%2520of%2520a%2520New%2520Class%2520of%2520Aromatase%2520Inhibitors%253A%2520Design%252C%2520Synthesis%2520and%2520Inhibitory%2520Activity%2520of%25203-Phenylchroman-4-One%2520%2528Isoflavanone%2529%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D2603%26epage%3D2613%26doi%3D10.1016%2Fj.bmc.2012.02.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Prachyawarakorn, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sangpetsiripan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surawatanawong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahidol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruchirawat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kittakoop, P.</span><span> </span><span class="NLM_article-title">Flavans from Desmos Cochinchinensis as Potent Aromatase Inhibitors</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1590</span><span class="NLM_x">–</span> <span class="NLM_lpage">1596</span><span class="refDoi"> DOI: 10.1039/c3md00166k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1039%2Fc3md00166k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1590-1596&author=V.+Prachyawarakornauthor=S.+Sangpetsiripanauthor=P.+Surawatanawongauthor=C.+Mahidolauthor=S.+Ruchirawatauthor=P.+Kittakoop&title=Flavans+from+Desmos+Cochinchinensis+as+Potent+Aromatase+Inhibitors&doi=10.1039%2Fc3md00166k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1039%2Fc3md00166k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00166k%26sid%3Dliteratum%253Aachs%26aulast%3DPrachyawarakorn%26aufirst%3DV.%26aulast%3DSangpetsiripan%26aufirst%3DS.%26aulast%3DSurawatanawong%26aufirst%3DP.%26aulast%3DMahidol%26aufirst%3DC.%26aulast%3DRuchirawat%26aufirst%3DS.%26aulast%3DKittakoop%26aufirst%3DP.%26atitle%3DFlavans%2520from%2520Desmos%2520Cochinchinensis%2520as%2520Potent%2520Aromatase%2520Inhibitors%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D1590%26epage%3D1596%26doi%3D10.1039%2Fc3md00166k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Imidazolyl Derivatives of 4,7-Disubstituted Coumarins as Aromatase Inhibitors Selective over 17-Alpha-Hydroxylase/C17-20 Lyase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1613</span><span class="NLM_x">–</span> <span class="NLM_lpage">1625</span><span class="refDoi"> DOI: 10.1021/jm101120u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101120u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1613-1625&author=A.+Stefanachiauthor=A.+D.+Faviaauthor=O.+Nicolottiauthor=F.+Leonettiauthor=L.+Pisaniauthor=M.+Cattoauthor=C.+Zimmerauthor=R.+W.+Hartmannauthor=A.+Carotti&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Imidazolyl+Derivatives+of+4%2C7-Disubstituted+Coumarins+as+Aromatase+Inhibitors+Selective+over+17-Alpha-Hydroxylase%2FC17-20+Lyase&doi=10.1021%2Fjm101120u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm101120u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101120u%26sid%3Dliteratum%253Aachs%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Imidazolyl%2520Derivatives%2520of%25204%252C7-Disubstituted%2520Coumarins%2520as%2520Aromatase%2520Inhibitors%2520Selective%2520over%252017-Alpha-Hydroxylase%252FC17-20%2520Lyase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1613%26epage%3D1625%26doi%3D10.1021%2Fjm101120u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Hong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span> </span><span class="NLM_article-title">Aromatase, Estrone Sulfatase, and 17beta-Hydroxysteroid Dehydrogenase: Structure-Function Studies and Inhibitor Development</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1016/j.mce.2010.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.mce.2010.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=20888390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFyrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2011&pages=120-126&author=Y.+Hongauthor=S.+Chen&title=Aromatase%2C+Estrone+Sulfatase%2C+and+17beta-Hydroxysteroid+Dehydrogenase%3A+Structure-Function+Studies+and+Inhibitor+Development&doi=10.1016%2Fj.mce.2010.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase: Structure-function studies and inhibitor development</span></div><div class="casAuthors">Hong, Yanyan; Chen, Shiuan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-126</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase type 1 are involved in the key steps of 17β-estradiol biosynthesis.  Structure-function studies of aromatase, estrone sulfatase and 17β-hydroxysteroid dehydrogenase type 1 are important to evaluate the mol. basis of the interaction between these enzymes and their inhibitors.  Selective and potent inhibitors of the three enzymes have been developed as antiproliferative agents in hormone-dependent breast carcinoma.  New treatment strategies for hormone-dependent breast cancer are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq0icjv4GMC7Vg90H21EOLACvtfcHk0lhLMmpsa0VEFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFyrtL8%253D&md5=2f8c55500a7d36ca875fcf68d181407d</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2010.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2010.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DAromatase%252C%2520Estrone%2520Sulfatase%252C%2520and%252017beta-Hydroxysteroid%2520Dehydrogenase%253A%2520Structure-Function%2520Studies%2520and%2520Inhibitor%2520Development%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2011%26volume%3D340%26spage%3D120%26epage%3D126%26doi%3D10.1016%2Fj.mce.2010.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Woo, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V.</span><span> </span><span class="NLM_article-title">Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4h-1,2,4-Triazol-4-Yl)Amino]Methyl}Phenyl Sulfamate</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span><span class="refDoi"> DOI: 10.1002/cmdc.201300015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fcmdc.201300015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=779-799&author=L.+W.+Wooauthor=P.+M.+Woodauthor=C.+Bubertauthor=M.+P.+Thomasauthor=A.+Purohitauthor=B.+V.+Potter&title=Synthesis+and+Structure-Activity+Relationship+Studies+of+Derivatives+of+the+Dual+Aromatase-Sulfatase+Inhibitor+4-%7B%5B%284-Cyanophenyl%29%284h-1%2C2%2C4-Triazol-4-Yl%29Amino%5DMethyl%7DPhenyl+Sulfamate&doi=10.1002%2Fcmdc.201300015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300015%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%26atitle%3DSynthesis%2520and%2520Structure-Activity%2520Relationship%2520Studies%2520of%2520Derivatives%2520of%2520the%2520Dual%2520Aromatase-Sulfatase%2520Inhibitor%25204-%257B%255B%25284-Cyanophenyl%2529%25284h-1%252C2%252C4-Triazol-4-Yl%2529Amino%255DMethyl%257DPhenyl%2520Sulfamate%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D779%26epage%3D799%26doi%3D10.1002%2Fcmdc.201300015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrosse, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V.</span><span> </span><span class="NLM_article-title">Bicyclic Derivatives of the Potent Dual Aromatase-Steroid Sulfatase Inhibitor 2-Bromo-4-{[(4-Cyanophenyl)(4h-1,2,4-Triazol-4-Yl)Amino]Methyl}Phenylsulfamate: Synthesis, SAR, Crystal Structure, and in Vitro and in Vivo Activities</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1577</span><span class="NLM_x">–</span> <span class="NLM_lpage">1593</span><span class="refDoi"> DOI: 10.1002/cmdc.201000203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fcmdc.201000203" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1577-1593&author=P.+M.+Woodauthor=L.+W.+Wooauthor=J.+R.+Labrosseauthor=M.+P.+Thomasauthor=M.+F.+Mahonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+Potter&title=Bicyclic+Derivatives+of+the+Potent+Dual+Aromatase-Steroid+Sulfatase+Inhibitor+2-Bromo-4-%7B%5B%284-Cyanophenyl%29%284h-1%2C2%2C4-Triazol-4-Yl%29Amino%5DMethyl%7DPhenylsulfamate%3A+Synthesis%2C+SAR%2C+Crystal+Structure%2C+and+in+Vitro+and+in+Vivo+Activities&doi=10.1002%2Fcmdc.201000203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000203%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%26aulast%3DLabrosse%26aufirst%3DJ.%2BR.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%26atitle%3DBicyclic%2520Derivatives%2520of%2520the%2520Potent%2520Dual%2520Aromatase-Steroid%2520Sulfatase%2520Inhibitor%25202-Bromo-4-%257B%255B%25284-Cyanophenyl%2529%25284h-1%252C2%252C4-Triazol-4-Yl%2529Amino%255DMethyl%257DPhenylsulfamate%253A%2520Synthesis%252C%2520SAR%252C%2520Crystal%2520Structure%252C%2520and%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Activities%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1577%26epage%3D1593%26doi%3D10.1002%2Fcmdc.201000203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Woo, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V.</span><span> </span><span class="NLM_article-title">Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory Activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span><span class="refDoi"> DOI: 10.1021/ml100273k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100273k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=243-247&author=L.+W.+Wooauthor=C.+Bubertauthor=A.+Purohitauthor=B.+V.+Potter&title=Hybrid+Dual+Aromatase-Steroid+Sulfatase+Inhibitors+with+Exquisite+Picomolar+Inhibitory+Activity&doi=10.1021%2Fml100273k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fml100273k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100273k%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%26atitle%3DHybrid%2520Dual%2520Aromatase-Steroid%2520Sulfatase%2520Inhibitors%2520with%2520Exquisite%2520Picomolar%2520Inhibitory%2520Activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D243%26epage%3D247%26doi%3D10.1021%2Fml100273k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Woo, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozier, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V.</span><span> </span><span class="NLM_article-title">Highly Potent First Examples of Dual Aromatase-Steroid Sulfatase Inhibitors Based on a Biphenyl Template</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2155</span><span class="NLM_x">–</span> <span class="NLM_lpage">2170</span><span class="refDoi"> DOI: 10.1021/jm901705h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901705h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFKit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2155-2170&author=L.+W.+Wooauthor=T.+Jacksonauthor=A.+Puteyauthor=G.+Cozierauthor=P.+Leonardauthor=K.+R.+Acharyaauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+Potter&title=Highly+Potent+First+Examples+of+Dual+Aromatase-Steroid+Sulfatase+Inhibitors+Based+on+a+Biphenyl+Template&doi=10.1021%2Fjm901705h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent First Examples of Dual Aromatase-Steroid Sulfatase Inhibitors based on a Biphenyl Template</span></div><div class="casAuthors">Woo, L. W. Lawrence; Jackson, Toby; Putey, Aurelien; Cozier, Gyles; Leonard, Philip; Acharya, K. Ravi; Chander, Surinder K.; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2155-2170</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hormone-dependent breast cancer may be more effectively treated by dual inhibition of aromatase and steroid sulfatase (STS).  Therefore, an aromatase inhibitory pharmacophore was introduced into a known biphenyl STS inhibitor to give a series of novel dual aromatase-sulfatase inhibitors (DASIs).  Several compds. were good aromatase or STS inhibitors and DASI I (R = H) (IC50: aromatase, 2.0 nM; STS, 35 nM) and its chlorinated congener I (R = Cl) (IC50: aromatase, 0.5 nM; STS, 5.5 nM) were examples that showed exceptional dual potency in JEG-3 cells.  At 1 mg/kg po, I (R = H, Cl) strongly reduced plasma estradiol levels and inhibited liver STS activity potently in vivo.  DASI I (R = Cl) was non-estrogenic and potently inhibited carbonic anhydrase II (hCAII) (IC50 86 nM).  A complex of I (R = Cl) and hCAII was crystd. and its structure solved by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMz59lyRAt-rVg90H21EOLACvtfcHk0liTKqlSPuao7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFKit70%253D&md5=3cdf0a54b96c189fd18cae4361f3338e</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fjm901705h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901705h%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%26aulast%3DJackson%26aufirst%3DT.%26aulast%3DPutey%26aufirst%3DA.%26aulast%3DCozier%26aufirst%3DG.%26aulast%3DLeonard%26aufirst%3DP.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%26atitle%3DHighly%2520Potent%2520First%2520Examples%2520of%2520Dual%2520Aromatase-Steroid%2520Sulfatase%2520Inhibitors%2520Based%2520on%2520a%2520Biphenyl%2520Template%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2155%26epage%3D2170%26doi%3D10.1021%2Fjm901705h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V.</span><span> </span><span class="NLM_article-title">Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1438</span><span class="refDoi"> DOI: 10.1002/cmdc.201100145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fcmdc.201100145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=21608133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptFKrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1423-1438&author=P.+M.+Woodauthor=L.+W.+Wooauthor=M.+P.+Thomasauthor=M.+F.+Mahonauthor=A.+Purohitauthor=B.+V.+Potter&title=Aromatase+and+Dual+Aromatase-Steroid+Sulfatase+Inhibitors+from+the+Letrozole+and+Vorozole+Templates&doi=10.1002%2Fcmdc.201100145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates</span></div><div class="casAuthors">Wood, Paul M.; Woo, L. W. Lawrence; Thomas, Mark P.; Mahon, Mary F.; Purohit, Atul; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1423-1438</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Concurrent inhibition of aromatase and steroid sulfatase (STS) may provide a more effective treatment for hormone-dependent breast cancer than monotherapy against individual enzymes, and several dual aromatase-sulfatase inhibitors (DASIs) have been reported.  Three aromatase inhibitors with sub-nanomolar potency, better than the benchmark agent letrozole, were designed.  To further explore the DASI concept, a new series of letrozole-derived sulfamates and a vorozole-based sulfamate were designed and biol. evaluated in JEG-3 cells to reveal structure-activity relationships.  Amongst achiral and racemic compds., 2-bromo-4-(2-(4-cyanophenyl)-2-(1H-1,2,4-triazol-1-yl)ethyl)phenyl sulfamate is the most potent DASI (aromatase: IC50=0.87 nM; STS: IC50=593 nM).  The enantiomers of the phenolic precursor to this compd. were sepd. by chiral HPLC and their abs. configuration detd. by X-ray crystallog.  Following conversion to their corresponding sulfamates, the S-(+)-enantiomer was found to inhibit aromatase and sulfatase most potently (aromatase: IC50=0.52 nM; STS: IC50=280 nM).  The docking of each enantiomer and other ligands into the aromatase and sulfatase active sites was also investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq91XsDqvKlHrVg90H21EOLACvtfcHk0ljobHxZqKuzcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptFKrtrw%253D&md5=94dae7013fdf874ffe1540b8d31122c5</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100145%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%26atitle%3DAromatase%2520and%2520Dual%2520Aromatase-Steroid%2520Sulfatase%2520Inhibitors%2520from%2520the%2520Letrozole%2520and%2520Vorozole%2520Templates%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1423%26epage%3D1438%26doi%3D10.1002%2Fcmdc.201100145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Lu, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhoub, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flockhart, D. A.</span><span> </span><span class="NLM_article-title">The Tamoxifen Metabolite Norendoxifen Is a Potent and Selective Inhibitor of Aromatase (CYP19) and a Potential Lead Compound for Novel Therapeutic Agents</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span><span class="refDoi"> DOI: 10.1007/s10549-011-1699-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2Fs10549-011-1699-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=21814747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlOlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2012&pages=99-109&author=W.+J.+Luauthor=C.+Xuauthor=Z.+Peiauthor=A.+S.+Mayhoubauthor=M.+Cushmanauthor=D.+A.+Flockhart&title=The+Tamoxifen+Metabolite+Norendoxifen+Is+a+Potent+and+Selective+Inhibitor+of+Aromatase+%28CYP19%29+and+a+Potential+Lead+Compound+for+Novel+Therapeutic+Agents&doi=10.1007%2Fs10549-011-1699-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents</span></div><div class="casAuthors">Lu, Wenjie Jessie; Xu, Cong; Pei, Zifan; Mayhoub, Abdelrahman S.; Cushman, Mark; Flockhart, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-109</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">To improve the treatment of breast cancer, there has been a need for alternative aromatase inhibitors (AIs) that bring about adequate aromatase inhibition, while limiting side effects.  Since two tamoxifen metabolites have been documented as AIs, we tested a wide range of tamoxifen metabolites on aromatase in order to better understand structural interactions with aromatase and constructed structure-function relationships as a first step toward the development of novel inhibitors.  The ability of ten tamoxifen metabolites to inhibit recombinant aromatase (CYP19) was tested using microsomal incubations.  The selectivity of the most potent aromatase inhibitor identified, norendoxifen, was characterized by studying its ability to inhibit CYP450 enzymes important in clin. drug-drug interactions, including CYP2B6, 2C9, 2C19, 2D6, and 3A.  Computerized mol. docking with the X-ray crystallog. structure of aromatase was used to describe the detailed biochem. interactions involved.  The inhibitory potency order of the tested compds. was as follows: norendoxifen » 4,4'-dihydroxy-tamoxifen > endoxifen > N-desmethyl-tamoxifen, N-desmethyl-4'-hydroxy-tamoxifen, tamoxifen-N-oxide, 4'-hydroxy-tamoxifen, N-desmethyl-droloxifene > 4-hydroxy-tamoxifen, tamoxifen.  Norendoxifen inhibited recombinant aromatase via a competitive mechanism with a K i of 35 nM.  Norendoxifen inhibited placental aromatase with an IC50 of 90 nM, while it inhibited human liver CYP2C9 and CYP3A with IC50 values of 990 and 908 nM, resp.  Inhibition of human liver CYP2C19 by norendoxifen appeared even weaker.  No substantial inhibition of CYP2B6 and CYP2D6 by norendoxifen was obsd.  These data suggest that multiple metabolites of tamoxifen may contribute to its action in the treatment of breast cancer via aromatase inhibition.  Most of all, norendoxifen may be able to serve as a potent and selective lead compd. in the development of improved therapeutic agents.  The range of structures tested in this study and their pharmacol. potencies provide a reasonable pharmacophore upon which to build novel AIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAIonbKYUflbVg90H21EOLACvtfcHk0ljobHxZqKuzcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlOlurk%253D&md5=fecad8a08ab5cd6c6db6a3047f8a5678</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1007%2Fs10549-011-1699-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-011-1699-4%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DW.%2BJ.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DMayhoub%26aufirst%3DA.%2BS.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DFlockhart%26aufirst%3DD.%2BA.%26atitle%3DThe%2520Tamoxifen%2520Metabolite%2520Norendoxifen%2520Is%2520a%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Aromatase%2520%2528CYP19%2529%2520and%2520a%2520Potential%2520Lead%2520Compound%2520for%2520Novel%2520Therapeutic%2520Agents%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2012%26volume%3D133%26spage%3D99%26epage%3D109%26doi%3D10.1007%2Fs10549-011-1699-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Lv, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flockhart, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span> </span><span class="NLM_article-title">Synthesis of Mixed (E,Z)-, (E)-, and (Z)-Norendoxifen with Dual Aromatase Inhibitory and Estrogen Receptor Modulatory Activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4611</span><span class="NLM_x">–</span> <span class="NLM_lpage">4618</span><span class="refDoi"> DOI: 10.1021/jm400364h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400364h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslSqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4611-4618&author=W.+Lvauthor=J.+Liuauthor=D.+Luauthor=D.+A.+Flockhartauthor=M.+Cushman&title=Synthesis+of+Mixed+%28E%2CZ%29-%2C+%28E%29-%2C+and+%28Z%29-Norendoxifen+with+Dual+Aromatase+Inhibitory+and+Estrogen+Receptor+Modulatory+Activities&doi=10.1021%2Fjm400364h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Mixed (E,Z)-, (E)-, and (Z)-Norendoxifen with Dual Aromatase Inhibitory and Estrogen Receptor Modulatory Activities</span></div><div class="casAuthors">Lv, Wei; Liu, Jinzhong; Lu, Deshun; Flockhart, David A.; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4611-4618</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first synthesis of the tamoxifen metabolite norendoxifen (I) is reported.  This included syntheses of (E)-norendoxifen, (Z)-norendoxifen, and (E,Z)-norendoxifen isomers.  (Z)-Norendoxifen displayed affinity for aromatase (Ki 442 nM), estrogen receptor-α (EC50 17 nM), and estrogen receptor-β (EC50 27.5 nM), while the corresponding values for (E)-norendoxifen were aromatase (Ki 48 nM), estrogen receptor-α (EC50 58.7 nM), and estrogen receptor-β (EC50 78.5 nM).  Docking and energy minimization studies were performed with (E)-norendoxifen on aromatase, and the results provide a foundation for structure-based drug design.  The oral pharmacokinetic parameters for (E,Z)-norendoxifen were detd. in mice, and (Z)-norendoxifen was found to result in significantly higher plasma concns. and exposures (AUC values) than (E)-norendoxifen.  The affinities of both isomers for aromatase and the estrogen receptors, as well as the pharmacokinetic results, support the further development of norendoxifen and its analogs for breast cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr7zDwcQogpLVg90H21EOLACvtfcHk0ljobHxZqKuzcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslSqu7c%253D&md5=7d22eddb3a907eaa425604525ec55793</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm400364h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400364h%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DFlockhart%26aufirst%3DD.%2BA.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520Mixed%2520%2528E%252CZ%2529-%252C%2520%2528E%2529-%252C%2520and%2520%2528Z%2529-Norendoxifen%2520with%2520Dual%2520Aromatase%2520Inhibitory%2520and%2520Estrogen%2520Receptor%2520Modulatory%2520Activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4611%26epage%3D4618%26doi%3D10.1021%2Fjm400364h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Pingaew, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prachayasittikul, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantasenamat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prachayasittikul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruchirawat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prachayasittikul, V.</span><span> </span><span class="NLM_article-title">Synthesis and Molecular Docking of 1,2,3-Triazole-Based Sulfonamides as Aromatase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3472</span><span class="NLM_x">–</span> <span class="NLM_lpage">3480</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.04.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bmc.2015.04.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=3472-3480&author=R.+Pingaewauthor=V.+Prachayasittikulauthor=P.+Mandiauthor=C.+Nantasenamatauthor=S.+Prachayasittikulauthor=S.+Ruchirawatauthor=V.+Prachayasittikul&title=Synthesis+and+Molecular+Docking+of+1%2C2%2C3-Triazole-Based+Sulfonamides+as+Aromatase+Inhibitors&doi=10.1016%2Fj.bmc.2015.04.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.04.036%26sid%3Dliteratum%253Aachs%26aulast%3DPingaew%26aufirst%3DR.%26aulast%3DPrachayasittikul%26aufirst%3DV.%26aulast%3DMandi%26aufirst%3DP.%26aulast%3DNantasenamat%26aufirst%3DC.%26aulast%3DPrachayasittikul%26aufirst%3DS.%26aulast%3DRuchirawat%26aufirst%3DS.%26aulast%3DPrachayasittikul%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520Molecular%2520Docking%2520of%25201%252C2%252C3-Triazole-Based%2520Sulfonamides%2520as%2520Aromatase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D3472%26epage%3D3480%26doi%3D10.1016%2Fj.bmc.2015.04.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">McNulty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiFrancesco, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vurgun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crankshaw, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, A. C.</span><span> </span><span class="NLM_article-title">Investigation of Aryl Halides as Ketone Bioisosteres: Refinement of Potent and Selective Inhibitors of Human Cytochrome P450 19A1 (Aromatase)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6060</span><span class="NLM_x">–</span> <span class="NLM_lpage">6063</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bmcl.2013.09.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=24113062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFymsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6060-6063&author=J.+McNultyauthor=A.+J.+Nielsenauthor=C.+E.+Brownauthor=B.+R.+DiFrancescoauthor=N.+Vurgunauthor=J.+J.+Nairauthor=D.+J.+Crankshawauthor=A.+C.+Holloway&title=Investigation+of+Aryl+Halides+as+Ketone+Bioisosteres%3A+Refinement+of+Potent+and+Selective+Inhibitors+of+Human+Cytochrome+P450+19A1+%28Aromatase%29&doi=10.1016%2Fj.bmcl.2013.09.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of aryl halides as ketone bioisosteres: Refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase)</span></div><div class="casAuthors">McNulty, James; Nielsen, Alexander J.; Brown, Carla E.; DiFrancesco, Benjamin R.; Vurgun, Nesrin; Nair, Jerald J.; Crankshaw, Denis J.; Holloway, Alison C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6060-6063</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bioisosteric replacement of cyclic ketone functionality with aryl halides was studied on a centrally-flexible, five-component 1,2,3-triazole-contg. pharmacophore, resulting in enhanced inhibition of aromatase (CYP450 19A1).  Structure-activity data generated from both syn- and anti-aldol precursors provides significant insights into the requirements for enhanced potency, validating this novel ketone-to-aryl halide bioisostere hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4UUcXtu7PMrVg90H21EOLACvtfcHk0lgTlp1YV8MJ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFymsrrN&md5=0ac871f3833c97130a2ff7e7386ba82a</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DMcNulty%26aufirst%3DJ.%26aulast%3DNielsen%26aufirst%3DA.%2BJ.%26aulast%3DBrown%26aufirst%3DC.%2BE.%26aulast%3DDiFrancesco%26aufirst%3DB.%2BR.%26aulast%3DVurgun%26aufirst%3DN.%26aulast%3DNair%26aufirst%3DJ.%2BJ.%26aulast%3DCrankshaw%26aufirst%3DD.%2BJ.%26aulast%3DHolloway%26aufirst%3DA.%2BC.%26atitle%3DInvestigation%2520of%2520Aryl%2520Halides%2520as%2520Ketone%2520Bioisosteres%253A%2520Refinement%2520of%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Human%2520Cytochrome%2520P450%252019A1%2520%2528Aromatase%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6060%26epage%3D6063%26doi%3D10.1016%2Fj.bmcl.2013.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. P.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Aromatase Inhibitory Activities of Novel Indole-Imidazole Derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1760</span><span class="NLM_x">–</span> <span class="NLM_lpage">1762</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.01.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bmcl.2013.01.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1760-1762&author=R.+Wangauthor=H.+F.+Shiauthor=J.+F.+Zhaoauthor=Y.+P.+Heauthor=H.+B.+Zhangauthor=J.+P.+Liu&title=Design%2C+Synthesis+and+Aromatase+Inhibitory+Activities+of+Novel+Indole-Imidazole+Derivatives&doi=10.1016%2Fj.bmcl.2013.01.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.01.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.01.045%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DH.%2BF.%26aulast%3DZhao%26aufirst%3DJ.%2BF.%26aulast%3DHe%26aufirst%3DY.%2BP.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DLiu%26aufirst%3DJ.%2BP.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Aromatase%2520Inhibitory%2520Activities%2520of%2520Novel%2520Indole-Imidazole%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1760%26epage%3D1762%26doi%3D10.1016%2Fj.bmcl.2013.01.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Maiti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturdy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegan, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesecar, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pezzuto, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span> </span><span class="NLM_article-title">Synthesis of Casimiroin and Optimization of Its Quinone Reductase 2 and Aromatase Inhibitory Activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1873</span><span class="NLM_x">–</span> <span class="NLM_lpage">1884</span><span class="refDoi"> DOI: 10.1021/jm801335z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801335z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisl2kur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1873-1884&author=A.+Maitiauthor=P.+V.+Reddyauthor=M.+Sturdyauthor=L.+Marlerauthor=S.+D.+Peganauthor=A.+D.+Mesecarauthor=J.+M.+Pezzutoauthor=M.+Cushman&title=Synthesis+of+Casimiroin+and+Optimization+of+Its+Quinone+Reductase+2+and+Aromatase+Inhibitory+Activities&doi=10.1021%2Fjm801335z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Casimiroin and Optimization of Its Quinone Reductase 2 and Aromatase Inhibitory Activities</span></div><div class="casAuthors">Maiti, Arup; Reddy, P. V. Narasimha; Sturdy, Megan; Marler, Laura; Pegan, Scott D.; Mesecar, Andrew D.; Pezzuto, John M.; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1873-1884</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient method has been developed to synthesize casimiroin (I), a component of the edible fruit of Casimiroa edulis, on a multigram scale in good overall yield.  The route was versatile enough to provide an array of I's analogs that were evaluated as QR2 and aromatase inhibitors.  In addn., X-ray crystallog. studies of QR2 in complex with I and one of its more potent analog II has provided insight into the mechanism of action of this new series of QR2 inhibitors.  The initial biol. investigations suggest that I and its analogs merit further investigation as potential chemopreventive or chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxfer9QooPoLVg90H21EOLACvtfcHk0lgZQRnmUo3wrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisl2kur8%253D&md5=e1fdf097ef37bff1b3d167f9d834c427</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fjm801335z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801335z%26sid%3Dliteratum%253Aachs%26aulast%3DMaiti%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DP.%2BV.%26aulast%3DSturdy%26aufirst%3DM.%26aulast%3DMarler%26aufirst%3DL.%26aulast%3DPegan%26aufirst%3DS.%2BD.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520Casimiroin%2520and%2520Optimization%2520of%2520Its%2520Quinone%2520Reductase%25202%2520and%2520Aromatase%2520Inhibitory%2520Activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1873%26epage%3D1884%26doi%3D10.1021%2Fjm801335z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span> </span><span class="NLM_article-title">Novel Highly Potent and Selective Nonsteroidal Aromatase Inhibitors: Synthesis, Biological Evaluation and Structure-Activity Relationships Investigation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5347</span><span class="NLM_x">–</span> <span class="NLM_lpage">5351</span><span class="refDoi"> DOI: 10.1021/jm100319h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100319h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVKqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5347-5351&author=S.+Gobbiauthor=C.+Zimmerauthor=F.+Bellutiauthor=A.+Rampaauthor=R.+W.+Hartmannauthor=M.+Recanatiniauthor=A.+Bisi&title=Novel+Highly+Potent+and+Selective+Nonsteroidal+Aromatase+Inhibitors%3A+Synthesis%2C+Biological+Evaluation+and+Structure-Activity+Relationships+Investigation&doi=10.1021%2Fjm100319h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Highly Potent and Selective Nonsteroidal Aromatase Inhibitors: Synthesis, Biological Evaluation and Structure-Activity Relationships Investigation</span></div><div class="casAuthors">Gobbi, Silvia; Zimmer, Christina; Belluti, Federica; Rampa, Angela; Hartmann, Rolf W.; Recanatini, Maurizio; Bisi, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5347-5351</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of mols. were designed and synthesized, in search for potent and selective aromatase inhibitors.  The substitution of the heterocyclic oxygen atom in the xanthone core by a sulfur atom and/or increase in structure flexibility seemed to be favorable for the interaction with the enzyme.  Among the new compds., I and II (IC50 3.98 and 5.59 nM, resp.) resulted the most potent aromatase inhibitors synthesized in this project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxvriNb7PmOrVg90H21EOLACvtfcHk0lgZQRnmUo3wrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVKqsbs%253D&md5=9634dbf062b35d9b9a12667c5a70cf99</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm100319h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100319h%26sid%3Dliteratum%253Aachs%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DBisi%26aufirst%3DA.%26atitle%3DNovel%2520Highly%2520Potent%2520and%2520Selective%2520Nonsteroidal%2520Aromatase%2520Inhibitors%253A%2520Synthesis%252C%2520Biological%2520Evaluation%2520and%2520Structure-Activity%2520Relationships%2520Investigation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5347%26epage%3D5351%26doi%3D10.1021%2Fjm100319h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Caporuscio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbriano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Rio, A.</span><span> </span><span class="NLM_article-title">Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4006</span><span class="NLM_x">–</span> <span class="NLM_lpage">4017</span><span class="refDoi"> DOI: 10.1021/jm2000689</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2000689" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4006-4017&author=F.+Caporuscioauthor=G.+Rastelliauthor=C.+Imbrianoauthor=A.+Del+Rio&title=Structure-Based+Design+of+Potent+Aromatase+Inhibitors+by+High-Throughput+Docking&doi=10.1021%2Fjm2000689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking</span></div><div class="casAuthors">Caporuscio, Fabiana; Rastelli, Giulio; Imbriano, Carol; Del Rio, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4006-4017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytochrome P 450 aromatase catalyzes the conversion of androgen substrates into estrogens.  Aromatase inhibitors (AIs) have been used as first-line drugs in the treatment of estrogen-dependent breast cancer in postmenopausal women.  However, the search for new, more potent, and selective AIs still remains necessary to avoid the risk of possible resistances and reduce toxicity and side effects of current available drugs.  The publication of a high resoln. x-ray structure of human aromatase has opened the way to structure-based virtual screening to identify new small-mol. inhibitors with structural motifs different from all known AIs.  In this context, a high-throughput docking protocol was set up and led to the identification of nanomolar AIs with new core structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBteVWbhM8PLVg90H21EOLACvtfcHk0lgZQRnmUo3wrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFylsL8%253D&md5=93b8b8a30807469412b6a88db79b4a4c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm2000689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2000689%26sid%3Dliteratum%253Aachs%26aulast%3DCaporuscio%26aufirst%3DF.%26aulast%3DRastelli%26aufirst%3DG.%26aulast%3DImbriano%26aufirst%3DC.%26aulast%3DDel%2BRio%26aufirst%3DA.%26atitle%3DStructure-Based%2520Design%2520of%2520Potent%2520Aromatase%2520Inhibitors%2520by%2520High-Throughput%2520Docking%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4006%26epage%3D4017%26doi%3D10.1021%2Fjm2000689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Neves, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinis, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sa e Melo, M. L.</span><span> </span><span class="NLM_article-title">An Efficient Steroid Pharmacophore-Based Strategy to Identify New Aromatase Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4121</span><span class="NLM_x">–</span> <span class="NLM_lpage">4127</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2009.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.ejmech.2009.05.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=4121-4127&author=M.+A.+Nevesauthor=T.+C.+Dinisauthor=G.+Colomboauthor=M.+L.+Sa+e+Melo&title=An+Efficient+Steroid+Pharmacophore-Based+Strategy+to+Identify+New+Aromatase+Inhibitors&doi=10.1016%2Fj.ejmech.2009.05.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DNeves%26aufirst%3DM.%2BA.%26aulast%3DDinis%26aufirst%3DT.%2BC.%26aulast%3DColombo%26aufirst%3DG.%26aulast%3DSa%2Be%2BMelo%26aufirst%3DM.%2BL.%26atitle%3DAn%2520Efficient%2520Steroid%2520Pharmacophore-Based%2520Strategy%2520to%2520Identify%2520New%2520Aromatase%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D4121%26epage%3D4127%26doi%3D10.1016%2Fj.ejmech.2009.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Nikolic, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petri, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klisuric, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celic, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakimov, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djurendic, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penov Gasi, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakac, M. N.</span><span> </span><span class="NLM_article-title">Synthesis and Anticancer Cell Potential of Steroidal 16,17-Seco-16,17a-Dinitriles: Identification of a Selective Inhibitor of Hormone-Independent Breast Cancer Cells</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.12.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bmc.2014.12.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=703-711&author=A.+R.+Nikolicauthor=E.+T.+Petriauthor=O.+R.+Klisuricauthor=A.+S.+Celicauthor=D.+S.+Jakimovauthor=E.+A.+Djurendicauthor=K.+M.+Penov+Gasiauthor=M.+N.+Sakac&title=Synthesis+and+Anticancer+Cell+Potential+of+Steroidal+16%2C17-Seco-16%2C17a-Dinitriles%3A+Identification+of+a+Selective+Inhibitor+of+Hormone-Independent+Breast+Cancer+Cells&doi=10.1016%2Fj.bmc.2014.12.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.12.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.12.069%26sid%3Dliteratum%253Aachs%26aulast%3DNikolic%26aufirst%3DA.%2BR.%26aulast%3DPetri%26aufirst%3DE.%2BT.%26aulast%3DKlisuric%26aufirst%3DO.%2BR.%26aulast%3DCelic%26aufirst%3DA.%2BS.%26aulast%3DJakimov%26aufirst%3DD.%2BS.%26aulast%3DDjurendic%26aufirst%3DE.%2BA.%26aulast%3DPenov%2BGasi%26aufirst%3DK.%2BM.%26aulast%3DSakac%26aufirst%3DM.%2BN.%26atitle%3DSynthesis%2520and%2520Anticancer%2520Cell%2520Potential%2520of%2520Steroidal%252016%252C17-Seco-16%252C17a-Dinitriles%253A%2520Identification%2520of%2520a%2520Selective%2520Inhibitor%2520of%2520Hormone-Independent%2520Breast%2520Cancer%2520Cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D703%26epage%3D711%26doi%3D10.1016%2Fj.bmc.2014.12.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Vosooghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firoozpour, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pordeli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safavi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardestani, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dadgar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asadipour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moshafi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foroumadi, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis, Docking Study and Cytotoxic Activity Evaluation of Some Novel Letrozole Analogs</span> <span class="citation_source-journal">Daru, J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="refDoi"> DOI: 10.1186/s40199-014-0083-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1186%2Fs40199-014-0083-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=83&author=M.+Vosooghiauthor=L.+Firoozpourauthor=A.+Rodakiauthor=M.+Pordeliauthor=M.+Safaviauthor=S.+K.+Ardestaniauthor=A.+Dadgarauthor=A.+Asadipourauthor=M.+H.+Moshafiauthor=A.+Foroumadi&title=Design%2C+Synthesis%2C+Docking+Study+and+Cytotoxic+Activity+Evaluation+of+Some+Novel+Letrozole+Analogs&doi=10.1186%2Fs40199-014-0083-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1186%2Fs40199-014-0083-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40199-014-0083-4%26sid%3Dliteratum%253Aachs%26aulast%3DVosooghi%26aufirst%3DM.%26aulast%3DFiroozpour%26aufirst%3DL.%26aulast%3DRodaki%26aufirst%3DA.%26aulast%3DPordeli%26aufirst%3DM.%26aulast%3DSafavi%26aufirst%3DM.%26aulast%3DArdestani%26aufirst%3DS.%2BK.%26aulast%3DDadgar%26aufirst%3DA.%26aulast%3DAsadipour%26aufirst%3DA.%26aulast%3DMoshafi%26aufirst%3DM.%2BH.%26aulast%3DForoumadi%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%252C%2520Docking%2520Study%2520and%2520Cytotoxic%2520Activity%2520Evaluation%2520of%2520Some%2520Novel%2520Letrozole%2520Analogs%26jtitle%3DDaru%252C%2520J.%2520Pharm.%2520Sci.%26date%3D2014%26volume%3D22%26spage%3D83%26doi%3D10.1186%2Fs40199-014-0083-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Vasavi, H. S.; Arun, A. B.; Rekha, P. D.</span><span> </span><span class="NLM_article-title">Anti-Quorum Sensing Activity of Flavonoid-Rich Fraction from Centella Asiatica L. Against <i>Pseudomonas aeruginosa</i> PAO1</span>.  <span class="citation_source-journal">J. Microbiol., Immunol. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="refDoi"> DOI: 10.1016/j.jmii.2014.03.012</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jmii.2014.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=24856426" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=H.+S.+Vasavi&author=A.+B.+Arun&author=P.+D.+Rekha&title=Anti-Quorum+Sensing+Activity+of+Flavonoid-Rich+Fraction+from+Centella+Asiatica+L.+Against+Pseudomonas+aeruginosa+PAO1&doi=10.1016%2Fj.jmii.2014.03.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.jmii.2014.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmii.2014.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DVasavi%26aufirst%3DH.%2BS.%26atitle%3DAnti-Quorum%2520Sensing%2520Activity%2520of%2520Flavonoid-Rich%2520Fraction%2520from%2520Centella%2520Asiatica%2520L.%2520Against%2520Pseudomonas%2520aeruginosa%2520PAO1%26jtitle%3DJ.%2520Microbiol.%252C%2520Immunol.%2520Infect.%26date%3D2014%26doi%3D10.1016%2Fj.jmii.2014.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Mirzaie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chupani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asadabadi, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahverdi, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamalan, M.</span><span> </span><span class="NLM_article-title">Novel Inhibitor Discovery against Aromatase through Virtual Screening and Molecular Dynamic Simulation: A Computational Approach in Drug Design</span> <span class="citation_source-journal">Exp. Clin. Sci. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=168-183&author=S.+Mirzaieauthor=L.+Chupaniauthor=E.+B.+Asadabadiauthor=A.+R.+Shahverdiauthor=M.+Jamalan&title=Novel+Inhibitor+Discovery+against+Aromatase+through+Virtual+Screening+and+Molecular+Dynamic+Simulation%3A+A+Computational+Approach+in+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMirzaie%26aufirst%3DS.%26aulast%3DChupani%26aufirst%3DL.%26aulast%3DAsadabadi%26aufirst%3DE.%2BB.%26aulast%3DShahverdi%26aufirst%3DA.%2BR.%26aulast%3DJamalan%26aufirst%3DM.%26atitle%3DNovel%2520Inhibitor%2520Discovery%2520against%2520Aromatase%2520through%2520Virtual%2520Screening%2520and%2520Molecular%2520Dynamic%2520Simulation%253A%2520A%2520Computational%2520Approach%2520in%2520Drug%2520Design%26jtitle%3DExp.%2520Clin.%2520Sci.%2520J.%26date%3D2013%26volume%3D12%26spage%3D168%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Narayana, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pran Kishore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakumar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravikumar, M.</span><span> </span><span class="NLM_article-title">Molecular Modeling Evaluation of Non-Steroidal Aromatase Inhibitors†</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span><span class="refDoi"> DOI: 10.1111/j.1747-0285.2011.01277.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1111%2Fj.1747-0285.2011.01277.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22129073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlslagu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=674-682&author=B.+L.+Narayanaauthor=D.+Pran+Kishoreauthor=C.+Balakumarauthor=K.+V.+Raoauthor=R.+Kaurauthor=A.+R.+Raoauthor=J.+N.+Murthyauthor=M.+Ravikumar&title=Molecular+Modeling+Evaluation+of+Non-Steroidal+Aromatase+Inhibitors%E2%80%A0&doi=10.1111%2Fj.1747-0285.2011.01277.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular modeling evaluation of non-steroidal aromatase inhibitors</span></div><div class="casAuthors">Narayana, Bheemanapalli Lakshmi; Kishore, Deb Pran; Balakumar, Chadrasekaran; Rao, Kaki Venkata; Kaur, Rajwinder; Rao, Akkinepally Raghuram; Murthy, Javali Narashima; Ravikumar, Muttineni</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">674-682</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A recent discovery of aromatase crystal structure triggered the efforts to design novel aromatase inhibitors for breast cancer therapy.  While correlating docking scores with inhibitory potencies of known ligands, feeble robustness of scoring functions toward prediction was obsd.  This prompted us to develop new prediction models using stepwise regression anal. based on consensus of different docking and their scoring methods (GOLD, LIGANDFIT, and GLIDE).  Quant. structure-activity relationships were developed between the aromatase inhibitory activity (pIC50) of flavonoid derivs. (n = 39) and docking scores and docking descriptors.  QSAR models have been validated internally [using leave-one-out cross-validated r2cv (LOO - Q2)] and externally to ensure the predictive capacity of the models.  Model 2 [M2] developed using consensus of docking scores of scoring functions viz. ASP, potential of mean force and DOCK Score (r2cv = 0.850, r2 = 0.870, r2pred = 0.633, RMSE = 0.363 μM, r2m(test) = 0.831, r2m(overall) = 0.832) was found to be better in predicting aromatase inhibitory potency (pIC50) compared to the Model 1 [M1] based on docking descriptors (r2cv = 0.848, r2 = 0.825, r2pred = 0.788, RMSE = 0.421 μM, r2m(test) = 0.808, r2m(overall) = 0.821).  It has been obsd. that the natural flavonoids and their derivs. were less potent compared to these scaffolds with imidazolylmethyl substitution owing to the interaction of nitrogen atom of the imidazole ring toward the heme (Fe3+) of the aromatase.  Results confirm the potential of our methodol. for the design of new potent non-steroidal aromatase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqppgP8j9PyrVg90H21EOLACvtfcHk0lg-5sC4C1BsHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlslagu7k%253D&md5=3a1a7b7ca35c161f53366cecb2cffe88</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01277.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01277.x%26sid%3Dliteratum%253Aachs%26aulast%3DNarayana%26aufirst%3DB.%2BL.%26aulast%3DPran%2BKishore%26aufirst%3DD.%26aulast%3DBalakumar%26aufirst%3DC.%26aulast%3DRao%26aufirst%3DK.%2BV.%26aulast%3DKaur%26aufirst%3DR.%26aulast%3DRao%26aufirst%3DA.%2BR.%26aulast%3DMurthy%26aufirst%3DJ.%2BN.%26aulast%3DRavikumar%26aufirst%3DM.%26atitle%3DMolecular%2520Modeling%2520Evaluation%2520of%2520Non-Steroidal%2520Aromatase%2520Inhibitors%25E2%2580%25A0%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D79%26spage%3D674%26epage%3D682%26doi%3D10.1111%2Fj.1747-0285.2011.01277.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Nagar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saha, A.</span><span> </span><span class="NLM_article-title">Pharmacophore Searching of Benzofuran Derivatives for Selective CYP19 Aromatase Inhibition</span> <span class="citation_source-journal">Lett. Drug Des. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.2174/157018009787158607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.2174%2F157018009787158607" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=38-45&author=S.+Nagarauthor=M.+A.+Islamauthor=S.+Dasauthor=A.+Mukherjeeauthor=A.+Saha&title=Pharmacophore+Searching+of+Benzofuran+Derivatives+for+Selective+CYP19+Aromatase+Inhibition&doi=10.2174%2F157018009787158607"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.2174%2F157018009787158607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157018009787158607%26sid%3Dliteratum%253Aachs%26aulast%3DNagar%26aufirst%3DS.%26aulast%3DIslam%26aufirst%3DM.%2BA.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DMukherjee%26aufirst%3DA.%26aulast%3DSaha%26aufirst%3DA.%26atitle%3DPharmacophore%2520Searching%2520of%2520Benzofuran%2520Derivatives%2520for%2520Selective%2520CYP19%2520Aromatase%2520Inhibition%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2009%26volume%3D6%26spage%3D38%26epage%3D45%26doi%3D10.2174%2F157018009787158607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span> </span><span class="NLM_article-title">Molecular Docking and Qsar Study on Steroidal Compounds as Aromatase Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5612</span><span class="NLM_x">–</span> <span class="NLM_lpage">5620</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2010.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.ejmech.2010.09.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=5612-5620&author=Y.+Daiauthor=Q.+Wangauthor=X.+Zhangauthor=S.+Jiaauthor=H.+Zhengauthor=D.+Fengauthor=P.+Yu&title=Molecular+Docking+and+Qsar+Study+on+Steroidal+Compounds+as+Aromatase+Inhibitors&doi=10.1016%2Fj.ejmech.2010.09.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DP.%26atitle%3DMolecular%2520Docking%2520and%2520Qsar%2520Study%2520on%2520Steroidal%2520Compounds%2520as%2520Aromatase%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D5612%26epage%3D5620%26doi%3D10.1016%2Fj.ejmech.2010.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Roy, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, K.</span><span> </span><span class="NLM_article-title">Molecular Docking and QSAR Studies of Aromatase Inhibitor Androstenedione Derivatives</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1728</span><span class="refDoi"> DOI: 10.1111/j.2042-7158.2010.01154.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1111%2Fj.2042-7158.2010.01154.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=21054398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWiu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1717-1728&author=P.+P.+Royauthor=K.+Roy&title=Molecular+Docking+and+QSAR+Studies+of+Aromatase+Inhibitor+Androstenedione+Derivatives&doi=10.1111%2Fj.2042-7158.2010.01154.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives</span></div><div class="casAuthors">Roy, Partha Pratim; Roy, Kunal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1717-1728</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objectives Aromatase (CYP19) inhibitors have emerged as promising candidates for the treatment of estrogen-dependent breast cancer.  In this study, a series of androstenedione derivs. with CYP19 inhibitory activity was subjected to a mol. docking study followed by quant. structure-activity relationship (QSAR) analyses in search of ideal physicochem. characteristics of potential aromatase inhibitors.  Methods The QSAR studies were carried out using both two-dimensional (topol., and structural) and three-dimensional (spatial) descriptors.  We also used thermodn. parameters along with 2D and 3D descriptors.  Genetic function approxn. (GFA) and genetic partial least squares (G/PLS) were used as chemometric tools for QSAR modeling.  Key findings The docking study indicated that the important interacting amino acids in the active site were Met374, Arg115, Ile133, Ala306, Thr310, Asp309, Val370, Leu477 and Ser478.  The 17-keto oxygen of the ligands is responsible for the formation of a hydrogen bond with Met374 and the remaining parts of the mols. are stabilized by the hydrophobic interactions with the non-polar amino acids.  The C2 and C19 positions in the ligands are important for maintaining the appropriate orientation of the mols. in the active site.  The results of docking expts. and QSAR studies supported each other.  Conclusions The developed QSAR models indicated the importance of some Jurs parameters, structural parameters, topol. branching index and E-state indexes of different fragments.  All the developed QSAR models were statistically significant according to the internal and external validation parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP48gY8X1myrVg90H21EOLACvtfcHk0liOunxpXesMYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWiu7nN&md5=3d7136a14496d5b165e7eea8e2034be0</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.2010.01154.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.2010.01154.x%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DP.%2BP.%26aulast%3DRoy%26aufirst%3DK.%26atitle%3DMolecular%2520Docking%2520and%2520QSAR%2520Studies%2520of%2520Aromatase%2520Inhibitor%2520Androstenedione%2520Derivatives%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2010%26volume%3D62%26spage%3D1717%26epage%3D1728%26doi%3D10.1111%2Fj.2042-7158.2010.01154.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Muftuoglu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustata, G.</span><span> </span><span class="NLM_article-title">Pharmacophore Modeling Strategies for the Development of Novel Nonsteroidal Inhibitors of Human Aromatase (CYP19)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3050</span><span class="NLM_x">–</span> <span class="NLM_lpage">3064</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bmcl.2010.03.113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3050-3064&author=Y.+Muftuogluauthor=G.+Mustata&title=Pharmacophore+Modeling+Strategies+for+the+Development+of+Novel+Nonsteroidal+Inhibitors+of+Human+Aromatase+%28CYP19%29&doi=10.1016%2Fj.bmcl.2010.03.113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.113%26sid%3Dliteratum%253Aachs%26aulast%3DMuftuoglu%26aufirst%3DY.%26aulast%3DMustata%26aufirst%3DG.%26atitle%3DPharmacophore%2520Modeling%2520Strategies%2520for%2520the%2520Development%2520of%2520Novel%2520Nonsteroidal%2520Inhibitors%2520of%2520Human%2520Aromatase%2520%2528CYP19%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3050%26epage%3D3064%26doi%3D10.1016%2Fj.bmcl.2010.03.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Prakash, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathi, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tandon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pant, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, F.</span><span> </span><span class="NLM_article-title">In Silico Assay Development for Screening of Tetracyclic Triterpenoids as Anticancer Agents against Human Breast Cancer Cell Line MCF7</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e111049</span><span class="refDoi"> DOI: 10.1371/journal.pone.0111049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1371%2Fjournal.pone.0111049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e111049&author=O.+Prakashauthor=A.+Ahmadauthor=V.+K.+Tripathiauthor=S.+Tandonauthor=A.+B.+Pantauthor=F.+Khan&title=In+Silico+Assay+Development+for+Screening+of+Tetracyclic+Triterpenoids+as+Anticancer+Agents+against+Human+Breast+Cancer+Cell+Line+MCF7&doi=10.1371%2Fjournal.pone.0111049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0111049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0111049%26sid%3Dliteratum%253Aachs%26aulast%3DPrakash%26aufirst%3DO.%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DTripathi%26aufirst%3DV.%2BK.%26aulast%3DTandon%26aufirst%3DS.%26aulast%3DPant%26aufirst%3DA.%2BB.%26aulast%3DKhan%26aufirst%3DF.%26atitle%3DIn%2520Silico%2520Assay%2520Development%2520for%2520Screening%2520of%2520Tetracyclic%2520Triterpenoids%2520as%2520Anticancer%2520Agents%2520against%2520Human%2520Breast%2520Cancer%2520Cell%2520Line%2520MCF7%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De111049%26doi%3D10.1371%2Fjournal.pone.0111049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Petkov, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temelkov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeneuve, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ankley, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mekenyan, O. G.</span><span> </span><span class="NLM_article-title">Mechanism-Based Categorization of Aromatase Inhibitors: A Potential Discovery and Screening Tool</span> <span class="citation_source-journal">SAR QSAR Environ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span><span class="refDoi"> DOI: 10.1080/10629360903438347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1080%2F10629360903438347" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=657-678&author=P.+I.+Petkovauthor=S.+Temelkovauthor=D.+L.+Villeneuveauthor=G.+T.+Ankleyauthor=O.+G.+Mekenyan&title=Mechanism-Based+Categorization+of+Aromatase+Inhibitors%3A+A+Potential+Discovery+and+Screening+Tool&doi=10.1080%2F10629360903438347"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1080%2F10629360903438347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10629360903438347%26sid%3Dliteratum%253Aachs%26aulast%3DPetkov%26aufirst%3DP.%2BI.%26aulast%3DTemelkov%26aufirst%3DS.%26aulast%3DVilleneuve%26aufirst%3DD.%2BL.%26aulast%3DAnkley%26aufirst%3DG.%2BT.%26aulast%3DMekenyan%26aufirst%3DO.%2BG.%26atitle%3DMechanism-Based%2520Categorization%2520of%2520Aromatase%2520Inhibitors%253A%2520A%2520Potential%2520Discovery%2520and%2520Screening%2520Tool%26jtitle%3DSAR%2520QSAR%2520Environ.%2520Res.%26date%3D2009%26volume%3D20%26spage%3D657%26epage%3D678%26doi%3D10.1080%2F10629360903438347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Hernandez-Guzman, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangborn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Structure of Human Estrone Sulfatase Suggests Functional Roles of Membrane Association</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">22989</span><span class="NLM_x">–</span> <span class="NLM_lpage">22997</span><span class="refDoi"> DOI: 10.1074/jbc.M211497200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1074%2Fjbc.M211497200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=12657638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksF2iu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=22989-22997&author=F.+G.+Hernandez-Guzmanauthor=T.+Higashiyamaauthor=W.+Pangbornauthor=Y.+Osawaauthor=D.+Ghosh&title=Structure+of+Human+Estrone+Sulfatase+Suggests+Functional+Roles+of+Membrane+Association&doi=10.1074%2Fjbc.M211497200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Human Estrone Sulfatase Suggests Functional Roles of Membrane Association</span></div><div class="casAuthors">Hernandez-Guzman, Francisco G.; Higashiyama, Tadayoshi; Pangborn, Walter; Osawa, Yoshio; Ghosh, Debashis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">22989-22997</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Estrone sulfatase (ES; 562 amino acids), one of the key enzymes responsible for maintaining high levels of estrogens in breast tumor cells, is assocd. with the membrane of the endoplasmic reticulum (ER).  The structure of ES, purified from the microsomal fraction of human placentas, has been detd. at 2.60-Å resoln. by x-ray crystallog.  This structure shows a domain consisting of two antiparallel α-helixes that protrude from the roughly spherical mol., thereby giving the mol. a "mushroom-like" shape.  These highly hydrophobic helixes, each about 40 Å long, are capable of traversing the membrane, thus presumably anchoring the functional domain on the membrane surface facing the ER lumen.  The location of the transmembrane domain is such that the opening to the active site, buried deep in a cavity of the "gill" of the "mushroom," rests near the membrane surface, thereby suggesting a role of the lipid bilayer in catalysis.  This simple architecture could be a prototype utilized by the ER membrane in dictating the form and the function of ER-resident enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVqhs1xfxlQLVg90H21EOLACvtfcHk0lidM8fNg_KrqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksF2iu7s%253D&md5=b4b56bf8e881dce78adc36bdf0f15e40</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M211497200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M211497200%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Guzman%26aufirst%3DF.%2BG.%26aulast%3DHigashiyama%26aufirst%3DT.%26aulast%3DPangborn%26aufirst%3DW.%26aulast%3DOsawa%26aufirst%3DY.%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DStructure%2520of%2520Human%2520Estrone%2520Sulfatase%2520Suggests%2520Functional%2520Roles%2520of%2520Membrane%2520Association%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D22989%26epage%3D22997%26doi%3D10.1074%2Fjbc.M211497200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Cojocaru, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, R. C.</span><span> </span><span class="NLM_article-title">The Ins and Outs of Cytochrome P450s</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gen. Subj.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1770</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1016/j.bbagen.2006.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bbagen.2006.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=16920266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVyqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1770&publication_year=2007&pages=390-401&author=V.+Cojocaruauthor=P.+J.+Winnauthor=R.+C.+Wade&title=The+Ins+and+Outs+of+Cytochrome+P450s&doi=10.1016%2Fj.bbagen.2006.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">The ins and outs of cytochrome P 450s</span></div><div class="casAuthors">Cojocaru, Vlad; Winn, Peter J.; Wade, Rebecca C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1770</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">390-401</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The active site of cytochromes P 450 (P 450) is situated deep inside the protein next to the heme cofactor.  Consequently, enzyme specificity and kinetics can be influenced by how substrates pass through the protein to access the active site and how products egress from the active site.  The authors previously analyzed the channels between the active site and the protein surface in P 450 crystal structures available in Oct. 2003.  Since then, 52 new P 450 structures have been made available, including entries for 10 isoforms for which structures were not previously available.  Here, the authors present an updated survey covering all P 450 crystal structures available to March 2006.  This survey shows channels not obsd. earlier in crystal structures, some of which were identified in previous mol. dynamics simulations.  The crystal structures demonstrate how some of the channels can merge when the protein structure opens up resulting in a wide cleft to the active site, caused largely by movements of the F-G helix-loop-helix and the B-C loop.  Significant differences have been obsd. between the channels in the crystal structures of the mammalian and bacterial enzymes.  The multiplicity of channels suggests possibilities for substrate channeling to and from the P 450s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUuZo_Tu7XoLVg90H21EOLACvtfcHk0lidM8fNg_KrqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVyqug%253D%253D&md5=f332dc3f0c5c64ed946d0038236bf9d2</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2006.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2006.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DCojocaru%26aufirst%3DV.%26aulast%3DWinn%26aufirst%3DP.%2BJ.%26aulast%3DWade%26aufirst%3DR.%2BC.%26atitle%3DThe%2520Ins%2520and%2520Outs%2520of%2520Cytochrome%2520P450s%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2007%26volume%3D1770%26spage%3D390%26epage%3D401%26doi%3D10.1016%2Fj.bbagen.2006.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czapla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaro, R. E.</span><span> </span><span class="NLM_article-title">Molecular Simulations of Aromatase Reveal New Insights into the Mechanism of Ligand Binding</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2047</span><span class="NLM_x">–</span> <span class="NLM_lpage">2056</span><span class="refDoi"> DOI: 10.1021/ci400225w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci400225w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSqu7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=2047-2056&author=J.+Parkauthor=L.+Czaplaauthor=R.+E.+Amaro&title=Molecular+Simulations+of+Aromatase+Reveal+New+Insights+into+the+Mechanism+of+Ligand+Binding&doi=10.1021%2Fci400225w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular simulations of aromatase reveal new insights into the mechanism of ligand binding</span></div><div class="casAuthors">Park, Jiho; Czapla, Luke; Amaro, Rommie E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2047-2056</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CYP19A1, also known as aromatase or estrogen synthetase, is the rate-limiting enzyme in the biosynthesis of estrogens from their corresponding androgens.  Several clin. used breast cancer therapies target aromatase.  In this work, explicitly solvated all-atom mol. dynamics simulations of aromatase with a model of the lipid bilayer and the transmembrane helix are performed.  The dynamics of aromatase and the role of titrn. of an important amino acid residue involved in aromatization of androgens are investigated via two 250-ns long simulations.  One simulation treats the protonated form of the catalytic aspartate 309, which appears more consistent with crystallog. data for the active site, while the simulation of the deprotonated form shows some notable conformational shifts.  Ensemble-based computational solvent mapping expts. indicate possible novel druggable binding sites that could be utilized by next-generation inhibitors.  In addn., the effects of protonation on the ligand positioning and channel dynamics are investigated using geometrical models that est. the opening width of crit. channels.  Significant differences in channel dynamics between the protonated and deprotonated trajectories are exhibited, suggesting that the mechanism for substrate and product entry and the aromatization process may be coupled to a "locking" mechanism and channel opening.  Our results may be particularly relevant in the design of novel drugs, which may be useful therapeutic treatments of cancers such as those of the breast and prostate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotOp1E_sWz8rVg90H21EOLACvtfcHk0lidM8fNg_KrqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSqu7jN&md5=25427256e83e684c65af9c1ec433134e</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fci400225w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400225w%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DCzapla%26aufirst%3DL.%26aulast%3DAmaro%26aufirst%3DR.%2BE.%26atitle%3DMolecular%2520Simulations%2520of%2520Aromatase%2520Reveal%2520New%2520Insights%2520into%2520the%2520Mechanism%2520of%2520Ligand%2520Binding%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D2047%26epage%3D2056%26doi%3D10.1021%2Fci400225w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Sgrignani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magistrato, A.</span><span> </span><span class="NLM_article-title">Influence of the Membrane Lipophilic Environment on the Structure and on the Substrate Access/Egress Routes of the Human Aromatase Enzyme. A Computational Study</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1606</span><span class="refDoi"> DOI: 10.1021/ci300151h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci300151h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38XntlOnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1595-1606&author=J.+Sgrignaniauthor=A.+Magistrato&title=Influence+of+the+Membrane+Lipophilic+Environment+on+the+Structure+and+on+the+Substrate+Access%2FEgress+Routes+of+the+Human+Aromatase+Enzyme.+A+Computational+Study&doi=10.1021%2Fci300151h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of the Membrane Lipophilic Environment on the Structure and on the Substrate Access/Egress Routes of the Human Aromatase Enzyme. A Computational Study</span></div><div class="casAuthors">Sgrignani, Jacopo; Magistrato, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1595-1606</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human aromatase (HA), an enzyme located on the membrane of the endoplasmic reticulum (ER), is of crucial biol. importance in the biosynthesis of estrogens.  High levels of estrogens are related to important pathologies, conferring to HA a key role as a pharmacol. target.  In this study we provide, for the first time, an atomistic model of HA embedded on a membrane model to understand the influence of the membrane lipophilic environment on the structural and dynamical properties of HA and on the access/egress pathways of the substrate (androstenedione, ASD) and of the oxygen mol. (involved in the enzymic process) into/from the HA active site.  Toward this end we used several computational techniques such as force field-based mol. dynamics (MD) simulations, Random Expulsion MD, Steered MD, and Implicit Ligand Sampling.  Our results show that the membrane anchoring does not markedly affect the structural properties and the flexibility of the protein, but they clearly point out that the membrane has a marked effect on the access/egress routes of the reactants, stabilizing the formation of different channels for both ASD and O2 with respect to those obsd. in pure water soln.  Due to the importance of HA in medicine and since access/egress channels may influence its substrate selectivity, a detailed understanding of the role of the membrane in shaping these channels may be of valuable help in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKSTbSVma457Vg90H21EOLACvtfcHk0liLZtstemy2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntlOnsL8%253D&md5=b2a1a6ac64e619615ac6b8832c212a98</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fci300151h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300151h%26sid%3Dliteratum%253Aachs%26aulast%3DSgrignani%26aufirst%3DJ.%26aulast%3DMagistrato%26aufirst%3DA.%26atitle%3DInfluence%2520of%2520the%2520Membrane%2520Lipophilic%2520Environment%2520on%2520the%2520Structure%2520and%2520on%2520the%2520Substrate%2520Access%252FEgress%2520Routes%2520of%2520the%2520Human%2520Aromatase%2520Enzyme.%2520A%2520Computational%2520Study%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D1595%26epage%3D1606%26doi%3D10.1021%2Fci300151h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Catalano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizza, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malivindi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonofiglio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, S.</span><span> </span><span class="NLM_article-title">Rapid Estradiol/ER alpha Signaling Enhances Aromatase Enzymatic Activity in Breast Cancer Cells</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1634</span><span class="NLM_x">–</span> <span class="NLM_lpage">1645</span><span class="refDoi"> DOI: 10.1210/me.2009-0039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fme.2009-0039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19556341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSitbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=1634-1645&author=S.+Catalanoauthor=I.+Baroneauthor=C.+Giordanoauthor=P.+Rizzaauthor=H.+Qiauthor=G.+Guauthor=R.+Malivindiauthor=D.+Bonofiglioauthor=S.+Ando&title=Rapid+Estradiol%2FER+alpha+Signaling+Enhances+Aromatase+Enzymatic+Activity+in+Breast+Cancer+Cells&doi=10.1210%2Fme.2009-0039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid estradiol/ERα signaling enhances aromatase enzymatic activity in breast cancer cells</span></div><div class="casAuthors">Catalano, Stefania; Barone, Ines; Giordano, Cinzia; Rizza, Pietro; Qi, Hongyan; Gu, Guowei; Malivindi, Rocco; Bonofiglio, Daniela; Ando, Sebastiano</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1634-1645</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">In situ estrogen prodn. by aromatase conversion from androgens plays an important role in breast tumor promotion.  Here, we show that 17β-estradiol (E2) can rapidly enhance aromatase enzymic activity through an increase of aromatase protein phosphorylation in breast cancer cell lines.  In vivo labeling expts. and site-directed mutagenesis studies demonstrated that phosphorylation of the 361-tyrosine residue is crucial in the up-regulation of aromatase activity under E2 exposure.  Our results demonstrated a direct involvement of nonreceptor tyrosine-kinase c-Src in E2-stimulated aromatase activity because inhibition of its signaling abrogated the up-regulatory effects induced by E2 on aromatase activity as well as phosphorylation of aromatase protein.  In addn., from our data it emerges that aromatase is a target of cross talk between growth factor receptors and estrogen receptor α signaling.  These findings show, for the first time, that tyrosine phosphorylation processes play a key role in the rapid changes induced by E2 in aromatase enzymic activity, revealing the existence of a short nongenomic autocrine loop between E2 and aromatase in breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSpCww1C_zurVg90H21EOLACvtfcHk0liLZtstemy2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSitbzO&md5=49c0869bb262183f7069cb15b9ce59f5</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0039%26sid%3Dliteratum%253Aachs%26aulast%3DCatalano%26aufirst%3DS.%26aulast%3DBarone%26aufirst%3DI.%26aulast%3DGiordano%26aufirst%3DC.%26aulast%3DRizza%26aufirst%3DP.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DG.%26aulast%3DMalivindi%26aufirst%3DR.%26aulast%3DBonofiglio%26aufirst%3DD.%26aulast%3DAndo%26aufirst%3DS.%26atitle%3DRapid%2520Estradiol%252FER%2520alpha%2520Signaling%2520Enhances%2520Aromatase%2520Enzymatic%2520Activity%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DMol.%2520Endocrinol.%26date%3D2009%26volume%3D23%26spage%3D1634%26epage%3D1645%26doi%3D10.1210%2Fme.2009-0039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Barone, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malivindi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizza, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casaburi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonofiglio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, S.</span><span> </span><span class="NLM_article-title">Estrogens and PTP1B Function in a Novel Pathway to Regulate Aromatase Enzymatic Activity in Breast Cancer Cells</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">5157</span><span class="NLM_x">–</span> <span class="NLM_lpage">5166</span><span class="refDoi"> DOI: 10.1210/en.2012-1561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fen.2012-1561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22962253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1OnsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2012&pages=5157-5166&author=I.+Baroneauthor=C.+Giordanoauthor=R.+Malivindiauthor=M.+Lanzinoauthor=P.+Rizzaauthor=I.+Casaburiauthor=D.+Bonofiglioauthor=S.+Catalanoauthor=S.+Ando&title=Estrogens+and+PTP1B+Function+in+a+Novel+Pathway+to+Regulate+Aromatase+Enzymatic+Activity+in+Breast+Cancer+Cells&doi=10.1210%2Fen.2012-1561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells</span></div><div class="casAuthors">Barone, Ines; Giordano, Cinzia; Malivindi, Rocco; Lanzino, Marilena; Rizza, Pietro; Casaburi, Ivan; Bonofiglio, Daniela; Catalano, Stefania; Ando, Sebastiano</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5157-5166</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Local estrogen prodn. by aromatase is an important mechanism of autocrine stimulation in hormone-dependent breast cancer.  We have previously shown that 17-β estradiol (E2) rapidly enhances aromatase enzymic activity through an increase of tyrosine protein phosphorylation controlled by the activity of the c-Src kinase in breast cancer cells.  Here, we investigated the protein tyrosine phosphatase PTP1B (protein tyrosine phosphatase 1B) as a potential regulator of aromatase activity.  We demonstrated a specific assocn. between PTP1B and aromatase at protein-protein level and a redn. of aromatase activity in basal and E2-treated MCF-7 and ZR75 breast cancer cells when PTP1B was overexpressed.  Indeed, a specific tyrosine phosphatase inhibitor increased basal and E2-induced enzymic activity as well as tyrosine phosphorylation status of the purified aromatase protein.  Moreover, E2 through phosphatidylinositol 3 kinase/Akt activation caused a significant decrease of PTP1B catalytic activity along with an increase in its serine phosphorylation.  Concomitantly, the phosphatidylinositol 3 kinase inhibitor LY 294002 or a dominant neg. of Akt was able to reduce the E2 stimulatory effects on activity and tyrosine phosphorylation levels of aromatase.  Taken together, our results suggest that E2 can impair PTP1B ability to dephosphorylate aromatase, and thus it increases its enzymic activity, creating a pos. feedback mechanism for estradiol signaling in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpLNQM8Pn62bVg90H21EOLACvtfcHk0liLZtstemy2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1OnsLzF&md5=58c59c777a2c5c123c957f52636fd6a7</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1210%2Fen.2012-1561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2012-1561%26sid%3Dliteratum%253Aachs%26aulast%3DBarone%26aufirst%3DI.%26aulast%3DGiordano%26aufirst%3DC.%26aulast%3DMalivindi%26aufirst%3DR.%26aulast%3DLanzino%26aufirst%3DM.%26aulast%3DRizza%26aufirst%3DP.%26aulast%3DCasaburi%26aufirst%3DI.%26aulast%3DBonofiglio%26aufirst%3DD.%26aulast%3DCatalano%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DS.%26atitle%3DEstrogens%2520and%2520PTP1B%2520Function%2520in%2520a%2520Novel%2520Pathway%2520to%2520Regulate%2520Aromatase%2520Enzymatic%2520Activity%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DEndocrinology%26date%3D2012%26volume%3D153%26spage%3D5157%26epage%3D5166%26doi%3D10.1210%2Fen.2012-1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Gillies, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, S.</span><span> </span><span class="NLM_article-title">Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women: A Case for Sex-Specific Medicines</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span><span class="refDoi"> DOI: 10.1124/pr.109.002071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1124%2Fpr.109.002071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=155-198&author=G.+E.+Gilliesauthor=S.+McArthur&title=Estrogen+Actions+in+the+Brain+and+the+Basis+for+Differential+Action+in+Men+and+Women%3A+A+Case+for+Sex-Specific+Medicines&doi=10.1124%2Fpr.109.002071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002071%26sid%3Dliteratum%253Aachs%26aulast%3DGillies%26aufirst%3DG.%2BE.%26aulast%3DMcArthur%26aufirst%3DS.%26atitle%3DEstrogen%2520Actions%2520in%2520the%2520Brain%2520and%2520the%2520Basis%2520for%2520Differential%2520Action%2520in%2520Men%2520and%2520Women%253A%2520A%2520Case%2520for%2520Sex-Specific%2520Medicines%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D155%26epage%3D198%26doi%3D10.1124%2Fpr.109.002071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Roselli, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurn, P. D.</span><span> </span><span class="NLM_article-title">Brain Aromatization: Classic Roles and New Perspectives</span> <span class="citation_source-journal">Semin. Reprod. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span><span class="refDoi"> DOI: 10.1055/s-0029-1216274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1055%2Fs-0029-1216274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19401952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVamsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=207-217&author=C.+E.+Roselliauthor=M.+Liuauthor=P.+D.+Hurn&title=Brain+Aromatization%3A+Classic+Roles+and+New+Perspectives&doi=10.1055%2Fs-0029-1216274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Brain aromatization: classic roles and new perspectives</span></div><div class="casAuthors">Roselli, Charles E.; Liu, Mingyue; Hurn, Patricia D.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Reproductive Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-217</span>CODEN:
                <span class="NLM_cas:coden">SRMECJ</span>;
        ISSN:<span class="NLM_cas:issn">1526-8004</span>.
    
            (<span class="NLM_cas:orgname">Thieme Medical Publishers, Inc.</span>)
        </div><div class="casAbstract">A review.  Aromatization of testosterone to estradiol by neural tissue has classically been assocd. with the regulation of sexual differentiation, gonadotropin secretion, and copulatory behavior.  However, new data indicate that the capacity for aromatization is not restricted to the endocrine brain and demonstrate roles for locally formed estrogens in neurogenesis and in responses of brain tissue to injury.  This article summaries our current understanding of the distribution and regulation of aromatase in the brain and describes the classic and novel roles it plays.  A better understanding of brain aromatization could shed new light on its physiol. and pathol. functions and someday lead to new, centrally acting drug therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT1gRdEdRx-rVg90H21EOLACvtfcHk0liWWAgEkWRpvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVamsrw%253D&md5=70d816779ece8cbe92d03dda3b851be9</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1055%2Fs-0029-1216274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0029-1216274%26sid%3Dliteratum%253Aachs%26aulast%3DRoselli%26aufirst%3DC.%2BE.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DHurn%26aufirst%3DP.%2BD.%26atitle%3DBrain%2520Aromatization%253A%2520Classic%2520Roles%2520and%2520New%2520Perspectives%26jtitle%3DSemin.%2520Reprod.%2520Med.%26date%3D2009%26volume%3D27%26spage%3D207%26epage%3D217%26doi%3D10.1055%2Fs-0029-1216274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Balthazart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, G. F.</span><span> </span><span class="NLM_article-title">Is Brain Estradiol a Hormone or a Neurotransmitter?</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1016/j.tins.2006.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.tins.2006.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=16580076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVehtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=241-249&author=J.+Balthazartauthor=G.+F.+Ball&title=Is+Brain+Estradiol+a+Hormone+or+a+Neurotransmitter%3F&doi=10.1016%2Fj.tins.2006.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Is brain estradiol a hormone or a neurotransmitter?</span></div><div class="casAuthors">Balthazart, Jacques; Ball, Gregory F.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">241-249</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mounting evidence indicates that, besides their well-known hormonal mode of action at the genetic level, estrogens such as 17β-estradiol also influence brain function by direct effects on neuronal membranes.  Exptl. induced rapid changes in estradiol bioavailability in the brain have been shown to alter the expression of male sexual behavior significantly within minutes - probably too quickly to be accounted for by conventional genetic mechanisms.  In parallel, recent studies indicate that aromatase, the enzyme that converts testosterone to estradiol in the brain, is expressed in presynaptic terminals and modulated within minutes by Ca2+-dependent phosphorylation.  In this article, we develop the hypothesis that brain estrogens display many, if not all, functional characteristics of neuromodulators or even neurotransmitters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpon2FVQ9dWVrVg90H21EOLACvtfcHk0liWWAgEkWRpvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVehtLk%253D&md5=7bba34a059d12b9c182cf3cca07f9aca</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2006.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2006.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DBalthazart%26aufirst%3DJ.%26aulast%3DBall%26aufirst%3DG.%2BF.%26atitle%3DIs%2520Brain%2520Estradiol%2520a%2520Hormone%2520or%2520a%2520Neurotransmitter%253F%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D241%26epage%3D249%26doi%3D10.1016%2Fj.tins.2006.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">McEwen, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, S. E.</span><span> </span><span class="NLM_article-title">Estrogen Actions in the Central Nervous System</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1210/edrv.20.3.0365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fedrv.20.3.0365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10368772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK1MXktVaqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=279-307&author=B.+S.+McEwenauthor=S.+E.+Alves&title=Estrogen+Actions+in+the+Central+Nervous+System&doi=10.1210%2Fedrv.20.3.0365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen actions in the central nervous system</span></div><div class="casAuthors">Mcewen, Bruce S.; Alves, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-307</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review, with 362 refs., of the neural actions of estrogens in the central nervous system, focusing on brain structures outside of the hypothalamus and on neurally mediated processes other than reproductive behavior and reproductive neuroendocrine events.  Emphasis is placed on effects of estrogens on memory and learning and estrogens as neuroprotectants and their relationship to Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6aOcWG2uyIbVg90H21EOLACvtfcHk0liWWAgEkWRpvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVaqtL0%253D&md5=5cb790f107614dda94f4d14a883fc7f4</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1210%2Fedrv.20.3.0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fedrv.20.3.0365%26sid%3Dliteratum%253Aachs%26aulast%3DMcEwen%26aufirst%3DB.%2BS.%26aulast%3DAlves%26aufirst%3DS.%2BE.%26atitle%3DEstrogen%2520Actions%2520in%2520the%2520Central%2520Nervous%2520System%26jtitle%3DEndocr.%2520Rev.%26date%3D1999%26volume%3D20%26spage%3D279%26epage%3D307%26doi%3D10.1210%2Fedrv.20.3.0365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Sevrioukova, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span> </span><span class="NLM_article-title">Structure of a Cytochrome P450-Redox Partner Electron-Transfer Complex</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1863</span><span class="NLM_x">–</span> <span class="NLM_lpage">1868</span><span class="refDoi"> DOI: 10.1073/pnas.96.5.1863</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1073%2Fpnas.96.5.1863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10051560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVSrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=1863-1868&author=I.+F.+Sevrioukovaauthor=H.+Liauthor=H.+Zhangauthor=J.+A.+Petersonauthor=T.+L.+Poulos&title=Structure+of+a+Cytochrome+P450-Redox+Partner+Electron-Transfer+Complex&doi=10.1073%2Fpnas.96.5.1863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a cytochrome P450-redox partner electron-transfer complex</span></div><div class="casAuthors">Sevrioukova, Irina F.; Li, Huiying; Zhang, Hong; Peterson, Julian A.; Poulos, Thomas L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1863-1868</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The crystal structure of the complex between the heme- and FMN-binding domains of bacterial cytochrome P450BM-3, a prototype for the complex between eukaryotic microsomal P450s and P 450 reductase, has been detd. at 2.03 Å resoln.  The flavodoxin-like flavin domain is positioned at the proximal face of the heme domain with the FMN 4.0 and 18.4 Å from the peptide that precedes the heme-binding loop and the heme iron, resp.  The heme-binding peptide represents the most efficient and coupled through-bond electron pathway to the heme iron.  Substantial differences between the FMN-binding domains of P450BM-3 and microsomal P 450 reductase, obsd. around the flavin-binding sites, are responsible for different redox properties of the FMN, which, in turn, control electron flow to the P 450.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu9z7lDZk6LVg90H21EOLACvtfcHk0lhezr_dJh2uOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVSrtbc%253D&md5=c910ad0e46ec6d364a039c808f4decca</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.5.1863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.5.1863%26sid%3Dliteratum%253Aachs%26aulast%3DSevrioukova%26aufirst%3DI.%2BF.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DPeterson%26aufirst%3DJ.%2BA.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26atitle%3DStructure%2520of%2520a%2520Cytochrome%2520P450-Redox%2520Partner%2520Electron-Transfer%2520Complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D1863%26epage%3D1868%26doi%3D10.1073%2Fpnas.96.5.1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Aguilar, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mc, N. F.</span><span> </span><span class="NLM_article-title">Aminoglutethimide in the Treatment of Epilepsy</span> <span class="citation_source-journal">Can. Med. Assoc. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=13681724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaF3c%252FgtVyktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1961&pages=374-376&author=J.+A.+Aguilarauthor=H.+L.+Martinauthor=N.+F.+Mc&title=Aminoglutethimide+in+the+Treatment+of+Epilepsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoglutethimide in the treatment of epilepsy</span></div><div class="casAuthors">AGUILAR J A; MARTIN H L; McNAUGHTON F L</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Medical Association journal</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">374-6</span>
        ISSN:<span class="NLM_cas:issn">0008-4409</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoK7DHBhrpolUIs6wFK5xJfW6udTcc2eYreXo-DV13N7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF3c%252FgtVyktg%253D%253D&md5=34097416b6b2f0df57ef5a717257866a</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DJ.%2BA.%26aulast%3DMartin%26aufirst%3DH.%2BL.%26aulast%3DMc%26aufirst%3DN.%2BF.%26atitle%3DAminoglutethimide%2520in%2520the%2520Treatment%2520of%2520Epilepsy%26jtitle%3DCan.%2520Med.%2520Assoc.%2520J.%26date%3D1961%26volume%3D84%26spage%3D374%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Brodie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaikh, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, H. J.</span><span> </span><span class="NLM_article-title">The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene-3,17-Dione, on Estrogen-Dependent Processes in Reproduction and Breast Cancer</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1684</span><span class="NLM_x">–</span> <span class="NLM_lpage">1695</span><span class="refDoi"> DOI: 10.1210/endo-100-6-1684</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fendo-100-6-1684" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1977&pages=1684-1695&author=A.+M.+Brodieauthor=W.+C.+Schwarzelauthor=A.+A.+Shaikhauthor=H.+J.+Brodie&title=The+Effect+of+an+Aromatase+Inhibitor%2C+4-Hydroxy-4-Androstene-3%2C17-Dione%2C+on+Estrogen-Dependent+Processes+in+Reproduction+and+Breast+Cancer&doi=10.1210%2Fendo-100-6-1684"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1210%2Fendo-100-6-1684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fendo-100-6-1684%26sid%3Dliteratum%253Aachs%26aulast%3DBrodie%26aufirst%3DA.%2BM.%26aulast%3DSchwarzel%26aufirst%3DW.%2BC.%26aulast%3DShaikh%26aufirst%3DA.%2BA.%26aulast%3DBrodie%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520Effect%2520of%2520an%2520Aromatase%2520Inhibitor%252C%25204-Hydroxy-4-Androstene-3%252C17-Dione%252C%2520on%2520Estrogen-Dependent%2520Processes%2520in%2520Reproduction%2520and%2520Breast%2520Cancer%26jtitle%3DEndocrinology%26date%3D1977%26volume%3D100%26spage%3D1684%26epage%3D1695%26doi%3D10.1210%2Fendo-100-6-1684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Brodie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai-Morris, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C. H.</span><span> </span><span class="NLM_article-title">Inactivation of Aromatase in Vitro by 4-Hydroxy-4-Androstene-3,17-Dione and 4-Acetoxy-4-Androstene-3,17-Dione and Sustained Effects in Vivo</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span><span class="refDoi"> DOI: 10.1016/0039-128X(81)90087-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0039-128X%2881%2990087-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=7336466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaL38XhtlKit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1981&pages=693-702&author=A.+M.+Brodieauthor=W.+M.+Garrettauthor=J.+R.+Hendricksonauthor=C.+H.+Tsai-Morrisauthor=P.+A.+Marcotteauthor=C.+H.+Robinson&title=Inactivation+of+Aromatase+in+Vitro+by+4-Hydroxy-4-Androstene-3%2C17-Dione+and+4-Acetoxy-4-Androstene-3%2C17-Dione+and+Sustained+Effects+in+Vivo&doi=10.1016%2F0039-128X%2881%2990087-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo</span></div><div class="casAuthors">Brodie, Angela M. H.; Garrett, Wesley M.; Hendrickson, James R.; Tsai-Morris, Chon Hwa; Marcotte, Patrick A.; Robinson, Cecil H.</div><div class="citationInfo"><span class="NLM_cas:title">Steroids</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">693-702</span>CODEN:
                <span class="NLM_cas:coden">STEDAM</span>;
        ISSN:<span class="NLM_cas:issn">0039-128X</span>.
    </div><div class="casAbstract">4-hydroxy-4-androstene-3,17-dione (I)  [566-48-3] and 4-acetoxy-4-androstene-3,17-dione  [61630-32-8], in addn. to being competitive inhibitors of aromatase  [9039-48-9], cause time-dependent, irreversible, loss of enzyme activity in both human placental and rat ovarian microsomes.  In vivo, treatment of rats with I also causes loss of ovarian aromatase activity.  To test whether this loss of activity has in vivo significance, rats with hormone-dependent, mammary tumors were treated with I on alternate weeks.  Tumor regression occurred even during the weeks without treatment.  Apparently, inactivation of aromatase is important in the mechanism of action of the compds. in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNQtZhQG-k87Vg90H21EOLACvtfcHk0lhezr_dJh2uOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XhtlKit7w%253D&md5=71815490980acfd07aa0f9f1b7fd5650</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2F0039-128X%2881%2990087-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0039-128X%252881%252990087-8%26sid%3Dliteratum%253Aachs%26aulast%3DBrodie%26aufirst%3DA.%2BM.%26aulast%3DGarrett%26aufirst%3DW.%2BM.%26aulast%3DHendrickson%26aufirst%3DJ.%2BR.%26aulast%3DTsai-Morris%26aufirst%3DC.%2BH.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DRobinson%26aufirst%3DC.%2BH.%26atitle%3DInactivation%2520of%2520Aromatase%2520in%2520Vitro%2520by%25204-Hydroxy-4-Androstene-3%252C17-Dione%2520and%25204-Acetoxy-4-Androstene-3%252C17-Dione%2520and%2520Sustained%2520Effects%2520in%2520Vivo%26jtitle%3DSteroids%26date%3D1981%26volume%3D38%26spage%3D693%26epage%3D702%26doi%3D10.1016%2F0039-128X%2881%2990087-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Steele, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasvary, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, L. J.</span><span> </span><span class="NLM_article-title">In Vitro and in Vivo Studies Demonstrating Potent and Selective Estrogen Inhibition with the Nonsteroidal Aromatase Inhibitor Cgs 16949a</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span><span class="refDoi"> DOI: 10.1016/0039-128X(83)90068-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0039-128X%2883%2990068-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1987&pages=147-161&author=R.+E.+Steeleauthor=L.+B.+Mellorauthor=W.+K.+Sawyerauthor=J.+M.+Wasvaryauthor=L.+J.+Browne&title=In+Vitro+and+in+Vivo+Studies+Demonstrating+Potent+and+Selective+Estrogen+Inhibition+with+the+Nonsteroidal+Aromatase+Inhibitor+Cgs+16949a&doi=10.1016%2F0039-128X%2883%2990068-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2F0039-128X%2883%2990068-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0039-128X%252883%252990068-5%26sid%3Dliteratum%253Aachs%26aulast%3DSteele%26aufirst%3DR.%2BE.%26aulast%3DMellor%26aufirst%3DL.%2BB.%26aulast%3DSawyer%26aufirst%3DW.%2BK.%26aulast%3DWasvary%26aufirst%3DJ.%2BM.%26aulast%3DBrowne%26aufirst%3DL.%2BJ.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Studies%2520Demonstrating%2520Potent%2520and%2520Selective%2520Estrogen%2520Inhibition%2520with%2520the%2520Nonsteroidal%2520Aromatase%2520Inhibitor%2520Cgs%252016949a%26jtitle%3DSteroids%26date%3D1987%26volume%3D50%26spage%3D147%26epage%3D161%26doi%3D10.1016%2F0039-128X%2883%2990068-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Giudici, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briatico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzzetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span> </span><span class="NLM_article-title">6-Methylenandrosta-1,4-Diene-3,17-Dione (FCE24304): A New Irreversible Aromatase Inhibitor</span> <span class="citation_source-journal">J. Steroid Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span><span class="refDoi"> DOI: 10.1016/0022-4731(88)90129-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0022-4731%2888%2990129-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=3386266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaL1cXks1OitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1988&pages=391-394&author=D.+Giudiciauthor=G.+Ornatiauthor=G.+Briaticoauthor=F.+Buzzettiauthor=P.+Lombardiauthor=E.+di+Salle&title=6-Methylenandrosta-1%2C4-Diene-3%2C17-Dione+%28FCE24304%29%3A+A+New+Irreversible+Aromatase+Inhibitor&doi=10.1016%2F0022-4731%2888%2990129-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor</span></div><div class="casAuthors">Giudici, D.; Ornati, G.; Briatico, G.; Buzzetti, F.; Lombardi, P.; Di Salle, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1-6</span>),
    <span class="NLM_cas:pages">391-4</span>CODEN:
                <span class="NLM_cas:coden">JSTBBK</span>;
        ISSN:<span class="NLM_cas:issn">0022-4731</span>.
    </div><div class="casAbstract">FCE 24304 (6-methylenandrosta-1,4-diene-3,17-dione), a new irreversible aromatase inhibitor, was identified and characterized in vitro and in vivo.  The compd. caused time-dependent inactivation of human placental aromatase with a half-time of 13.9 min and Ki of 26 nM.  When tested in PMSG-treated rats, ovarian aromatase activity was reduced 24 h after dosing by both the s.c. (50% ED 1.8 mg/kg) and the oral (50% ED 3.7 mg/kg) routes.  No interference with 5α-reductase activity and no significant binding affinity for the estrogen receptor were found.  A slight binding affinity for the androgen receptor (relative binding affinity 0.2% of dihydrotestosterone) was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0X7BVetfC_LVg90H21EOLACvtfcHk0ljzEVGP-P4JgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXks1OitLY%253D&md5=bb45165bda30bd0807cb0779f3ce8628</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2F0022-4731%2888%2990129-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-4731%252888%252990129-X%26sid%3Dliteratum%253Aachs%26aulast%3DGiudici%26aufirst%3DD.%26aulast%3DOrnati%26aufirst%3DG.%26aulast%3DBriatico%26aufirst%3DG.%26aulast%3DBuzzetti%26aufirst%3DF.%26aulast%3DLombardi%26aufirst%3DP.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26atitle%3D6-Methylenandrosta-1%252C4-Diene-3%252C17-Dione%2520%2528FCE24304%2529%253A%2520A%2520New%2520Irreversible%2520Aromatase%2520Inhibitor%26jtitle%3DJ.%2520Steroid%2520Biochem.%26date%3D1988%26volume%3D30%26spage%3D391%26epage%3D394%26doi%3D10.1016%2F0022-4731%2888%2990129-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Zaccheo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giudici, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span> </span><span class="NLM_article-title">A New Irreversible Aromatase Inhibitor, 6-Methylenandrosta-1,4-Diene-3,17-Dione (FCE 24304): Antitumor Activity and Endocrine Effects in Rats with Dmba-Induced Mammary Tumors</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span><span class="refDoi"> DOI: 10.1007/BF00258457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2FBF00258457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2491793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK3cXkvVeluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1989&pages=47-50&author=T.+Zaccheoauthor=D.+Giudiciauthor=P.+Lombardiauthor=E.+di+Salle&title=A+New+Irreversible+Aromatase+Inhibitor%2C+6-Methylenandrosta-1%2C4-Diene-3%2C17-Dione+%28FCE+24304%29%3A+Antitumor+Activity+and+Endocrine+Effects+in+Rats+with+Dmba-Induced+Mammary+Tumors&doi=10.1007%2FBF00258457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors</span></div><div class="casAuthors">Zaccheo, T.; Giudici, D.; Lombardi, P.; Di Salle, E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-50</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">The antitumor activity of the new irreversible aromatase inhibitor FCE 24304 (I) was studied in rats with 7,12-dimethylbenzanthracene (DMBA)-induced tumors; several endocrine parameters were evaluated in these animals.  The compd. was given s.c. and orally twice daily, 6 days/wk, for 4 wk.  The control group showed 13% tumor regressions (0% complete remission; 13% partial remission).  I given s.c. induced 44% (22 + 22) regressions at 3 mg/kg per day, 70% (40 + 30) at 10 mg/kg per day, 73% (27 + 46) at 30 mg/kg per day, and 70% (50 + 20) at 100 mg/kg per day.  I given orally induced 25% (17 + 8) tumor regressions at 30 mg/kg per day and 50% (17 + 33) at 100 mg/kg per day.  Rats were killed 4 h after the last dose and the aromatase activity of ovarian microsomes (OAA) was evaluated.  OAA was reduced by 56% after s.c. treatment with 3 mg/kg per day; complete OAA suppression (≥96%) was obtained starting at 10 mg/kg per day s.c.  Oral treatment slightly reduced OAA only 100 mg/kg per day (36%).  Body wt. increased in all the groups s.c. treated with I but not in those treated orally.  The wts. of the pituitary, adrenals, and uterus were reduced in rats treated s.c. with 10 and 30 mg/kg per day; at 100 mg/kg per day, a decrease in ovarian wt. was obsd., while uterus wt. was similar to that of controls.  Oral I increased ovarian wt. at 30 mg/kg per day but not at 100 mg/kg per day.  Serum prolactin and LH levels did not change.  In conclusion, I given s.c. proved highly effective against DMBA-induced tumors in rats but had less activity when given orally.  Its intrinsic androgenic activity, higher after s.c. than after oral treatment, could contribute to the antitumor effect in the intact (premenopausal) rat model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlHxFMB0ytOrVg90H21EOLACvtfcHk0ljzEVGP-P4JgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvVeluw%253D%253D&md5=577d1971c7599fce5b49229731448db9</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1007%2FBF00258457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00258457%26sid%3Dliteratum%253Aachs%26aulast%3DZaccheo%26aufirst%3DT.%26aulast%3DGiudici%26aufirst%3DD.%26aulast%3DLombardi%26aufirst%3DP.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26atitle%3DA%2520New%2520Irreversible%2520Aromatase%2520Inhibitor%252C%25206-Methylenandrosta-1%252C4-Diene-3%252C17-Dione%2520%2528FCE%252024304%2529%253A%2520Antitumor%2520Activity%2520and%2520Endocrine%2520Effects%2520in%2520Rats%2520with%2520Dmba-Induced%2520Mammary%2520Tumors%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1989%26volume%3D23%26spage%3D47%26epage%3D50%26doi%3D10.1007%2FBF00258457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Bhatnagar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hausler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieweck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, R.</span><span> </span><span class="NLM_article-title">Highly Selective Inhibition of Estrogen Biosynthesis by CGS 20267, a New Non-Steroidal Aromatase Inhibitor</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span><span class="refDoi"> DOI: 10.1016/0960-0760(90)90460-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2890%2990460-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2149502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK3MXhtlGltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1990&pages=1021-1027&author=A.+S.+Bhatnagarauthor=A.+Hauslerauthor=K.+Schieweckauthor=M.+Langauthor=R.+Bowman&title=Highly+Selective+Inhibition+of+Estrogen+Biosynthesis+by+CGS+20267%2C+a+New+Non-Steroidal+Aromatase+Inhibitor&doi=10.1016%2F0960-0760%2890%2990460-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor</span></div><div class="casAuthors">Bhatnagar, A. S.; Haeusler, A.; Schieweck, K.; Lang, M.; Bowman, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1021-7</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">CGS 20267 (I) is a new nonsteroidal compd. which potently inhibits aromatase in vitro (IC50 of 11.5 nM) and in vivo (ED50 of 1-3 μg/kg p.o.).  CGS 20267 maximally inhibits estradiol prodn. in vitro in LH-stimulated hamster ovarian tissue at 0.1 μM with an IC50 of 0.02 μM and does not significantly affect progesterone prodn. up to 350 μM.  In ACTH-stimulated rat adrenal tissue in vitro, aldosterone prodn. was inhibited with an IC50 of 210 μM (10,000 times higher than the IC50 for estradiol prodn.); no significant effect on corticosterone prodn. was seen at 350 μM.  In vivo, in ACTH-treated rats, CGS 20267 does not affect plasma levels of corticosterone or aldosterone at a dose of 4 mg/kg p.o. (1000 times higher than the ED50 for aromatase inhibition in vivo).  In adult female rats, a 14-day treatment with 1 mg/kg p.o. daily, completely interrupts ovarian cyclicity and suppresses uterine wt. to that seen 14 days after ovariectomy.  In adult female rats bearing estrogen-dependent DMBA-induced mammary tumors, 0.1 mg/kg p.o. given daily for 42 days caused almost complete regression of tumors present at the start of treatment.  Thus compared to each other, CGS 16949A and CGS 20267 are both highly potent in inhibiting estrogen biosynthesis in vitro and in vivo.  The striking difference between them is that unlike CGS 16949A, CGS 20267 does not affect adrenal steroidogenesis in vitro or in vivo, at concns. and doses several orders of magnitude higher than those required to inhibit estrogen biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq83gKMUXDIe7Vg90H21EOLACvtfcHk0li9nZ64sH9veA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtlGltbs%253D&md5=1f3069c02a2a78083b0a0b1932b660f5</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2890%2990460-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252890%252990460-3%26sid%3Dliteratum%253Aachs%26aulast%3DBhatnagar%26aufirst%3DA.%2BS.%26aulast%3DHausler%26aufirst%3DA.%26aulast%3DSchieweck%26aufirst%3DK.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DBowman%26aufirst%3DR.%26atitle%3DHighly%2520Selective%2520Inhibition%2520of%2520Estrogen%2520Biosynthesis%2520by%2520CGS%252020267%252C%2520a%2520New%2520Non-Steroidal%2520Aromatase%2520Inhibitor%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1990%26volume%3D37%26spage%3D1021%26epage%3D1027%26doi%3D10.1016%2F0960-0760%2890%2990460-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Goss, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powles, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Treatment of Advanced Postmenopausal Breast Cancer with an Aromatase Inhibitor, 4-Hydroxyandrostenedione: Phase II Report</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4823</span><span class="NLM_x">–</span> <span class="NLM_lpage">4826</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1986&pages=4823-4826&author=P.+E.+Gossauthor=T.+J.+Powlesauthor=M.+Dowsettauthor=G.+Hutchisonauthor=A.+M.+Brodieauthor=J.+C.+Gazetauthor=R.+C.+Coombes&title=Treatment+of+Advanced+Postmenopausal+Breast+Cancer+with+an+Aromatase+Inhibitor%2C+4-Hydroxyandrostenedione%3A+Phase+II+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DP.%2BE.%26aulast%3DPowles%26aufirst%3DT.%2BJ.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DHutchison%26aufirst%3DG.%26aulast%3DBrodie%26aufirst%3DA.%2BM.%26aulast%3DGazet%26aufirst%3DJ.%2BC.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DTreatment%2520of%2520Advanced%2520Postmenopausal%2520Breast%2520Cancer%2520with%2520an%2520Aromatase%2520Inhibitor%252C%25204-Hydroxyandrostenedione%253A%2520Phase%2520II%2520Report%26jtitle%3DCancer%2520Res.%26date%3D1986%26volume%3D46%26spage%3D4823%26epage%3D4826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Demers, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambic, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span> </span><span class="NLM_article-title">The Efficacy of Cgs 20267 in Suppressing Estrogen Biosynthesis in Patients with Advanced Stage Breast Cancer</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1016/0960-0760(93)90283-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2893%2990283-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=8476785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK3sXksVSnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=687-691&author=L.+M.+Demersauthor=A.+Liptonauthor=H.+A.+Harveyauthor=K.+B.+Kambicauthor=H.+Grossbergauthor=C.+Bradyauthor=R.+J.+Santen&title=The+Efficacy+of+Cgs+20267+in+Suppressing+Estrogen+Biosynthesis+in+Patients+with+Advanced+Stage+Breast+Cancer&doi=10.1016%2F0960-0760%2893%2990283-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancer</span></div><div class="casAuthors">Demers, Laurence M.; Lipton, Allan; Harvey, Harold A.; Kambic, Kathleen B.; Grossberg, Howard; Brady, Carolyn; Santen, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">687-91</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">The pharmacol. inhibition of aromatase activity has been the focus of clin. trials in patients with advanced stage breast cancer.  Recent developments with imidazole compds. that inhibit aromatase activity suggest their clin. use as potent inhibitors of estrogen biosynthesis in postmenopausal breast cancer patients.  In this Phase I, open-label, dose-range finding study, the authors examd. the inhibitory potency of CGS 20267 on blood and urine levels of estradiol, estrone and estrone sulfate in 8 patients with metastatic breast cancer.  Studies included evaluation of adrenal and thyroid function to look for evidence of general hydroxylase inhibition at dose levels effective for aromatase blockade.  Patients were administered CGS 20267 at doses of 0.1 and 0.25 mg, once a day in ascending doses over a 12-wk period.  Preliminary data reveal that CGS 20267 elicits a striking suppression in plasma estradiol, estrone and estrone sulfate which was obsd. in some patients as quickly as within 25 h of the first dose.  Estrogen suppression of over 90% was achieved within 2 wk of therapy.  No alterations in either baseline or ACTH (cortrosyn) stimulated cortisol and aldosterone levels were obsd. through the 12 wk of therapy.  In addn., 24 h urine sodium and potassium values were not appreciably altered during therapy.  The authors conclude that CGS 20267 is a potent, specific inhibitor of estrogen biosynthesis in postmenopausal patients with metastatic breast cancer and effectively reduces blood and urine estrogens to undetectable levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhx9FAUoNiGbVg90H21EOLACvtfcHk0li9nZ64sH9veA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVSnsbo%253D&md5=f9bfb109ef9125bceeeaf21e272e824d</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2893%2990283-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252893%252990283-3%26sid%3Dliteratum%253Aachs%26aulast%3DDemers%26aufirst%3DL.%2BM.%26aulast%3DLipton%26aufirst%3DA.%26aulast%3DHarvey%26aufirst%3DH.%2BA.%26aulast%3DKambic%26aufirst%3DK.%2BB.%26aulast%3DGrossberg%26aufirst%3DH.%26aulast%3DBrady%26aufirst%3DC.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520Efficacy%2520of%2520Cgs%252020267%2520in%2520Suppressing%2520Estrogen%2520Biosynthesis%2520in%2520Patients%2520with%2520Advanced%2520Stage%2520Breast%2520Cancer%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D44%26spage%3D687%26epage%3D691%26doi%3D10.1016%2F0960-0760%2893%2990283-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Iveson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahern, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithers, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trunet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span> </span><span class="NLM_article-title">Phase I Study of the Oral Nonsteroidal Aromatase Inhibitor CGS 20267 in Postmenopausal Patients with Advanced Breast Cancer</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span><span class="refDoi"> DOI: 10.1210/jcem.77.2.8345035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem.77.2.8345035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=266-270&author=T.+J.+Ivesonauthor=I.+E.+Smithauthor=J.+Ahernauthor=D.+A.+Smithersauthor=P.+F.+Trunetauthor=M.+Dowsett&title=Phase+I+Study+of+the+Oral+Nonsteroidal+Aromatase+Inhibitor+CGS+20267+in+Postmenopausal+Patients+with+Advanced+Breast+Cancer&doi=10.1210%2Fjcem.77.2.8345035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1210%2Fjcem.77.2.8345035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem.77.2.8345035%26sid%3Dliteratum%253Aachs%26aulast%3DIveson%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DI.%2BE.%26aulast%3DAhern%26aufirst%3DJ.%26aulast%3DSmithers%26aufirst%3DD.%2BA.%26aulast%3DTrunet%26aufirst%3DP.%2BF.%26aulast%3DDowsett%26aufirst%3DM.%26atitle%3DPhase%2520I%2520Study%2520of%2520the%2520Oral%2520Nonsteroidal%2520Aromatase%2520Inhibitor%2520CGS%252020267%2520in%2520Postmenopausal%2520Patients%2520with%2520Advanced%2520Breast%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1993%26volume%3D53%26spage%3D266%26epage%3D270%26doi%3D10.1210%2Fjcem.77.2.8345035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Kitawaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honjo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, H.</span><span> </span><span class="NLM_article-title">Selective Aromatase Inhibition by Pyridoglutethimide, an Analogue of Aminoglutethimide</span> <span class="citation_source-journal">Eur. J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">592</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span><span class="refDoi"> DOI: 10.1530/acta.0.1220592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1530%2Facta.0.1220592" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1990&pages=592-598&author=J.+Kitawakiauthor=T.+Yamamotoauthor=M.+Urabeauthor=T.+Tamuraauthor=S.+Inoueauthor=H.+Honjoauthor=H.+Okada&title=Selective+Aromatase+Inhibition+by+Pyridoglutethimide%2C+an+Analogue+of+Aminoglutethimide&doi=10.1530%2Facta.0.1220592"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1530%2Facta.0.1220592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252Facta.0.1220592%26sid%3Dliteratum%253Aachs%26aulast%3DKitawaki%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DUrabe%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DS.%26aulast%3DHonjo%26aufirst%3DH.%26aulast%3DOkada%26aufirst%3DH.%26atitle%3DSelective%2520Aromatase%2520Inhibition%2520by%2520Pyridoglutethimide%252C%2520an%2520Analogue%2520of%2520Aminoglutethimide%26jtitle%3DEur.%2520J.%2520Endocrinol.%26date%3D1990%26volume%3D122%26spage%3D592%26epage%3D598%26doi%3D10.1530%2Facta.0.1220592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Bhatnagar, A. S.</span><span> </span><span class="NLM_article-title">The Discovery and Mechanism of Action of Letrozole</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1007/s10549-007-9696-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2Fs10549-007-9696-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=17912633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlektrbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2007&pages=7-17&issue=Suppl.+1&author=A.+S.+Bhatnagar&title=The+Discovery+and+Mechanism+of+Action+of+Letrozole&doi=10.1007%2Fs10549-007-9696-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery and mechanism of action of letrozole</span></div><div class="casAuthors">Bhatnagar, Ajay S.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">7-17</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Because estrogen contributes to the promotion and progression of breast cancer, a greater understanding of the role of estrogen in breast cancer has led to therapeutic strategies targeting estrogen synthesis, the estrogen receptor, and intracellular signaling pathways.  The enzyme aromatase catalyzes the final step in estrogen biosynthesis and was identified as an attractive target for selective inhibition.  Modern third-generation aromatase inhibitors (AIs) effectively block the prodn. of estrogen without exerting effects on other steroidogenic pathways.  The discovery of letrozole (Femara) achieved the goal of discovering a highly potent and totally selective AI.  Letrozole has greater potency than other AIs, including anastrozole, exemestane, formestane, and aminoglutethimide.  Moreover, letrozole produces near complete inhibition of aromatase in peripheral tissues and is assocd. with greater suppression of estrogen than is achieved with other AIs.  The potent anti-tumor effects of letrozole were demonstrated in several animal models.  Studies with MCF-7Ca xenografts successfully predicted that letrozole would be clin. superior to the previous gold std. tamoxifen and also indicated that it may be more effective than other AIs.  An extensive program of randomized clin. trials has demonstrated the clin. benefits of letrozole across the spectrum of hormone-responsive breast cancer in postmenopausal women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAJhzeEx05lrVg90H21EOLACvtfcHk0limacyF6WPKoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlektrbL&md5=4215659d9116c2cb13d100d04b4acb66</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1007%2Fs10549-007-9696-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-007-9696-3%26sid%3Dliteratum%253Aachs%26aulast%3DBhatnagar%26aufirst%3DA.%2BS.%26atitle%3DThe%2520Discovery%2520and%2520Mechanism%2520of%2520Action%2520of%2520Letrozole%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007%26volume%3D105%26issue%3DSuppl.%25201%26spage%3D7%26epage%3D17%26doi%3D10.1007%2Fs10549-007-9696-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Zhou, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. A.</span><span> </span><span class="NLM_article-title">Stable Expression of Human Aromatase Complementary DNA in Mammalian Cells: A Useful System for Aromatase Inhibitor Screening</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6949</span><span class="NLM_x">–</span> <span class="NLM_lpage">6954</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=6949-6954&author=D.+J.+Zhouauthor=D.+Pomponauthor=S.+A.+Chen&title=Stable+Expression+of+Human+Aromatase+Complementary+DNA+in+Mammalian+Cells%3A+A+Useful+System+for+Aromatase+Inhibitor+Screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DD.%2BJ.%26aulast%3DPompon%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DS.%2BA.%26atitle%3DStable%2520Expression%2520of%2520Human%2520Aromatase%2520Complementary%2520DNA%2520in%2520Mammalian%2520Cells%253A%2520A%2520Useful%2520System%2520for%2520Aromatase%2520Inhibitor%2520Screening%26jtitle%3DCancer%2520Res.%26date%3D1990%26volume%3D50%26spage%3D6949%26epage%3D6954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Gibson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliss, J.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors for Treatment of Advanced Breast Cancer in Postmenopausal Women</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD003370</span><span class="refDoi"> DOI: 10.1002/14651858.CD003370.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2F14651858.CD003370.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=CD003370&author=L.+Gibsonauthor=D.+Lawrenceauthor=C.+Dawsonauthor=J.+Bliss&title=Aromatase+Inhibitors+for+Treatment+of+Advanced+Breast+Cancer+in+Postmenopausal+Women&doi=10.1002%2F14651858.CD003370.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD003370.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD003370.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DL.%26aulast%3DLawrence%26aufirst%3DD.%26aulast%3DDawson%26aufirst%3DC.%26aulast%3DBliss%26aufirst%3DJ.%26atitle%3DAromatase%2520Inhibitors%2520for%2520Treatment%2520of%2520Advanced%2520Breast%2520Cancer%2520in%2520Postmenopausal%2520Women%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2009%26spage%3DCD003370%26doi%3D10.1002%2F14651858.CD003370.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Demers, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span> </span><span class="NLM_article-title">Aminoglutethimide Therapy in Breast Cancer: Relationship of Blood Levels to Drug-Related Side Effects</span> <span class="citation_source-journal">Clin. Physiol. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=3652603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaL1c%252Fgtlaguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1987&pages=287-291&author=L.+M.+Demersauthor=A.+E.+Boucherauthor=R.+J.+Santen&title=Aminoglutethimide+Therapy+in+Breast+Cancer%3A+Relationship+of+Blood+Levels+to+Drug-Related+Side+Effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoglutethimide therapy in breast cancer: relationship of blood levels to drug-related side effects</span></div><div class="casAuthors">Demers L M; Boucher A E; Santen R J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical physiology and biochemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">287-91</span>
        ISSN:<span class="NLM_cas:issn">0252-1164</span>.
    </div><div class="casAbstract">Aminoglutethimide (AG) is now an established agent for producing a 'medical adrenalectomy' in patients with breast cancer.  A number of annoying symptoms can occur in some patients placed on this medication.  It has been suggested that the expression of symptoms may be related to the ability of the patient to acetylate AG to N-acetyl aminoglutethimide (NAG).  Using high-pressure liquid chromatography (HPLC), we examined blood levels of AG and NAG in patients with breast cancer and compared the levels to the expression and frequency of drug symptoms. 43% of patients examined were judged to be slow acetylators in that 92% of the drug remained unacetylated irrespective of the dose administered.  There was no significant correlation between acetylator status (rapid vs. slow) and the frequency of drug symptoms noted.  In contrast, there was a significant correlation between the level of AG itself and the frequency of symptoms. 80% of patients with blood levels exceeding 12 mg/l had drug-related symptoms while only 36% of patients with levels below 8 mg/l showed symptoms (chi 2 p less than 0.05). 67% of patients with NAG levels in excess of 4 mg/l had symptoms.  These findings indicate the presence of slow and rapid acetylators of AG in a breast cancer population and the importance of determining blood levels of the drug to minimize the onset of drug-related symptoms in some patients without losing drug efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQge3e1rZyo_LqxQ2mb9Pu8fW6udTcc2eZVRmbm82p7JLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c%252Fgtlaguw%253D%253D&md5=704b5a52a20e0e63cc55e6ceb66761f4</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDemers%26aufirst%3DL.%2BM.%26aulast%3DBoucher%26aufirst%3DA.%2BE.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26atitle%3DAminoglutethimide%2520Therapy%2520in%2520Breast%2520Cancer%253A%2520Relationship%2520of%2520Blood%2520Levels%2520to%2520Drug-Related%2520Side%2520Effects%26jtitle%3DClin.%2520Physiol.%2520Biochem.%26date%3D1987%26volume%3D5%26spage%3D287%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Lawrence, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, T.</span><span> </span><span class="NLM_article-title">Pancytopenia Induced by Aminoglutethimide in the Treatment of Breast Cancer</span> <span class="citation_source-journal">Cancer Treat. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">1583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=213192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaE1M%252FktlGqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1978&pages=1581-1583&author=B.+Lawrenceauthor=R.+J.+Santenauthor=A.+Liptonauthor=H.+A.+Harveyauthor=R.+Hamiltonauthor=T.+Mercurio&title=Pancytopenia+Induced+by+Aminoglutethimide+in+the+Treatment+of+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Pancytopenia induced by aminoglutethimide in the treatment of breast cancer</span></div><div class="casAuthors">Lawrence B; Santen R J; Lipton A; Harvey H A; Hamilton R; Mercurio T</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment reports</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1581-3</span>
        ISSN:<span class="NLM_cas:issn">0361-5960</span>.
    </div><div class="casAbstract">Aminoglutethimide is an investigational agent of proven benefit in the treatment of metastatic breast carcinoma.  We report herein a case of aminoglutethimide-induced pancytopenia complicated by bleeding and gram-negative septicemia.  Severe pancytopenia is a rare but important side effect of this new drug and is rapidly reversible when the agent is withdrawn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPD9Bd3i63RUNoizSOkG_FfW6udTcc2eZVRmbm82p7JLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M%252FktlGqtA%253D%253D&md5=4120e644f01bbd20f84112ac0e5457a4</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DB.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26aulast%3DLipton%26aufirst%3DA.%26aulast%3DHarvey%26aufirst%3DH.%2BA.%26aulast%3DHamilton%26aufirst%3DR.%26aulast%3DMercurio%26aufirst%3DT.%26atitle%3DPancytopenia%2520Induced%2520by%2520Aminoglutethimide%2520in%2520the%2520Treatment%2520of%2520Breast%2520Cancer%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1978%26volume%3D62%26spage%3D1581%26epage%3D1583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Rowell, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowman, P. N.</span><span> </span><span class="NLM_article-title">Aminoglutethimide as Second-Line Hormonal Therapy in Advanced Breast Cancer: Response and Toxicity</span> <span class="citation_source-journal">Hum. Exp. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1177/096032718700600310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1177%2F096032718700600310" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1987&pages=227-232&author=N.+P.+Rowellauthor=O.+J.+Gilmoreauthor=P.+N.+Plowman&title=Aminoglutethimide+as+Second-Line+Hormonal+Therapy+in+Advanced+Breast+Cancer%3A+Response+and+Toxicity&doi=10.1177%2F096032718700600310"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1177%2F096032718700600310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F096032718700600310%26sid%3Dliteratum%253Aachs%26aulast%3DRowell%26aufirst%3DN.%2BP.%26aulast%3DGilmore%26aufirst%3DO.%2BJ.%26aulast%3DPlowman%26aufirst%3DP.%2BN.%26atitle%3DAminoglutethimide%2520as%2520Second-Line%2520Hormonal%2520Therapy%2520in%2520Advanced%2520Breast%2520Cancer%253A%2520Response%2520and%2520Toxicity%26jtitle%3DHum.%2520Exp.%2520Toxicol.%26date%3D1987%26volume%3D6%26spage%3D227%26epage%3D232%26doi%3D10.1177%2F096032718700600310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Lamberts, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruining, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzouk, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderwijk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitterlinden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blijd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackeng, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Jong, F. H.</span><span> </span><span class="NLM_article-title">The New Aromatase Inhibitor CGS-16949A Suppresses Aldosterone and Cortisol Production by Human Adrenal Cells in Vitro</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">896</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span><span class="refDoi"> DOI: 10.1210/jcem-69-4-896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem-69-4-896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2550511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaL1MXlvVOhur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1989&pages=896-901&author=S.+W.+Lambertsauthor=H.+A.+Bruiningauthor=H.+Marzoukauthor=J.+Zuiderwijkauthor=P.+Uitterlindenauthor=J.+J.+Blijdauthor=W.+H.+Hackengauthor=F.+H.+De+Jong&title=The+New+Aromatase+Inhibitor+CGS-16949A+Suppresses+Aldosterone+and+Cortisol+Production+by+Human+Adrenal+Cells+in+Vitro&doi=10.1210%2Fjcem-69-4-896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">The new aromatase inhibitor CGS-16949A suppresses aldosterone and cortisol production by human adrenal cells in vitro</span></div><div class="casAuthors">Lamberts, S. W. J.; Bruining, H. A.; Marzouk, H.; Zuiderwijk, J.; Uitterlinden, P.; Blijd, J. J.; Hackeng, W. H. L.; De Jong, F. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">896-901</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">CGS-16949A is a new orally active nonsteroidal aromatase inhibitor which is more than 100-fold more potent than aminoglutethimide.  This compd. is an imidazole deriv., and therefore, its possible effect on cytochrome P 450-dependent enzyme activities in the adrenal gland was evaluated.  In vitro investigations with dispersed normal and hyperplastic human adrenocortical cells showed that CGS-16949A at 10-7-10-6M is a potent 11β-hydroxylase inhibitor, which inhibits ACTH-stimulated cortisol release to a similar extent as an equimolar concn. of metyrapone (IC50 for both compds., 10-7-5 × 10-7M).  Etomidate was a more potent 11 β-hydroxylase inhibitor (IC50, ∼10-8M), while 10-7-10-6M ketoconazole caused (via 17α-hydroxylase inhibition) a similar inhibition of cortisol release as 10-7M CGS-16949A (IC50, 10-7-5 × 10-5M).  The 11β-hydroxylase inhibition by CGS-16949A was accompanied by a dose-dependent increase in the release of precursor steroids by the adrenocortical cells in vitro, including deoxycortisol, 17-hydroxyprogesterone, and androstenedione.  Aldosterone release was suppressed 50% by 10-8M CGS-16949A, while the IC50 for cortisol in the same cells was 10-7M.  Aldosterone release by the dispersed adenoma cells obtained from a patient with primary aldosteronism was also suppressed by CGS-16949A.  It is concluded that the new nonsteroidal aromatase inhibitor CGS 16949A is an inhibitor of 11β-hydroxylase which is equipotent to metyrapone.  At present it is unclear whether the compd. at the dose that causes complete aromatase inhibition in vivo also affects stress-induced cortisol release in man.  Also, CGS-16949A exerts a very potent inhibitory effect on normal aldosterone release (IC50, 10-9M) and on a tumorous aldosterone secretion.  CGS-16949A might, therefore, be a drug that can be used in the treatment of primary hyperaldosteronism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ1wecGffAJLVg90H21EOLACvtfcHk0liDD3reL5DSbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlvVOhur4%253D&md5=9c9846ae461e8242a07d225a8b20ebf6</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1210%2Fjcem-69-4-896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-69-4-896%26sid%3Dliteratum%253Aachs%26aulast%3DLamberts%26aufirst%3DS.%2BW.%26aulast%3DBruining%26aufirst%3DH.%2BA.%26aulast%3DMarzouk%26aufirst%3DH.%26aulast%3DZuiderwijk%26aufirst%3DJ.%26aulast%3DUitterlinden%26aufirst%3DP.%26aulast%3DBlijd%26aufirst%3DJ.%2BJ.%26aulast%3DHackeng%26aufirst%3DW.%2BH.%26aulast%3DDe%2BJong%26aufirst%3DF.%2BH.%26atitle%3DThe%2520New%2520Aromatase%2520Inhibitor%2520CGS-16949A%2520Suppresses%2520Aldosterone%2520and%2520Cortisol%2520Production%2520by%2520Human%2520Adrenal%2520Cells%2520in%2520Vitro%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1989%26volume%3D69%26spage%3D896%26epage%3D901%26doi%3D10.1210%2Fjcem-69-4-896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Falkson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raats, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falkson, H. C.</span><span> </span><span class="NLM_article-title">Fadrozole Hydrochloride, a New Nontoxic Aromatase Inhibitor for the Treatment of Patients with Metastatic Breast Cancer</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span><span class="refDoi"> DOI: 10.1016/0960-0760(92)90202-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2892%2990202-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1388048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK38zpvFaqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1992&pages=161-165&author=G.+Falksonauthor=J.+I.+Raatsauthor=H.+C.+Falkson&title=Fadrozole+Hydrochloride%2C+a+New+Nontoxic+Aromatase+Inhibitor+for+the+Treatment+of+Patients+with+Metastatic+Breast+Cancer&doi=10.1016%2F0960-0760%2892%2990202-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Fadrozole hydrochloride, a new nontoxic aromatase inhibitor for the treatment of patients with metastatic breast cancer</span></div><div class="casAuthors">Falkson G; Raats J I; Falkson H C</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of steroid biochemistry and molecular biology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">161-5</span>
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">Eighty previously treated postmenopausal women with metastatic breast cancer were randomized to receive fadrozole (CGS 16 949A), a new aromatase inhibitor, 1 or 4 mg orally per day.  Seventy eight patients were evaluable for toxicity and response.  Only mild to moderate toxicity, namely hot flushes (28%), nausea and vomiting (13%), fatigue (8%) and loss of appetite (5%) occurred.  Complete response was documented in 10% and partial response in 13% of patients with 45% having a no change status for at least 2 months.  The median time to treatment failure is 4.1 months.  The median survival is 23.7 months.  The median survival is 23.7 months.  The response and survival in patients with estrogen receptor positive and estrogen receptor unknown disease were not significantly different.  Neither response nor survival was significantly different between the patients receiving 1 or 4 mg of fadrozole per day.  Fadrozole is a well tolerated, effective second line treatment for women with metastatic breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQx_JTjobezRMScOqQTSkOffW6udTcc2eZhrBTxHmQ0b7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zpvFaqsQ%253D%253D&md5=13d7616930325ee381d2377ccbe08112</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2892%2990202-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252892%252990202-T%26sid%3Dliteratum%253Aachs%26aulast%3DFalkson%26aufirst%3DG.%26aulast%3DRaats%26aufirst%3DJ.%2BI.%26aulast%3DFalkson%26aufirst%3DH.%2BC.%26atitle%3DFadrozole%2520Hydrochloride%252C%2520a%2520New%2520Nontoxic%2520Aromatase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Patients%2520with%2520Metastatic%2520Breast%2520Cancer%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1992%26volume%3D43%26spage%3D161%26epage%3D165%26doi%3D10.1016%2F0960-0760%2892%2990202-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Lonning, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisler, J.</span><span> </span><span class="NLM_article-title">Experience with Exemestane in the Treatment of Early and Advanced Breast Cancer</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">997</span><span class="refDoi"> DOI: 10.1517/17425255.4.7.987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1517%2F17425255.4.7.987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=18624685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1Chtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=987-997&author=P.+E.+Lonningauthor=J.+Geisler&title=Experience+with+Exemestane+in+the+Treatment+of+Early+and+Advanced+Breast+Cancer&doi=10.1517%2F17425255.4.7.987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Experience with Exemestane in the Treatment of Early and Advanced Breast Cancer</span></div><div class="casAuthors">Lonning, Per Eystein; Geisler, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">987-997</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Exemestane represents the only steroidal third-generation aromatase inactivator implemented for breast cancer therapy.  Present clin. and translational data defining the role of exemestane as an aromatase inhibitor.  Literature search including PubMed and ISI Web of Science.  Exemestane potently inhibits in vivo aromatization resembling anastrozole and letrozole.  Randomized trials have revealed superiority for exemestane compared to conventional therapy in metastatic breast cancer.  In addn. sequential treatment with tamoxifen (for 2-3 years) followed by exemestane (for 3-2 years) has revealed superiority with respect not only to relapse-free but also borderline improvement in overall survival in adjuvant therapy.  Several studies now confirm lack of cross-resistance between non-steroidal aromatase inhibitors and exemestane, which could be due to exemestane's low androgen-agonistic activity through its 17-hydro metabolite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUijZ-l2ISDbVg90H21EOLACvtfcHk0liwjqGIsPgGow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1Chtbg%253D&md5=a899115b2d8c6c14f84cbbeeea17ff2c</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1517%2F17425255.4.7.987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.4.7.987%26sid%3Dliteratum%253Aachs%26aulast%3DLonning%26aufirst%3DP.%2BE.%26aulast%3DGeisler%26aufirst%3DJ.%26atitle%3DExperience%2520with%2520Exemestane%2520in%2520the%2520Treatment%2520of%2520Early%2520and%2520Advanced%2520Breast%2520Cancer%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2008%26volume%3D4%26spage%3D987%26epage%3D997%26doi%3D10.1517%2F17425255.4.7.987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">Tominaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabei, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takatsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suwa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, Y.</span><span> </span><span class="NLM_article-title">Double-Blind Randomised Trial Comparing the Non-Steroidal Aromatase Inhibitors Letrozole and Fadrozole in Postmenopausal Women with Advanced Breast Cancer</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1093/annonc/mdg014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1093%2Fannonc%2Fmdg014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=12488294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADC%252BD38jisFersA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=62-70&author=T.+Tominagaauthor=I.+Adachiauthor=Y.+Sasakiauthor=T.+Tabeiauthor=T.+Ikedaauthor=Y.+Takatsukaauthor=M.+Toiauthor=T.+Suwaauthor=Y.+Ohashi&title=Double-Blind+Randomised+Trial+Comparing+the+Non-Steroidal+Aromatase+Inhibitors+Letrozole+and+Fadrozole+in+Postmenopausal+Women+with+Advanced+Breast+Cancer&doi=10.1093%2Fannonc%2Fmdg014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer</span></div><div class="casAuthors">Tominaga T; Adachi I; Sasaki Y; Tabei T; Ikeda T; Takatsuka Y; Toi M; Suwa T; Ohashi Y</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology / ESMO</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-70</span>
        ISSN:<span class="NLM_cas:issn">0923-7534</span>.
    </div><div class="casAbstract">BACKGROUND:  To compare the efficacy, safety and tolerability of letrozole, an advanced non-steroidal aromatase inhibitor, and fadrozole hydrochloride, an older-generation drug in this class, we conducted a randomised double-blind trial in postmenopausal women with advanced breast cancer.  PATIENTS AND METHODS:  One hundred and fifty-seven postmenopausal women with advanced breast cancer were enrolled and randomly assigned to receive letrozole or fadrozole in a multicentre, randomised double-blind trial in Japan.  One hundred and fifty-four eligible patients were treated with either letrozole 1.0 mg once daily (n = 77) or fadrozole 1.0 mg twice daily (n = 77), for a minimum of 8 weeks.  RESULTS:  Letrozole showed a significantly higher overall objective response rate [complete response (CR) + partial response (PR)] than fadrozole (31.2% and 13.0%, respectively; P = 0.011, Fisher's exact test).  Clinical benefits defined as CR, PR and stable disease (no change in status for more than 24 weeks) were also higher in patients treated with letrozole (50.6%) than fadrozole (35.1%).  Letrozole was significantly superior to fadrozole in terms of the dominant lesion in soft tissue, bone and viscera (P = 0.011, stratified Mantel-Haenszel test).  Median time to progression was 211 days in the letrozole group and 113 days in the fadrozole group with no significant difference (P = 0.175, log-rank test).  Letrozole markedly reduced the estradiol, estrone and estrone sulfate levels in peripheral blood within 4 weeks.  The suppressive effect of fadrozole on these hormone levels was insufficient.  Adverse drug reactions were observed in 35.9% of the patients treated with letrozole and in 39.5% of those treated with fadrozole with no significant difference between the two groups (P = 0.74, Fisher's exact test).  Most of the adverse drug reactions were rated as grade 1 or 2.  CONCLUSIONS:  The results show letrozole at a dose of 1.0 mg once daily to be more effective in treating postmenopausal women with advanced breast cancer than fadrozole at 1.0 mg twice daily, with similar safety and tolerability profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_Erb0Sv4o2JWtyewyzkyLfW6udTcc2eY5o8KsA5dn1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jisFersA%253D%253D&md5=851a6d688f240d4ea8fa34e28f44ab8b</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdg014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdg014%26sid%3Dliteratum%253Aachs%26aulast%3DTominaga%26aufirst%3DT.%26aulast%3DAdachi%26aufirst%3DI.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DTabei%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DT.%26aulast%3DTakatsuka%26aufirst%3DY.%26aulast%3DToi%26aufirst%3DM.%26aulast%3DSuwa%26aufirst%3DT.%26aulast%3DOhashi%26aufirst%3DY.%26atitle%3DDouble-Blind%2520Randomised%2520Trial%2520Comparing%2520the%2520Non-Steroidal%2520Aromatase%2520Inhibitors%2520Letrozole%2520and%2520Fadrozole%2520in%2520Postmenopausal%2520Women%2520with%2520Advanced%2520Breast%2520Cancer%26jtitle%3DAnn.%2520Oncol.%26date%3D2003%26volume%3D14%26spage%3D62%26epage%3D70%26doi%3D10.1093%2Fannonc%2Fmdg014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 45 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Nicholas A. Clanton, Shayne D. Hastings, Griffin B. Foultz, Julie A. Contreras, Samantha S. Yee, Hadi D. Arman, April L. Risinger, <span class="NLM_string-name hlFld-ContribAuthor">Doug E. Frantz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluations of Electrophilic Steroids Inspired by the Taccalonolides. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 2534-2543. <a href="https://doi.org/10.1021/acsmedchemlett.0c00534" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00534%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluations%252Bof%252BElectrophilic%252BSteroids%252BInspired%252Bby%252Bthe%252BTaccalonolides%26aulast%3DClanton%26aufirst%3DNicholas%2BA.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06102020%26date%3D18112020%26date%3D20112020%26volume%3D11%26issue%3D12%26spage%3D2534%26epage%3D2543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jessica Caciolla, Angelo Spinello, Silvia Martini, Alessandra Bisi, Nadia Zaffaroni, Silvia Gobbi, <span class="NLM_string-name hlFld-ContribAuthor">Alessandra Magistrato</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Orthosteric and Allosteric Pockets of Aromatase via Dual-Mode Novel Azole Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 732-739. <a href="https://doi.org/10.1021/acsmedchemlett.9b00591" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00591%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTargeting%252BOrthosteric%252Band%252BAllosteric%252BPockets%252Bof%252BAromatase%252Bvia%252BDual-Mode%252BNovel%252BAzole%252BInhibitors%26aulast%3DCaciolla%26aufirst%3DJessica%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D11122019%26date%3D23032020%26date%3D26032020%26date%3D23032020%26volume%3D11%26issue%3D5%26spage%3D732%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen J.  Barigye</span>, <span class="hlFld-ContribAuthor ">Matheus P.  Freitas</span>, <span class="hlFld-ContribAuthor ">Priscila  Ausina</span>, <span class="hlFld-ContribAuthor ">Patricia  Zancan</span>, <span class="hlFld-ContribAuthor ">Mauro  Sola-Penna</span>, and <span class="hlFld-ContribAuthor ">Juan A.  Castillo-Garit</span>  . </span><span class="cited-content_cbyCitation_article-title">Discrete Fourier Transform-Based Multivariate Image Analysis: Application to Modeling of Aromatase Inhibitory Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2018,</strong> <em>20 </em>
                                    (2)
                                     , 75-81. <a href="https://doi.org/10.1021/acscombsci.7b00155" title="DOI URL">https://doi.org/10.1021/acscombsci.7b00155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.7b00155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.7b00155%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DDiscrete%252BFourier%252BTransform-Based%252BMultivariate%252BImage%252BAnalysis%25253A%252BApplication%252Bto%252BModeling%252Bof%252BAromatase%252BInhibitory%252BActivity%26aulast%3DBarigye%26aufirst%3DStephen%2BJ.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D23102017%26date%3D17122017%26date%3D22012018%26date%3D12022018%26date%3D03012018%26volume%3D20%26issue%3D2%26spage%3D75%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Magistrato</span>, <span class="hlFld-ContribAuthor ">Jacopo  Sgrignani</span>, <span class="hlFld-ContribAuthor ">Rolf  Krause</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">Single or Multiple Access Channels to the CYP450s Active Site? An Answer from Free Energy Simulations of the Human Aromatase Enzyme. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 2036-2042. <a href="https://doi.org/10.1021/acs.jpclett.7b00697" title="DOI URL">https://doi.org/10.1021/acs.jpclett.7b00697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpclett.7b00697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpclett.7b00697%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520Letters%26atitle%3DSingle%252Bor%252BMultiple%252BAccess%252BChannels%252Bto%252Bthe%252BCYP450s%252BActive%252BSite%25253F%252BAn%252BAnswer%252Bfrom%252BFree%252BEnergy%252BSimulations%252Bof%252Bthe%252BHuman%252BAromatase%252BEnzyme%26aulast%3DMagistrato%26aufirst%3DAlessandra%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23032017%26date%3D19042017%26date%3D24042017%26date%3D04052017%26date%3D19042017%26volume%3D8%26issue%3D9%26spage%3D2036%26epage%3D2042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ignacio  Viciano</span> and <span class="hlFld-ContribAuthor ">Sergio  Martí</span>  . </span><span class="cited-content_cbyCitation_article-title">Theoretical Study of the Mechanism of Exemestane Hydroxylation Catalyzed by Human Aromatase Enzyme. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2016,</strong> <em>120 </em>
                                    (13)
                                     , 3331-3343. <a href="https://doi.org/10.1021/acs.jpcb.6b01014" title="DOI URL">https://doi.org/10.1021/acs.jpcb.6b01014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.6b01014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.6b01014%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DTheoretical%252BStudy%252Bof%252Bthe%252BMechanism%252Bof%252BExemestane%252BHydroxylation%252BCatalyzed%252Bby%252BHuman%252BAromatase%252BEnzyme%26aulast%3DViciano%26aufirst%3DIgnacio%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29012016%26date%3D11032016%26date%3D25032016%26date%3D07042016%26date%3D14032016%26volume%3D120%26issue%3D13%26spage%3D3331%26epage%3D3343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sudesh  Rani</span>, <span class="hlFld-ContribAuthor ">Konpal  Raheja</span>, <span class="hlFld-ContribAuthor ">Vijay  Luxami</span>, <span class="hlFld-ContribAuthor ">Kamaldeep  Paul</span>. </span><span class="cited-content_cbyCitation_article-title">A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>113 </em>, 105017. <a href="https://doi.org/10.1016/j.bioorg.2021.105017" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DA%252Breview%252Bon%252Bdiverse%252Bheterocyclic%252Bcompounds%252Bas%252Bthe%252Bprivileged%252Bscaffolds%252Bin%252Bnon-steroidal%252Baromatase%252Binhibitors%26aulast%3DRani%26aufirst%3DSudesh%26date%3D2021%26volume%3D113%26spage%3D105017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tara  Hyder</span>, <span class="hlFld-ContribAuthor ">Christopher C.  Marino</span>, <span class="hlFld-ContribAuthor ">Sasha  Ahmad</span>, <span class="hlFld-ContribAuthor ">Azadeh  Nasrazadani</span>, <span class="hlFld-ContribAuthor ">Adam M.  Brufsky</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Endocrinology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fendo.2021.713700" title="DOI URL">https://doi.org/10.3389/fendo.2021.713700</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fendo.2021.713700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffendo.2021.713700%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Endocrinology%26atitle%3DAromatase%252BInhibitor-Associated%252BMusculoskeletal%252BSyndrome%25253A%252BUnderstanding%252BMechanisms%252Band%252BManagement%26aulast%3DHyder%26aufirst%3DTara%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angelo  Spinello</span>, <span class="hlFld-ContribAuthor ">Jure  Borišek</span>, <span class="hlFld-ContribAuthor ">Matic  Pavlin</span>, <span class="hlFld-ContribAuthor ">Pavel  Janoš</span>, <span class="hlFld-ContribAuthor ">Alessandra  Magistrato</span>. </span><span class="cited-content_cbyCitation_article-title">Computing Metal‐Binding Proteins for Therapeutic Benefit. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (13)
                                     , 2034-2049. <a href="https://doi.org/10.1002/cmdc.202100109" title="DOI URL">https://doi.org/10.1002/cmdc.202100109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100109%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DComputing%252BMetal%2525E2%252580%252590Binding%252BProteins%252Bfor%252BTherapeutic%252BBenefit%26aulast%3DSpinello%26aufirst%3DAngelo%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D13%26spage%3D2034%26epage%3D2049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatjana  Abaffy</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Matsunami</span>. </span><span class="cited-content_cbyCitation_article-title">19-hydroxy Steroids in the Aromatase Reaction: Review on Expression and Potential Functions. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Endocrine Society</span><span> <strong>2021,</strong> <em>5 </em>
                                    (7)
                                     <a href="https://doi.org/10.1210/jendso/bvab050" title="DOI URL">https://doi.org/10.1210/jendso/bvab050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1210/jendso/bvab050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1210%2Fjendso%2Fbvab050%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Endocrine%2520Society%26atitle%3D19-hydroxy%252BSteroids%252Bin%252Bthe%252BAromatase%252BReaction%25253A%252BReview%252Bon%252BExpression%252Band%252BPotential%252BFunctions%26aulast%3DAbaffy%26aufirst%3DTatjana%26date%3D2021%26date%3D2021%26volume%3D5%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Palermo</span>, <span class="hlFld-ContribAuthor ">Angelo  Spinello</span>, <span class="hlFld-ContribAuthor ">Aakash  Saha</span>, <span class="hlFld-ContribAuthor ">Alessandra  Magistrato</span>. </span><span class="cited-content_cbyCitation_article-title">Frontiers of metal-coordinating drug design. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , 497-511. <a href="https://doi.org/10.1080/17460441.2021.1851188" title="DOI URL">https://doi.org/10.1080/17460441.2021.1851188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1851188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1851188%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DFrontiers%252Bof%252Bmetal-coordinating%252Bdrug%252Bdesign%26aulast%3DPalermo%26aufirst%3DGiulia%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D5%26spage%3D497%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Ammazzalorso</span>, <span class="hlFld-ContribAuthor ">Marialucia  Gallorini</span>, <span class="hlFld-ContribAuthor ">Marialuigia  Fantacuzzi</span>, <span class="hlFld-ContribAuthor ">Nicola  Gambacorta</span>, <span class="hlFld-ContribAuthor ">Barbara  De Filippis</span>, <span class="hlFld-ContribAuthor ">Letizia  Giampietro</span>, <span class="hlFld-ContribAuthor ">Cristina  Maccallini</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Amelia  Cataldi</span>, <span class="hlFld-ContribAuthor ">Rosa  Amoroso</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113115. <a href="https://doi.org/10.1016/j.ejmech.2020.113115" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113115%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bimidazole%252Band%252Btriazole-based%252Bcarbamates%252Bas%252Bnovel%252Baromatase%252Binhibitors%26aulast%3DAmmazzalorso%26aufirst%3DAlessandra%26date%3D2021%26volume%3D211%26spage%3D113115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaheen  Begum</span>, <span class="hlFld-ContribAuthor ">P.  Jaswanthi</span>, <span class="hlFld-ContribAuthor ">B.  Venkata Lakshmi</span>, <span class="hlFld-ContribAuthor ">K.  Bharathi</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR studies on indole-azole Analogues using DTC tools; imidazole ring is more favorable for aromatase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Indian Chemical Society</span><span> <strong>2021,</strong> <em>98 </em>
                                    (1)
                                     , 100016. <a href="https://doi.org/10.1016/j.jics.2021.100016" title="DOI URL">https://doi.org/10.1016/j.jics.2021.100016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jics.2021.100016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jics.2021.100016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Indian%2520Chemical%2520Society%26atitle%3DQSAR%252Bstudies%252Bon%252Bindole-azole%252BAnalogues%252Busing%252BDTC%252Btools%25253B%252Bimidazole%252Bring%252Bis%252Bmore%252Bfavorable%252Bfor%252Baromatase%252Binhibition%26aulast%3DBegum%26aufirst%3DShaheen%26date%3D2021%26volume%3D98%26issue%3D1%26spage%3D100016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hani A.  Alhadrami</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Sayed</span>, <span class="hlFld-ContribAuthor ">Sami A.  Melebari</span>, <span class="hlFld-ContribAuthor ">Asem A.  Khogeer</span>, <span class="hlFld-ContribAuthor ">Wesam H.  Abdulaal</span>, <span class="hlFld-ContribAuthor ">Mohamed B.  Al-Fageeh</span>, <span class="hlFld-ContribAuthor ">Mohammad  Algahtani</span>, <span class="hlFld-ContribAuthor ">Mostafa E.  Rateb</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting allosteric sites of human aromatase: a comprehensive
              in-silico
              and
              in-vitro
              workflow to find potential plant-based anti-breast cancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 1334-1345. <a href="https://doi.org/10.1080/14756366.2021.1937145" title="DOI URL">https://doi.org/10.1080/14756366.2021.1937145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1937145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1937145%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Ballosteric%252Bsites%252Bof%252Bhuman%252Baromatase%25253A%252Ba%252Bcomprehensive%252Bin-silico%252Band%252Bin-vitro%252Bworkflow%252Bto%252Bfind%252Bpotential%252Bplant-based%252Banti-breast%252Bcancer%252Btherapeutics%26aulast%3DAlhadrami%26aufirst%3DHani%2BA.%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D1334%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Teng</span>, <span class="hlFld-ContribAuthor ">Hong Ju  Chen</span>, <span class="hlFld-ContribAuthor ">Gao Peng  Xu</span>, <span class="hlFld-ContribAuthor ">Yao Yao  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiang Shan  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative comparative analysis uncovered the role of E2 in Nile tilapia GSD + TE. </span><span class="cited-content_cbyCitation_journal-name">Aquaculture</span><span> <strong>2020,</strong> <em>529 </em>, 735656. <a href="https://doi.org/10.1016/j.aquaculture.2020.735656" title="DOI URL">https://doi.org/10.1016/j.aquaculture.2020.735656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.aquaculture.2020.735656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.aquaculture.2020.735656%26sid%3Dliteratum%253Aachs%26jtitle%3DAquaculture%26atitle%3DQuantitative%252Bcomparative%252Banalysis%252Buncovered%252Bthe%252Brole%252Bof%252BE2%252Bin%252BNile%252Btilapia%252BGSD%2525C2%2525A0%25252B%2525C2%2525A0TE%26aulast%3DTeng%26aufirst%3DJian%26date%3D2020%26volume%3D529%26spage%3D735656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Sandip Kumar  Baidya</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>. </span><span class="cited-content_cbyCitation_article-title">Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112845. <a href="https://doi.org/10.1016/j.ejmech.2020.112845" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112845%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEffective%252Banti-aromatase%252Btherapy%252Bto%252Bbattle%252Bagainst%252Bestrogen-mediated%252Bbreast%252Bcancer%25253A%252BComparative%252BSAR%25252FQSAR%252Bassessment%252Bon%252Bsteroidal%252Baromatase%252Binhibitors%26aulast%3DAdhikari%26aufirst%3DNilanjan%26date%3D2020%26volume%3D208%26spage%3D112845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pooja  Ratre</span>, <span class="hlFld-ContribAuthor ">Keerti  Mishra</span>, <span class="hlFld-ContribAuthor ">Amit  Dubey</span>, <span class="hlFld-ContribAuthor ">Amber  Vyas</span>, <span class="hlFld-ContribAuthor ">Akhlesh  Jain</span>, <span class="hlFld-ContribAuthor ">Suresh  Thareja</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Agents in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (17)
                                     , 1994-2004. <a href="https://doi.org/10.2174/1871520620666200627204105" title="DOI URL">https://doi.org/10.2174/1871520620666200627204105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871520620666200627204105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871520620666200627204105%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Agents%2520in%2520Medicinal%2520Chemistry%26atitle%3DAromatase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBreast%252BCancer%25253A%252BA%252BJourney%252Bfrom%252Bthe%252BScratch%26aulast%3DRatre%26aufirst%3DPooja%26date%3D2020%26volume%3D20%26issue%3D17%26spage%3D1994%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Caciolla</span>, <span class="hlFld-ContribAuthor ">Alessandra  Bisi</span>, <span class="hlFld-ContribAuthor ">Federica  Belluti</span>, <span class="hlFld-ContribAuthor ">Angela  Rampa</span>, <span class="hlFld-ContribAuthor ">Silvia  Gobbi</span>. </span><span class="cited-content_cbyCitation_article-title">Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (22)
                                     , 5351. <a href="https://doi.org/10.3390/molecules25225351" title="DOI URL">https://doi.org/10.3390/molecules25225351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25225351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25225351%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DReconsidering%252BAromatase%252Bfor%252BBreast%252BCancer%252BTreatment%25253A%252BNew%252BRoles%252Bfor%252Ban%252BOld%252BTarget%26aulast%3DCaciolla%26aufirst%3DJessica%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D22%26spage%3D5351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaliyan  Bhuvaneswari</span>, <span class="hlFld-ContribAuthor ">Paramasivam  Sivaguru</span>, <span class="hlFld-ContribAuthor ">Appaswami  Lalitha</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, anticancer evaluation, and docking studies of some novel azo chromene derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Chinese Chemical Society</span><span> <strong>2020,</strong> <em>67 </em>
                                    (10)
                                     , 1877-1886. <a href="https://doi.org/10.1002/jccs.201900481" title="DOI URL">https://doi.org/10.1002/jccs.201900481</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jccs.201900481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjccs.201900481%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Chinese%2520Chemical%2520Society%26atitle%3DSynthesis%25252C%252Banticancer%252Bevaluation%25252C%252Band%252Bdocking%252Bstudies%252Bof%252Bsome%252Bnovel%252Bazo%252Bchromene%252Bderivatives%26aulast%3DBhuvaneswari%26aufirst%3DKaliyan%26date%3D2020%26date%3D2020%26volume%3D67%26issue%3D10%26spage%3D1877%26epage%3D1886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esteban  Ferreiro</span>, <span class="hlFld-ContribAuthor ">Belén López  de Uralde</span>, <span class="hlFld-ContribAuthor ">Rita  Abreu</span>, <span class="hlFld-ContribAuthor ">Juan A  García-Velasco</span>, <span class="hlFld-ContribAuthor ">Elkin  Muñoz</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatase Inhibitors for Ovarian Stimulation in Patients with Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Targets</span><span> <strong>2020,</strong> <em>21 </em>
                                    (9)
                                     , 910-921. <a href="https://doi.org/10.2174/1389450121666200220124607" title="DOI URL">https://doi.org/10.2174/1389450121666200220124607</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389450121666200220124607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389450121666200220124607%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Targets%26atitle%3DAromatase%252BInhibitors%252Bfor%252BOvarian%252BStimulation%252Bin%252BPatients%252Bwith%252BBreast%252BCancer%26aulast%3DFerreiro%26aufirst%3DEsteban%26date%3D2020%26volume%3D21%26issue%3D9%26spage%3D910%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Ferreira Almeida</span>, <span class="hlFld-ContribAuthor ">Ana  Oliveira</span>, <span class="hlFld-ContribAuthor ">Maria  João Ramos</span>, <span class="hlFld-ContribAuthor ">Pedro A.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Natércia  Teixeira</span>, <span class="hlFld-ContribAuthor ">Cristina  Amaral</span>. </span><span class="cited-content_cbyCitation_article-title">Estrogen receptor-positive (ER+) breast cancer treatment: Are multi-target compounds the next promising approach?. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>, 113989. <a href="https://doi.org/10.1016/j.bcp.2020.113989" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.113989</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.113989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.113989%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DEstrogen%252Breceptor-positive%252B%252528ER%25252B%252529%252Bbreast%252Bcancer%252Btreatment%25253A%252BAre%252Bmulti-target%252Bcompounds%252Bthe%252Bnext%252Bpromising%252Bapproach%25253F%26aulast%3DFerreira%2BAlmeida%26aufirst%3DCristina%26date%3D2020%26volume%3D177%26spage%3D113989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ulviye  Acar Çevik</span>, <span class="hlFld-ContribAuthor ">Begüm N.  Sağlık</span>, <span class="hlFld-ContribAuthor ">Derya  Osmaniye</span>, <span class="hlFld-ContribAuthor ">Serkan  Levent</span>, <span class="hlFld-ContribAuthor ">Betül  Kaya Çavuşoğlu</span>, <span class="hlFld-ContribAuthor ">Abdullah B.  Karaduman</span>, <span class="hlFld-ContribAuthor ">Yusuf  Özkay</span>, <span class="hlFld-ContribAuthor ">Zafer A.  Kaplancıklı</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and docking study of benzimidazole–triazolothiadiazine hybrids as aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2020,</strong> <em>353 </em>
                                    (5)
                                     <a href="https://doi.org/10.1002/ardp.202000008" title="DOI URL">https://doi.org/10.1002/ardp.202000008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202000008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202000008%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252Bdocking%252Bstudy%252Bof%252Bbenzimidazole%2525E2%252580%252593triazolothiadiazine%252Bhybrids%252Bas%252Baromatase%252Binhibitors%26aulast%3DAcar%2B%25C3%2587evik%26aufirst%3DUlviye%26date%3D2020%26date%3D2020%26volume%3D353%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosa Luz  Luna-Palencia</span>, <span class="hlFld-ContribAuthor ">Eliseo Neftali  De la Cruz-Escobar</span>. </span><span class="cited-content_cbyCitation_article-title">Actualidades en el manejo sistémico del cáncer de mama. </span><span class="cited-content_cbyCitation_journal-name">Revista Mexicana de Mastología</span><span> <strong>2020,</strong> <em>10 </em>
                                    (3)
                                     , 71-82. <a href="https://doi.org/10.35366/99156" title="DOI URL">https://doi.org/10.35366/99156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.35366/99156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.35366%2F99156%26sid%3Dliteratum%253Aachs%26jtitle%3DRevista%2520Mexicana%2520de%2520Mastolog%25C3%25ADa%26atitle%3DActualidades%252Ben%252Bel%252Bmanejo%252Bsist%2525C3%2525A9mico%252Bdel%252Bc%2525C3%2525A1ncer%252Bde%252Bmama%26aulast%3DLuna-Palencia%26aufirst%3DRosa%2BLuz%26date%3D2020%26volume%3D10%26issue%3D3%26spage%3D71%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chanamon  Chamduang</span>, <span class="hlFld-ContribAuthor ">Ratchanok  Pingaew</span>, <span class="hlFld-ContribAuthor ">Veda  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Supaluk  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Somsak  Ruchirawat</span>, <span class="hlFld-ContribAuthor ">Virapong  Prachayasittikul</span>. </span><span class="cited-content_cbyCitation_article-title">Novel triazole-tetrahydroisoquinoline hybrids as human aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>93 </em>, 103327. <a href="https://doi.org/10.1016/j.bioorg.2019.103327" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103327%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Btriazole-tetrahydroisoquinoline%252Bhybrids%252Bas%252Bhuman%252Baromatase%252Binhibitors%26aulast%3DChamduang%26aufirst%3DChanamon%26date%3D2019%26volume%3D93%26spage%3D103327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiago V.  Augusto</span>, <span class="hlFld-ContribAuthor ">Cristina  Amaral</span>, <span class="hlFld-ContribAuthor ">Carla L.  Varela</span>, <span class="hlFld-ContribAuthor ">Fernanda  Bernardo</span>, <span class="hlFld-ContribAuthor ">Elisiário Tavares  da Silva</span>, <span class="hlFld-ContribAuthor ">Fernanda F.M.  Roleira</span>, <span class="hlFld-ContribAuthor ">Saul  Costa</span>, <span class="hlFld-ContribAuthor ">Natércia  Teixeira</span>, <span class="hlFld-ContribAuthor ">Georgina  Correia-da-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Steroid Biochemistry and Molecular Biology</span><span> <strong>2019,</strong> <em>195 </em>, 105486. <a href="https://doi.org/10.1016/j.jsbmb.2019.105486" title="DOI URL">https://doi.org/10.1016/j.jsbmb.2019.105486</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsbmb.2019.105486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsbmb.2019.105486%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Steroid%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DEffects%252Bof%252Bnew%252BC6-substituted%252Bsteroidal%252Baromatase%252Binhibitors%252Bin%252Bhormone-sensitive%252Bbreast%252Bcancer%252Bcells%25253A%252BCell%252Bdeath%252Bmechanisms%252Band%252Bmodulation%252Bof%252Bestrogen%252Band%252Bandrogen%252Breceptors%26aulast%3DAugusto%26aufirst%3DTiago%2BV.%26date%3D2019%26volume%3D195%26spage%3D105486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debashis  Ghosh</span>, <span class="hlFld-ContribAuthor ">Chinaza  Egbuta</span>, <span class="hlFld-ContribAuthor ">Jean E.  Kanyo</span>, <span class="hlFld-ContribAuthor ">TuKiet T.  Lam</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphorylation of human placental aromatase CYP19A1. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2019,</strong> <em>476 </em>
                                    (21)
                                     , 3313-3331. <a href="https://doi.org/10.1042/BCJ20190633" title="DOI URL">https://doi.org/10.1042/BCJ20190633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20190633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20190633%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DPhosphorylation%252Bof%252Bhuman%252Bplacental%252Baromatase%252BCYP19A1%26aulast%3DGhosh%26aufirst%3DDebashis%26date%3D2019%26date%3D2019%26volume%3D476%26issue%3D21%26spage%3D3313%26epage%3D3331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angelo  Spinello</span>, <span class="hlFld-ContribAuthor ">Ida  Ritacco</span>, <span class="hlFld-ContribAuthor ">Alessandra  Magistrato</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in computational design of potent aromatase inhibitors: open-eye on endocrine-resistant breast cancers. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (10)
                                     , 1065-1076. <a href="https://doi.org/10.1080/17460441.2019.1646245" title="DOI URL">https://doi.org/10.1080/17460441.2019.1646245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1646245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1646245%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DRecent%252Badvances%252Bin%252Bcomputational%252Bdesign%252Bof%252Bpotent%252Baromatase%252Binhibitors%25253A%252Bopen-eye%252Bon%252Bendocrine-resistant%252Bbreast%252Bcancers%26aulast%3DSpinello%26aufirst%3DAngelo%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D10%26spage%3D1065%26epage%3D1076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiago V.  Augusto</span>, <span class="hlFld-ContribAuthor ">Sara C.  Cunha</span>, <span class="hlFld-ContribAuthor ">Cristina  Amaral</span>, <span class="hlFld-ContribAuthor ">José O.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Elisiário Tavares  da Silva</span>, <span class="hlFld-ContribAuthor ">Fernanda F. M.  Roleira</span>, <span class="hlFld-ContribAuthor ">Natércia  Teixeira</span>, <span class="hlFld-ContribAuthor ">Georgina  Correia-da-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">A novel GC-MS methodology to evaluate aromatase activity in human placental microsomes: a comparative study with the standard radiometric assay. </span><span class="cited-content_cbyCitation_journal-name">Analytical and Bioanalytical Chemistry</span><span> <strong>2019,</strong> <em>411 </em>
                                    (26)
                                     , 7005-7013. <a href="https://doi.org/10.1007/s00216-019-02076-7" title="DOI URL">https://doi.org/10.1007/s00216-019-02076-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00216-019-02076-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00216-019-02076-7%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520and%2520Bioanalytical%2520Chemistry%26atitle%3DA%252Bnovel%252BGC-MS%252Bmethodology%252Bto%252Bevaluate%252Baromatase%252Bactivity%252Bin%252Bhuman%252Bplacental%252Bmicrosomes%25253A%252Ba%252Bcomparative%252Bstudy%252Bwith%252Bthe%252Bstandard%252Bradiometric%252Bassay%26aulast%3DAugusto%26aufirst%3DTiago%2BV.%26date%3D2019%26date%3D2019%26volume%3D411%26issue%3D26%26spage%3D7005%26epage%3D7013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronnakorn  Leechaisit</span>, <span class="hlFld-ContribAuthor ">Ratchanok  Pingaew</span>, <span class="hlFld-ContribAuthor ">Veda  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Apilak  Worachartcheewan</span>, <span class="hlFld-ContribAuthor ">Supaluk  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Somsak  Ruchirawat</span>, <span class="hlFld-ContribAuthor ">Virapong  Prachayasittikul</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (19)
                                     , 115040. <a href="https://doi.org/10.1016/j.bmc.2019.08.001" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bmolecular%252Bdocking%25252C%252Band%252BQSAR%252Bstudy%252Bof%252Bbis-sulfonamide%252Bderivatives%252Bas%252Bpotential%252Baromatase%252Binhibitors%26aulast%3DLeechaisit%26aufirst%3DRonnakorn%26date%3D2019%26volume%3D27%26issue%3D19%26spage%3D115040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Yun  Guo</span>, <span class="hlFld-ContribAuthor ">Shang-Ming-Zhu  Zeng</span>, <span class="hlFld-ContribAuthor ">Girdhar Singh  Deora</span>, <span class="hlFld-ContribAuthor ">Qing-Shan  Li</span>, <span class="hlFld-ContribAuthor ">Ban-Feng  Ruan</span>. </span><span class="cited-content_cbyCitation_article-title">Estrogen Receptor α (ERα)-targeting Compounds and Derivatives: Recent Advances in Structural Modification and Bioactivity. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (15)
                                     , 1318-1337. <a href="https://doi.org/10.2174/1568026619666190619142504" title="DOI URL">https://doi.org/10.2174/1568026619666190619142504</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190619142504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190619142504%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DEstrogen%252BReceptor%252B%2525CE%2525B1%252B%252528ER%2525CE%2525B1%252529-targeting%252BCompounds%252Band%252BDerivatives%25253A%252BRecent%252BAdvances%252Bin%252BStructural%252BModification%252Band%252BBioactivity%26aulast%3DGuo%26aufirst%3DWei-Yun%26date%3D2019%26volume%3D19%26issue%3D15%26spage%3D1318%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander M.  Andrianov</span>, <span class="hlFld-ContribAuthor ">Grigory I.  Nikolaev</span>, <span class="hlFld-ContribAuthor ">Yuri V.  Kornoushenko</span>, <span class="hlFld-ContribAuthor ">Sergei A.  Usanov</span>. </span><span class="cited-content_cbyCitation_article-title">Click chemistry in silico, docking, quantum chemical calculations, and molecular dynamics simulations to identify novel 1,2,4-triazole-based compounds as potential aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">SN Applied Sciences</span><span> <strong>2019,</strong> <em>1 </em>
                                    (9)
                                     <a href="https://doi.org/10.1007/s42452-019-1051-x" title="DOI URL">https://doi.org/10.1007/s42452-019-1051-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s42452-019-1051-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs42452-019-1051-x%26sid%3Dliteratum%253Aachs%26jtitle%3DSN%2520Applied%2520Sciences%26atitle%3DClick%252Bchemistry%252Bin%252Bsilico%25252C%252Bdocking%25252C%252Bquantum%252Bchemical%252Bcalculations%25252C%252Band%252Bmolecular%252Bdynamics%252Bsimulations%252Bto%252Bidentify%252Bnovel%252B1%25252C2%25252C4-triazole-based%252Bcompounds%252Bas%252Bpotential%252Baromatase%252Binhibitors%26aulast%3DAndrianov%26aufirst%3DAlexander%2BM.%26date%3D2019%26date%3D2019%26volume%3D1%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kamalpreet  Kaur</span>, <span class="hlFld-ContribAuthor ">Vikas  Jaitak</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Development in Indole Derivatives as Anticancer Agents for Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Agents in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (8)
                                     , 962-983. <a href="https://doi.org/10.2174/1871520619666190312125602" title="DOI URL">https://doi.org/10.2174/1871520619666190312125602</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871520619666190312125602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871520619666190312125602%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Agents%2520in%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BDevelopment%252Bin%252BIndole%252BDerivatives%252Bas%252BAnticancer%252BAgents%252Bfor%252BBreast%252BCancer%26aulast%3DKaur%26aufirst%3DKamalpreet%26date%3D2019%26volume%3D19%26issue%3D8%26spage%3D962%26epage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander J.  Nielsen</span>, <span class="hlFld-ContribAuthor ">Sergio  Raez-Villanueva</span>, <span class="hlFld-ContribAuthor ">Denis J.  Crankshaw</span>, <span class="hlFld-ContribAuthor ">Alison C.  Holloway</span>, <span class="hlFld-ContribAuthor ">James  McNulty</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of α-methylstilbenes using an aqueous Wittig methodology and application toward the development of potent human aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (11)
                                     , 1395-1398. <a href="https://doi.org/10.1016/j.bmcl.2019.03.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.03.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.03.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B1-methylstilbenes%252Busing%252Ban%252Baqueous%252BWittig%252Bmethodology%252Band%252Bapplication%252Btoward%252Bthe%252Bdevelopment%252Bof%252Bpotent%252Bhuman%252Baromatase%252Binhibitors%26aulast%3DNielsen%26aufirst%3DAlexander%2BJ.%26date%3D2019%26volume%3D29%26issue%3D11%26spage%3D1395%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Senem  Ozcan-Sezer</span>, <span class="hlFld-ContribAuthor ">Elif  Ince</span>, <span class="hlFld-ContribAuthor ">Atilla  Akdemir</span>, <span class="hlFld-ContribAuthor ">Özlem Öztürk  Ceylan</span>, <span class="hlFld-ContribAuthor ">Sibel  Suzen</span>, <span class="hlFld-ContribAuthor ">Hande  Gurer-Orhan</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatase inhibition by 2-methyl indole hydrazone derivatives evaluated via molecular docking and
              in vitro
              activity studies. </span><span class="cited-content_cbyCitation_journal-name">Xenobiotica</span><span> <strong>2019,</strong> <em>49 </em>
                                    (5)
                                     , 549-556. <a href="https://doi.org/10.1080/00498254.2018.1482029" title="DOI URL">https://doi.org/10.1080/00498254.2018.1482029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00498254.2018.1482029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00498254.2018.1482029%26sid%3Dliteratum%253Aachs%26jtitle%3DXenobiotica%26atitle%3DAromatase%252Binhibition%252Bby%252B2-methyl%252Bindole%252Bhydrazone%252Bderivatives%252Bevaluated%252Bvia%252Bmolecular%252Bdocking%252Band%252Bin%252Bvitro%252Bactivity%252Bstudies%26aulast%3DOzcan-Sezer%26aufirst%3DSenem%26date%3D2019%26date%3D2018%26volume%3D49%26issue%3D5%26spage%3D549%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angelo  Spinello</span>, <span class="hlFld-ContribAuthor ">Silvia  Martini</span>, <span class="hlFld-ContribAuthor ">Federico  Berti</span>, <span class="hlFld-ContribAuthor ">Marzia  Pennati</span>, <span class="hlFld-ContribAuthor ">Matic  Pavlin</span>, <span class="hlFld-ContribAuthor ">Jacopo  Sgrignani</span>, <span class="hlFld-ContribAuthor ">Giovanni  Grazioso</span>, <span class="hlFld-ContribAuthor ">Giorgio  Colombo</span>, <span class="hlFld-ContribAuthor ">Nadia  Zaffaroni</span>, <span class="hlFld-ContribAuthor ">Alessandra  Magistrato</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>168 </em>, 253-262. <a href="https://doi.org/10.1016/j.ejmech.2019.02.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdesign%252Bof%252Ballosteric%252Bmodulators%252Bof%252Bthe%252Baromatase%252Benzyme%25253A%252BAn%2525C2%2525A0unprecedented%252Btherapeutic%252Bstrategy%252Bto%252Bfight%252Bbreast%252Bcancer%26aulast%3DSpinello%26aufirst%3DAngelo%26date%3D2019%26volume%3D168%26spage%3D253%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nisal  Gajadeera</span>, <span class="hlFld-ContribAuthor ">Robert N.  Hanson</span>. </span><span class="cited-content_cbyCitation_article-title">Review of fluorescent steroidal ligands for the estrogen receptor 1995–2018. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2019,</strong> <em>144 </em>, 30-46. <a href="https://doi.org/10.1016/j.steroids.2019.02.002" title="DOI URL">https://doi.org/10.1016/j.steroids.2019.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2019.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2019.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DReview%252Bof%252Bfluorescent%252Bsteroidal%252Bligands%252Bfor%252Bthe%252Bestrogen%252Breceptor%252B1995%2525E2%252580%2525932018%26aulast%3DGajadeera%26aufirst%3DNisal%26date%3D2019%26volume%3D144%26spage%3D30%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ratchanok  Pingaew</span>, <span class="hlFld-ContribAuthor ">Veda  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Nuttapat  Anuwongcharoen</span>, <span class="hlFld-ContribAuthor ">Supaluk  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Somsak  Ruchirawat</span>, <span class="hlFld-ContribAuthor ">Virapong  Prachayasittikul</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and molecular docking of N,N′-disubstituted thiourea derivatives as novel aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>79 </em>, 171-178. <a href="https://doi.org/10.1016/j.bioorg.2018.05.002" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bmolecular%252Bdocking%252Bof%252BN%25252CN%2525E2%252580%2525B2-disubstituted%252Bthiourea%252Bderivatives%252Bas%252Bnovel%252Baromatase%252Binhibitors%26aulast%3DPingaew%26aufirst%3DRatchanok%26date%3D2018%26volume%3D79%26spage%3D171%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alma  Campos-Parra</span>, <span class="hlFld-ContribAuthor ">Eduardo  López-Urrutia</span>, <span class="hlFld-ContribAuthor ">Luz  Orozco Moreno</span>, <span class="hlFld-ContribAuthor ">César  López-Camarillo</span>, <span class="hlFld-ContribAuthor ">Thuluz  Meza-Menchaca</span>, <span class="hlFld-ContribAuthor ">Gabriela  Figueroa González</span>, <span class="hlFld-ContribAuthor ">Lilia  Bustamante Montes</span>, <span class="hlFld-ContribAuthor ">Carlos  Pérez-Plasencia</span>. </span><span class="cited-content_cbyCitation_article-title">Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (9)
                                     , 2711. <a href="https://doi.org/10.3390/ijms19092711" title="DOI URL">https://doi.org/10.3390/ijms19092711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19092711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19092711%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DLong%252BNon-Coding%252BRNAs%252Bas%252BNew%252BMaster%252BRegulators%252Bof%252BResistance%252Bto%252BSystemic%252BTreatments%252Bin%252BBreast%252BCancer%26aulast%3DCampos-Parra%26aufirst%3DAlma%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D9%26spage%3D2711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. M.  Andrianov</span>, <span class="hlFld-ContribAuthor ">G. I.  Nikolaev</span>, <span class="hlFld-ContribAuthor ">I. A.  Kashyn</span>, <span class="hlFld-ContribAuthor ">Yu. V.  Kornoushenko</span>, <span class="hlFld-ContribAuthor ">S. A.  Usanov</span>. </span><span class="cited-content_cbyCitation_article-title">COMPUTER-AIDED DESIGN OF POTENTIAL AROMATASE INHIBITORS  BASED ON 1,2,4-TRIAZOLE DERIVATIVES. </span><span class="cited-content_cbyCitation_journal-name">Doklady of the National Academy of Sciences of Belarus</span><span> <strong>2018,</strong> <em>62 </em>
                                    (3)
                                     , 281-292. <a href="https://doi.org/10.29235/1561-8323-2018-62-3-281-292" title="DOI URL">https://doi.org/10.29235/1561-8323-2018-62-3-281-292</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.29235/1561-8323-2018-62-3-281-292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.29235%2F1561-8323-2018-62-3-281-292%26sid%3Dliteratum%253Aachs%26jtitle%3DDoklady%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%2520of%2520Belarus%26atitle%3DCOMPUTER-AIDED%252BDESIGN%252BOF%252BPOTENTIAL%252BAROMATASE%252BINHIBITORS%252BBASED%252BON%252B1%25252C2%25252C4-TRIAZOLE%252BDERIVATIVES%26aulast%3DAndrianov%26aufirst%3DA.%2BM.%26date%3D2018%26date%3D2018%26volume%3D62%26issue%3D3%26spage%3D281%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiago Vieira  Augusto</span>, <span class="hlFld-ContribAuthor ">Georgina  Correia-da-Silva</span>, <span class="hlFld-ContribAuthor ">Cecília M P  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Natércia  Teixeira</span>, <span class="hlFld-ContribAuthor ">Cristina  Amaral</span>. </span><span class="cited-content_cbyCitation_article-title">Acquired resistance to aromatase inhibitors: where we stand!. </span><span class="cited-content_cbyCitation_journal-name">Endocrine-Related Cancer</span><span> <strong>2018,</strong> <em>25 </em>
                                    (5)
                                     , R283-R301. <a href="https://doi.org/10.1530/ERC-17-0425" title="DOI URL">https://doi.org/10.1530/ERC-17-0425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1530/ERC-17-0425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1530%2FERC-17-0425%26sid%3Dliteratum%253Aachs%26jtitle%3DEndocrine-Related%2520Cancer%26atitle%3DAcquired%252Bresistance%252Bto%252Baromatase%252Binhibitors%25253A%252Bwhere%252Bwe%252Bstand%252521%26aulast%3DAugusto%26aufirst%3DTiago%2BVieira%26date%3D2018%26volume%3D25%26issue%3D5%26spage%3DR283%26epage%3DR301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nivin  Samara</span>, <span class="hlFld-ContribAuthor ">Robert F.  Casper</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 119-133. <a href="https://doi.org/10.1007/978-3-319-45534-1_10" title="DOI URL">https://doi.org/10.1007/978-3-319-45534-1_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-45534-1_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-45534-1_10%26sid%3Dliteratum%253Aachs%26atitle%3DAromatase%252BInhibitors%26aulast%3DSamara%26aufirst%3DNivin%26date%3D2018%26date%3D2017%26spage%3D119%26epage%3D133%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DInfertility%252Bin%252BWomen%252Bwith%252BPolycystic%252BOvary%252BSyndrome%26aulast%3DPalomba%26aufirst%3DStefano%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer R.  Wood</span>, <span class="hlFld-ContribAuthor ">Andrea S.  Cupp</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatization. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 195-201. <a href="https://doi.org/10.1016/B978-0-12-801238-3.64642-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-801238-3.64642-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-801238-3.64642-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-801238-3.64642-1%26sid%3Dliteratum%253Aachs%26atitle%3DAromatization%26aulast%3DWood%26aufirst%3DJennifer%2BR.%26date%3D2018%26spage%3D195%26epage%3D201%26pub%3DElsevier%26atitle%3DEncyclopedia%252Bof%252BReproduction%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ratchanok  Pingaew</span>, <span class="hlFld-ContribAuthor ">Prasit  Mandi</span>, <span class="hlFld-ContribAuthor ">Veda  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Supaluk  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Somsak  Ruchirawat</span>, <span class="hlFld-ContribAuthor ">Virapong  Prachayasittikul</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, molecular docking, and QSAR study of sulfonamide-based indoles as aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 1604-1615. <a href="https://doi.org/10.1016/j.ejmech.2017.10.057" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.10.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.10.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.10.057%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bmolecular%252Bdocking%25252C%252Band%252BQSAR%252Bstudy%252Bof%252Bsulfonamide-based%252Bindoles%252Bas%252Baromatase%252Binhibitors%26aulast%3DPingaew%26aufirst%3DRatchanok%26date%3D2018%26volume%3D143%26spage%3D1604%26epage%3D1615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Anti-hormonal Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 233-255. <a href="https://doi.org/10.1002/9781118696194.ch2.4" title="DOI URL">https://doi.org/10.1002/9781118696194.ch2.4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118696194.ch2.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118696194.ch2.4%26sid%3Dliteratum%253Aachs%26atitle%3DAnti-hormonal%252BAgents%26date%3D2017%26date%3D2017%26spage%3D233%26epage%3D255%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DAnticancer%252BTherapeutics%26aulast%3DTodd%26aufirst%3DAdam%26date%3D2018%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allan M.  Prior</span>, <span class="hlFld-ContribAuthor ">Xufen  Yu</span>, <span class="hlFld-ContribAuthor ">Eun-Jung  Park</span>, <span class="hlFld-ContribAuthor ">Tamara P.  Kondratyuk</span>, <span class="hlFld-ContribAuthor ">Yan  Lin</span>, <span class="hlFld-ContribAuthor ">John M.  Pezzuto</span>, <span class="hlFld-ContribAuthor ">Dianqing  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (24)
                                     , 5393-5399. <a href="https://doi.org/10.1016/j.bmcl.2017.11.010" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.11.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.11.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-activity%252Brelationships%252Band%252Bdocking%252Bstudies%252Bof%252Bsynthetic%252B2-arylindole%252Bderivatives%252Bdetermined%252Bwith%252Baromatase%252Band%252Bquinone%252Breductase%252B1%26aulast%3DPrior%26aufirst%3DAllan%2BM.%26date%3D2017%26volume%3D27%26issue%3D24%26spage%3D5393%26epage%3D5399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Amaral</span>, <span class="hlFld-ContribAuthor ">Carla L.  Varela</span>, <span class="hlFld-ContribAuthor ">João  Maurício</span>, <span class="hlFld-ContribAuthor ">Ana Filipa  Sobral</span>, <span class="hlFld-ContribAuthor ">Saul C.  Costa</span>, <span class="hlFld-ContribAuthor ">Fernanda M.F.  Roleira</span>, <span class="hlFld-ContribAuthor ">Elisiário J.  Tavares-da-Silva</span>, <span class="hlFld-ContribAuthor ">Georgina  Correia-da-Silva</span>, <span class="hlFld-ContribAuthor ">Natércia  Teixeira</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Steroid Biochemistry and Molecular Biology</span><span> <strong>2017,</strong> <em>171 </em>, 218-228. <a href="https://doi.org/10.1016/j.jsbmb.2017.04.002" title="DOI URL">https://doi.org/10.1016/j.jsbmb.2017.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsbmb.2017.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsbmb.2017.04.002%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Steroid%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DAnti-tumor%252Befficacy%252Bof%252Bnew%252B7%2525CE%2525B1-substituted%252Bandrostanes%252Bas%252Baromatase%252Binhibitors%252Bin%252Bhormone-sensitive%252Band%252Bresistant%252Bbreast%252Bcancer%252Bcells%26aulast%3DAmaral%26aufirst%3DCristina%26date%3D2017%26volume%3D171%26spage%3D218%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The AROM active site is shaped like an androgen backbone. A van der Waals interaction surface cast by the protein and heme atoms at the active site is shown. The semitransparent surface closely resembles the shape, size, and puckering of the steroid backbone. The surfaces are color-coded green for hydrophobic and magenta for polar. The protein atoms defining the van der Waals surface are also shown: C gray, N blue, and O red. The only opening to the pocket is the one to the active site access channel indicated by an arrow. Water oxygen atoms in the channel and bound to the protonated Asp309 carboxylate are shown as red spheres. Adapted from ref <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">6</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Previous and current generation AIs. The chemical structures of known AIs are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Androgen-binding environment: schematic diagram of the X-ray structure depicting the residues lining the ASD binding pocket, and ASD making hydrophobic and hydrogen-bonding contacts (hydrophobic, green; acidic, red; basic, blue; polar, purple; S-containing, yellow). Exposure at the C4 and C6 positions of the steroid to the access channel opening is indicated. Also shown schematically is a water molecule trapped between Asp309 and Arg192 side chains, postulated to have a role in the proton relay network and enolization of 3-keto. Arg192 and its salt bridge partner Glu483 are the “gatekeepers” of the access channel. Adapted from ref <a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">46</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reaction center and perspective on catalysis. (a) Modeling of Fe (III) as an oxyferryl Fe(IV)═O (compound <b>I</b>) moiety. The C19-methyl hydrogen atoms are shown at the calculated ideal positions. Important side chains, heme, and water molecules are depicted in element colors: C, gray; N, blue; O, red; S, yellow; Fe, firebrick; H, orange. The C atoms of ASD are colored in cornflower blue. (b) Close-up view of the 306AlaCO···HOThr310 pair that may have a role in aromatization of the A-ring of ASD. Calculated hydrogen atom positions of C2 of the bound ASD are shown. The distances shown are in Å. (c) Possible mechanism for H2β abstraction and 2,3-enolization. The direction of proton flow from the proton relay network through Asp309 carboxylate is indicated. Adapted from ref <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">6</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structural basis for the design of potent inhibitors. The chemical structures of the three most potent steroidal inhibitors <b>4</b>, <b>5</b>, and <b>9</b> of the 6β-2-alkynyloxy series are shown in the upper panel. Lower panel: Schematic diagram depicting the X-ray structure of the tight hydrophobic binding pocket for the designed steroidal inhibitor <b>5</b>, the proton donors at the 3- and 17-keto positions, and the 6β-2-alkynyloxy side group that nearly fills the access channel. Compound <b>4</b> also binds the same way. The residues lining the binding pocket making hydrophobic and hydrogen-bonding contacts are shown. Adapted from ref <a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">46</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Recently developed steroidal and nonsteroidal AIs. The compounds are numbered and grouped in the same way as referenced in the text and in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. (b) Compounds that exhibit antiproliferative effects on breast cancer cells. Compounds <b>65</b> and <b>66</b> exhibit antiproliferative effects on breast cancer cells. No direct aromatase inhibition was measured; therefore, they are not classified as AIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Influence of lipid bilayer. In this membrane integration model, the opening to the active-site access channel rests on the lipid bilayer surface, allowing the steroids to enter the AROM active site directly from within the bilayer. The backbone ribbon is drawn in rainbow color: the N terminus is blue, and the C terminus is red. The model suggests lipid integration/association of the N-terminal helices A<sub>NT</sub>, A′, and A, the F–G loop that includes helix G′, and loop 7–8 between β7 and β8 near the C terminus. Asn12 is shown as facing the lumen of the endoplasmic reticulum. Atom color scheme is the following: oxygen in red; nitrogen blue; phosphorus orange; ASD in cornflower blue; heme and protein side chains in gray; lipid in light blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/medium/jm-2015-01281f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Strategic location of Y361 in the proximal cavity. The redox partner cytochrome P450 reductase is presumed to bind at this interface, and electrons are transferred from FMN to heme as illustrated by the dashed line. Y361 side chain sits in the path of electron transfer. Atom color code is the same as in other figures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.5b01281/20160603/images/large/jm-2015-01281f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01281&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85186" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85186" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 182 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Santen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siiteri, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, A.</span><span> </span><span class="NLM_article-title">History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span><span class="refDoi"> DOI: 10.1210/er.2008-0016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fer.2008-0016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19389994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVejt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=343-375&author=R.+J.+Santenauthor=H.+Brodieauthor=E.+R.+Simpsonauthor=P.+K.+Siiteriauthor=A.+Brodie&title=History+of+Aromatase%3A+Saga+of+an+Important+Biological+Mediator+and+Therapeutic+Target&doi=10.1210%2Fer.2008-0016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">History of aromatase: saga of an important biological mediator and therapeutic target</span></div><div class="casAuthors">Santen, R. J.; Brodie, H.; Simpson, E. R.; Siiteri, P. K.; Brodie, A.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-375</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Aromatase is the enzyme that catalyzes the conversion of androgens to estrogens.  Initial studies of its enzymic activity and function took place in an environment focused on estrogen as a component of the birth control pill.  At an early stage, investigators recognized that inhibition of this enzyme could have major practical applications for treatment of hormone-dependent breast cancer, alterations of ovarian and endometrial function, and treatment of benign disorders such as gynecomastia.  Two general approaches ultimately led to the development of potent and selective aromatase inhibitors.  One targeted the enzyme using analogs of natural steroidal substrates to work out the relationships between structure and function.  The other approach initially sought to block adrenal function as a treatment for breast cancer but led to the serendipitous finding that a nonsteroidal P 450 steroidogenesis inhibitor, aminoglutethimide, served as a potent but nonselective aromatase inhibitor.  Proof of the therapeutic concept of aromatase inhibition involved a variety of studies with aminoglutethimide and the selective steroidal inhibitor, formestane.  The requirement for even more potent and selective inhibitors led to intensive mol. studies to identify the structure of aromatase, to development of high-sensitivity estrogen assays, and to "mega" clin. trials of the third-generation aromatase inhibitors, letrozole, anastrozole, and exemestane, which are now in clin. use in breast cancer.  During these studies, unexpected findings led investigators to appreciate the important role of estrogens in males as well as in females and in multiple organs, particularly the bone and brain.  These studies identified the important regulatory properties of aromatase acting in an autocrine, paracrine, intracrine, neurocrine, and juxtacrine fashion and the organ-specific enhancers and promoters controlling its transcription.  The saga of these studies of aromatase and the ultimate utilization of inhibitors as highly effective treatments of breast cancer and for use in reproductive disorders serves as the basis for this first Endocrine Reviews history manuscript.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolTcJN4d5tIbVg90H21EOLACvtfcHk0ljaZzpkypkD7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVejt7w%253D&md5=634ab7996e915361c7e0045dbda75e99</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1210%2Fer.2008-0016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2008-0016%26sid%3Dliteratum%253Aachs%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26aulast%3DBrodie%26aufirst%3DH.%26aulast%3DSimpson%26aufirst%3DE.%2BR.%26aulast%3DSiiteri%26aufirst%3DP.%2BK.%26aulast%3DBrodie%26aufirst%3DA.%26atitle%3DHistory%2520of%2520Aromatase%253A%2520Saga%2520of%2520an%2520Important%2520Biological%2520Mediator%2520and%2520Therapeutic%2520Target%26jtitle%3DEndocr.%2520Rev.%26date%3D2009%26volume%3D30%26spage%3D343%26epage%3D375%26doi%3D10.1210%2Fer.2008-0016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Simpson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boon, W. C.</span><span> </span><span class="NLM_article-title">Estrogen, a Fundamental Player in Energy Homeostasis</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2005.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jsbmb.2005.04.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=16054355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntVOhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=3-8&author=E.+Simpsonauthor=M.+Jonesauthor=M.+Missoauthor=K.+Hewittauthor=R.+Hillauthor=L.+Maffeiauthor=C.+Caraniauthor=W.+C.+Boon&title=Estrogen%2C+a+Fundamental+Player+in+Energy+Homeostasis&doi=10.1016%2Fj.jsbmb.2005.04.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen, a fundamental player in energy homeostasis</span></div><div class="casAuthors">Simpson, Evan; Jones, Margaret; Misso, Marie; Hewitt, Kylie; Hill, Rachel; Maffei, Laura; Carani, Cesare; Boon, Wah Chin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1-5</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The aromatase knockout mouse was generated to investigate the phenotypes resulting from lack of estrogen.  The main features of the phenotype of this mouse can be summarized as follows: infertility and lack of sexual behavior in both males and females; progressive defects in folliculogenesis and spermatogenesis; elevated gonadotropins and T levels; loss of bone mass; and a metabolic syndrome with insulin resistance, truncal obesity and hepatic steatosis.  Results from this mouse suggest that estrogen has an important role to play in energy homeostasis.  Lack of estrogen leads to the development of a metabolic syndrome.  This results in a sexually dimorphic partitioning of lipids such that in males there is profound hepatic steatosis which is not seen in females.  Estrogen administration results in a prompt reversal of these symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_6G87qfR5y7Vg90H21EOLACvtfcHk0ljaZzpkypkD7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntVOhtbY%253D&md5=422cc945508783ef3da93c1d2b0b1288</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2005.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2005.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DSimpson%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DMisso%26aufirst%3DM.%26aulast%3DHewitt%26aufirst%3DK.%26aulast%3DHill%26aufirst%3DR.%26aulast%3DMaffei%26aufirst%3DL.%26aulast%3DCarani%26aufirst%3DC.%26aulast%3DBoon%26aufirst%3DW.%2BC.%26atitle%3DEstrogen%252C%2520a%2520Fundamental%2520Player%2520in%2520Energy%2520Homeostasis%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D95%26spage%3D3%26epage%3D8%26doi%3D10.1016%2Fj.jsbmb.2005.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ryan, K. J.</span><span> </span><span class="NLM_article-title">Biological Aromatization of Steroids</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=13630892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaG1MXksFGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1959&pages=268-272&author=K.+J.+Ryan&title=Biological+Aromatization+of+Steroids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Biological aromatization of steroids</span></div><div class="casAuthors">Ryan, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1959</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">268-72</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">cf. C.A. 52, 11147h.  A steroid aromatization reaction is described which reproducibly converts C19 steroids to estrogens in high yield.  The enzymic activity resides in the microsomal fraction of the human placenta and requires reduced triphosphopyridine nucleotide and O.  The relation of this reaction to other biol. aromatization systems is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKvbzogo4XxbVg90H21EOLACvtfcHk0ljaZzpkypkD7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXksFGruw%253D%253D&md5=5dd35004decf78adab3f80abb0190152</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DK.%2BJ.%26atitle%3DBiological%2520Aromatization%2520of%2520Steroids%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1959%26volume%3D234%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Smith, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors in Breast Cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">2431</span><span class="NLM_x">–</span> <span class="NLM_lpage">2442</span><span class="refDoi"> DOI: 10.1056/NEJMra023246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1056%2FNEJMra023246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=12802030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksFKguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=2431-2442&author=I.+E.+Smithauthor=M.+Dowsett&title=Aromatase+Inhibitors+in+Breast+Cancer&doi=10.1056%2FNEJMra023246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase inhibitors in breast cancer</span></div><div class="casAuthors">Smith, Ian E.; Dowsett, Mitch</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2431-2442</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  This review discusses the role of aromatase inhibitors and assess their potential for clin. use in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYF49NFDFgm7Vg90H21EOLACvtfcHk0lhg4YxyAD7w1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksFKguro%253D&md5=da7b56d4a1f0e7b2e27c8819a0ae0951</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMra023246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra023246%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DI.%2BE.%26aulast%3DDowsett%26aufirst%3DM.%26atitle%3DAromatase%2520Inhibitors%2520in%2520Breast%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D2431%26epage%3D2442%26doi%3D10.1056%2FNEJMra023246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Buzdar, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabholtz, J. M.</span><span> </span><span class="NLM_article-title">An Overview of the Pharmacology and Pharmacokinetics of the Newer Generation Aromatase Inhibitors Anastrozole, Letrozole, and Exemestane</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2006</span><span class="NLM_x">–</span> <span class="NLM_lpage">2016</span><span class="refDoi"> DOI: 10.1002/cncr.10908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fcncr.10908" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2002&pages=2006-2016&author=A.+U.+Buzdarauthor=J.+F.+Robertsonauthor=W.+Eiermannauthor=J.+M.+Nabholtz&title=An+Overview+of+the+Pharmacology+and+Pharmacokinetics+of+the+Newer+Generation+Aromatase+Inhibitors+Anastrozole%2C+Letrozole%2C+and+Exemestane&doi=10.1002%2Fcncr.10908"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fcncr.10908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcncr.10908%26sid%3Dliteratum%253Aachs%26aulast%3DBuzdar%26aufirst%3DA.%2BU.%26aulast%3DRobertson%26aufirst%3DJ.%2BF.%26aulast%3DEiermann%26aufirst%3DW.%26aulast%3DNabholtz%26aufirst%3DJ.%2BM.%26atitle%3DAn%2520Overview%2520of%2520the%2520Pharmacology%2520and%2520Pharmacokinetics%2520of%2520the%2520Newer%2520Generation%2520Aromatase%2520Inhibitors%2520Anastrozole%252C%2520Letrozole%252C%2520and%2520Exemestane%26jtitle%3DCancer%26date%3D2002%26volume%3D95%26spage%3D2006%26epage%3D2016%26doi%3D10.1002%2Fcncr.10908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangborn, W.</span><span> </span><span class="NLM_article-title">Structural Basis for Androgen Specificity and Oestrogen Synthesis in Human Aromatase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">457</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1038/nature07614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Fnature07614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19129847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlSitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2009&pages=219-223&author=D.+Ghoshauthor=J.+Griswoldauthor=M.+Ermanauthor=W.+Pangborn&title=Structural+Basis+for+Androgen+Specificity+and+Oestrogen+Synthesis+in+Human+Aromatase&doi=10.1038%2Fnature07614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for androgen specificity and estrogen synthesis in human aromatase</span></div><div class="casAuthors">Ghosh, Debashis; Griswold, Jennifer; Erman, Mary; Pangborn, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">7226</span>),
    <span class="NLM_cas:pages">219-223</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aromatase cytochrome P 450 is the only enzyme in vertebrates known to catalyze the biosynthesis of all estrogens from androgens.  Aromatase inhibitors therefore constitute a frontline therapy for estrogen-dependent breast cancer.  In a three-step process, each step requiring 1 mol of O2, 1 mol of NADPH, and coupling with its redox partner cytochrome P 450 reductase, aromatase converts androstenedione, testosterone and 16α-hydroxytestosterone to estrone, 17β-estradiol and 17β,16α-estriol, resp.  The first two steps are C19-Me hydroxylation steps, and the third involves the aromatization of the steroid A-ring, unique to aromatase.  Whereas most P450s are not highly substrate selective, it is the hallmark androgenic specificity that sets aromatase apart.  The structure of this enzyme of the endoplasmic reticulum membrane has remained unknown for decades, hindering elucidation of the biochem. mechanism.  Here we present the crystal structure of human placental aromatase, the only natural mammalian, full-length P 450 and P 450 in hormone biosynthetic pathways to be crystd. so far.  Unlike the active sites of many microsomal P450s that metabolize drugs and xenobiotics, aromatase has an androgen-specific cleft that binds the androstenedione mol. snugly.  Hydrophobic and polar residues exquisitely complement the steroid backbone.  The locations of catalytically important residues shed light on the reaction mechanism.  The relative juxtaposition of the hydrophobic amino-terminal region and the opening to the catalytic cleft shows why membrane anchoring is necessary for the lipophilic substrates to gain access to the active site.  The mol. basis for the enzyme's androgenic specificity and unique catalytic mechanism can be used for developing next-generation aromatase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyHy-xf0PxkbVg90H21EOLACvtfcHk0lhg4YxyAD7w1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlSitA%253D%253D&md5=7f224e20c34cf5be770bb1c8b33c6e8c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature07614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07614%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DGriswold%26aufirst%3DJ.%26aulast%3DErman%26aufirst%3DM.%26aulast%3DPangborn%26aufirst%3DW.%26atitle%3DStructural%2520Basis%2520for%2520Androgen%2520Specificity%2520and%2520Oestrogen%2520Synthesis%2520in%2520Human%2520Aromatase%26jtitle%3DNature%26date%3D2009%26volume%3D457%26spage%3D219%26epage%3D223%26doi%3D10.1038%2Fnature07614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Szklarz, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halpert, J. R.</span><span> </span><span class="NLM_article-title">Use of Homology Modeling in Conjunction with Site-Directed Mutagenesis for Analysis of Structure-Function Relationships of Mammalian Cytochromes P450</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">2507</span><span class="NLM_x">–</span> <span class="NLM_lpage">2520</span><span class="refDoi"> DOI: 10.1016/S0024-3205(97)00717-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2FS0024-3205%2897%2900717-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1997&pages=2507-2520&author=G.+D.+Szklarzauthor=J.+R.+Halpert&title=Use+of+Homology+Modeling+in+Conjunction+with+Site-Directed+Mutagenesis+for+Analysis+of+Structure-Function+Relationships+of+Mammalian+Cytochromes+P450&doi=10.1016%2FS0024-3205%2897%2900717-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2897%2900717-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252897%252900717-0%26sid%3Dliteratum%253Aachs%26aulast%3DSzklarz%26aufirst%3DG.%2BD.%26aulast%3DHalpert%26aufirst%3DJ.%2BR.%26atitle%3DUse%2520of%2520Homology%2520Modeling%2520in%2520Conjunction%2520with%2520Site-Directed%2520Mutagenesis%2520for%2520Analysis%2520of%2520Structure-Function%2520Relationships%2520of%2520Mammalian%2520Cytochromes%2520P450%26jtitle%3DLife%2520Sci.%26date%3D1997%26volume%3D61%26spage%3D2507%26epage%3D2520%26doi%3D10.1016%2FS0024-3205%2897%2900717-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Laughton, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelbil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidle, S.</span><span> </span><span class="NLM_article-title">A Detailed Molecular Model for Human Aromatase</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.1016/0960-0760(93)90243-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2893%2990243-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=8476753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1eltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=399-407&author=C.+A.+Laughtonauthor=M.+J.+Zvelbilauthor=S.+Neidle&title=A+Detailed+Molecular+Model+for+Human+Aromatase&doi=10.1016%2F0960-0760%2893%2990243-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A detailed molecular model for human aromatase</span></div><div class="casAuthors">Laughton, C. A.; Zvelebil, M. J. J. M.; Neidle, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">Using a variety of techniques, including sequence alignment, secondary structure prediction, mol. mechanics and mol. dynamics, a model was constructed for the three-dimensional structure of P-450arom (human aromatase) based on that of P-450cam, the only cytochrome P 450 enzyme for which the crystal structure is known.  The predicted structure is found to be in good agreement with current exptl. data; both direct, from site-directed mutagenesis studies, and indirect, from the consideration of the structures and activities of known substrates and inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9ZRmHSnN_b7Vg90H21EOLACvtfcHk0lhg4YxyAD7w1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1eltrc%253D&md5=3684a8d54578aa7b5e3a8d780b02b026</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2893%2990243-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252893%252990243-P%26sid%3Dliteratum%253Aachs%26aulast%3DLaughton%26aufirst%3DC.%2BA.%26aulast%3DZvelbil%26aufirst%3DM.%2BJ.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DA%2520Detailed%2520Molecular%2520Model%2520for%2520Human%2520Aromatase%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D44%26spage%3D399%26epage%3D407%26doi%3D10.1016%2F0960-0760%2893%2990243-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Three-Dimensional Model of the Human Aromatase Enzyme and Density Functional Parameterization of the Iron-Containing Protoporphyrin IX for a Molecular Dynamics Study of Heme-Cysteinato Cytochromes</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1074</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span><span class="refDoi"> DOI: 10.1002/prot.20829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fprot.20829" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=1074-1087&author=A.+D.+Faviaauthor=A.+Cavalliauthor=M.+Masettiauthor=A.+Carottiauthor=M.+Recanatini&title=Three-Dimensional+Model+of+the+Human+Aromatase+Enzyme+and+Density+Functional+Parameterization+of+the+Iron-Containing+Protoporphyrin+IX+for+a+Molecular+Dynamics+Study+of+Heme-Cysteinato+Cytochromes&doi=10.1002%2Fprot.20829"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fprot.20829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.20829%26sid%3Dliteratum%253Aachs%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DMasetti%26aufirst%3DM.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DThree-Dimensional%2520Model%2520of%2520the%2520Human%2520Aromatase%2520Enzyme%2520and%2520Density%2520Functional%2520Parameterization%2520of%2520the%2520Iron-Containing%2520Protoporphyrin%2520IX%2520for%2520a%2520Molecular%2520Dynamics%2520Study%2520of%2520Heme-Cysteinato%2520Cytochromes%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2006%26volume%3D62%26spage%3D1074%26epage%3D1087%26doi%3D10.1002%2Fprot.20829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Karkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtje, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahala, K.</span><span> </span><span class="NLM_article-title">A Three-Dimensional Model of CYP19 Aromatase for Structure-Based Drug Design</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2006.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jsbmb.2006.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=17583493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFyiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2007&pages=63-70&author=S.+Karkolaauthor=H.+D.+Holtjeauthor=K.+Wahala&title=A+Three-Dimensional+Model+of+CYP19+Aromatase+for+Structure-Based+Drug+Design&doi=10.1016%2Fj.jsbmb.2006.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A three-dimensional model of CYP19 aromatase for structure-based drug design</span></div><div class="casAuthors">Karkola, Sampo; Hoeltje, Hans-Dieter; Waehaelae, Kristiina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1-5</span>),
    <span class="NLM_cas:pages">63-70</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Aromatase (CYP 450arom, CYP19) is an enzyme responsible for converting the aliph. androgens androstenedione and testosterone to the arom. estrogens estrone and estradiol, resp.  These endogenous hormones are a key factor in cancer tumor formation and proliferation through a cascade starting from estrogen binding to estrogen receptor.  To interfere with the overprodn. of estrogens esp. in tumor tissue, it is possible to inhibit aromatase activity.  This can be achieved using aromatase inhibitors.  To design novel aromatase inhibitors, it is necessary to have an understanding of the active site of aromatase.  As no crystal structure of the enzyme has yet been published, we built a homol. model of aromatase using the first crystd. mammalian cytochrome enzyme, rabbit 21-progesterone hydroxylase 2C5, as a template structure.  The initial model was validated with exhaustive mol. dynamics simulation with and without the natural substrate androstenedione.  The resulting enzyme-substrate complex shows very good stability and only two of the residues are in disallowed regions in a Ramachandran plot.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprIT5CCNN_dbVg90H21EOLACvtfcHk0lh3J-RuKS16wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFyiurw%253D&md5=284f56b899908a447896a402c075e726</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2006.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2006.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DKarkola%26aufirst%3DS.%26aulast%3DHoltje%26aufirst%3DH.%2BD.%26aulast%3DWahala%26aufirst%3DK.%26atitle%3DA%2520Three-Dimensional%2520Model%2520of%2520CYP19%2520Aromatase%2520for%2520Structure-Based%2520Drug%2520Design%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D105%26spage%3D63%26epage%3D70%26doi%3D10.1016%2Fj.jsbmb.2006.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Graham-Lorence, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarneh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, E. R.</span><span> </span><span class="NLM_article-title">A Three-Dimensional Model of Aromatase Cytochrome P450</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1080</span><span class="refDoi"> DOI: 10.1002/pro.5560040605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fpro.5560040605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=7549871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK2MXmsFyrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1995&pages=1065-1080&author=S.+Graham-Lorenceauthor=B.+Amarnehauthor=R.+E.+Whiteauthor=J.+A.+Petersonauthor=E.+R.+Simpson&title=A+Three-Dimensional+Model+of+Aromatase+Cytochrome+P450&doi=10.1002%2Fpro.5560040605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A three-dimensional model of aromatase cytochrome P450</span></div><div class="casAuthors">Graham-Lorence, Sandra; Amarneh, Bilal; White, Ronald E.; Peterson, Julian A.; Simpson, Evan R.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1065-80</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">P 450 heme proteins comprise a large gene superfamily that catalyzes monooxygenase reactions in the presence of a redox partner.  Because the mammalian members are, without exception, membrane-bound proteins, they have resisted structure-function anal. by means of x-ray crystallog. methods.  Among P 450-catalyzed reactions, the aromatase reaction that catalyzes the conversion of C19 steroids to estrogens is one of the most complex and least understood.  Thus, to better understand the reaction mechanism, we have constructed a three-dimensional model of P450arom not only to examine the active site and those residues potentially involved in catalysis, but to study other important structural features such as substrate recognition and redox-partner binding, which require examn. of the entire mol. (excepting the putative membrane-spanning region).  This model of P450arom was built based on a core structure identified from the structures of the sol., bacterial P450s (P450cam, P450terp, and P450BM-P) rather than by mol. replacement, after which the less conserved elements and loops were added in a rational fashion.  Minimization and dynamic simulations were used to optimize the model and the reasonableness of the structure was evaluated.  From this model we have postulated a membrane-assocd. hydrophobic region of aliph. and arom. residues involved in substrate recognition, a redox-partner binding region that may be unique compared to other P450s, as well as residues involved in active site orientation of substrates and an inhibitor of P450arom, namely vorozole.  We also have proposed a scheme for the reaction mechanism in which a threonine switch dets. whether oxygen insertion into the substrate mol. involves an oxygen radical or a peroxide intermediate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl2opoEDIt7LVg90H21EOLACvtfcHk0lh3J-RuKS16wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsFyrs70%253D&md5=e5ae05ab3e8105eecc146d610f60174f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560040605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560040605%26sid%3Dliteratum%253Aachs%26aulast%3DGraham-Lorence%26aufirst%3DS.%26aulast%3DAmarneh%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DR.%2BE.%26aulast%3DPeterson%26aufirst%3DJ.%2BA.%26aulast%3DSimpson%26aufirst%3DE.%2BR.%26atitle%3DA%2520Three-Dimensional%2520Model%2520of%2520Aromatase%2520Cytochrome%2520P450%26jtitle%3DProtein%2520Sci.%26date%3D1995%26volume%3D4%26spage%3D1065%26epage%3D1080%26doi%3D10.1002%2Fpro.5560040605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Suppression of Human Cytochrome P450 Aromatase Activity by Monoclonal and Recombinant Antibody Fragments and Identification of a Stable Antigenic Complex</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2003.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jsbmb.2003.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=15120417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1eru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2004&pages=235-245&author=P.+Lalaauthor=T.+Higashiyamaauthor=M.+Ermanauthor=J.+Griswoldauthor=T.+Wagnerauthor=Y.+Osawaauthor=D.+Ghosh&title=Suppression+of+Human+Cytochrome+P450+Aromatase+Activity+by+Monoclonal+and+Recombinant+Antibody+Fragments+and+Identification+of+a+Stable+Antigenic+Complex&doi=10.1016%2Fj.jsbmb.2003.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of human cytochrome P450 aromatase activity by monoclonal and recombinant antibody fragments and identification of a stable antigenic complex</span></div><div class="casAuthors">Lala, Puloma; Higashiyama, Tadayoshi; Erman, Mary; Griswold, Jennifer; Wagner, Traci; Osawa, Yoshio; Ghosh, Debashis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-245</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">: Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Human cytochrome P 450 aromatase (P450arom) is responsible for biosynthesis of estrogens from androgens.  Monoclonal antibody MAb3-2C2 to P450arom specifically binds to a conformational epitope and suppresses the enzyme activity in a dose-dependent manner.  The crystal structure of the Fab fragment of MAb3-2C2 has been used to engineer a recombinant single chain antibody fragment (scFv) and a homodimeric variable domain of the light chain (VL2).  These recombinant antibody fragments have been expressed in Escherichia coli and purified.  Here, we show that the recombinant scFv suppresses P450arom activity with an IC50 value similar to that of natural MAb3-2C2 F(ab')2.  The recombinant VL2 also exhibits dose-dependent suppression of the P450arom activity, but at a reduced level, demonstrating that the homodimer is unable to fully mimic the complementarity detg. region (CDR) of a variable heavy chain (VH)-VL heterodimer.  We prep. and purify a stable complex of P450arom with MAb3-2C2 F(ab')2 and show that the complex migrates and ppts. as a single mol. assembly.  Efforts to crystallize P450arom for structure-function studies have yielded small single crystals.  Our results suggest that formation of stable complexes with fragments of the monoclonal antibody could provide an alternative method for crystn. of P450arom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSWKOHRdLUXbVg90H21EOLACvtfcHk0liHOqx-5WGXxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1eru70%253D&md5=32e8d0389b8961fdc20e7ebfd1f684d0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2003.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2003.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DLala%26aufirst%3DP.%26aulast%3DHigashiyama%26aufirst%3DT.%26aulast%3DErman%26aufirst%3DM.%26aulast%3DGriswold%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DOsawa%26aufirst%3DY.%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DSuppression%2520of%2520Human%2520Cytochrome%2520P450%2520Aromatase%2520Activity%2520by%2520Monoclonal%2520and%2520Recombinant%2520Antibody%2520Fragments%2520and%2520Identification%2520of%2520a%2520Stable%2520Antigenic%2520Complex%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D88%26spage%3D235%26epage%3D245%26doi%3D10.1016%2Fj.jsbmb.2003.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangborn, W.</span><span> </span><span class="NLM_article-title">X-Ray Structure of Human Aromatase Reveals an Androgen-Specific Active Site</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2009.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jsbmb.2009.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19808095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlSltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=197-202&author=D.+Ghoshauthor=J.+Griswoldauthor=M.+Ermanauthor=W.+Pangborn&title=X-Ray+Structure+of+Human+Aromatase+Reveals+an+Androgen-Specific+Active+Site&doi=10.1016%2Fj.jsbmb.2009.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray structure of human aromatase reveals an androgen-specific active site</span></div><div class="casAuthors">Ghosh, Debashis; Griswold, Jennifer; Erman, Mary; Pangborn, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">197-202</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Aromatase (I) is a unique cytochrome P 450-dependent enzyme that catalyzes the removal of the 19-Me group and aromatization of the A-ring of androgens for the synthesis of estrogens.  All human estrogens are synthesized via this enzymic aromatization pathway.  I inhibitors thus constitute a frontline therapy for estrogen-dependent breast cancer.  Despite decades of intense investigation, this enzyme of the endoplasmic reticulum membrane has eluded all structure detn. efforts.  Here, the authors report the crystal structure of highly active I purified from human placenta, in complex with its natural substrate, androstenedione.  The structure showed the binding mode of androstenedione in the catalytically active oxidized high-spin ferric state of the enzyme.  H-bond-forming interactions and tight packing hydrophobic side-chains that complement the puckering of the steroid backbone provided the mol. basis for the exclusive androgenic specificity of I.  The locations of catalytic residues and water mols. shed new light on the mechanism of the aromatization step.  The structure also suggested a membrane integration model indicative of the passage of steroids through the lipid bilayer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowU4rLC5S_fbVg90H21EOLACvtfcHk0liHOqx-5WGXxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlSltL4%253D&md5=19a6d40418c6f8f35c4b582ff6ae6439</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2009.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2009.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DGriswold%26aufirst%3DJ.%26aulast%3DErman%26aufirst%3DM.%26aulast%3DPangborn%26aufirst%3DW.%26atitle%3DX-Ray%2520Structure%2520of%2520Human%2520Aromatase%2520Reveals%2520an%2520Androgen-Specific%2520Active%2520Site%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D118%26spage%3D197%26epage%3D202%26doi%3D10.1016%2Fj.jsbmb.2009.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Lo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Nardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbuta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilardi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Structural Basis for the Functional Roles of Critical Residues in Human Cytochrome P450 Aromatase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5821</span><span class="NLM_x">–</span> <span class="NLM_lpage">5829</span><span class="refDoi"> DOI: 10.1021/bi400669h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi400669h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOqu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=5821-5829&author=J.+Loauthor=G.+Di+Nardoauthor=J.+Griswoldauthor=C.+Egbutaauthor=W.+Jiangauthor=G.+Gilardiauthor=D.+Ghosh&title=Structural+Basis+for+the+Functional+Roles+of+Critical+Residues+in+Human+Cytochrome+P450+Aromatase&doi=10.1021%2Fbi400669h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Functional Roles of Critical Residues in Human Cytochrome P450 Aromatase</span></div><div class="casAuthors">Lo, Jessica; Di Nardo, Giovanna; Griswold, Jennifer; Egbuta, Chinaza; Jiang, Wenhua; Gilardi, Gianfranco; Ghosh, Debashis</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5821-5829</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytochrome P 450 aromatase (CYP19A1) is the only enzyme known to catalyze the biosynthesis of estrogens from androgens.  The crystal structure of human placental aromatase (pArom) has paved the way toward understanding the structure-function relationships of this remarkable enzyme.  Using an amino terminus-truncated recombinant human aromatase (rArom) construct, we investigate the roles of key amino acids in the active site, at the intermol. interface, inside the access channel, and at the lipid-protein boundary for their roles in enzyme function and higher-order organization.  Replacing the active site residue D309 with an N yields an inactive enzyme, consistent with its proposed involvement in aromatization.  Mutation of R192 at the lipid interface, pivotal to the proton relay network in the access channel, results in the loss of enzyme activity.  In addn. to the distal catalytic residues, we show that mutation of K440 and Y361 of the heme-proximal region critically interferes with substrate binding, enzyme activity, and heme stability.  The D-E loop deletion mutant Del7 that disrupts the intermol. interaction significantly reduces enzyme activity.  However, the less drastic Del4 and point mutants E181A and E181K do not.  Furthermore, native gel electrophoresis, size-exclusion chromatog., and anal. ultracentrifugation are used to show that mutations in the intermol. interface alter the quaternary organization of the enzyme in soln.  As a validation for interpretation of the mutational results in the context of the innate mol., we det. the crystal structure of rArom to show that the active site, tertiary, and quaternary structures are identical to those of pArom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGBahgDCrIOLVg90H21EOLACvtfcHk0liHOqx-5WGXxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOqu7vO&md5=eb67eab5c2902f2b57c04171452fa17d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fbi400669h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400669h%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DDi%2BNardo%26aufirst%3DG.%26aulast%3DGriswold%26aufirst%3DJ.%26aulast%3DEgbuta%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DGilardi%26aufirst%3DG.%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Functional%2520Roles%2520of%2520Critical%2520Residues%2520in%2520Human%2520Cytochrome%2520P450%2520Aromatase%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D5821%26epage%3D5829%26doi%3D10.1021%2Fbi400669h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Waterman, M. R.</span><span> </span><span class="NLM_article-title">Anticancer Drug Target Pictured</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">457</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span><span class="refDoi"> DOI: 10.1038/457159a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2F457159a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2009&pages=159-160&author=M.+R.+Waterman&title=Anticancer+Drug+Target+Pictured&doi=10.1038%2F457159a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2F457159a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F457159a%26sid%3Dliteratum%253Aachs%26aulast%3DWaterman%26aufirst%3DM.%2BR.%26atitle%3DAnticancer%2520Drug%2520Target%2520Pictured%26jtitle%3DNature%26date%3D2009%26volume%3D457%26spage%3D159%26epage%3D160%26doi%3D10.1038%2F457159a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Computational Methods for the Design of Potent Aromatase Inhibitors</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.1517/17460441.2013.768983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1517%2F17460441.2013.768983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=23373669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksVKksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=395-409&author=A.+D.+Faviaauthor=O.+Nicolottiauthor=A.+Stefanachiauthor=F.+Leonettiauthor=A.+Carotti&title=Computational+Methods+for+the+Design+of+Potent+Aromatase+Inhibitors&doi=10.1517%2F17460441.2013.768983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Computational methods for the design of potent aromatase inhibitors</span></div><div class="casAuthors">Favia, Angelo Danilo; Nicolotti, Orazio; Stefanachi, Angela; Leonetti, Francesco; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-409</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: It has long been considered that the most significant risks for breast cancer are gender and age but, as many other tumors, this cancer has also been undeniably linked to gene mutations.  The vast majority of breast cancers in postmenopausal women are estrogen-responsive, a hormone which is biosynthesized from blood-circulating androgens through an aromatization reaction, catalyzed by aromatase (AR).  One strategy, therefore, to combat breast cancer, has been to find compds. that can inhibit the activity of aromatase to reduce estrogen levels.  Areas covered: The authors provide a broad and updated overview of the general structure-activity relationships and on the latest ligand- and structure-based approaches applied to the discovery of potent, selective and safer breast cancer drugs.  Specifically the authors review the most consolidated techniques, based on structure-activity relationships, pharmacophore mapping, rigid and flexible mol. docking, as well as sophisticated and reliable protocols simulating crit. biol. events.  Expert opinion: The recently solved X-ray structures of aromatase represent solid milestones to breathe new life into the search of newer chemotypes with reduced risks of cross-reactivity toward other CYPs and safer pharmacol. profiles.  We anticipate that great benefits will arrive from the wealth of information obtained by integrating genomics, site-directed mutagenesis expts. with protein modeling.  Furthermore, we welcome the advent of GPU technol. that, in conjunction with dedicated algorithms, grants scientists an unprecedented point of view on physiol. relevant phenomena, occurring on the μs time scale, such as ligand binding/unbinding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1eHel0TrwSrVg90H21EOLACvtfcHk0lgmdOdTgw7sYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksVKksb8%253D&md5=5767757f7a3f8a19c1c64e3abe28eda1</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.768983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.768983%26sid%3Dliteratum%253Aachs%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DComputational%2520Methods%2520for%2520the%2520Design%2520of%2520Potent%2520Aromatase%2520Inhibitors%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D395%26epage%3D409%26doi%3D10.1517%2F17460441.2013.768983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Di Nardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilardi, G.</span><span> </span><span class="NLM_article-title">Evidence for an Elevated Aspartate pKa in the Active Site of Human Aromatase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">1186</span><span class="NLM_x">–</span> <span class="NLM_lpage">1196</span><span class="refDoi"> DOI: 10.1074/jbc.M114.595108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1074%2Fjbc.M114.595108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=25425647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFSjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=1186-1196&author=G.+Di+Nardoauthor=M.+Breitnerauthor=A.+Bandinoauthor=D.+Ghoshauthor=G.+K.+Jenningsauthor=J.+C.+Hackettauthor=G.+Gilardi&title=Evidence+for+an+Elevated+Aspartate+pKa+in+the+Active+Site+of+Human+Aromatase&doi=10.1074%2Fjbc.M114.595108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for an Elevated Aspartate pKa in the Active Site of Human Aromatase</span></div><div class="casAuthors">Di Nardo, Giovanna; Breitner, Maximilian; Bandino, Andrea; Ghosh, Debashis; Jennings, Gareth K.; Hackett, John C.; Gilardi, Gianfranco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1186-1196</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aromatase (CYP19A1), the enzyme that converts androgens to estrogens, is of significant mechanistic and therapeutic interest.  Crystal structures and computational studies of this enzyme shed light on the crit. role of Asp309 in substrate binding and catalysis.  These studies predicted an elevated pKa for Asp309 and proposed that protonation of this residue was required for function.  In this study, UV-visible absorption, CD, resonance Raman spectroscopy, and enzyme kinetics were used to study the impact of pH on aromatase structure and androstenedione binding.  Spectroscopic studies demonstrate that androstenedione binding is pH-dependent, whereas in contrast, the D309N mutant retains its ability to bind to androstenedione across the entire pH range studied.  Neither pH nor mutation perturbed the secondary structure or heme environment.  The origin of the obsd. pH dependence was further narrowed to the protonation equil. of Asp309 with a parallel set of spectroscopic studies using exemestane and anastrozole.  Because exemestane interacts with Asp309 based on its co-crystal structure with the enzyme, its binding is pH-dependent.  Aromatase binding to anastrozole is pH-independent, consistent with the hypothesis that this ligand exploits a distinct set of interactions in the active site.  In summary, we assign the apparent pKa of 8.2 obsd. for androstenedione binding to the side chain of Asp309.  To our knowledge, this work represents the first exptl. assignment of a pKa value to a residue in a cytochrome P 450.  This value is in agreement with theor. calcns. (7.7-8.1) despite the reliance of the computational methods on the conformational snapshots provided by crystal structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAKZ7aLlJ_RLVg90H21EOLACvtfcHk0lgmdOdTgw7sYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFSjsQ%253D%253D&md5=b26767f83835699a92e113915ae5e05d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.595108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.595108%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BNardo%26aufirst%3DG.%26aulast%3DBreitner%26aufirst%3DM.%26aulast%3DBandino%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DJennings%26aufirst%3DG.%2BK.%26aulast%3DHackett%26aufirst%3DJ.%2BC.%26aulast%3DGilardi%26aufirst%3DG.%26atitle%3DEvidence%2520for%2520an%2520Elevated%2520Aspartate%2520pKa%2520in%2520the%2520Active%2520Site%2520of%2520Human%2520Aromatase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D1186%26epage%3D1196%26doi%3D10.1074%2Fjbc.M114.595108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Sen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackett, J. C.</span><span> </span><span class="NLM_article-title">Coupled Electron Transfer and Proton Hopping in the Final Step of CYP19-Catalyzed Androgen Aromatization</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3039</span><span class="NLM_x">–</span> <span class="NLM_lpage">3049</span><span class="refDoi"> DOI: 10.1021/bi300017p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi300017p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlGnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=3039-3049&author=K.+Senauthor=J.+C.+Hackett&title=Coupled+Electron+Transfer+and+Proton+Hopping+in+the+Final+Step+of+CYP19-Catalyzed+Androgen+Aromatization&doi=10.1021%2Fbi300017p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Coupled electron transfer and proton hopping in the final step of CYP19-catalyzed androgen aromatization</span></div><div class="casAuthors">Sen, Kakali; Hackett, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3039-3049</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aromatase/cytochrome P 450 19 (CYP19) catalyzes the terminal step in estrogen biosynthesis, which requires 3 sep. oxidn. reactions, culminating in an enigmatic aromatization that converts an androgen to an estrogen.  A stable ferric peroxo (Fe3+O22-) intermediate has been seen by ESR, but its role in this complex reaction remains controversial.  Here, combining mol. dynamics (MD) simulation and hybrid quantum mechanics/mol. mechanics (QM/MM), the authors show that ferric peroxo addn. to the 19-aldehyde initiates the reaction.  Stepwise cleavage of the C10-C19 and O-O bonds of the peroxohemiacetal extrudes formate and yields compd. II, which in turn desaturates the steroid through successive abstraction of the 1β-H atom and deprotonation of the 2β-position.  Throughout the transformation, a proton is cyclically relayed between Arg-309 and the substrate to stabilize reaction intermediates.  This mechanism invokes novel O intermediates and provides a unifying interpretation of past exptl. mechanistic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOtW7FCj2vcrVg90H21EOLACvtfcHk0lgmdOdTgw7sYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlGnu74%253D&md5=1fc5b54d48957c722b36ebc333b95ab6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi300017p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi300017p%26sid%3Dliteratum%253Aachs%26aulast%3DSen%26aufirst%3DK.%26aulast%3DHackett%26aufirst%3DJ.%2BC.%26atitle%3DCoupled%2520Electron%2520Transfer%2520and%2520Proton%2520Hopping%2520in%2520the%2520Final%2520Step%2520of%2520CYP19-Catalyzed%2520Androgen%2520Aromatization%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D3039%26epage%3D3049%26doi%3D10.1021%2Fbi300017p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Lipton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span> </span><span class="NLM_article-title">Proceedings: Medical Adrenalectomy Using Aminoglutethimide and Dexamethasone in Advanced Breast Cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span><span class="refDoi"> DOI: 10.1002/1097-0142(197402)33:2<503::AID-CNCR2820330227>3.0.CO;2-L</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2F1097-0142%28197402%2933%3A2%3C503%3A%3AAID-CNCR2820330227%3E3.0.CO%3B2-L" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1974&pages=503-512&author=A.+Liptonauthor=R.+J.+Santen&title=Proceedings%3A+Medical+Adrenalectomy+Using+Aminoglutethimide+and+Dexamethasone+in+Advanced+Breast+Cancer&doi=10.1002%2F1097-0142%28197402%2933%3A2%3C503%3A%3AAID-CNCR2820330227%3E3.0.CO%3B2-L"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2F1097-0142%28197402%2933%3A2%3C503%3A%3AAID-CNCR2820330227%3E3.0.CO%3B2-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0142%2528197402%252933%253A2%253C503%253A%253AAID-CNCR2820330227%253E3.0.CO%253B2-L%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DA.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26atitle%3DProceedings%253A%2520Medical%2520Adrenalectomy%2520Using%2520Aminoglutethimide%2520and%2520Dexamethasone%2520in%2520Advanced%2520Breast%2520Cancer%26jtitle%3DCancer%26date%3D1974%26volume%3D33%26spage%3D503%26epage%3D512%26doi%3D10.1002%2F1097-0142%28197402%2933%3A2%3C503%3A%3AAID-CNCR2820330227%3E3.0.CO%3B2-L" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giudici, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Exemestane (FCE 24304), a New Steroidal Aromatase Inhibitor</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1016/0960-0760(92)90198-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2892%2990198-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1525055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK38Xmt1KgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1992&pages=137-143&author=E.+di+Salleauthor=G.+Ornatiauthor=D.+Giudiciauthor=M.+Lassusauthor=T.+R.+Evansauthor=R.+C.+Coombes&title=Exemestane+%28FCE+24304%29%2C+a+New+Steroidal+Aromatase+Inhibitor&doi=10.1016%2F0960-0760%2892%2990198-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Exemestane (FCE 24304), a new steroidal aromatase inhibitor</span></div><div class="casAuthors">Di Salle, E.; Ornati, G.; Giudici, D.; Lassus, M.; Evans, T. R. J.; Coombes, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">137-43</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">A review with 42 refs.  Exemestane (FCE 24304; I) is a novel orally active irreversible aromatase inhibitor.  Its in vivo pharmacol. properties have been compared to 4-hydroxyandrostenedione (4-OHA).  In preincubation studies with human placental aromatase, I, like 4-OHA, showed enzyme-inactivating properties with a similar affinity (Ki 26 vs. 29 nM) and a lower rate of inactivation (t1/2 13.9 vs. 2.1 min).  Conversely, when tested in pregnant mares' serum gonodotropin-treated rats, I was more potent in reducing microsomal ovarian aromatase activity than 4-OHA, after both s.c. (ED50 1.8 vs. 3.1 mg/kg) and oral dosing (ED50 3.7 vs. >100 mg/kg).  No interference of I on desmolase or 5α-reductase activity was found.  I did not show any relevant binding affinity to steroidal receptors, but slight binding to the androgen receptor (≈0.2% of dihydrotestosterone), like 4-OHA.  In the 1st phase I trial, healthy postmenopausal volunteers were given single oral doses of I, ranging from 0.5 to 800 mg, and plasma [estrone (E1), estradiol (E2) and estrone sulfate (E1S)] and urinary estrogens (E1 and E2) were measured up to 5-8 days.  The minimal ED in decreasing estrogens was 5 mg.  At 25 mg the maximal suppression was obsd. at day 3: plasma estrogens fell to 35 (E1), 39 (E2) and 28% (E1S), and urinary estrogens fell to 20 (E1) and 25% (E2) of basal values, these effects still persisting on day 5.  No effects on plasma levels of cortisol, aldosterone, 17-hydroxyprogesterone, DHEAS, LH and FSH, and no significant adverse events were obsd. up to the highest tested dose of 800 mg I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovP_bOfA8wbbVg90H21EOLACvtfcHk0liT9rOJJ6lUxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xmt1KgtL0%253D&md5=2ba0300b931351d69f4c95a2ad103a27</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2892%2990198-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252892%252990198-R%26sid%3Dliteratum%253Aachs%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26aulast%3DOrnati%26aufirst%3DG.%26aulast%3DGiudici%26aufirst%3DD.%26aulast%3DLassus%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DT.%2BR.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DExemestane%2520%2528FCE%252024304%2529%252C%2520a%2520New%2520Steroidal%2520Aromatase%2520Inhibitor%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1992%26volume%3D43%26spage%3D137%26epage%3D143%26doi%3D10.1016%2F0960-0760%2892%2990198-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Dexter, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ney, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddle, G. W.</span><span> </span><span class="NLM_article-title">Inhibition of Adrenal Corticosteroid Synthesis by Aminoglutethimide: Studies of the Mechanism of Action</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span><span class="refDoi"> DOI: 10.1210/jcem-27-4-473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem-27-4-473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=4290076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaF2sXhtFChtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1967&pages=473-480&author=R.+N.+Dexterauthor=L.+M.+Fishmanauthor=R.+L.+Neyauthor=G.+W.+Liddle&title=Inhibition+of+Adrenal+Corticosteroid+Synthesis+by+Aminoglutethimide%3A+Studies+of+the+Mechanism+of+Action&doi=10.1210%2Fjcem-27-4-473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of adrenal corticosteroid synthesis by aminoglutethimide:  the mechanism of action</span></div><div class="casAuthors">Dexter, Richard N.; Fishman, Lawrence M.; Ney, Robert L.; Liddle, Grant W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">473-80</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">cf. following abstr.  Aminoglutethimide phosphate (I) inhibited the synthesis of corticosterone by the rat adrenal cortex both in vivo and in vitro.  In intact rats the decrease in corticosterone production was accompanied by an increase in plasma ACTH.  In the presence of endogenous or exogenous ACTH, I caused a marked accumulation of adrenal cholesterol.  I did not impair the conversion of pregnenolone to corticosterone, indicating that the drug inhibited the conversion of cholesterol to pregnenolone.  I administration resulted in adrenal enlargement, an effect probably partly due to cholesterol accumulation and partly due to the adrenal growth-promoting effect of increased endogenous ACTH.  18 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNv8AAnJl98LVg90H21EOLACvtfcHk0liT9rOJJ6lUxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXhtFChtb4%253D&md5=f02f236260689320215fcaabe837d057</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1210%2Fjcem-27-4-473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-27-4-473%26sid%3Dliteratum%253Aachs%26aulast%3DDexter%26aufirst%3DR.%2BN.%26aulast%3DFishman%26aufirst%3DL.%2BM.%26aulast%3DNey%26aufirst%3DR.%2BL.%26aulast%3DLiddle%26aufirst%3DG.%2BW.%26atitle%3DInhibition%2520of%2520Adrenal%2520Corticosteroid%2520Synthesis%2520by%2520Aminoglutethimide%253A%2520Studies%2520of%2520the%2520Mechanism%2520of%2520Action%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1967%26volume%3D27%26spage%3D473%26epage%3D480%26doi%3D10.1210%2Fjcem-27-4-473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Pittman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. W.</span><span> </span><span class="NLM_article-title">Antithyroid and Antiadrenocortical Activity of Aminoglutethimide</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1014</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span><span class="refDoi"> DOI: 10.1210/jcem-26-9-1014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem-26-9-1014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=4162763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaF28XkvVCqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1966&pages=1014-1016&author=J.+A.+Pittmanauthor=R.+W.+Brown&title=Antithyroid+and+Antiadrenocortical+Activity+of+Aminoglutethimide&doi=10.1210%2Fjcem-26-9-1014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Antithyroid and antiadrenocortical activity of aminoglutethimide</span></div><div class="casAuthors">Pittman, J. A.; Brown, R. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1014-16</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">Aminoglutethimide (I) (0.3% in the diet or at 10, 25, or 50 mg./100 g. body wt.) increased thyroid wt., depressed 131I uptake, and caused adrenal enlargement in rats to a degree comparable to that in rats given amphenone B, and in addn. caused ovarian enlargement; these changes were not observed in hypophysectomized rats.  I had a goitrogenic action in rats maintained on an I-rich diet.  I may prove useful in the investigation of adrenal physiology and may block steroid synthesis in the ovaries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiAKkuwJmHqLVg90H21EOLACvtfcHk0ljPSOb5DGlvUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28XkvVCqsbk%253D&md5=585d75ea1a84b17b61c854270f10185e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1210%2Fjcem-26-9-1014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-26-9-1014%26sid%3Dliteratum%253Aachs%26aulast%3DPittman%26aufirst%3DJ.%2BA.%26aulast%3DBrown%26aufirst%3DR.%2BW.%26atitle%3DAntithyroid%2520and%2520Antiadrenocortical%2520Activity%2520of%2520Aminoglutethimide%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1966%26volume%3D26%26spage%3D1014%26epage%3D1016%26doi%3D10.1210%2Fjcem-26-9-1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Häusler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krähenbühl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span> </span><span class="NLM_article-title">An in Vitro Method to Determine the Selective Inhibition of Estrogen Biosynthesis by Aromatase Inhibitors</span> <span class="citation_source-journal">J. Steroid Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><span class="refDoi"> DOI: 10.1016/0022-4731(89)90367-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0022-4731%2889%2990367-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2527324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaL1MzktlajsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1989&pages=125-131&author=A.+H%C3%A4uslerauthor=L.+Schenkelauthor=C.+Kr%C3%A4henb%C3%BChlauthor=G.+Monnetauthor=A.+Bhatnagar&title=An+in+Vitro+Method+to+Determine+the+Selective+Inhibition+of+Estrogen+Biosynthesis+by+Aromatase+Inhibitors&doi=10.1016%2F0022-4731%2889%2990367-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">An in vitro method to determine the selective inhibition of estrogen biosynthesis by aromatase inhibitors</span></div><div class="casAuthors">Hausler A; Schenkel L; Krahenbuhl C; Monnet G; Bhatnagar A S</div><div class="citationInfo"><span class="NLM_cas:title">Journal of steroid biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-31</span>
        ISSN:<span class="NLM_cas:issn">0022-4731</span>.
    </div><div class="casAbstract">Potency and selectivity of aromatase inhibition are parameters which ultimately influence the therapeutic efficacy of aromatase inhibitors.  This report describes an in vitro model which allows an assessment of the selectivity with which aromatase inhibitors inhibit estrogen biosynthesis.  Estrogen production was stimulated by incubating adult female hamster ovarian tissue with ovine LH.  The production rates of estrogens (E), testosterone (T) and progesterone (P) were determined using radioimmunoassays to measure the amount of these steroids released into the incubation medium over a 4-hour incubation period.  The selectivity of aromatase inhibition was assessed by determining the IC50S with which each inhibitor inhibited the production of E (end product), T (immediate precursor of E) and P (early precursor of E).  Selectivity was studied for each of the 4 aromatase inhibitors, CGS 16949A (a new non-steroidal compound), 4-OH-androstenedione, aminoglutethimide and testolactone.  CGS 16949A was the most potent of the four, followed by 4-OH-androstenedione, aminoglutethimide and testolactone.  As far as selectivity was concerned, both CGS 16949A and 4-OH-androstenedione selectively inhibited aromatase judging from the IC50s for E and P production (CGS 16949A: IC50 for E & P = 0.03 & 160 microM, resp.; 4-OH-androstenedione: IC50 for E & P = 0.88 & greater than or equal to 330 microM, resp.).  Aminoglutethimide was the least selective inhibitor of aromatase (IC50 for E & P = 13 & 60 microM, resp.).  For testolactone, the least potent of the four (IC50 for E = 130 microM), no conclusive data were obtained concerning the selectivity of aromatase inhibition.  Thus a simple, effective and reproducible method is described for assessing the selectivity with which aromatase inhibitors inhibit aromatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFhjeLd4Ym9ynGiHuhFGv8fW6udTcc2eY_y9WWbvhrO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1MzktlajsA%253D%253D&md5=a58499083cdab46f25568abd546f1425</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0022-4731%2889%2990367-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-4731%252889%252990367-1%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A4usler%26aufirst%3DA.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DKr%25C3%25A4henb%25C3%25BChl%26aufirst%3DC.%26aulast%3DMonnet%26aufirst%3DG.%26aulast%3DBhatnagar%26aufirst%3DA.%26atitle%3DAn%2520in%2520Vitro%2520Method%2520to%2520Determine%2520the%2520Selective%2520Inhibition%2520of%2520Estrogen%2520Biosynthesis%2520by%2520Aromatase%2520Inhibitors%26jtitle%3DJ.%2520Steroid%2520Biochem.%26date%3D1989%26volume%3D33%26spage%3D125%26epage%3D131%26doi%3D10.1016%2F0022-4731%2889%2990367-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santner, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffcoate, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I. E.</span><span> </span><span class="NLM_article-title">Effective Inhibition by Low Dose Aminoglutethimide of Peripheral Aromatization in Postmenopausal Breast Cancer Patients</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1038/bjc.1985.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Fbjc.1985.144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=4015950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaL2M3lt1ClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1985&pages=31-35&author=M.+Dowsettauthor=S.+J.+Santnerauthor=R.+J.+Santenauthor=S.+L.+Jeffcoateauthor=I.+E.+Smith&title=Effective+Inhibition+by+Low+Dose+Aminoglutethimide+of+Peripheral+Aromatization+in+Postmenopausal+Breast+Cancer+Patients&doi=10.1038%2Fbjc.1985.144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients</span></div><div class="casAuthors">Dowsett M; Santner S J; Santen R J; Jeffcoate S L; Smith I E</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-5</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">Aminoglutethimide without glucocorticoid has been shown to be a clinically effective treatment for postmenopausal breast cancer in low dosage (250 mg day-1).  The mechanism of action of this approach is thought to be the inhibition of peripheral aromatase, the enzyme which converts androstenedione to oestrone.  The activity of this enzyme was measured in vivo by injection with 3H-androstenedione and 14C-oestrone and found to be 0.20% +/- 0.05 in 5 patients on low dose AG therapy.  In comparison with previously published data this demonstrates a 92% inhibition of peripheral aromatase activity confirming aromatase inhibition as a viable aim in the endocrine treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvz16H1bhpT4qdXsLcGTEUfW6udTcc2eY_y9WWbvhrO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M3lt1ClsA%253D%253D&md5=443f9971349fee3d38aa4b62db348d78</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1985.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1985.144%26sid%3Dliteratum%253Aachs%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DSantner%26aufirst%3DS.%2BJ.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26aulast%3DJeffcoate%26aufirst%3DS.%2BL.%26aulast%3DSmith%26aufirst%3DI.%2BE.%26atitle%3DEffective%2520Inhibition%2520by%2520Low%2520Dose%2520Aminoglutethimide%2520of%2520Peripheral%2520Aromatization%2520in%2520Postmenopausal%2520Breast%2520Cancer%2520Patients%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1985%26volume%3D52%26spage%3D31%26epage%3D35%26doi%3D10.1038%2Fbjc.1985.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Santen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veldhuis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samojlik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruby, E.</span><span> </span><span class="NLM_article-title">Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1257</span><span class="NLM_x">–</span> <span class="NLM_lpage">1265</span><span class="refDoi"> DOI: 10.1210/jcem-47-6-1257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem-47-6-1257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=263348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaL3s7os1Kguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1978&pages=1257-1265&author=R.+Santenauthor=S.+Santnerauthor=B.+Davisauthor=J.+Veldhuisauthor=E.+Samojlikauthor=E.+Ruby&title=Aminoglutethimide+Inhibits+Extraglandular+Estrogen+Production+in+Postmenopausal+Women+with+Breast+Carcinoma*&doi=10.1210%2Fjcem-47-6-1257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma</span></div><div class="casAuthors">Santen R J; Santner S; Davis B; Veldhuis J; Samojlik E; Ruby E</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical endocrinology and metabolism</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1257-65</span>
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSU8gT-p8vnf36oPH0mYWL1fW6udTcc2eZtKPDFzjX1w7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s7os1Kguw%253D%253D&md5=749daeb3ca4ed3c89cb5494197483191</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1210%2Fjcem-47-6-1257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-47-6-1257%26sid%3Dliteratum%253Aachs%26aulast%3DSanten%26aufirst%3DR.%26aulast%3DSantner%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DVeldhuis%26aufirst%3DJ.%26aulast%3DSamojlik%26aufirst%3DE.%26aulast%3DRuby%26aufirst%3DE.%26atitle%3DAminoglutethimide%2520Inhibits%2520Extraglandular%2520Estrogen%2520Production%2520in%2520Postmenopausal%2520Women%2520with%2520Breast%2520Carcinoma%252A%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1978%26volume%3D47%26spage%3D1257%26epage%3D1265%26doi%3D10.1210%2Fjcem-47-6-1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Burnett, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, D. N.</span><span> </span><span class="NLM_article-title">Some Observations on the Preparation of 2-Hydroxy-Steroid 4-En-3 Ones</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1830</span><span class="NLM_x">–</span> <span class="NLM_lpage">1836</span><span class="refDoi"> DOI: 10.1039/p19730001830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1039%2Fp19730001830" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1973&pages=1830-1836&author=R.+D.+Burnettauthor=D.+N.+Kirk&title=Some+Observations+on+the+Preparation+of+2-Hydroxy-Steroid+4-En-3+Ones&doi=10.1039%2Fp19730001830"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2Fp19730001830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp19730001830%26sid%3Dliteratum%253Aachs%26aulast%3DBurnett%26aufirst%3DR.%2BD.%26aulast%3DKirk%26aufirst%3DD.%2BN.%26atitle%3DSome%2520Observations%2520on%2520the%2520Preparation%2520of%25202-Hydroxy-Steroid%25204-En-3%2520Ones%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1973%26volume%3D17%26spage%3D1830%26epage%3D1836%26doi%3D10.1039%2Fp19730001830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, A.</span><span> </span><span class="NLM_article-title">4-Hydroxyandrostenedione in Treatment of Postmenopausal Patients with Advanced Breast Cancer</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1237</span><span class="NLM_x">–</span> <span class="NLM_lpage">1239</span><span class="refDoi"> DOI: 10.1016/S0140-6736(84)92795-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2FS0140-6736%2884%2992795-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=1984&pages=1237-1239&author=R.+C.+Coombesauthor=P.+Gossauthor=M.+Dowsettauthor=J.+C.+Gazetauthor=A.+Brodie&title=4-Hydroxyandrostenedione+in+Treatment+of+Postmenopausal+Patients+with+Advanced+Breast+Cancer&doi=10.1016%2FS0140-6736%2884%2992795-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2884%2992795-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252884%252992795-8%26sid%3Dliteratum%253Aachs%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DGoss%26aufirst%3DP.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DGazet%26aufirst%3DJ.%2BC.%26aulast%3DBrodie%26aufirst%3DA.%26atitle%3D4-Hydroxyandrostenedione%2520in%2520Treatment%2520of%2520Postmenopausal%2520Patients%2520with%2520Advanced%2520Breast%2520Cancer%26jtitle%3DLancet%26date%3D1984%26volume%3D324%26spage%3D1237%26epage%3D1239%26doi%3D10.1016%2FS0140-6736%2884%2992795-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goss, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, A. M.</span><span> </span><span class="NLM_article-title">4-Hydroxyandrostenedione Treatment for Postmenopausal Patients with Advanced Breast Cancer</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span><span class="refDoi"> DOI: 10.1016/0039-128X(83)90075-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0039-128X%2883%2990075-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1987&pages=245-252&author=R.+C.+Coombesauthor=P.+E.+Gossauthor=M.+Dowsettauthor=G.+Hutchinsonauthor=D.+Cunninghamauthor=M.+Jarmanauthor=A.+M.+Brodie&title=4-Hydroxyandrostenedione+Treatment+for+Postmenopausal+Patients+with+Advanced+Breast+Cancer&doi=10.1016%2F0039-128X%2883%2990075-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0039-128X%2883%2990075-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0039-128X%252883%252990075-2%26sid%3Dliteratum%253Aachs%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DGoss%26aufirst%3DP.%2BE.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DHutchinson%26aufirst%3DG.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DJarman%26aufirst%3DM.%26aulast%3DBrodie%26aufirst%3DA.%2BM.%26atitle%3D4-Hydroxyandrostenedione%2520Treatment%2520for%2520Postmenopausal%2520Patients%2520with%2520Advanced%2520Breast%2520Cancer%26jtitle%3DSteroids%26date%3D1987%26volume%3D50%26spage%3D245%26epage%3D252%26doi%3D10.1016%2F0039-128X%2883%2990075-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehennin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Dose-Related Endocrine Effects and Pharmacokinetics of Oral and Intramuscular 4-Hydroxyandrostenedione in Postmenopausal Breast Cancer Patients</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span><span class="refDoi"> DOI: 10.1016/0378-5122(89)90231-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0378-5122%2889%2990231-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1989&pages=1306-1312&author=M.+Dowsettauthor=D.+C.+Cunninghamauthor=R.+C.+Steinauthor=S.+Evansauthor=L.+Dehenninauthor=A.+Hedleyauthor=R.+C.+Coombes&title=Dose-Related+Endocrine+Effects+and+Pharmacokinetics+of+Oral+and+Intramuscular+4-Hydroxyandrostenedione+in+Postmenopausal+Breast+Cancer+Patients&doi=10.1016%2F0378-5122%2889%2990231-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2F0378-5122%2889%2990231-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-5122%252889%252990231-4%26sid%3Dliteratum%253Aachs%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DCunningham%26aufirst%3DD.%2BC.%26aulast%3DStein%26aufirst%3DR.%2BC.%26aulast%3DEvans%26aufirst%3DS.%26aulast%3DDehennin%26aufirst%3DL.%26aulast%3DHedley%26aufirst%3DA.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DDose-Related%2520Endocrine%2520Effects%2520and%2520Pharmacokinetics%2520of%2520Oral%2520and%2520Intramuscular%25204-Hydroxyandrostenedione%2520in%2520Postmenopausal%2520Breast%2520Cancer%2520Patients%26jtitle%3DCancer%2520Res.%26date%3D1989%26volume%3D49%26spage%3D1306%26epage%3D1312%26doi%3D10.1016%2F0378-5122%2889%2990231-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Stein, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Treatment of Advanced Breast Cancer in Postmenopausal Women with 4-Hydroxyandrostenedione</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1007/BF02940300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2FBF02940300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2322991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK3c3htlOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1990&pages=75-78&author=R.+C.+Steinauthor=M.+Dowsettauthor=A.+Hedleyauthor=J.+Davenportauthor=J.+C.+Gazetauthor=H.+T.+Fordauthor=R.+C.+Coombes&title=Treatment+of+Advanced+Breast+Cancer+in+Postmenopausal+Women+with+4-Hydroxyandrostenedione&doi=10.1007%2FBF02940300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione</span></div><div class="casAuthors">Stein R C; Dowsett M; Hedley A; Davenport J; Gazet J C; Ford H T; Coombes R C</div><div class="citationInfo"><span class="NLM_cas:title">Cancer chemotherapy and pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-8</span>
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">4-Hydroxyandrostenedione (4-OHA), a new specific aromatase inhibitor, was used to treat 57 postmenopausal women with advanced breast cancer at a dose of 250 mg by i.m. injection every 2 weeks; 55 women were assessable for response.  In all, 18 patients (33%) had objective evidence of a response to treatment, with a median duration of 12 months; the disease stabilised in 8 (14%) patients.  Serum oestradiol levels, which were measured weekly in nine of the patients, were found to be suppressed to a mean of between 36% and 51% of pretreatment levels during the first 6 weeks of treatment.  Three patients were withdrawn from treatment because of toxicity (pain at injection site, sterile abscess and rash).  One patient had an isolated episode of anaphylaxis after 6 months of treatment.  In comparison with our previous reports of 4-OHA treatment, a dose of 250 mg given i.m. fortnightly appears to be the optimal dose regimen.  The efficacy of the drug seems to be similar to that of tamoxifen and aminoglutethimide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtCGYCvXCB4WhHGZei4OW9fW6udTcc2eZtKPDFzjX1w7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c3htlOltA%253D%253D&md5=aa22dceadf08dfdb28ad2ef47c866d2f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FBF02940300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02940300%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DR.%2BC.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DHedley%26aufirst%3DA.%26aulast%3DDavenport%26aufirst%3DJ.%26aulast%3DGazet%26aufirst%3DJ.%2BC.%26aulast%3DFord%26aufirst%3DH.%2BT.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DTreatment%2520of%2520Advanced%2520Breast%2520Cancer%2520in%2520Postmenopausal%2520Women%2520with%25204-Hydroxyandrostenedione%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1990%26volume%3D26%26spage%3D75%26epage%3D78%26doi%3D10.1007%2FBF02940300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Stein, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">The Clinical and Endocrine Effects of 4-Hydroxyandrostenedione Alone and in Combination with Goserelin in Premenopausal Women with Advanced Breast Cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span><span class="refDoi"> DOI: 10.1038/bjc.1990.356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Fbjc.1990.356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2145964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK3M%252FislCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1990&pages=679-683&author=R.+C.+Steinauthor=M.+Dowsettauthor=A.+Hedleyauthor=J.+C.+Gazetauthor=H.+T.+Fordauthor=R.+C.+Coombes&title=The+Clinical+and+Endocrine+Effects+of+4-Hydroxyandrostenedione+Alone+and+in+Combination+with+Goserelin+in+Premenopausal+Women+with+Advanced+Breast+Cancer&doi=10.1038%2Fbjc.1990.356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer</span></div><div class="casAuthors">Stein R C; Dowsett M; Hedley A; Gazet J C; Ford H T; Coombes R C</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">679-83</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">The aromatase inhibitor, 4-hydroxyandrostenedione (4OHA) is an effective treatment for advanced post-menopausal breast cancer.  The clinical and endocrine effects of 4OHA treatment were studied in five pre- and perimenopausal women with metastatic breast cancer.  Serum oestradiol levels were not significantly reduced as a result of treatment with 500 mg of 4OHA by weekly i.m. injections and no patient had a tumour response.  Four patients were subsequently treated with the luteinising hormone releasing hormone (LHRH) analogue, gosereline, and three had objective responses.  The endocrine effects of combined treatment with goserelin (Zoladex), and 4OHA were studied in a further five premenopausal women.  Serum oestradiol levels after treatment with goserelin alone were typical of post-menopausal women.  Addition of 4OHA led to a further suppression of oestradiol to within the range observed in post-menopausal patients treated with further suppression of oestradiol to within the range observed in post-menopausal patients treated with 4OHA.  Six patients whose tumours had regressed as a result of goserelin treatment and who subsequently relapsed were then given combined treatment.  Four of the six experienced a second remission.  We conclude that while 4OHA alone is unlikely to be a satisfactory treatment for premenopausal patients with advanced breast cancer, 4OHA in conjunction with goserelin leads to profound suppression of oestradiol.  The combination of LHRH analogue and aromatase inhibitor may prove to be a superior treatment to LHRH analogue alone in these patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSy1pRqlJLHcf3jf77P2BG3fW6udTcc2eYqc43ZdWj25Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M%252FislCrsg%253D%253D&md5=dcbf6639d988d44a17231329ec1bc9c9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1990.356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1990.356%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DR.%2BC.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DHedley%26aufirst%3DA.%26aulast%3DGazet%26aufirst%3DJ.%2BC.%26aulast%3DFord%26aufirst%3DH.%2BT.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DThe%2520Clinical%2520and%2520Endocrine%2520Effects%2520of%25204-Hydroxyandrostenedione%2520Alone%2520and%2520in%2520Combination%2520with%2520Goserelin%2520in%2520Premenopausal%2520Women%2520with%2520Advanced%2520Breast%2520Cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1990%26volume%3D62%26spage%3D679%26epage%3D683%26doi%3D10.1038%2Fbjc.1990.356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Brodie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, H. J.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors and Their Use in Controlling Oestrogen-Dependent Processes</span> <span class="citation_source-journal">J. Steroid Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1016/0022-4731(79)90283-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0022-4731%2879%2990283-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=114710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaE1MXls1yqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1979&pages=107-112&author=A.+M.+Brodieauthor=D.+A.+Marshauthor=J.+T.+Wuauthor=H.+J.+Brodie&title=Aromatase+Inhibitors+and+Their+Use+in+Controlling+Oestrogen-Dependent+Processes&doi=10.1016%2F0022-4731%2879%2990283-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase inhibitors and their use in controlling estrogen-dependent processes</span></div><div class="casAuthors">Brodie, Angela M. H.; Marsh, David A.; Wu, J. T.; Brodie, Harry J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1A</span>),
    <span class="NLM_cas:pages">107-12</span>CODEN:
                <span class="NLM_cas:coden">JSTBBK</span>;
        ISSN:<span class="NLM_cas:issn">0022-4731</span>.
    </div><div class="casAbstract">In antifertility studies, rats were treated from diestrus 1 of the cycle with aromatase  [9039-48-9] inhibitors, 4-acetoxy-4-androstene-3,17-dione (I)  [61630-32-8], 4-hydroxy-4-androstene-3,17-dione  [566-48-3], and 1,4,6-androstatriene-3,17-dione  [633-35-2].  The estrogen surge and subsequent LH  [9002-67-9] surge normally occurring during proestrus were inhibited and mating and ovulation prevented.  These effects were counteracted when estradiol benzoate  [50-50-0] was administered concomitantly with aromatase inhibitors.  The compds. also retared implantation, an estrogen-dependent process in the rat, and ovarian estradiol  [50-28-2] secretion was reduced on day 4 of pregnancy.  In contrast, hamsters did not require estrogen for implantation and aromatase inhibitors were without effect.  The compds. were also highly effective in causing regression of dimethylbenzanthracene-induced, hormone-dependent, mammary tumors of the rat.  Ovarian estrogen secretion measured at the end of treatment with I was reduced compared with controls, and when supplemental estradiol was given, together with aromatase inhibitors, tumor regression was prevented.  Aromatase inhibitors apparently act in vivo to reduce estrogen prodn. by aromatase inhibition.  They thus have potential for treating estrogen-related disorders, for fertility control, and as tools for investigating the role of estrogen in physiol. and pathol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR2Wu7-6dA3bVg90H21EOLACvtfcHk0libPUv8ZAOgCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXls1yqsb0%253D&md5=62cbfa21dc603adf0f39440990f27b89</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0022-4731%2879%2990283-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-4731%252879%252990283-8%26sid%3Dliteratum%253Aachs%26aulast%3DBrodie%26aufirst%3DA.%2BM.%26aulast%3DMarsh%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BT.%26aulast%3DBrodie%26aufirst%3DH.%2BJ.%26atitle%3DAromatase%2520Inhibitors%2520and%2520Their%2520Use%2520in%2520Controlling%2520Oestrogen-Dependent%2520Processes%26jtitle%3DJ.%2520Steroid%2520Biochem.%26date%3D1979%26volume%3D11%26spage%3D107%26epage%3D112%26doi%3D10.1016%2F0022-4731%2879%2990283-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briatico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giudici, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaccheo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzzetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzeri, A.</span><span> </span><span class="NLM_article-title">Novel Aromatase and 5 Alpha-Reductase Inhibitors</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1016/0960-0760(94)90270-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2894%2990270-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=8043491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFKhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1994&pages=289-294&author=E.+Di+Salleauthor=G.+Briaticoauthor=D.+Giudiciauthor=G.+Ornatiauthor=T.+Zaccheoauthor=F.+Buzzettiauthor=M.+Nesiauthor=A.+Panzeri&title=Novel+Aromatase+and+5+Alpha-Reductase+Inhibitors&doi=10.1016%2F0960-0760%2894%2990270-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel aromatase and 5α-reductase inhibitors</span></div><div class="casAuthors">Di Salle, E.; Briatico, G.; Giudici, D.; Ornati, G.; Zaccheo, T.; Buzzetti, F.; Nesi, M.; Panzeri, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">289-94</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">Inhibitors of aromatase and 5α-reductase may be of use for the therapy of postmenopausal breast cancer and benign prostatic hyperplasia, resp.  FCE 27993 is a novel steroidal irreversible aromatase inhibitor structurally related to exemestane (FCE 24304).  The compd. was found to be a very potent competitive inhibitor of human placental aromatase, with a Ki of 7.2 nM (4.3 nM for exemestane).  In preincubation studies with placental aromatase FCE 27993, like exemestane, was found to cause time-dependent inhibition with a higher rate of inactivation (t1/2 4.5 vs 15.1 min) and a similar Ki(inact) (56 vs 66 nM).  The compd. was found to have a very low binding affinity to the androgen receptor (RBA 0.09% of dihydrotestosterone) and, in contrast to exemestane, no androgenic activity up to 100 mg/kg/day s.c. in immature castrated rats.  Among a series of novel 4-azasteroids with fluoro-substituted-17β-amidic side chains, three compds., namely FCE 28260, FCE 28175 and FCE 27837, were identified as potent in vitro and in vivo inhibitors of prostatic 5α-reductase.  Their IC50 values were found to be 16, 38 and 51 nM for the inhibition of the human enzyme, and 15, 20 and 60 nM for the inhibition of the rat enzyme, resp.  When given orally for 7 days in castrated and testosterone (Silastic implants) supplemented rats, the new compds. were very effective in reducing prostate growth.  At a dose of 0.3 mg/kg/day inhibitions of 42, 36 and 41% were caused by FCE 28260, FCE 28175 and FCE 27837, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe1POpwjBSaLVg90H21EOLACvtfcHk0libPUv8ZAOgCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFKhs7w%253D&md5=9575b614af25a96aaddeeedfdc695ce1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2894%2990270-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252894%252990270-4%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BSalle%26aufirst%3DE.%26aulast%3DBriatico%26aufirst%3DG.%26aulast%3DGiudici%26aufirst%3DD.%26aulast%3DOrnati%26aufirst%3DG.%26aulast%3DZaccheo%26aufirst%3DT.%26aulast%3DBuzzetti%26aufirst%3DF.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DPanzeri%26aufirst%3DA.%26atitle%3DNovel%2520Aromatase%2520and%25205%2520Alpha-Reductase%2520Inhibitors%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1994%26volume%3D49%26spage%3D289%26epage%3D294%26doi%3D10.1016%2F0960-0760%2894%2990270-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Santen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langecker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swerdloff, R.</span><span> </span><span class="NLM_article-title">Potency and Specificity of CGS-16949A as an Aromatase Inhibitor</span> <span class="citation_source-journal">Endocr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span><span class="refDoi"> DOI: 10.1080/07435809009035921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1080%2F07435809009035921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2139412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK3cXitFSlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1990&pages=77-91&author=R.+Santenauthor=P.+Langeckerauthor=S.+Santnerauthor=S.+Sikkaauthor=J.+Rajferauthor=R.+Swerdloff&title=Potency+and+Specificity+of+CGS-16949A+as+an+Aromatase+Inhibitor&doi=10.1080%2F07435809009035921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Potency and specificity of CGS-16949A as an aromatase inhibitor</span></div><div class="casAuthors">Santen, R. J.; Langecker, P.; Santner, S. J.; Sikka, S.; Rajfer, J.; Swerdloff, R.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-91</span>CODEN:
                <span class="NLM_cas:coden">ENRSE8</span>;
        ISSN:<span class="NLM_cas:issn">0743-5800</span>.
    </div><div class="casAbstract">The potency and specificity of a new aromatase inhibitor, CGS-16949A, were compared with that of aminoglutethimide in a variety of in vitro enzyme prepns.  CGS-16949A blocked aromatase by 50% in human breast cancer homogenates, live breast cancer cells, human placental microsomes and porcine ovarian microsomes at concns. of 0.008 to 0.02 μM.  In contrast, concns. of 10-25 μM of aminoglutethimide were required to inhibit aromatase similarly in these tissues.  For human placental microsomes, the Ki for CGS 16949A was 0.17 nM and for aminoglutethimide, 0.54 μM.  Preincubation studies indicated that CGS-16949A acts by a competitive inhibitory mechanism and not by "suicide inhibitory" properties.  With respect to specificity, CGS-16949A had no effect on cholesterol side-chain cleavage activity in rat testicular mitochondria.  A 54% redn. in enzyme activity was obsd. in adrenal mitochondria but only at concns. 5 orders of magnitude higher (i.e. 100 μM) than required to inhibit aromatase.  In contrast, 10 μM concns. of aminoglutethimide blocked cholesterol side-chain cleavage activity in rat testicular and adrenal mitochondria by 67 and 91%, resp.  These data suggest that CGS-16949A has favorable properties as a specific and potent aromatase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWRfSJqz10mLVg90H21EOLACvtfcHk0lglfHuF9muPfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFSlsLg%253D&md5=b5db121c5ba4f8102aefb99bf43a418f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1080%2F07435809009035921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07435809009035921%26sid%3Dliteratum%253Aachs%26aulast%3DSanten%26aufirst%3DR.%26aulast%3DLangecker%26aufirst%3DP.%26aulast%3DSantner%26aufirst%3DS.%26aulast%3DSikka%26aufirst%3DS.%26aulast%3DRajfer%26aufirst%3DJ.%26aulast%3DSwerdloff%26aufirst%3DR.%26atitle%3DPotency%2520and%2520Specificity%2520of%2520CGS-16949A%2520as%2520an%2520Aromatase%2520Inhibitor%26jtitle%3DEndocr.%2520Res.%26date%3D1990%26volume%3D16%26spage%3D77%26epage%3D91%26doi%3D10.1080%2F07435809009035921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Browne, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnager, A.</span><span> </span><span class="NLM_article-title">Fadrozole Hydrochloride: A Potent, Selective, Nonsteroidal Inhibitor of Aromatase for the Treatment of Estrogen-Dependent Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span><span class="refDoi"> DOI: 10.1021/jm00106a038</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00106a038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=725-736&author=L.+J.+Browneauthor=C.+Gudeauthor=H.+Rodriguezauthor=R.+E.+Steeleauthor=A.+Bhatnager&title=Fadrozole+Hydrochloride%3A+A+Potent%2C+Selective%2C+Nonsteroidal+Inhibitor+of+Aromatase+for+the+Treatment+of+Estrogen-Dependent+Disease&doi=10.1021%2Fjm00106a038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm00106a038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00106a038%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DL.%2BJ.%26aulast%3DGude%26aufirst%3DC.%26aulast%3DRodriguez%26aufirst%3DH.%26aulast%3DSteele%26aufirst%3DR.%2BE.%26aulast%3DBhatnager%26aufirst%3DA.%26atitle%3DFadrozole%2520Hydrochloride%253A%2520A%2520Potent%252C%2520Selective%252C%2520Nonsteroidal%2520Inhibitor%2520of%2520Aromatase%2520for%2520the%2520Treatment%2520of%2520Estrogen-Dependent%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D725%26epage%3D736%26doi%3D10.1021%2Fjm00106a038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Bossche, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moereels, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koymans, L. M.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors—Mechanisms for Non-Steroidal Inhibitors</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1007/BF00682740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2FBF00682740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=7949204" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1994&pages=43-55&author=H.+V.+Bosscheauthor=H.+Moereelsauthor=L.+M.+Koymans&title=Aromatase+Inhibitors%E2%80%94Mechanisms+for+Non-Steroidal+Inhibitors&doi=10.1007%2FBF00682740"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2FBF00682740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00682740%26sid%3Dliteratum%253Aachs%26aulast%3DBossche%26aufirst%3DH.%2BV.%26aulast%3DMoereels%26aufirst%3DH.%26aulast%3DKoymans%26aufirst%3DL.%2BM.%26atitle%3DAromatase%2520Inhibitors%25E2%2580%2594Mechanisms%2520for%2520Non-Steroidal%2520Inhibitors%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1994%26volume%3D30%26spage%3D43%26epage%3D55%26doi%3D10.1007%2FBF00682740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Santen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demers, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adlercreutz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, A.</span><span> </span><span class="NLM_article-title">Inhibition of Aromatase with CGS 16949A in Postmenopausal Women</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1210/jcem-68-1-99</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem-68-1-99" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2521224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaL1MXhtVOksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1989&pages=99-106&author=R.+J.+Santenauthor=L.+M.+Demersauthor=H.+Adlercreutzauthor=H.+Harveyauthor=S.+Santnerauthor=S.+Sandersauthor=A.+Lipton&title=Inhibition+of+Aromatase+with+CGS+16949A+in+Postmenopausal+Women&doi=10.1210%2Fjcem-68-1-99"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of aromatase with CGS 16949A in postmenopausal women</span></div><div class="casAuthors">Santen, R. J.; Demers, L. M.; Adlercreutz, H.; Harvey, H.; Santner, S.; Sanders, S.; Lipton, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-106</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">The effects of CGS 16949 (I), a nonsteroidal inhibitor of aromatase activity were evaluated, in postmenopausal women with breast cancer by measuring plasma and/or urinary androgens and estrogens after oral administration at 0.6-16 mg daily, given for 2 wk.  The 0.6-mg daily dose partially lowered estrogen levels, and max. redn. occurred at 2-16 mg daily.  The fall in plasma and urinary estrogens without a concomitant fall in plasma androgens confirmed the blockade of aromatase activity.  The degree of estrogen redn. was greatest for urinary estrone, followed in order by plasma estrone sulfate, plasma estrone, urine estradiol, and plasma estradiol.  Use of gas liq. chromatog.-mass spectrometry techniques revealed similar patterns of redn. in catechol estrogens, estriol, and total urinary estrogens, suggesting that CGS 16949A does not alter the pathways of estrogen metab.  The degree of estrogen redn. was remarkably similar to that caused with aminoglutethimide.  At 4-16 mg daily, CGS 16949A inhibited the C21-hydroxylase enzyme as well, based on concomitant rises in plasma androstenedione, testosterone, and 17α-hydroxyprogesterone.  This effect was insufficient to lower urinary cortisol excretion during the study.  However, a blunting of plasma cortisol responses to ACTH occurred with the 16-mg daily dose.  No changes in plasma dehydroepiandrosterone sulfate levels or in thyroid, hematol., liver, or renal parameters were found.  No side-effects of the medication were encountered.  CGS 16949A appears to be a specific inhibitor of aromatase at <4 mg daily and to lack apparent side-effects or toxic actions at ≤16 mg daily.  This agent shows promise as a potent aromatase inhibitor for physiol. and clin. studies, and to be useful for the treatment of breast cancer and other disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxq61cvYJMgbVg90H21EOLACvtfcHk0lglfHuF9muPfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtVOksbo%253D&md5=aab246213f8d762a4b0777e94da3129e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1210%2Fjcem-68-1-99&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-68-1-99%26sid%3Dliteratum%253Aachs%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26aulast%3DDemers%26aufirst%3DL.%2BM.%26aulast%3DAdlercreutz%26aufirst%3DH.%26aulast%3DHarvey%26aufirst%3DH.%26aulast%3DSantner%26aufirst%3DS.%26aulast%3DSanders%26aufirst%3DS.%26aulast%3DLipton%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520Aromatase%2520with%2520CGS%252016949A%2520in%2520Postmenopausal%2520Women%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1989%26volume%3D68%26spage%3D99%26epage%3D106%26doi%3D10.1210%2Fjcem-68-1-99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Lipton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demers, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanagan, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulagha, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochak, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzsimmons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span> </span><span class="NLM_article-title">A Phase I Trial of CGS 16949A. A New Aromatase Inhibitor</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1285</span><span class="refDoi"> DOI: 10.1002/1097-0142(19900315)65:6<1279::AID-CNCR2820650604>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2F1097-0142%2819900315%2965%3A6%3C1279%3A%3AAID-CNCR2820650604%3E3.0.CO%3B2-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1990&pages=1279-1285&author=A.+Liptonauthor=H.+A.+Harveyauthor=L.+M.+Demersauthor=J.+R.+Hanaganauthor=M.+T.+Mulaghaauthor=G.+M.+Kochakauthor=S.+Fitzsimmonsauthor=S.+I.+Sandersauthor=R.+J.+Santen&title=A+Phase+I+Trial+of+CGS+16949A.+A+New+Aromatase+Inhibitor&doi=10.1002%2F1097-0142%2819900315%2965%3A6%3C1279%3A%3AAID-CNCR2820650604%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2F1097-0142%2819900315%2965%3A6%3C1279%3A%3AAID-CNCR2820650604%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0142%252819900315%252965%253A6%253C1279%253A%253AAID-CNCR2820650604%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DA.%26aulast%3DHarvey%26aufirst%3DH.%2BA.%26aulast%3DDemers%26aufirst%3DL.%2BM.%26aulast%3DHanagan%26aufirst%3DJ.%2BR.%26aulast%3DMulagha%26aufirst%3DM.%2BT.%26aulast%3DKochak%26aufirst%3DG.%2BM.%26aulast%3DFitzsimmons%26aufirst%3DS.%26aulast%3DSanders%26aufirst%3DS.%2BI.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26atitle%3DA%2520Phase%2520I%2520Trial%2520of%2520CGS%252016949A.%2520A%2520New%2520Aromatase%2520Inhibitor%26jtitle%3DCancer%26date%3D1990%26volume%3D65%26spage%3D1279%26epage%3D1285%26doi%3D10.1002%2F1097-0142%2819900315%2965%3A6%3C1279%3A%3AAID-CNCR2820650604%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Potency and Selectivity of the Non-Steroidal Aromatase Inhibitor CGS 16949A in Postmenopausal Breast Cancer Patients</span> <span class="citation_source-journal">Clin. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span><span class="refDoi"> DOI: 10.1111/j.1365-2265.1990.tb00906.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1111%2Fj.1365-2265.1990.tb00906.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2142026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK3czgsFWqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1990&pages=623-634&author=M.+Dowsettauthor=R.+C.+Steinauthor=A.+Mehtaauthor=R.+C.+Coombes&title=Potency+and+Selectivity+of+the+Non-Steroidal+Aromatase+Inhibitor+CGS+16949A+in+Postmenopausal+Breast+Cancer+Patients&doi=10.1111%2Fj.1365-2265.1990.tb00906.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients</span></div><div class="casAuthors">Dowsett M; Stein R C; Mehta A; Coombes R C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical endocrinology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">623-34</span>
        ISSN:<span class="NLM_cas:issn">0300-0664</span>.
    </div><div class="casAbstract">A selective inhibitor of aromatase is widely sought for the treatment of postmenopausal women with breast cancer.  CGS 16949A has been shown to be a highly selective, potent inhibitor of aromatase in vitro.  Its potency as an oestrogen suppressant and its selectivity were examined by treating 24 postmenopausal patients with advanced breast cancer for 4 weeks with doses of 0.3, 1.0 and 2.0 mg twice daily.  The study was conducted in two parts which compared the two lower doses and the two higher doses separately in a cross-over design protocol.  All doses significantly suppressed serum oestradiol and oestrone levels below pretreatment levels.  Cross-over analysis indicated that the 2.0 mg twice daily dose achieved significantly greater suppression of oestradiol levels than 0.1 mg twice daily but there was no significant differences between any of the doses in the suppression of oestrone.  No significant effects were noted on serum levels of LH, FSH, SHBG, prolactin, testosterone, androstenedione, 17-hydroxyprogesterone or cortisol.  For the four steroids this was true both for basal samples and those collected after Synacthen stimulation.  However, serum aldosterone levels were significantly suppressed by 1.0 mg twice daily CGS 16949A and further suppressed by 2.0 mg twice daily.  It is concluded that CGS 16949A is a potent oestrogen suppressant in postmenopausal patients but that its effect is not totally selective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhFUz3M74neYUSrryheKE6fW6udTcc2ebQzmeFGgxVubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3czgsFWqsg%253D%253D&md5=1296c601596b6c535f2f0e217d2f42b8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2265.1990.tb00906.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2265.1990.tb00906.x%26sid%3Dliteratum%253Aachs%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DStein%26aufirst%3DR.%2BC.%26aulast%3DMehta%26aufirst%3DA.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DPotency%2520and%2520Selectivity%2520of%2520the%2520Non-Steroidal%2520Aromatase%2520Inhibitor%2520CGS%252016949A%2520in%2520Postmenopausal%2520Breast%2520Cancer%2520Patients%26jtitle%3DClin.%2520Endocrinol.%26date%3D1990%26volume%3D32%26spage%3D623%26epage%3D634%26doi%3D10.1111%2Fj.1365-2265.1990.tb00906.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Stein, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Preliminary Study of the Treatment of Advanced Breast Cancer in Postmenopausal Women with the Aromatase Inhibitor CGS 16949A</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=1381-1384&author=R.+C.+Steinauthor=M.+Dowsettauthor=J.+Davenportauthor=A.+Hedleyauthor=H.+T.+Fordauthor=J.+C.+Gazetauthor=R.+C.+Coombes&title=Preliminary+Study+of+the+Treatment+of+Advanced+Breast+Cancer+in+Postmenopausal+Women+with+the+Aromatase+Inhibitor+CGS+16949A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DR.%2BC.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DDavenport%26aufirst%3DJ.%26aulast%3DHedley%26aufirst%3DA.%26aulast%3DFord%26aufirst%3DH.%2BT.%26aulast%3DGazet%26aufirst%3DJ.%2BC.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DPreliminary%2520Study%2520of%2520the%2520Treatment%2520of%2520Advanced%2520Breast%2520Cancer%2520in%2520Postmenopausal%2520Women%2520with%2520the%2520Aromatase%2520Inhibitor%2520CGS%252016949A%26jtitle%3DCancer%2520Res.%26date%3D1990%26volume%3D50%26spage%3D1381%26epage%3D1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Santen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demers, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulagha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanagan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garber, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navari, R. M.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Specificity of Low Dose Fadrozole Hydrochloride (CGS 16949A) as an Aromatase Inhibitor</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1210/jcem-73-1-99</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem-73-1-99" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1646219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK3M3lvVGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1991&pages=99-106&author=R.+J.+Santenauthor=L.+M.+Demersauthor=J.+Lynchauthor=H.+Harveyauthor=A.+Liptonauthor=M.+Mulaghaauthor=J.+Hanaganauthor=J.+E.+Garberauthor=I.+C.+Hendersonauthor=R.+M.+Navari&title=Specificity+of+Low+Dose+Fadrozole+Hydrochloride+%28CGS+16949A%29+as+an+Aromatase+Inhibitor&doi=10.1210%2Fjcem-73-1-99"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor</span></div><div class="casAuthors">Santen R J; Demers L M; Lynch J; Harvey H; Lipton A; Mulagha M; Hanagan J; Garber J E; Henderson I C; Navari R M; et al</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical endocrinology and metabolism</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-106</span>
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">CGS 16949A (fadrozole hydrochloride), a potent cytochrome P450-mediated steroidogenesis inhibitor, blocks aromatase at low doses, but other biosynthetic steps at higher concentrations.  Recent studies demonstrated inhibition of C11-hydroxylase, corticosterone methyloxidase-II, and deoxycorticosterone to corticosterone conversion with this agent at some-what higher concentrations than those required for blockade of aromatase.  Based upon phase I studies, we postulated that relatively selective inhibition of aromatase might be possible if sufficiently low doses of CGS 16949A were used.  A phase II study in 54 postmenopausal women with metastatic breast cancer examined the effects of low dose CGS 16949A on estrogen, mineralocorticoid, and glucocorticoid secretion.  Two dose schedules and two dose levels were chosen based upon our prior dose escalation protocol study.  Plasma estrone, estradiol, and estrone sulfate as well as urinary estrone and estradiol fell equally with 1.8-4 mg CGS 16949A given either on a twice daily or three times daily dose schedule.  Isotopic kinetic studies demonstrated an 84% decrease in the rate of conversion of androstenedione to estrone to 0.40 +/- 0.07% (patients receiving 1.8-4 mg CGS 16949A daily).  With these three regimens, basal levels of aldosterone and cortisol did not change significantly over a 12-week period of observation.  Clinical examination, plasma electrolytes, and urinary sodium/potassium ratios suggested no biological evidence of mineralo-corticoid deficiency.  ACTH-stimulated cortisol concentrations, however, were blunted at each dose level compared to pretreatment values.  Nonetheless, peak responses exceeded 550 nmol/L, or a basal to peak difference of 190 nmol/L or greater, in 97% of instances.  This probably reflected inhibition of C11-hydroxylase, since basal and ACTH-stimulated levels of 11-deoxycortisol were increased in response to CGS 16949A.  Androstenedione and 17 alpha-hydroxyprogesterone also exhibited an upward trend in response to drug treatment.  ACTH-stimulated aldosterone levels were blunted to a greater extent than those of cortisol, probably as a reflection of corticosterone methyloxidase type II blockade.  Overall, the results suggest that CGS 16949A, at doses of 1.8-2 mg daily, blocks aromatase effectively and does not produce clinically important inhibition of cortisol or aldosterone biosynthesis.  Thus, this agent can probably be used safely without glucocorticoid or mineralocorticoid supplementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSG3H0oyaye84FEOhA_Im3cfW6udTcc2ebQzmeFGgxVubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3lvVGitw%253D%253D&md5=49734a62d6a4be5f05ffb6e5e0853cc6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1210%2Fjcem-73-1-99&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-73-1-99%26sid%3Dliteratum%253Aachs%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26aulast%3DDemers%26aufirst%3DL.%2BM.%26aulast%3DLynch%26aufirst%3DJ.%26aulast%3DHarvey%26aufirst%3DH.%26aulast%3DLipton%26aufirst%3DA.%26aulast%3DMulagha%26aufirst%3DM.%26aulast%3DHanagan%26aufirst%3DJ.%26aulast%3DGarber%26aufirst%3DJ.%2BE.%26aulast%3DHenderson%26aufirst%3DI.%2BC.%26aulast%3DNavari%26aufirst%3DR.%2BM.%26atitle%3DSpecificity%2520of%2520Low%2520Dose%2520Fadrozole%2520Hydrochloride%2520%2528CGS%252016949A%2529%2520as%2520an%2520Aromatase%2520Inhibitor%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1991%26volume%3D73%26spage%3D99%26epage%3D106%26doi%3D10.1210%2Fjcem-73-1-99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Raats, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falkson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falkson, H. C.</span><span> </span><span class="NLM_article-title">A Study of Fadrozole, a New Aromatase Inhibitor, in Postmenopausal Women with Advanced Metastatic Breast Cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1530798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK38%252Fpt1Smsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1992&pages=111-116&author=J.+I.+Raatsauthor=G.+Falksonauthor=H.+C.+Falkson&title=A+Study+of+Fadrozole%2C+a+New+Aromatase+Inhibitor%2C+in+Postmenopausal+Women+with+Advanced+Metastatic+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer</span></div><div class="casAuthors">Raats J I; Falkson G; Falkson H C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-6</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">PURPOSE:  The study investigated the therapeutic effects of fadrozole (CGS 16949A), a new aromatase inhibitor, in women who had received prior treatment for metastatic breast cancer.  MATERIALS AND METHODS:  Eighty postmenopausal women who had received prior treatment for metastatic breast cancer were randomized to receive fadrozole 1 mg/d or 4 mg/d per day orally.  Seventy-eight patients were assessable for toxicity and response.  RESULTS:  Toxicity was limited to mild (grade 1) to moderate (grade 2) hot flashes in 28%, nausea and vomiting in 13%, fatigue in 8%, and mild loss of appetite in 5% of patients.  No electrolyte or unanticipated hormonal changes occurred.  The overall response was 23% (complete response, 10%; partial response, 13%).  In addition, 45% of the patients had a no change status.  There was no difference in response rate between the patients randomized to the two different doses of fadrozole.  Only dominant site of metastases significantly affected response.  The median time to treatment failure (TTF) was 4.4 months (4.7 months on 1 mg/d and 3.7 months on 4 mg/d).  The median survival was 22.6 months (17.5 months on 1 mg/d; median survival has not been reached in patients on 4 mg/d).  The response and survival in patients with estrogen receptor (ER)-positive and ER-unknown disease were not significantly different.  CONCLUSIONS:  Fadrozole has good therapeutic effect as a second-line treatment in postmenopausal women with metastatic breast cancer.  In this study there was no significant difference in toxicity or response between 1 mg/d and 4 mg/d.  Further trials comparing fadrozole to other hormone treatment are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDFxhnqm7MlIFEOhA_Im3cfW6udTcc2eYDvkB5Sfv7f7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38%252Fpt1Smsw%253D%253D&md5=6a702f198ab97dff12812e224eccf309</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaats%26aufirst%3DJ.%2BI.%26aulast%3DFalkson%26aufirst%3DG.%26aulast%3DFalkson%26aufirst%3DH.%2BC.%26atitle%3DA%2520Study%2520of%2520Fadrozole%252C%2520a%2520New%2520Aromatase%2520Inhibitor%252C%2520in%2520Postmenopausal%2520Women%2520with%2520Advanced%2520Metastatic%2520Breast%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D1992%26volume%3D10%26spage%3D111%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Miller, W. R.</span><span> </span><span class="NLM_article-title">Biology of Aromatase Inhibitors: Pharmacology/Endocrinology within the Breast</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1677/erc.0.0060187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1677%2Ferc.0.0060187" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=187-195&author=W.+R.+Miller&title=Biology+of+Aromatase+Inhibitors%3A+Pharmacology%2FEndocrinology+within+the+Breast&doi=10.1677%2Ferc.0.0060187"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1677%2Ferc.0.0060187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Ferc.0.0060187%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DW.%2BR.%26atitle%3DBiology%2520of%2520Aromatase%2520Inhibitors%253A%2520Pharmacology%252FEndocrinology%2520within%2520the%2520Breast%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D1999%26volume%3D6%26spage%3D187%26epage%3D195%26doi%3D10.1677%2Ferc.0.0060187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Brodie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njar, V. C.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors in Advanced Breast Cancer: Mechanism of Action and Clinical Implications</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1016/S0960-0760(98)00022-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2FS0960-0760%2898%2900022-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=9712406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK1cXkvV2gs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1998&pages=1-10&author=A.+M.+Brodieauthor=V.+C.+Njar&title=Aromatase+Inhibitors+in+Advanced+Breast+Cancer%3A+Mechanism+of+Action+and+Clinical+Implications&doi=10.1016%2FS0960-0760%2898%2900022-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications</span></div><div class="casAuthors">Brodie, Angela M. H.; Njar, Vincent C. O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 84 refs.  A no. of potent and selective inhibitors of aromatase have been developed that possess impressive pharmacol. and clin. properties in breast tumors.  Three compds., formestane, anastrozole, and letrozole, are now available for use in treatment of advanced breast cancer in postmenopausal women.  Other promising aromatase inhibitors are presently in clin. trials.  As drug resistance remains a major problem in cancer treatment, the variety of well-tolerated aromatase inhibitors with differing chem. structures offers the possibility that several useful drugs will be available for extending the treatment of breast cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovYubbfg1MrLVg90H21EOLACvtfcHk0lj-49FXCasGzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvV2gs74%253D&md5=53296b1a231cdc13af8aa3d979ae0961</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2898%2900022-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252898%252900022-3%26sid%3Dliteratum%253Aachs%26aulast%3DBrodie%26aufirst%3DA.%2BM.%26aulast%3DNjar%26aufirst%3DV.%2BC.%26atitle%3DAromatase%2520Inhibitors%2520in%2520Advanced%2520Breast%2520Cancer%253A%2520Mechanism%2520of%2520Action%2520and%2520Clinical%2520Implications%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D66%26spage%3D1%26epage%3D10%26doi%3D10.1016%2FS0960-0760%2898%2900022-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Gibson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliss, J. M.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors for Treatment of Advanced Breast Cancer in Postmenopausal Women</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD003370</span><span class="refDoi"> DOI: 10.1002/14651858.CD003370.pub2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2F14651858.CD003370.pub2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=CD003370&author=L.+J.+Gibsonauthor=C.+Dawsonauthor=D.+H.+Lawrenceauthor=J.+M.+Bliss&title=Aromatase+Inhibitors+for+Treatment+of+Advanced+Breast+Cancer+in+Postmenopausal+Women&doi=10.1002%2F14651858.CD003370.pub2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD003370.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD003370.pub2%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DL.%2BJ.%26aulast%3DDawson%26aufirst%3DC.%26aulast%3DLawrence%26aufirst%3DD.%2BH.%26aulast%3DBliss%26aufirst%3DJ.%2BM.%26atitle%3DAromatase%2520Inhibitors%2520for%2520Treatment%2520of%2520Advanced%2520Breast%2520Cancer%2520in%2520Postmenopausal%2520Women%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2007%26spage%3DCD003370%26doi%3D10.1002%2F14651858.CD003370.pub2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbuta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, H. M.</span><span> </span><span class="NLM_article-title">Novel Aromatase Inhibitors by Structure-Guided Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8464</span><span class="NLM_x">–</span> <span class="NLM_lpage">8476</span><span class="refDoi"> DOI: 10.1021/jm300930n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300930n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12ru7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8464-8476&author=D.+Ghoshauthor=J.+Loauthor=D.+Mortonauthor=D.+Valetteauthor=J.+Xiauthor=J.+Griswoldauthor=S.+Hubbellauthor=C.+Egbutaauthor=W.+Jiangauthor=J.+Anauthor=H.+M.+Davies&title=Novel+Aromatase+Inhibitors+by+Structure-Guided+Design&doi=10.1021%2Fjm300930n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Aromatase Inhibitors by Structure-Guided Design</span></div><div class="casAuthors">Ghosh, Debashis; Lo, Jessica; Morton, Daniel; Valette, Damien; Xi, Jingle; Griswold, Jennifer; Hubbell, Susan; Egbuta, Chinaza; Jiang, Wenhua; An, Jing; Davies, Huw M. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8464-8476</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human cytochrome P 450 aromatase catalyzes with high specificity the synthesis of estrogens from androgens.  Aromatase inhibitors (AIs) such as exemestane, 6-methylideneandrosta-1,4-diene-3,17-dione, are preeminent drugs for the treatment of estrogen-dependent breast cancer.  The crystal structure of human placental aromatase has shown an androgen-specific active site.  By utilization of the structural data, novel C6-substituted androsta-1,4-diene-3,17-dione inhibitors have been designed.  Several of the C6-substituted 2-alkynyloxy compds. inhibit purified placental aromatase with IC50 values in the nanomolar range.  Antiproliferation studies in a MCF-7 breast cancer cell line demonstrate that some of these compds. have EC50 values better than 1 nM, exceeding that for exemestane.  X-ray structures of aromatase complexes of two potent compds. reveal that, per their design, the novel side groups protrude into the opening to the access channel unoccupied in the enzyme-substrate/exemestane complexes.  The obsd. structure-activity relationship is borne out by the x-ray data.  Structure-guided design permits utilization of the aromatase-specific interactions for the development of next generation AIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6lNS6WadtgLVg90H21EOLACvtfcHk0lj-49FXCasGzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12ru7bN&md5=4417d055eedf62bf196f5f0172067585</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm300930n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300930n%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DMorton%26aufirst%3DD.%26aulast%3DValette%26aufirst%3DD.%26aulast%3DXi%26aufirst%3DJ.%26aulast%3DGriswold%26aufirst%3DJ.%26aulast%3DHubbell%26aufirst%3DS.%26aulast%3DEgbuta%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DAn%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DH.%2BM.%26atitle%3DNovel%2520Aromatase%2520Inhibitors%2520by%2520Structure-Guided%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8464%26epage%3D8476%26doi%3D10.1021%2Fjm300930n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Egbuta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Mechanism of Inhibition of Estrogen Biosynthesis by Azole Fungicides</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">4622</span><span class="NLM_x">–</span> <span class="NLM_lpage">4628</span><span class="refDoi"> DOI: 10.1210/en.2014-1561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fen.2014-1561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=25243857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsVOntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=4622-4628&author=C.+Egbutaauthor=J.+Loauthor=D.+Ghosh&title=Mechanism+of+Inhibition+of+Estrogen+Biosynthesis+by+Azole+Fungicides&doi=10.1210%2Fen.2014-1561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of inhibition of estrogen biosynthesis by azole fungicides</span></div><div class="casAuthors">Egbuta, Chinaza; Lo, Jessica; Ghosh, Debashis</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4622-4628, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">1945-7170</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Biosynthesis of estrogens from androgens is catalyzed by cytochrome P 450 aromatase.  Aromatase inhibition by the triazole compds. letrozole (LTZ) and anastrozole is a prevalent therapy for estrogen-dependent postmenopausal breast cancer.  Azoles are widely used as agricultural fungicides and antimycotic drugs that target 14α-demethylase.  Some were previously shown to inhibit aromatase, thereby raising the possibility of endocrine disruptive effects.  However, mechanistic anal. of their inhibition has never been undertaken.  We have evaluated the inhibitory effects of 3 common fungicides, bifonazole, imazalil, and flusilazole, in human aromatase purified from placenta and compared them with LTZ, the most potent inhibitor of aromatase.  Bifonazole exhibits strong inhibitory effects with an IC50 of 270nM and Ki (Michaeles-Menten inhibition const.) of 68nM, compared with 10nM and 13nM, resp., for LTZ.  The IC50 and Ki are 1100nM and 278nM for imazilil and 3200nM and 547nM for flusilazole, resp.  Analyses of inhibition kinetics suggest that the modes of inhibition by azole fungicides are mixed or competitive, whereas LTZ inhibition could be noncompetitive or mixed.  We interpret the inhibition mechanism in the context of the x-ray structure of aromatase-androstenedione complex.  Structural data show that aromatase has 3 binding pockets in relation to the heme.  The substrate-binding cavity at the heme-distal site closely compliments the structures of the natural substrate, androstenedione, and steroidal aromatase inhibitors.  Because the structures of LTZ and the azole fungicides are entirely dissimilar to the androstenedione backbone, the azoles possibly inhibit by binding to a structurally rearranged active site, the 2 other catalytically important sites, or both, in agreement with the kinetics data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoirx-jImpAnbVg90H21EOLACvtfcHk0lj5acu1e4LLOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsVOntA%253D%253D&md5=b0e5b6a2a92f87dd112b9abefbb42bc3</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1210%2Fen.2014-1561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2014-1561%26sid%3Dliteratum%253Aachs%26aulast%3DEgbuta%26aufirst%3DC.%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DMechanism%2520of%2520Inhibition%2520of%2520Estrogen%2520Biosynthesis%2520by%2520Azole%2520Fungicides%26jtitle%3DEndocrinology%26date%3D2014%26volume%3D155%26spage%3D4622%26epage%3D4628%26doi%3D10.1210%2Fen.2014-1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Goss, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingle, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sledge, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabaglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Souza, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalchal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spadafora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liedke, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelmon, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, L. E.</span><span> </span><span class="NLM_article-title">Exemestane Versus Anastrozole in Postmenopausal Women with Early Breast Cancer: NCIC CTG MA.27--a Randomized Controlled Phase Iii Trial</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1398</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span><span class="refDoi"> DOI: 10.1200/JCO.2012.44.7805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1200%2FJCO.2012.44.7805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=23358971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt12rtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=1398-1404&author=P.+E.+Gossauthor=J.+N.+Ingleauthor=K.+I.+Pritchardauthor=M.+J.+Ellisauthor=G.+W.+Sledgeauthor=G.+T.+Buddauthor=M.+Rabaglioauthor=R.+H.+Ansariauthor=D.+B.+Johnsonauthor=R.+Tozerauthor=D.+P.+D%E2%80%99Souzaauthor=H.+Chalchalauthor=S.+Spadaforaauthor=V.+Stearnsauthor=E.+A.+Perezauthor=P.+E.+Liedkeauthor=I.+Langauthor=C.+Elliottauthor=K.+A.+Gelmonauthor=J.+A.+Chapmanauthor=L.+E.+Shepherd&title=Exemestane+Versus+Anastrozole+in+Postmenopausal+Women+with+Early+Breast+Cancer%3A+NCIC+CTG+MA.27%2D%2Da+Randomized+Controlled+Phase+Iii+Trial&doi=10.1200%2FJCO.2012.44.7805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27-a randomized controlled phase III trial</span></div><div class="casAuthors">Goss, Paul E.; Ingle, James N.; Pritchard, Kathleen I.; Ellis, Matthew J.; Sledge, George W.; Budd, G. Thomas; Rabaglio, Manuela; Ansari, Rafat H.; Johnson, David B.; Tozer, Richard; D'Souza, David P.; Chalchal, Haji; Spadafora, Silvana; Stearns, Vered; Perez, Edith A.; Liedke, Pedro E. R.; Lang, Istvan; Elliott, Catherine; Gelmon, Karen A.; Chapman, Judy-Anne W.; Shepherd, Lois E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1398-1404</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: In patients with hormone-dependent postmenopausal breast cancer, std. adjuvant therapy involves 5 years of the nonsteroidal aromatase inhibitors anastrozole and letrozole.  The steroidal inhibitor exemestane is partially non-cross-resistant with nonsteroidal aromatase inhibitors and is a mild androgen and could prove superior to anastrozole regarding efficacy and toxicity, specifically with less bone loss.  Patients and Methods: We designed an open-label, randomized, phase III trial of 5 years of exemestane vs. anastrozole with a two-sided test of superiority to detect a 2.4% improvement with exemestane in 5-yr event-free survival (EFS).  Secondary objectives included assessment of overall survival, distant disease-free survival, incidence of contralateral new primary breast cancer, and safety.  Results: In the study, 7,576 women (median age, 64.1 years) were enrolled.  At median follow-up of 4.1 years, 4-yr EFS was 91% for exemestane and 91.2% for anastrozole (stratified hazard ratio, 1.02; 95% CI, 0.87 to 1.18; P = .85).  Overall, distant disease-free survival and disease-specific survival were also similar.  In all, 31.6% of patients discontinued treatment as a result of adverse effects, concomitant disease, or study refusal.  Osteoporosis/osteopenia, hypertriglyceridemia, vaginal bleeding, and hypercholesterolemia were less frequent on exemestane, whereas mild liver function abnormalities and rare episodes of atrial fibrillation were less frequent on anastrozole.  Vasomotor and musculoskeletal symptoms were similar between arms.  Conclusion: This first comparison of steroidal and nonsteroidal classes of aromatase inhibitors showed neither to be superior in terms of breast cancer outcomes as 5-yr initial adjuvant therapy for postmenopausal breast cancer by two-way test.  Less toxicity on bone is compatible with one hypothesis behind MA.27 but requires confirmation.  Exemestane should be considered another option as up-front adjuvant therapy for postmenopausal hormone receptor-pos. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHX4Gl5b5J6rVg90H21EOLACvtfcHk0lj5acu1e4LLOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt12rtbc%253D&md5=9198d6feed728d6d7426b70973cb9e48</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1200%2FJCO.2012.44.7805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2012.44.7805%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DP.%2BE.%26aulast%3DIngle%26aufirst%3DJ.%2BN.%26aulast%3DPritchard%26aufirst%3DK.%2BI.%26aulast%3DEllis%26aufirst%3DM.%2BJ.%26aulast%3DSledge%26aufirst%3DG.%2BW.%26aulast%3DBudd%26aufirst%3DG.%2BT.%26aulast%3DRabaglio%26aufirst%3DM.%26aulast%3DAnsari%26aufirst%3DR.%2BH.%26aulast%3DJohnson%26aufirst%3DD.%2BB.%26aulast%3DTozer%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DD.%2BP.%26aulast%3DChalchal%26aufirst%3DH.%26aulast%3DSpadafora%26aufirst%3DS.%26aulast%3DStearns%26aufirst%3DV.%26aulast%3DPerez%26aufirst%3DE.%2BA.%26aulast%3DLiedke%26aufirst%3DP.%2BE.%26aulast%3DLang%26aufirst%3DI.%26aulast%3DElliott%26aufirst%3DC.%26aulast%3DGelmon%26aufirst%3DK.%2BA.%26aulast%3DChapman%26aufirst%3DJ.%2BA.%26aulast%3DShepherd%26aufirst%3DL.%2BE.%26atitle%3DExemestane%2520Versus%2520Anastrozole%2520in%2520Postmenopausal%2520Women%2520with%2520Early%2520Breast%2520Cancer%253A%2520NCIC%2520CTG%2520MA.27--a%2520Randomized%2520Controlled%2520Phase%2520Iii%2520Trial%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D31%26spage%3D1398%26epage%3D1404%26doi%3D10.1200%2FJCO.2012.44.7805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renshaw, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. M.</span><span> </span><span class="NLM_article-title">A Randomised Study of the Effects of Letrozole and Anastrozole on Oestrogen Receptor Positive Breast Cancers in Postmenopausal Women</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1007/s10549-008-0027-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2Fs10549-008-0027-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=18438705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFSqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=495-501&author=J.+Murrayauthor=O.+E.+Youngauthor=L.+Renshawauthor=S.+Whiteauthor=L.+Williamsauthor=D.+B.+Evansauthor=J.+S.+Thomasauthor=M.+Dowsettauthor=J.+M.+Dixon&title=A+Randomised+Study+of+the+Effects+of+Letrozole+and+Anastrozole+on+Oestrogen+Receptor+Positive+Breast+Cancers+in+Postmenopausal+Women&doi=10.1007%2Fs10549-008-0027-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women</span></div><div class="casAuthors">Murray, J.; Young, O. E.; Renshaw, L.; White, S.; Williams, L.; Evans, D. B.; Thomas, J. St. J.; Dowsett, M.; Dixon, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-501</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Changes in proliferation as measured by Ki67 occur within 14 days of starting treatment with an aromatase inhibitor and these changes have been shown to be predictors of long term outcome.  This study aimed to compare changes in proliferation following 14 days of treatment with anastrozole and letrozole.  Two hundred and six women with 209 estrogen receptor (ER) pos. operable breast cancers (three bilateral) were randomly allocated to receive either 14 days treatment with 2.5 mg of letrozole or 1 mg of anastrozole prior to surgery.  Changes in expression of estrogen (ER) and progesterone receptors (PgR) as assessed by ALLRED scores and proliferation as assessed by Ki67 were analyzed.  The HER2 status of each tumor was also assessed using a combination of the Hercept test and FISH.  Both letrozole and anastrozole reduced ER expression (ALLRED score) by a mean of 0.32 (0.20-0.44), P < 0.001 and PgR fell by a mean of 2.54 (2.20-2.89) P < 0.0001.  Letrozole reduced proliferation from a geometric mean of 6.37% to 0.81%, P < 0.0001 and anastrozole reduced proliferation from 5.81% to 0.77%, P < 0.0001.  There was no differences between drugs in the fall in ER, PgR or proliferation.  Both letrozole and anastrozole produced significant falls in proliferation in both HER2 pos. and HER2 neg. cancers, all P < 0.001.  Fourteen days of both letrozole and anastrozole reduces proliferation, ER and PgR expression.  No significant difference between these two drugs was identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqINvh0jx6zBrVg90H21EOLACvtfcHk0lj5tWsR5DIUwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFSqt7s%253D&md5=0e4221284288466ecd88c48739aff862</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2Fs10549-008-0027-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-008-0027-0%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DO.%2BE.%26aulast%3DRenshaw%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26aulast%3DThomas%26aufirst%3DJ.%2BS.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DDixon%26aufirst%3DJ.%2BM.%26atitle%3DA%2520Randomised%2520Study%2520of%2520the%2520Effects%2520of%2520Letrozole%2520and%2520Anastrozole%2520on%2520Oestrogen%2520Receptor%2520Positive%2520Breast%2520Cancers%2520in%2520Postmenopausal%2520Women%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2009%26volume%3D114%26spage%3D495%26epage%3D501%26doi%3D10.1007%2Fs10549-008-0027-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Zilembo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noberasco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajetta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orefice, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzzoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bartolomeo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Leo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laffranchi, A.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Endocrinological and Clinical Evaluation of Exemestane, a New Steroidal Aromatase Inhibitor</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span><span class="refDoi"> DOI: 10.1038/bjc.1995.451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Fbjc.1995.451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=7547212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK2MXptlKjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1995&pages=1007-1012&author=N.+Zilemboauthor=C.+Noberascoauthor=E.+Bajettaauthor=A.+Martinettiauthor=L.+Marianiauthor=S.+Oreficeauthor=R.+Buzzoniauthor=M.+Di+Bartolomeoauthor=A.+Di+Leoauthor=A.+Laffranchi&title=Endocrinological+and+Clinical+Evaluation+of+Exemestane%2C+a+New+Steroidal+Aromatase+Inhibitor&doi=10.1038%2Fbjc.1995.451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor</span></div><div class="casAuthors">Zilembo, N.; Noberasco, C.; Bajetta, E.; Martinetti, A.; Mariani, L.; Orefice, S.; Buzzoni, R.; Di Bartolomeo, M.; Di Leo, A.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1007-12</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Scientific & Medical Division</span>)
        </div><div class="casAbstract">The androstenedione deriv., exemestane (FCE 24304), is a new orally active irreversible aromatase inhibitor.  Fifty-six post-menopausal advanced breast cancer patients entered this study to evaluate the activity of four low exemestane doses in reducing estrogen levels.  The drug's tolerability and clin. efficacy were also assessed.  Exemestane was orally administered to four consecutive groups at daily doses of 25, 12.5, 5 and 2.5 mg, and the changes in estrogen, gonadotrophins, sex-hormone binding globulin and dehydroepiandrosterone sulfate levels were evaluated.  Drug selectivity was studied by measuring 17-hydroxycorticosteroid urinary levels.  After 7 days of treatment, mean estrone and estradiol levels had decreased by resp. 64% and 65% (a decrease which was maintained over time); in the 2.5 mg group, oestrone sulfate levels also decreased by 74%.  Gonadotropin-levels were significantly higher, whereas no changes in the other serum hormone levels or any interference with adrenal synthesis were detected.  Treatment tolerability was satisfactory: nausea and dyspepsia were reported in 16% of patients.  The overall objective response rate was 18%.  In conclusion, exemestane is effective in reducing estrogen levels at all of the tested doses and shows interesting clin. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr7k3C7fR6jbVg90H21EOLACvtfcHk0lj5tWsR5DIUwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlKjurk%253D&md5=8ff051c0df55fb4de7ad26c617d97b3f</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1995.451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1995.451%26sid%3Dliteratum%253Aachs%26aulast%3DZilembo%26aufirst%3DN.%26aulast%3DNoberasco%26aufirst%3DC.%26aulast%3DBajetta%26aufirst%3DE.%26aulast%3DMartinetti%26aufirst%3DA.%26aulast%3DMariani%26aufirst%3DL.%26aulast%3DOrefice%26aufirst%3DS.%26aulast%3DBuzzoni%26aufirst%3DR.%26aulast%3DDi%2BBartolomeo%26aufirst%3DM.%26aulast%3DDi%2BLeo%26aufirst%3DA.%26aulast%3DLaffranchi%26aufirst%3DA.%26atitle%3DEndocrinological%2520and%2520Clinical%2520Evaluation%2520of%2520Exemestane%252C%2520a%2520New%2520Steroidal%2520Aromatase%2520Inhibitor%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1995%26volume%3D72%26spage%3D1007%26epage%3D1012%26doi%3D10.1038%2Fbjc.1995.451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Johannessen, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurlo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paolini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvinnsland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonning, P. E.</span><span> </span><span class="NLM_article-title">Endocrine and Clinical Effects of Exemestane (PNU155971), a Novel Steroidal Aromatase Inhibitor, in Postmenopausal Breast Cancer Patients: A Phase I Study</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1101</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=9815789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFCgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=1101-1108&author=D.+C.+Johannessenauthor=T.+Enganauthor=E.+Di+Salleauthor=M.+G.+Zurloauthor=J.+Paoliniauthor=G.+Ornatiauthor=G.+Piscitelliauthor=S.+Kvinnslandauthor=P.+E.+Lonning&title=Endocrine+and+Clinical+Effects+of+Exemestane+%28PNU155971%29%2C+a+Novel+Steroidal+Aromatase+Inhibitor%2C+in+Postmenopausal+Breast+Cancer+Patients%3A+A+Phase+I+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study</span></div><div class="casAuthors">Johannessen, Dag Clement; Engan, Terje; Salle, Enrico Di; Zurlo, Maria Grazia; Paolini, Jolanda; Ornati, Giorgio; Piscitelli, Gabriella; Kvinnsland, Stener; Loenning, Per Eystein</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1101-1108</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Clin. and endocrinol. effects of exemestane (6-methylenandrosta-1,4-diene-3,17-dione; PNU 155971) were evaluated in an open Phase I study.  Thirteen postmenopausal women suffering from advanced breast cancer received exemestane in escalating doses over a 12-wk period.  Starting on 5 mg once daily (o.d.), exemestane was subsequently escalated at 2-wk intervals to 10, 25, 50, 100, and 200 mg o.d.  Each patient subsequently continued treatment on the highest tolerated dose until time of progression.  One patient terminated treatment after 6 days due to diarrhea that was probably not related to drug therapy, although a relationship could not be excluded.  Apart from this, no serious side effects were seen during the dose escalation period.  Exemestane (10 mg o.d.) caused maximal suppression of plasma estradiol (E2) and estrone (E1) to a mean of 14.6 and 5.8% of pretreatment levels, resp., whereas 25 mg of exemestane o.d. suppressed estrone sulfate (E1S) to 8.9% of pretreatment levels.  No fall in adrenal steroid levels was recorded.  Exemestane (5 mg o.d.) suppressed urinary E2 and E1 to a mean of 11.9 and 12.2% of pretreatment levels, resp.  Administering exemestane at doses of 50-200 mg o.d. caused no further suppression of urinary E1, whereas urinary E2 fell to 6-7% of pretreatment levels.  Median time to progression was 63 wk.  We conclude that exemestane is a well-tolerated aromatase inhibitor that effectively suppresses plasma and urinary estrogens in postmenopausal patients with breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDaBiEQ3tJP7Vg90H21EOLACvtfcHk0lj5tWsR5DIUwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFCgsLw%253D&md5=841bd78e5623a850ccda005b9dd64903</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohannessen%26aufirst%3DD.%2BC.%26aulast%3DEngan%26aufirst%3DT.%26aulast%3DDi%2BSalle%26aufirst%3DE.%26aulast%3DZurlo%26aufirst%3DM.%2BG.%26aulast%3DPaolini%26aufirst%3DJ.%26aulast%3DOrnati%26aufirst%3DG.%26aulast%3DPiscitelli%26aufirst%3DG.%26aulast%3DKvinnsland%26aufirst%3DS.%26aulast%3DLonning%26aufirst%3DP.%2BE.%26atitle%3DEndocrine%2520and%2520Clinical%2520Effects%2520of%2520Exemestane%2520%2528PNU155971%2529%252C%2520a%2520Novel%2520Steroidal%2520Aromatase%2520Inhibitor%252C%2520in%2520Postmenopausal%2520Breast%2520Cancer%2520Patients%253A%2520A%2520Phase%2520I%2520Study%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1997%26volume%3D3%26spage%3D1101%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Lonning, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paridaens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurlimann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span> </span><span class="NLM_article-title">Exemestane Experience in Breast Cancer Treatment</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span><span class="refDoi"> DOI: 10.1016/S0960-0760(97)80007-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2FS0960-0760%2897%2980007-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=9365185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1antL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1997&pages=151-155&author=P.+E.+Lonningauthor=R.+Paridaensauthor=B.+Thurlimannauthor=G.+Piscitelliauthor=E.+di+Salle&title=Exemestane+Experience+in+Breast+Cancer+Treatment&doi=10.1016%2FS0960-0760%2897%2980007-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Exemestane experience in breast cancer treatment</span></div><div class="casAuthors">Lonning, P. E.; Paridaens, R.; Thurlimann, B.; Piscitelli, G.; di Salle, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3-6</span>),
    <span class="NLM_cas:pages">151-155</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 32 refs.  Exemestane is a very potent, orally active, selective and long-lasting steroidal irreversible inhibitor of aromatase.  It is 150 times more potent than aminoglutethimide (AG) in inhibiting human placental aromatase (Ki of 4.3 and 671 nM, resp.).  The compd. is presently under phase III evaluation in Europe and the U.S.A. for the treatment of postmenopausal advanced breast cancer (ABC).  Clin. pharmacol. studies have been carried out with single doses ranging from 0.5 to 800 mg and repeated doses of up to 600 mg a day, in 132 postmenopausal healthy volunteers and in 185 postmenopausal women with ABC.  Results obtained using a very specific and sensitive anal. method (high performance liq. chromatog.-RIA; HPLC-RIA) indicted that exemestane is extremely effective in inhibiting plasma estrogens levels.  Estrogen inhibition is clearly evident at 5 mg a day and maximal suppression for E2, E1 aned E1S (>85%, >90% and >90%, resp.) is obtained at 10-25 mg a day.  Data from non-controlled phase II studies involving more than 400 patients indicated a clear anti-tumor activity in postmenopausal ABC patients failing multiple hormonal treatments.  In 62 patients progressing on AG (≥500 mg a day) exemestane treatment resulted in an objective response rate of approx. 24%; disease stabilization ≥24 wk was obsd. in an addnl. 24% of cases.  With regard to safety, although daily doses up to 600 mg were administered, the maximal tolerated dose was not achieved; reported symptoms were mainly related to the pharmacol. action of the compd. and were usually mild to moderate in severity, resulting in the discontinuation of therapy in less than 3% of cases.  In conclusion, the available results suggest that exemestane treatment is assocd. with minimal toxicity, and may be of significant benefit for ABC women who have exhausted conventional therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt23tph81cyrVg90H21EOLACvtfcHk0lhymQFKcvXfEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1antL4%253D&md5=3e2b4a70aba3192c9f9e954ac1db698b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2897%2980007-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252897%252980007-6%26sid%3Dliteratum%253Aachs%26aulast%3DLonning%26aufirst%3DP.%2BE.%26aulast%3DParidaens%26aufirst%3DR.%26aulast%3DThurlimann%26aufirst%3DB.%26aulast%3DPiscitelli%26aufirst%3DG.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26atitle%3DExemestane%2520Experience%2520in%2520Breast%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D61%26spage%3D151%26epage%3D155%26doi%3D10.1016%2FS0960-0760%2897%2980007-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Thurlimann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paridaens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneterre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzalone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurlo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, G.</span><span> </span><span class="NLM_article-title">Third-Line Hormonal Treatment with Exemestane in Postmenopausal Patients with Advanced Breast Cancer Progressing on Aminoglutethimide: A Phase II Multicentre Multinational Study. Exemestane Study Group</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1773</span><span class="refDoi"> DOI: 10.1016/S0959-8049(97)00283-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2FS0959-8049%2897%2900283-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1997&pages=1767-1773&author=B.+Thurlimannauthor=R.+Paridaensauthor=D.+Serinauthor=J.+Bonneterreauthor=H.+Rocheauthor=R.+Murrayauthor=E.+di+Salleauthor=S.+Lanzaloneauthor=M.+G.+Zurloauthor=G.+Piscitelli&title=Third-Line+Hormonal+Treatment+with+Exemestane+in+Postmenopausal+Patients+with+Advanced+Breast+Cancer+Progressing+on+Aminoglutethimide%3A+A+Phase+II+Multicentre+Multinational+Study.+Exemestane+Study+Group&doi=10.1016%2FS0959-8049%2897%2900283-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2897%2900283-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252897%252900283-9%26sid%3Dliteratum%253Aachs%26aulast%3DThurlimann%26aufirst%3DB.%26aulast%3DParidaens%26aufirst%3DR.%26aulast%3DSerin%26aufirst%3DD.%26aulast%3DBonneterre%26aufirst%3DJ.%26aulast%3DRoche%26aufirst%3DH.%26aulast%3DMurray%26aufirst%3DR.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26aulast%3DLanzalone%26aufirst%3DS.%26aulast%3DZurlo%26aufirst%3DM.%2BG.%26aulast%3DPiscitelli%26aufirst%3DG.%26atitle%3DThird-Line%2520Hormonal%2520Treatment%2520with%2520Exemestane%2520in%2520Postmenopausal%2520Patients%2520with%2520Advanced%2520Breast%2520Cancer%2520Progressing%2520on%2520Aminoglutethimide%253A%2520A%2520Phase%2520II%2520Multicentre%2520Multinational%2520Study.%2520Exemestane%2520Study%2520Group%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1997%26volume%3D33%26spage%3D1767%26epage%3D1773%26doi%3D10.1016%2FS0959-8049%2897%2900283-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Geisler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonning, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span> </span><span class="NLM_article-title">In Vivo Inhibition of Aromatization by Exemestane, a Novel Irreversible Aromatase Inhibitor, in Postmenopausal Breast Cancer Patients</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2089</span><span class="NLM_x">–</span> <span class="NLM_lpage">2093</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=9748124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK1cXmslCjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=2089-2093&author=J.+Geislerauthor=N.+Kingauthor=G.+Ankerauthor=G.+Ornatiauthor=E.+Di+Salleauthor=P.+E.+Lonningauthor=M.+Dowsett&title=In+Vivo+Inhibition+of+Aromatization+by+Exemestane%2C+a+Novel+Irreversible+Aromatase+Inhibitor%2C+in+Postmenopausal+Breast+Cancer+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients</span></div><div class="casAuthors">Geisler, Jurgen; King, Nick; Anker, Gun; Ornati, Giorgio; Di Salle, Enrico; Lonning, Per Eystein; Dowsett, Mitch</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2089-2093</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The effect of exemestane (6-methylenandrosta-1,4-diene-3,17-dione) 25 mg p.o. once daily on in vivo aromatization was studied in 10 postmenopausal women with advanced breast cancer.  Aromatization was detd. before treatment and after 6-8 wk on therapy by administering a bolus injection of [3H]androstenedione (500 μCi) and [14C]estrone (5 μCi) followed by measurement of the isotope ratio of urinary estrogens after high-performance liq. chromatog. purifn.  In addn., plasma endogenous estrogens were measured with highly sensitive RIAs after sepn. with high-performance liq. chromatog.  Treatment with exemestane suppressed whole body aromatization from a mean pretreatment value of 2.059% to 0.042% (mean suppression of 97.9%).  Plasma levels of estrone, estradiol, and estrone sulfate were found to be suppressed by 94.5%, 92.2%, and 93.2%, resp.  This is the first study revealing near total aromatase inhibition in vivo with the use of a steroidal aromatase inhibitor.  The observation that exemestane is a highly potent aromatase inhibitor, together with the fact that the drug is administered p.o. and causes limited side effects, suggests that exemestane is a promising new drug for the treatment of hormone sensitive breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv3SeR-LYYP7Vg90H21EOLACvtfcHk0lhymQFKcvXfEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmslCjs70%253D&md5=df5ccff7835d08261cd63c0a5a06199e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeisler%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DN.%26aulast%3DAnker%26aufirst%3DG.%26aulast%3DOrnati%26aufirst%3DG.%26aulast%3DDi%2BSalle%26aufirst%3DE.%26aulast%3DLonning%26aufirst%3DP.%2BE.%26aulast%3DDowsett%26aufirst%3DM.%26atitle%3DIn%2520Vivo%2520Inhibition%2520of%2520Aromatization%2520by%2520Exemestane%252C%2520a%2520Novel%2520Irreversible%2520Aromatase%2520Inhibitor%252C%2520in%2520Postmenopausal%2520Breast%2520Cancer%2520Patients%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1998%26volume%3D4%26spage%3D2089%26epage%3D2093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Lonning, P. E.</span><span> </span><span class="NLM_article-title">Pharmacological Profiles of Exemestane and Formestane, Steroidal Aromatase Inhibitors Used for Treatment of Postmenopausal Breast Cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S45</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><div class="note"><p class="first last">(discussion S73–47)</p></div><span class="refDoi"> DOI: 10.1023/A:1006048722559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1023%2FA%3A1006048722559" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1998&pages=S45-52&issue=Suppl.+1&author=P.+E.+Lonning&title=Pharmacological+Profiles+of+Exemestane+and+Formestane%2C+Steroidal+Aromatase+Inhibitors+Used+for+Treatment+of+Postmenopausal+Breast+Cancer&doi=10.1023%2FA%3A1006048722559"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006048722559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006048722559%26sid%3Dliteratum%253Aachs%26aulast%3DLonning%26aufirst%3DP.%2BE.%26atitle%3DPharmacological%2520Profiles%2520of%2520Exemestane%2520and%2520Formestane%252C%2520Steroidal%2520Aromatase%2520Inhibitors%2520Used%2520for%2520Treatment%2520of%2520Postmenopausal%2520Breast%2520Cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1998%26volume%3D49%26issue%3DSuppl.%25201%26spage%3DS45%26epage%3D52%26doi%3D10.1023%2FA%3A1006048722559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arkhipov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehrenbacher, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiffany, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Consonni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L.</span><span> </span><span class="NLM_article-title">Multicenter, Phase II Trial of Exemestane as Third-Line Hormonal Therapy of Postmenopausal Women with Metastatic Breast Cancer. Aromasin Study Group</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3418</span><span class="NLM_x">–</span> <span class="NLM_lpage">3425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10550136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK1MXnvVGlt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=3418-3425&author=S.+Jonesauthor=C.+Vogelauthor=A.+Arkhipovauthor=L.+Fehrenbacherauthor=P.+Eisenbergauthor=B.+Cooperauthor=S.+Honigauthor=A.+Polliauthor=F.+Whaleyauthor=E.+di+Salleauthor=J.+Tiffanyauthor=A.+Consonniauthor=L.+Miller&title=Multicenter%2C+Phase+II+Trial+of+Exemestane+as+Third-Line+Hormonal+Therapy+of+Postmenopausal+Women+with+Metastatic+Breast+Cancer.+Aromasin+Study+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer</span></div><div class="casAuthors">Jones, S.; Vogel, C.; Arkhipov, A.; Fehrenbacher, L.; Eisenberg, P.; Cooper, B.; Honig, S.; Polli, A.; Whaley, F.; Di Salle, E.; Tiffany, J.; Consonni, A.; Miller, L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3418-3425</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose: To assess the antitumor activity, safety, and hormone-suppressive effects of the irreversible aromatase inactivator, exemestane (Aromasin, Pharmacia & Upjohn, Kalamazoo, MI), administered as third-line hormone therapy to postmenopausal women with metastatic breast cancer that is refractory to tamoxifen and megestrol acetate.  Patients and Methods: Exemestane was administered at a dose of 25 mg/d orally until patients experienced disease progression.  The efficacy and safety of exemestane were clin. and radiog. evaluated.  The impact of exemestane treatment on tumor-related signs and symptoms was assessed.  The effect of exemestane on serum levels of estrogens and other steroidal hormones was detd.  Results: Ninety-one patients were treated.  There were four complete responses (CR) and eight partial responses (PR), for an objective response rate of 13% in the entire treated population.  The overall success rate (CR, PR, or stable disease [SD] ≥ 24 wk) was 30%.  The median duration of response and overall success was 9 mo and 8 mo, resp.  Most patients with CR/PR (83%; 10 of 12 patients) and SD ≥ 24 wk (80%; 12 of 15 patients) had improved or stable tumor-related signs and symptoms.  Mean levels of circulating estrone (E1), estradiol (E2), and estrone sulfate decreased to 11%, 22%, and 13% of baseline levels, resp. (at week 8 or 16 of treatment).  One half of the patients had undetectable E1 and E2 levels during treatment, including at the time of disease progression.  Mild nausea (20% of patients) and hot flashes (20%) were the most common drug-related adverse events and were generally grade 1.  Conclusion: Exemestane is an active and well-tolerated third-line hormonal therapy that represents a new treatment option for postmenopausal patients with advanced breast cancer that has become refractory to std. first- and second-line hormonal therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPcIYUNTviuLVg90H21EOLACvtfcHk0lgrOE3wudarzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvVGlt70%253D&md5=02a686e394759597612e998815b1f43f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%26aulast%3DVogel%26aufirst%3DC.%26aulast%3DArkhipov%26aufirst%3DA.%26aulast%3DFehrenbacher%26aufirst%3DL.%26aulast%3DEisenberg%26aufirst%3DP.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DHonig%26aufirst%3DS.%26aulast%3DPolli%26aufirst%3DA.%26aulast%3DWhaley%26aufirst%3DF.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26aulast%3DTiffany%26aufirst%3DJ.%26aulast%3DConsonni%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DL.%26atitle%3DMulticenter%252C%2520Phase%2520II%2520Trial%2520of%2520Exemestane%2520as%2520Third-Line%2520Hormonal%2520Therapy%2520of%2520Postmenopausal%2520Women%2520with%2520Metastatic%2520Breast%2520Cancer.%2520Aromasin%2520Study%2520Group%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D1999%26volume%3D17%26spage%3D3418%26epage%3D3425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Kaufmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajetta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirix, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massimini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, G.</span><span> </span><span class="NLM_article-title">Exemestane Improves Survival Compared with Megoestrol Acetate in Postmenopausal Patients with Advanced Breast Cancer Who Have Failed on Tamoxifen. Results of a Double-Blind Randomised Phase III Trial</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">S86</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1016/S0959-8049(00)00240-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2FS0959-8049%2800%2900240-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2000&pages=S86-87&issue=Suppl.+4&author=M.+Kaufmannauthor=E.+Bajettaauthor=L.+Y.+Dirixauthor=L.+E.+Feinauthor=S.+E.+Jonesauthor=J.+Cervekauthor=C.+Fowstauthor=A.+Polliauthor=E.+Di+Salleauthor=G.+Massiminiauthor=G.+Piscitelli&title=Exemestane+Improves+Survival+Compared+with+Megoestrol+Acetate+in+Postmenopausal+Patients+with+Advanced+Breast+Cancer+Who+Have+Failed+on+Tamoxifen.+Results+of+a+Double-Blind+Randomised+Phase+III+Trial&doi=10.1016%2FS0959-8049%2800%2900240-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2800%2900240-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252800%252900240-9%26sid%3Dliteratum%253Aachs%26aulast%3DKaufmann%26aufirst%3DM.%26aulast%3DBajetta%26aufirst%3DE.%26aulast%3DDirix%26aufirst%3DL.%2BY.%26aulast%3DFein%26aufirst%3DL.%2BE.%26aulast%3DJones%26aufirst%3DS.%2BE.%26aulast%3DCervek%26aufirst%3DJ.%26aulast%3DFowst%26aufirst%3DC.%26aulast%3DPolli%26aufirst%3DA.%26aulast%3DDi%2BSalle%26aufirst%3DE.%26aulast%3DMassimini%26aufirst%3DG.%26aulast%3DPiscitelli%26aufirst%3DG.%26atitle%3DExemestane%2520Improves%2520Survival%2520Compared%2520with%2520Megoestrol%2520Acetate%2520in%2520Postmenopausal%2520Patients%2520with%2520Advanced%2520Breast%2520Cancer%2520Who%2520Have%2520Failed%2520on%2520Tamoxifen.%2520Results%2520of%2520a%2520Double-Blind%2520Randomised%2520Phase%2520III%2520Trial%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2000%26volume%3D36%26issue%3DSuppl.%25204%26spage%3DS86%26epage%3D87%26doi%3D10.1016%2FS0959-8049%2800%2900240-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Kaufmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajetta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirix, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zilembo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugardyn, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasurdi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennel, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arkhipov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massimini, G.</span><span> </span><span class="NLM_article-title">Exemestane Improves Survival in Metastatic Breast Cancer: Results of a Phase III Randomized Study</span> <span class="citation_source-journal">Clin. Breast Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S15</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.3816/CBC.2000.s.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.3816%2FCBC.2000.s.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=S15-18&issue=Suppl.+1&author=M.+Kaufmannauthor=E.+Bajettaauthor=L.+Y.+Dirixauthor=L.+E.+Feinauthor=S.+E.+Jonesauthor=N.+Zilemboauthor=J.+L.+Dugardynauthor=C.+Nasurdiauthor=R.+G.+Mennelauthor=J.+Cervekauthor=C.+Fowstauthor=A.+Polliauthor=E.+di+Salleauthor=A.+Arkhipovauthor=G.+Piscitelliauthor=L.+L.+Millerauthor=G.+Massimini&title=Exemestane+Improves+Survival+in+Metastatic+Breast+Cancer%3A+Results+of+a+Phase+III+Randomized+Study&doi=10.3816%2FCBC.2000.s.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.3816%2FCBC.2000.s.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCBC.2000.s.003%26sid%3Dliteratum%253Aachs%26aulast%3DKaufmann%26aufirst%3DM.%26aulast%3DBajetta%26aufirst%3DE.%26aulast%3DDirix%26aufirst%3DL.%2BY.%26aulast%3DFein%26aufirst%3DL.%2BE.%26aulast%3DJones%26aufirst%3DS.%2BE.%26aulast%3DZilembo%26aufirst%3DN.%26aulast%3DDugardyn%26aufirst%3DJ.%2BL.%26aulast%3DNasurdi%26aufirst%3DC.%26aulast%3DMennel%26aufirst%3DR.%2BG.%26aulast%3DCervek%26aufirst%3DJ.%26aulast%3DFowst%26aufirst%3DC.%26aulast%3DPolli%26aufirst%3DA.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26aulast%3DArkhipov%26aufirst%3DA.%26aulast%3DPiscitelli%26aufirst%3DG.%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DMassimini%26aufirst%3DG.%26atitle%3DExemestane%2520Improves%2520Survival%2520in%2520Metastatic%2520Breast%2520Cancer%253A%2520Results%2520of%2520a%2520Phase%2520III%2520Randomized%2520Study%26jtitle%3DClin.%2520Breast%2520Cancer%26date%3D2000%26volume%3D1%26issue%3DSuppl.%25201%26spage%3DS15%26epage%3D18%26doi%3D10.3816%2FCBC.2000.s.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Kaufmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajetta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirix, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zilembo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugardyn, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasurdi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennel, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arkhipov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massimini, G.</span><span> </span><span class="NLM_article-title">Exemestane Is Superior to Megestrol Acetate after Tamoxifen Failure in Postmenopausal Women with Advanced Breast Cancer: Results of a Phase Iii Randomized Double-Blind Trial. The Exemestane Study Group</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10735887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivVeisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=1399-1411&author=M.+Kaufmannauthor=E.+Bajettaauthor=L.+Y.+Dirixauthor=L.+E.+Feinauthor=S.+E.+Jonesauthor=N.+Zilemboauthor=J.+L.+Dugardynauthor=C.+Nasurdiauthor=R.+G.+Mennelauthor=J.+Cervekauthor=C.+Fowstauthor=A.+Polliauthor=E.+di+Salleauthor=A.+Arkhipovauthor=G.+Piscitelliauthor=L.+L.+Millerauthor=G.+Massimini&title=Exemestane+Is+Superior+to+Megestrol+Acetate+after+Tamoxifen+Failure+in+Postmenopausal+Women+with+Advanced+Breast+Cancer%3A+Results+of+a+Phase+Iii+Randomized+Double-Blind+Trial.+The+Exemestane+Study+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial</span></div><div class="casAuthors">Kaufmann, Manfred; Bajetta, Emilio; Dirix, Luc Yves; Fein, Luis Enrique; Jones, Stephen E.; Zilembo, Nicoletta; Dugardyn, Jean-Louis; Nasurdi, Cristina; Mennel, Robert G.; Cervek, Jozica; Fowst, Camilla; Polli, Anna; Di Salle, Enrico; Arkhipov, Alexei; Piscitelli, Gabriella; Miller, Langdon L.; Massimini, Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1399-1411</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose: This phase III, double-blind, randomized, multicenter study evaluated the efficacy, pharmacodynamics, and safety of the oral aromatase inactivator exemestane (EXE) vs. megestrol acetate (MA) in postmenopausal women with progressive advanced breast cancer who experienced failure of tamoxifen.  Patients and Methods: A total of 769 patients were randomized to EXE 25 mg/d (n = 366) or MA (n = 403) 40 mg four times daily.  Tumor response, duration of tumor control, tumor-related signs and symptoms (TRSS), quality of life (QOL), survival, and tolerability were evaluated.  Results: Overall objective response (OR) rates were higher in patients treated with EXE than in those treated with MA (15.0% v 12.4%); a similar trend was noted in patients with visceral metastases (13.5% v 10.5%).  Median survival time was significantly longer with EXE (median not reached) than with MA (123.4 wk; P =.039), as were the median duration of overall success (OR or stable disease ≥ 24 wk; 60.1 v 49.1 wk; P =.025), time to tumor progression (20.3 v 16.6 wk; P =.037), and time to treatment failure (16.3 v 15.7 wk; P =.042).  Compared with MA, there were similar or greater improvements in pain, TRSS, and QOL with EXE.  Both drugs were well tolerated.  Grade 3 or 4 wt. changes were more common with MA (17.1% v 7.6%; P =.001).  Conclusion: EXE prolongs survival time, time to tumor progression, and time to treatment failure compared with MA and offers a well-tolerated treatment option for postmenopausal women with progressive advanced breast cancer who experienced failure of tamoxifen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrffZzAcqsFVbVg90H21EOLACvtfcHk0liVik8wSlzYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivVeisrw%253D&md5=64645ae933bb362b518597871e910c6e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaufmann%26aufirst%3DM.%26aulast%3DBajetta%26aufirst%3DE.%26aulast%3DDirix%26aufirst%3DL.%2BY.%26aulast%3DFein%26aufirst%3DL.%2BE.%26aulast%3DJones%26aufirst%3DS.%2BE.%26aulast%3DZilembo%26aufirst%3DN.%26aulast%3DDugardyn%26aufirst%3DJ.%2BL.%26aulast%3DNasurdi%26aufirst%3DC.%26aulast%3DMennel%26aufirst%3DR.%2BG.%26aulast%3DCervek%26aufirst%3DJ.%26aulast%3DFowst%26aufirst%3DC.%26aulast%3DPolli%26aufirst%3DA.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26aulast%3DArkhipov%26aufirst%3DA.%26aulast%3DPiscitelli%26aufirst%3DG.%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DMassimini%26aufirst%3DG.%26atitle%3DExemestane%2520Is%2520Superior%2520to%2520Megestrol%2520Acetate%2520after%2520Tamoxifen%2520Failure%2520in%2520Postmenopausal%2520Women%2520with%2520Advanced%2520Breast%2520Cancer%253A%2520Results%2520of%2520a%2520Phase%2520Iii%2520Randomized%2520Double-Blind%2520Trial.%2520The%2520Exemestane%2520Study%2520Group%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2000%26volume%3D18%26spage%3D1399%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Plourde, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyroff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukes, M.</span><span> </span><span class="NLM_article-title">Arimidex: A Potent and Selective Fourth-Generation Aromatase Inhibitor</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1007/BF00682745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2FBF00682745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=7949201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fjs1ektw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1994&pages=103-111&author=P.+V.+Plourdeauthor=M.+Dyroffauthor=M.+Dukes&title=Arimidex%3A+A+Potent+and+Selective+Fourth-Generation+Aromatase+Inhibitor&doi=10.1007%2FBF00682745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Arimidex: a potent and selective fourth-generation aromatase inhibitor</span></div><div class="casAuthors">Plourde P V; Dyroff M; Dukes M</div><div class="citationInfo"><span class="NLM_cas:title">Breast cancer research and treatment</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-11</span>
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    </div><div class="casAbstract">Arimidex is a potent and selective aromatase inhibitor undergoing evaluation as a treatment for postmenopausal women with advanced breast cancer.  Studies to determine the pharmacology of Arimidex were conducted in both animals and humans.  In animals, Arimidex was selective for the aromatase enzyme, elicited maximal activity at about 0.1 mg/kg, did not interfere with steroid hormones produced by the adrenal glands, and, at a dose of 1 mg/kg, had no detectable pharmacologic activity other than aromatase inhibition.  Absorption of ZD1033, the active component of Arimidex, was rapid and virtually complete after oral administration to animals.  ZD1033 was extensively metabolized in animals after oral administration; the metabolites were excreted predominantly in urine.  The pharmacodynamic, pharmacokinetic, and safety profiles of single and multiple daily doses of Arimidex were determined in humans.  Doses of 1 to 10 mg of Arimidex suppressed estradiol to the maximum degree measurable.  Arimidex had no clinically significant effects on key enzymes that regulate cortisol and aldosterone biosynthesis.  Absorption of ZD1033 was rapid, with maximum plasma concentrations occurring within 2 hours after oral administration.  Plasma concentrations of ZD1033 rose with increasing doses of Arimidex.  The elimination half-life of ZD1033 in humans ranged from 30 to 60 hours.  Urinary excretion accounted for a small percentage of each dose.  A 3- to 4-fold accumulation of ZD1033 in plasma occurred after daily administration of 3-, 5-, or 10-mg doses.  Arimidex was well tolerated.  Phase III studies are under way to determine the efficacy and safety of Arimidex in postmenopausal women with advanced breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTC7v8Jka1FsgyMywPm6HgQfW6udTcc2eagYmITgRTAirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fjs1ektw%253D%253D&md5=ef2d16210e3f984ab59c9a3904a5c0dd</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1007%2FBF00682745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00682745%26sid%3Dliteratum%253Aachs%26aulast%3DPlourde%26aufirst%3DP.%2BV.%26aulast%3DDyroff%26aufirst%3DM.%26aulast%3DDukes%26aufirst%3DM.%26atitle%3DArimidex%253A%2520A%2520Potent%2520and%2520Selective%2520Fourth-Generation%2520Aromatase%2520Inhibitor%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1994%26volume%3D30%26spage%3D103%26epage%3D111%26doi%3D10.1007%2FBF00682745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Dukes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Large, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, T.</span><span> </span><span class="NLM_article-title">The Preclinical Pharmacology of “Arimidex” (Anastrozole; ZD1033)--a Potent, Selective Aromatase Inhibitor</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span><span class="refDoi"> DOI: 10.1016/0960-0760(96)00064-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2896%2900064-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=8903429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK28Xmslaht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1996&pages=439-445&author=M.+Dukesauthor=P.+N.+Edwardsauthor=M.+Largeauthor=I.+K.+Smithauthor=T.+Boyle&title=The+Preclinical+Pharmacology+of+%E2%80%9CArimidex%E2%80%9D+%28Anastrozole%3B+ZD1033%29%2D%2Da+Potent%2C+Selective+Aromatase+Inhibitor&doi=10.1016%2F0960-0760%2896%2900064-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The preclinical pharmacology of "Arimidex" (anastrozole; ZD1033) - a potent, selective aromatase inhibitor</span></div><div class="casAuthors">Dukes, Michael; Edwards, Philip N.; Large, Michael; Smith, Ian K.; Boyle, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">439-445</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Anastrozole is a comparatively simple, achiral benzyltriazole deriv., 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropiononitrile), that inhibits human placental aromatase with an IC50 of 15 nM and elicits maximal activity in vivo in rats (inhibition of ovulation and androstenedione-induced uterine hypertrophy) and monkeys (lowering of plasma estradiol) at 0.1 mg/kg p.o.  At 30 times this dose, anastrozole does not elevate plasma 11-deoxycorticosterone in monkeys, and at 100 times this dose, does not affect plasma aldosterone levels or Na+/K+ excretion in rats, plasma K+ concns. in dogs, or cause adrenal hypertrophy in rats or dogs.  It therefore has no discernible effect on adrenocorticoid hormone synthesis in vivo at very large multiples of its maximally effective aromatase-inhibiting dose.  At similar large multiples in rats it displays no estrogenic, anti-estrogenic, androgenic, anti-androgenic, progestogenic, glucocorticoid, antiglucocorticoid or mineralocorticoid activity.  Anastrozole is thus a potent and highly selective aromatase inhibitor, with no intrinsic hormonal activities - a pharmacol. profile particularly suitable for the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhHcAJCkrdrVg90H21EOLACvtfcHk0liVik8wSlzYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmslaht7o%253D&md5=e30e5876b89cbe19d8555bdf7878b34b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2896%2900064-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252896%252900064-7%26sid%3Dliteratum%253Aachs%26aulast%3DDukes%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DP.%2BN.%26aulast%3DLarge%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DI.%2BK.%26aulast%3DBoyle%26aufirst%3DT.%26atitle%3DThe%2520Preclinical%2520Pharmacology%2520of%2520%25E2%2580%259CArimidex%25E2%2580%259D%2520%2528Anastrozole%253B%2520ZD1033%2529--a%2520Potent%252C%2520Selective%2520Aromatase%2520Inhibitor%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D58%26spage%3D439%26epage%3D445%26doi%3D10.1016%2F0960-0760%2896%2900064-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Buzdar, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonat, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomqvist, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolter, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span> </span><span class="NLM_article-title">Anastrozole Versus Megestrol Acetate in the Treatment of Postmenopausal Women with Advanced Breast Carcinoma: Results of a Survival Update Based on a Combined Analysis of Data from Two Mature Phase III Trials. Arimidex Study Group</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span><span class="refDoi"> DOI: 10.1002/(SICI)1097-0142(19980915)83:6<1142::AID-CNCR13>3.0.CO;2-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1142%3A%3AAID-CNCR13%3E3.0.CO%3B2-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1998&pages=1142-1152&author=A.+U.+Buzdarauthor=W.+Jonatauthor=A.+Howellauthor=S.+E.+Jonesauthor=C.+P.+Blomqvistauthor=C.+L.+Vogelauthor=W.+Eiermannauthor=J.+M.+Wolterauthor=M.+Steinbergauthor=A.+Websterauthor=D.+Lee&title=Anastrozole+Versus+Megestrol+Acetate+in+the+Treatment+of+Postmenopausal+Women+with+Advanced+Breast+Carcinoma%3A+Results+of+a+Survival+Update+Based+on+a+Combined+Analysis+of+Data+from+Two+Mature+Phase+III+Trials.+Arimidex+Study+Group&doi=10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1142%3A%3AAID-CNCR13%3E3.0.CO%3B2-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1142%3A%3AAID-CNCR13%3E3.0.CO%3B2-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0142%252819980915%252983%253A6%253C1142%253A%253AAID-CNCR13%253E3.0.CO%253B2-5%26sid%3Dliteratum%253Aachs%26aulast%3DBuzdar%26aufirst%3DA.%2BU.%26aulast%3DJonat%26aufirst%3DW.%26aulast%3DHowell%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DS.%2BE.%26aulast%3DBlomqvist%26aufirst%3DC.%2BP.%26aulast%3DVogel%26aufirst%3DC.%2BL.%26aulast%3DEiermann%26aufirst%3DW.%26aulast%3DWolter%26aufirst%3DJ.%2BM.%26aulast%3DSteinberg%26aufirst%3DM.%26aulast%3DWebster%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DD.%26atitle%3DAnastrozole%2520Versus%2520Megestrol%2520Acetate%2520in%2520the%2520Treatment%2520of%2520Postmenopausal%2520Women%2520with%2520Advanced%2520Breast%2520Carcinoma%253A%2520Results%2520of%2520a%2520Survival%2520Update%2520Based%2520on%2520a%2520Combined%2520Analysis%2520of%2520Data%2520from%2520Two%2520Mature%2520Phase%2520III%2520Trials.%2520Arimidex%2520Study%2520Group%26jtitle%3DCancer%26date%3D1998%26volume%3D83%26spage%3D1142%26epage%3D1152%26doi%3D10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1142%3A%3AAID-CNCR13%3E3.0.CO%3B2-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Yates, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyld, P. J.</span><span> </span><span class="NLM_article-title">Arimidex (ZD1033): A Selective, Potent Inhibitor of Aromatase in Postmenopausal Female Volunteers</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1038/bjc.1996.94</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Fbjc.1996.94" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=8595172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK28Xhs1Kjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1996&pages=543-548&author=R.+A.+Yatesauthor=M.+Dowsettauthor=G.+V.+Fisherauthor=A.+Selenauthor=P.+J.+Wyld&title=Arimidex+%28ZD1033%29%3A+A+Selective%2C+Potent+Inhibitor+of+Aromatase+in+Postmenopausal+Female+Volunteers&doi=10.1038%2Fbjc.1996.94"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Arimidex (ZD1033): A selective, potent inhibitor of aromatase in postmenopausal female volunteers</span></div><div class="casAuthors">Yates, R. A.; Dowsett, M.; Fisher, G. V.; Selen, A.; Wyld, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">543-8</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">Two multiple-dose studies were conducted in healthy post-menopausal female volunteers to investigate the pharmacokinetics and effects on endocrinol. of Arimidex (ZD1033).  Volunteers in the first trial were dosed with 3 mg of ZD1033 daily over 10 days to assess the effects on endocrinol. of ZD1033 and establish the pharmacokinetic profile.  In the second trial volunteers received 14 daily doses of either 0.5 or 1.0 mg of ZD1033 to assess the pharmacokinetics of ZD1033 and the effects of low doses of ZD1033 on serum estradiol concns.  Following multiple dosing a significant redn. in the concn. of serum estradiol of approx. 80% of baseline was obtained with all three doses; no recovery in estradiol was apparent for up to 144 h after the last dose.  There was no overall difference in the level of estradiol suppression between the 0.5 or 1.0 mg doses of ZD1033.  However, comparison of the no. of volunteers with estradiol concns. below the limits of detection of the assay, 24 h after the last dose of ZD1033, suggested that 1.0 mg was the minimal dose required for maximal suppression of estradiol.  No significant effect was recorded on serum concns. of gonadotropins over the dosing period.  Serum concns. of a range of adrenal steroids were not affected by administration of ZD1033; furthermore, steroid response to std. adrenocorticotrophic hormone (ACTH) challenge was unimpaired by ZD1033.  Together these data demonstrate the potency, tolerability and selectivity of ZD1033.  The pharmacokinetic profile of ZD1033 supports its use as a once-daily treatment given orally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVnIc317voOrVg90H21EOLACvtfcHk0lg5QgKRRGAbYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhs1Kjt7o%253D&md5=1584550bccbcdd7dec7eb8f000b11e08</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1996.94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1996.94%26sid%3Dliteratum%253Aachs%26aulast%3DYates%26aufirst%3DR.%2BA.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DFisher%26aufirst%3DG.%2BV.%26aulast%3DSelen%26aufirst%3DA.%26aulast%3DWyld%26aufirst%3DP.%2BJ.%26atitle%3DArimidex%2520%2528ZD1033%2529%253A%2520A%2520Selective%252C%2520Potent%2520Inhibitor%2520of%2520Aromatase%2520in%2520Postmenopausal%2520Female%2520Volunteers%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1996%26volume%3D73%26spage%3D543%26epage%3D548%26doi%3D10.1038%2Fbjc.1996.94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Buzdar, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plourde, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, A.</span><span> </span><span class="NLM_article-title">A Phase III Trial Comparing Anastrozole (1 and 10 Milligrams), a Potent and Selective Aromatase Inhibitor, with Megestrol Acetate in Postmenopausal Women with Advanced Breast Carcinoma. Arimidex Study Group</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span><span class="refDoi"> DOI: 10.1002/(SICI)1097-0142(19970215)79:4<730::AID-CNCR10>3.0.CO;2-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2F%28SICI%291097-0142%2819970215%2979%3A4%3C730%3A%3AAID-CNCR10%3E3.0.CO%3B2-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1997&pages=730-739&author=A.+U.+Buzdarauthor=S.+E.+Jonesauthor=C.+L.+Vogelauthor=J.+Wolterauthor=P.+Plourdeauthor=A.+Webster&title=A+Phase+III+Trial+Comparing+Anastrozole+%281+and+10+Milligrams%29%2C+a+Potent+and+Selective+Aromatase+Inhibitor%2C+with+Megestrol+Acetate+in+Postmenopausal+Women+with+Advanced+Breast+Carcinoma.+Arimidex+Study+Group&doi=10.1002%2F%28SICI%291097-0142%2819970215%2979%3A4%3C730%3A%3AAID-CNCR10%3E3.0.CO%3B2-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0142%2819970215%2979%3A4%3C730%3A%3AAID-CNCR10%3E3.0.CO%3B2-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0142%252819970215%252979%253A4%253C730%253A%253AAID-CNCR10%253E3.0.CO%253B2-0%26sid%3Dliteratum%253Aachs%26aulast%3DBuzdar%26aufirst%3DA.%2BU.%26aulast%3DJones%26aufirst%3DS.%2BE.%26aulast%3DVogel%26aufirst%3DC.%2BL.%26aulast%3DWolter%26aufirst%3DJ.%26aulast%3DPlourde%26aufirst%3DP.%26aulast%3DWebster%26aufirst%3DA.%26atitle%3DA%2520Phase%2520III%2520Trial%2520Comparing%2520Anastrozole%2520%25281%2520and%252010%2520Milligrams%2529%252C%2520a%2520Potent%2520and%2520Selective%2520Aromatase%2520Inhibitor%252C%2520with%2520Megestrol%2520Acetate%2520in%2520Postmenopausal%2520Women%2520with%2520Advanced%2520Breast%2520Carcinoma.%2520Arimidex%2520Study%2520Group%26jtitle%3DCancer%26date%3D1997%26volume%3D79%26spage%3D730%26epage%3D739%26doi%3D10.1002%2F%28SICI%291097-0142%2819970215%2979%3A4%3C730%3A%3AAID-CNCR10%3E3.0.CO%3B2-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Buzdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabholtz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, C.</span><span> </span><span class="NLM_article-title">Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol Acetate</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3357</span><span class="NLM_x">–</span> <span class="NLM_lpage">3366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=11454883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvVamsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=3357-3366&author=A.+Buzdarauthor=J.+Doumaauthor=N.+Davidsonauthor=R.+Elledgeauthor=M.+Morganauthor=R.+Smithauthor=L.+Porterauthor=J.+Nabholtzauthor=X.+Xiangauthor=C.+Brady&title=Phase+III%2C+Multicenter%2C+Double-Blind%2C+Randomized+Study+of+Letrozole%2C+an+Aromatase+Inhibitor%2C+for+Advanced+Breast+Cancer+Versus+Megestrol+Acetate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate</span></div><div class="casAuthors">Buzdar, A.; Douma, J.; Davidson, N.; Elledge, R.; Morgan, M.; Smith, R.; Porter, L.; Nabholtz, J.; Xiang, X.; Brady, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3357-3366</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Aim of this study was to compare two doses of letrozole (0.5 mg and 2.5 mg every day) and megestrol acetate (40 mg qid) as endocrine therapy in postmenopausal women with advanced breast cancer previously treated with antiestrogens.  This double-blind, randomized, multicenter, multinational study enrolled 602 patients, all of whom were included in the primary anal. in the protocol.  Patients had advanced or metastatic breast cancer with evidence of disease progression while receiving continuous adjuvant antiestrogen therapy, had experienced relapse within 12 mo of stopping adjuvant antiestrogen therapy given for at least 6 mo, or had experienced disease progression while receiving antiestrogen therapy for advanced disease.  Tumors were required to be estrogen receptor- and/or progesterone receptor-pos. or of unknown status.  Confirmed objective response rate was the primary efficacy variable.  Karnofsky Performance Status and European Organization for Research and Treatment of Cancer quality-of-life assessments were collected for 1 yr.  There were no statistically significant differences among the three treatment groups for overall objective tumor response.  Patients treated with letrozole 0.5 mg had improvements in disease progression (P = .044) and a decreased risk of treatment failure (P = .018), compared with patients treated with megestrol acetate.  Letrozole 0.5 mg showed a trend (P = .053) for survival benefit when compared with megestrol acetate.  Megestrol acetate was more likely to produce wt. gain, dyspnea, and vaginal bleeding, and the letrozole groups were more likely to experience headache, hair thinning, and diarrhea.  Given a favorable tolerability profile, once-daily dosing, and evidence of clin. relevant benefit, letrozole is equiv. to megestrol acetate and should be considered for use as an alternative treatment of advanced breast cancer in postmenopausal women after treatment failure with antiestrogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3SFhM4_v_irVg90H21EOLACvtfcHk0lg5QgKRRGAbYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvVamsro%253D&md5=a46e148001b32c3dc78275f7477d77b1</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuzdar%26aufirst%3DA.%26aulast%3DDouma%26aufirst%3DJ.%26aulast%3DDavidson%26aufirst%3DN.%26aulast%3DElledge%26aufirst%3DR.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DPorter%26aufirst%3DL.%26aulast%3DNabholtz%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DX.%26aulast%3DBrady%26aufirst%3DC.%26atitle%3DPhase%2520III%252C%2520Multicenter%252C%2520Double-Blind%252C%2520Randomized%2520Study%2520of%2520Letrozole%252C%2520an%2520Aromatase%2520Inhibitor%252C%2520for%2520Advanced%2520Breast%2520Cancer%2520Versus%2520Megestrol%2520Acetate%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2001%26volume%3D19%26spage%3D3357%26epage%3D3366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Cohen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazdur, R.</span><span> </span><span class="NLM_article-title">Approval Summary: Letrozole in the Treatment of Postmenopausal Women with Advanced Breast Cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=11895893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD38XislOqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=665-669&author=M.+H.+Cohenauthor=J.+R.+Johnsonauthor=N.+Liauthor=G.+Chenauthor=R.+Pazdur&title=Approval+Summary%3A+Letrozole+in+the+Treatment+of+Postmenopausal+Women+with+Advanced+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer</span></div><div class="casAuthors">Cohen, Martin H.; Johnson, John R.; Li, Ning; Chen, Gang; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">665-669</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Letrozole (Femara; Novartis Pharmaceuticals Corp., East Hanover, NJ) is a nonsteroidal inhibitor of aromatase enzyme complex.  It inhibits the peripheral conversion of circulating androgens to estrogens.  In postmenopausal women, letrozole decreases plasma concns. of estradiol, estrone, and estrone sulfate by 75-95% from baseline with maximal suppression achieved within 2-3 days of treatment initiation.  Suppression is dose related, with doses of ≥0.5 mg giving estrone and estrone sulfate values that were often below assay detection limits.  At clin. used dosage, letrozole does not impair adrenal synthesis of glucocorticoids or aldosterone.  In 1998, letrozole was approved by the United States Food and Drug Administration (FDA) for the treatment of advanced breast cancer in postmenopausal women, with hormone receptor pos. or unknown breast cancer, who had failed one prior antiestrogen treatment (i.e., for "second-line" treatment).  Approval was based on two randomized trials comparing tumor RRs of patients receiving 0.5 mg of letrozole, 2.5 mg of letrozole, and either megestrol acetate (MA) or aminoglutethimide.  In the megestrol trial, 2.5 mg/day letrozole was superior to 0.5 mg of letrozole and MA (RRs 24, 13, and 16%, resp.), whereas in the aminoglutethimide trial, there was no significant difference in 2.5 mg of letrozole and 0.5 mg of letrozole RRs (20 and 17%).  There was a trend toward RR superiority of 2.5 mg of letrozole over aminoglutethimide (P = 0.06).  Letrozole (2.5 mg) was the dose chosen for comparison with tamoxifen in the first-line setting.  In July 2000, a marketing application for first-line letrozole treatment of postmenopausal women with hormone receptor pos. or hormone receptor unknown locally advanced or metastatic breast cancer was submitted to the FDA.  A single double-blind, double dummy, randomized, and multicenter trial compared 2.5 mg of letrozole to 20 mg of tamoxifen (456 patients/arm).  Letrozole was superior to tamoxifen with regard to time to progression (TTP) and objective response rate (RR).  The median TTP for letrozole treatment was 9.9 mo [95% confidence interval (CI) 9.1-12.2] vs. 6.2 mo (95% CI 5.8-8.5) for tamoxifen, P = 0.0001, hazard ratio 0.713, (95% CI 0.61-0.84).  RR was 32% for letrozole vs. 21% for tamoxifen (odds ratio 1.74, 95% CI 1.29-2.34, P = 0.0003).  Preliminary survival data (survival data are still blinded) indicate that letrozole is unlikely to be worse than tamoxifen.  Both treatments were similarly tolerated.  On the basis of these results, the United States FDA approved letrozole tablets, 2.5 mg/day, for first-line treatment of postmenopausal women with hormone receptor-pos. or hormone receptor-unknown locally advanced or metastatic breast cancer.  The manufacturer made a commitment to provide updated information on survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9jwOPyOIOh7Vg90H21EOLACvtfcHk0lgqJnN1or6F3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislOqt7o%253D&md5=697123a2d97086fae20a5d8bedc47648</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DM.%2BH.%26aulast%3DJohnson%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DApproval%2520Summary%253A%2520Letrozole%2520in%2520the%2520Treatment%2520of%2520Postmenopausal%2520Women%2520with%2520Advanced%2520Breast%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D665%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Goss, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingle, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muss, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castiglione, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pater, J. L.</span><span> </span><span class="NLM_article-title">Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1262</span><span class="NLM_x">–</span> <span class="NLM_lpage">1271</span><span class="refDoi"> DOI: 10.1093/jnci/dji250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1093%2Fjnci%2Fdji250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=16145047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFKjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2005&pages=1262-1271&author=P.+E.+Gossauthor=J.+N.+Ingleauthor=S.+Martinoauthor=N.+J.+Robertauthor=H.+B.+Mussauthor=M.+J.+Piccartauthor=M.+Castiglioneauthor=D.+Tuauthor=L.+E.+Shepherdauthor=K.+I.+Pritchardauthor=R.+B.+Livingstonauthor=N.+E.+Davidsonauthor=L.+Nortonauthor=E.+A.+Perezauthor=J.+S.+Abramsauthor=D.+A.+Cameronauthor=M.+J.+Palmerauthor=J.+L.+Pater&title=Randomized+Trial+of+Letrozole+Following+Tamoxifen+as+Extended+Adjuvant+Therapy+in+Receptor-Positive+Breast+Cancer%3A+Updated+Findings+from+NCIC+CTG+MA.17&doi=10.1093%2Fjnci%2Fdji250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17</span></div><div class="casAuthors">Goss, Paul E.; Ingle, James N.; Martino, Silvana; Robert, Nicholas J.; Muss, Hyman B.; Piccart, Martine J.; Castiglione, Monica; Tu, Dongsheng; Shepherd, Lois E.; Pritchard, Kathleen I.; Livingston, Robert B.; Davidson, Nancy E.; Norton, Larry; Perez, Edith A.; Abrams, Jeffrey S.; Cameron, David A.; Palmer, Michael J.; Pater, Joseph L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1262-1271</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Most recurrences in women with breast cancer receiving 5 years of adjuvant tamoxifen occur after 5 years.  The MA.17 trial, which was designed to det. whether extended adjuvant therapy with the aromatase inhibitor letrozole after tamoxifen reduces the risk of such late recurrences, was stopped early after an interim anal. showed that letrozole improved disease-free survival.  This report presents updated findings from the trial.  Methods: Postmenopausal women completing 5 years of tamoxifen treatment were randomly assigned to a planned 5 years of letrozole (n = 2593) or placebo (n = 2594).  The primary endpoint was disease-free survival (DFS); secondary endpoints included distant disease-free survival, overall survival, incidence of contralateral tumors, and toxic effects.  Survival was examd. using Kaplan-Meier anal. and log-rank tests.  Planned subgroup analyses included those by axillary lymph node status.  All statistical tests were two-sided.  Results: After a median follow-up of 30 mo (range = 1.5-61.4 mo), women in the letrozole arm had statistically significantly better DFS and distant DFS than women in the placebo arm (DFS: hazard ratio [HR] for recurrence or contralateral breast cancer = 0.58, 95% confidence interval [CI] = 0.45 to 0.76; P < .001; distant DFS: HR = 0.60, 95% CI = 0.43 to 0.84; P = .002).  Overall survival was the same in both arms (HR for death from any cause = 0.82, 95% CI = 0.57 to 1.19; P = .3).  However, among lymph node-pos. patients, overall survival was statistically significantly improved with letrozole (HR = 0.61, 95% CI = 0.38 to 0.98; P = .04).  The incidence of contralateral breast cancer was lower in women receiving letrozole, but the difference was not statistically significant.  Women receiving letrozole experienced more hormonally related side effects than those receiving placebo, but the incidences of bone fractures and cardiovascular events were the same.  Conclusion: Letrozole after tamoxifen is well-tolerated and improves both disease-free and distant disease-free survival but not overall survival, except in node-pos. patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW5fLONV5SxbVg90H21EOLACvtfcHk0lgqJnN1or6F3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFKjsrY%253D&md5=465c4494254315b309a70b8f7edd41dc</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdji250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdji250%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DP.%2BE.%26aulast%3DIngle%26aufirst%3DJ.%2BN.%26aulast%3DMartino%26aufirst%3DS.%26aulast%3DRobert%26aufirst%3DN.%2BJ.%26aulast%3DMuss%26aufirst%3DH.%2BB.%26aulast%3DPiccart%26aufirst%3DM.%2BJ.%26aulast%3DCastiglione%26aufirst%3DM.%26aulast%3DTu%26aufirst%3DD.%26aulast%3DShepherd%26aufirst%3DL.%2BE.%26aulast%3DPritchard%26aufirst%3DK.%2BI.%26aulast%3DLivingston%26aufirst%3DR.%2BB.%26aulast%3DDavidson%26aufirst%3DN.%2BE.%26aulast%3DNorton%26aufirst%3DL.%26aulast%3DPerez%26aufirst%3DE.%2BA.%26aulast%3DAbrams%26aufirst%3DJ.%2BS.%26aulast%3DCameron%26aufirst%3DD.%2BA.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DPater%26aufirst%3DJ.%2BL.%26atitle%3DRandomized%2520Trial%2520of%2520Letrozole%2520Following%2520Tamoxifen%2520as%2520Extended%2520Adjuvant%2520Therapy%2520in%2520Receptor-Positive%2520Breast%2520Cancer%253A%2520Updated%2520Findings%2520from%2520NCIC%2520CTG%2520MA.17%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2005%26volume%3D97%26spage%3D1262%26epage%3D1271%26doi%3D10.1093%2Fjnci%2Fdji250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Goss, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingle, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muss, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castiglione, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therasse, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pater, J. L.</span><span> </span><span class="NLM_article-title">A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1802</span><span class="refDoi"> DOI: 10.1056/NEJMoa032312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1056%2FNEJMoa032312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=14551341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosl2gtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2003&pages=1793-1802&author=P.+E.+Gossauthor=J.+N.+Ingleauthor=S.+Martinoauthor=N.+J.+Robertauthor=H.+B.+Mussauthor=M.+J.+Piccartauthor=M.+Castiglioneauthor=D.+Tuauthor=L.+E.+Shepherdauthor=K.+I.+Pritchardauthor=R.+B.+Livingstonauthor=N.+E.+Davidsonauthor=L.+Nortonauthor=E.+A.+Perezauthor=J.+S.+Abramsauthor=P.+Therasseauthor=M.+J.+Palmerauthor=J.+L.+Pater&title=A+Randomized+Trial+of+Letrozole+in+Postmenopausal+Women+after+Five+Years+of+Tamoxifen+Therapy+for+Early-Stage+Breast+Cancer&doi=10.1056%2FNEJMoa032312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer</span></div><div class="casAuthors">Goss, Paul E.; Ingle, James N.; Martino, Silvana; Robert, Nicholas J.; Muss, Hyman B.; Piccart, Martine J.; Castiglione, Monica; Tu, Dongsheng; Shepherd, Lois E.; Pritchard, Kathleen I.; Livingston, Robert B.; Davidson, Nancy E.; Norton, Larry; Perez, Edith A.; Abrams, Jeffrey S.; Therasse, Patrick; Palmer, Michael J.; Pater, Joseph L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1793-1802</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: In hormone-dependent breast cancer, five years of postoperative tamoxifen therapy - but not tamoxifen therapy of longer duration - prolongs disease-free and overall survival.  The aromatase inhibitor letrozole, by suppressing estrogen prodn., might improve the outcome after the discontinuation of tamoxifen therapy.  Methods: We conducted a double-blind, placebo-controlled trial to test the effectiveness of five years of letrozole therapy in postmenopausal women with breast cancer who have completed five years of tamoxifen therapy.  The primary end point was disease-free survival.  Results: A total of 5187 women were enrolled (median follow-up, 2.4 yr).  At the first interim anal., there were 207 local or metastatic recurrences of breast cancer or new primary cancers in the contralateral breast - 75 in the letrozole group and 132 in the placebo group - with estd. four-year disease-free survival rates of 93% and 87%, resp., in the two groups (p ≤ 0.001 for the comparison of disease-free survival).  A total of 42 women in the placebo group and 31 women in the letrozole group died (P = 0.25 for the comparison of overall survival).  Low-grade hot flashes, arthritis, arthralgia, and myalgia were more frequent in the letrozole group, but vaginal bleeding was less frequent.  There were new diagnoses of osteoporosis in 5.8% of the women in the letrozole group and 4.5% of the women in the placebo group (P = 0.07); the rates of fracture were similar.  After the first interim anal., the independent data and safety monitoring committee recommended termination of the trial and prompt communication of the results to the participants.  Conclusions: As compared with placebo, letrozole therapy after the completion of std. tamoxifen treatment significantly improves disease-free survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn8Yeh_0VFRbVg90H21EOLACvtfcHk0lgqJnN1or6F3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosl2gtbc%253D&md5=b7ccc0fb80f769bc70d2768567a4c31f</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa032312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa032312%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DP.%2BE.%26aulast%3DIngle%26aufirst%3DJ.%2BN.%26aulast%3DMartino%26aufirst%3DS.%26aulast%3DRobert%26aufirst%3DN.%2BJ.%26aulast%3DMuss%26aufirst%3DH.%2BB.%26aulast%3DPiccart%26aufirst%3DM.%2BJ.%26aulast%3DCastiglione%26aufirst%3DM.%26aulast%3DTu%26aufirst%3DD.%26aulast%3DShepherd%26aufirst%3DL.%2BE.%26aulast%3DPritchard%26aufirst%3DK.%2BI.%26aulast%3DLivingston%26aufirst%3DR.%2BB.%26aulast%3DDavidson%26aufirst%3DN.%2BE.%26aulast%3DNorton%26aufirst%3DL.%26aulast%3DPerez%26aufirst%3DE.%2BA.%26aulast%3DAbrams%26aufirst%3DJ.%2BS.%26aulast%3DTherasse%26aufirst%3DP.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DPater%26aufirst%3DJ.%2BL.%26atitle%3DA%2520Randomized%2520Trial%2520of%2520Letrozole%2520in%2520Postmenopausal%2520Women%2520after%2520Five%2520Years%2520of%2520Tamoxifen%2520Therapy%2520for%2520Early-Stage%2520Breast%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D349%26spage%3D1793%26epage%3D1802%26doi%3D10.1056%2FNEJMoa032312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Lipton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudri-Ross, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, W.</span><span> </span><span class="NLM_article-title">Serum HER-2/Neu Conversion to Positive at the Time of Disease Progression in Patients with Breast Carcinoma on Hormone Therapy</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span><span class="refDoi"> DOI: 10.1002/cncr.21202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fcncr.21202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2005&pages=257-263&author=A.+Liptonauthor=K.+Leitzelauthor=S.+M.+Aliauthor=L.+Demersauthor=H.+A.+Harveyauthor=H.+A.+Chaudri-Rossauthor=D.+Evansauthor=R.+Langauthor=W.+Hacklauthor=P.+Hamerauthor=W.+Carney&title=Serum+HER-2%2FNeu+Conversion+to+Positive+at+the+Time+of+Disease+Progression+in+Patients+with+Breast+Carcinoma+on+Hormone+Therapy&doi=10.1002%2Fcncr.21202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fcncr.21202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcncr.21202%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DA.%26aulast%3DLeitzel%26aufirst%3DK.%26aulast%3DAli%26aufirst%3DS.%2BM.%26aulast%3DDemers%26aufirst%3DL.%26aulast%3DHarvey%26aufirst%3DH.%2BA.%26aulast%3DChaudri-Ross%26aufirst%3DH.%2BA.%26aulast%3DEvans%26aufirst%3DD.%26aulast%3DLang%26aufirst%3DR.%26aulast%3DHackl%26aufirst%3DW.%26aulast%3DHamer%26aufirst%3DP.%26aulast%3DCarney%26aufirst%3DW.%26atitle%3DSerum%2520HER-2%252FNeu%2520Conversion%2520to%2520Positive%2520at%2520the%2520Time%2520of%2520Disease%2520Progression%2520in%2520Patients%2520with%2520Breast%2520Carcinoma%2520on%2520Hormone%2520Therapy%26jtitle%3DCancer%26date%3D2005%26volume%3D104%26spage%3D257%26epage%3D263%26doi%3D10.1002%2Fcncr.21202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Meng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shete, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashfaq, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beitsch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Euhus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenkel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifford, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitetta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlyn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terstappen, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehm, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhr, J.</span><span> </span><span class="NLM_article-title">HER-2 Gene Amplification Can Be Acquired as Breast Cancer Progresses</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">9393</span><span class="NLM_x">–</span> <span class="NLM_lpage">9398</span><span class="refDoi"> DOI: 10.1073/pnas.0402993101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1073%2Fpnas.0402993101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=9393-9398&author=S.+Mengauthor=D.+Tripathyauthor=S.+Sheteauthor=R.+Ashfaqauthor=B.+Haleyauthor=S.+Perkinsauthor=P.+Beitschauthor=A.+Khanauthor=D.+Euhusauthor=C.+Osborneauthor=E.+Frenkelauthor=S.+Hooverauthor=M.+Leitchauthor=E.+Cliffordauthor=E.+Vitettaauthor=L.+Morrisonauthor=D.+Herlynauthor=L.+W.+Terstappenauthor=T.+Flemingauthor=T.+Fehmauthor=T.+Tuckerauthor=N.+Laneauthor=J.+Wangauthor=J.+Uhr&title=HER-2+Gene+Amplification+Can+Be+Acquired+as+Breast+Cancer+Progresses&doi=10.1073%2Fpnas.0402993101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0402993101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0402993101%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DS.%26aulast%3DTripathy%26aufirst%3DD.%26aulast%3DShete%26aufirst%3DS.%26aulast%3DAshfaq%26aufirst%3DR.%26aulast%3DHaley%26aufirst%3DB.%26aulast%3DPerkins%26aufirst%3DS.%26aulast%3DBeitsch%26aufirst%3DP.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DEuhus%26aufirst%3DD.%26aulast%3DOsborne%26aufirst%3DC.%26aulast%3DFrenkel%26aufirst%3DE.%26aulast%3DHoover%26aufirst%3DS.%26aulast%3DLeitch%26aufirst%3DM.%26aulast%3DClifford%26aufirst%3DE.%26aulast%3DVitetta%26aufirst%3DE.%26aulast%3DMorrison%26aufirst%3DL.%26aulast%3DHerlyn%26aufirst%3DD.%26aulast%3DTerstappen%26aufirst%3DL.%2BW.%26aulast%3DFleming%26aufirst%3DT.%26aulast%3DFehm%26aufirst%3DT.%26aulast%3DTucker%26aufirst%3DT.%26aulast%3DLane%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DUhr%26aufirst%3DJ.%26atitle%3DHER-2%2520Gene%2520Amplification%2520Can%2520Be%2520Acquired%2520as%2520Breast%2520Cancer%2520Progresses%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D9393%26epage%3D9398%26doi%3D10.1073%2Fpnas.0402993101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Hu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokbel, K.</span><span> </span><span class="NLM_article-title">Does C-Erbb2/HER2 Overexpression Predict Adjuvant Tamoxifen Failure in Patients with Early Breast Cancer?</span> <span class="citation_source-journal">European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span><span class="refDoi"> DOI: 10.1053/ejso.2000.1078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1053%2Fejso.2000.1078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=11417974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFeisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2001&pages=335-337&author=J.+C.+Huauthor=K.+Mokbel&title=Does+C-Erbb2%2FHER2+Overexpression+Predict+Adjuvant+Tamoxifen+Failure+in+Patients+with+Early+Breast+Cancer%3F&doi=10.1053%2Fejso.2000.1078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of silicon on physiological target and yield of hybrid rice</span></div><div class="casAuthors">Hu, Ruizhi; Fang, Shuijiao; Chen, Guiqiu</div><div class="citationInfo"><span class="NLM_cas:title">Hunan Nongye Daxue Xuebao</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">335-338</span>CODEN:
                <span class="NLM_cas:coden">HNDXFL</span>;
        ISSN:<span class="NLM_cas:issn">1007-1032</span>.
    
            (<span class="NLM_cas:orgname">Hunan Nongye Daxue Xuebao Bianjibu</span>)
        </div><div class="casAbstract">The soil-less culture was used to study of the effects of silicon on the contents of MDA, the REC (relative elec. cond.), SOD in hybrid rice and the component of yield.  The results show that suitable silicon contents can decrease the contents of MDA and REC in hybrid rice plant, while increase the activities of SOD, strengthen the resistance of adverse circumstances and increase its yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy0z4pD5OhGrVg90H21EOLACvtfcHk0ljzqlaWT2klvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFeisb4%253D&md5=e1847ef225425c42c3fe9581f815c3e2</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1053%2Fejso.2000.1078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fejso.2000.1078%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%2BC.%26aulast%3DMokbel%26aufirst%3DK.%26atitle%3DDoes%2520C-Erbb2%252FHER2%2520Overexpression%2520Predict%2520Adjuvant%2520Tamoxifen%2520Failure%2520in%2520Patients%2520with%2520Early%2520Breast%2520Cancer%253F%26jtitle%3DEuropean%2520journal%2520of%2520surgical%2520oncology%253A%2520the%2520journal%2520of%2520the%2520European%2520Society%2520of%2520Surgical%2520Oncology%2520and%2520the%2520British%2520Association%2520of%2520Surgical%2520Oncology%26date%3D2001%26volume%3D27%26spage%3D335%26epage%3D337%26doi%3D10.1053%2Fejso.2000.1078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Osborne, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopp, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamness, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilsenbeck, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuqua, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allred, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, R.</span><span> </span><span class="NLM_article-title">Role of the Estrogen Receptor Coactivator AIB1 (Src-3) and HER-2/Neu in Tamoxifen Resistance in Breast Cancer</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span><span class="refDoi"> DOI: 10.1093/jnci/95.5.353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1093%2Fjnci%2F95.5.353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=12618500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVeqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2003&pages=353-361&author=C.+K.+Osborneauthor=V.+Bardouauthor=T.+A.+Hoppauthor=G.+C.+Chamnessauthor=S.+G.+Hilsenbeckauthor=S.+A.+Fuquaauthor=J.+Wongauthor=D.+C.+Allredauthor=G.+M.+Clarkauthor=R.+Schiff&title=Role+of+the+Estrogen+Receptor+Coactivator+AIB1+%28Src-3%29+and+HER-2%2FNeu+in+Tamoxifen+Resistance+in+Breast+Cancer&doi=10.1093%2Fjnci%2F95.5.353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer</span></div><div class="casAuthors">Osborne, C. Kent; Bardou, Valerie; Hopp, Torsten A.; Chamness, Gary C.; Hilsenbeck, Susan G.; Fuqua, Suzanne A. W.; Wong, Jiemin; Allred, D. Craig; Clark, Gary M.; Schiff, Rachel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">353-361</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">AIB1 (SRC-3) is an estrogen receptor (ER) coactivator that, when overexpressed in cultured cells, can reduce the antagonist activity of tamoxifen-bound ERs.  Signaling through the HER-2 receptor pathway activates AIB1 by phosphorylation.  To det. whether high AIB1 expression alone or together with HER-2 reduces the effectiveness of tamoxifen in breast cancer patients, we quantified expression of AIB1 and HER-2 in tumors from breast cancer patients with long-term clin. follow-up who received either no adjuvant therapy or adjuvant tamoxifen therapy after breast cancer surgery.  AIB1 and HER-2 protein levels in tumors from 316 breast cancer patients were detd. using western blot anal.  Mol. variables (e.g., expression of AIB1, ER, progesterone receptor, p53, Bcl-2), tumor characteristics, and patient outcome were assessed using Spearman rank correlation.  Disease-free survival (DFS) curves were derived from Kaplan-Meier ests., and the curves were compared by log-rank tests.  The effect of AIB1 on DFS adjusted for other prognostic factors was assessed by multivariable anal. using the Cox proportional hazards model.  All statistical tests were two-sided.  High AIB1 expression in patients not receiving adjuvant tamoxifen therapy was assocd. with better prognosis and longer DFS (P = .018, log-rank test).  In contrast, for patients who did receive tamoxifen therapy, high AIB1 expression was assocd. with worse DFS (P = .049, log-rank test), which is indicative of tamoxifen resistance.  The test for interaction between AIB1 expression and tamoxifen therapy was statistically significant (P = .004).  When expression of AIB1 and HER-2 were considered together, patients whose tumors expressed high levels of both AIB1 and HER-2 had worse outcomes with tamoxifen therapy than all other patients combined (P = .002, log-rank test).  The antitumor activity of tamoxifen in patients with breast cancer may be detd., in part, by tumor levels of AIB1 and HER-2.  Thus, AIB1 may be an important diagnostic and therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC6PAwU7VOrrVg90H21EOLACvtfcHk0lg1OsWXFMSQ0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVeqsrg%253D&md5=5469b2ee206ada6b884eab780a5884e4</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F95.5.353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F95.5.353%26sid%3Dliteratum%253Aachs%26aulast%3DOsborne%26aufirst%3DC.%2BK.%26aulast%3DBardou%26aufirst%3DV.%26aulast%3DHopp%26aufirst%3DT.%2BA.%26aulast%3DChamness%26aufirst%3DG.%2BC.%26aulast%3DHilsenbeck%26aufirst%3DS.%2BG.%26aulast%3DFuqua%26aufirst%3DS.%2BA.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DAllred%26aufirst%3DD.%2BC.%26aulast%3DClark%26aufirst%3DG.%2BM.%26aulast%3DSchiff%26aufirst%3DR.%26atitle%3DRole%2520of%2520the%2520Estrogen%2520Receptor%2520Coactivator%2520AIB1%2520%2528Src-3%2529%2520and%2520HER-2%252FNeu%2520in%2520Tamoxifen%2520Resistance%2520in%2520Breast%2520Cancer%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2003%26volume%3D95%26spage%3D353%26epage%3D361%26doi%3D10.1093%2Fjnci%2F95.5.353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Liehr, J. G.</span><span> </span><span class="NLM_article-title">Is Estradiol a Genotoxic Mutagenic Carcinogen?</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1210/edrv.21.1.0386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fedrv.21.1.0386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10696569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhs12hu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=40-54&author=J.+G.+Liehr&title=Is+Estradiol+a+Genotoxic+Mutagenic+Carcinogen%3F&doi=10.1210%2Fedrv.21.1.0386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Is estradiol a genotoxic mutagenic carcinogen?</span></div><div class="casAuthors">Liehr, Joachim G.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-54</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review, with 203 refs.  The natural hormone 17β-estradiol (E2) induces tumors in various organs of rats, mice, and hamsters.  In humans, slightly elevated circulating estrogen levels caused either by increased endogenous hormone prodn. or by therapeutic doses of estrogen medications increase breast or uterine cancer risk.  Several epigenetic mechanisms of tumor induction by this hormone have been proposed based on its lack of mutagenic activity in bacterial and mammalian cell test systems.  More recent evidence supports a dual role of estrogen in carcinogenesis as a hormone stimulating cell proliferation and as a procarcinogen inducing genetic damage.  Tumors may be initiated by metabolic conversion of E2 to 4-hydroxyestradiol catalyzed by a specific 4-hydroxylase (CYP1B1) and by further activation of this catechol to reactive semiquinone/quinone intermediates.  Several types of direct and indirect free radical-mediated DNA damage are induced by E2, 4-hydroxyestradiol, or its corresponding quinone in cell-free systems, in cells in culture, and/or in vivo.  E2 also induces various chromosomal and genetic lesions including aneuploidy, chromosomal aberrations, gene amplification, and microsatellite instability in cells in culture and/or in vivo and gene mutations in several cell test systems.  These data suggest that E2 is a weak carcinogen and weak mutagen capable of inducing genetic lesions with low frequency.  Tumors may develop by hormone receptor-mediated proliferation of such damaged cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomqHoWEpbMYLVg90H21EOLACvtfcHk0lg1OsWXFMSQ0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhs12hu74%253D&md5=b6d420c699606d51e070a59aae34b803</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1210%2Fedrv.21.1.0386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fedrv.21.1.0386%26sid%3Dliteratum%253Aachs%26aulast%3DLiehr%26aufirst%3DJ.%2BG.%26atitle%3DIs%2520Estradiol%2520a%2520Genotoxic%2520Mutagenic%2520Carcinogen%253F%26jtitle%3DEndocr.%2520Rev.%26date%3D2000%26volume%3D21%26spage%3D40%26epage%3D54%26doi%3D10.1210%2Fedrv.21.1.0386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Breast International Group 1-98 Collaborative Group</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurlimann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshaviah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouridsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauriac, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paridaens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castiglione-Gertsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelber, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabaglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldhirsch, A.</span><span> </span><span class="NLM_article-title">Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">2747</span><span class="NLM_x">–</span> <span class="NLM_lpage">2757</span><span class="refDoi"> DOI: 10.1056/NEJMoa052258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1056%2FNEJMoa052258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=16382061" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=2747-2757&author=Breast+International+Group+1-98+Collaborative+Groupauthor=B.+Thurlimannauthor=A.+Keshaviahauthor=A.+S.+Coatesauthor=H.+Mouridsenauthor=L.+Mauriacauthor=J.+F.+Forbesauthor=R.+Paridaensauthor=M.+Castiglione-Gertschauthor=R.+D.+Gelberauthor=M.+Rabaglioauthor=I.+Smithauthor=A.+Wardleyauthor=K.+N.+Priceauthor=A.+Goldhirsch&title=Comparison+of+Letrozole+and+Tamoxifen+in+Postmenopausal+Women+with+Early+Breast+Cancer&doi=10.1056%2FNEJMoa052258"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa052258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa052258%26sid%3Dliteratum%253Aachs%26aulast%3D%26aulast%3DThurlimann%26aufirst%3DB.%26aulast%3DKeshaviah%26aufirst%3DA.%26aulast%3DCoates%26aufirst%3DA.%2BS.%26aulast%3DMouridsen%26aufirst%3DH.%26aulast%3DMauriac%26aufirst%3DL.%26aulast%3DForbes%26aufirst%3DJ.%2BF.%26aulast%3DParidaens%26aufirst%3DR.%26aulast%3DCastiglione-Gertsch%26aufirst%3DM.%26aulast%3DGelber%26aufirst%3DR.%2BD.%26aulast%3DRabaglio%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DI.%26aulast%3DWardley%26aufirst%3DA.%26aulast%3DPrice%26aufirst%3DK.%2BN.%26aulast%3DGoldhirsch%26aufirst%3DA.%26atitle%3DComparison%2520of%2520Letrozole%2520and%2520Tamoxifen%2520in%2520Postmenopausal%2520Women%2520with%2520Early%2520Breast%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D2747%26epage%3D2757%26doi%3D10.1056%2FNEJMoa052258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Goss, P. E.</span><span> </span><span class="NLM_article-title">Pre-Clinical and Clinical Review of Vorozole, a New Third Generation Aromatase Inhibitor</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S59</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><div class="note"><p class="first last">(discussion S73–57)</p></div><span class="refDoi"> DOI: 10.1023/A:1006052923468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1023%2FA%3A1006052923468" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1998&pages=S59-65&issue=Suppl.+1&author=P.+E.+Goss&title=Pre-Clinical+and+Clinical+Review+of+Vorozole%2C+a+New+Third+Generation+Aromatase+Inhibitor&doi=10.1023%2FA%3A1006052923468"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006052923468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006052923468%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DP.%2BE.%26atitle%3DPre-Clinical%2520and%2520Clinical%2520Review%2520of%2520Vorozole%252C%2520a%2520New%2520Third%2520Generation%2520Aromatase%2520Inhibitor%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1998%26volume%3D49%26issue%3DSuppl.%25201%26spage%3DS59%26epage%3D65%26doi%3D10.1023%2FA%3A1006052923468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Goss, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winer, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannock, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, L. H.</span><span> </span><span class="NLM_article-title">Randomized Phase III Trial Comparing the New Potent and Selective Third-Generation Aromatase Inhibitor Vorozole with Megestrol Acetate in Postmenopausal Advanced Breast Cancer Patients. North American Vorozole Study Group</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10458218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK1MXltVyktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=52-63&author=P.+E.+Gossauthor=E.+P.+Winerauthor=I.+F.+Tannockauthor=L.+H.+Schwartz&title=Randomized+Phase+III+Trial+Comparing+the+New+Potent+and+Selective+Third-Generation+Aromatase+Inhibitor+Vorozole+with+Megestrol+Acetate+in+Postmenopausal+Advanced+Breast+Cancer+Patients.+North+American+Vorozole+Study+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients</span></div><div class="casAuthors">Goss, P. E.; Winer, E. P.; Tannock, I. F.; Schwartz, L. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-63</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">To compare the efficacy and safety of vorozole (VOR) 2.5 mg once daily with that of megestrol acetate (MA) 40 mg four times per day as second-line therapy in postmenopausal women with advanced breast cancer whose disease progressed after tamoxifen treatment.  A total of 452 patients were enrolled onto an open, multicenter, randomized phase III trial comparing VOR to MA for tumor response, safety, and quality of life (as indicated by the Functional Living Index-Cancer score).  Vorozole produced a response rate of 9.7%, compared with 6.8% for MA (P = .24).  Clin. benefit (complete response + partial response + no change in > 6 mo) was demonstrated in 23.5% and 27.2% of patients treated with VOR and MA, resp. (P = .42).  Median duration of response was 18.2 mo for VOR vs. 12.5 mo for MA (P = .074).  There was no significant difference in time to progression or survival between the treatment groups.  Discontinuation of treatment because of adverse events occurred less frequently in the VOR-treated group (3.1% v 6.2%; P = .18).  Patients on the VOR arm reported significantly more nausea, hot flushes, arthralgia, upper respiratory tract infection, anorexia, and paresthesia, whereas those treated with MA had significantly more dyspnea, increased appetite, and wt. increase.  There was no difference between the two treatment groups in Functional Living Index-Cancer scores (total or subscales).  However, when analyzed by objective response, patients with complete or partial responses (P = .032) or no change (P = .033) who were receiving VOR had significant improvement in the psychol. well-being subscale, compared with patients given MA.  Vorozole is well tolerated and as effective as MA in the treatment of postmenopausal advanced breast cancer patients with disease progression after tamoxifen treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLOMxt055ACLVg90H21EOLACvtfcHk0lg1OsWXFMSQ0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVyktw%253D%253D&md5=31c654185ca7aaa4d792ced51d59202c</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DP.%2BE.%26aulast%3DWiner%26aufirst%3DE.%2BP.%26aulast%3DTannock%26aufirst%3DI.%2BF.%26aulast%3DSchwartz%26aufirst%3DL.%2BH.%26atitle%3DRandomized%2520Phase%2520III%2520Trial%2520Comparing%2520the%2520New%2520Potent%2520and%2520Selective%2520Third-Generation%2520Aromatase%2520Inhibitor%2520Vorozole%2520with%2520Megestrol%2520Acetate%2520in%2520Postmenopausal%2520Advanced%2520Breast%2520Cancer%2520Patients.%2520North%2520American%2520Vorozole%2520Study%2520Group%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D1999%26volume%3D17%26spage%3D52%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Williams, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinkovic, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angove, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tickle, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span><span class="refDoi"> DOI: 10.1126/science.1099736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1126%2Fscience.1099736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=15256616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFWqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=683-686&author=P.+A.+Williamsauthor=J.+Cosmeauthor=D.+M.+Vinkovicauthor=A.+Wardauthor=H.+C.+Angoveauthor=P.+J.+Dayauthor=C.+Vonrheinauthor=I.+J.+Tickleauthor=H.+Jhoti&title=Crystal+Structures+of+Human+Cytochrome+P450+3A4+Bound+to+Metyrapone+and+Progesterone&doi=10.1126%2Fscience.1099736"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone</span></div><div class="casAuthors">Williams, Pamela A.; Cosme, Jose; Vinkovic, Dijana Matak; Ward, Alison; Angove, Hayley C.; Day, Philip J.; Vonrhein, Clemens; Tickle, Ian J.; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">5684</span>),
    <span class="NLM_cas:pages">683-686</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cytochromes P 450 (P 450s) metabolize a wide range of endogenous compds. and xenobiotics, such as pollutants, environmental compds., and drug mols.  The microsomal, membrane-assocd., P 450 isoforms CYP3A4, CYP2D6, CYP2C9, CYP2C19, CYP2E1, and CYP1A2 are responsible for the oxidative metab. of >90% of marketed drugs.  Cytochrome P 450 3A4 (CYP3A4) metabolizes more drug mols. than all other isoforms combined.  Here, the authors report 3 crystal structures of CYP3A4: (1) unliganded, (2) bound to the inhibitor, metyrapone, and (3) bound to the substrate, progesterone.  The structures revealed a surprisingly small active site, with little conformational change assocd. with the binding of either compd.  An unexpected peripheral binding site was identified, located above a Phe cluster, which may be involved in the initial recognition of substrates or allosteric effectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMG5YfnJT6DrVg90H21EOLACvtfcHk0ljQEGC0SZaqLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFWqsrY%253D&md5=a2275c2d7ee2dc65e3e99be3bfa56331</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1126%2Fscience.1099736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1099736%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DCosme%26aufirst%3DJ.%26aulast%3DVinkovic%26aufirst%3DD.%2BM.%26aulast%3DWard%26aufirst%3DA.%26aulast%3DAngove%26aufirst%3DH.%2BC.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DCrystal%2520Structures%2520of%2520Human%2520Cytochrome%2520P450%25203A4%2520Bound%2520to%2520Metyrapone%2520and%2520Progesterone%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D683%26epage%3D686%26doi%3D10.1126%2Fscience.1099736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leydon, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxbrow, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggleston, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenery, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. M.</span><span> </span><span class="NLM_article-title">Crystal Structure of Human Cytochrome P450 2D6</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">7614</span><span class="NLM_x">–</span> <span class="NLM_lpage">7622</span><span class="refDoi"> DOI: 10.1074/jbc.M511232200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1074%2Fjbc.M511232200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=16352597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ygtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7614-7622&author=P.+Rowlandauthor=F.+E.+Blaneyauthor=M.+G.+Smythauthor=J.+J.+Jonesauthor=V.+R.+Leydonauthor=A.+K.+Oxbrowauthor=C.+J.+Lewisauthor=M.+G.+Tennantauthor=S.+Modiauthor=D.+S.+Egglestonauthor=R.+J.+Cheneryauthor=A.+M.+Bridges&title=Crystal+Structure+of+Human+Cytochrome+P450+2D6&doi=10.1074%2Fjbc.M511232200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human cytochrome P 450 2D6</span></div><div class="casAuthors">Rowland, Paul; Blaney, Frank E.; Smyth, Martin G.; Jones, Jo J.; Leydon, Vaughan R.; Oxbrow, Amanda K.; Lewis, Ceri J.; Tennant, Mike G.; Modi, Sandeep; Eggleston, Drake S.; Chenery, Richard J.; Bridges, Angela M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7614-7622</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 2D6 is a heme-contg. enzyme that is responsible for the metab. of at least 20% of known drugs.  Substrates of 2D6 typically contain a basic N atom and a planar arom. ring.  Here, the crystal structure of human 2D6 was solved and refined to 3.0Å resoln.  The structure showed the characteristic P 450 fold as seen in other members of the family, with the lengths and orientations of the individual secondary structural elements being very similar to those seen in 2C9.  There were, however, several important differences, the most notable involving the F helix, the F-G loop, the B' helix, β-sheet 4, and part of β-sheet 1, all of which were situated on the distal face of the protein.  The 2D6 structure had a well-defined active site cavity above the heme group, contg. many important residues that have been implicated in substrate recognition and binding, including Asp-301, Glu-216, Phe-483, and Phe-120.  The crystal structure helped to explain how Asp-301, Glu-216, and Phe-483 could act as substrate-binding residues and suggested that the role of Phe-120 is to control the orientation of the arom. ring found in most substrates with respect to the heme.  The structure was compared with published homol. models and has been used to explain much of the reported site-directed mutagenesis data and to help understand the metab. of several compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon7FdjHI2WD7Vg90H21EOLACvtfcHk0ljQEGC0SZaqLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ygtbg%253D&md5=f31403bf56fadab86a694b1add06859c</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M511232200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M511232200%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DSmyth%26aufirst%3DM.%2BG.%26aulast%3DJones%26aufirst%3DJ.%2BJ.%26aulast%3DLeydon%26aufirst%3DV.%2BR.%26aulast%3DOxbrow%26aufirst%3DA.%2BK.%26aulast%3DLewis%26aufirst%3DC.%2BJ.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DChenery%26aufirst%3DR.%2BJ.%26aulast%3DBridges%26aufirst%3DA.%2BM.%26atitle%3DCrystal%2520Structure%2520of%2520Human%2520Cytochrome%2520P450%25202D6%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7614%26epage%3D7622%26doi%3D10.1074%2Fjbc.M511232200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Strushkevich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilep, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usanov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. W.</span><span> </span><span class="NLM_article-title">Structural Insights into Aldosterone Synthase Substrate Specificity and Targeted Inhibition</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><span class="refDoi"> DOI: 10.1210/me.2012-1287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fme.2012-1287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=23322723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=315-324&author=N.+Strushkevichauthor=A.+A.+Gilepauthor=L.+Shenauthor=C.+H.+Arrowsmithauthor=A.+M.+Edwardsauthor=S.+A.+Usanovauthor=H.+W.+Park&title=Structural+Insights+into+Aldosterone+Synthase+Substrate+Specificity+and+Targeted+Inhibition&doi=10.1210%2Fme.2012-1287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into aldosterone synthase substrate specificity and targeted inhibition</span></div><div class="casAuthors">Strushkevich, Natallia; Gilep, Andrei A.; Shen, Limin; Arrowsmith, Cheryl H.; Edwards, Aled M.; Usanov, Sergey A.; Park, Hee-Won</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">315-324</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Aldosterone is a major mineralocorticoid hormone that plays a key role in the regulation of electrolyte balance and blood pressure.  Excess aldosterone levels can arise from dysregulation of the renin-angiotensin-aldosterone system and are implicated in the pathogenesis of hypertension and heart failure.  Aldosterone synthase (cytochrome P 450 11B2, CYP11B2) is the sole enzyme responsible for the prodn. of aldosterone in humans.  Blocking of aldosterone synthesis by mediating aldosterone synthase activity is thus a recently emerging pharmacol. therapy for hypertension, yet a lack of structural information has limited this approach.  Here, we present the crystal structures of human aldosterone synthase in complex with a substrate deoxycorticosterone and an inhibitor fadrozole.  The structures reveal a hydrophobic cavity with specific features assocd. with corticosteroid recognition.  The substrate binding mode, along with biochem. data, explains the high 11β-hydroxylase activity of aldosterone synthase toward both gluco- and mineralocorticoid formation.  The low processivity of aldosterone synthase with a high extent of intermediates release might be one of the mechanisms of controlled aldosterone prodn. from deoxycorticosterone.  Although the active site pocket is lined by identical residues between CYP11B isoforms, most of the divergent residues that confer addnl. 18-oxidase activity of aldosterone synthase are located in the I-helix (vicinity of the O2 activation path) and loops around the H-helix (affecting an egress channel closure required for retaining intermediates in the active site).  This intrinsic flexibility is also reflected in isoform-selective inhibitor binding.  Fadrozole binds to aldosterone synthase in the R-configuration, using part of the active site cavity pointing toward the egress channel.  The structural organization of aldosterone synthase provides crit. insights into the mol. mechanism of catalysis and enables rational design of more specific antihypertensive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy06hMTGcZQ7Vg90H21EOLACvtfcHk0ljQEGC0SZaqLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOgur8%253D&md5=808e61fa02a12b63809bf3787ba83318</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1210%2Fme.2012-1287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2012-1287%26sid%3Dliteratum%253Aachs%26aulast%3DStrushkevich%26aufirst%3DN.%26aulast%3DGilep%26aufirst%3DA.%2BA.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DUsanov%26aufirst%3DS.%2BA.%26aulast%3DPark%26aufirst%3DH.%2BW.%26atitle%3DStructural%2520Insights%2520into%2520Aldosterone%2520Synthase%2520Substrate%2520Specificity%2520and%2520Targeted%2520Inhibition%26jtitle%3DMol.%2520Endocrinol.%26date%3D2013%26volume%3D27%26spage%3D315%26epage%3D324%26doi%3D10.1210%2Fme.2012-1287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">DeVore, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, E. E.</span><span> </span><span class="NLM_article-title">Structures of Cytochrome P450 17A1 with Prostate Cancer Drugs Abiraterone and Tok-001</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">482</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span><span class="refDoi"> DOI: 10.1038/nature10743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Fnature10743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22266943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=116-119&author=N.+M.+DeVoreauthor=E.+E.+Scott&title=Structures+of+Cytochrome+P450+17A1+with+Prostate+Cancer+Drugs+Abiraterone+and+Tok-001&doi=10.1038%2Fnature10743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001</span></div><div class="casAuthors">DeVore, Natasha M.; Scott, Emily E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">7383</span>),
    <span class="NLM_cas:pages">116-119</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The structures of CYP17A1 with steroid inhibitors abiraterone or TOK-001 provide a better understanding of the enzyme's catalytic capabilities and inhibition, and hence assist in understanding steroidogenic diseases and designing drugs to improve the treatment of prostate and other steroid-responsive cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRAzwETu-JGbVg90H21EOLACvtfcHk0livSB-AEUVuDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGqsb0%253D&md5=6cb6058ac0e52c951cd09d86d0eee613</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fnature10743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10743%26sid%3Dliteratum%253Aachs%26aulast%3DDeVore%26aufirst%3DN.%2BM.%26aulast%3DScott%26aufirst%3DE.%2BE.%26atitle%3DStructures%2520of%2520Cytochrome%2520P450%252017A1%2520with%2520Prostate%2520Cancer%2520Drugs%2520Abiraterone%2520and%2520Tok-001%26jtitle%3DNature%26date%3D2012%26volume%3D482%26spage%3D116%26epage%3D119%26doi%3D10.1038%2Fnature10743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guengerich, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterman, M. R.</span><span> </span><span class="NLM_article-title">Three-Dimensional Structure of Steroid 21-Hydroxylase (Cytochrome P450 21A2) with Two Substrates Reveals Locations of Disease-Associated Variants</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">10613</span><span class="NLM_x">–</span> <span class="NLM_lpage">10622</span><span class="refDoi"> DOI: 10.1074/jbc.M111.323501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1074%2Fjbc.M111.323501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22262854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlKrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=10613-10622&author=B.+Zhaoauthor=L.+Leiauthor=N.+Kagawaauthor=M.+Sundaramoorthyauthor=S.+Banerjeeauthor=L.+D.+Nagyauthor=F.+P.+Guengerichauthor=M.+R.+Waterman&title=Three-Dimensional+Structure+of+Steroid+21-Hydroxylase+%28Cytochrome+P450+21A2%29+with+Two+Substrates+Reveals+Locations+of+Disease-Associated+Variants&doi=10.1074%2Fjbc.M111.323501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Three-dimensional structure of steroid 21-hydroxylase (cytochrome P 450 21A2) with two substrates reveals locations of disease-associated variants</span></div><div class="casAuthors">Zhao, Bin; Lei, Li; Kagawa, Norio; Sundaramoorthy, Munirathinam; Banerjee, Surajit; Nagy, Leslie D.; Guengerich, F. Peter; Waterman, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">10613-10622</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Steroid 21-hydroxylase (cytochrome P 450 21A2; CYP21A2) deficiency accounts for ∼95% of individuals with congenital adrenal hyperplasia, a common autosomal recessive metabolic disorder of adrenal steroidogenesis.  The effects of amino acid mutations on CYP21A2 activity lead to impairment of the synthesis of cortisol and aldosterone and the excessive prodn. of androgens.  In order to understand the structural and mol. basis of this group of diseases, the bovine CYP21A2 crystal structure complexed with the substrate, 17-hydroxyprogesterone (17OHP), was detd. to 3.0 Å resoln.  An intriguing result from this structure was that there were 2 mols. of 17OHP bound to the enzyme, the distal one being located at the entrance of the substrate access channel and the proximal one bound in the active site.  The substrate-binding features located the key substrate recognition residues not only around the heme but also along the substrate access channel.  In addn., orientation of the skeleton of the proximal mol. was toward the interior of the enzyme away from the substrate access channel.  The 17OHP complex of CYP21A2 provided a good relation between the crystal structure, clin. data, and genetic mutants documented in the literature, thereby enhancing the understanding of congenital adrenal hyperplasia.  In addn., the location of certain CYP21A2 mutations provided general understanding of structure-function relations in P 450s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotrfBvem3dXbVg90H21EOLACvtfcHk0livSB-AEUVuDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlKrtr4%253D&md5=ce4b02f036d51904af1d1d4250587104</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.323501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.323501%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DLei%26aufirst%3DL.%26aulast%3DKagawa%26aufirst%3DN.%26aulast%3DSundaramoorthy%26aufirst%3DM.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DNagy%26aufirst%3DL.%2BD.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DWaterman%26aufirst%3DM.%2BR.%26atitle%3DThree-Dimensional%2520Structure%2520of%2520Steroid%252021-Hydroxylase%2520%2528Cytochrome%2520P450%252021A2%2529%2520with%2520Two%2520Substrates%2520Reveals%2520Locations%2520of%2520Disease-Associated%2520Variants%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D10613%26epage%3D10622%26doi%3D10.1074%2Fjbc.M111.323501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Annalora, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodin, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span> </span><span class="NLM_article-title">Crystal Structure of CYP24A1, a Mitochondrial Cytochrome P450 Involved in Vitamin D Metabolism</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">396</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span><span class="refDoi"> DOI: 10.1016/j.jmb.2009.11.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jmb.2009.11.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19961857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12murk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2010&pages=441-451&author=A.+J.+Annaloraauthor=D.+B.+Goodinauthor=W.+X.+Hongauthor=Q.+Zhangauthor=E.+F.+Johnsonauthor=C.+D.+Stout&title=Crystal+Structure+of+CYP24A1%2C+a+Mitochondrial+Cytochrome+P450+Involved+in+Vitamin+D+Metabolism&doi=10.1016%2Fj.jmb.2009.11.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of CYP24A1, a Mitochondrial Cytochrome P450 Involved in Vitamin D Metabolism</span></div><div class="casAuthors">Annalora, Andrew J.; Goodin, David B.; Hong, Wen-Xu; Zhang, Qinghai; Johnson, Eric F.; Stout, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-451</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cytochrome P 450 (CYP) 24A1 catalyzes the side-chain oxidn. of the hormonal form of vitamin D.  Expression of CYP24A1 is up-regulated to attenuate vitamin D signaling assocd. with calcium homeostasis and cellular growth processes.  The development of therapeutics for disorders linked to vitamin D insufficiency would be greatly facilitated by structural knowledge of CYP24A1.  Here, we report the crystal structure of rat CYP24A1 at 2.5 Å resoln.  The structure exhibits an open cleft leading to the active-site heme prosthetic group on the distal surface that is likely to define the path of substrate access into the active site.  The entrance to the cleft is flanked by conserved hydrophobic residues on helixes A' and G', suggesting a mode of insertion into the inner mitochondrial membrane.  A docking model for 1α,25-dihydroxyvitamin D3 binding in the open form of CYP24A1 that clarifies the structural determinants of secosteroid recognition and validates the predictive power of existing homol. models of CYP24A1 is proposed.  Anal. of CYP24A1's proximal surface identifies the determinants of adrenodoxin recognition as a constellation of conserved residues from helixes K, K'', and L that converge with an adjacent lysine-rich loop for binding the redox protein.  Overall, the CYP24A1 structure provides the first template for understanding membrane insertion, substrate binding, and redox partner interaction in mitochondrial P450s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeevmsDxW8SrVg90H21EOLACvtfcHk0livSB-AEUVuDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12murk%253D&md5=76c9ed44d954363c5a11e614b2efa388</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.11.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.11.057%26sid%3Dliteratum%253Aachs%26aulast%3DAnnalora%26aufirst%3DA.%2BJ.%26aulast%3DGoodin%26aufirst%3DD.%2BB.%26aulast%3DHong%26aufirst%3DW.%2BX.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStout%26aufirst%3DC.%2BD.%26atitle%3DCrystal%2520Structure%2520of%2520CYP24A1%252C%2520a%2520Mitochondrial%2520Cytochrome%2520P450%2520Involved%2520in%2520Vitamin%2520D%2520Metabolism%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D396%26spage%3D441%26epage%3D451%26doi%3D10.1016%2Fj.jmb.2009.11.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Strushkevich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usanov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. W.</span><span> </span><span class="NLM_article-title">Structural Basis of Human CYP51 Inhibition by Antifungal Azoles</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">397</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1078</span><span class="refDoi"> DOI: 10.1016/j.jmb.2010.01.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jmb.2010.01.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=20149798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2010&pages=1067-1078&author=N.+Strushkevichauthor=S.+A.+Usanovauthor=H.+W.+Park&title=Structural+Basis+of+Human+CYP51+Inhibition+by+Antifungal+Azoles&doi=10.1016%2Fj.jmb.2010.01.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Human CYP51 Inhibition by Antifungal Azoles</span></div><div class="casAuthors">Strushkevich, Natallia; Usanov, Sergey A.; Park, Hee-Won</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">397</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1067-1078</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The obligatory step in sterol biosynthesis in eukaryotes is demethylation of sterol precursors at the C14-position, which is catalyzed by CYP51 (sterol 14α demethylase) in three sequential reactions.  In mammals, the final product of the pathway is cholesterol, while important intermediates, meiosis-activating sterols, are produced by CYP51.  Three crystal structures of human CYP51, ligand-free and complexed with antifungal drugs ketoconazole and econazole, were detd., allowing anal. of the mol. basis for functional conservation within the CYP51 family.  Azole binding occurs mostly through hydrophobic interactions with conservative residues of the active site.  The substantial conformational changes in the B' helix and F-G loop regions are induced upon ligand binding, consistent with the membrane nature of the protein and its substrate.  The access channel is typical for mammalian sterol-metabolizing P 450 enzymes, but is different from that obsd. in Mycobacterium tuberculosis CYP51.  Comparison of the azole-bound structures provides insight into the relative binding affinities of human and bacterial P 450 enzymes to ketoconazole and fluconazole, which can be useful for the rational design of antifungal compds. and specific modulators of human CYP51.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpno6jtTo75W7Vg90H21EOLACvtfcHk0liln4qM8cCVVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKmurY%253D&md5=4d48592355aedba6ea92da98faef2ebd</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.01.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.01.075%26sid%3Dliteratum%253Aachs%26aulast%3DStrushkevich%26aufirst%3DN.%26aulast%3DUsanov%26aufirst%3DS.%2BA.%26aulast%3DPark%26aufirst%3DH.%2BW.%26atitle%3DStructural%2520Basis%2520of%2520Human%2520CYP51%2520Inhibition%2520by%2520Antifungal%2520Azoles%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D397%26spage%3D1067%26epage%3D1078%26doi%3D10.1016%2Fj.jmb.2010.01.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Bouchoucha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samara-Boustani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bony-Trifunovic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigrain, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluck, C. E.</span><span> </span><span class="NLM_article-title">Characterization of a Novel CYP19A1 (Aromatase) R192H Mutation Causing Virilization of a 46,XX Newborn, Undervirilization of the 46,XY Brother, but No Virilization of the Mother During Pregnancies</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">390</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1016/j.mce.2014.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.mce.2014.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=24705274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotlOrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2014&pages=8-17&author=N.+Bouchouchaauthor=D.+Samara-Boustaniauthor=A.+V.+Pandeyauthor=H.+Bony-Trifunovicauthor=G.+Hoferauthor=Y.+Aigrainauthor=M.+Polakauthor=C.+E.+Fluck&title=Characterization+of+a+Novel+CYP19A1+%28Aromatase%29+R192H+Mutation+Causing+Virilization+of+a+46%2CXX+Newborn%2C+Undervirilization+of+the+46%2CXY+Brother%2C+but+No+Virilization+of+the+Mother+During+Pregnancies&doi=10.1016%2Fj.mce.2014.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies</span></div><div class="casAuthors">Bouchoucha, Nadia; Samara-Boustani, Dinane; Pandey, Amit V.; Bony-Trifunovic, Helene; Hofer, Gaby; Aigrain, Yves; Polak, Michel; Fluck, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">8-17</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">P 450 aromatase (CYP19A1) is essential for the biosynthesis of estrogens from androgen precursors.  Mutations in the coding region of CYP19A1 lead to autosomal recessive aromatase deficiency.  To date over 20 subjects have been reported with aromatase deficiency which may manifest during fetal life with maternal virilization and virilization of the external genitalia of a female fetus due to low aromatase activity in the steroid metabolizing fetal-placental unit and thus high androgen levels.  During infancy, girls often have ovarian cysts and thereafter fail to enter puberty showing signs of variable degree of androgen excess.  Moreover, impact on growth, skeletal maturation and other metabolic parameters is seen in both sexes.  We found a novel homozygous CYP19A1 mutation in a 46,XX girl who was born at term to consanguineous parents.  Although the mother did not virilize during pregnancy, the baby was found to have a complex genital anomaly at birth (enlarged genital tubercle, fusion of labioscrotal folds) with elevated androgens at birth, normalizing thereafter.  Presence of 46,XX karyotype and female internal genital organs (uterus, vagina) together with biochem. findings and follow-up showing regression of clitoral hypertrophy, as well as elevated FSH suggested aromatase deficiency.  Interestingly, her older brother presented with mild hypospadias and bilateral cryptorchidism and was found to carry the same homozygous CYP19A1 mutation.  To confirm the clin. diagnosis, genetic, functional and computational studies were performed.  Genetic anal. revealed a homozygous R192H mutation in the CYP19A1 gene.  This novel mutation was characterized for its enzymic activity (Km, Vmax) in a cell model and found to have markedly reduced catalytic activity when compared to wild-type aromatase; thus explaining the phenotype.  Computational studies suggest that R192H disrupts the substrate access channel in CYP19A1 that may affect binding of substrates and exit of catalytic products.  R192H is a novel CYP19A1 mutation which causes a severe phenotype of aromatase deficiency in a 46,XX newborn and maybe hypospadias and cryptorchidism in a 46,XY, but no maternal androgen excess during pregnancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVLq-hMwHdUbVg90H21EOLACvtfcHk0liln4qM8cCVVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotlOrtrs%253D&md5=92559defb684341aa3f6215264beb9a0</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2014.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2014.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DBouchoucha%26aufirst%3DN.%26aulast%3DSamara-Boustani%26aufirst%3DD.%26aulast%3DPandey%26aufirst%3DA.%2BV.%26aulast%3DBony-Trifunovic%26aufirst%3DH.%26aulast%3DHofer%26aufirst%3DG.%26aulast%3DAigrain%26aufirst%3DY.%26aulast%3DPolak%26aufirst%3DM.%26aulast%3DFluck%26aufirst%3DC.%2BE.%26atitle%3DCharacterization%2520of%2520a%2520Novel%2520CYP19A1%2520%2528Aromatase%2529%2520R192H%2520Mutation%2520Causing%2520Virilization%2520of%2520a%252046%252CXX%2520Newborn%252C%2520Undervirilization%2520of%2520the%252046%252CXY%2520Brother%252C%2520but%2520No%2520Virilization%2520of%2520the%2520Mother%2520During%2520Pregnancies%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2014%26volume%3D390%26spage%3D8%26epage%3D17%26doi%3D10.1016%2Fj.mce.2014.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Marino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez Garrido, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guercio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juanes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaccio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, G.</span><span> </span><span class="NLM_article-title">Five New Cases of 46, XX Aromatase Deficiency: Clinical Follow-up from Birth to Puberty, a Novel Mutation, and a Founder Effect</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">E301</span><span class="NLM_x">–</span> <span class="NLM_lpage">E307</span><span class="refDoi"> DOI: 10.1210/jc.2014-2967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjc.2014-2967" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=E301-E307&author=R.+Marinoauthor=N.+Perez+Garridoauthor=M.+Costanzoauthor=G.+Guercioauthor=M.+Juanesauthor=C.+Roccoauthor=P.+Ramirezauthor=D.+M.+Warmanauthor=M.+Ciaccioauthor=G.+Pena&title=Five+New+Cases+of+46%2C+XX+Aromatase+Deficiency%3A+Clinical+Follow-up+from+Birth+to+Puberty%2C+a+Novel+Mutation%2C+and+a+Founder+Effect&doi=10.1210%2Fjc.2014-2967"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1210%2Fjc.2014-2967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2014-2967%26sid%3Dliteratum%253Aachs%26aulast%3DMarino%26aufirst%3DR.%26aulast%3DPerez%2BGarrido%26aufirst%3DN.%26aulast%3DCostanzo%26aufirst%3DM.%26aulast%3DGuercio%26aufirst%3DG.%26aulast%3DJuanes%26aufirst%3DM.%26aulast%3DRocco%26aufirst%3DC.%26aulast%3DRamirez%26aufirst%3DP.%26aulast%3DWarman%26aufirst%3DD.%2BM.%26aulast%3DCiaccio%26aufirst%3DM.%26aulast%3DPena%26aufirst%3DG.%26atitle%3DFive%2520New%2520Cases%2520of%252046%252C%2520XX%2520Aromatase%2520Deficiency%253A%2520Clinical%2520Follow-up%2520from%2520Birth%2520to%2520Puberty%252C%2520a%2520Novel%2520Mutation%252C%2520and%2520a%2520Founder%2520Effect%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2015%26volume%3D100%26spage%3DE301%26epage%3DE307%26doi%3D10.1210%2Fjc.2014-2967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Motion and Flexibility in Human Cytochrome P450 Aromatase</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e32565</span><span class="refDoi"> DOI: 10.1371/journal.pone.0032565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1371%2Fjournal.pone.0032565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22384274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFyktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e32565&author=W.+Jiangauthor=D.+Ghosh&title=Motion+and+Flexibility+in+Human+Cytochrome+P450+Aromatase&doi=10.1371%2Fjournal.pone.0032565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Motion and flexibility in human cytochrome P450 aromatase</span></div><div class="casAuthors">Jiang, Wenhua; Ghosh, Debashis</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e32565</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The crystal structures of human placental aromatase in complex with the substrate androstenedione and exemestane have revealed an androgen-specific active site and the structural basis for higher order organization.  However, X-ray structures do not provide accounts of movements due to short-range fluctuations, ligand binding and protein-protein assocn.  In this work, we conduct normal mode anal. (NMA) revealing the intrinsic fluctuations of aromatase, deduce the internal modes in membrane-free and membrane-integrated monomers as well as the intermol. modes in oligomers, and propose a quaternary organization for the endoplasmic reticulum (ER) membrane integration.  Dynamics of the crystallog. oligomers from NMA is found to be in agreement with the isotropic thermal factors from the X-ray anal.  Calcns. of the root mean square fluctuations of the C-alpha atoms from their equil. positions confirm that the rigid-core structure of aromatase is intrinsic regardless of the changes in steroid binding interactions, and that aromatase self-assocn. does not deteriorate the rigidity of the catalytic cleft.  Furthermore, NMA on membrane-integrated aromatase shows that the internal modes in all likelihood contribute to breathing of the active site access channel.  The collective intermol. hinge bending and twisting modes provide the flexibility in the quaternary assocn. necessary for membrane integration of the aromatase oligomers.  Taken together, fluctuations of the active site, the access channel, and the heme-proximal cavity, and a dynamic quaternary organization could all be essential components of the functional aromatase in its role as an ER membrane-embedded steroidogenic enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryfsCESF8WQbVg90H21EOLACvtfcHk0ljmfJMD4qp2jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFyktr8%253D&md5=5270cea39643ecccbf45c2e2b2f4e30a</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0032565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0032565%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DMotion%2520and%2520Flexibility%2520in%2520Human%2520Cytochrome%2520P450%2520Aromatase%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De32565%26doi%3D10.1371%2Fjournal.pone.0032565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Akhtar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calder, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corina, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. N.</span><span> </span><span class="NLM_article-title">Mechanistic Studies on C-19 Demethylation in Oestrogen Biosynthesis</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1042/bj2010569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1042%2Fbj2010569" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=1982&pages=569-580&author=M.+Akhtarauthor=M.+R.+Calderauthor=D.+L.+Corinaauthor=J.+N.+Wright&title=Mechanistic+Studies+on+C-19+Demethylation+in+Oestrogen+Biosynthesis&doi=10.1042%2Fbj2010569"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1042%2Fbj2010569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2010569%26sid%3Dliteratum%253Aachs%26aulast%3DAkhtar%26aufirst%3DM.%26aulast%3DCalder%26aufirst%3DM.%2BR.%26aulast%3DCorina%26aufirst%3DD.%2BL.%26aulast%3DWright%26aufirst%3DJ.%2BN.%26atitle%3DMechanistic%2520Studies%2520on%2520C-19%2520Demethylation%2520in%2520Oestrogen%2520Biosynthesis%26jtitle%3DBiochem.%2520J.%26date%3D1982%26volume%3D201%26spage%3D569%26epage%3D580%26doi%3D10.1042%2Fbj2010569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Akhtar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njar, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. N.</span><span> </span><span class="NLM_article-title">Mechanistic Studies on Aromatase and Related C-C Bond Cleaving P-450 Enzymes</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1016/0960-0760(93)90241-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2893%2990241-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=8476751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1enurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=375-387&author=M.+Akhtarauthor=V.+C.+Njarauthor=J.+N.+Wright&title=Mechanistic+Studies+on+Aromatase+and+Related+C-C+Bond+Cleaving+P-450+Enzymes&doi=10.1016%2F0960-0760%2893%2990241-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic studies on aromatase and related carbon-carbon bond cleaving P-450 enzymes</span></div><div class="casAuthors">Akhtar, Muhammad; Njar, Vincent C. O.; Wright, J. Neville</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">375-87</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">Some cytochrome P 450 systems, notably aromatase and 14α-dimethylase, catalyze not only the hydroxylate reaction but also the oxidn. of an alc. into a carbonyl compd. as well as a C-C bond cleavage process.  All these reactions occur at the same active site.  A somewhat analogous situation is noted with 17α-hydroxylase-17,20-lyase that participates in hydroxylation as well as C-C bond cleavage reactions.  It is argued that all three types of reaction catalyzed by these enzymes may be viewed as variations on a common theme.  In P 450-dependent hydroxylation, the initially formed FeIII-O-O. species is converted into FeIII-O-OH and the heterolysis of the oxygen-oxygen bond of the latter then gives the oxo deriv., for which a no. of canonical structures are possible.  One of these, FeIV-O. behaves like an alkoxyl radical and participates in hydrogen abstraction from C-H bond to produce FeIV-OH and carbon radical.  The latter is then quenched by the delivery of a hydroxyl radical from FeIV-OH.  The latter species may thus be regarded as a carrier of a hydroxyl radical.  It has been proposed that the C-C bond cleavage reaction occurs through the participation of a FeIII-O-OH species that is trapped by the electrophilic property of the carbonyl compd. giving a peroxide adduct that fragments to produce an acyl-carbon cleavage.  Scientific developments leading up to this conclusion are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBUI3llod9srVg90H21EOLACvtfcHk0ljmfJMD4qp2jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1enurc%253D&md5=d16d7726c82037b6699f0dd3107382a0</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2893%2990241-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252893%252990241-N%26sid%3Dliteratum%253Aachs%26aulast%3DAkhtar%26aufirst%3DM.%26aulast%3DNjar%26aufirst%3DV.%2BC.%26aulast%3DWright%26aufirst%3DJ.%2BN.%26atitle%3DMechanistic%2520Studies%2520on%2520Aromatase%2520and%2520Related%2520C-C%2520Bond%2520Cleaving%2520P-450%2520Enzymes%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D44%26spage%3D375%26epage%3D387%26doi%3D10.1016%2F0960-0760%2893%2990241-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Hackett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggemeier, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadad, C. M.</span><span> </span><span class="NLM_article-title">The Final Catalytic Step of Cytochrome P450 Aromatase: A Density Functional Theory Study</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">5224</span><span class="NLM_x">–</span> <span class="NLM_lpage">5237</span><span class="refDoi"> DOI: 10.1021/ja044716w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja044716w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVyqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=5224-5237&author=J.+C.+Hackettauthor=R.+W.+Brueggemeierauthor=C.+M.+Hadad&title=The+Final+Catalytic+Step+of+Cytochrome+P450+Aromatase%3A+A+Density+Functional+Theory+Study&doi=10.1021%2Fja044716w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">The Final Catalytic Step of Cytochrome P450 Aromatase: A Density Functional Theory Study</span></div><div class="casAuthors">Hackett, John C.; Brueggemeier, Robert W.; Hadad, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5224-5237</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">B3LYP d. functional theory calcns. are used to unravel the mysterious third step of aromatase catalysis.  The feasibility of mechanisms in which the reduced ferrous dioxygen intermediate mediates androgen aromatization is explored and detd. to be unlikely.  However, proton-assisted homolysis of the peroxo hemiacetal intermediate to produce P 450 compd. I and the C19 gem-diol likely proceeds with a low energetic barrier.  Mechanisms for the aromatization and deformylation sequence which are initiated by 1β-hydrogen atom abstraction by P 450 compd. I are considered. 1β-Hydrogen atom abstraction from substrates in the presence of the 2,3-enol encounters strikingly low barriers (5.3-7.8 kcal/mol), whereas barriers for this same process rise to 17.0-27.1 kcal/mol in the keto tautomer.  Transition states for 1β-hydrogen atom abstraction from enolized substrates in the presence of the 19-gem-diol decayed directly to the exptl. obsd. products.  If the C19 aldehyde remains unhydrated, aromatization occurs with concomitant decarbonylation and therefore does not support dehydration of the C19 aldehyde prior to the final catalytic step.  On the doublet surface, the transition state connects to a potentially labile 1(10) dehydrogenated product, which may undergo rapid aromatization, as well as formic acid.  Ab initio mol. dynamics confirmed that the 1β-hydrogen atom abstraction and deformylation or decarbonylation occur in a nonsynchronous, coordinated manner.  These calcns. support a dehydrogenase behavior of aromatase in the final catalytic step, which can be summarized by 1β-hydrogen atom abstraction followed by gem-diol deprotonation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmOr8sj-omyrVg90H21EOLACvtfcHk0ljmfJMD4qp2jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVyqu7k%253D&md5=adb795b16645e13ccc0071806e6ea337</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fja044716w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja044716w%26sid%3Dliteratum%253Aachs%26aulast%3DHackett%26aufirst%3DJ.%2BC.%26aulast%3DBrueggemeier%26aufirst%3DR.%2BW.%26aulast%3DHadad%26aufirst%3DC.%2BM.%26atitle%3DThe%2520Final%2520Catalytic%2520Step%2520of%2520Cytochrome%2520P450%2520Aromatase%253A%2520A%2520Density%2520Functional%2520Theory%2520Study%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D5224%26epage%3D5237%26doi%3D10.1021%2Fja044716w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Akhtar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee-Robichaud, P.</span><span> </span><span class="NLM_article-title">A Review of Mechanistic Studies on Aromatase (CYP19) and 17alpha-Hydroxylase-17,20-Lyase (CYP17)</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2010.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jsbmb.2010.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=21094255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvVeitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2011&pages=2-12&author=M.+Akhtarauthor=J.+N.+Wrightauthor=P.+Lee-Robichaud&title=A+Review+of+Mechanistic+Studies+on+Aromatase+%28CYP19%29+and+17alpha-Hydroxylase-17%2C20-Lyase+%28CYP17%29&doi=10.1016%2Fj.jsbmb.2010.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">A review of mechanistic studies on aromatase (CYP19) and 17α-hydroxylase-17,20-lyase (CYP17)</span></div><div class="casAuthors">Akhtar, Muhammad; Wright, J. Neville; Lee-Robichaud, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In the conventional cytochrome P 450 (CYP)-dependent hydroxylation reaction, the FeIII resting state of the enzyme, by a single electron transfer, is reduced to FeII, which reacts with O2 to produce a FeIII-O-O· intermediate.  The latter following the transfer of another electron furnishes a ferric-peroxyanion, FeIII-O-O-, which after protonation leads to the fission of the O-O bond resulting in the formation of FeV:O, the key player in the hydroxylation process.  Certain members of the P 450 family, including CYP17 and CYP19, catalyze, at the same active site, not only the hydroxylation process but also an acyl-C bond cleavage reaction which has been interpreted to involve the nucleophilic attack of the ferric-peroxyanion, FeIII-O-O-, on the acyl C atom to furnish a tetrahedral intermediate which fragments, leading to acyl-C cleavage.  Evidence is presented to show that in the case of CYP17 the attack of FeIII-O-O- on the target C atom is promoted by cytochrome b5, which acts as a conformational regulator of CYP17.  It is this regulation of CYP17 that provides a safety mechanism which ensures that during corticoid biosynthesis, which involves 17α-hydroxylation by CYP17, androgen formation is avoided.  Finally, a brief account is presented of the inhibitors of the 2 enzymes, which have been designed on the basis of their mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK8H66p74u_7Vg90H21EOLACvtfcHk0lhKUfsP_ALVFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvVeitr0%253D&md5=3c096fa0a1b08c92f5b6a253423c2e13</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2010.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2010.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DAkhtar%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DJ.%2BN.%26aulast%3DLee-Robichaud%26aufirst%3DP.%26atitle%3DA%2520Review%2520of%2520Mechanistic%2520Studies%2520on%2520Aromatase%2520%2528CYP19%2529%2520and%252017alpha-Hydroxylase-17%252C20-Lyase%2520%2528CYP17%2529%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D125%26spage%3D2%26epage%3D12%26doi%3D10.1016%2Fj.jsbmb.2010.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Guallar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baik, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">Peripheral Heme Substituents Control the Hydrogen-Atom Abstraction Chemistry in Cytochromes P450</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">6998</span><span class="NLM_x">–</span> <span class="NLM_lpage">7002</span><span class="refDoi"> DOI: 10.1073/pnas.0732000100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1073%2Fpnas.0732000100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=12771375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkslOntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=6998-7002&author=V.+Guallarauthor=M.-H.+Baikauthor=S.+J.+Lippardauthor=R.+A.+Friesner&title=Peripheral+Heme+Substituents+Control+the+Hydrogen-Atom+Abstraction+Chemistry+in+Cytochromes+P450&doi=10.1073%2Fpnas.0732000100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral heme substituents control the hydrogen-atom abstraction chemistry in cytochromes P450</span></div><div class="casAuthors">Guallar, Victor; Baik, Mu-Hyun; Lippard, Stephen J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6998-7002</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We elucidate the hydroxylation of camphor by cytochrome P 450 with the use of d. functional and mixed quantum mechanics/mol. mechanics methods.  Our results reveal that the enzyme catalyzes the hydrogen-atom abstraction step with a remarkably low free-energy barrier.  This result provides a satisfactory explanation for the exptl. failure to trap the proposed catalytically competent high-valent heme Fe(IV) oxo (oxyferryl) species responsible for this hydroxylation chem.  The primary and previously unappreciated contribution to stabilization of the transition state is the interaction of pos. charged residues in the active-site cavity with carboxylate groups on the heme periphery.  A similar stabilization found in dioxygen binding to hemerythrin, albeit with reversed polarity, suggests that this mechanism for controlling the relative energetics of redox-active intermediates and transition states in metalloproteins may be widespread in nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz2gQwufu_37Vg90H21EOLACvtfcHk0lhKUfsP_ALVFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkslOntLY%253D&md5=42fb299da6a4d5987b6d7931da1a549d</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0732000100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0732000100%26sid%3Dliteratum%253Aachs%26aulast%3DGuallar%26aufirst%3DV.%26aulast%3DBaik%26aufirst%3DM.-H.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DPeripheral%2520Heme%2520Substituents%2520Control%2520the%2520Hydrogen-Atom%2520Abstraction%2520Chemistry%2520in%2520Cytochromes%2520P450%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D6998%26epage%3D7002%26doi%3D10.1073%2Fpnas.0732000100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Gantt, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denisov, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinkova, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sligar, S. G.</span><span> </span><span class="NLM_article-title">The Critical Iron-Oxygen Intermediate in Human Aromatase</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2009.06.154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bbrc.2009.06.154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19591804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptValtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=169-173&author=S.+L.+Ganttauthor=I.+G.+Denisovauthor=Y.+V.+Grinkovaauthor=S.+G.+Sligar&title=The+Critical+Iron-Oxygen+Intermediate+in+Human+Aromatase&doi=10.1016%2Fj.bbrc.2009.06.154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">The critical iron-oxygen intermediate in human aromatase</span></div><div class="casAuthors">Gantt, Stephanie L.; Denisov, Ilia G.; Grinkova, Yelena V.; Sligar, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-173</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aromatase (CYP19) is the target of several therapeutics used for breast cancer treatment and catalyzes the three-step conversion of androgens to estrogens, with an unusual C-C cleavage reaction in the third step.  To better understand the CYP19 reaction, the oxy-ferrous complex of CYP19 with androstenedione substrate was cryotrapped, characterized by UV-vis spectroscopy, and cryoreduced to generate the next reaction cycle intermediate.  EPR anal. revealed that the initial intermediate obsd. following cryoredn. is the unprotonated g1 = 2.254 peroxo-ferric intermediate, which is stable up to 180 K.  Upon gradual cryoannealing, the low-spin (g1 = 2.39) product complex is formed, with no evidence for accumulation of the g1 = 2.30 hydroperoxo-ferric intermediate.  The relative stabilization of the peroxo-ferric heme and the lack of obsd. hydroperoxo-ferric heme distinguish CYP19 from other P450s, suggesting that the proton delivery pathway is more hindered in CYP19 than in most other P450s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosKzr6ReLA4LVg90H21EOLACvtfcHk0lhKUfsP_ALVFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptValtrw%253D&md5=8c41e32ef0e498ea742a7fc70220959b</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.06.154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.06.154%26sid%3Dliteratum%253Aachs%26aulast%3DGantt%26aufirst%3DS.%2BL.%26aulast%3DDenisov%26aufirst%3DI.%2BG.%26aulast%3DGrinkova%26aufirst%3DY.%2BV.%26aulast%3DSligar%26aufirst%3DS.%2BG.%26atitle%3DThe%2520Critical%2520Iron-Oxygen%2520Intermediate%2520in%2520Human%2520Aromatase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D387%26spage%3D169%26epage%3D173%26doi%3D10.1016%2Fj.bbrc.2009.06.154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Tosha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterman, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, T.</span><span> </span><span class="NLM_article-title">Raman Evidence for Specific Substrate-Induced Structural Changes in the Heme Pocket of Human Cytochrome P450 Aromatase During the Three Consecutive Oxygen Activation Steps</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5631</span><span class="NLM_x">–</span> <span class="NLM_lpage">5640</span><span class="refDoi"> DOI: 10.1021/bi060094a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi060094a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=5631-5640&author=T.+Toshaauthor=N.+Kagawaauthor=T.+Ohtaauthor=S.+Yoshiokaauthor=M.+R.+Watermanauthor=T.+Kitagawa&title=Raman+Evidence+for+Specific+Substrate-Induced+Structural+Changes+in+the+Heme+Pocket+of+Human+Cytochrome+P450+Aromatase+During+the+Three+Consecutive+Oxygen+Activation+Steps&doi=10.1021%2Fbi060094a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fbi060094a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi060094a%26sid%3Dliteratum%253Aachs%26aulast%3DTosha%26aufirst%3DT.%26aulast%3DKagawa%26aufirst%3DN.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DYoshioka%26aufirst%3DS.%26aulast%3DWaterman%26aufirst%3DM.%2BR.%26aulast%3DKitagawa%26aufirst%3DT.%26atitle%3DRaman%2520Evidence%2520for%2520Specific%2520Substrate-Induced%2520Structural%2520Changes%2520in%2520the%2520Heme%2520Pocket%2520of%2520Human%2520Cytochrome%2520P450%2520Aromatase%2520During%2520the%2520Three%2520Consecutive%2520Oxygen%2520Activation%2520Steps%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D5631%26epage%3D5640%26doi%3D10.1021%2Fbi060094a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Mak, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sligar, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kincaid, J. R.</span><span> </span><span class="NLM_article-title">Resonance Raman Spectroscopy of the Oxygenated Intermediates of Human CYP19A1 Implicates a Compound I Intermediate in the Final Lyase Step</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">4825</span><span class="NLM_x">–</span> <span class="NLM_lpage">4828</span><span class="refDoi"> DOI: 10.1021/ja500054c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja500054c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=4825-4828&author=P.+J.+Makauthor=A.+Luthraauthor=S.+G.+Sligarauthor=J.+R.+Kincaid&title=Resonance+Raman+Spectroscopy+of+the+Oxygenated+Intermediates+of+Human+CYP19A1+Implicates+a+Compound+I+Intermediate+in+the+Final+Lyase+Step&doi=10.1021%2Fja500054c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fja500054c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja500054c%26sid%3Dliteratum%253Aachs%26aulast%3DMak%26aufirst%3DP.%2BJ.%26aulast%3DLuthra%26aufirst%3DA.%26aulast%3DSligar%26aufirst%3DS.%2BG.%26aulast%3DKincaid%26aufirst%3DJ.%2BR.%26atitle%3DResonance%2520Raman%2520Spectroscopy%2520of%2520the%2520Oxygenated%2520Intermediates%2520of%2520Human%2520CYP19A1%2520Implicates%2520a%2520Compound%2520I%2520Intermediate%2520in%2520the%2520Final%2520Lyase%2520Step%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D4825%26epage%3D4828%26doi%3D10.1021%2Fja500054c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Khatri, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sligar, S. G.</span><span> </span><span class="NLM_article-title">Kinetic Solvent Isotope Effect in Steady-State Turnover by CYP19A1 Suggests Involvement of Compound 1 for Both Hydroxylation and Aromatization Steps</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">588</span><span class="NLM_x">, </span> <span class="NLM_fpage">3117</span><span class="NLM_x">–</span> <span class="NLM_lpage">3122</span><span class="refDoi"> DOI: 10.1016/j.febslet.2014.06.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.febslet.2014.06.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=588&publication_year=2014&pages=3117-3122&author=Y.+Khatriauthor=A.+Luthraauthor=R.+Duggalauthor=S.+G.+Sligar&title=Kinetic+Solvent+Isotope+Effect+in+Steady-State+Turnover+by+CYP19A1+Suggests+Involvement+of+Compound+1+for+Both+Hydroxylation+and+Aromatization+Steps&doi=10.1016%2Fj.febslet.2014.06.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2014.06.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2014.06.050%26sid%3Dliteratum%253Aachs%26aulast%3DKhatri%26aufirst%3DY.%26aulast%3DLuthra%26aufirst%3DA.%26aulast%3DDuggal%26aufirst%3DR.%26aulast%3DSligar%26aufirst%3DS.%2BG.%26atitle%3DKinetic%2520Solvent%2520Isotope%2520Effect%2520in%2520Steady-State%2520Turnover%2520by%2520CYP19A1%2520Suggests%2520Involvement%2520of%2520Compound%25201%2520for%2520Both%2520Hydroxylation%2520and%2520Aromatization%2520Steps%26jtitle%3DFEBS%2520Lett.%26date%3D2014%26volume%3D588%26spage%3D3117%26epage%3D3122%26doi%3D10.1016%2Fj.febslet.2014.06.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Yoshimoto, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guengerich, F. P.</span><span> </span><span class="NLM_article-title">Mechanism of the Third Oxidative Step in the Conversion of Androgens to Estrogens by Cytochrome P450 19A1 Steroid Aromatase</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">15016</span><span class="NLM_x">–</span> <span class="NLM_lpage">15025</span><span class="refDoi"> DOI: 10.1021/ja508185d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja508185d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WlurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=15016-15025&author=F.+K.+Yoshimotoauthor=F.+P.+Guengerich&title=Mechanism+of+the+Third+Oxidative+Step+in+the+Conversion+of+Androgens+to+Estrogens+by+Cytochrome+P450+19A1+Steroid+Aromatase&doi=10.1021%2Fja508185d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of the Third Oxidative Step in the Conversion of Androgens to Estrogens by Cytochrome P450 19A1 Steroid Aromatase</span></div><div class="casAuthors">Yoshimoto, Francis K.; Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">15016-15025</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aromatase is the cytochrome P 450 enzyme that cleaves the C10-C19 carbon-carbon bond of androgens to form estrogens, in a three-step process.  Compd. I (FeO3+) and ferric peroxide (FeO2-) have both been proposed in the literature as the active iron species in the third step, yielding an estrogen and formic acid.  Incubation of purified aromatase with its 19-deutero-19-oxo androgen substrate was performed in the presence of 18O2, and the products were derivatized using a novel diazo reagent.  Anal. of the products by high-resoln. mass spectrometry showed a lack of 18O incorporation in the product formic acid, supporting only the Compd. I pathway.  Furthermore, a new androgen 19-carboxylic acid product was identified.  The rates of nonenzymic hydration of the 19-oxo androgen and dehydration of the 19,19-gem-diol were shown to be catalytically competent.  Thus, the evidence supports Compd. I and not ferric peroxide as the active iron species in the third step of the steroid aromatase reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooAoM6JkXTY7Vg90H21EOLACvtfcHk0lj0rg2ip3Ud8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WlurzE&md5=39701c467c900a04e733842c711d7565</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fja508185d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja508185d%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimoto%26aufirst%3DF.%2BK.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DMechanism%2520of%2520the%2520Third%2520Oxidative%2520Step%2520in%2520the%2520Conversion%2520of%2520Androgens%2520to%2520Estrogens%2520by%2520Cytochrome%2520P450%252019A1%2520Steroid%2520Aromatase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D15016%26epage%3D15025%26doi%3D10.1021%2Fja508185d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Ghosh, D.; Lo, J.; Egbuta, C.</span><span> </span><span class="NLM_article-title">Structure, Function and Inhibition of Aromatase</span>. In  <span class="citation_source-book">Resistance to Aromatase Inhibitors in Breast Cancer</span>; <span class="NLM_publisher-name">Springer</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2F978-3-319-17972-8_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=33-61&author=D.+Ghosh&author=J.+Lo&author=C.+Egbuta&title=Resistance+to+Aromatase+Inhibitors+in+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-17972-8_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-17972-8_3%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DStructure%252C%2520Function%2520and%2520Inhibition%2520of%2520Aromatase%26btitle%3DResistance%2520to%2520Aromatase%2520Inhibitors%2520in%2520Breast%2520Cancer%26pub%3DSpringer%26date%3D2015%26spage%3D33%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Sasano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yajima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshihama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. R.</span><span> </span><span class="NLM_article-title">Effects of Aromatase Inhibitors on the Pathobiology of the Human Breast, Endometrial and Ovarian Carcinoma</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1677/erc.0.0060197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1677%2Ferc.0.0060197" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=197-204&author=H.+Sasanoauthor=S.+Satoauthor=K.+Itoauthor=A.+Yajimaauthor=J.+Nakamuraauthor=M.+Yoshihamaauthor=K.+Arigaauthor=T.+J.+Andersonauthor=W.+R.+Miller&title=Effects+of+Aromatase+Inhibitors+on+the+Pathobiology+of+the+Human+Breast%2C+Endometrial+and+Ovarian+Carcinoma&doi=10.1677%2Ferc.0.0060197"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1677%2Ferc.0.0060197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Ferc.0.0060197%26sid%3Dliteratum%253Aachs%26aulast%3DSasano%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DYajima%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DYoshihama%26aufirst%3DM.%26aulast%3DAriga%26aufirst%3DK.%26aulast%3DAnderson%26aufirst%3DT.%2BJ.%26aulast%3DMiller%26aufirst%3DW.%2BR.%26atitle%3DEffects%2520of%2520Aromatase%2520Inhibitors%2520on%2520the%2520Pathobiology%2520of%2520the%2520Human%2520Breast%252C%2520Endometrial%2520and%2520Ovarian%2520Carcinoma%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D1999%26volume%3D6%26spage%3D197%26epage%3D204%26doi%3D10.1677%2Ferc.0.0060197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Pavone, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulun, S. E.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors for the Treatment of Endometriosis</span> <span class="citation_source-journal">Fertil. Steril.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1370</span><span class="NLM_x">–</span> <span class="NLM_lpage">1379</span><span class="refDoi"> DOI: 10.1016/j.fertnstert.2012.08.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.fertnstert.2012.08.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22999792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2gtrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2012&pages=1370-1379&author=M.+E.+Pavoneauthor=S.+E.+Bulun&title=Aromatase+Inhibitors+for+the+Treatment+of+Endometriosis&doi=10.1016%2Fj.fertnstert.2012.08.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase inhibitors for the treatment of endometriosis</span></div><div class="casAuthors">Pavone, Mary Ellen; Bulun, Serdar E.</div><div class="citationInfo"><span class="NLM_cas:title">Fertility and Sterility</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1370-1379</span>CODEN:
                <span class="NLM_cas:coden">FESTAS</span>;
        ISSN:<span class="NLM_cas:issn">0015-0282</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">To review the use of aromatase inhibitors (AIs) for the treatment of endometriosis. Literature review. Most studies show that in reproductive-age women, the combination of AI with conventional therapy alleviates endometriosis-related pain.  In postmenopausal women, using an AI alone has been shown to be an effective treatment, although more studies are needed in this subgroup.  Side effects of using AIs appear to be tolerable in most women, although special consideration should be given to monitoring bone mineral d.  More studies need to be done examg. pregnancy rates and outcomes after AI treatment for endometriosis.  In addn., larger randomized clin. trials using AIs need to be done.  In summary, AIs may be effective in treating endometriosis-related chronic pelvic pain in both reproductive-age and postmenopausal women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovzBV_63oqkbVg90H21EOLACvtfcHk0lhAuztXc-LIlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2gtrjI&md5=b4aef281162169d4a939e53de5b5d886</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.fertnstert.2012.08.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fertnstert.2012.08.053%26sid%3Dliteratum%253Aachs%26aulast%3DPavone%26aufirst%3DM.%2BE.%26aulast%3DBulun%26aufirst%3DS.%2BE.%26atitle%3DAromatase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Endometriosis%26jtitle%3DFertil.%2520Steril.%26date%3D2012%26volume%3D98%26spage%3D1370%26epage%3D1379%26doi%3D10.1016%2Fj.fertnstert.2012.08.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Li, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, S. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanagh, J. J.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors in Ovarian Cancer: Is There a Role?</span> <span class="citation_source-journal">International Gynecological Cancer Society</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span><span class="refDoi"> DOI: 10.1111/j.1525-1438.2007.01075.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1111%2Fj.1525-1438.2007.01075.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=17894799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADC%252BD1crisl2itg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=600-614&author=Y.+F.+Liauthor=W.+Huauthor=S.+Q.+Fuauthor=J.+D.+Liauthor=J.+H.+Liuauthor=J.+J.+Kavanagh&title=Aromatase+Inhibitors+in+Ovarian+Cancer%3A+Is+There+a+Role%3F&doi=10.1111%2Fj.1525-1438.2007.01075.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase inhibitors in ovarian cancer: is there a role?</span></div><div class="casAuthors">Li Y F; Hu W; Fu S Q; Li J D; Liu J H; Kavanagh J J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">600-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Estrogen plays a role in ovarian tumorigenesis.  Aromatase is the enzyme required for the synthesis of estrogen via conversion of androgen to estrogen, which is the major source of estrogen in postmenopausal women.  Aromatase is present in normal ovaries and other tissues (e.g., fat and muscle) as well as in 33-81% tumor tissues of ovarian cancer.  Aromatase inhibitors (AIs) block estrogen synthesis by inhibiting aromatase activity.  In patients with recurrent ovarian cancer, single-agent AI therapy has been shown to elicit clinical response rates of up to 35.7% and stable disease rates of 20-42%.  Given the limited treatment options for recurrent ovarian cancer and the favorable safety profile and convenient use, AI is a rational option for prolonging platinum-free interval in recurrent ovarian cancer.  Further studies are required to determine the efficacy of combination treatment with AIs and biological agents, determine the benefit of AIs for treating special types of ovarian cancer (e.g., endometrioid type), and identify biomarkers for targeted patient selection.  This review summarizes the current epidemiologic, preclinical, and clinical data regarding estrogen's role in ovarian cancer, the expression and regulation of aromatase in this disease, the development and characteristics of the three generations of AIs, and the preclinical and clinical studies of AIs in the treatment of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2sq3DigA5w5QHPYJuLg8TfW6udTcc2eajVBkTTeT_hbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crisl2itg%253D%253D&md5=7d5655f8ea8fb13c0f9fd28f1964ea9c</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1111%2Fj.1525-1438.2007.01075.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1525-1438.2007.01075.x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BF.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DFu%26aufirst%3DS.%2BQ.%26aulast%3DLi%26aufirst%3DJ.%2BD.%26aulast%3DLiu%26aufirst%3DJ.%2BH.%26aulast%3DKavanagh%26aufirst%3DJ.%2BJ.%26atitle%3DAromatase%2520Inhibitors%2520in%2520Ovarian%2520Cancer%253A%2520Is%2520There%2520a%2520Role%253F%26jtitle%3DInternational%2520Gynecological%2520Cancer%2520Society%26date%3D2008%26volume%3D18%26spage%3D600%26epage%3D614%26doi%3D10.1111%2Fj.1525-1438.2007.01075.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Weinberg, O. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Garban, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishbein, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodglick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garban, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubinett, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietras, R. J.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors in Human Lung Cancer Therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">11287</span><span class="NLM_x">–</span> <span class="NLM_lpage">11291</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1158%2F0008-5472.CAN-05-2737" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=11287-11291&author=O.+K.+Weinbergauthor=D.+C.+Marquez-Garbanauthor=M.+C.+Fishbeinauthor=L.+Goodglickauthor=H.+J.+Garbanauthor=S.+M.+Dubinettauthor=R.+J.+Pietras&title=Aromatase+Inhibitors+in+Human+Lung+Cancer+Therapy&doi=10.1158%2F0008-5472.CAN-05-2737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2737%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberg%26aufirst%3DO.%2BK.%26aulast%3DMarquez-Garban%26aufirst%3DD.%2BC.%26aulast%3DFishbein%26aufirst%3DM.%2BC.%26aulast%3DGoodglick%26aufirst%3DL.%26aulast%3DGarban%26aufirst%3DH.%2BJ.%26aulast%3DDubinett%26aufirst%3DS.%2BM.%26aulast%3DPietras%26aufirst%3DR.%2BJ.%26atitle%3DAromatase%2520Inhibitors%2520in%2520Human%2520Lung%2520Cancer%2520Therapy%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D11287%26epage%3D11291%26doi%3D10.1158%2F0008-5472.CAN-05-2737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Brueggemeier, R. W.</span><span> </span><span class="NLM_article-title">Aromatase, Aromatase Inhibitors, and Breast Cancer</span> <span class="citation_source-journal">American Journal of Therapeutics.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1097/00045391-200109000-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1097%2F00045391-200109000-00007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=333-344&author=R.+W.+Brueggemeier&title=Aromatase%2C+Aromatase+Inhibitors%2C+and+Breast+Cancer&doi=10.1097%2F00045391-200109000-00007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1097%2F00045391-200109000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00045391-200109000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DBrueggemeier%26aufirst%3DR.%2BW.%26atitle%3DAromatase%252C%2520Aromatase%2520Inhibitors%252C%2520and%2520Breast%2520Cancer%26jtitle%3DAmerican%2520Journal%2520of%2520Therapeutics.%26date%3D2001%26volume%3D8%26spage%3D333%26epage%3D344%26doi%3D10.1097%2F00045391-200109000-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Brueggemeier, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Cruz, E. S.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors in the Treatment of Breast Cancer</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span><span class="refDoi"> DOI: 10.1210/er.2004-0015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fer.2004-0015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=15814851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVWru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=331-345&author=R.+W.+Brueggemeierauthor=J.+C.+Hackettauthor=E.+S.+Diaz-Cruz&title=Aromatase+Inhibitors+in+the+Treatment+of+Breast+Cancer&doi=10.1210%2Fer.2004-0015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase inhibitors in the treatment of breast cancer</span></div><div class="casAuthors">Brueggemeier, Robert W.; Hackett, John C.; Diaz-Cruz, Edgar S.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-345</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Estradiol, the most potent endogenous estrogen, is biosynthesized from androgens by the cytochrome P 450 enzyme complex called aromatase.  Aromatase is present in breast tissue, and intratumoral aromatase is the source of local estrogen prodn. in breast cancer tissues.  Inhibition of aromatase is an important approach for reducing growth-stimulatory effects of estrogens in estrogen-dependent breast cancer.  Steroidal inhibitors that have been developed to date build upon the basic androstenedione nucleus and incorporate chem. substituents at varying positions on the steroid.  Nonsteroidal aromatase inhibitors can be divided into three classes: aminoglutethimide-like mols., imidazole/triazole derivs., and flavonoid analogs.  Mechanism-based aromatase inhibitors are steroidal inhibitors that mimic the substrate, are converted by the enzyme to a reactive intermediate, and result in the inactivation of aromatase.  Both steroidal and non-steroidal aromatase inhibitors have shown clin. efficacy in the treatment of breast cancer.  The potent and selective third-generation aromatase inhibitors, anastrozole, letrozole, and exemestane, were introduced into the market as endocrine therapy in postmenopausal patients failing antiestrogen therapy alone or multiple hormonal therapies.  These agents are currently approved as first-line therapy for the treatment of postmenopausal women with metastatic estrogen-dependent breast cancer.  Several clin. studies of aromatase inhibitors are currently focusing on the use of these agents in the adjuvant setting for the treatment of early breast cancer.  Use of an aromatase inhibitor as initial therapy or after treatment with tamoxifen is now recommended as adjuvant hormonal therapy for a postmenopausal woman with hormone-dependent breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5rFlkckpA4bVg90H21EOLACvtfcHk0lhAuztXc-LIlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVWru7w%253D&md5=d65778c7f1aea9ad16a3d24f37dccb07</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1210%2Fer.2004-0015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2004-0015%26sid%3Dliteratum%253Aachs%26aulast%3DBrueggemeier%26aufirst%3DR.%2BW.%26aulast%3DHackett%26aufirst%3DJ.%2BC.%26aulast%3DDiaz-Cruz%26aufirst%3DE.%2BS.%26atitle%3DAromatase%2520Inhibitors%2520in%2520the%2520Treatment%2520of%2520Breast%2520Cancer%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26spage%3D331%26epage%3D345%26doi%3D10.1210%2Fer.2004-0015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Brueggemeier, R. W.</span><span> </span><span class="NLM_article-title">Update on the Use of Aromatase Inhibitors in Breast Cancer</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1919</span><span class="NLM_x">–</span> <span class="NLM_lpage">1930</span><span class="refDoi"> DOI: 10.1517/14656566.7.14.1919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1517%2F14656566.7.14.1919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=17020418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVartbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1919-1930&author=R.+W.+Brueggemeier&title=Update+on+the+Use+of+Aromatase+Inhibitors+in+Breast+Cancer&doi=10.1517%2F14656566.7.14.1919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the use of aromatase inhibitors in breast cancer</span></div><div class="casAuthors">Brueggemeier, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1919-1930</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Estrogens are biosynthesised from androgens by the CYP450 enzyme complex called aromatase.  Aromatase is expressed in the ovary, placenta, brain, bone, adipose tissue and breast tissue.  In breast cancer, intratumoral aromatase is the source for local estrogen prodn. in the tissue.  Inhibition of aromatase is an important approach for reducing growth stimulatory effects of estrogens in estrogen-dependent breast cancer.  The potent and selective third-generation aromatase inhibitors anastrozole, letrozole and exemestane were introduced to the market as endocrine therapy in postmenopausal patients failing anti-estrogen therapy alone, or multiple hormonal therapies.  Anastrozole and letrozole are both non-steroidal aromatase inhibitors that compete with the substrate for binding to the enzyme active site.  Exemestane is a mechanism-based steroidal inhibitor that mimics the substrate, is converted by the enzyme to a reactive intermediate, and results in inactivation of aromatase.  These third-generation aromatase inhibitors are currently approved as first-line therapy for the treatment of postmenopausal women with metastatic estrogen-dependent breast cancer.  The use of an aromatase inhibitor as initial therapy, or after treatment with tamoxifen, is now recommended as adjuvant hormonal therapy for postmenopausal women with hormone-dependent breast cancer.  Several clin. studies of aromatase inhibitors focus on the use of these agents in the adjuvant setting, for the treatment of early breast cancer.  Recently published results show improved responses with these agents compared with tamoxifen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDIjz5Yvq9k7Vg90H21EOLACvtfcHk0lgNSMo7FWirYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVartbfO&md5=2dabce35b873215f82f94bc15e7b3509</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1517%2F14656566.7.14.1919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.7.14.1919%26sid%3Dliteratum%253Aachs%26aulast%3DBrueggemeier%26aufirst%3DR.%2BW.%26atitle%3DUpdate%2520on%2520the%2520Use%2520of%2520Aromatase%2520Inhibitors%2520in%2520Breast%2520Cancer%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2006%26volume%3D7%26spage%3D1919%26epage%3D1930%26doi%3D10.1517%2F14656566.7.14.1919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Grimm, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyroff, M. C.</span><span> </span><span class="NLM_article-title">Inhibition of Human Drug Metabolizing Cytochromes P450 by Anastrozole, a Potent and Selective Inhibitor of Aromatase</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1997&pages=598-602&author=S.+W.+Grimmauthor=M.+C.+Dyroff&title=Inhibition+of+Human+Drug+Metabolizing+Cytochromes+P450+by+Anastrozole%2C+a+Potent+and+Selective+Inhibitor+of+Aromatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrimm%26aufirst%3DS.%2BW.%26aulast%3DDyroff%26aufirst%3DM.%2BC.%26atitle%3DInhibition%2520of%2520Human%2520Drug%2520Metabolizing%2520Cytochromes%2520P450%2520by%2520Anastrozole%252C%2520a%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Aromatase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1997%26volume%3D25%26spage%3D598%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Miller, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larionov, A. A.</span><span> </span><span class="NLM_article-title">Understanding the Mechanisms of Aromatase Inhibitor Resistance</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="refDoi"> DOI: 10.1186/bcr2931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1186%2Fbcr2931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22277572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis12nsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=201&author=W.+R.+Millerauthor=A.+A.+Larionov&title=Understanding+the+Mechanisms+of+Aromatase+Inhibitor+Resistance&doi=10.1186%2Fbcr2931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the mechanisms of aromatase inhibitor resistance</span></div><div class="casAuthors">Miller, William R.; Larionov, Alexey A.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201</span>CODEN:
                <span class="NLM_cas:coden">BRCRFS</span>;
        ISSN:<span class="NLM_cas:issn">1465-542X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Aromatase inhibitors (AIs) have a central role in the treatment of breast cancer; however, resistance is a major obstacle to optimal management.  Evidence from endocrine, mol. and pathol. measurements in clin. material taken before and after therapy with AIs and data from clin. trials in which AIs have been given as treatment either alone or in combination with other targeted agents suggest diverse causes for resistance.  These include inherent tumor insensitivity to estrogen, ineffective inhibition of aromatase, sources of estrogenic hormones independent of aromatase, activation of signalling by non-endocrine pathways, enhanced cell survival and selection of hormone-insensitive cellular clones during treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqclb5RObdyD7Vg90H21EOLACvtfcHk0lgNSMo7FWirYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis12nsbo%253D&md5=d50d0feed79bba2912273d1f946efff2</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1186%2Fbcr2931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fbcr2931%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DW.%2BR.%26aulast%3DLarionov%26aufirst%3DA.%2BA.%26atitle%3DUnderstanding%2520the%2520Mechanisms%2520of%2520Aromatase%2520Inhibitor%2520Resistance%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2012%26volume%3D14%26spage%3D201%26doi%3D10.1186%2Fbcr2931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Kamdem, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flockhart, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desta, Z.</span><span> </span><span class="NLM_article-title">In Vitro Cytochrome P450-Mediated Metabolism of Exemestane</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1124/dmd.110.032276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1124%2Fdmd.110.032276" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=98-105&author=L.+K.+Kamdemauthor=D.+A.+Flockhartauthor=Z.+Desta&title=In+Vitro+Cytochrome+P450-Mediated+Metabolism+of+Exemestane&doi=10.1124%2Fdmd.110.032276"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.032276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.032276%26sid%3Dliteratum%253Aachs%26aulast%3DKamdem%26aufirst%3DL.%2BK.%26aulast%3DFlockhart%26aufirst%3DD.%2BA.%26aulast%3DDesta%26aufirst%3DZ.%26atitle%3DIn%2520Vitro%2520Cytochrome%2520P450-Mediated%2520Metabolism%2520of%2520Exemestane%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D98%26epage%3D105%26doi%3D10.1124%2Fdmd.110.032276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span>Femara (Letrozole) Prescribing Information. Novartis, East Hanover, NJ,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Femara+%28Letrozole%29+Prescribing+Information.+Novartis%2C+East+Hanover%2C+NJ%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Ariazi, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oprea, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shupp, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyle, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madrack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donato, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, V. C.</span><span> </span><span class="NLM_article-title">Exemestane’s 17-Hydroxylated Metabolite Exerts Biological Effects as an Androgen</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2817</span><span class="NLM_x">–</span> <span class="NLM_lpage">2827</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-07-0312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1158%2F1535-7163.MCT-07-0312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=17989318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWkt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=2817-2827&author=E.+A.+Ariaziauthor=A.+Leitaoauthor=T.+I.+Opreaauthor=B.+Chenauthor=T.+Louisauthor=A.+M.+Bertucciauthor=C.+G.+Sharmaauthor=S.+D.+Gillauthor=H.+R.+Kimauthor=H.+A.+Shuppauthor=J.+R.+Pyleauthor=A.+Madrackauthor=A.+L.+Donatoauthor=D.+Chengauthor=J.+R.+Paigeauthor=V.+C.+Jordan&title=Exemestane%E2%80%99s+17-Hydroxylated+Metabolite+Exerts+Biological+Effects+as+an+Androgen&doi=10.1158%2F1535-7163.MCT-07-0312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen</span></div><div class="casAuthors">Ariazi, Eric A.; Leitao, Andrei; Oprea, Tudor I.; Chen, Bin; Louis, Teresa; Bertucci, Anne Marie; Sharma, Catherine G. N.; Gill, Shaun D.; Kim, Helen R.; Shupp, Heather A.; Pyle, Jennifer R.; Madrack, Alexis; Donato, Anne L.; Cheng, Dong; Paige, James R.; Jordan, V. Craig</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2817-2827</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aromatase inhibitors (AI) are being evaluated as long-term adjuvant therapies and chemopreventives in breast cancer.  However, there are concerns about bone mineral d. loss in an estrogen-free environment.  Unlike nonsteroidal AIs, the steroidal AI exemestane may exert beneficial effects on bone through its primary metabolite 17-hydroexemestane.  We investigated 17-hydroexemestane and obsd. it bound estrogen receptor α (ERα) very weakly and androgen receptor (AR) strongly.  Next, we evaluated 17-hydroexemestane in MCF-7 and T47D breast cancer cells and attributed dependency of its effects on ER or AR using the antiestrogen fulvestrant or the antiandrogen bicalutamide.  17-Hydroexemestane induced proliferation, stimulated cell cycle progression and regulated transcription at high sub-micromolar and micromolar concns. through ER in both cell lines, but through AR at low nanomolar concns. selectively in T47D cells.  Responses of each cell type to high and low concns. of the non-aromatizable synthetic androgen R1881 paralleled those of 17-hydroexemestane. 17-Hydroexemestane down-regulated ERα protein levels at high concns. in a cell type-specific manner similarly as 17β-estradiol, and increased AR protein accumulation at low concns. in both cell types similarly as R1881.  Computer docking indicated that the 17β-OH group of 17-hydroexemestane relative to the 17-keto group of exemestane contributed significantly more intermol. interaction energy toward binding AR than ERα.  Mol. modeling also indicated that 17-hydroexemestane interacted with ERα and AR through selective recognition motifs employed by 17β-estradiol and R1881, resp.  We conclude that 17-hydroexemestane exerts biol. effects as an androgen.  These results may have important implications for long-term maintenance of patients with AIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSPj7C1jpERLVg90H21EOLACvtfcHk0lhdn-MhLmmBjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWkt7nN&md5=e342daad6dedd8bada898fe777182d0f</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0312%26sid%3Dliteratum%253Aachs%26aulast%3DAriazi%26aufirst%3DE.%2BA.%26aulast%3DLeitao%26aufirst%3DA.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DLouis%26aufirst%3DT.%26aulast%3DBertucci%26aufirst%3DA.%2BM.%26aulast%3DSharma%26aufirst%3DC.%2BG.%26aulast%3DGill%26aufirst%3DS.%2BD.%26aulast%3DKim%26aufirst%3DH.%2BR.%26aulast%3DShupp%26aufirst%3DH.%2BA.%26aulast%3DPyle%26aufirst%3DJ.%2BR.%26aulast%3DMadrack%26aufirst%3DA.%26aulast%3DDonato%26aufirst%3DA.%2BL.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DPaige%26aufirst%3DJ.%2BR.%26aulast%3DJordan%26aufirst%3DV.%2BC.%26atitle%3DExemestane%25E2%2580%2599s%252017-Hydroxylated%2520Metabolite%2520Exerts%2520Biological%2520Effects%2520as%2520an%2520Androgen%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D2817%26epage%3D2827%26doi%3D10.1158%2F1535-7163.MCT-07-0312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Masri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span> </span><span class="NLM_article-title">Characterization of the Weak Estrogen Receptor Alpha Agonistic Activity of Exemestane</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span><span class="refDoi"> DOI: 10.1007/s10549-008-0151-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2Fs10549-008-0151-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=18677558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGmtrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2009&pages=461-470&author=S.+Masriauthor=K.+Luiauthor=S.+Phungauthor=J.+Yeauthor=D.+Zhouauthor=X.+Wangauthor=S.+Chen&title=Characterization+of+the+Weak+Estrogen+Receptor+Alpha+Agonistic+Activity+of+Exemestane&doi=10.1007%2Fs10549-008-0151-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the weak estrogen receptor α agonistic activity of exemestane</span></div><div class="casAuthors">Masri, Selma; Lui, Ki; Phung, Sheryl; Ye, Jingjing; Zhou, Dujin; Wang, Xin; Chen, Shiuan</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-470</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Third generation aromatase inhibitors (AI) have shown good clin. efficacy in comparison to the anti-estrogen tamoxifen.  The steroidal AI, exemestane (EXE) has previously been shown to act as an androgen, but this report demonstrates the estrogen-like activity of EXE.  Based on genome-wide microarray anal., high correlation was seen between EXE-Only (EXE O, hormone-free) and hormone-contg. AI-resistant lines.  In addn., the top regulated genes in the EXE O lines were mostly estrogen-responsive genes.  This estrogen-like activity of EXE was further validated using estrogen receptor (ER) activity assays, where in comparison to 17β-estradiol (E2), EXE was able to induce ER activity, though at a higher concn.  Also, this EXE-mediated ER activity was blocked by the ER antagonist ICI as well as the ERα-specific antagonist methyl-piperidino-pyrazole (MPP).  Similarly, EXE was able to induce proliferation of breast cancer cell lines, MCF-7 and MCF-7aro, as well as activate transcription of known estrogen-responsive genes, i.e., PGR, pS2 and AREG.  These results suggest that EXE does have weak estrogen-like activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGougUhxJ93PqLVg90H21EOLACvtfcHk0lhdn-MhLmmBjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGmtrzL&md5=0c9336f42035f88147b610c8939dd8ed</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1007%2Fs10549-008-0151-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-008-0151-x%26sid%3Dliteratum%253Aachs%26aulast%3DMasri%26aufirst%3DS.%26aulast%3DLui%26aufirst%3DK.%26aulast%3DPhung%26aufirst%3DS.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DCharacterization%2520of%2520the%2520Weak%2520Estrogen%2520Receptor%2520Alpha%2520Agonistic%2520Activity%2520of%2520Exemestane%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2009%26volume%3D116%26spage%3D461%26epage%3D470%26doi%3D10.1007%2Fs10549-008-0151-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Varela, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares da Silva, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaral, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia da Silva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalho, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roleira, F. M.</span><span> </span><span class="NLM_article-title">New Structure-Activity Relationships of A- and D-Ring Modified Steroidal Aromatase Inhibitors: Design, Synthesis, and Biochemical Evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3992</span><span class="NLM_x">–</span> <span class="NLM_lpage">4002</span><span class="refDoi"> DOI: 10.1021/jm300262w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300262w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3992-4002&author=C.+Varelaauthor=E.+J.+Tavares+da+Silvaauthor=C.+Amaralauthor=G.+Correia+da+Silvaauthor=T.+Baptistaauthor=S.+Alcaroauthor=G.+Costaauthor=R.+A.+Carvalhoauthor=N.+A.+Teixeiraauthor=F.+M.+Roleira&title=New+Structure-Activity+Relationships+of+A-+and+D-Ring+Modified+Steroidal+Aromatase+Inhibitors%3A+Design%2C+Synthesis%2C+and+Biochemical+Evaluation&doi=10.1021%2Fjm300262w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fjm300262w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300262w%26sid%3Dliteratum%253Aachs%26aulast%3DVarela%26aufirst%3DC.%26aulast%3DTavares%2Bda%2BSilva%26aufirst%3DE.%2BJ.%26aulast%3DAmaral%26aufirst%3DC.%26aulast%3DCorreia%2Bda%2BSilva%26aufirst%3DG.%26aulast%3DBaptista%26aufirst%3DT.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DG.%26aulast%3DCarvalho%26aufirst%3DR.%2BA.%26aulast%3DTeixeira%26aufirst%3DN.%2BA.%26aulast%3DRoleira%26aufirst%3DF.%2BM.%26atitle%3DNew%2520Structure-Activity%2520Relationships%2520of%2520A-%2520and%2520D-Ring%2520Modified%2520Steroidal%2520Aromatase%2520Inhibitors%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Biochemical%2520Evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3992%26epage%3D4002%26doi%3D10.1021%2Fjm300262w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Varela, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaral, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia-da-Silva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalho, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roleira, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares-da-Silva, E. J.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biochemical Studies of New 7alpha-Allylandrostanes as Aromatase Inhibitors</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span><span class="refDoi"> DOI: 10.1016/j.steroids.2013.02.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.steroids.2013.02.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=662-669&author=C.+L.+Varelaauthor=C.+Amaralauthor=G.+Correia-da-Silvaauthor=R.+A.+Carvalhoauthor=N.+A.+Teixeiraauthor=S.+C.+Costaauthor=F.+M.+Roleiraauthor=E.+J.+Tavares-da-Silva&title=Design%2C+Synthesis+and+Biochemical+Studies+of+New+7alpha-Allylandrostanes+as+Aromatase+Inhibitors&doi=10.1016%2Fj.steroids.2013.02.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2013.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2013.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DVarela%26aufirst%3DC.%2BL.%26aulast%3DAmaral%26aufirst%3DC.%26aulast%3DCorreia-da-Silva%26aufirst%3DG.%26aulast%3DCarvalho%26aufirst%3DR.%2BA.%26aulast%3DTeixeira%26aufirst%3DN.%2BA.%26aulast%3DCosta%26aufirst%3DS.%2BC.%26aulast%3DRoleira%26aufirst%3DF.%2BM.%26aulast%3DTavares-da-Silva%26aufirst%3DE.%2BJ.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biochemical%2520Studies%2520of%2520New%25207alpha-Allylandrostanes%2520as%2520Aromatase%2520Inhibitors%26jtitle%3DSteroids%26date%3D2013%26volume%3D78%26spage%3D662%26epage%3D669%26doi%3D10.1016%2Fj.steroids.2013.02.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Bansal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guleria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodhankar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patwardhan, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, A. L.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of Novel 16-Imidazolyl Substituted Steroidal Derivatives Possessing Potent Diversified Pharmacological Properties</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span><span class="refDoi"> DOI: 10.1016/j.steroids.2012.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.steroids.2012.02.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=621-629&author=R.+Bansalauthor=S.+Guleriaauthor=S.+Thotaauthor=S.+L.+Bodhankarauthor=M.+R.+Patwardhanauthor=C.+Zimmerauthor=R.+W.+Hartmannauthor=A.+L.+Harvey&title=Design%2C+Synthesis+and+Evaluation+of+Novel+16-Imidazolyl+Substituted+Steroidal+Derivatives+Possessing+Potent+Diversified+Pharmacological+Properties&doi=10.1016%2Fj.steroids.2012.02.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2012.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2012.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DBansal%26aufirst%3DR.%26aulast%3DGuleria%26aufirst%3DS.%26aulast%3DThota%26aufirst%3DS.%26aulast%3DBodhankar%26aufirst%3DS.%2BL.%26aulast%3DPatwardhan%26aufirst%3DM.%2BR.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DHarvey%26aufirst%3DA.%2BL.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%2520Novel%252016-Imidazolyl%2520Substituted%2520Steroidal%2520Derivatives%2520Possessing%2520Potent%2520Diversified%2520Pharmacological%2520Properties%26jtitle%3DSteroids%26date%3D2012%26volume%3D77%26spage%3D621%26epage%3D629%26doi%3D10.1016%2Fj.steroids.2012.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Yadav, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabale, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giridhar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haupenthal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Synthesis of Some Novel Androstanes as Potential Aromatase Inhibitors</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span><span class="refDoi"> DOI: 10.1016/j.steroids.2010.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.steroids.2010.12.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=464-470&author=M.+R.+Yadavauthor=P.+M.+Sabaleauthor=R.+Giridharauthor=C.+Zimmerauthor=J.+Haupenthalauthor=R.+W.+Hartmann&title=Synthesis+of+Some+Novel+Androstanes+as+Potential+Aromatase+Inhibitors&doi=10.1016%2Fj.steroids.2010.12.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2010.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2010.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DM.%2BR.%26aulast%3DSabale%26aufirst%3DP.%2BM.%26aulast%3DGiridhar%26aufirst%3DR.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DHaupenthal%26aufirst%3DJ.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DSynthesis%2520of%2520Some%2520Novel%2520Androstanes%2520as%2520Potential%2520Aromatase%2520Inhibitors%26jtitle%3DSteroids%26date%3D2011%26volume%3D76%26spage%3D464%26epage%3D470%26doi%3D10.1016%2Fj.steroids.2010.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Yadav, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabale, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giridhar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Steroidal Carbonitriles as Potential Aromatase Inhibitors</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">857</span><span class="refDoi"> DOI: 10.1016/j.steroids.2012.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.steroids.2012.04.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=850-857&author=M.+R.+Yadavauthor=P.+M.+Sabaleauthor=R.+Giridharauthor=C.+Zimmerauthor=R.+W.+Hartmann&title=Steroidal+Carbonitriles+as+Potential+Aromatase+Inhibitors&doi=10.1016%2Fj.steroids.2012.04.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2012.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2012.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DM.%2BR.%26aulast%3DSabale%26aufirst%3DP.%2BM.%26aulast%3DGiridhar%26aufirst%3DR.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DSteroidal%2520Carbonitriles%2520as%2520Potential%2520Aromatase%2520Inhibitors%26jtitle%3DSteroids%26date%3D2012%26volume%3D77%26spage%3D850%26epage%3D857%26doi%3D10.1016%2Fj.steroids.2012.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Ghosh, D.; Di Nardo, G.; Lo, J.; Jiang, W.; Griswold, J.; Gilardi, G.</span><span> </span><span class="NLM_article-title">Ligand-Binding Interactions and Quaternary Association in Human Aromatase</span>.  <span class="citation_source-book">36th FEBS Congress</span>, Torino, Italy; <span class="NLM_contrib-group">Perham, R.</span>, Ed.; <span class="NLM_publisher-name">Wiley-Blackwell</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">30</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=30&author=D.+Ghosh&author=G.+Di+Nardo&author=J.+Lo&author=W.+Jiang&author=J.+Griswold&author=G.+Gilardiauthor=R.+Perham&title=36th+FEBS+Congress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DLigand-Binding%2520Interactions%2520and%2520Quaternary%2520Association%2520in%2520Human%2520Aromatase%26btitle%3D36th%2520FEBS%2520Congress%26aulast%3DPerham%26aufirst%3DR.%26pub%3DWiley-Blackwell%26date%3D2011%26spage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Sgrignani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magistrato, A.</span><span> </span><span class="NLM_article-title">Computational Approaches Elucidate the Allosteric Mechanism of Human Aromatase Inhibition: A Novel Possible Route to Small-Molecule Regulation of Cyp450s Activities?</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2856</span><span class="NLM_x">–</span> <span class="NLM_lpage">2868</span><span class="refDoi"> DOI: 10.1021/ci500425y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500425y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVCmsrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=2856-2868&author=J.+Sgrignaniauthor=M.+Bonauthor=G.+Colomboauthor=A.+Magistrato&title=Computational+Approaches+Elucidate+the+Allosteric+Mechanism+of+Human+Aromatase+Inhibition%3A+A+Novel+Possible+Route+to+Small-Molecule+Regulation+of+Cyp450s+Activities%3F&doi=10.1021%2Fci500425y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Approaches Elucidate the Allosteric Mechanism of Human Aromatase Inhibition: A Novel Possible Route to Small-Molecule Regulation of CYP450s Activities?</span></div><div class="casAuthors">Sgrignani, Jacopo; Bon, Marta; Colombo, Giorgio; Magistrato, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2856-2868</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human aromatase (HA) is a P 450 cytochrome (CYP) with an essential role in estrogen biosynthesis.  Since more than 70% of breast cancers are pos. for estrogenic receptor (ER), the redn. of estrogen physiol. concns. through HA inhibition is one of most important therapeutic strategies against this cancer type.  Recently, exptl. evidence showed that selected taxmoxifen metabolites, which are typically used as estrogen receptor modulators (SERMs), inhibit HA through an allosteric mechanism.  In this work, we present a computational protocol to (i) characterize the structural framework and (ii) define the atomistic details of the determinants for the noncompetitive inhibition mechanism.  Our calcns. identify two putative binding sites able to efficiently bind all tamoxifen metabolites.  Anal. of long-scale mol. dynamics simulations reveal that endoxifen, the most effective noncompetitive inhibitor, induces significant enzyme rigidity by binding in one of the possible peripheral sites.  The consequence of this binding event is the suppression of one of the functional enzymic collective motions assocd. with breathing of the substrate access channel.  Moreover, an internal dynamics-based alignment of HA with six other human cytochromes shows that this collective motion is common to other members of the CYP450 protein family.  On this basis, our findings may thus be of help for the development of new (pan)inhibitors for the therapeutic treatment of cancer, targeting and modulating the activity of HA and of estrogen receptor, and may also stimulate the development of new drug design strategies for chemoprevention and chemoprotection via allosteric inhibition of CYP450 proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4wfeRHIieRrVg90H21EOLACvtfcHk0liddck1Yo-vVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVCmsrfN&md5=3199db4b7f97e188bfa5d9158092e30b</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fci500425y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500425y%26sid%3Dliteratum%253Aachs%26aulast%3DSgrignani%26aufirst%3DJ.%26aulast%3DBon%26aufirst%3DM.%26aulast%3DColombo%26aufirst%3DG.%26aulast%3DMagistrato%26aufirst%3DA.%26atitle%3DComputational%2520Approaches%2520Elucidate%2520the%2520Allosteric%2520Mechanism%2520of%2520Human%2520Aromatase%2520Inhibition%253A%2520A%2520Novel%2520Possible%2520Route%2520to%2520Small-Molecule%2520Regulation%2520of%2520Cyp450s%2520Activities%253F%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D2856%26epage%3D2868%26doi%3D10.1021%2Fci500425y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Jiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Q.</span><span> </span><span class="NLM_article-title">Recent Advancement in Nonsteroidal Aromatase Inhibitors for Treatment of Estrogen-Dependent Breast Cancer</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3476</span><span class="NLM_x">–</span> <span class="NLM_lpage">3487</span><span class="refDoi"> DOI: 10.2174/092986710792927877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.2174%2F092986710792927877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=20738251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWrt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=3476-3487&author=J.+Jiaoauthor=H.+Xiangauthor=Q.+Liao&title=Recent+Advancement+in+Nonsteroidal+Aromatase+Inhibitors+for+Treatment+of+Estrogen-Dependent+Breast+Cancer&doi=10.2174%2F092986710792927877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer</span></div><div class="casAuthors">Jiao, J.; Xiang, H.; Liao, Q.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">3476-3487</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Estrogen-dependent breast cancer (EDBC) is a kind of common malignant tumor in postmenopausal women with growing tendency in recent years.  Aromatase (AR) is the key enzyme responsible for estrogen biosynthesis and has been considered as an important target for designing inhibitors as potent therapeutic agents for EDBC.  AR inhibitors (AIs) are divided into steroidal and nonsteroidal compds., and the latter shows high inhibitory potency against AR.  This review summarizes recent advancement in nonsteroidal AIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuVwxKHLHeMbVg90H21EOLACvtfcHk0lhONy1geze5aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWrt7fL&md5=d3dbcf26d22b72f07e8a3a32c3bd855c</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.2174%2F092986710792927877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710792927877%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DQ.%26atitle%3DRecent%2520Advancement%2520in%2520Nonsteroidal%2520Aromatase%2520Inhibitors%2520for%2520Treatment%2520of%2520Estrogen-Dependent%2520Breast%2520Cancer%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D3476%26epage%3D3487%26doi%3D10.2174%2F092986710792927877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Tetrahydropyrroloquinolinone Type Dual Inhibitors of Aromatase/Aldosterone Synthase as a Novel Strategy for Breast Cancer Patients with Elevated Cardiovascular Risks</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span><span class="refDoi"> DOI: 10.1021/jm301408t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301408t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVanug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=460-470&author=L.+Yinauthor=Q.+Huauthor=R.+W.+Hartmann&title=Tetrahydropyrroloquinolinone+Type+Dual+Inhibitors+of+Aromatase%2FAldosterone+Synthase+as+a+Novel+Strategy+for+Breast+Cancer+Patients+with+Elevated+Cardiovascular+Risks&doi=10.1021%2Fjm301408t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydropyrroloquinolinone Type Dual Inhibitors of Aromatase/Aldosterone Synthase as a Novel Strategy for Breast Cancer Patients with Elevated Cardiovascular Risks</span></div><div class="casAuthors">Yin, Lina; Hu, Qingzhong; Hartmann, Rolf W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">460-470</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The application of aromatase inhibitors to postmenopausal breast cancer patients increases the risk of cardiovascular diseases (CVD), which is believed to be caused by the abnormally high concns. of aldosterone as a consequence of the estrogen deficiency.  Dual inhibitors of aromatase (CYP19) and aldosterone synthase (CYP11B2) are therefore proposed as a novel strategy for the adjuvant therapy to reduce the CVD risk for these patients.  By combining decisive structural features of CYP11B2 and CYP19 inhibitors into a common template, a series of pyridinylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones were designed and synthesized.  Interestingly, the substituents on the methylene bridge showed strong influences on the inhibitory activities leading to opposite effects, i.e., a given substituent showed an increase in inhibition of one enzyme, while it led to a decrease for the other enzyme.  The compromise of this conflict led to compds. 3j, 3k, 3n, and 3p as potent and selective dual inhibitors of CYP19 and CYP11B2, esp. compd. 3p (I), which exhibited IC50 values of 32 and 41 nM for CYP19 and CYP11B2, resp., and a high selectivity toward CYP17 and CYP11B1.  This compd. is considered as a candidate for further evaluation in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwYyrAmpIzorVg90H21EOLACvtfcHk0lhONy1geze5aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVanug%253D%253D&md5=71a8d28d9b81108446073c259a48b498</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fjm301408t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301408t%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DTetrahydropyrroloquinolinone%2520Type%2520Dual%2520Inhibitors%2520of%2520Aromatase%252FAldosterone%2520Synthase%2520as%2520a%2520Novel%2520Strategy%2520for%2520Breast%2520Cancer%2520Patients%2520with%2520Elevated%2520Cardiovascular%2520Risks%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D460%26epage%3D470%26doi%3D10.1021%2Fjm301408t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Ferlin, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolozzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghodsi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimento, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pezzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanke, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola, G.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Structure-Activity Relationships of Azolylmethylpyrroloquinolines as Nonsteroidal Aromatase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7536</span><span class="NLM_x">–</span> <span class="NLM_lpage">7551</span><span class="refDoi"> DOI: 10.1021/jm400377z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400377z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7536-7551&author=M.+G.+Ferlinauthor=D.+Cartaauthor=R.+Bortolozziauthor=R.+Ghodsiauthor=A.+Chimentoauthor=V.+Pezziauthor=S.+Moroauthor=N.+Hankeauthor=R.+W.+Hartmannauthor=G.+Bassoauthor=G.+Viola&title=Design%2C+Synthesis%2C+and+Structure-Activity+Relationships+of+Azolylmethylpyrroloquinolines+as+Nonsteroidal+Aromatase+Inhibitors&doi=10.1021%2Fjm400377z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fjm400377z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400377z%26sid%3Dliteratum%253Aachs%26aulast%3DFerlin%26aufirst%3DM.%2BG.%26aulast%3DCarta%26aufirst%3DD.%26aulast%3DBortolozzi%26aufirst%3DR.%26aulast%3DGhodsi%26aufirst%3DR.%26aulast%3DChimento%26aufirst%3DA.%26aulast%3DPezzi%26aufirst%3DV.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DHanke%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DViola%26aufirst%3DG.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Structure-Activity%2520Relationships%2520of%2520Azolylmethylpyrroloquinolines%2520as%2520Nonsteroidal%2520Aromatase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7536%26epage%3D7551%26doi%3D10.1021%2Fjm400377z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Ji, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lao, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. Y.</span><span> </span><span class="NLM_article-title">Discovery of Novel Aromatase Inhibitors Using a Homogeneous Time-Resolved Fluorescence Assay</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1082</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span><span class="refDoi"> DOI: 10.1038/aps.2014.53</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1038%2Faps.2014.53" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=25047514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislOqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=1082-1092&author=J.+Z.+Jiauthor=K.+J.+Laoauthor=J.+Huauthor=T.+Pangauthor=Z.+Z.+Jiangauthor=H.+L.+Yuanauthor=J.+S.+Miaoauthor=X.+Chenauthor=S.+S.+Ningauthor=H.+Xiangauthor=Y.+M.+Guoauthor=M.+Yanauthor=L.+Y.+Zhang&title=Discovery+of+Novel+Aromatase+Inhibitors+Using+a+Homogeneous+Time-Resolved+Fluorescence+Assay&doi=10.1038%2Faps.2014.53"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel aromatase inhibitors using a homogeneous time-resolved fluorescence assay</span></div><div class="casAuthors">Ji, Jin-zi; Lao, Ke-jing; Hu, Jie; Pang, Tao; Jiang, Zhen-zhou; Yuan, Hao-liang; Miao, Jing-shan; Chen, Xin; Ning, Shan-shan; Xiang, Hua; Guo, Yu-meng; Yan, Ming; Zhang, Lu-yong</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1082-1092</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aim: Aromatase is an important target for drugs to treat hormone-dependent diseases, including breast cancer.  The aim of this study was to develop a homogeneous time-resolved fluorescence (HTRF) aromatase assay suitable for high-throughput screening (HTS).  Methods: A 384-well aromatase HTRF assay was established, and used to screen about 7000 compds. from a compd. library.  Anti-proliferation activity of the hit was evaluated using alamarBlue(R) assay in a hormone-dependent breast cancer cell line T47D.  Mol. docking was conducted to elucidate the binding mode of the hit using the Discovery Studio program.  Results: The Z' value and signal to background (S/B) ratio were 0.74 and 5.4, resp.  Among the 7000 compds., 4 hits (XHN22, XHN26, XHN27 and triptoquinone A) were found to inhibit aromatase with IC50 values of 1.60±0.07, 2.76±0.24, 0.81±0.08 and 45.8±11.3 μmol /L, resp.  The hits XHN22, XHN26 and XHN27 shared the same chem. scaffold of 4-imidazolyl quinoline.  Moreover, the most potent hit XHN27 at 10 and 50 μmol/L inhibited the proliferation of T47D cells by 45.3% and 35.2%, resp.  The docking study revealed that XHN27 docked within the active site of aromatase and might form a hydrogen bond and had a π-cation interaction with amino acid residues of the protein.  Conclusion: XHN27, an imidazolyl quinoline deriv. of flavonoid, is a potent aromatase inhibitor with anti-proliferation activity against breast cancer in vitro.  The established assay can be used in HTS for discovering novel aromatase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQmyHM4vOx77Vg90H21EOLACvtfcHk0lhONy1geze5aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislOqtQ%253D%253D&md5=b751337ce795ff615e33e4942daf24e0</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1038%2Faps.2014.53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2014.53%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DJ.%2BZ.%26aulast%3DLao%26aufirst%3DK.%2BJ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DZ.%2BZ.%26aulast%3DYuan%26aufirst%3DH.%2BL.%26aulast%3DMiao%26aufirst%3DJ.%2BS.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DNing%26aufirst%3DS.%2BS.%26aulast%3DXiang%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DY.%2BM.%26aulast%3DYan%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%2BY.%26atitle%3DDiscovery%2520of%2520Novel%2520Aromatase%2520Inhibitors%2520Using%2520a%2520Homogeneous%2520Time-Resolved%2520Fluorescence%2520Assay%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2014%26volume%3D35%26spage%3D1082%26epage%3D1092%26doi%3D10.1038%2Faps.2014.53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Bonfield, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankemper, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeler, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCallum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span> </span><span class="NLM_article-title">Development of a New Class of Aromatase Inhibitors: Design, Synthesis and Inhibitory Activity of 3-Phenylchroman-4-One (Isoflavanone) Derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2603</span><span class="NLM_x">–</span> <span class="NLM_lpage">2613</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.02.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bmc.2012.02.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2603-2613&author=K.+Bonfieldauthor=E.+Amatoauthor=T.+Bankemperauthor=H.+Agardauthor=J.+Stellerauthor=J.+M.+Keelerauthor=D.+Royauthor=A.+McCallumauthor=S.+Paulaauthor=L.+Ma&title=Development+of+a+New+Class+of+Aromatase+Inhibitors%3A+Design%2C+Synthesis+and+Inhibitory+Activity+of+3-Phenylchroman-4-One+%28Isoflavanone%29+Derivatives&doi=10.1016%2Fj.bmc.2012.02.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.02.042%26sid%3Dliteratum%253Aachs%26aulast%3DBonfield%26aufirst%3DK.%26aulast%3DAmato%26aufirst%3DE.%26aulast%3DBankemper%26aufirst%3DT.%26aulast%3DAgard%26aufirst%3DH.%26aulast%3DSteller%26aufirst%3DJ.%26aulast%3DKeeler%26aufirst%3DJ.%2BM.%26aulast%3DRoy%26aufirst%3DD.%26aulast%3DMcCallum%26aufirst%3DA.%26aulast%3DPaula%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DL.%26atitle%3DDevelopment%2520of%2520a%2520New%2520Class%2520of%2520Aromatase%2520Inhibitors%253A%2520Design%252C%2520Synthesis%2520and%2520Inhibitory%2520Activity%2520of%25203-Phenylchroman-4-One%2520%2528Isoflavanone%2529%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D2603%26epage%3D2613%26doi%3D10.1016%2Fj.bmc.2012.02.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Prachyawarakorn, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sangpetsiripan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surawatanawong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahidol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruchirawat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kittakoop, P.</span><span> </span><span class="NLM_article-title">Flavans from Desmos Cochinchinensis as Potent Aromatase Inhibitors</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1590</span><span class="NLM_x">–</span> <span class="NLM_lpage">1596</span><span class="refDoi"> DOI: 10.1039/c3md00166k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1039%2Fc3md00166k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1590-1596&author=V.+Prachyawarakornauthor=S.+Sangpetsiripanauthor=P.+Surawatanawongauthor=C.+Mahidolauthor=S.+Ruchirawatauthor=P.+Kittakoop&title=Flavans+from+Desmos+Cochinchinensis+as+Potent+Aromatase+Inhibitors&doi=10.1039%2Fc3md00166k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1039%2Fc3md00166k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00166k%26sid%3Dliteratum%253Aachs%26aulast%3DPrachyawarakorn%26aufirst%3DV.%26aulast%3DSangpetsiripan%26aufirst%3DS.%26aulast%3DSurawatanawong%26aufirst%3DP.%26aulast%3DMahidol%26aufirst%3DC.%26aulast%3DRuchirawat%26aufirst%3DS.%26aulast%3DKittakoop%26aufirst%3DP.%26atitle%3DFlavans%2520from%2520Desmos%2520Cochinchinensis%2520as%2520Potent%2520Aromatase%2520Inhibitors%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D1590%26epage%3D1596%26doi%3D10.1039%2Fc3md00166k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Imidazolyl Derivatives of 4,7-Disubstituted Coumarins as Aromatase Inhibitors Selective over 17-Alpha-Hydroxylase/C17-20 Lyase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1613</span><span class="NLM_x">–</span> <span class="NLM_lpage">1625</span><span class="refDoi"> DOI: 10.1021/jm101120u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101120u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1613-1625&author=A.+Stefanachiauthor=A.+D.+Faviaauthor=O.+Nicolottiauthor=F.+Leonettiauthor=L.+Pisaniauthor=M.+Cattoauthor=C.+Zimmerauthor=R.+W.+Hartmannauthor=A.+Carotti&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Imidazolyl+Derivatives+of+4%2C7-Disubstituted+Coumarins+as+Aromatase+Inhibitors+Selective+over+17-Alpha-Hydroxylase%2FC17-20+Lyase&doi=10.1021%2Fjm101120u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm101120u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101120u%26sid%3Dliteratum%253Aachs%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Imidazolyl%2520Derivatives%2520of%25204%252C7-Disubstituted%2520Coumarins%2520as%2520Aromatase%2520Inhibitors%2520Selective%2520over%252017-Alpha-Hydroxylase%252FC17-20%2520Lyase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1613%26epage%3D1625%26doi%3D10.1021%2Fjm101120u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Hong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span> </span><span class="NLM_article-title">Aromatase, Estrone Sulfatase, and 17beta-Hydroxysteroid Dehydrogenase: Structure-Function Studies and Inhibitor Development</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1016/j.mce.2010.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.mce.2010.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=20888390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFyrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2011&pages=120-126&author=Y.+Hongauthor=S.+Chen&title=Aromatase%2C+Estrone+Sulfatase%2C+and+17beta-Hydroxysteroid+Dehydrogenase%3A+Structure-Function+Studies+and+Inhibitor+Development&doi=10.1016%2Fj.mce.2010.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase: Structure-function studies and inhibitor development</span></div><div class="casAuthors">Hong, Yanyan; Chen, Shiuan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-126</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase type 1 are involved in the key steps of 17β-estradiol biosynthesis.  Structure-function studies of aromatase, estrone sulfatase and 17β-hydroxysteroid dehydrogenase type 1 are important to evaluate the mol. basis of the interaction between these enzymes and their inhibitors.  Selective and potent inhibitors of the three enzymes have been developed as antiproliferative agents in hormone-dependent breast carcinoma.  New treatment strategies for hormone-dependent breast cancer are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq0icjv4GMC7Vg90H21EOLACvtfcHk0lhc9-H4teE6Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFyrtL8%253D&md5=2f8c55500a7d36ca875fcf68d181407d</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2010.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2010.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DAromatase%252C%2520Estrone%2520Sulfatase%252C%2520and%252017beta-Hydroxysteroid%2520Dehydrogenase%253A%2520Structure-Function%2520Studies%2520and%2520Inhibitor%2520Development%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2011%26volume%3D340%26spage%3D120%26epage%3D126%26doi%3D10.1016%2Fj.mce.2010.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Woo, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V.</span><span> </span><span class="NLM_article-title">Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4h-1,2,4-Triazol-4-Yl)Amino]Methyl}Phenyl Sulfamate</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span><span class="refDoi"> DOI: 10.1002/cmdc.201300015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fcmdc.201300015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=779-799&author=L.+W.+Wooauthor=P.+M.+Woodauthor=C.+Bubertauthor=M.+P.+Thomasauthor=A.+Purohitauthor=B.+V.+Potter&title=Synthesis+and+Structure-Activity+Relationship+Studies+of+Derivatives+of+the+Dual+Aromatase-Sulfatase+Inhibitor+4-%7B%5B%284-Cyanophenyl%29%284h-1%2C2%2C4-Triazol-4-Yl%29Amino%5DMethyl%7DPhenyl+Sulfamate&doi=10.1002%2Fcmdc.201300015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300015%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%26atitle%3DSynthesis%2520and%2520Structure-Activity%2520Relationship%2520Studies%2520of%2520Derivatives%2520of%2520the%2520Dual%2520Aromatase-Sulfatase%2520Inhibitor%25204-%257B%255B%25284-Cyanophenyl%2529%25284h-1%252C2%252C4-Triazol-4-Yl%2529Amino%255DMethyl%257DPhenyl%2520Sulfamate%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D779%26epage%3D799%26doi%3D10.1002%2Fcmdc.201300015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrosse, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V.</span><span> </span><span class="NLM_article-title">Bicyclic Derivatives of the Potent Dual Aromatase-Steroid Sulfatase Inhibitor 2-Bromo-4-{[(4-Cyanophenyl)(4h-1,2,4-Triazol-4-Yl)Amino]Methyl}Phenylsulfamate: Synthesis, SAR, Crystal Structure, and in Vitro and in Vivo Activities</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1577</span><span class="NLM_x">–</span> <span class="NLM_lpage">1593</span><span class="refDoi"> DOI: 10.1002/cmdc.201000203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fcmdc.201000203" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1577-1593&author=P.+M.+Woodauthor=L.+W.+Wooauthor=J.+R.+Labrosseauthor=M.+P.+Thomasauthor=M.+F.+Mahonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+Potter&title=Bicyclic+Derivatives+of+the+Potent+Dual+Aromatase-Steroid+Sulfatase+Inhibitor+2-Bromo-4-%7B%5B%284-Cyanophenyl%29%284h-1%2C2%2C4-Triazol-4-Yl%29Amino%5DMethyl%7DPhenylsulfamate%3A+Synthesis%2C+SAR%2C+Crystal+Structure%2C+and+in+Vitro+and+in+Vivo+Activities&doi=10.1002%2Fcmdc.201000203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000203%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%26aulast%3DLabrosse%26aufirst%3DJ.%2BR.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%26atitle%3DBicyclic%2520Derivatives%2520of%2520the%2520Potent%2520Dual%2520Aromatase-Steroid%2520Sulfatase%2520Inhibitor%25202-Bromo-4-%257B%255B%25284-Cyanophenyl%2529%25284h-1%252C2%252C4-Triazol-4-Yl%2529Amino%255DMethyl%257DPhenylsulfamate%253A%2520Synthesis%252C%2520SAR%252C%2520Crystal%2520Structure%252C%2520and%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Activities%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1577%26epage%3D1593%26doi%3D10.1002%2Fcmdc.201000203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Woo, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V.</span><span> </span><span class="NLM_article-title">Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory Activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span><span class="refDoi"> DOI: 10.1021/ml100273k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100273k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=243-247&author=L.+W.+Wooauthor=C.+Bubertauthor=A.+Purohitauthor=B.+V.+Potter&title=Hybrid+Dual+Aromatase-Steroid+Sulfatase+Inhibitors+with+Exquisite+Picomolar+Inhibitory+Activity&doi=10.1021%2Fml100273k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fml100273k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100273k%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%26atitle%3DHybrid%2520Dual%2520Aromatase-Steroid%2520Sulfatase%2520Inhibitors%2520with%2520Exquisite%2520Picomolar%2520Inhibitory%2520Activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D243%26epage%3D247%26doi%3D10.1021%2Fml100273k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Woo, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozier, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V.</span><span> </span><span class="NLM_article-title">Highly Potent First Examples of Dual Aromatase-Steroid Sulfatase Inhibitors Based on a Biphenyl Template</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2155</span><span class="NLM_x">–</span> <span class="NLM_lpage">2170</span><span class="refDoi"> DOI: 10.1021/jm901705h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901705h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFKit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2155-2170&author=L.+W.+Wooauthor=T.+Jacksonauthor=A.+Puteyauthor=G.+Cozierauthor=P.+Leonardauthor=K.+R.+Acharyaauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+Potter&title=Highly+Potent+First+Examples+of+Dual+Aromatase-Steroid+Sulfatase+Inhibitors+Based+on+a+Biphenyl+Template&doi=10.1021%2Fjm901705h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent First Examples of Dual Aromatase-Steroid Sulfatase Inhibitors based on a Biphenyl Template</span></div><div class="casAuthors">Woo, L. W. Lawrence; Jackson, Toby; Putey, Aurelien; Cozier, Gyles; Leonard, Philip; Acharya, K. Ravi; Chander, Surinder K.; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2155-2170</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hormone-dependent breast cancer may be more effectively treated by dual inhibition of aromatase and steroid sulfatase (STS).  Therefore, an aromatase inhibitory pharmacophore was introduced into a known biphenyl STS inhibitor to give a series of novel dual aromatase-sulfatase inhibitors (DASIs).  Several compds. were good aromatase or STS inhibitors and DASI I (R = H) (IC50: aromatase, 2.0 nM; STS, 35 nM) and its chlorinated congener I (R = Cl) (IC50: aromatase, 0.5 nM; STS, 5.5 nM) were examples that showed exceptional dual potency in JEG-3 cells.  At 1 mg/kg po, I (R = H, Cl) strongly reduced plasma estradiol levels and inhibited liver STS activity potently in vivo.  DASI I (R = Cl) was non-estrogenic and potently inhibited carbonic anhydrase II (hCAII) (IC50 86 nM).  A complex of I (R = Cl) and hCAII was crystd. and its structure solved by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMz59lyRAt-rVg90H21EOLACvtfcHk0ljgLuR1l_l9Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFKit70%253D&md5=3cdf0a54b96c189fd18cae4361f3338e</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fjm901705h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901705h%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%26aulast%3DJackson%26aufirst%3DT.%26aulast%3DPutey%26aufirst%3DA.%26aulast%3DCozier%26aufirst%3DG.%26aulast%3DLeonard%26aufirst%3DP.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%26atitle%3DHighly%2520Potent%2520First%2520Examples%2520of%2520Dual%2520Aromatase-Steroid%2520Sulfatase%2520Inhibitors%2520Based%2520on%2520a%2520Biphenyl%2520Template%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2155%26epage%3D2170%26doi%3D10.1021%2Fjm901705h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V.</span><span> </span><span class="NLM_article-title">Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1438</span><span class="refDoi"> DOI: 10.1002/cmdc.201100145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2Fcmdc.201100145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=21608133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptFKrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1423-1438&author=P.+M.+Woodauthor=L.+W.+Wooauthor=M.+P.+Thomasauthor=M.+F.+Mahonauthor=A.+Purohitauthor=B.+V.+Potter&title=Aromatase+and+Dual+Aromatase-Steroid+Sulfatase+Inhibitors+from+the+Letrozole+and+Vorozole+Templates&doi=10.1002%2Fcmdc.201100145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates</span></div><div class="casAuthors">Wood, Paul M.; Woo, L. W. Lawrence; Thomas, Mark P.; Mahon, Mary F.; Purohit, Atul; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1423-1438</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Concurrent inhibition of aromatase and steroid sulfatase (STS) may provide a more effective treatment for hormone-dependent breast cancer than monotherapy against individual enzymes, and several dual aromatase-sulfatase inhibitors (DASIs) have been reported.  Three aromatase inhibitors with sub-nanomolar potency, better than the benchmark agent letrozole, were designed.  To further explore the DASI concept, a new series of letrozole-derived sulfamates and a vorozole-based sulfamate were designed and biol. evaluated in JEG-3 cells to reveal structure-activity relationships.  Amongst achiral and racemic compds., 2-bromo-4-(2-(4-cyanophenyl)-2-(1H-1,2,4-triazol-1-yl)ethyl)phenyl sulfamate is the most potent DASI (aromatase: IC50=0.87 nM; STS: IC50=593 nM).  The enantiomers of the phenolic precursor to this compd. were sepd. by chiral HPLC and their abs. configuration detd. by X-ray crystallog.  Following conversion to their corresponding sulfamates, the S-(+)-enantiomer was found to inhibit aromatase and sulfatase most potently (aromatase: IC50=0.52 nM; STS: IC50=280 nM).  The docking of each enantiomer and other ligands into the aromatase and sulfatase active sites was also investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq91XsDqvKlHrVg90H21EOLACvtfcHk0ljgLuR1l_l9Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptFKrtrw%253D&md5=94dae7013fdf874ffe1540b8d31122c5</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100145%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%26atitle%3DAromatase%2520and%2520Dual%2520Aromatase-Steroid%2520Sulfatase%2520Inhibitors%2520from%2520the%2520Letrozole%2520and%2520Vorozole%2520Templates%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1423%26epage%3D1438%26doi%3D10.1002%2Fcmdc.201100145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Lu, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhoub, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flockhart, D. A.</span><span> </span><span class="NLM_article-title">The Tamoxifen Metabolite Norendoxifen Is a Potent and Selective Inhibitor of Aromatase (CYP19) and a Potential Lead Compound for Novel Therapeutic Agents</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span><span class="refDoi"> DOI: 10.1007/s10549-011-1699-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2Fs10549-011-1699-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=21814747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlOlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2012&pages=99-109&author=W.+J.+Luauthor=C.+Xuauthor=Z.+Peiauthor=A.+S.+Mayhoubauthor=M.+Cushmanauthor=D.+A.+Flockhart&title=The+Tamoxifen+Metabolite+Norendoxifen+Is+a+Potent+and+Selective+Inhibitor+of+Aromatase+%28CYP19%29+and+a+Potential+Lead+Compound+for+Novel+Therapeutic+Agents&doi=10.1007%2Fs10549-011-1699-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents</span></div><div class="casAuthors">Lu, Wenjie Jessie; Xu, Cong; Pei, Zifan; Mayhoub, Abdelrahman S.; Cushman, Mark; Flockhart, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-109</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">To improve the treatment of breast cancer, there has been a need for alternative aromatase inhibitors (AIs) that bring about adequate aromatase inhibition, while limiting side effects.  Since two tamoxifen metabolites have been documented as AIs, we tested a wide range of tamoxifen metabolites on aromatase in order to better understand structural interactions with aromatase and constructed structure-function relationships as a first step toward the development of novel inhibitors.  The ability of ten tamoxifen metabolites to inhibit recombinant aromatase (CYP19) was tested using microsomal incubations.  The selectivity of the most potent aromatase inhibitor identified, norendoxifen, was characterized by studying its ability to inhibit CYP450 enzymes important in clin. drug-drug interactions, including CYP2B6, 2C9, 2C19, 2D6, and 3A.  Computerized mol. docking with the X-ray crystallog. structure of aromatase was used to describe the detailed biochem. interactions involved.  The inhibitory potency order of the tested compds. was as follows: norendoxifen » 4,4'-dihydroxy-tamoxifen > endoxifen > N-desmethyl-tamoxifen, N-desmethyl-4'-hydroxy-tamoxifen, tamoxifen-N-oxide, 4'-hydroxy-tamoxifen, N-desmethyl-droloxifene > 4-hydroxy-tamoxifen, tamoxifen.  Norendoxifen inhibited recombinant aromatase via a competitive mechanism with a K i of 35 nM.  Norendoxifen inhibited placental aromatase with an IC50 of 90 nM, while it inhibited human liver CYP2C9 and CYP3A with IC50 values of 990 and 908 nM, resp.  Inhibition of human liver CYP2C19 by norendoxifen appeared even weaker.  No substantial inhibition of CYP2B6 and CYP2D6 by norendoxifen was obsd.  These data suggest that multiple metabolites of tamoxifen may contribute to its action in the treatment of breast cancer via aromatase inhibition.  Most of all, norendoxifen may be able to serve as a potent and selective lead compd. in the development of improved therapeutic agents.  The range of structures tested in this study and their pharmacol. potencies provide a reasonable pharmacophore upon which to build novel AIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAIonbKYUflbVg90H21EOLACvtfcHk0ljFrwPu3G62Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlOlurk%253D&md5=fecad8a08ab5cd6c6db6a3047f8a5678</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1007%2Fs10549-011-1699-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-011-1699-4%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DW.%2BJ.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DMayhoub%26aufirst%3DA.%2BS.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DFlockhart%26aufirst%3DD.%2BA.%26atitle%3DThe%2520Tamoxifen%2520Metabolite%2520Norendoxifen%2520Is%2520a%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Aromatase%2520%2528CYP19%2529%2520and%2520a%2520Potential%2520Lead%2520Compound%2520for%2520Novel%2520Therapeutic%2520Agents%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2012%26volume%3D133%26spage%3D99%26epage%3D109%26doi%3D10.1007%2Fs10549-011-1699-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Lv, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flockhart, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span> </span><span class="NLM_article-title">Synthesis of Mixed (E,Z)-, (E)-, and (Z)-Norendoxifen with Dual Aromatase Inhibitory and Estrogen Receptor Modulatory Activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4611</span><span class="NLM_x">–</span> <span class="NLM_lpage">4618</span><span class="refDoi"> DOI: 10.1021/jm400364h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400364h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslSqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4611-4618&author=W.+Lvauthor=J.+Liuauthor=D.+Luauthor=D.+A.+Flockhartauthor=M.+Cushman&title=Synthesis+of+Mixed+%28E%2CZ%29-%2C+%28E%29-%2C+and+%28Z%29-Norendoxifen+with+Dual+Aromatase+Inhibitory+and+Estrogen+Receptor+Modulatory+Activities&doi=10.1021%2Fjm400364h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Mixed (E,Z)-, (E)-, and (Z)-Norendoxifen with Dual Aromatase Inhibitory and Estrogen Receptor Modulatory Activities</span></div><div class="casAuthors">Lv, Wei; Liu, Jinzhong; Lu, Deshun; Flockhart, David A.; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4611-4618</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first synthesis of the tamoxifen metabolite norendoxifen (I) is reported.  This included syntheses of (E)-norendoxifen, (Z)-norendoxifen, and (E,Z)-norendoxifen isomers.  (Z)-Norendoxifen displayed affinity for aromatase (Ki 442 nM), estrogen receptor-α (EC50 17 nM), and estrogen receptor-β (EC50 27.5 nM), while the corresponding values for (E)-norendoxifen were aromatase (Ki 48 nM), estrogen receptor-α (EC50 58.7 nM), and estrogen receptor-β (EC50 78.5 nM).  Docking and energy minimization studies were performed with (E)-norendoxifen on aromatase, and the results provide a foundation for structure-based drug design.  The oral pharmacokinetic parameters for (E,Z)-norendoxifen were detd. in mice, and (Z)-norendoxifen was found to result in significantly higher plasma concns. and exposures (AUC values) than (E)-norendoxifen.  The affinities of both isomers for aromatase and the estrogen receptors, as well as the pharmacokinetic results, support the further development of norendoxifen and its analogs for breast cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr7zDwcQogpLVg90H21EOLACvtfcHk0ljFrwPu3G62Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslSqu7c%253D&md5=7d22eddb3a907eaa425604525ec55793</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm400364h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400364h%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DFlockhart%26aufirst%3DD.%2BA.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520Mixed%2520%2528E%252CZ%2529-%252C%2520%2528E%2529-%252C%2520and%2520%2528Z%2529-Norendoxifen%2520with%2520Dual%2520Aromatase%2520Inhibitory%2520and%2520Estrogen%2520Receptor%2520Modulatory%2520Activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4611%26epage%3D4618%26doi%3D10.1021%2Fjm400364h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Pingaew, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prachayasittikul, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantasenamat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prachayasittikul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruchirawat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prachayasittikul, V.</span><span> </span><span class="NLM_article-title">Synthesis and Molecular Docking of 1,2,3-Triazole-Based Sulfonamides as Aromatase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3472</span><span class="NLM_x">–</span> <span class="NLM_lpage">3480</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.04.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bmc.2015.04.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=3472-3480&author=R.+Pingaewauthor=V.+Prachayasittikulauthor=P.+Mandiauthor=C.+Nantasenamatauthor=S.+Prachayasittikulauthor=S.+Ruchirawatauthor=V.+Prachayasittikul&title=Synthesis+and+Molecular+Docking+of+1%2C2%2C3-Triazole-Based+Sulfonamides+as+Aromatase+Inhibitors&doi=10.1016%2Fj.bmc.2015.04.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.04.036%26sid%3Dliteratum%253Aachs%26aulast%3DPingaew%26aufirst%3DR.%26aulast%3DPrachayasittikul%26aufirst%3DV.%26aulast%3DMandi%26aufirst%3DP.%26aulast%3DNantasenamat%26aufirst%3DC.%26aulast%3DPrachayasittikul%26aufirst%3DS.%26aulast%3DRuchirawat%26aufirst%3DS.%26aulast%3DPrachayasittikul%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520Molecular%2520Docking%2520of%25201%252C2%252C3-Triazole-Based%2520Sulfonamides%2520as%2520Aromatase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D3472%26epage%3D3480%26doi%3D10.1016%2Fj.bmc.2015.04.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">McNulty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiFrancesco, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vurgun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crankshaw, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, A. C.</span><span> </span><span class="NLM_article-title">Investigation of Aryl Halides as Ketone Bioisosteres: Refinement of Potent and Selective Inhibitors of Human Cytochrome P450 19A1 (Aromatase)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6060</span><span class="NLM_x">–</span> <span class="NLM_lpage">6063</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bmcl.2013.09.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=24113062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFymsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6060-6063&author=J.+McNultyauthor=A.+J.+Nielsenauthor=C.+E.+Brownauthor=B.+R.+DiFrancescoauthor=N.+Vurgunauthor=J.+J.+Nairauthor=D.+J.+Crankshawauthor=A.+C.+Holloway&title=Investigation+of+Aryl+Halides+as+Ketone+Bioisosteres%3A+Refinement+of+Potent+and+Selective+Inhibitors+of+Human+Cytochrome+P450+19A1+%28Aromatase%29&doi=10.1016%2Fj.bmcl.2013.09.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of aryl halides as ketone bioisosteres: Refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase)</span></div><div class="casAuthors">McNulty, James; Nielsen, Alexander J.; Brown, Carla E.; DiFrancesco, Benjamin R.; Vurgun, Nesrin; Nair, Jerald J.; Crankshaw, Denis J.; Holloway, Alison C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6060-6063</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bioisosteric replacement of cyclic ketone functionality with aryl halides was studied on a centrally-flexible, five-component 1,2,3-triazole-contg. pharmacophore, resulting in enhanced inhibition of aromatase (CYP450 19A1).  Structure-activity data generated from both syn- and anti-aldol precursors provides significant insights into the requirements for enhanced potency, validating this novel ketone-to-aryl halide bioisostere hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4UUcXtu7PMrVg90H21EOLACvtfcHk0lh7URlMIvyfJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFymsrrN&md5=0ac871f3833c97130a2ff7e7386ba82a</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DMcNulty%26aufirst%3DJ.%26aulast%3DNielsen%26aufirst%3DA.%2BJ.%26aulast%3DBrown%26aufirst%3DC.%2BE.%26aulast%3DDiFrancesco%26aufirst%3DB.%2BR.%26aulast%3DVurgun%26aufirst%3DN.%26aulast%3DNair%26aufirst%3DJ.%2BJ.%26aulast%3DCrankshaw%26aufirst%3DD.%2BJ.%26aulast%3DHolloway%26aufirst%3DA.%2BC.%26atitle%3DInvestigation%2520of%2520Aryl%2520Halides%2520as%2520Ketone%2520Bioisosteres%253A%2520Refinement%2520of%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Human%2520Cytochrome%2520P450%252019A1%2520%2528Aromatase%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6060%26epage%3D6063%26doi%3D10.1016%2Fj.bmcl.2013.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. P.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Aromatase Inhibitory Activities of Novel Indole-Imidazole Derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1760</span><span class="NLM_x">–</span> <span class="NLM_lpage">1762</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.01.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bmcl.2013.01.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1760-1762&author=R.+Wangauthor=H.+F.+Shiauthor=J.+F.+Zhaoauthor=Y.+P.+Heauthor=H.+B.+Zhangauthor=J.+P.+Liu&title=Design%2C+Synthesis+and+Aromatase+Inhibitory+Activities+of+Novel+Indole-Imidazole+Derivatives&doi=10.1016%2Fj.bmcl.2013.01.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.01.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.01.045%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DH.%2BF.%26aulast%3DZhao%26aufirst%3DJ.%2BF.%26aulast%3DHe%26aufirst%3DY.%2BP.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DLiu%26aufirst%3DJ.%2BP.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Aromatase%2520Inhibitory%2520Activities%2520of%2520Novel%2520Indole-Imidazole%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1760%26epage%3D1762%26doi%3D10.1016%2Fj.bmcl.2013.01.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Maiti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturdy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegan, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesecar, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pezzuto, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span> </span><span class="NLM_article-title">Synthesis of Casimiroin and Optimization of Its Quinone Reductase 2 and Aromatase Inhibitory Activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1873</span><span class="NLM_x">–</span> <span class="NLM_lpage">1884</span><span class="refDoi"> DOI: 10.1021/jm801335z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801335z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisl2kur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1873-1884&author=A.+Maitiauthor=P.+V.+Reddyauthor=M.+Sturdyauthor=L.+Marlerauthor=S.+D.+Peganauthor=A.+D.+Mesecarauthor=J.+M.+Pezzutoauthor=M.+Cushman&title=Synthesis+of+Casimiroin+and+Optimization+of+Its+Quinone+Reductase+2+and+Aromatase+Inhibitory+Activities&doi=10.1021%2Fjm801335z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Casimiroin and Optimization of Its Quinone Reductase 2 and Aromatase Inhibitory Activities</span></div><div class="casAuthors">Maiti, Arup; Reddy, P. V. Narasimha; Sturdy, Megan; Marler, Laura; Pegan, Scott D.; Mesecar, Andrew D.; Pezzuto, John M.; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1873-1884</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient method has been developed to synthesize casimiroin (I), a component of the edible fruit of Casimiroa edulis, on a multigram scale in good overall yield.  The route was versatile enough to provide an array of I's analogs that were evaluated as QR2 and aromatase inhibitors.  In addn., X-ray crystallog. studies of QR2 in complex with I and one of its more potent analog II has provided insight into the mechanism of action of this new series of QR2 inhibitors.  The initial biol. investigations suggest that I and its analogs merit further investigation as potential chemopreventive or chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxfer9QooPoLVg90H21EOLACvtfcHk0lh7URlMIvyfJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisl2kur8%253D&md5=e1fdf097ef37bff1b3d167f9d834c427</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fjm801335z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801335z%26sid%3Dliteratum%253Aachs%26aulast%3DMaiti%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DP.%2BV.%26aulast%3DSturdy%26aufirst%3DM.%26aulast%3DMarler%26aufirst%3DL.%26aulast%3DPegan%26aufirst%3DS.%2BD.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520Casimiroin%2520and%2520Optimization%2520of%2520Its%2520Quinone%2520Reductase%25202%2520and%2520Aromatase%2520Inhibitory%2520Activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1873%26epage%3D1884%26doi%3D10.1021%2Fjm801335z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span> </span><span class="NLM_article-title">Novel Highly Potent and Selective Nonsteroidal Aromatase Inhibitors: Synthesis, Biological Evaluation and Structure-Activity Relationships Investigation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5347</span><span class="NLM_x">–</span> <span class="NLM_lpage">5351</span><span class="refDoi"> DOI: 10.1021/jm100319h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100319h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVKqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5347-5351&author=S.+Gobbiauthor=C.+Zimmerauthor=F.+Bellutiauthor=A.+Rampaauthor=R.+W.+Hartmannauthor=M.+Recanatiniauthor=A.+Bisi&title=Novel+Highly+Potent+and+Selective+Nonsteroidal+Aromatase+Inhibitors%3A+Synthesis%2C+Biological+Evaluation+and+Structure-Activity+Relationships+Investigation&doi=10.1021%2Fjm100319h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Highly Potent and Selective Nonsteroidal Aromatase Inhibitors: Synthesis, Biological Evaluation and Structure-Activity Relationships Investigation</span></div><div class="casAuthors">Gobbi, Silvia; Zimmer, Christina; Belluti, Federica; Rampa, Angela; Hartmann, Rolf W.; Recanatini, Maurizio; Bisi, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5347-5351</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of mols. were designed and synthesized, in search for potent and selective aromatase inhibitors.  The substitution of the heterocyclic oxygen atom in the xanthone core by a sulfur atom and/or increase in structure flexibility seemed to be favorable for the interaction with the enzyme.  Among the new compds., I and II (IC50 3.98 and 5.59 nM, resp.) resulted the most potent aromatase inhibitors synthesized in this project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxvriNb7PmOrVg90H21EOLACvtfcHk0lh7URlMIvyfJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVKqsbs%253D&md5=9634dbf062b35d9b9a12667c5a70cf99</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm100319h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100319h%26sid%3Dliteratum%253Aachs%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DBisi%26aufirst%3DA.%26atitle%3DNovel%2520Highly%2520Potent%2520and%2520Selective%2520Nonsteroidal%2520Aromatase%2520Inhibitors%253A%2520Synthesis%252C%2520Biological%2520Evaluation%2520and%2520Structure-Activity%2520Relationships%2520Investigation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5347%26epage%3D5351%26doi%3D10.1021%2Fjm100319h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Caporuscio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbriano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Rio, A.</span><span> </span><span class="NLM_article-title">Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4006</span><span class="NLM_x">–</span> <span class="NLM_lpage">4017</span><span class="refDoi"> DOI: 10.1021/jm2000689</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2000689" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4006-4017&author=F.+Caporuscioauthor=G.+Rastelliauthor=C.+Imbrianoauthor=A.+Del+Rio&title=Structure-Based+Design+of+Potent+Aromatase+Inhibitors+by+High-Throughput+Docking&doi=10.1021%2Fjm2000689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking</span></div><div class="casAuthors">Caporuscio, Fabiana; Rastelli, Giulio; Imbriano, Carol; Del Rio, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4006-4017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytochrome P 450 aromatase catalyzes the conversion of androgen substrates into estrogens.  Aromatase inhibitors (AIs) have been used as first-line drugs in the treatment of estrogen-dependent breast cancer in postmenopausal women.  However, the search for new, more potent, and selective AIs still remains necessary to avoid the risk of possible resistances and reduce toxicity and side effects of current available drugs.  The publication of a high resoln. x-ray structure of human aromatase has opened the way to structure-based virtual screening to identify new small-mol. inhibitors with structural motifs different from all known AIs.  In this context, a high-throughput docking protocol was set up and led to the identification of nanomolar AIs with new core structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBteVWbhM8PLVg90H21EOLACvtfcHk0lhvaj0fUGqo2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFylsL8%253D&md5=93b8b8a30807469412b6a88db79b4a4c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm2000689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2000689%26sid%3Dliteratum%253Aachs%26aulast%3DCaporuscio%26aufirst%3DF.%26aulast%3DRastelli%26aufirst%3DG.%26aulast%3DImbriano%26aufirst%3DC.%26aulast%3DDel%2BRio%26aufirst%3DA.%26atitle%3DStructure-Based%2520Design%2520of%2520Potent%2520Aromatase%2520Inhibitors%2520by%2520High-Throughput%2520Docking%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4006%26epage%3D4017%26doi%3D10.1021%2Fjm2000689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Neves, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinis, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sa e Melo, M. L.</span><span> </span><span class="NLM_article-title">An Efficient Steroid Pharmacophore-Based Strategy to Identify New Aromatase Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4121</span><span class="NLM_x">–</span> <span class="NLM_lpage">4127</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2009.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.ejmech.2009.05.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=4121-4127&author=M.+A.+Nevesauthor=T.+C.+Dinisauthor=G.+Colomboauthor=M.+L.+Sa+e+Melo&title=An+Efficient+Steroid+Pharmacophore-Based+Strategy+to+Identify+New+Aromatase+Inhibitors&doi=10.1016%2Fj.ejmech.2009.05.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DNeves%26aufirst%3DM.%2BA.%26aulast%3DDinis%26aufirst%3DT.%2BC.%26aulast%3DColombo%26aufirst%3DG.%26aulast%3DSa%2Be%2BMelo%26aufirst%3DM.%2BL.%26atitle%3DAn%2520Efficient%2520Steroid%2520Pharmacophore-Based%2520Strategy%2520to%2520Identify%2520New%2520Aromatase%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D4121%26epage%3D4127%26doi%3D10.1016%2Fj.ejmech.2009.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Nikolic, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petri, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klisuric, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celic, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakimov, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djurendic, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penov Gasi, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakac, M. N.</span><span> </span><span class="NLM_article-title">Synthesis and Anticancer Cell Potential of Steroidal 16,17-Seco-16,17a-Dinitriles: Identification of a Selective Inhibitor of Hormone-Independent Breast Cancer Cells</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.12.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bmc.2014.12.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=703-711&author=A.+R.+Nikolicauthor=E.+T.+Petriauthor=O.+R.+Klisuricauthor=A.+S.+Celicauthor=D.+S.+Jakimovauthor=E.+A.+Djurendicauthor=K.+M.+Penov+Gasiauthor=M.+N.+Sakac&title=Synthesis+and+Anticancer+Cell+Potential+of+Steroidal+16%2C17-Seco-16%2C17a-Dinitriles%3A+Identification+of+a+Selective+Inhibitor+of+Hormone-Independent+Breast+Cancer+Cells&doi=10.1016%2Fj.bmc.2014.12.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.12.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.12.069%26sid%3Dliteratum%253Aachs%26aulast%3DNikolic%26aufirst%3DA.%2BR.%26aulast%3DPetri%26aufirst%3DE.%2BT.%26aulast%3DKlisuric%26aufirst%3DO.%2BR.%26aulast%3DCelic%26aufirst%3DA.%2BS.%26aulast%3DJakimov%26aufirst%3DD.%2BS.%26aulast%3DDjurendic%26aufirst%3DE.%2BA.%26aulast%3DPenov%2BGasi%26aufirst%3DK.%2BM.%26aulast%3DSakac%26aufirst%3DM.%2BN.%26atitle%3DSynthesis%2520and%2520Anticancer%2520Cell%2520Potential%2520of%2520Steroidal%252016%252C17-Seco-16%252C17a-Dinitriles%253A%2520Identification%2520of%2520a%2520Selective%2520Inhibitor%2520of%2520Hormone-Independent%2520Breast%2520Cancer%2520Cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D703%26epage%3D711%26doi%3D10.1016%2Fj.bmc.2014.12.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Vosooghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firoozpour, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pordeli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safavi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardestani, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dadgar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asadipour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moshafi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foroumadi, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis, Docking Study and Cytotoxic Activity Evaluation of Some Novel Letrozole Analogs</span> <span class="citation_source-journal">Daru, J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="refDoi"> DOI: 10.1186/s40199-014-0083-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1186%2Fs40199-014-0083-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=83&author=M.+Vosooghiauthor=L.+Firoozpourauthor=A.+Rodakiauthor=M.+Pordeliauthor=M.+Safaviauthor=S.+K.+Ardestaniauthor=A.+Dadgarauthor=A.+Asadipourauthor=M.+H.+Moshafiauthor=A.+Foroumadi&title=Design%2C+Synthesis%2C+Docking+Study+and+Cytotoxic+Activity+Evaluation+of+Some+Novel+Letrozole+Analogs&doi=10.1186%2Fs40199-014-0083-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1186%2Fs40199-014-0083-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40199-014-0083-4%26sid%3Dliteratum%253Aachs%26aulast%3DVosooghi%26aufirst%3DM.%26aulast%3DFiroozpour%26aufirst%3DL.%26aulast%3DRodaki%26aufirst%3DA.%26aulast%3DPordeli%26aufirst%3DM.%26aulast%3DSafavi%26aufirst%3DM.%26aulast%3DArdestani%26aufirst%3DS.%2BK.%26aulast%3DDadgar%26aufirst%3DA.%26aulast%3DAsadipour%26aufirst%3DA.%26aulast%3DMoshafi%26aufirst%3DM.%2BH.%26aulast%3DForoumadi%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%252C%2520Docking%2520Study%2520and%2520Cytotoxic%2520Activity%2520Evaluation%2520of%2520Some%2520Novel%2520Letrozole%2520Analogs%26jtitle%3DDaru%252C%2520J.%2520Pharm.%2520Sci.%26date%3D2014%26volume%3D22%26spage%3D83%26doi%3D10.1186%2Fs40199-014-0083-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Vasavi, H. S.; Arun, A. B.; Rekha, P. D.</span><span> </span><span class="NLM_article-title">Anti-Quorum Sensing Activity of Flavonoid-Rich Fraction from Centella Asiatica L. Against <i>Pseudomonas aeruginosa</i> PAO1</span>.  <span class="citation_source-journal">J. Microbiol., Immunol. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="refDoi"> DOI: 10.1016/j.jmii.2014.03.012</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.jmii.2014.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=24856426" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=H.+S.+Vasavi&author=A.+B.+Arun&author=P.+D.+Rekha&title=Anti-Quorum+Sensing+Activity+of+Flavonoid-Rich+Fraction+from+Centella+Asiatica+L.+Against+Pseudomonas+aeruginosa+PAO1&doi=10.1016%2Fj.jmii.2014.03.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.jmii.2014.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmii.2014.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DVasavi%26aufirst%3DH.%2BS.%26atitle%3DAnti-Quorum%2520Sensing%2520Activity%2520of%2520Flavonoid-Rich%2520Fraction%2520from%2520Centella%2520Asiatica%2520L.%2520Against%2520Pseudomonas%2520aeruginosa%2520PAO1%26jtitle%3DJ.%2520Microbiol.%252C%2520Immunol.%2520Infect.%26date%3D2014%26doi%3D10.1016%2Fj.jmii.2014.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Mirzaie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chupani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asadabadi, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahverdi, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamalan, M.</span><span> </span><span class="NLM_article-title">Novel Inhibitor Discovery against Aromatase through Virtual Screening and Molecular Dynamic Simulation: A Computational Approach in Drug Design</span> <span class="citation_source-journal">Exp. Clin. Sci. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=168-183&author=S.+Mirzaieauthor=L.+Chupaniauthor=E.+B.+Asadabadiauthor=A.+R.+Shahverdiauthor=M.+Jamalan&title=Novel+Inhibitor+Discovery+against+Aromatase+through+Virtual+Screening+and+Molecular+Dynamic+Simulation%3A+A+Computational+Approach+in+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMirzaie%26aufirst%3DS.%26aulast%3DChupani%26aufirst%3DL.%26aulast%3DAsadabadi%26aufirst%3DE.%2BB.%26aulast%3DShahverdi%26aufirst%3DA.%2BR.%26aulast%3DJamalan%26aufirst%3DM.%26atitle%3DNovel%2520Inhibitor%2520Discovery%2520against%2520Aromatase%2520through%2520Virtual%2520Screening%2520and%2520Molecular%2520Dynamic%2520Simulation%253A%2520A%2520Computational%2520Approach%2520in%2520Drug%2520Design%26jtitle%3DExp.%2520Clin.%2520Sci.%2520J.%26date%3D2013%26volume%3D12%26spage%3D168%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Narayana, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pran Kishore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakumar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravikumar, M.</span><span> </span><span class="NLM_article-title">Molecular Modeling Evaluation of Non-Steroidal Aromatase Inhibitors†</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span><span class="refDoi"> DOI: 10.1111/j.1747-0285.2011.01277.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1111%2Fj.1747-0285.2011.01277.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22129073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlslagu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=674-682&author=B.+L.+Narayanaauthor=D.+Pran+Kishoreauthor=C.+Balakumarauthor=K.+V.+Raoauthor=R.+Kaurauthor=A.+R.+Raoauthor=J.+N.+Murthyauthor=M.+Ravikumar&title=Molecular+Modeling+Evaluation+of+Non-Steroidal+Aromatase+Inhibitors%E2%80%A0&doi=10.1111%2Fj.1747-0285.2011.01277.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular modeling evaluation of non-steroidal aromatase inhibitors</span></div><div class="casAuthors">Narayana, Bheemanapalli Lakshmi; Kishore, Deb Pran; Balakumar, Chadrasekaran; Rao, Kaki Venkata; Kaur, Rajwinder; Rao, Akkinepally Raghuram; Murthy, Javali Narashima; Ravikumar, Muttineni</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">674-682</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A recent discovery of aromatase crystal structure triggered the efforts to design novel aromatase inhibitors for breast cancer therapy.  While correlating docking scores with inhibitory potencies of known ligands, feeble robustness of scoring functions toward prediction was obsd.  This prompted us to develop new prediction models using stepwise regression anal. based on consensus of different docking and their scoring methods (GOLD, LIGANDFIT, and GLIDE).  Quant. structure-activity relationships were developed between the aromatase inhibitory activity (pIC50) of flavonoid derivs. (n = 39) and docking scores and docking descriptors.  QSAR models have been validated internally [using leave-one-out cross-validated r2cv (LOO - Q2)] and externally to ensure the predictive capacity of the models.  Model 2 [M2] developed using consensus of docking scores of scoring functions viz. ASP, potential of mean force and DOCK Score (r2cv = 0.850, r2 = 0.870, r2pred = 0.633, RMSE = 0.363 μM, r2m(test) = 0.831, r2m(overall) = 0.832) was found to be better in predicting aromatase inhibitory potency (pIC50) compared to the Model 1 [M1] based on docking descriptors (r2cv = 0.848, r2 = 0.825, r2pred = 0.788, RMSE = 0.421 μM, r2m(test) = 0.808, r2m(overall) = 0.821).  It has been obsd. that the natural flavonoids and their derivs. were less potent compared to these scaffolds with imidazolylmethyl substitution owing to the interaction of nitrogen atom of the imidazole ring toward the heme (Fe3+) of the aromatase.  Results confirm the potential of our methodol. for the design of new potent non-steroidal aromatase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqppgP8j9PyrVg90H21EOLACvtfcHk0lgZV_Lv_4kSsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlslagu7k%253D&md5=3a1a7b7ca35c161f53366cecb2cffe88</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01277.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01277.x%26sid%3Dliteratum%253Aachs%26aulast%3DNarayana%26aufirst%3DB.%2BL.%26aulast%3DPran%2BKishore%26aufirst%3DD.%26aulast%3DBalakumar%26aufirst%3DC.%26aulast%3DRao%26aufirst%3DK.%2BV.%26aulast%3DKaur%26aufirst%3DR.%26aulast%3DRao%26aufirst%3DA.%2BR.%26aulast%3DMurthy%26aufirst%3DJ.%2BN.%26aulast%3DRavikumar%26aufirst%3DM.%26atitle%3DMolecular%2520Modeling%2520Evaluation%2520of%2520Non-Steroidal%2520Aromatase%2520Inhibitors%25E2%2580%25A0%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D79%26spage%3D674%26epage%3D682%26doi%3D10.1111%2Fj.1747-0285.2011.01277.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Nagar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saha, A.</span><span> </span><span class="NLM_article-title">Pharmacophore Searching of Benzofuran Derivatives for Selective CYP19 Aromatase Inhibition</span> <span class="citation_source-journal">Lett. Drug Des. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.2174/157018009787158607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.2174%2F157018009787158607" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=38-45&author=S.+Nagarauthor=M.+A.+Islamauthor=S.+Dasauthor=A.+Mukherjeeauthor=A.+Saha&title=Pharmacophore+Searching+of+Benzofuran+Derivatives+for+Selective+CYP19+Aromatase+Inhibition&doi=10.2174%2F157018009787158607"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.2174%2F157018009787158607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157018009787158607%26sid%3Dliteratum%253Aachs%26aulast%3DNagar%26aufirst%3DS.%26aulast%3DIslam%26aufirst%3DM.%2BA.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DMukherjee%26aufirst%3DA.%26aulast%3DSaha%26aufirst%3DA.%26atitle%3DPharmacophore%2520Searching%2520of%2520Benzofuran%2520Derivatives%2520for%2520Selective%2520CYP19%2520Aromatase%2520Inhibition%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2009%26volume%3D6%26spage%3D38%26epage%3D45%26doi%3D10.2174%2F157018009787158607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span> </span><span class="NLM_article-title">Molecular Docking and Qsar Study on Steroidal Compounds as Aromatase Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5612</span><span class="NLM_x">–</span> <span class="NLM_lpage">5620</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2010.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.ejmech.2010.09.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=5612-5620&author=Y.+Daiauthor=Q.+Wangauthor=X.+Zhangauthor=S.+Jiaauthor=H.+Zhengauthor=D.+Fengauthor=P.+Yu&title=Molecular+Docking+and+Qsar+Study+on+Steroidal+Compounds+as+Aromatase+Inhibitors&doi=10.1016%2Fj.ejmech.2010.09.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DP.%26atitle%3DMolecular%2520Docking%2520and%2520Qsar%2520Study%2520on%2520Steroidal%2520Compounds%2520as%2520Aromatase%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D5612%26epage%3D5620%26doi%3D10.1016%2Fj.ejmech.2010.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Roy, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, K.</span><span> </span><span class="NLM_article-title">Molecular Docking and QSAR Studies of Aromatase Inhibitor Androstenedione Derivatives</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1728</span><span class="refDoi"> DOI: 10.1111/j.2042-7158.2010.01154.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1111%2Fj.2042-7158.2010.01154.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=21054398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWiu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1717-1728&author=P.+P.+Royauthor=K.+Roy&title=Molecular+Docking+and+QSAR+Studies+of+Aromatase+Inhibitor+Androstenedione+Derivatives&doi=10.1111%2Fj.2042-7158.2010.01154.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives</span></div><div class="casAuthors">Roy, Partha Pratim; Roy, Kunal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1717-1728</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objectives Aromatase (CYP19) inhibitors have emerged as promising candidates for the treatment of estrogen-dependent breast cancer.  In this study, a series of androstenedione derivs. with CYP19 inhibitory activity was subjected to a mol. docking study followed by quant. structure-activity relationship (QSAR) analyses in search of ideal physicochem. characteristics of potential aromatase inhibitors.  Methods The QSAR studies were carried out using both two-dimensional (topol., and structural) and three-dimensional (spatial) descriptors.  We also used thermodn. parameters along with 2D and 3D descriptors.  Genetic function approxn. (GFA) and genetic partial least squares (G/PLS) were used as chemometric tools for QSAR modeling.  Key findings The docking study indicated that the important interacting amino acids in the active site were Met374, Arg115, Ile133, Ala306, Thr310, Asp309, Val370, Leu477 and Ser478.  The 17-keto oxygen of the ligands is responsible for the formation of a hydrogen bond with Met374 and the remaining parts of the mols. are stabilized by the hydrophobic interactions with the non-polar amino acids.  The C2 and C19 positions in the ligands are important for maintaining the appropriate orientation of the mols. in the active site.  The results of docking expts. and QSAR studies supported each other.  Conclusions The developed QSAR models indicated the importance of some Jurs parameters, structural parameters, topol. branching index and E-state indexes of different fragments.  All the developed QSAR models were statistically significant according to the internal and external validation parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP48gY8X1myrVg90H21EOLACvtfcHk0liWHnz7SV6Jgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWiu7nN&md5=3d7136a14496d5b165e7eea8e2034be0</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.2010.01154.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.2010.01154.x%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DP.%2BP.%26aulast%3DRoy%26aufirst%3DK.%26atitle%3DMolecular%2520Docking%2520and%2520QSAR%2520Studies%2520of%2520Aromatase%2520Inhibitor%2520Androstenedione%2520Derivatives%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2010%26volume%3D62%26spage%3D1717%26epage%3D1728%26doi%3D10.1111%2Fj.2042-7158.2010.01154.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Muftuoglu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustata, G.</span><span> </span><span class="NLM_article-title">Pharmacophore Modeling Strategies for the Development of Novel Nonsteroidal Inhibitors of Human Aromatase (CYP19)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3050</span><span class="NLM_x">–</span> <span class="NLM_lpage">3064</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bmcl.2010.03.113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3050-3064&author=Y.+Muftuogluauthor=G.+Mustata&title=Pharmacophore+Modeling+Strategies+for+the+Development+of+Novel+Nonsteroidal+Inhibitors+of+Human+Aromatase+%28CYP19%29&doi=10.1016%2Fj.bmcl.2010.03.113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.113%26sid%3Dliteratum%253Aachs%26aulast%3DMuftuoglu%26aufirst%3DY.%26aulast%3DMustata%26aufirst%3DG.%26atitle%3DPharmacophore%2520Modeling%2520Strategies%2520for%2520the%2520Development%2520of%2520Novel%2520Nonsteroidal%2520Inhibitors%2520of%2520Human%2520Aromatase%2520%2528CYP19%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3050%26epage%3D3064%26doi%3D10.1016%2Fj.bmcl.2010.03.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Prakash, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathi, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tandon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pant, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, F.</span><span> </span><span class="NLM_article-title">In Silico Assay Development for Screening of Tetracyclic Triterpenoids as Anticancer Agents against Human Breast Cancer Cell Line MCF7</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e111049</span><span class="refDoi"> DOI: 10.1371/journal.pone.0111049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1371%2Fjournal.pone.0111049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e111049&author=O.+Prakashauthor=A.+Ahmadauthor=V.+K.+Tripathiauthor=S.+Tandonauthor=A.+B.+Pantauthor=F.+Khan&title=In+Silico+Assay+Development+for+Screening+of+Tetracyclic+Triterpenoids+as+Anticancer+Agents+against+Human+Breast+Cancer+Cell+Line+MCF7&doi=10.1371%2Fjournal.pone.0111049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0111049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0111049%26sid%3Dliteratum%253Aachs%26aulast%3DPrakash%26aufirst%3DO.%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DTripathi%26aufirst%3DV.%2BK.%26aulast%3DTandon%26aufirst%3DS.%26aulast%3DPant%26aufirst%3DA.%2BB.%26aulast%3DKhan%26aufirst%3DF.%26atitle%3DIn%2520Silico%2520Assay%2520Development%2520for%2520Screening%2520of%2520Tetracyclic%2520Triterpenoids%2520as%2520Anticancer%2520Agents%2520against%2520Human%2520Breast%2520Cancer%2520Cell%2520Line%2520MCF7%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De111049%26doi%3D10.1371%2Fjournal.pone.0111049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Petkov, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temelkov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeneuve, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ankley, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mekenyan, O. G.</span><span> </span><span class="NLM_article-title">Mechanism-Based Categorization of Aromatase Inhibitors: A Potential Discovery and Screening Tool</span> <span class="citation_source-journal">SAR QSAR Environ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span><span class="refDoi"> DOI: 10.1080/10629360903438347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1080%2F10629360903438347" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=657-678&author=P.+I.+Petkovauthor=S.+Temelkovauthor=D.+L.+Villeneuveauthor=G.+T.+Ankleyauthor=O.+G.+Mekenyan&title=Mechanism-Based+Categorization+of+Aromatase+Inhibitors%3A+A+Potential+Discovery+and+Screening+Tool&doi=10.1080%2F10629360903438347"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1080%2F10629360903438347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10629360903438347%26sid%3Dliteratum%253Aachs%26aulast%3DPetkov%26aufirst%3DP.%2BI.%26aulast%3DTemelkov%26aufirst%3DS.%26aulast%3DVilleneuve%26aufirst%3DD.%2BL.%26aulast%3DAnkley%26aufirst%3DG.%2BT.%26aulast%3DMekenyan%26aufirst%3DO.%2BG.%26atitle%3DMechanism-Based%2520Categorization%2520of%2520Aromatase%2520Inhibitors%253A%2520A%2520Potential%2520Discovery%2520and%2520Screening%2520Tool%26jtitle%3DSAR%2520QSAR%2520Environ.%2520Res.%26date%3D2009%26volume%3D20%26spage%3D657%26epage%3D678%26doi%3D10.1080%2F10629360903438347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Hernandez-Guzman, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangborn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Structure of Human Estrone Sulfatase Suggests Functional Roles of Membrane Association</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">22989</span><span class="NLM_x">–</span> <span class="NLM_lpage">22997</span><span class="refDoi"> DOI: 10.1074/jbc.M211497200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1074%2Fjbc.M211497200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=12657638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksF2iu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=22989-22997&author=F.+G.+Hernandez-Guzmanauthor=T.+Higashiyamaauthor=W.+Pangbornauthor=Y.+Osawaauthor=D.+Ghosh&title=Structure+of+Human+Estrone+Sulfatase+Suggests+Functional+Roles+of+Membrane+Association&doi=10.1074%2Fjbc.M211497200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Human Estrone Sulfatase Suggests Functional Roles of Membrane Association</span></div><div class="casAuthors">Hernandez-Guzman, Francisco G.; Higashiyama, Tadayoshi; Pangborn, Walter; Osawa, Yoshio; Ghosh, Debashis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">22989-22997</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Estrone sulfatase (ES; 562 amino acids), one of the key enzymes responsible for maintaining high levels of estrogens in breast tumor cells, is assocd. with the membrane of the endoplasmic reticulum (ER).  The structure of ES, purified from the microsomal fraction of human placentas, has been detd. at 2.60-Å resoln. by x-ray crystallog.  This structure shows a domain consisting of two antiparallel α-helixes that protrude from the roughly spherical mol., thereby giving the mol. a "mushroom-like" shape.  These highly hydrophobic helixes, each about 40 Å long, are capable of traversing the membrane, thus presumably anchoring the functional domain on the membrane surface facing the ER lumen.  The location of the transmembrane domain is such that the opening to the active site, buried deep in a cavity of the "gill" of the "mushroom," rests near the membrane surface, thereby suggesting a role of the lipid bilayer in catalysis.  This simple architecture could be a prototype utilized by the ER membrane in dictating the form and the function of ER-resident enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVqhs1xfxlQLVg90H21EOLACvtfcHk0liWHnz7SV6Jgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksF2iu7s%253D&md5=b4b56bf8e881dce78adc36bdf0f15e40</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M211497200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M211497200%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Guzman%26aufirst%3DF.%2BG.%26aulast%3DHigashiyama%26aufirst%3DT.%26aulast%3DPangborn%26aufirst%3DW.%26aulast%3DOsawa%26aufirst%3DY.%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DStructure%2520of%2520Human%2520Estrone%2520Sulfatase%2520Suggests%2520Functional%2520Roles%2520of%2520Membrane%2520Association%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D22989%26epage%3D22997%26doi%3D10.1074%2Fjbc.M211497200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Cojocaru, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, R. C.</span><span> </span><span class="NLM_article-title">The Ins and Outs of Cytochrome P450s</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gen. Subj.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1770</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1016/j.bbagen.2006.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.bbagen.2006.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=16920266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVyqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1770&publication_year=2007&pages=390-401&author=V.+Cojocaruauthor=P.+J.+Winnauthor=R.+C.+Wade&title=The+Ins+and+Outs+of+Cytochrome+P450s&doi=10.1016%2Fj.bbagen.2006.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">The ins and outs of cytochrome P 450s</span></div><div class="casAuthors">Cojocaru, Vlad; Winn, Peter J.; Wade, Rebecca C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1770</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">390-401</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The active site of cytochromes P 450 (P 450) is situated deep inside the protein next to the heme cofactor.  Consequently, enzyme specificity and kinetics can be influenced by how substrates pass through the protein to access the active site and how products egress from the active site.  The authors previously analyzed the channels between the active site and the protein surface in P 450 crystal structures available in Oct. 2003.  Since then, 52 new P 450 structures have been made available, including entries for 10 isoforms for which structures were not previously available.  Here, the authors present an updated survey covering all P 450 crystal structures available to March 2006.  This survey shows channels not obsd. earlier in crystal structures, some of which were identified in previous mol. dynamics simulations.  The crystal structures demonstrate how some of the channels can merge when the protein structure opens up resulting in a wide cleft to the active site, caused largely by movements of the F-G helix-loop-helix and the B-C loop.  Significant differences have been obsd. between the channels in the crystal structures of the mammalian and bacterial enzymes.  The multiplicity of channels suggests possibilities for substrate channeling to and from the P 450s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUuZo_Tu7XoLVg90H21EOLACvtfcHk0lghgtUDB6U-0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVyqug%253D%253D&md5=f332dc3f0c5c64ed946d0038236bf9d2</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2006.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2006.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DCojocaru%26aufirst%3DV.%26aulast%3DWinn%26aufirst%3DP.%2BJ.%26aulast%3DWade%26aufirst%3DR.%2BC.%26atitle%3DThe%2520Ins%2520and%2520Outs%2520of%2520Cytochrome%2520P450s%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2007%26volume%3D1770%26spage%3D390%26epage%3D401%26doi%3D10.1016%2Fj.bbagen.2006.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czapla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaro, R. E.</span><span> </span><span class="NLM_article-title">Molecular Simulations of Aromatase Reveal New Insights into the Mechanism of Ligand Binding</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2047</span><span class="NLM_x">–</span> <span class="NLM_lpage">2056</span><span class="refDoi"> DOI: 10.1021/ci400225w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci400225w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSqu7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=2047-2056&author=J.+Parkauthor=L.+Czaplaauthor=R.+E.+Amaro&title=Molecular+Simulations+of+Aromatase+Reveal+New+Insights+into+the+Mechanism+of+Ligand+Binding&doi=10.1021%2Fci400225w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular simulations of aromatase reveal new insights into the mechanism of ligand binding</span></div><div class="casAuthors">Park, Jiho; Czapla, Luke; Amaro, Rommie E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2047-2056</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CYP19A1, also known as aromatase or estrogen synthetase, is the rate-limiting enzyme in the biosynthesis of estrogens from their corresponding androgens.  Several clin. used breast cancer therapies target aromatase.  In this work, explicitly solvated all-atom mol. dynamics simulations of aromatase with a model of the lipid bilayer and the transmembrane helix are performed.  The dynamics of aromatase and the role of titrn. of an important amino acid residue involved in aromatization of androgens are investigated via two 250-ns long simulations.  One simulation treats the protonated form of the catalytic aspartate 309, which appears more consistent with crystallog. data for the active site, while the simulation of the deprotonated form shows some notable conformational shifts.  Ensemble-based computational solvent mapping expts. indicate possible novel druggable binding sites that could be utilized by next-generation inhibitors.  In addn., the effects of protonation on the ligand positioning and channel dynamics are investigated using geometrical models that est. the opening width of crit. channels.  Significant differences in channel dynamics between the protonated and deprotonated trajectories are exhibited, suggesting that the mechanism for substrate and product entry and the aromatization process may be coupled to a "locking" mechanism and channel opening.  Our results may be particularly relevant in the design of novel drugs, which may be useful therapeutic treatments of cancers such as those of the breast and prostate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotOp1E_sWz8rVg90H21EOLACvtfcHk0lghgtUDB6U-0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSqu7jN&md5=25427256e83e684c65af9c1ec433134e</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fci400225w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400225w%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DCzapla%26aufirst%3DL.%26aulast%3DAmaro%26aufirst%3DR.%2BE.%26atitle%3DMolecular%2520Simulations%2520of%2520Aromatase%2520Reveal%2520New%2520Insights%2520into%2520the%2520Mechanism%2520of%2520Ligand%2520Binding%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D2047%26epage%3D2056%26doi%3D10.1021%2Fci400225w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Sgrignani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magistrato, A.</span><span> </span><span class="NLM_article-title">Influence of the Membrane Lipophilic Environment on the Structure and on the Substrate Access/Egress Routes of the Human Aromatase Enzyme. A Computational Study</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1606</span><span class="refDoi"> DOI: 10.1021/ci300151h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci300151h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38XntlOnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1595-1606&author=J.+Sgrignaniauthor=A.+Magistrato&title=Influence+of+the+Membrane+Lipophilic+Environment+on+the+Structure+and+on+the+Substrate+Access%2FEgress+Routes+of+the+Human+Aromatase+Enzyme.+A+Computational+Study&doi=10.1021%2Fci300151h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of the Membrane Lipophilic Environment on the Structure and on the Substrate Access/Egress Routes of the Human Aromatase Enzyme. A Computational Study</span></div><div class="casAuthors">Sgrignani, Jacopo; Magistrato, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1595-1606</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human aromatase (HA), an enzyme located on the membrane of the endoplasmic reticulum (ER), is of crucial biol. importance in the biosynthesis of estrogens.  High levels of estrogens are related to important pathologies, conferring to HA a key role as a pharmacol. target.  In this study we provide, for the first time, an atomistic model of HA embedded on a membrane model to understand the influence of the membrane lipophilic environment on the structural and dynamical properties of HA and on the access/egress pathways of the substrate (androstenedione, ASD) and of the oxygen mol. (involved in the enzymic process) into/from the HA active site.  Toward this end we used several computational techniques such as force field-based mol. dynamics (MD) simulations, Random Expulsion MD, Steered MD, and Implicit Ligand Sampling.  Our results show that the membrane anchoring does not markedly affect the structural properties and the flexibility of the protein, but they clearly point out that the membrane has a marked effect on the access/egress routes of the reactants, stabilizing the formation of different channels for both ASD and O2 with respect to those obsd. in pure water soln.  Due to the importance of HA in medicine and since access/egress channels may influence its substrate selectivity, a detailed understanding of the role of the membrane in shaping these channels may be of valuable help in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKSTbSVma457Vg90H21EOLACvtfcHk0lghgtUDB6U-0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntlOnsL8%253D&md5=b2a1a6ac64e619615ac6b8832c212a98</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fci300151h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300151h%26sid%3Dliteratum%253Aachs%26aulast%3DSgrignani%26aufirst%3DJ.%26aulast%3DMagistrato%26aufirst%3DA.%26atitle%3DInfluence%2520of%2520the%2520Membrane%2520Lipophilic%2520Environment%2520on%2520the%2520Structure%2520and%2520on%2520the%2520Substrate%2520Access%252FEgress%2520Routes%2520of%2520the%2520Human%2520Aromatase%2520Enzyme.%2520A%2520Computational%2520Study%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D1595%26epage%3D1606%26doi%3D10.1021%2Fci300151h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Catalano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizza, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malivindi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonofiglio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, S.</span><span> </span><span class="NLM_article-title">Rapid Estradiol/ER alpha Signaling Enhances Aromatase Enzymatic Activity in Breast Cancer Cells</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1634</span><span class="NLM_x">–</span> <span class="NLM_lpage">1645</span><span class="refDoi"> DOI: 10.1210/me.2009-0039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fme.2009-0039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19556341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSitbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=1634-1645&author=S.+Catalanoauthor=I.+Baroneauthor=C.+Giordanoauthor=P.+Rizzaauthor=H.+Qiauthor=G.+Guauthor=R.+Malivindiauthor=D.+Bonofiglioauthor=S.+Ando&title=Rapid+Estradiol%2FER+alpha+Signaling+Enhances+Aromatase+Enzymatic+Activity+in+Breast+Cancer+Cells&doi=10.1210%2Fme.2009-0039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid estradiol/ERα signaling enhances aromatase enzymatic activity in breast cancer cells</span></div><div class="casAuthors">Catalano, Stefania; Barone, Ines; Giordano, Cinzia; Rizza, Pietro; Qi, Hongyan; Gu, Guowei; Malivindi, Rocco; Bonofiglio, Daniela; Ando, Sebastiano</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1634-1645</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">In situ estrogen prodn. by aromatase conversion from androgens plays an important role in breast tumor promotion.  Here, we show that 17β-estradiol (E2) can rapidly enhance aromatase enzymic activity through an increase of aromatase protein phosphorylation in breast cancer cell lines.  In vivo labeling expts. and site-directed mutagenesis studies demonstrated that phosphorylation of the 361-tyrosine residue is crucial in the up-regulation of aromatase activity under E2 exposure.  Our results demonstrated a direct involvement of nonreceptor tyrosine-kinase c-Src in E2-stimulated aromatase activity because inhibition of its signaling abrogated the up-regulatory effects induced by E2 on aromatase activity as well as phosphorylation of aromatase protein.  In addn., from our data it emerges that aromatase is a target of cross talk between growth factor receptors and estrogen receptor α signaling.  These findings show, for the first time, that tyrosine phosphorylation processes play a key role in the rapid changes induced by E2 in aromatase enzymic activity, revealing the existence of a short nongenomic autocrine loop between E2 and aromatase in breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSpCww1C_zurVg90H21EOLACvtfcHk0lg6ts7pQfd_kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSitbzO&md5=49c0869bb262183f7069cb15b9ce59f5</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0039%26sid%3Dliteratum%253Aachs%26aulast%3DCatalano%26aufirst%3DS.%26aulast%3DBarone%26aufirst%3DI.%26aulast%3DGiordano%26aufirst%3DC.%26aulast%3DRizza%26aufirst%3DP.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DG.%26aulast%3DMalivindi%26aufirst%3DR.%26aulast%3DBonofiglio%26aufirst%3DD.%26aulast%3DAndo%26aufirst%3DS.%26atitle%3DRapid%2520Estradiol%252FER%2520alpha%2520Signaling%2520Enhances%2520Aromatase%2520Enzymatic%2520Activity%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DMol.%2520Endocrinol.%26date%3D2009%26volume%3D23%26spage%3D1634%26epage%3D1645%26doi%3D10.1210%2Fme.2009-0039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Barone, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malivindi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizza, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casaburi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonofiglio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, S.</span><span> </span><span class="NLM_article-title">Estrogens and PTP1B Function in a Novel Pathway to Regulate Aromatase Enzymatic Activity in Breast Cancer Cells</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">5157</span><span class="NLM_x">–</span> <span class="NLM_lpage">5166</span><span class="refDoi"> DOI: 10.1210/en.2012-1561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fen.2012-1561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=22962253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1OnsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2012&pages=5157-5166&author=I.+Baroneauthor=C.+Giordanoauthor=R.+Malivindiauthor=M.+Lanzinoauthor=P.+Rizzaauthor=I.+Casaburiauthor=D.+Bonofiglioauthor=S.+Catalanoauthor=S.+Ando&title=Estrogens+and+PTP1B+Function+in+a+Novel+Pathway+to+Regulate+Aromatase+Enzymatic+Activity+in+Breast+Cancer+Cells&doi=10.1210%2Fen.2012-1561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells</span></div><div class="casAuthors">Barone, Ines; Giordano, Cinzia; Malivindi, Rocco; Lanzino, Marilena; Rizza, Pietro; Casaburi, Ivan; Bonofiglio, Daniela; Catalano, Stefania; Ando, Sebastiano</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5157-5166</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Local estrogen prodn. by aromatase is an important mechanism of autocrine stimulation in hormone-dependent breast cancer.  We have previously shown that 17-β estradiol (E2) rapidly enhances aromatase enzymic activity through an increase of tyrosine protein phosphorylation controlled by the activity of the c-Src kinase in breast cancer cells.  Here, we investigated the protein tyrosine phosphatase PTP1B (protein tyrosine phosphatase 1B) as a potential regulator of aromatase activity.  We demonstrated a specific assocn. between PTP1B and aromatase at protein-protein level and a redn. of aromatase activity in basal and E2-treated MCF-7 and ZR75 breast cancer cells when PTP1B was overexpressed.  Indeed, a specific tyrosine phosphatase inhibitor increased basal and E2-induced enzymic activity as well as tyrosine phosphorylation status of the purified aromatase protein.  Moreover, E2 through phosphatidylinositol 3 kinase/Akt activation caused a significant decrease of PTP1B catalytic activity along with an increase in its serine phosphorylation.  Concomitantly, the phosphatidylinositol 3 kinase inhibitor LY 294002 or a dominant neg. of Akt was able to reduce the E2 stimulatory effects on activity and tyrosine phosphorylation levels of aromatase.  Taken together, our results suggest that E2 can impair PTP1B ability to dephosphorylate aromatase, and thus it increases its enzymic activity, creating a pos. feedback mechanism for estradiol signaling in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpLNQM8Pn62bVg90H21EOLACvtfcHk0lgudW_h1AubSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1OnsLzF&md5=58c59c777a2c5c123c957f52636fd6a7</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1210%2Fen.2012-1561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2012-1561%26sid%3Dliteratum%253Aachs%26aulast%3DBarone%26aufirst%3DI.%26aulast%3DGiordano%26aufirst%3DC.%26aulast%3DMalivindi%26aufirst%3DR.%26aulast%3DLanzino%26aufirst%3DM.%26aulast%3DRizza%26aufirst%3DP.%26aulast%3DCasaburi%26aufirst%3DI.%26aulast%3DBonofiglio%26aufirst%3DD.%26aulast%3DCatalano%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DS.%26atitle%3DEstrogens%2520and%2520PTP1B%2520Function%2520in%2520a%2520Novel%2520Pathway%2520to%2520Regulate%2520Aromatase%2520Enzymatic%2520Activity%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DEndocrinology%26date%3D2012%26volume%3D153%26spage%3D5157%26epage%3D5166%26doi%3D10.1210%2Fen.2012-1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Gillies, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, S.</span><span> </span><span class="NLM_article-title">Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women: A Case for Sex-Specific Medicines</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span><span class="refDoi"> DOI: 10.1124/pr.109.002071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1124%2Fpr.109.002071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=155-198&author=G.+E.+Gilliesauthor=S.+McArthur&title=Estrogen+Actions+in+the+Brain+and+the+Basis+for+Differential+Action+in+Men+and+Women%3A+A+Case+for+Sex-Specific+Medicines&doi=10.1124%2Fpr.109.002071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002071%26sid%3Dliteratum%253Aachs%26aulast%3DGillies%26aufirst%3DG.%2BE.%26aulast%3DMcArthur%26aufirst%3DS.%26atitle%3DEstrogen%2520Actions%2520in%2520the%2520Brain%2520and%2520the%2520Basis%2520for%2520Differential%2520Action%2520in%2520Men%2520and%2520Women%253A%2520A%2520Case%2520for%2520Sex-Specific%2520Medicines%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D155%26epage%3D198%26doi%3D10.1124%2Fpr.109.002071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Roselli, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurn, P. D.</span><span> </span><span class="NLM_article-title">Brain Aromatization: Classic Roles and New Perspectives</span> <span class="citation_source-journal">Semin. Reprod. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span><span class="refDoi"> DOI: 10.1055/s-0029-1216274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1055%2Fs-0029-1216274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=19401952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVamsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=207-217&author=C.+E.+Roselliauthor=M.+Liuauthor=P.+D.+Hurn&title=Brain+Aromatization%3A+Classic+Roles+and+New+Perspectives&doi=10.1055%2Fs-0029-1216274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Brain aromatization: classic roles and new perspectives</span></div><div class="casAuthors">Roselli, Charles E.; Liu, Mingyue; Hurn, Patricia D.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Reproductive Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-217</span>CODEN:
                <span class="NLM_cas:coden">SRMECJ</span>;
        ISSN:<span class="NLM_cas:issn">1526-8004</span>.
    
            (<span class="NLM_cas:orgname">Thieme Medical Publishers, Inc.</span>)
        </div><div class="casAbstract">A review.  Aromatization of testosterone to estradiol by neural tissue has classically been assocd. with the regulation of sexual differentiation, gonadotropin secretion, and copulatory behavior.  However, new data indicate that the capacity for aromatization is not restricted to the endocrine brain and demonstrate roles for locally formed estrogens in neurogenesis and in responses of brain tissue to injury.  This article summaries our current understanding of the distribution and regulation of aromatase in the brain and describes the classic and novel roles it plays.  A better understanding of brain aromatization could shed new light on its physiol. and pathol. functions and someday lead to new, centrally acting drug therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT1gRdEdRx-rVg90H21EOLACvtfcHk0lgudW_h1AubSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVamsrw%253D&md5=70d816779ece8cbe92d03dda3b851be9</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1055%2Fs-0029-1216274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0029-1216274%26sid%3Dliteratum%253Aachs%26aulast%3DRoselli%26aufirst%3DC.%2BE.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DHurn%26aufirst%3DP.%2BD.%26atitle%3DBrain%2520Aromatization%253A%2520Classic%2520Roles%2520and%2520New%2520Perspectives%26jtitle%3DSemin.%2520Reprod.%2520Med.%26date%3D2009%26volume%3D27%26spage%3D207%26epage%3D217%26doi%3D10.1055%2Fs-0029-1216274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Balthazart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, G. F.</span><span> </span><span class="NLM_article-title">Is Brain Estradiol a Hormone or a Neurotransmitter?</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1016/j.tins.2006.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2Fj.tins.2006.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=16580076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVehtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=241-249&author=J.+Balthazartauthor=G.+F.+Ball&title=Is+Brain+Estradiol+a+Hormone+or+a+Neurotransmitter%3F&doi=10.1016%2Fj.tins.2006.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Is brain estradiol a hormone or a neurotransmitter?</span></div><div class="casAuthors">Balthazart, Jacques; Ball, Gregory F.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">241-249</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mounting evidence indicates that, besides their well-known hormonal mode of action at the genetic level, estrogens such as 17β-estradiol also influence brain function by direct effects on neuronal membranes.  Exptl. induced rapid changes in estradiol bioavailability in the brain have been shown to alter the expression of male sexual behavior significantly within minutes - probably too quickly to be accounted for by conventional genetic mechanisms.  In parallel, recent studies indicate that aromatase, the enzyme that converts testosterone to estradiol in the brain, is expressed in presynaptic terminals and modulated within minutes by Ca2+-dependent phosphorylation.  In this article, we develop the hypothesis that brain estrogens display many, if not all, functional characteristics of neuromodulators or even neurotransmitters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpon2FVQ9dWVrVg90H21EOLACvtfcHk0lgudW_h1AubSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVehtLk%253D&md5=7bba34a059d12b9c182cf3cca07f9aca</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2006.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2006.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DBalthazart%26aufirst%3DJ.%26aulast%3DBall%26aufirst%3DG.%2BF.%26atitle%3DIs%2520Brain%2520Estradiol%2520a%2520Hormone%2520or%2520a%2520Neurotransmitter%253F%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D241%26epage%3D249%26doi%3D10.1016%2Fj.tins.2006.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">McEwen, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, S. E.</span><span> </span><span class="NLM_article-title">Estrogen Actions in the Central Nervous System</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1210/edrv.20.3.0365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fedrv.20.3.0365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10368772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK1MXktVaqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=279-307&author=B.+S.+McEwenauthor=S.+E.+Alves&title=Estrogen+Actions+in+the+Central+Nervous+System&doi=10.1210%2Fedrv.20.3.0365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen actions in the central nervous system</span></div><div class="casAuthors">Mcewen, Bruce S.; Alves, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-307</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review, with 362 refs., of the neural actions of estrogens in the central nervous system, focusing on brain structures outside of the hypothalamus and on neurally mediated processes other than reproductive behavior and reproductive neuroendocrine events.  Emphasis is placed on effects of estrogens on memory and learning and estrogens as neuroprotectants and their relationship to Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6aOcWG2uyIbVg90H21EOLACvtfcHk0lgmwMysTqVH3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVaqtL0%253D&md5=5cb790f107614dda94f4d14a883fc7f4</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1210%2Fedrv.20.3.0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fedrv.20.3.0365%26sid%3Dliteratum%253Aachs%26aulast%3DMcEwen%26aufirst%3DB.%2BS.%26aulast%3DAlves%26aufirst%3DS.%2BE.%26atitle%3DEstrogen%2520Actions%2520in%2520the%2520Central%2520Nervous%2520System%26jtitle%3DEndocr.%2520Rev.%26date%3D1999%26volume%3D20%26spage%3D279%26epage%3D307%26doi%3D10.1210%2Fedrv.20.3.0365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Sevrioukova, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span> </span><span class="NLM_article-title">Structure of a Cytochrome P450-Redox Partner Electron-Transfer Complex</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1863</span><span class="NLM_x">–</span> <span class="NLM_lpage">1868</span><span class="refDoi"> DOI: 10.1073/pnas.96.5.1863</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1073%2Fpnas.96.5.1863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10051560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVSrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=1863-1868&author=I.+F.+Sevrioukovaauthor=H.+Liauthor=H.+Zhangauthor=J.+A.+Petersonauthor=T.+L.+Poulos&title=Structure+of+a+Cytochrome+P450-Redox+Partner+Electron-Transfer+Complex&doi=10.1073%2Fpnas.96.5.1863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a cytochrome P450-redox partner electron-transfer complex</span></div><div class="casAuthors">Sevrioukova, Irina F.; Li, Huiying; Zhang, Hong; Peterson, Julian A.; Poulos, Thomas L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1863-1868</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The crystal structure of the complex between the heme- and FMN-binding domains of bacterial cytochrome P450BM-3, a prototype for the complex between eukaryotic microsomal P450s and P 450 reductase, has been detd. at 2.03 Å resoln.  The flavodoxin-like flavin domain is positioned at the proximal face of the heme domain with the FMN 4.0 and 18.4 Å from the peptide that precedes the heme-binding loop and the heme iron, resp.  The heme-binding peptide represents the most efficient and coupled through-bond electron pathway to the heme iron.  Substantial differences between the FMN-binding domains of P450BM-3 and microsomal P 450 reductase, obsd. around the flavin-binding sites, are responsible for different redox properties of the FMN, which, in turn, control electron flow to the P 450.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu9z7lDZk6LVg90H21EOLACvtfcHk0lgmwMysTqVH3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVSrtbc%253D&md5=c910ad0e46ec6d364a039c808f4decca</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.5.1863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.5.1863%26sid%3Dliteratum%253Aachs%26aulast%3DSevrioukova%26aufirst%3DI.%2BF.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DPeterson%26aufirst%3DJ.%2BA.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26atitle%3DStructure%2520of%2520a%2520Cytochrome%2520P450-Redox%2520Partner%2520Electron-Transfer%2520Complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D1863%26epage%3D1868%26doi%3D10.1073%2Fpnas.96.5.1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Aguilar, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mc, N. F.</span><span> </span><span class="NLM_article-title">Aminoglutethimide in the Treatment of Epilepsy</span> <span class="citation_source-journal">Can. Med. Assoc. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=13681724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaF3c%252FgtVyktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1961&pages=374-376&author=J.+A.+Aguilarauthor=H.+L.+Martinauthor=N.+F.+Mc&title=Aminoglutethimide+in+the+Treatment+of+Epilepsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoglutethimide in the treatment of epilepsy</span></div><div class="casAuthors">AGUILAR J A; MARTIN H L; McNAUGHTON F L</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Medical Association journal</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">374-6</span>
        ISSN:<span class="NLM_cas:issn">0008-4409</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoK7DHBhrpolUIs6wFK5xJfW6udTcc2eYiWntqKri2Nrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF3c%252FgtVyktg%253D%253D&md5=34097416b6b2f0df57ef5a717257866a</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DJ.%2BA.%26aulast%3DMartin%26aufirst%3DH.%2BL.%26aulast%3DMc%26aufirst%3DN.%2BF.%26atitle%3DAminoglutethimide%2520in%2520the%2520Treatment%2520of%2520Epilepsy%26jtitle%3DCan.%2520Med.%2520Assoc.%2520J.%26date%3D1961%26volume%3D84%26spage%3D374%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Brodie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaikh, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, H. J.</span><span> </span><span class="NLM_article-title">The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene-3,17-Dione, on Estrogen-Dependent Processes in Reproduction and Breast Cancer</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1684</span><span class="NLM_x">–</span> <span class="NLM_lpage">1695</span><span class="refDoi"> DOI: 10.1210/endo-100-6-1684</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fendo-100-6-1684" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1977&pages=1684-1695&author=A.+M.+Brodieauthor=W.+C.+Schwarzelauthor=A.+A.+Shaikhauthor=H.+J.+Brodie&title=The+Effect+of+an+Aromatase+Inhibitor%2C+4-Hydroxy-4-Androstene-3%2C17-Dione%2C+on+Estrogen-Dependent+Processes+in+Reproduction+and+Breast+Cancer&doi=10.1210%2Fendo-100-6-1684"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1210%2Fendo-100-6-1684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fendo-100-6-1684%26sid%3Dliteratum%253Aachs%26aulast%3DBrodie%26aufirst%3DA.%2BM.%26aulast%3DSchwarzel%26aufirst%3DW.%2BC.%26aulast%3DShaikh%26aufirst%3DA.%2BA.%26aulast%3DBrodie%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520Effect%2520of%2520an%2520Aromatase%2520Inhibitor%252C%25204-Hydroxy-4-Androstene-3%252C17-Dione%252C%2520on%2520Estrogen-Dependent%2520Processes%2520in%2520Reproduction%2520and%2520Breast%2520Cancer%26jtitle%3DEndocrinology%26date%3D1977%26volume%3D100%26spage%3D1684%26epage%3D1695%26doi%3D10.1210%2Fendo-100-6-1684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Brodie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai-Morris, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C. H.</span><span> </span><span class="NLM_article-title">Inactivation of Aromatase in Vitro by 4-Hydroxy-4-Androstene-3,17-Dione and 4-Acetoxy-4-Androstene-3,17-Dione and Sustained Effects in Vivo</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span><span class="refDoi"> DOI: 10.1016/0039-128X(81)90087-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0039-128X%2881%2990087-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=7336466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaL38XhtlKit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1981&pages=693-702&author=A.+M.+Brodieauthor=W.+M.+Garrettauthor=J.+R.+Hendricksonauthor=C.+H.+Tsai-Morrisauthor=P.+A.+Marcotteauthor=C.+H.+Robinson&title=Inactivation+of+Aromatase+in+Vitro+by+4-Hydroxy-4-Androstene-3%2C17-Dione+and+4-Acetoxy-4-Androstene-3%2C17-Dione+and+Sustained+Effects+in+Vivo&doi=10.1016%2F0039-128X%2881%2990087-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo</span></div><div class="casAuthors">Brodie, Angela M. H.; Garrett, Wesley M.; Hendrickson, James R.; Tsai-Morris, Chon Hwa; Marcotte, Patrick A.; Robinson, Cecil H.</div><div class="citationInfo"><span class="NLM_cas:title">Steroids</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">693-702</span>CODEN:
                <span class="NLM_cas:coden">STEDAM</span>;
        ISSN:<span class="NLM_cas:issn">0039-128X</span>.
    </div><div class="casAbstract">4-hydroxy-4-androstene-3,17-dione (I)  [566-48-3] and 4-acetoxy-4-androstene-3,17-dione  [61630-32-8], in addn. to being competitive inhibitors of aromatase  [9039-48-9], cause time-dependent, irreversible, loss of enzyme activity in both human placental and rat ovarian microsomes.  In vivo, treatment of rats with I also causes loss of ovarian aromatase activity.  To test whether this loss of activity has in vivo significance, rats with hormone-dependent, mammary tumors were treated with I on alternate weeks.  Tumor regression occurred even during the weeks without treatment.  Apparently, inactivation of aromatase is important in the mechanism of action of the compds. in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNQtZhQG-k87Vg90H21EOLACvtfcHk0lhD2e4y6f25Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XhtlKit7w%253D&md5=71815490980acfd07aa0f9f1b7fd5650</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2F0039-128X%2881%2990087-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0039-128X%252881%252990087-8%26sid%3Dliteratum%253Aachs%26aulast%3DBrodie%26aufirst%3DA.%2BM.%26aulast%3DGarrett%26aufirst%3DW.%2BM.%26aulast%3DHendrickson%26aufirst%3DJ.%2BR.%26aulast%3DTsai-Morris%26aufirst%3DC.%2BH.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DRobinson%26aufirst%3DC.%2BH.%26atitle%3DInactivation%2520of%2520Aromatase%2520in%2520Vitro%2520by%25204-Hydroxy-4-Androstene-3%252C17-Dione%2520and%25204-Acetoxy-4-Androstene-3%252C17-Dione%2520and%2520Sustained%2520Effects%2520in%2520Vivo%26jtitle%3DSteroids%26date%3D1981%26volume%3D38%26spage%3D693%26epage%3D702%26doi%3D10.1016%2F0039-128X%2881%2990087-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Steele, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasvary, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, L. J.</span><span> </span><span class="NLM_article-title">In Vitro and in Vivo Studies Demonstrating Potent and Selective Estrogen Inhibition with the Nonsteroidal Aromatase Inhibitor Cgs 16949a</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span><span class="refDoi"> DOI: 10.1016/0039-128X(83)90068-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0039-128X%2883%2990068-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1987&pages=147-161&author=R.+E.+Steeleauthor=L.+B.+Mellorauthor=W.+K.+Sawyerauthor=J.+M.+Wasvaryauthor=L.+J.+Browne&title=In+Vitro+and+in+Vivo+Studies+Demonstrating+Potent+and+Selective+Estrogen+Inhibition+with+the+Nonsteroidal+Aromatase+Inhibitor+Cgs+16949a&doi=10.1016%2F0039-128X%2883%2990068-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2F0039-128X%2883%2990068-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0039-128X%252883%252990068-5%26sid%3Dliteratum%253Aachs%26aulast%3DSteele%26aufirst%3DR.%2BE.%26aulast%3DMellor%26aufirst%3DL.%2BB.%26aulast%3DSawyer%26aufirst%3DW.%2BK.%26aulast%3DWasvary%26aufirst%3DJ.%2BM.%26aulast%3DBrowne%26aufirst%3DL.%2BJ.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Studies%2520Demonstrating%2520Potent%2520and%2520Selective%2520Estrogen%2520Inhibition%2520with%2520the%2520Nonsteroidal%2520Aromatase%2520Inhibitor%2520Cgs%252016949a%26jtitle%3DSteroids%26date%3D1987%26volume%3D50%26spage%3D147%26epage%3D161%26doi%3D10.1016%2F0039-128X%2883%2990068-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Giudici, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briatico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzzetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span> </span><span class="NLM_article-title">6-Methylenandrosta-1,4-Diene-3,17-Dione (FCE24304): A New Irreversible Aromatase Inhibitor</span> <span class="citation_source-journal">J. Steroid Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span><span class="refDoi"> DOI: 10.1016/0022-4731(88)90129-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0022-4731%2888%2990129-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=3386266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaL1cXks1OitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1988&pages=391-394&author=D.+Giudiciauthor=G.+Ornatiauthor=G.+Briaticoauthor=F.+Buzzettiauthor=P.+Lombardiauthor=E.+di+Salle&title=6-Methylenandrosta-1%2C4-Diene-3%2C17-Dione+%28FCE24304%29%3A+A+New+Irreversible+Aromatase+Inhibitor&doi=10.1016%2F0022-4731%2888%2990129-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor</span></div><div class="casAuthors">Giudici, D.; Ornati, G.; Briatico, G.; Buzzetti, F.; Lombardi, P.; Di Salle, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1-6</span>),
    <span class="NLM_cas:pages">391-4</span>CODEN:
                <span class="NLM_cas:coden">JSTBBK</span>;
        ISSN:<span class="NLM_cas:issn">0022-4731</span>.
    </div><div class="casAbstract">FCE 24304 (6-methylenandrosta-1,4-diene-3,17-dione), a new irreversible aromatase inhibitor, was identified and characterized in vitro and in vivo.  The compd. caused time-dependent inactivation of human placental aromatase with a half-time of 13.9 min and Ki of 26 nM.  When tested in PMSG-treated rats, ovarian aromatase activity was reduced 24 h after dosing by both the s.c. (50% ED 1.8 mg/kg) and the oral (50% ED 3.7 mg/kg) routes.  No interference with 5α-reductase activity and no significant binding affinity for the estrogen receptor were found.  A slight binding affinity for the androgen receptor (relative binding affinity 0.2% of dihydrotestosterone) was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0X7BVetfC_LVg90H21EOLACvtfcHk0lhD2e4y6f25Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXks1OitLY%253D&md5=bb45165bda30bd0807cb0779f3ce8628</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2F0022-4731%2888%2990129-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-4731%252888%252990129-X%26sid%3Dliteratum%253Aachs%26aulast%3DGiudici%26aufirst%3DD.%26aulast%3DOrnati%26aufirst%3DG.%26aulast%3DBriatico%26aufirst%3DG.%26aulast%3DBuzzetti%26aufirst%3DF.%26aulast%3DLombardi%26aufirst%3DP.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26atitle%3D6-Methylenandrosta-1%252C4-Diene-3%252C17-Dione%2520%2528FCE24304%2529%253A%2520A%2520New%2520Irreversible%2520Aromatase%2520Inhibitor%26jtitle%3DJ.%2520Steroid%2520Biochem.%26date%3D1988%26volume%3D30%26spage%3D391%26epage%3D394%26doi%3D10.1016%2F0022-4731%2888%2990129-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Zaccheo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giudici, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Salle, E.</span><span> </span><span class="NLM_article-title">A New Irreversible Aromatase Inhibitor, 6-Methylenandrosta-1,4-Diene-3,17-Dione (FCE 24304): Antitumor Activity and Endocrine Effects in Rats with Dmba-Induced Mammary Tumors</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span><span class="refDoi"> DOI: 10.1007/BF00258457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2FBF00258457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2491793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK3cXkvVeluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1989&pages=47-50&author=T.+Zaccheoauthor=D.+Giudiciauthor=P.+Lombardiauthor=E.+di+Salle&title=A+New+Irreversible+Aromatase+Inhibitor%2C+6-Methylenandrosta-1%2C4-Diene-3%2C17-Dione+%28FCE+24304%29%3A+Antitumor+Activity+and+Endocrine+Effects+in+Rats+with+Dmba-Induced+Mammary+Tumors&doi=10.1007%2FBF00258457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors</span></div><div class="casAuthors">Zaccheo, T.; Giudici, D.; Lombardi, P.; Di Salle, E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-50</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">The antitumor activity of the new irreversible aromatase inhibitor FCE 24304 (I) was studied in rats with 7,12-dimethylbenzanthracene (DMBA)-induced tumors; several endocrine parameters were evaluated in these animals.  The compd. was given s.c. and orally twice daily, 6 days/wk, for 4 wk.  The control group showed 13% tumor regressions (0% complete remission; 13% partial remission).  I given s.c. induced 44% (22 + 22) regressions at 3 mg/kg per day, 70% (40 + 30) at 10 mg/kg per day, 73% (27 + 46) at 30 mg/kg per day, and 70% (50 + 20) at 100 mg/kg per day.  I given orally induced 25% (17 + 8) tumor regressions at 30 mg/kg per day and 50% (17 + 33) at 100 mg/kg per day.  Rats were killed 4 h after the last dose and the aromatase activity of ovarian microsomes (OAA) was evaluated.  OAA was reduced by 56% after s.c. treatment with 3 mg/kg per day; complete OAA suppression (≥96%) was obtained starting at 10 mg/kg per day s.c.  Oral treatment slightly reduced OAA only 100 mg/kg per day (36%).  Body wt. increased in all the groups s.c. treated with I but not in those treated orally.  The wts. of the pituitary, adrenals, and uterus were reduced in rats treated s.c. with 10 and 30 mg/kg per day; at 100 mg/kg per day, a decrease in ovarian wt. was obsd., while uterus wt. was similar to that of controls.  Oral I increased ovarian wt. at 30 mg/kg per day but not at 100 mg/kg per day.  Serum prolactin and LH levels did not change.  In conclusion, I given s.c. proved highly effective against DMBA-induced tumors in rats but had less activity when given orally.  Its intrinsic androgenic activity, higher after s.c. than after oral treatment, could contribute to the antitumor effect in the intact (premenopausal) rat model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlHxFMB0ytOrVg90H21EOLACvtfcHk0lhD2e4y6f25Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvVeluw%253D%253D&md5=577d1971c7599fce5b49229731448db9</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1007%2FBF00258457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00258457%26sid%3Dliteratum%253Aachs%26aulast%3DZaccheo%26aufirst%3DT.%26aulast%3DGiudici%26aufirst%3DD.%26aulast%3DLombardi%26aufirst%3DP.%26aulast%3Ddi%2BSalle%26aufirst%3DE.%26atitle%3DA%2520New%2520Irreversible%2520Aromatase%2520Inhibitor%252C%25206-Methylenandrosta-1%252C4-Diene-3%252C17-Dione%2520%2528FCE%252024304%2529%253A%2520Antitumor%2520Activity%2520and%2520Endocrine%2520Effects%2520in%2520Rats%2520with%2520Dmba-Induced%2520Mammary%2520Tumors%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1989%26volume%3D23%26spage%3D47%26epage%3D50%26doi%3D10.1007%2FBF00258457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Bhatnagar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hausler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieweck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, R.</span><span> </span><span class="NLM_article-title">Highly Selective Inhibition of Estrogen Biosynthesis by CGS 20267, a New Non-Steroidal Aromatase Inhibitor</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span><span class="refDoi"> DOI: 10.1016/0960-0760(90)90460-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2890%2990460-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2149502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK3MXhtlGltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1990&pages=1021-1027&author=A.+S.+Bhatnagarauthor=A.+Hauslerauthor=K.+Schieweckauthor=M.+Langauthor=R.+Bowman&title=Highly+Selective+Inhibition+of+Estrogen+Biosynthesis+by+CGS+20267%2C+a+New+Non-Steroidal+Aromatase+Inhibitor&doi=10.1016%2F0960-0760%2890%2990460-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor</span></div><div class="casAuthors">Bhatnagar, A. S.; Haeusler, A.; Schieweck, K.; Lang, M.; Bowman, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1021-7</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">CGS 20267 (I) is a new nonsteroidal compd. which potently inhibits aromatase in vitro (IC50 of 11.5 nM) and in vivo (ED50 of 1-3 μg/kg p.o.).  CGS 20267 maximally inhibits estradiol prodn. in vitro in LH-stimulated hamster ovarian tissue at 0.1 μM with an IC50 of 0.02 μM and does not significantly affect progesterone prodn. up to 350 μM.  In ACTH-stimulated rat adrenal tissue in vitro, aldosterone prodn. was inhibited with an IC50 of 210 μM (10,000 times higher than the IC50 for estradiol prodn.); no significant effect on corticosterone prodn. was seen at 350 μM.  In vivo, in ACTH-treated rats, CGS 20267 does not affect plasma levels of corticosterone or aldosterone at a dose of 4 mg/kg p.o. (1000 times higher than the ED50 for aromatase inhibition in vivo).  In adult female rats, a 14-day treatment with 1 mg/kg p.o. daily, completely interrupts ovarian cyclicity and suppresses uterine wt. to that seen 14 days after ovariectomy.  In adult female rats bearing estrogen-dependent DMBA-induced mammary tumors, 0.1 mg/kg p.o. given daily for 42 days caused almost complete regression of tumors present at the start of treatment.  Thus compared to each other, CGS 16949A and CGS 20267 are both highly potent in inhibiting estrogen biosynthesis in vitro and in vivo.  The striking difference between them is that unlike CGS 16949A, CGS 20267 does not affect adrenal steroidogenesis in vitro or in vivo, at concns. and doses several orders of magnitude higher than those required to inhibit estrogen biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq83gKMUXDIe7Vg90H21EOLACvtfcHk0ljg81iV3NLOZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtlGltbs%253D&md5=1f3069c02a2a78083b0a0b1932b660f5</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2890%2990460-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252890%252990460-3%26sid%3Dliteratum%253Aachs%26aulast%3DBhatnagar%26aufirst%3DA.%2BS.%26aulast%3DHausler%26aufirst%3DA.%26aulast%3DSchieweck%26aufirst%3DK.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DBowman%26aufirst%3DR.%26atitle%3DHighly%2520Selective%2520Inhibition%2520of%2520Estrogen%2520Biosynthesis%2520by%2520CGS%252020267%252C%2520a%2520New%2520Non-Steroidal%2520Aromatase%2520Inhibitor%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1990%26volume%3D37%26spage%3D1021%26epage%3D1027%26doi%3D10.1016%2F0960-0760%2890%2990460-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Goss, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powles, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Treatment of Advanced Postmenopausal Breast Cancer with an Aromatase Inhibitor, 4-Hydroxyandrostenedione: Phase II Report</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4823</span><span class="NLM_x">–</span> <span class="NLM_lpage">4826</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1986&pages=4823-4826&author=P.+E.+Gossauthor=T.+J.+Powlesauthor=M.+Dowsettauthor=G.+Hutchisonauthor=A.+M.+Brodieauthor=J.+C.+Gazetauthor=R.+C.+Coombes&title=Treatment+of+Advanced+Postmenopausal+Breast+Cancer+with+an+Aromatase+Inhibitor%2C+4-Hydroxyandrostenedione%3A+Phase+II+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DP.%2BE.%26aulast%3DPowles%26aufirst%3DT.%2BJ.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DHutchison%26aufirst%3DG.%26aulast%3DBrodie%26aufirst%3DA.%2BM.%26aulast%3DGazet%26aufirst%3DJ.%2BC.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DTreatment%2520of%2520Advanced%2520Postmenopausal%2520Breast%2520Cancer%2520with%2520an%2520Aromatase%2520Inhibitor%252C%25204-Hydroxyandrostenedione%253A%2520Phase%2520II%2520Report%26jtitle%3DCancer%2520Res.%26date%3D1986%26volume%3D46%26spage%3D4823%26epage%3D4826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Demers, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambic, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span> </span><span class="NLM_article-title">The Efficacy of Cgs 20267 in Suppressing Estrogen Biosynthesis in Patients with Advanced Stage Breast Cancer</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1016/0960-0760(93)90283-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2893%2990283-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=8476785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaK3sXksVSnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=687-691&author=L.+M.+Demersauthor=A.+Liptonauthor=H.+A.+Harveyauthor=K.+B.+Kambicauthor=H.+Grossbergauthor=C.+Bradyauthor=R.+J.+Santen&title=The+Efficacy+of+Cgs+20267+in+Suppressing+Estrogen+Biosynthesis+in+Patients+with+Advanced+Stage+Breast+Cancer&doi=10.1016%2F0960-0760%2893%2990283-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancer</span></div><div class="casAuthors">Demers, Laurence M.; Lipton, Allan; Harvey, Harold A.; Kambic, Kathleen B.; Grossberg, Howard; Brady, Carolyn; Santen, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">687-91</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">The pharmacol. inhibition of aromatase activity has been the focus of clin. trials in patients with advanced stage breast cancer.  Recent developments with imidazole compds. that inhibit aromatase activity suggest their clin. use as potent inhibitors of estrogen biosynthesis in postmenopausal breast cancer patients.  In this Phase I, open-label, dose-range finding study, the authors examd. the inhibitory potency of CGS 20267 on blood and urine levels of estradiol, estrone and estrone sulfate in 8 patients with metastatic breast cancer.  Studies included evaluation of adrenal and thyroid function to look for evidence of general hydroxylase inhibition at dose levels effective for aromatase blockade.  Patients were administered CGS 20267 at doses of 0.1 and 0.25 mg, once a day in ascending doses over a 12-wk period.  Preliminary data reveal that CGS 20267 elicits a striking suppression in plasma estradiol, estrone and estrone sulfate which was obsd. in some patients as quickly as within 25 h of the first dose.  Estrogen suppression of over 90% was achieved within 2 wk of therapy.  No alterations in either baseline or ACTH (cortrosyn) stimulated cortisol and aldosterone levels were obsd. through the 12 wk of therapy.  In addn., 24 h urine sodium and potassium values were not appreciably altered during therapy.  The authors conclude that CGS 20267 is a potent, specific inhibitor of estrogen biosynthesis in postmenopausal patients with metastatic breast cancer and effectively reduces blood and urine estrogens to undetectable levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhx9FAUoNiGbVg90H21EOLACvtfcHk0ljg81iV3NLOZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVSnsbo%253D&md5=f9bfb109ef9125bceeeaf21e272e824d</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2893%2990283-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252893%252990283-3%26sid%3Dliteratum%253Aachs%26aulast%3DDemers%26aufirst%3DL.%2BM.%26aulast%3DLipton%26aufirst%3DA.%26aulast%3DHarvey%26aufirst%3DH.%2BA.%26aulast%3DKambic%26aufirst%3DK.%2BB.%26aulast%3DGrossberg%26aufirst%3DH.%26aulast%3DBrady%26aufirst%3DC.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520Efficacy%2520of%2520Cgs%252020267%2520in%2520Suppressing%2520Estrogen%2520Biosynthesis%2520in%2520Patients%2520with%2520Advanced%2520Stage%2520Breast%2520Cancer%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D44%26spage%3D687%26epage%3D691%26doi%3D10.1016%2F0960-0760%2893%2990283-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Iveson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahern, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithers, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trunet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span> </span><span class="NLM_article-title">Phase I Study of the Oral Nonsteroidal Aromatase Inhibitor CGS 20267 in Postmenopausal Patients with Advanced Breast Cancer</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span><span class="refDoi"> DOI: 10.1210/jcem.77.2.8345035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem.77.2.8345035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=266-270&author=T.+J.+Ivesonauthor=I.+E.+Smithauthor=J.+Ahernauthor=D.+A.+Smithersauthor=P.+F.+Trunetauthor=M.+Dowsett&title=Phase+I+Study+of+the+Oral+Nonsteroidal+Aromatase+Inhibitor+CGS+20267+in+Postmenopausal+Patients+with+Advanced+Breast+Cancer&doi=10.1210%2Fjcem.77.2.8345035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1210%2Fjcem.77.2.8345035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem.77.2.8345035%26sid%3Dliteratum%253Aachs%26aulast%3DIveson%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DI.%2BE.%26aulast%3DAhern%26aufirst%3DJ.%26aulast%3DSmithers%26aufirst%3DD.%2BA.%26aulast%3DTrunet%26aufirst%3DP.%2BF.%26aulast%3DDowsett%26aufirst%3DM.%26atitle%3DPhase%2520I%2520Study%2520of%2520the%2520Oral%2520Nonsteroidal%2520Aromatase%2520Inhibitor%2520CGS%252020267%2520in%2520Postmenopausal%2520Patients%2520with%2520Advanced%2520Breast%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1993%26volume%3D53%26spage%3D266%26epage%3D270%26doi%3D10.1210%2Fjcem.77.2.8345035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Kitawaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honjo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, H.</span><span> </span><span class="NLM_article-title">Selective Aromatase Inhibition by Pyridoglutethimide, an Analogue of Aminoglutethimide</span> <span class="citation_source-journal">Eur. J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">592</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span><span class="refDoi"> DOI: 10.1530/acta.0.1220592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1530%2Facta.0.1220592" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1990&pages=592-598&author=J.+Kitawakiauthor=T.+Yamamotoauthor=M.+Urabeauthor=T.+Tamuraauthor=S.+Inoueauthor=H.+Honjoauthor=H.+Okada&title=Selective+Aromatase+Inhibition+by+Pyridoglutethimide%2C+an+Analogue+of+Aminoglutethimide&doi=10.1530%2Facta.0.1220592"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1530%2Facta.0.1220592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252Facta.0.1220592%26sid%3Dliteratum%253Aachs%26aulast%3DKitawaki%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DUrabe%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DS.%26aulast%3DHonjo%26aufirst%3DH.%26aulast%3DOkada%26aufirst%3DH.%26atitle%3DSelective%2520Aromatase%2520Inhibition%2520by%2520Pyridoglutethimide%252C%2520an%2520Analogue%2520of%2520Aminoglutethimide%26jtitle%3DEur.%2520J.%2520Endocrinol.%26date%3D1990%26volume%3D122%26spage%3D592%26epage%3D598%26doi%3D10.1530%2Facta.0.1220592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Bhatnagar, A. S.</span><span> </span><span class="NLM_article-title">The Discovery and Mechanism of Action of Letrozole</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1007/s10549-007-9696-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1007%2Fs10549-007-9696-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=17912633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlektrbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2007&pages=7-17&issue=Suppl.+1&author=A.+S.+Bhatnagar&title=The+Discovery+and+Mechanism+of+Action+of+Letrozole&doi=10.1007%2Fs10549-007-9696-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery and mechanism of action of letrozole</span></div><div class="casAuthors">Bhatnagar, Ajay S.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">7-17</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Because estrogen contributes to the promotion and progression of breast cancer, a greater understanding of the role of estrogen in breast cancer has led to therapeutic strategies targeting estrogen synthesis, the estrogen receptor, and intracellular signaling pathways.  The enzyme aromatase catalyzes the final step in estrogen biosynthesis and was identified as an attractive target for selective inhibition.  Modern third-generation aromatase inhibitors (AIs) effectively block the prodn. of estrogen without exerting effects on other steroidogenic pathways.  The discovery of letrozole (Femara) achieved the goal of discovering a highly potent and totally selective AI.  Letrozole has greater potency than other AIs, including anastrozole, exemestane, formestane, and aminoglutethimide.  Moreover, letrozole produces near complete inhibition of aromatase in peripheral tissues and is assocd. with greater suppression of estrogen than is achieved with other AIs.  The potent anti-tumor effects of letrozole were demonstrated in several animal models.  Studies with MCF-7Ca xenografts successfully predicted that letrozole would be clin. superior to the previous gold std. tamoxifen and also indicated that it may be more effective than other AIs.  An extensive program of randomized clin. trials has demonstrated the clin. benefits of letrozole across the spectrum of hormone-responsive breast cancer in postmenopausal women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAJhzeEx05lrVg90H21EOLACvtfcHk0lgdjsmu1CyfcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlektrbL&md5=4215659d9116c2cb13d100d04b4acb66</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1007%2Fs10549-007-9696-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-007-9696-3%26sid%3Dliteratum%253Aachs%26aulast%3DBhatnagar%26aufirst%3DA.%2BS.%26atitle%3DThe%2520Discovery%2520and%2520Mechanism%2520of%2520Action%2520of%2520Letrozole%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007%26volume%3D105%26issue%3DSuppl.%25201%26spage%3D7%26epage%3D17%26doi%3D10.1007%2Fs10549-007-9696-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Zhou, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. A.</span><span> </span><span class="NLM_article-title">Stable Expression of Human Aromatase Complementary DNA in Mammalian Cells: A Useful System for Aromatase Inhibitor Screening</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6949</span><span class="NLM_x">–</span> <span class="NLM_lpage">6954</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=6949-6954&author=D.+J.+Zhouauthor=D.+Pomponauthor=S.+A.+Chen&title=Stable+Expression+of+Human+Aromatase+Complementary+DNA+in+Mammalian+Cells%3A+A+Useful+System+for+Aromatase+Inhibitor+Screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DD.%2BJ.%26aulast%3DPompon%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DS.%2BA.%26atitle%3DStable%2520Expression%2520of%2520Human%2520Aromatase%2520Complementary%2520DNA%2520in%2520Mammalian%2520Cells%253A%2520A%2520Useful%2520System%2520for%2520Aromatase%2520Inhibitor%2520Screening%26jtitle%3DCancer%2520Res.%26date%3D1990%26volume%3D50%26spage%3D6949%26epage%3D6954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Gibson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliss, J.</span><span> </span><span class="NLM_article-title">Aromatase Inhibitors for Treatment of Advanced Breast Cancer in Postmenopausal Women</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD003370</span><span class="refDoi"> DOI: 10.1002/14651858.CD003370.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1002%2F14651858.CD003370.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=CD003370&author=L.+Gibsonauthor=D.+Lawrenceauthor=C.+Dawsonauthor=J.+Bliss&title=Aromatase+Inhibitors+for+Treatment+of+Advanced+Breast+Cancer+in+Postmenopausal+Women&doi=10.1002%2F14651858.CD003370.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD003370.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD003370.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DL.%26aulast%3DLawrence%26aufirst%3DD.%26aulast%3DDawson%26aufirst%3DC.%26aulast%3DBliss%26aufirst%3DJ.%26atitle%3DAromatase%2520Inhibitors%2520for%2520Treatment%2520of%2520Advanced%2520Breast%2520Cancer%2520in%2520Postmenopausal%2520Women%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2009%26spage%3DCD003370%26doi%3D10.1002%2F14651858.CD003370.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Demers, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span> </span><span class="NLM_article-title">Aminoglutethimide Therapy in Breast Cancer: Relationship of Blood Levels to Drug-Related Side Effects</span> <span class="citation_source-journal">Clin. Physiol. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=3652603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaL1c%252Fgtlaguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1987&pages=287-291&author=L.+M.+Demersauthor=A.+E.+Boucherauthor=R.+J.+Santen&title=Aminoglutethimide+Therapy+in+Breast+Cancer%3A+Relationship+of+Blood+Levels+to+Drug-Related+Side+Effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoglutethimide therapy in breast cancer: relationship of blood levels to drug-related side effects</span></div><div class="casAuthors">Demers L M; Boucher A E; Santen R J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical physiology and biochemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">287-91</span>
        ISSN:<span class="NLM_cas:issn">0252-1164</span>.
    </div><div class="casAbstract">Aminoglutethimide (AG) is now an established agent for producing a 'medical adrenalectomy' in patients with breast cancer.  A number of annoying symptoms can occur in some patients placed on this medication.  It has been suggested that the expression of symptoms may be related to the ability of the patient to acetylate AG to N-acetyl aminoglutethimide (NAG).  Using high-pressure liquid chromatography (HPLC), we examined blood levels of AG and NAG in patients with breast cancer and compared the levels to the expression and frequency of drug symptoms. 43% of patients examined were judged to be slow acetylators in that 92% of the drug remained unacetylated irrespective of the dose administered.  There was no significant correlation between acetylator status (rapid vs. slow) and the frequency of drug symptoms noted.  In contrast, there was a significant correlation between the level of AG itself and the frequency of symptoms. 80% of patients with blood levels exceeding 12 mg/l had drug-related symptoms while only 36% of patients with levels below 8 mg/l showed symptoms (chi 2 p less than 0.05). 67% of patients with NAG levels in excess of 4 mg/l had symptoms.  These findings indicate the presence of slow and rapid acetylators of AG in a breast cancer population and the importance of determining blood levels of the drug to minimize the onset of drug-related symptoms in some patients without losing drug efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQge3e1rZyo_LqxQ2mb9Pu8fW6udTcc2eaaSF9vEaHC3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c%252Fgtlaguw%253D%253D&md5=704b5a52a20e0e63cc55e6ceb66761f4</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDemers%26aufirst%3DL.%2BM.%26aulast%3DBoucher%26aufirst%3DA.%2BE.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26atitle%3DAminoglutethimide%2520Therapy%2520in%2520Breast%2520Cancer%253A%2520Relationship%2520of%2520Blood%2520Levels%2520to%2520Drug-Related%2520Side%2520Effects%26jtitle%3DClin.%2520Physiol.%2520Biochem.%26date%3D1987%26volume%3D5%26spage%3D287%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Lawrence, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, T.</span><span> </span><span class="NLM_article-title">Pancytopenia Induced by Aminoglutethimide in the Treatment of Breast Cancer</span> <span class="citation_source-journal">Cancer Treat. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">1583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=213192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaE1M%252FktlGqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1978&pages=1581-1583&author=B.+Lawrenceauthor=R.+J.+Santenauthor=A.+Liptonauthor=H.+A.+Harveyauthor=R.+Hamiltonauthor=T.+Mercurio&title=Pancytopenia+Induced+by+Aminoglutethimide+in+the+Treatment+of+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Pancytopenia induced by aminoglutethimide in the treatment of breast cancer</span></div><div class="casAuthors">Lawrence B; Santen R J; Lipton A; Harvey H A; Hamilton R; Mercurio T</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment reports</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1581-3</span>
        ISSN:<span class="NLM_cas:issn">0361-5960</span>.
    </div><div class="casAbstract">Aminoglutethimide is an investigational agent of proven benefit in the treatment of metastatic breast carcinoma.  We report herein a case of aminoglutethimide-induced pancytopenia complicated by bleeding and gram-negative septicemia.  Severe pancytopenia is a rare but important side effect of this new drug and is rapidly reversible when the agent is withdrawn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPD9Bd3i63RUNoizSOkG_FfW6udTcc2eZLa8x7-NTr_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M%252FktlGqtA%253D%253D&md5=4120e644f01bbd20f84112ac0e5457a4</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DB.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26aulast%3DLipton%26aufirst%3DA.%26aulast%3DHarvey%26aufirst%3DH.%2BA.%26aulast%3DHamilton%26aufirst%3DR.%26aulast%3DMercurio%26aufirst%3DT.%26atitle%3DPancytopenia%2520Induced%2520by%2520Aminoglutethimide%2520in%2520the%2520Treatment%2520of%2520Breast%2520Cancer%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1978%26volume%3D62%26spage%3D1581%26epage%3D1583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Rowell, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowman, P. N.</span><span> </span><span class="NLM_article-title">Aminoglutethimide as Second-Line Hormonal Therapy in Advanced Breast Cancer: Response and Toxicity</span> <span class="citation_source-journal">Hum. Exp. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1177/096032718700600310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1177%2F096032718700600310" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1987&pages=227-232&author=N.+P.+Rowellauthor=O.+J.+Gilmoreauthor=P.+N.+Plowman&title=Aminoglutethimide+as+Second-Line+Hormonal+Therapy+in+Advanced+Breast+Cancer%3A+Response+and+Toxicity&doi=10.1177%2F096032718700600310"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1177%2F096032718700600310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F096032718700600310%26sid%3Dliteratum%253Aachs%26aulast%3DRowell%26aufirst%3DN.%2BP.%26aulast%3DGilmore%26aufirst%3DO.%2BJ.%26aulast%3DPlowman%26aufirst%3DP.%2BN.%26atitle%3DAminoglutethimide%2520as%2520Second-Line%2520Hormonal%2520Therapy%2520in%2520Advanced%2520Breast%2520Cancer%253A%2520Response%2520and%2520Toxicity%26jtitle%3DHum.%2520Exp.%2520Toxicol.%26date%3D1987%26volume%3D6%26spage%3D227%26epage%3D232%26doi%3D10.1177%2F096032718700600310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Lamberts, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruining, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzouk, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderwijk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitterlinden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blijd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackeng, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Jong, F. H.</span><span> </span><span class="NLM_article-title">The New Aromatase Inhibitor CGS-16949A Suppresses Aldosterone and Cortisol Production by Human Adrenal Cells in Vitro</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">896</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span><span class="refDoi"> DOI: 10.1210/jcem-69-4-896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1210%2Fjcem-69-4-896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=2550511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADyaL1MXlvVOhur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1989&pages=896-901&author=S.+W.+Lambertsauthor=H.+A.+Bruiningauthor=H.+Marzoukauthor=J.+Zuiderwijkauthor=P.+Uitterlindenauthor=J.+J.+Blijdauthor=W.+H.+Hackengauthor=F.+H.+De+Jong&title=The+New+Aromatase+Inhibitor+CGS-16949A+Suppresses+Aldosterone+and+Cortisol+Production+by+Human+Adrenal+Cells+in+Vitro&doi=10.1210%2Fjcem-69-4-896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">The new aromatase inhibitor CGS-16949A suppresses aldosterone and cortisol production by human adrenal cells in vitro</span></div><div class="casAuthors">Lamberts, S. W. J.; Bruining, H. A.; Marzouk, H.; Zuiderwijk, J.; Uitterlinden, P.; Blijd, J. J.; Hackeng, W. H. L.; De Jong, F. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">896-901</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">CGS-16949A is a new orally active nonsteroidal aromatase inhibitor which is more than 100-fold more potent than aminoglutethimide.  This compd. is an imidazole deriv., and therefore, its possible effect on cytochrome P 450-dependent enzyme activities in the adrenal gland was evaluated.  In vitro investigations with dispersed normal and hyperplastic human adrenocortical cells showed that CGS-16949A at 10-7-10-6M is a potent 11β-hydroxylase inhibitor, which inhibits ACTH-stimulated cortisol release to a similar extent as an equimolar concn. of metyrapone (IC50 for both compds., 10-7-5 × 10-7M).  Etomidate was a more potent 11 β-hydroxylase inhibitor (IC50, ∼10-8M), while 10-7-10-6M ketoconazole caused (via 17α-hydroxylase inhibition) a similar inhibition of cortisol release as 10-7M CGS-16949A (IC50, 10-7-5 × 10-5M).  The 11β-hydroxylase inhibition by CGS-16949A was accompanied by a dose-dependent increase in the release of precursor steroids by the adrenocortical cells in vitro, including deoxycortisol, 17-hydroxyprogesterone, and androstenedione.  Aldosterone release was suppressed 50% by 10-8M CGS-16949A, while the IC50 for cortisol in the same cells was 10-7M.  Aldosterone release by the dispersed adenoma cells obtained from a patient with primary aldosteronism was also suppressed by CGS-16949A.  It is concluded that the new nonsteroidal aromatase inhibitor CGS 16949A is an inhibitor of 11β-hydroxylase which is equipotent to metyrapone.  At present it is unclear whether the compd. at the dose that causes complete aromatase inhibition in vivo also affects stress-induced cortisol release in man.  Also, CGS-16949A exerts a very potent inhibitory effect on normal aldosterone release (IC50, 10-9M) and on a tumorous aldosterone secretion.  CGS-16949A might, therefore, be a drug that can be used in the treatment of primary hyperaldosteronism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ1wecGffAJLVg90H21EOLACvtfcHk0lgFOmL1a6Vp_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlvVOhur4%253D&md5=9c9846ae461e8242a07d225a8b20ebf6</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1210%2Fjcem-69-4-896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-69-4-896%26sid%3Dliteratum%253Aachs%26aulast%3DLamberts%26aufirst%3DS.%2BW.%26aulast%3DBruining%26aufirst%3DH.%2BA.%26aulast%3DMarzouk%26aufirst%3DH.%26aulast%3DZuiderwijk%26aufirst%3DJ.%26aulast%3DUitterlinden%26aufirst%3DP.%26aulast%3DBlijd%26aufirst%3DJ.%2BJ.%26aulast%3DHackeng%26aufirst%3DW.%2BH.%26aulast%3DDe%2BJong%26aufirst%3DF.%2BH.%26atitle%3DThe%2520New%2520Aromatase%2520Inhibitor%2520CGS-16949A%2520Suppresses%2520Aldosterone%2520and%2520Cortisol%2520Production%2520by%2520Human%2520Adrenal%2520Cells%2520in%2520Vitro%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1989%26volume%3D69%26spage%3D896%26epage%3D901%26doi%3D10.1210%2Fjcem-69-4-896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Falkson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raats, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falkson, H. C.</span><span> </span><span class="NLM_article-title">Fadrozole Hydrochloride, a New Nontoxic Aromatase Inhibitor for the Treatment of Patients with Metastatic Breast Cancer</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span><span class="refDoi"> DOI: 10.1016/0960-0760(92)90202-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1016%2F0960-0760%2892%2990202-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1388048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADyaK38zpvFaqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1992&pages=161-165&author=G.+Falksonauthor=J.+I.+Raatsauthor=H.+C.+Falkson&title=Fadrozole+Hydrochloride%2C+a+New+Nontoxic+Aromatase+Inhibitor+for+the+Treatment+of+Patients+with+Metastatic+Breast+Cancer&doi=10.1016%2F0960-0760%2892%2990202-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Fadrozole hydrochloride, a new nontoxic aromatase inhibitor for the treatment of patients with metastatic breast cancer</span></div><div class="casAuthors">Falkson G; Raats J I; Falkson H C</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of steroid biochemistry and molecular biology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">161-5</span>
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">Eighty previously treated postmenopausal women with metastatic breast cancer were randomized to receive fadrozole (CGS 16 949A), a new aromatase inhibitor, 1 or 4 mg orally per day.  Seventy eight patients were evaluable for toxicity and response.  Only mild to moderate toxicity, namely hot flushes (28%), nausea and vomiting (13%), fatigue (8%) and loss of appetite (5%) occurred.  Complete response was documented in 10% and partial response in 13% of patients with 45% having a no change status for at least 2 months.  The median time to treatment failure is 4.1 months.  The median survival is 23.7 months.  The median survival is 23.7 months.  The response and survival in patients with estrogen receptor positive and estrogen receptor unknown disease were not significantly different.  Neither response nor survival was significantly different between the patients receiving 1 or 4 mg of fadrozole per day.  Fadrozole is a well tolerated, effective second line treatment for women with metastatic breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQx_JTjobezRMScOqQTSkOffW6udTcc2eZLa8x7-NTr_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zpvFaqsQ%253D%253D&md5=13d7616930325ee381d2377ccbe08112</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2892%2990202-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252892%252990202-T%26sid%3Dliteratum%253Aachs%26aulast%3DFalkson%26aufirst%3DG.%26aulast%3DRaats%26aufirst%3DJ.%2BI.%26aulast%3DFalkson%26aufirst%3DH.%2BC.%26atitle%3DFadrozole%2520Hydrochloride%252C%2520a%2520New%2520Nontoxic%2520Aromatase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Patients%2520with%2520Metastatic%2520Breast%2520Cancer%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1992%26volume%3D43%26spage%3D161%26epage%3D165%26doi%3D10.1016%2F0960-0760%2892%2990202-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Lonning, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisler, J.</span><span> </span><span class="NLM_article-title">Experience with Exemestane in the Treatment of Early and Advanced Breast Cancer</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">997</span><span class="refDoi"> DOI: 10.1517/17425255.4.7.987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1517%2F17425255.4.7.987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=18624685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1Chtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=987-997&author=P.+E.+Lonningauthor=J.+Geisler&title=Experience+with+Exemestane+in+the+Treatment+of+Early+and+Advanced+Breast+Cancer&doi=10.1517%2F17425255.4.7.987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Experience with Exemestane in the Treatment of Early and Advanced Breast Cancer</span></div><div class="casAuthors">Lonning, Per Eystein; Geisler, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">987-997</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Exemestane represents the only steroidal third-generation aromatase inactivator implemented for breast cancer therapy.  Present clin. and translational data defining the role of exemestane as an aromatase inhibitor.  Literature search including PubMed and ISI Web of Science.  Exemestane potently inhibits in vivo aromatization resembling anastrozole and letrozole.  Randomized trials have revealed superiority for exemestane compared to conventional therapy in metastatic breast cancer.  In addn. sequential treatment with tamoxifen (for 2-3 years) followed by exemestane (for 3-2 years) has revealed superiority with respect not only to relapse-free but also borderline improvement in overall survival in adjuvant therapy.  Several studies now confirm lack of cross-resistance between non-steroidal aromatase inhibitors and exemestane, which could be due to exemestane's low androgen-agonistic activity through its 17-hydro metabolite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUijZ-l2ISDbVg90H21EOLACvtfcHk0lhi6a4m1Dyiiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1Chtbg%253D&md5=a899115b2d8c6c14f84cbbeeea17ff2c</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1517%2F17425255.4.7.987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.4.7.987%26sid%3Dliteratum%253Aachs%26aulast%3DLonning%26aufirst%3DP.%2BE.%26aulast%3DGeisler%26aufirst%3DJ.%26atitle%3DExperience%2520with%2520Exemestane%2520in%2520the%2520Treatment%2520of%2520Early%2520and%2520Advanced%2520Breast%2520Cancer%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2008%26volume%3D4%26spage%3D987%26epage%3D997%26doi%3D10.1517%2F17425255.4.7.987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">Tominaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabei, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takatsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suwa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, Y.</span><span> </span><span class="NLM_article-title">Double-Blind Randomised Trial Comparing the Non-Steroidal Aromatase Inhibitors Letrozole and Fadrozole in Postmenopausal Women with Advanced Breast Cancer</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1093/annonc/mdg014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=10.1093%2Fannonc%2Fmdg014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=12488294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;key=1%3ACAS%3A280%3ADC%252BD38jisFersA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=62-70&author=T.+Tominagaauthor=I.+Adachiauthor=Y.+Sasakiauthor=T.+Tabeiauthor=T.+Ikedaauthor=Y.+Takatsukaauthor=M.+Toiauthor=T.+Suwaauthor=Y.+Ohashi&title=Double-Blind+Randomised+Trial+Comparing+the+Non-Steroidal+Aromatase+Inhibitors+Letrozole+and+Fadrozole+in+Postmenopausal+Women+with+Advanced+Breast+Cancer&doi=10.1093%2Fannonc%2Fmdg014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer</span></div><div class="casAuthors">Tominaga T; Adachi I; Sasaki Y; Tabei T; Ikeda T; Takatsuka Y; Toi M; Suwa T; Ohashi Y</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology / ESMO</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-70</span>
        ISSN:<span class="NLM_cas:issn">0923-7534</span>.
    </div><div class="casAbstract">BACKGROUND:  To compare the efficacy, safety and tolerability of letrozole, an advanced non-steroidal aromatase inhibitor, and fadrozole hydrochloride, an older-generation drug in this class, we conducted a randomised double-blind trial in postmenopausal women with advanced breast cancer.  PATIENTS AND METHODS:  One hundred and fifty-seven postmenopausal women with advanced breast cancer were enrolled and randomly assigned to receive letrozole or fadrozole in a multicentre, randomised double-blind trial in Japan.  One hundred and fifty-four eligible patients were treated with either letrozole 1.0 mg once daily (n = 77) or fadrozole 1.0 mg twice daily (n = 77), for a minimum of 8 weeks.  RESULTS:  Letrozole showed a significantly higher overall objective response rate [complete response (CR) + partial response (PR)] than fadrozole (31.2% and 13.0%, respectively; P = 0.011, Fisher's exact test).  Clinical benefits defined as CR, PR and stable disease (no change in status for more than 24 weeks) were also higher in patients treated with letrozole (50.6%) than fadrozole (35.1%).  Letrozole was significantly superior to fadrozole in terms of the dominant lesion in soft tissue, bone and viscera (P = 0.011, stratified Mantel-Haenszel test).  Median time to progression was 211 days in the letrozole group and 113 days in the fadrozole group with no significant difference (P = 0.175, log-rank test).  Letrozole markedly reduced the estradiol, estrone and estrone sulfate levels in peripheral blood within 4 weeks.  The suppressive effect of fadrozole on these hormone levels was insufficient.  Adverse drug reactions were observed in 35.9% of the patients treated with letrozole and in 39.5% of those treated with fadrozole with no significant difference between the two groups (P = 0.74, Fisher's exact test).  Most of the adverse drug reactions were rated as grade 1 or 2.  CONCLUSIONS:  The results show letrozole at a dose of 1.0 mg once daily to be more effective in treating postmenopausal women with advanced breast cancer than fadrozole at 1.0 mg twice daily, with similar safety and tolerability profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_Erb0Sv4o2JWtyewyzkyLfW6udTcc2ebeIW7Lq3lNkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jisFersA%253D%253D&md5=851a6d688f240d4ea8fa34e28f44ab8b</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdg014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdg014%26sid%3Dliteratum%253Aachs%26aulast%3DTominaga%26aufirst%3DT.%26aulast%3DAdachi%26aufirst%3DI.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DTabei%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DT.%26aulast%3DTakatsuka%26aufirst%3DY.%26aulast%3DToi%26aufirst%3DM.%26aulast%3DSuwa%26aufirst%3DT.%26aulast%3DOhashi%26aufirst%3DY.%26atitle%3DDouble-Blind%2520Randomised%2520Trial%2520Comparing%2520the%2520Non-Steroidal%2520Aromatase%2520Inhibitors%2520Letrozole%2520and%2520Fadrozole%2520in%2520Postmenopausal%2520Women%2520with%2520Advanced%2520Breast%2520Cancer%26jtitle%3DAnn.%2520Oncol.%26date%3D2003%26volume%3D14%26spage%3D62%26epage%3D70%26doi%3D10.1093%2Fannonc%2Fmdg014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01281&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-11%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01281%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01281" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b83a7cb3a3c82","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
